0000200406-19-000009.txt : 20190220 0000200406-19-000009.hdr.sgml : 20190220 20190220164034 ACCESSION NUMBER: 0000200406-19-000009 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 144 CONFORMED PERIOD OF REPORT: 20181230 FILED AS OF DATE: 20190220 DATE AS OF CHANGE: 20190220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 19618842 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 10-K 1 form10-k20181230.htm 10-K 2018 Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 30, 2018
Commission file number 1-3215
JOHNSON & JOHNSON
(Exact name of registrant as specified in its charter)
New Jersey
 
22-1024240
(State of incorporation)
 
(I.R.S. Employer Identification No.)
One Johnson & Johnson Plaza
New Brunswick, New Jersey
 
08933
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (732) 524-0400
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each class
 
Name of each exchange on which registered
Common Stock, Par Value $1.00
 
New York Stock Exchange
4.75% Notes Due November 2019
 
New York Stock Exchange
0.250% Notes Due January 2022
 
New York Stock Exchange
0.650% Notes Due May 2024
 
New York Stock Exchange
5.50% Notes Due November 2024
 
New York Stock Exchange
1.150% Notes Due November 2028
 
New York Stock Exchange
1.650% Notes Due May 2035
 
New York Stock Exchange
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes þ     No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.  Yes o     No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes þ     No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   o 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer þ
 
Accelerated filer o
 
 
Non-accelerated filer o
 
Smaller reporting company o
 
 
Emerging growth company o
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o     No þ


The aggregate market value of the Common Stock held by non-affiliates computed by reference to the price at which the Common Stock was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter was approximately $325 billion.
On February 15, 2019, there were 2,663,138,579 shares of Common Stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Parts I and III:
Portions of registrant’s proxy statement for its 2019 annual meeting of shareholders filed within 120 days after the close of the registrant’s fiscal year (the "Proxy Statement"), are incorporated by reference to this report on Form 10-K (this "Report").



Item
 
Page
 
 
 
1
 
 
 
 
 
 
 
 
 
 
 
1A.
1B.
2
3
4
 
 
5
6
7
7A.
8
9
9A.
9B.
 
10
11
12
13
14
 
15
16
 
 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS




This Annual Report on Form 10-K and Johnson & Johnson's other publicly available documents contain "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Management and representatives of Johnson & Johnson and its subsidiaries (the "Company") also may from time to time make forward-looking statements. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning in conjunction with, among other things: discussions of future operations; expected operating results and financial performance; impact of planned acquisitions and dispositions; the Company’s strategy for growth; product development; regulatory approvals; market position and expenditures.

Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of the Company's control. Investors should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, the Company’s actual results and financial condition could vary materially from expectations and projections expressed or implied in its forward-looking statements. Investors are therefore cautioned not to rely on these forward-looking statements. Risks and uncertainties include, but are not limited to:

Risks Related to Product Development, Market Success and Competition
•
Challenges and uncertainties inherent in innovation and development of new and improved products and technologies on which the Company’s continued growth and success depend, including uncertainty of clinical outcomes, additional analysis of existing clinical data, obtaining regulatory approvals, health plan coverage and customer access, and initial and continued commercial success;
•
Challenges to the Company’s ability to obtain and protect adequate patent and other intellectual property rights for new and existing products and technologies in the United States and other important markets;
•
The impact of patent expirations, typically followed by the introduction of competing biosimilars and generics and resulting revenue and market share losses;
•
Increasingly aggressive and frequent challenges to the Company’s patents by competitors and others seeking to launch competing generic, biosimilar or other products and increased receptivity of courts, the United States Patent and Trademark Office and other decision makers to such challenges, potentially resulting in loss of market exclusivity and rapid decline in sales for the relevant product sooner than expected;
•
Competition in research and development of new and improved products, processes and technologies, which can result in product and process obsolescence;
•
Competition to reach agreement with third parties for collaboration, licensing, development and marketing agreements for products and technologies;
•
Competition based on cost-effectiveness, product performance, technological advances and patents attained by competitors; and
•
Allegations that the Company’s products infringe the patents and other intellectual property rights of third parties, which could adversely affect the Company’s ability to sell the products in question and require the payment of money damages and future royalties.
Risks Related to Product Liability, Litigation and Regulatory Activity
•
Product efficacy or safety concerns, whether or not based on scientific evidence, potentially resulting in product withdrawals, recalls, regulatory action on the part of the United States Food and Drug Administration (or international counterparts), declining sales, reputational damage, increased litigation expense and share price impact;
•
Impact, including declining sales and reputational damage, of significant litigation or government action adverse to the Company, including product liability claims and allegations related to pharmaceutical marketing practices and contracting strategies;
•
Impact of an adverse judgment or settlement and the adequacy of reserves related to legal proceedings, including patent litigation, product liability, personal injury claims, securities class actions, government investigations, employment and other legal proceedings;
•
Increased scrutiny of the health care industry by government agencies and state attorneys general resulting in investigations and prosecutions, which carry the risk of significant civil and criminal penalties, including, but not limited to, debarment from government business;



•
Failure to meet compliance obligations in the McNEIL-PPC, Inc. Consent Decree or any other compliance agreements with governments or government agencies, which could result in significant sanctions;
•
Potential changes to applicable laws and regulations affecting United States and international operations, including relating to: approval of new products; licensing and patent rights; sales and promotion of health care products; access to, and reimbursement and pricing for, health care products and services; environmental protection and sourcing of raw materials;
•
Compliance with local regulations and laws that may restrict the Company’s ability to manufacture or sell its products in relevant markets including, requirements to comply with medical device reporting regulations and other requirements such as the European Union's Medical Devices Regulation;
•
Changes in domestic and international tax laws and regulations, including changes related to The Tax Cuts and Jobs Act in the United States, the Federal Act on Tax Reform and AHV Financing in Switzerland, increasing audit scrutiny by tax authorities around the world and exposures to additional tax liabilities potentially in excess of existing reserves; and
•
Issuance of new or revised accounting standards by the Financial Accounting Standards Board and regulations by the Securities and Exchange Commission.
Risks Related to the Company’s Strategic Initiatives and Healthcare Market Trends
•
Pricing pressures resulting from trends toward health care cost containment, including the continued consolidation among health care providers and other market participants, trends toward managed care, the shift toward governments increasingly becoming the primary payers of health care expenses, significant new entrants to the health care markets seeking to reduce costs and government pressure on companies to voluntarily reduce costs and price increases;
•
Restricted spending patterns of individual, institutional and governmental purchasers of health care products and services due to economic hardship and budgetary constraints;
•
Challenges to the Company’s ability to realize its strategy for growth including through externally sourced innovations, such as development collaborations, strategic acquisitions, licensing and marketing agreements, and the potential heightened costs of any such external arrangements due to competitive pressures;
•
The potential that the expected strategic benefits and opportunities from any planned or completed acquisition or divestiture by the Company may not be realized or may take longer to realize than expected; and
•
The potential that the expected benefits and opportunities related to past and ongoing restructuring actions may not be realized or may take longer to realize than expected.
Risks Related to Economic Conditions, Financial Markets and Operating Internationally
•
Market conditions and the possibility that the Company’s share repurchase program may be delayed, suspended or discontinued;
•
Impact of inflation and fluctuations in interest rates and currency exchange rates and the potential effect of such fluctuations on revenues, expenses and resulting margins;
•
Potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs and potential drug reimportation legislation;
•
The impact on international operations from financial instability in international economies, sovereign risk, possible imposition of governmental controls and restrictive economic policies, and unstable international governments and legal systems;
•
Changes to global climate, extreme weather and natural disasters that could affect demand for the Company's products and services, cause disruptions in manufacturing and distribution networks, alter the availability of goods and services within the supply chain, and affect the overall design and integrity of the Company's products and operations; and
•
The impact of armed conflicts and terrorist attacks in the United States and other parts of the world including social and economic disruptions and instability of financial and other markets.
Risks Related to Supply Chain and Operations
•
Difficulties and delays in manufacturing, internally through third party providers or otherwise within the supply chain, that may lead to voluntary or involuntary business interruptions or shutdowns, product shortages, withdrawals or suspensions of products from the market, and potential regulatory action;
•
Interruptions and breaches of the Company's information technology systems or those of the Company's vendors which, could result in reputational, competitive, operational or other business harm as well as financial costs and regulatory action;



•
Reliance on global supply chains and production and distribution processes that are complex and subject to increasing regulatory requirements that may adversely affect supply, sourcing and pricing of materials used in the Company’s products; and
•
The potential that the expected benefits and opportunities related to restructuring actions contemplated for the global supply chain may not be realized or may take longer to realize than expected, including due to any required approvals from applicable regulatory authorities. Disruptions associated with the announced global supply chain actions may adversely affect supply and sourcing of materials used in the Company's products.
Investors also should carefully read the Risk Factors described in Item 1A of this Annual Report on Form 10-K for a description of certain risks that could, among other things, cause the Company’s actual results to differ materially from those expressed in its forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above and in Item 1A to be a complete statement of all potential risks and uncertainties. The Company does not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments.


PART I
Item 1.
BUSINESS
General
Johnson & Johnson and its subsidiaries (the Company) have approximately 135,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 260 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
The Executive Committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of the resources of the Company. This Committee oversees and coordinates the activities of the Company's three business segments: Consumer, Pharmaceutical and Medical Devices. Within the strategic parameters provided by the Committee, senior management groups at U.S. and international operating companies are each responsible for their own strategic plans and the day-to-day operations of those companies. Each subsidiary within the business segments is, with limited exceptions, managed by residents of the country where located.
Segments of Business
The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. Additional information required by this item is incorporated herein by reference to the narrative and tabular descriptions of segments and operating results under: “Item 7. Management’s Discussion and Analysis of Results of Operations and Financial Condition” of this Report; and Note 18 “Segments of Business and Geographic Areas” of the Notes to Consolidated Financial Statements included in Item 8 of this Report.
Consumer
The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. Baby Care includes the JOHNSON’S® line of products. Oral Care includes the LISTERINE® product line. Major brands in Beauty include the AVEENO®; CLEAN & CLEAR®; DABAO™; JOHNSON’S® Adult; LE PETITE MARSEILLAIS®; NEUTROGENA® and OGX® product lines. Over-the-counter medicines include the broad family of TYLENOL® acetaminophen products; SUDAFED® cold, flu and allergy products; BENADRYL® and ZYRTEC® allergy products; MOTRIN® IB ibuprofen products; and the PEPCID® line of acid reflux products. Major brands in Women’s Health outside of North America are STAYFREE® and CAREFREE® sanitary pads and o.b.® tampon brands. Wound Care brands include the BAND-AID® Brand Adhesive Bandages and NEOSPORIN® First Aid product lines. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world.
Pharmaceutical
The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases and Vaccines (e.g., HIV/AIDS), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer and hematologic malignancies), Cardiovascular and Metabolism (e.g., thrombosis and diabetes) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. Key products in the Pharmaceutical segment include: REMICADE® (infliximab), a treatment for a number of immune-mediated inflammatory diseases; SIMPONI® (golimumab), a subcutaneous treatment for adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis and moderately active to severely active ulcerative colitis; SIMPONI ARIA® (golimumab), an intravenous treatment for adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis and active ankylosing spondylitis; STELARA® (ustekinumab), a treatment for adults and children with moderate to severe plaque psoriasis, for adults with active psoriatic arthritis, and for adults with moderately to severely active Crohn's disease; TREMFYA® (guselkumab), a treatment for adults with moderate to severe plaque psoriasis; EDURANT® (rilpivirine), INTELENCE® (etravirine), PREZISTA® (darunavir) and PREZCOBIX®/REZOLSTA® (darunavir/cobicistat), antiretroviral medicines for the treatment of human immunodeficiency virus (HIV-1) in combination with other antiretroviral products and SYMTUZA® ( darunavir/cobicistat/emtricitabine/tenofovir alafenamide), a once-daily single tablet regimen for the treatment of HIV ; CONCERTA® (methylphenidate HCl) extended-release tablets CII, a treatment for attention deficit hyperactivity disorder; INVEGA SUSTENNA®/XEPLION® (paliperidone palmitate), for the treatment of schizophrenia and schizoaffective disorder in adults; INVEGA TRINZA®/TREVICTA® (paliperidone palmitate), for the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA® for at least four months; RISPERDAL CONSTA® (risperidone long-acting injection), for the treatment of schizophrenia and the maintenance treatment of Bipolar 1 Disorder in adults; ZYTIGA® (abiraterone acetate), a treatment for metastatic castration-

                
 
1
                                

resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer; IMBRUVICA® (ibrutinib), a treatment for certain B-cell malignancies, or blood cancers, chronic graft versus host disease and Waldenström's Macroglobulinemia; DARZALEX® (daratumumab), a treatment for relapsed/refractory multiple myeloma; VELCADE® (bortezomib), a treatment for multiple myeloma mantle cell lymphoma; PROCRIT®/EPREX® (epoetin alfa), a treatment for chemotherapy-induced anemia and patients with chronic kidney disease; XARELTO® (rivaroxaban), an oral anticoagulant for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in patients undergoing hip or knee replacement surgery, to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and for the treatment and reduction of risk of recurrence of DVT and PE; INVOKANA® (canagliflozin), for the treatment of adults with type 2 diabetes; INVOKAMET®/VOKANAMET® (canagliflozin/metformin HCl), a combination therapy of fixed doses of canagliflozin and metformin hydrochloride for the treatment of adults with type 2 diabetes; and INVOKAMET® XR (canagliflozin/metformin hydrochloride extended-release), a once-daily, fixed-dose combination therapy of canagliflozin and metformin hydrochloride extended-release, for the treatment of adults with type 2 diabetes; OPSUMIT® (macitentan) as monotherapy or in combination, indicated for the long-term treatment of pulmonary arterial hypertension (PAH); UPTRAVI® (selexipag), the only approved oral, selective IP receptor agonist targeting a prostacyclin pathway in PAH. Many of these medicines were developed in collaboration with strategic partners or are licensed from other companies and maintain active lifecycle development programs.
Medical Devices
The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular), diabetes care (divested in the fiscal fourth quarter of 2018) and eye health fields. These products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. They include orthopaedic products; general surgery, biosurgical, endomechanical and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; and vision products such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery.
Geographic Areas
The business of Johnson & Johnson is conducted by more than 260 operating companies located in more than 60 countries, including the U.S., which sell products in virtually all countries throughout the world. The products made and sold in the international business include many of those described above under “– Segments of Business – Consumer,” “– Pharmaceutical” and “– Medical Devices.” However, the principal markets, products and methods of distribution in the international business vary with the country and the culture. The products sold in international business include those developed in the U.S. and by subsidiaries abroad.
Investments and activities in some countries outside the U.S. are subject to higher risks than comparable U.S. activities because the investment and commercial climate may be influenced by financial instability in international economies, restrictive economic policies and political and legal system uncertainties.
Raw Materials
Raw materials essential to the Company's business are generally readily available from multiple sources. Where there are exceptions, the temporary unavailability of those raw materials would not likely have a material adverse effect on the financial results of the Company.
Patents
The Company's subsidiaries have made a practice of obtaining patent protection on their products and processes where possible. They own, or are licensed under, a significant number of patents in the U.S. and other countries relating to their products, product uses, formulations and manufacturing processes, which in the aggregate are believed to be of material importance to the Company in the operation of its businesses. The Company’s subsidiaries face patent challenges from third parties, including challenges seeking to manufacture and market generic and biosimilar versions of the Company's key pharmaceutical products prior to expiration of the applicable patents covering those products. Significant legal proceedings and claims involving the Company's patent and other intellectual property are described in Note 21, “Legal Proceedings—Intellectual Property” of the Notes to Consolidated Financial Statements included in Item 8 of this Report.
Sales of the Company’s 2nd largest product, STELARA® (ustekinumab), accounted for approximately 6.3% of the Company's total revenues for fiscal 2018. Accordingly, the patents related to this product are believed to be material to the Company.
There is one set of granted patents related specifically to STELARA®. This set of patents is owned by Janssen Biotech, Inc., a wholly-owned subsidiary of Johnson & Johnson. These patents are in force in the U.S. and many countries outside the

                
 
2
                                

United States. In the U.S., the latest projected expiration date for patents in this set is 2023 due to a patent term extension. In Europe, the latest projected expiration date for patents in this set is 2024 due to a Supplemental Patent Certificate (patent term extension). In most other countries, the latest projected expiration date is 2021.
In addition to competing in the immunology market with STELARA®, the Company is currently marketing SIMPONI® (golimumab) and SIMPONI ARIA® (golimumab), next generation immunology products with remaining patent lives of up to six years. The Company also markets REMICADE® (infliximab) in the immunology market which is the Company’s largest product. Patents on this product have expired and the Food and Drug Administration approved the first infliximab biosimilar for sale in the U.S. in 2016, and a number of such products have been launched since then. For a more extensive description of legal matters regarding the patents related to REMICADE®, see Note 21 “Legal Proceedings - Intellectual Property - Pharmaceutical - REMICADE® Related Cases” of the Notes to Consolidated Financial Statements included in Item 8 of this Report.

Trademarks
The Company’s subsidiaries have made a practice of selling their products under trademarks and of obtaining protection for these trademarks by all available means. These trademarks are protected by registration in the U.S. and other countries where such products are marketed. The Company considers these trademarks in the aggregate to be of material importance in the operation of its businesses.
Seasonality
Worldwide sales do not reflect any significant degree of seasonality; however, spending has been heavier in the fourth quarter of each year than in other quarters. This reflects increased spending decisions, principally for advertising and research and development activity.
Competition
In all of their product lines, the Company's subsidiaries compete with companies both locally and globally. Competition exists in all product lines without regard to the number and size of the competing companies involved. Competition in research, both internally and externally sourced, involving the development and the improvement of new and existing products and processes, is particularly significant. The development of new and innovative products, as well as protecting the underlying intellectual property of the Company’s product portfolio, is important to the Company's success in all areas of its business. The competitive environment requires substantial investments in continuing research. In addition, the development and maintenance of customer demand for the Company’s consumer products involve significant expenditures for advertising and promotion.
Environment
The Company is subject to a variety of U.S. and international environmental protection measures. The Company believes that its operations comply in all material respects with applicable environmental laws and regulations. The Company’s compliance with these requirements did not change during the past year, and is not expected to have a material effect upon its capital expenditures, cash flows, earnings or competitive position.
Regulation
The Company’s businesses are subject to varying degrees of governmental regulation in the countries in which operations are conducted, and the general trend is toward increasingly stringent regulation. In the U.S., the drug, device and cosmetic industries have long been subject to regulation by various federal and state agencies, primarily as to product safety, efficacy, manufacturing, advertising, labeling and safety reporting. The exercise of broad regulatory powers by the U.S. Food and Drug Administration (the FDA) continues to result in increases in the amounts of testing and documentation required for FDA approval of new drugs and devices and a corresponding increase in the expense of product introduction. Similar trends are also evident in major markets outside of the U.S. The new medical device regulatory framework and the new privacy regulations in Europe are examples of such increased regulation.
The costs of human health care have been and continue to be a subject of study, investigation and regulation by governmental agencies and legislative bodies around the world. In the U.S., attention has been focused on drug prices and profits and programs that encourage doctors to write prescriptions for particular drugs, or to recommend, use or purchase particular medical devices. Payers have become a more potent force in the market place and increased attention is being paid to drug and medical device pricing, appropriate drug and medical device utilization and the quality and costs of health care generally.

                
 
3
                                

U.S. government agencies continue to implement the extensive requirements of the Patient Protection and Affordable Care Act (the ACA). These have both positive and negative impacts on the U.S. healthcare industry with much remaining uncertain as to how various provisions of the ACA, and potential modification or repeal of ACA provisions, will ultimately affect the industry.
The regulatory agencies under whose purview the Company operates have administrative powers that may subject it to actions such as product withdrawals, recalls, seizure of products and other civil and criminal sanctions. In some cases, the Company’s subsidiaries may deem it advisable to initiate product recalls.
In addition, business practices in the health care industry have come under increased scrutiny, particularly in the U.S., by government agencies and state attorneys general, and resulting investigations and prosecutions carry the risk of significant civil and criminal penalties.
Further, the Company relies on global supply chains, and production and distribution processes, that are complex, are subject to increasing regulatory requirements, and may be faced with unexpected changes such as those resulting from Brexit, that may affect sourcing, supply and pricing of materials used in the Company's products. These processes also are subject to lengthy regulatory approvals.
Available Information
The Company’s main corporate website address is www.jnj.com. All of the Company’s SEC filings are also available on the Company’s website at www.investor.jnj.com/sec.cfm, as soon as reasonably practicable after having been electronically filed or furnished to the SEC. All SEC filings are also available at the SEC’s website at www.sec.gov. In addition, the written charters of the Audit Committee, the Compensation & Benefits Committee, the Nominating & Corporate Governance Committee, the Regulatory Compliance Committee and the Science, Technology & Sustainability Committee of the Board of Directors and the Company’s Principles of Corporate Governance, Code of Business Conduct (for employees), Code of Business Conduct & Ethics for Members of the Board of Directors and Executive Officers, and other corporate governance materials, are available at www.investor.jnj.com/gov.cfm on the Company's website and will be provided without charge to any shareholder submitting a written request, as provided above. The information on the Company’s website is not, and will not be deemed, a part of this Report or incorporated into any other filings the Company makes with the SEC.

                
 
4
                                

Item 1A.
RISK FACTORS
The Company faces a number of uncertainties and risks that are difficult to predict and many of which are outside of the Company's control. In addition to the other information in this report and the Company’s other filings with the SEC, investors should consider carefully the factors set forth below. Investors should be aware that it is not possible to predict or identify all such factors and that the following is not meant to be a complete discussion of all potential risks or uncertainties. If known or unknown risks or uncertainties materialize, the Company’s business, results of operations or financial condition could be adversely affected, potentially in a material way.
Global sales in the Company’s pharmaceutical and medical devices segments may be negatively impacted by healthcare reforms and increasing pricing pressures.
Sales of the Company’s pharmaceutical and medical device products are significantly affected by reimbursements by third-party payers such as government healthcare programs, private insurance plans and managed care organizations. As part of various efforts to contain healthcare costs, these payers are putting downward pressure on prices at which products will be reimbursed. In the U.S., increased purchasing power of entities that negotiate on behalf of Medicare, Medicaid, and private sector beneficiaries, in part due to continued consolidation among health care providers, could result in further pricing pressures. In addition, increased political scrutiny could result in additional pricing pressures. Outside the U.S., numerous major markets, including the EU and Japan, have pervasive government involvement in funding healthcare and, in that regard, directly or indirectly impose price controls, limit access to, or reimbursement for, the Company’s products, or reduce the value of its intellectual property protection.
The Company is subject to significant legal proceedings that can result in significant expenses, fines and reputational damage.
In the ordinary course of business, Johnson & Johnson and its subsidiaries are subject to numerous claims and lawsuits involving various issues such as patent disputes, product liability and claims that their product sales, marketing and pricing practices violate various antitrust, unfair trade practices and/or consumer protection laws. The most significant of these proceedings are described in Note 21, “Legal Proceedings” under Notes to the Consolidated Financial Statements included in Item 8 of this Report. While the Company believes it has substantial defenses in these matters, it is not feasible to predict the ultimate outcome of litigation. The Company could in the future be required to pay significant amounts as a result of settlements or judgments in these matters, potentially in excess of accruals, including matters where the Company could be held jointly and severally liable among other defendants. The resolution of, or increase in accruals for, one or more of these matters in any reporting period could have a material adverse effect on the Company's results of operations and cash flows for that period. Furthermore, as a result of cost and availability factors, effective November 1, 2005, the Company ceased purchasing third-party product liability insurance.
Product reliability, safety and effectiveness concerns can have significant negative impacts on sales and results of operations, lead to litigation and cause reputational damage.
Concerns about product safety, whether raised internally or by litigants, regulators or consumer advocates, and whether or not based on scientific evidence, can result in safety alerts, product recalls, governmental investigations, regulatory action on the part of the FDA (or its counterpart in other countries), private claims and lawsuits, payment of fines and settlements, declining sales and reputational damage. These circumstances can also result in damage to brand image, brand equity and consumer trust in the Company’s products. Product recalls have in the past, and could in the future, prompt government investigations and inspections, the shutdown of manufacturing facilities, continued product shortages and related sales declines, significant remediation costs, reputational damage, possible civil penalties and criminal prosecution.
Changes in tax laws or exposures to additional tax liabilities could negatively impact the Company’s operating results.
Changes in tax laws or regulations around the world could negatively impact the Company’s effective tax rate and results of operations. A change in statutory tax rate in any country would result in the revaluation of the Company’s deferred tax assets and liabilities related to that particular jurisdiction in the period in which the new tax law is enacted. This change would result in an expense or benefit recorded to the Company’s Consolidated Statement of Earnings. The Company closely monitors these proposals as they arise in the countries where it operates. Changes to the statutory tax rate may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted.

On December 22, 2017, the U.S. enacted The Tax Cuts and Jobs Act (the TCJA), which introduced significant changes to U.S. corporate income tax law that will have a meaningful impact on the Company’s provision for income taxes. Accounting for the income tax effects of the TCJA requires significant judgments to be made in interpreting its provisions. Anticipated guidance from the U.S. Treasury about implementing the TCJA, which should be final by June 22, 2019 (18 months after enactment),

                
 
5
                                

may result in adjustments that could materially affect the Company’s financial position and results of operations as well as the effective tax rate in the period in which the adjustments are made.

On September 28, 2018, the Swiss Parliament approved the Federal Act on Tax Reform and AHV Financing (Swiss Tax Reform). However, a referendum has been called and, as a result, a public vote on the Swiss Tax Reform will take place on May 19th, 2019. If the Swiss Tax Reform passes, then the measures are expected to come into force in either January 2020 or January 2021. Prior to approval in the referendum and its subsequent cantonal implementation, the proposed Swiss Tax Reform is not enacted and therefore the Company has not reflected any of the potential impacts in its fiscal results. The Company is currently assessing the impact of the proposed Swiss Tax Reform, and when enacted, the law may have a material impact on the Company’s operating results. 

The Company conducts business and files tax returns in numerous countries and is addressing tax audits and disputes with many tax authorities. In connection with the Organization for Economic Cooperation and Development Base Erosion and Profit Shifting (BEPS) project, companies are required to disclose more information to tax authorities on operations around the world, which may lead to greater audit scrutiny of profits earned in other countries. The Company regularly assesses the likely outcomes of its tax audits and disputes to determine the appropriateness of its tax reserves. However, any tax authority could take a position on tax treatment that is contrary to the Company’s expectations, which could result in tax liabilities in excess of reserves.

The Company may not be able to successfully secure and defend intellectual property rights essential to the Company’s businesses.
The Company owns or licenses a significant number of patents and other proprietary rights, determined by patent offices, courts and lawmakers in various countries, relating to its products and manufacturing processes. These rights are essential to the Company’s businesses and materially important to the Company’s results of operations. Public policy, both within and outside the U.S., has become increasingly unfavorable toward intellectual property rights. The Company cannot be certain that it will obtain adequate patent protection for new products and technologies in the U.S. and other important markets or that such protections, once granted, will last as long as originally anticipated.
Competitors routinely challenge the validity or extent of the Company’s owned or licensed patents and proprietary rights through litigation, interferences, oppositions and other proceedings. These proceedings absorb resources and can be protracted as well as unpredictable. In addition, challenges that the Company’s products infringe the patents of third parties could result in the need to pay past damages and future royalties and adversely affect the competitive position and sales of the products in question.
The Company has faced increasing patent challenges from third parties seeking to manufacture and market generic and biosimilar versions of the Company's key pharmaceutical products prior to expiration of the applicable patents covering those products. In the U.S., manufacturers of generic versions of innovative human pharmaceutical products may challenge the validity, or claim non-infringement, of innovator products through the Abbreviated New Drug Application, or ANDA, process with the FDA. The Biologics Price Competition and Innovation Act (BPCIA), enacted in 2010, which created a new regulatory pathway for the approval by the FDA of biosimilar alternatives to innovator-developed biological products, also created mechanisms for biosimilar applicants to challenge the patents on the innovator biologics. The inter partes review (IPR) process with the USPTO, created under the 2011 America Invents Act, is also being used by competitors to challenge patents held by the Company’s subsidiaries.
In the event the Company is not successful in defending its patents against such challenges, or upon the “at-risk” launch (despite pending patent infringement litigation) by the generic or biosimilar firm of its product, the Company can lose a major portion of revenues for the referenced product in a very short period of time. Current legal proceedings involving the Company’s patents and other intellectual property rights are described in Note 21, “Legal Proceedings—Intellectual Property” of the Notes to the Consolidated Financial Statements included in Item 8 of this Report.
The Company’s businesses operate in highly competitive product markets and competitive pressures could adversely affect the Company’s earnings.
The Company faces substantial competition in all three operating segments and in all geographic markets. The Company’s businesses compete with companies of all sizes on the basis of cost-effectiveness, technological innovations, intellectual property rights, product performance, real or perceived product advantages, pricing and availability and rate of reimbursement. The Company also competes with other market participants in securing rights to acquisitions, collaborations and licensing agreements with third parties. Competition for rights to product candidates and technologies may result in significant investment and acquisition costs and onerous agreement terms for the Company. Competitors’ development of more effective or

                
 
6
                                

less costly products, and/or their ability to secure patent and other intellectual property rights and successfully market products ahead of the Company, could negatively impact sales of the Company’s existing products as well as its ability to bring new products to market despite significant prior investment in the related product development.
For the Company’s pharmaceutical businesses, loss of patent exclusivity for a product often is followed by a substantial reduction in sales as competitors gain regulatory approval for generic and other competing products and enter the market. Similar competition can be triggered by the loss of exclusivity for a biological product. For the Company’s medical device businesses, technological innovation, product quality, reputation and customer service are especially important to competitiveness. Development by other companies of new or improved products, processes and technologies could threaten to make the Company’s products or technologies less desirable, less economical or obsolete. The Company’s consumer businesses face intense competition from other branded products and retailers’ private-label brands. If the Company fails to sufficiently differentiate and market its brand name consumer products, this could adversely affect revenues and profitability of those products.
Significant challenges or delays in the Company’s innovation and development of new products, technologies and indications could have an adverse impact on the Company’s long-term success.
The Company’s continued growth and success depends on its ability to innovate and develop new and differentiated products and services that address the evolving health care needs of patients, providers and consumers. Development of successful products and technologies is also necessary to offset revenue losses when the Company’s existing products lose market share due to various factors such as competition and loss of patent exclusivity. New products introduced within the past five years accounted for approximately 25% of 2018 sales. The Company cannot be certain when or whether it will be able to develop, license or otherwise acquire companies, products and technologies, whether particular product candidates will be granted regulatory approval, and, if approved, whether the products will be commercially successful.
The Company pursues product development through internal research and development as well as through collaborations, acquisitions, joint ventures and licensing or other arrangements with third parties. In all of these contexts, developing new products, particularly pharmaceutical and biotechnology products and medical devices, requires significant investment of resources over many years. Only a very few biopharmaceutical research and development programs result in commercially viable products. The process depends on many factors including the ability to discern patients’ and health care providers’ future needs; develop promising new compounds, strategies and technologies; achieve successful clinical trial results; secure effective intellectual property protection; obtain regulatory approvals on a timely basis; and, if and when they reach the market, successfully differentiate the Company’s products from competing products and approaches to treatment. New products or enhancements to existing products may not be accepted quickly or significantly in the marketplace due to product and price competition, changes in customer preferences or healthcare purchasing patterns, resistance by healthcare providers or uncertainty over third-party reimbursement. Even following initial regulatory approval, the success of a product can be adversely impacted by safety and efficacy findings in larger real world patient populations, as well as market entry of competitive products.
The Company faces increasing regulatory scrutiny which imposes significant compliance costs and exposes the Company to government investigations, legal actions and penalties.
Like other companies in the healthcare industry, the Company is subject to extensive regulation, investigations and legal action, by national, state and local government agencies in the U.S. and other countries in which they operate. Regulatory issues regarding compliance with Good Manufacturing Practices (cGMP) (and comparable quality regulations in foreign countries) by manufacturers of drugs, devices and consumer products can lead to fines and penalties, product recalls, product shortages, interruptions in production, delays in new product approvals and litigation. In addition, the marketing, pricing and sale of the Company’s products are subject to regulation, investigations and legal actions including under the Federal Food, Drug, and Cosmetic Act, the Medicaid Rebate Program, federal and state false claims acts, state unfair trade practices acts and consumer protection laws. Increased scrutiny of health care industry business practices in recent years by government agencies and state attorneys general in the U.S., and any resulting investigations and prosecutions, carry risk of significant civil and criminal penalties including, but not limited to, debarment from participation in government healthcare programs. Any such debarment could have a material adverse effect on the Company’s business and results of operations. The most significant current investigations and litigation brought by government agencies are described in Note 21, “Legal Proceedings-Government Proceedings” under Notes to the Consolidated Financial Statements included in Item 8 of this Report.
The Company faces a variety of risks associated with conducting business internationally.
The Company’s extensive operations and business activity outside the U.S. are accompanied by certain financial, economic and political risks, including those listed below.

                
 
7
                                

Foreign Currency Exchange: In fiscal 2018, approximately 49% of the Company’s sales occurred outside of the U.S., with approximately 23% in Europe, 8% in the Western Hemisphere, excluding the U.S., and 18% in the Asia-Pacific and Africa region. Changes in non-U.S. currencies relative to the U.S. dollar impact the Company’s revenues and expenses. While the Company uses financial instruments to mitigate the impact of fluctuations in currency exchange rates on its cash flows, unhedged exposures continue to be subject to currency fluctuations. In addition, the weakening or strengthening of the U.S. dollar may result in significant favorable or unfavorable translation effects when the operating results of the Company’s non-U.S. business activity are translated into U.S. dollars.
Inflation and Currency Devaluation Risks: The Company faces challenges in maintaining profitability of operations in economies experiencing high inflation rates. The Company has accounted for operations in Argentina (beginning in the fiscal third quarter of 2018) and Venezuela as highly inflationary, as the prior three-year cumulative inflation rate surpassed 100%. While the Company strives to maintain profit margins in these areas through cost reduction programs, productivity improvements and periodic price increases, it might experience operating losses as a result of continued inflation. In addition, the impact of currency devaluations in countries experiencing high inflation rates or significant currency exchange fluctuations could negatively impact the Company’s operating results.
Illegal Importation of Pharmaceutical Products: The illegal importation of pharmaceutical products from countries where government price controls or other market dynamics result in lower prices may adversely affect the Company’s sales and profitability in the U.S. and other countries in which the Company operates. With the exception of limited quantities of prescription drugs for personal use, foreign imports of pharmaceutical products are illegal under current U.S. law. However, the volume of illegal imports continues to rise as the ability of patients and other customers to obtain the lower-priced imports has grown significantly.
Anti-Bribery and Other Regulations: The Company is subject to various federal and foreign laws that govern its international business practices with respect to payments to government officials. Those laws include the U.S. Foreign Corrupt Practices Act (FCPA), which prohibits U.S. publicly traded companies from promising, offering, or giving anything of value to foreign officials with the corrupt intent of influencing the foreign official for the purpose of helping the Company obtain or retain business or gain any improper advantage. The Company’s business is heavily regulated and therefore involves significant interaction with foreign officials. Also, in many countries outside the U.S., the health care providers who prescribe human pharmaceuticals are employed by the government and the purchasers of human pharmaceuticals are government entities; therefore, the Company’s interactions with these prescribers and purchasers are subject to regulation under the FCPA. In addition to the U.S. application and enforcement of the FCPA, various jurisdictions in which the Company operates have laws and regulations, including the U.K Bribery Act 2010, aimed at preventing and penalizing corrupt and anticompetitive behavior. Enforcement activities under these laws could subject the Company to additional administrative and legal proceedings and actions, which could include claims for civil penalties, criminal sanctions, and administrative remedies, including exclusion from health care programs.

Other Legal, Social and Political Risks. Other risks inherent in conducting business globally include:
•
protective economic policies taken by governments such as trade protection measures and import/export licensing requirements;
•
compliance with local regulations and laws including, in some countries, regulatory requirements restricting the Company’s ability to manufacture or sell its products in the relevant market;
•
diminished protection of intellectual property and contractual rights in certain jurisdictions;
•
potential nationalization or expropriation of the Company’s foreign assets; and
•
disruptions to markets due to war, armed conflict, terrorism, social upheavals or pandemics.
Interruptions and delays in manufacturing operations could adversely affect the Company’s business, sales and reputation.
The Company’s manufacture of products requires the timely delivery of sufficient amounts of complex, high-quality components and materials. The Company's subsidiaries operate 111 manufacturing facilities as well as sourcing from hundreds of suppliers around the world. The Company has in the past, and may in the future, face unanticipated interruptions and delays in manufacturing through its internal or external supply chain. Manufacturing disruptions can occur for many reasons including regulatory action, production quality deviations or safety issues, labor disputes, site-specific incidents (such as fires), natural disasters such as hurricanes and other severe weather events, raw material shortages, political unrest and terrorist attacks. Such delays and difficulties in manufacturing can result in product shortages, declines in sales and reputational impact as well as significant remediation and related costs associated with addressing the shortage.

                
 
8
                                

The Company relies on third parties to manufacture certain of our products. Any failure by or loss of a third party manufacturer could result in delays and increased costs, which may adversely affect our business.

The Company relies on third parties to manufacture certain of our products. We depend on these third party manufacturers to allocate to us a portion of their manufacturing capacity sufficient to meet our needs, to produce products of acceptable quality and at acceptable manufacturing yields and to deliver those products to us on a timely basis and at acceptable prices. However, we cannot guarantee that these third party manufacturers will be able to meet our near-term or long-term manufacturing requirements, which could result in lost sales and have an adverse effect on our business.

Other risks associated with our reliance on third parties to manufacture these products include, reliance on the third party for regulatory compliance and quality assurance, misappropriation of the Company’s intellectual property, limited ability to manage our inventory, possible breach of the manufacturing agreement by the third party and the possible termination or nonrenewal of the manufacturing agreement by the third party at a time that is costly or inconvenient for us. Moreover, if any of our third party manufacturers suffer any damage to facilities, lose benefits under material agreements, experience power outages, encounter financial difficulties, are unable to secure necessary raw materials from their suppliers or suffer any other reduction in efficiency, the Company may experience significant business disruption. In the event of any such disruption, the Company would need to seek and source other qualified third party manufacturers, likely resulting in further delays and increased costs which could affect our business adversely.
An information security incident, including a cybersecurity breach, could have a negative impact to the Company’s business or reputation
To meet business objectives, the Company relies on both internal information technology (IT) systems and networks, and those of third parties and their vendors, to process and store sensitive data, including confidential research, business plans, financial information, intellectual property, and personal data that may be subject to legal protection. The extensive information security and cybersecurity threats, which affect companies globally, pose a risk to the security and availability of these IT systems and networks, and the confidentiality, integrity, and availability of the Company’s sensitive data. The Company continually assesses these threats and makes investments to increase internal protection, detection, and response capabilities, as well as ensure the Company’s third party providers have required capabilities and controls, to address this risk. To date, the Company has not experienced any material impact to the business or operations resulting from information or cybersecurity attacks; however, because of the frequently changing attack techniques, along with the increased volume and sophistication of the attacks, there is the potential for the Company to be adversely impacted. This impact could result in reputational, competitive, operational or other business harm as well as financial costs and regulatory action. The Company maintains cybersecurity insurance in the event of an information security or cyber incident, however, the coverage may not be sufficient to cover all financial losses.



                
 
9
                                

Item 1B.
UNRESOLVED STAFF COMMENTS
Not applicable.

Item 2.PROPERTIES
The Company's subsidiaries operate 111 manufacturing facilities occupying approximately 20.5 million square feet of floor space. The manufacturing facilities are used by the industry segments of the Company’s business approximately as follows:
Segment
 
Square Feet
(in thousands)
Consumer
 
6,503

Pharmaceutical
 
6,819

Medical Devices
 
7,183

Worldwide Total
 
20,505

Within the U.S., five facilities are used by the Consumer segment, five by the Pharmaceutical segment and 27 by the Medical Devices segment. Outside of the U.S., 25 facilities are used by the Consumer segment, 14 by the Pharmaceutical segment and 35 by the Medical Devices segment.
The locations of the manufacturing facilities by major geographic areas of the world are as follows:
Geographic Area
 
Number of Facilities
 
Square Feet
(in thousands)
United States
 
37

 
5,855

Europe
 
34

 
7,587

Western Hemisphere, excluding U.S. 
 
12

 
2,800

Africa, Asia and Pacific
 
28

 
4,263

Worldwide Total
 
111

 
20,505

In addition to the manufacturing facilities discussed above, the Company maintains numerous office and warehouse facilities throughout the world. Research facilities are also discussed in Item 7. Management’s Discussion and Analysis of Results of Operations and Financial Condition” of this Report.
The Company's subsidiaries generally seek to own, rather than lease, their manufacturing facilities, although some, principally in non-U.S. locations, are leased. Office and warehouse facilities are often leased. The Company also engages contract manufacturers.
The Company is committed to maintaining all of its properties in good operating condition.
McNEIL-PPC, Inc. (now Johnson & Johnson Consumer Inc.) (McNEIL-PPC) continues to operate under a consent decree, signed in 2011 with the FDA, which governs certain McNeil Consumer Healthcare manufacturing operations, and requires McNEIL-PPC to remediate the facilities it operates in Lancaster, Pennsylvania, Fort Washington, Pennsylvania, and Las Piedras, Puerto Rico (the "Consent Decree"). Following FDA inspections in 2015, McNEIL-PPC received notifications from the FDA that all three manufacturing facilities are in conformity with applicable laws and regulations, and commercial production has restarted.
Under the Consent Decree, after receiving notice from the FDA of being in compliance with applicable laws and regulations, each of the three facilities is subject to a five-year audit period by a third-party cGMP expert. Thus, a third-party expert will continue to reassess the sites at various times until at least 2020.
For information regarding lease obligations, see Note 16 “Rental Expense and Lease Commitments” of the Notes to Consolidated Financial Statements included in Item 8 of this Report. Segment information on additions to property, plant and equipment is contained in Note 18 “Segments of Business and Geographic Areas” of the Notes to Consolidated Financial Statements included in Item 8 of this Report.

                
 
10
                                


Item 3.
LEGAL PROCEEDINGS
The information called for by this item is incorporated herein by reference to the information set forth in Note 21 “Legal Proceedings” of the Notes to Consolidated Financial Statements included in Item 8 of this Report.
In addition, Johnson & Johnson and its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.

Item 4.
MINE SAFETY DISCLOSURES
Not applicable.
EXECUTIVE OFFICERS OF THE REGISTRANT
Listed below are the executive officers of the Company. There are no family relationships between any of the executive officers, and there is no arrangement or understanding between any executive officer and any other person pursuant to which the executive officer was selected. At the annual meeting of the Board of Directors, the executive officers are elected by the Board to hold office for one year and until their respective successors are elected and qualified, or until earlier resignation or removal.
Information with regard to the directors of the Company, including information for Alex Gorsky, who is also an executive officer, is incorporated herein by reference to the material captioned “Item 1. Election of Directors” in the Proxy Statement.
Name
 
Age
 
Position
Joaquin Duato
 
56
 
Vice Chairman, Executive Committee(a)
Peter M. Fasolo
 
56
 
Member, Executive Committee; Executive Vice President, Chief Human Resources Officer(b)
Alex Gorsky
 
58
 
Chairman, Board of Directors; Chairman, Executive Committee; Chief Executive Officer
Ashley McEvoy
 
48
 
Member, Executive Committee; Executive Vice President, Worldwide Chairman, Medical Devices(c)
Jorge Mesquita
 
57
 
Member, Executive Committee; Executive Vice President, Worldwide Chairman, Consumer(d)
Thibaut Mongon
 
49
 
Appointee, Member, Executive Committee, Executive Vice President, Worldwide Chairman, Consumer(e)
Michael E. Sneed
 
59
 
Member, Executive Committee; Executive Vice President, Global Corporate Affairs and Chief Communication Officer(f)
Paulus Stoffels
 
56
 
Vice Chairman, Executive Committee; Chief Scientific Officer(g)
Jennifer L. Taubert
 
55
 
Member, Executive Committee; Executive Vice President, Worldwide Chairman, Pharmaceuticals(h)
Michael H. Ullmann
 
60
 
Member, Executive Committee; Executive Vice President, General Counsel(i)
Kathryn E. Wengel
 
53
 
Member, Executive Committee; Executive Vice President, Chief Global Supply Chain Officer(j)
Joseph J. Wolk
 
52
 
Member, Executive Committee; Executive Vice President, Chief Financial Officer(k)
(a)
Mr. J. Duato joined the Company in 1989 with Janssen-Farmaceutica S.A. (Spain), a subsidiary of the Company, and held executive positions of increasing responsibility in the Pharmaceutical sector. In 2009, he was named Company Group Chairman, Pharmaceuticals, and in 2011, he was named Worldwide Chairman, Pharmaceuticals. In 2016, Mr. Duato became a member of the Executive Committee and was named Executive Vice President, Worldwide Chairman,

                
 
11
                                

Pharmaceuticals. In July 2018, Mr. Duato was promoted to Vice Chairman of the Executive Committee, with responsibility for the company's Pharmaceutical and Consumer sectors, supply chain, information technology, global services and the Health & Wellness groups.
(b)
Dr. P. M. Fasolo joined the Company in 2004 as Vice President, Worldwide Human Resources for Cordis Corporation, a subsidiary of the Company, and was subsequently named Vice President, Global Talent Management for the Company. He left Johnson & Johnson in 2007 to join Kohlberg Kravis Roberts & Co. as Chief Talent Officer. Dr. Fasolo returned to the Company in 2010 as the Vice President, Global Human Resources, and in 2011, he became a member of the Executive Committee. In April 2016, he was named Executive Vice President, Chief Human Resources Officer. Mr. Fasolo has responsibility for global talent, recruiting, diversity, compensation, benefits, employee relations and all aspects of the human resources agenda for the Company.
(c)
Ms. A. McEvoy joined the Company in 1997 as Assistant Brand Manager of McNeil Consumer Health, a subsidiary of the Company, advancing through positions of increasing responsibilities until she was appointed Company Group Chairman, Vision Care in 2012, followed by Company Group Chairman, Consumer Medical Devices in 2014. In July 2018, Ms. McEvoy was promoted to Executive Vice President, Worldwide Chairman, Medical Devices, and became a member of the Executive Committee. She has responsibility for the surgery, orthopaedics, interventional solutions and eye health businesses across Ethicon, DePuy Synthes, Biosense Webster and Johnson & Johnson Vision.
(d)
Mr. J. Mesquita joined the Company in 2014 as Worldwide Chairman, Consumer. Prior to joining the Company, he served in various marketing and leadership capacities across Latin America, including roles in Oral Care and Beauty at The Procter & Gamble Company from 1984 to 2013. In April 2016, Mr. Mesquita became a member of the Executive Committee and was promoted to Executive Vice President, Worldwide Chairman, Consumer. Mr. Mesquita plans to retire from the Company in March 2019.
(e)
Mr. T. Mongon joined the Company in 2000 as Director of Marketing for the Vision Care group in France and subsequently held general management positions as Country Manager France, Belgium and North Africa, Managing Director Latin America, and President Asia-Pacific. Mr. Mongon transitioned to the Pharmaceutical sector in 2012 as the Global Commercial Strategy Leader for the Neuroscience therapeutic area, before joining the consumer sector as Company Group Chairman Asia-Pacific. The Company has announced that Mr. Mongon will be named Executive Vice President and Worldwide Chairman, Consumer, and a member of the Executive Committee, upon the retirement of his predecessor, Mr. Mesquita, effective March 1, 2019. In addition to leading the Consumer business, Mr. Mongon will have responsibility for Johnson & Johnson Southeast Asia.
(f)
Mr. M. E. Sneed joined the Company in 1986 as Product Director for Personal Products, a subsidiary of the Company, and gained increased responsibilities in executive positions across the global enterprise. In 2004, Mr. Sneed was appointed Company Group Chairman, Consumer North America, followed by Company Group Chairman, Vision Care Franchise in 2007. In 2012, he became the Vice President, Global Corporate Affairs and Chief Communications Officer. Mr. Sneed was appointed Executive Vice President, Global Corporate Affairs and Chief Communications Officer in January 2018, and became a member of the Executive Committee in July 2018, leading the corporation's global marketing, communication, design and philanthropy functions.
(g)
Dr. P. Stoffels joined the Company in 2002 with the acquisition of Tibotec Virco NV, where he was Chief Executive Officer of Virco NV and Chairman of Tibotec NV. In 2005, he was appointed Company Group Chairman, Global Virology. In 2006, he assumed the role of Company Group Chairman, Pharmaceuticals. Dr. Stoffels was appointed Global Head, Research & Development, Pharmaceuticals in 2009, and in 2011, became Worldwide Chairman, Pharmaceuticals. In 2012, Dr. Stoffels was appointed Chief Scientific Officer, and became a member of the Executive Committee. In 2016, Dr. Stoffels was named Executive Vice President, Chief Scientific Officer. In 2018, Dr. Stoffels was promoted to Vice Chairman of the Executive Committee, Chief Scientific Officer. He is responsible for the Company’s innovation agenda across the Pharmaceutical, Medical Devices and Consumer sectors, product safety strategy, and the Company’s global public health strategy.
(h)
Ms. J. L. Taubert joined the Company in 2005 as Worldwide Vice President at Johnson & Johnson Pharmaceutical Services, a subsidiary of the Company. She held several executive positions in the Pharmaceutical sector until 2012 when she was appointed Company Group Chairman, North America Pharmaceuticals, and in 2015 became Company Group Chairman, The Americas, Pharmaceuticals. In July 2018, Ms. Taubert was promoted to Executive Vice President, Worldwide Chairman, Pharmaceuticals, and became a member of the Executive Committee.
(i)
Mr. M. H. Ullmann joined the Company in 1989 as a corporate attorney in the Law Department. He was appointed Corporate Secretary in 1999 and served in that role until 2006.  During that time, he also held various management positions in the Law Department.  In 2006, he was named General Counsel, Medical Devices and Diagnostics and was appointed Vice President, General Counsel and became a member of the Executive Committee in 2012. In April 2016, Mr. Ullmann was named Executive Vice President, General Counsel. Mr. Ullmann has worldwide responsibility for legal, government affairs & policy, global security, aviation and health care compliance & privacy.

                
 
12
                                

(j)
Ms. K. E. Wengel joined the Company in 1988 as Project Engineer and Engineering Supervisor at Janssen, a subsidiary of the Company. During her tenure with the Company, she has held a variety of strategic leadership and executive positions across the global enterprise, in roles within operations, quality, engineering, new products, information technology, and other technical and business functions. In 2010, Ms. Wengel became the first Chief Quality Officer of the Company. In 2014, she was promoted to Vice President, Johnson & Johnson Supply Chain. In July 2018, she was promoted to Executive Vice President, Chief Global Supply Chain Officer, and became a member of the Executive Committee.
(k)
Mr. J. J. Wolk joined the Company in 1998 as Finance Manager, Business Development for Ortho-McNeil, a subsidiary of the Company, and through the years held a variety of senior leadership roles in several segments and functions across the Company's subsidiaries, in Pharmaceuticals, Medical Devices and Supply Chain. From 2014 to 2016, he served as Vice President, Finance and Chief Financial Officer of the Janssen Pharmaceutical Companies of Johnson & Johnson. In 2016, Mr. Wolk became the Vice President, Investor Relations. In July 2018, he was appointed Executive Vice President, Chief Financial Officer and became a member of the Executive Committee. Mr. Wolk is responsible for leading the development and execution of the Company's global long-term financial strategy.

                
 
13
                                

PART II
Item 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
As of February 15, 2019, there were 142,029 record holders of common stock of the Company. Additional information called for by this item is incorporated herein by reference to the following sections of this Report: Note 17 “Common Stock, Stock Option Plans and Stock Compensation Agreements” of the Notes to Consolidated Financial Statements included in Item 8; and Item 12 “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters – Equity Compensation Plan Information”.
Issuer Purchases of Equity Securities
On December 17, 2018, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to $5.0 billion of the Company's Common Stock. Share repurchases take place from time to time on the open market or through privately negotiated transactions. The repurchase program has no time limit and may be suspended for periods or discontinued at any time.
The following table provides information with respect to common stock purchases by the Company during the fiscal fourth quarter of 2018. Common stock purchases on the open market are made as part of a systematic plan to meet the needs of the Company’s compensation programs. The repurchases below also include the stock-for-stock option exercises that settled in the fiscal fourth quarter.
Period
 
Total Number
of Shares Purchased(1)
 
Avg. Price
Paid Per Share
 
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs(2)
 
Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs(3)
October 1, 2018 through October 28, 2018
 
2,192,500

 
$
138.74

 
-
 
-
October 29, 2018 through November 25, 2018
 
6,849,298

 
143.27

 
-
 
-
November 26, 2018 through December 30, 2018
 
18,130,189

 
139.10

 
7,073,136
 
32,131,870
Total
 
27,171,987

 
 
 

 
 
(1)
During the fiscal fourth quarter of 2018, the Company repurchased an aggregate of 27,171,987 shares of Johnson & Johnson Common Stock in open-market transactions, of which 7,073,136 shares were purchased pursuant to the repurchase program that was publicly announced on December 17, 2018, and of which 20,098,851 shares were purchased in open-market transactions as part of a systematic plan to meet the needs of the Company’s compensation programs.
(2)
As of December 30, 2018, an aggregate of 7,073,136 shares were purchased for a total of $0.9 billion since the inception of the repurchase program announced on December 17, 2018.
(3)
As of December 30, 2018, the maximum number of shares that may yet be purchased under the plan is 32,131,870 based on the closing price of Johnson & Johnson Common Stock on the New York Stock Exchange on December 28, 2018 of $127.27 per share.





                
 
14
                                

Item 6.
SELECTED FINANCIAL DATA
    
Summary of Operations and Statistical Data 2008-2018*
(Dollars in Millions Except Per Share Amounts)
2018
 
2017
 
2016
 
2015
 
2014
 
2013
 
2012
 
2011
 
2010
 
2009
 
2008
Sales to customers — U.S. 
$41,884
 
39,863
 
37,811
 
35,687
 
34,782

 
31,910

 
29,830

 
28,908

 
29,450

 
30,889

 
32,309

Sales to customers — International
39,697
 
36,587
 
34,079
 
34,387
 
39,549

 
39,402

 
37,394

 
36,122

 
32,137

 
31,008

 
31,438

Total sales
81,581
 
76,450
 
71,890
 
70,074
 
74,331

 
71,312

 
67,224

 
65,030

 
61,587

 
61,897

 
63,747

Cost of products sold
27,091
 
25,439
 
21,789
 
21,426
 
22,684

 
22,181

 
21,515

 
20,219

 
18,688

 
18,380

 
18,463

Selling, marketing and administrative expenses
22,540
 
21,520
 
20,067
 
21,079
 
21,887

 
21,650

 
20,697

 
20,800

 
19,296

 
19,712

 
21,431

Research and development expense
10,775
 
10,594
 
9,143
 
8,999
 
8,471

 
8,119

 
7,602

 
7,486

 
6,796

 
6,949

 
7,554

In-process research and development
1,126
 
408
 
29
 
224
 
178

 
580

 
1,163

 
—

 
—

 
—

 
181

Interest income
(611)
 
(385)
 
(368)
 
(128)
 
(67
)
 
(74
)
 
(64
)
 
(91
)
 
(107
)
 
(90
)
 
(361
)
Interest expense, net of portion capitalized
1,005
 
934
 
726
 
552
 
533

 
482

 
532

 
571

 
455

 
451

 
435

Other (income) expense, net
1,405
 
(42)
 
210
 
(1,783)
 
82

 
2,903

 
2,004

 
3,115

 
(488
)
 
(333
)
 
(885
)
Restructuring
251
 
309
 
491
 
509
 
—

 
—

 
—

 
569

 
—

 
1,073

 
—

 
63,582
 
58,777
 
52,087
 
50,878
 
53,768

 
55,841

 
53,449

 
52,669

 
44,640

 
46,142

 
46,818

Earnings before provision for taxes on income
$17,999
 
17,673
 
19,803
 
19,196
 
20,563

 
15,471

 
13,775

 
12,361

 
16,947

 
15,755

 
16,929

Provision for taxes on income
2,702
 
16,373
 
3,263
 
3,787
 
4,240

 
1,640

 
3,261

 
2,689

 
3,613

 
3,489

 
3,980

Net earnings
15,297
 
1,300
 
16,540
 
15,409
 
16,323

 
13,831

 
10,514

 
9,672

 
13,334

 
12,266

 
12,949

Add: Net loss attributable to noncontrolling interest
—
 
—
 
—
 
—
 
—

 
—

 
339

 
—

 
—

 
—

 
—

Net earnings attributable to Johnson & Johnson
15,297
 
1,300
 
16,540
 
15,409
 
16,323

 
13,831

 
10,853

 
9,672

 
13,334

 
12,266

 
12,949

Percent of sales to customers
18.8%
 
1.7
 
23.0
 
22.0
 
22.0

 
19.4

 
16.1

 
14.9

 
21.7

 
19.8

 
20.3

Diluted net earnings per share of common stock (1)
$5.61
 
0.47
 
5.93
 
5.48
 
5.70

 
4.81

 
3.86

 
3.49

 
4.78

 
4.40

 
4.57

Percent return on average shareholders’ equity
25.5%
 
2.0
 
23.4
 
21.9
 
22.7

 
19.9

 
17.8

 
17.0

 
24.9

 
26.4

 
30.2

Percent increase (decrease) over previous year:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 

 
 

 
 

Sales to customers
6.7%
 
6.3
 
2.6
 
(5.7)
 
4.2

 
6.1

 
3.4

 
5.6

 
(0.5
)
 
(2.9
)
 
4.3

Diluted net earnings per share
N/M
 
(92.1)%
 
8.2
 
(3.9)
 
18.5

 
24.6

 
10.6

 
(27.0
)
 
8.6

 
(3.7
)
 
25.9

Supplementary balance sheet data:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 

 
 

 
 

Property, plant and equipment, net
17,035
 
17,005
 
15,912
 
15,905
 
16,126

 
16,710

 
16,097

 
14,739

 
14,553

 
14,759

 
14,365

Additions to property, plant and equipment
3,670
 
3,279
 
3,226
 
3,463
 
3,714

 
3,595

 
2,934

 
2,893

 
2,384

 
2,365

 
3,066

Total assets
152,954
 
157,303
 
141,208
 
133,411
 
130,358

 
131,754

 
121,347

 
113,644

 
102,908

 
94,682

 
84,912

Long-term debt
27,684
 
30,675
 
22,442
 
12,857
 
15,122

 
13,328

 
11,489

 
12,969

 
9,156

 
8,223

 
8,120

Operating cash flow
22,201
 
21,056
 
18,767
 
19,569
 
18,710

 
17,414

 
15,396

 
14,298

 
16,385

 
16,571

 
14,972

Common stock information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 

 
 

 
 

Dividends paid per share
$3.54
 
3.32
 
3.15
 
2.95
 
2.76

 
2.59

 
2.40

 
2.25

 
2.11

 
1.93

 
1.795

Shareholders’ equity per share
22.44
 
22.43
 
26.02
 
25.82
 
25.06

 
26.25

 
23.33

 
20.95

 
20.66

 
18.37

 
15.35

Market price per share (year-end close)
$127.27
 
139.72
 
115.21
 
102.72
 
105.06

 
92.35

 
69.48

 
65.58

 
61.85

 
64.41

 
58.56

Average shares outstanding (millions)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 — basic
2,681.5
 
2,692.0
 
2,737.3
 
2,771.8
 
2,815.2

 
2,809.2

 
2,753.3

 
2,736.0

 
2,751.4

 
2,759.5

 
2,802.5

 — diluted
2,728.7
 
2,745.3
 
2,788.9
 
2,812.9
 
2,863.9

 
2,877.0

 
2,812.6

 
2,775.3

 
2,788.8

 
2,789.1

 
2,835.6

Employees (thousands)
135.1
 
134.0
 
126.4
 
127.1
 
126.5

 
128.1

 
127.6

 
117.9

 
114.0

 
115.5

 
118.7

(1) Attributable to Johnson & Johnson
* Per the adoption of ASU 2017-07 prior year amounts on the Consolidated Statement of Earnings have been reclassified to retroactively apply classification of the service cost component and the other components of net periodic benefit cost
N/M = Not Meaningful



    

                
 
15
                                


Item 7.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Organization and Business Segments
Description of the Company and Business Segments
Johnson & Johnson and its subsidiaries (the Company) have approximately 135,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the world with the primary focus on products related to human health and well-being.
The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. The Pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular), diabetes care (divested in the fiscal fourth quarter of 2018) and vision fields which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.
The Executive Committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of the resources of the Company. This Committee oversees and coordinates the activities of the Consumer, Pharmaceutical and Medical Devices business segments.
In all of its product lines, the Company competes with companies both locally and globally, throughout the world. Competition exists in all product lines without regard to the number and size of the competing companies involved. Competition in research, involving the development and the improvement of new and existing products and processes, is particularly significant. The development of new and innovative products, as well as protecting the underlying intellectual property of the Company's product portfolio, is important to the Company’s success in all areas of its business. The competitive environment requires substantial investments in continuing research. In addition, the development and maintenance of customer demand for the Company’s consumer products involves significant expenditures for advertising and promotion.

Management’s Objectives
With “Our Credo” as the foundation, the Company’s purpose is to blend heart, science and ingenuity to profoundly change the trajectory of health for humanity. The Company is committed to bringing its full breadth and depth to ensure health for people today and for future generations. United around this common ambition, the Company is poised to fulfill its purpose and successfully meet the demands of the rapidly evolving markets in which it competes.
The Company is broadly based in human healthcare, and is committed to creating value by developing accessible, high quality, innovative products and services. New products introduced within the past five years accounted for approximately 25% of 2018 sales. In 2018, $10.8 billion was invested in research and development and $0.9 billion spent on acquisitions, reflecting management’s commitment to create life-enhancing innovations and to create value through partnerships that will profoundly change the trajectory of health for humanity.
A critical driver of the Company’s success, is the 135,100 diverse employees that work across more than 260 operating companies, which are located in more than 60 countries. Employees are empowered and inspired to lead with the Company’s Our Credo and purpose as guides. This allows every employee to use the Company’s reach and size to advance the Company's purpose, and to also lead with agility and urgency. Leveraging the extensive resources across the enterprise, enables the Company to innovate and execute with excellence. This ensures the Company can remain focused on addressing the unmet needs of society every day and invest for an enduring impact, ultimately delivering value to its patients, consumers and healthcare professionals, employees, communities and shareholders.
chart-41ca3965692af9c6bb7a01.jpg chart-e7661660c6305f08a59.jpg chart-cc2b3d8be061d530eafa01.jpg

                
 
16
                                



Results of Operations
Analysis of Consolidated Sales
In 2018, worldwide sales increased 6.7% to $81.6 billion, compared to an increases of 6.3% and 2.6% in 2017 and 2016, respectively. These sales changes consisted of the following:
Sales increase/(decrease) due to:
 
2018
 
2017
 
2016
Volume
 
8.5
 %
 
8.0
%
 
3.2
%
Price
 
(2.2
)
 
(2.0
)
 
0.7

Currency
 
0.4

 
0.3

 
(1.3
)
Total
 
6.7
 %
 
6.3
%
 
2.6
%

In 2018, the net impact of acquisitions and divestitures on the worldwide sales growth was a positive impact of 0.8%. In 2017, acquisitions and divestitures had a positive impact of 3.6% on the worldwide sales growth. In 2016, acquisitions and divestitures had a negative impact of 1.1% on the worldwide sales growth and competitive products to the Company's Hepatitis C products, OLYSIO®/SOVRIAD® (simeprevir) and INCIVO® (telaprevir), had a negative impact of 0.8% on the worldwide sales growth. Operations in Venezuela negatively impacted the worldwide sales growth 0.3%.
Sales by U.S. companies were $41.9 billion in 2018, $39.9 billion in 2017 and $37.8 billion in 2016. This represents increases of 5.1% in 2018, 5.4% in 2017 and 6.0% in 2016. Sales by international companies were $39.7 billion in 2018, $36.6 billion in 2017 and $34.1 billion in 2016. This represents an increase of 8.5% in 2018, 7.4% in 2017, and a decrease of 0.9% in 2016.
The five-year compound annual growth rates for worldwide, U.S. and international sales were 2.7%, 5.6% and 0.1%, respectively. The ten-year compound annual growth rates for worldwide, U.S. and international sales were 2.5%, 2.6% and 2.4%, respectively.
In 2018, sales by companies in Europe achieved growth of 9.5% as compared to the prior year, including operational growth of 6.2% and a positive currency impact of 3.3%. Sales by companies in the Western Hemisphere (excluding the U.S.) achieved growth of 1.2% as compared to the prior year, including operational growth of 8.2% and a negative currency impact of 7.0%. Sales by companies in the Asia-Pacific, Africa region achieved growth of 10.5% as compared to the prior year, including operational growth of 9.4% and a positive currency impact of 1.1%.
In 2018, the Company had three wholesalers distributing products for all three segments that represented approximately 14.0%, 11.0% and 11.0% of the total consolidated revenues. In 2017, the Company had two wholesalers distributing products for all three segments that represented approximately 14.0% and 10.0% of the total consolidated revenues. In 2016, the Company had two wholesalers distributing products for all three segments that represented approximately 13.5% and 10.7% of the total consolidated revenues.

chart-07e0e4edcb372a3b7d2a01.jpgchart-906465fb51727442c0ba01.jpg

                
 
17
                                



Analysis of Sales by Business Segments
Consumer Segment
Consumer segment sales in 2018 were $13.9 billion, an increase of 1.8% from 2017, which included 2.2% operational growth and a negative currency impact of 0.4%. U.S. Consumer segment sales were $5.8 billion, an increase of 3.5%. International sales were $8.1 billion, an increase of 0.7%, which included 1.4% operational growth and a negative currency impact of 0.7%. In 2018, acquisitions and divestitures had a net negative impact of 1.0% on the operational sales growth of the worldwide Consumer segment.
Major Consumer Franchise Sales:
 
 
 
 
 
 
 
 
% Change
(Dollars in Millions)
 
2018
 
2017
 
2016
 
’18 vs. ’17
 
’17 vs. ’16
Beauty
 
$
4,382

 
4,200

 
3,897

 
4.3
 %
 
7.8

OTC
 
4,334

 
4,126

 
3,977

 
5.0

 
3.7

Baby Care
 
1,858

 
1,916

 
2,001

 
(3.0
)
 
(4.2
)
Oral Care
 
1,555

 
1,531

 
1,568

 
1.6

 
(2.4
)
Women’s Health
 
1,049

 
1,050

 
1,067

 
(0.1
)
 
(1.6
)
Wound Care/Other
 
675

 
779

 
797

 
(13.4
)
 
(2.3
)
Total Consumer Sales
 
$
13,853

 
13,602

 
13,307

 
1.8
 %
 
2.2

 
The Beauty franchise sales of $4.4 billion increased 4.3% as compared to the prior year. Growth was primarily driven by NEUTROGENA®, OGX® and AVEENO® products as well as strength of DR. CI: LABO and DABAO® products outside the U.S. Growth was partially offset by the divestiture of NIZORAL®.
The Over-the-Counter (OTC) franchise sales of $4.3 billion increased 5.0% as compared to the prior year. Growth was primarily driven by share, consumption and market growth across multiple brands including ZYRTEC® , TYLENOL® and Children's MOTRIN®, as well as digestive health products and anti-smoking aids. Additionally, sales from the recent U.S. acquisition of Zarbee's Inc. contributed approximately 0.9% to growth.
The Baby Care franchise sales were $1.9 billion in 2018, a decrease of 3.0% compared to the prior year, primarily due to JOHNSON's® share decline and increased trade promotions due to the JOHNSON's® baby relaunch and the negative impact of currency. This was partially offset by strong growth of AVEENO® baby driven by geographic expansion.
The Oral Care franchise sales of $1.6 billion increased 1.6% as compared to the prior year, primarily driven by strong marketing campaigns and new product launches.
The Women’s Health franchise sales were $1.0 billion in 2018, a decrease of 0.1% as compared to the prior year. Growth in Latin America was offset by the negative impact of currency.
The Wound Care/Other franchise sales were $0.7 billion in 2018, a decrease of 13.4% as compared to the prior year, primarily due to the divestiture of COMPEED®.
Consumer segment sales in 2017 were $13.6 billion, an increase of 2.2% from 2016, which included 1.3% operational growth and a positive currency impact of 0.9%. U.S. Consumer segment sales were $5.6 billion, an increase of 2.7%. International sales were $8.0 billion, an increase of 1.9%, which included 0.4% operational growth and a positive currency impact of 1.5%. In 2017, acquisitions and divestitures had a net positive impact of 1.8% on the operational sales growth of the worldwide Consumer segment.




                
 
18
                                



Pharmaceutical Segment
Pharmaceutical segment sales in 2018 were $40.7 billion, an increase of 12.4% from 2017, which included operational growth of 11.8% and a positive currency impact of 0.6%. U.S. sales were $23.3 billion, an increase of 8.4%. International sales were $17.4 billion, an increase of 18.0%, which included 16.5% operational growth and a positive currency impact of 1.5%. In 2018, acquisitions and divestitures had a net positive impact of 3.4% on the operational sales growth of the worldwide Pharmaceutical segment.

Major Pharmaceutical Therapeutic Area Sales:*
 
 
 
 
 
 
 
 
% Change
(Dollars in Millions)
 
2018
 
2017
 
2016
 
’18 vs. ’17
 
’17 vs. ’16
Total Immunology
 
$
13,120

 
12,244

 
11,968

 
7.2
 %
 
2.3

     REMICADE®
 
5,326

 
6,315

 
6,966

 
(15.7
)
 
(9.3
)
     SIMPONI®/SIMPONI ARIA®
 
2,084

 
1,833

 
1,745

 
13.7

 
5.0

     STELARA®
 
5,156

 
4,011

 
3,232

 
28.5

 
24.1

     TREMFYA®
 
544

 
63

 
—

 
**

 
**

     Other Immunology
 
10

 
22

 
25

 
(54.5
)
 
(12.0
)
Total Infectious Diseases
 
3,304

 
3,154

 
3,208

 
4.8

 
(1.7
)
     EDURANT®/rilpivirine
 
816

 
714

 
573

 
14.3

 
24.6

     PREZISTA®/ PREZCOBIX®/REZOLSTA®/SYMTUZA®
 
1,955

 
1,821

 
1,851

 
7.4

 
(1.6
)
     Other Infectious Diseases
 
533

 
619

 
784

 
(13.9
)
 
(21.0
)
Total Neuroscience
 
6,077

 
5,986

 
6,085

 
1.5

 
(1.6
)
     CONCERTA®/methylphenidate
 
663

 
791

 
863

 
(16.2
)
 
(8.3
)
     INVEGA SUSTENNA®/XEPLION®/INVEGA TRINZA®/TREVICTA®
 
2,928

 
2,569

 
2,214

 
14.0

 
16.0

     RISPERDAL CONSTA®
 
737

 
805

 
893

 
(8.4
)
 
(9.9
)
     Other Neuroscience
 
1,749

 
1,821

 
2,115

 
(4.0
)
 
(13.9
)
Total Oncology
 
9,844

 
7,258

 
5,807

 
35.6

 
25.0

     DARZALEX®
 
2,025

 
1,242

 
572

 
63.0

 
**

     IMBRUVICA®
 
2,615

 
1,893

 
1,251

 
38.1

 
51.3

     VELCADE®
 
1,116

 
1,114

 
1,224

 
0.2

 
(9.0
)
     ZYTIGA® /abiraterone acetate
 
3,498

 
2,505

 
2,260

 
39.6

 
10.8

     Other Oncology
 
590

 
504

 
500

 
17.1

 
0.8

Pulmonary Hypertension
 
2,573

 
1,327

 
—

 
93.9

 
***

     OPSUMIT®
 
1,215

 
573

 
—

 
**

 
***

     TRACLEER®
 
546

 
403

 
—

 
35.5

 
***

     UPTRAVI®
 
663

 
263

 
—

 
**

 
***

     Other
 
149

 
88

 
—

 
69.3

 
***

Cardiovascular / Metabolism / Other
 
5,816

 
6,287

 
6,396

 
(7.5
)
 
(1.7
)
     XARELTO®
 
2,477

 
2,500

 
2,288

 
(0.9
)
 
9.3

     INVOKANA®/ INVOKAMET®
 
881

 
1,111

 
1,407

 
(20.7
)
 
(21.0
)
     PROCRIT®/EPREX®
 
988

 
972

 
1,105

 
1.6

 
(12.0
)
     Other
 
1,470

 
1,704

 
1,596

 
(13.7
)
 
6.8

Total Pharmaceutical Sales
 
$
40,734

 
36,256

 
33,464

 
12.4
 %
 
8.3

* Prior year amounts have been reclassified to conform to current year presentation
** Percentage greater than 100% or not meaningful
***Products acquired from Actelion on June 16, 2017


                
 
19
                                


Immunology products sales were $13.1 billion in 2018, representing an increase of 7.2% as compared to the prior year. Growth was driven by strong uptake of STELARA® (ustekinumab) in Crohn's disease, strong launch uptake of TREMFYA® (guselkumab), expanded indications of SIMPONI®/SIMPONI ARIA® (golimumab), and the U.S. immunology market growth. Immunology was negatively impacted by lower sales of REMICADE® (infliximab) due to increased discounts/rebates and biosimilar competition.
The patents for REMICADE® (infliximab) in certain countries in Europe expired in February 2015. Biosimilar versions of REMICADE® have been introduced in certain markets outside the U.S., resulting in a reduction in sales of REMICADE® in those markets. Additional biosimilar competition will likely result in a further reduction in REMICADE® sales in markets outside the United States. In the U.S., a biosimilar version of REMICADE® was introduced in 2016, and additional competitors continue to enter the market. Continued infliximab biosimilar competition in the U.S. market will result in a further reduction in U.S. sales of REMICADE®. See Note 21 to the Consolidated Financial Statements for a description of legal matters regarding the REMICADE® patents.
Infectious disease products sales were $3.3 billion in 2018, representing an increase of 4.8% as compared to the prior year. Sales growth of PREZCOBIX®/REZOLSTA® (darunavir/cobicistat), EDURANT®/rilpivirine, and the launch of SYMTUZA® and JULUCA® (dolutegravir/rilpivirine) was partially offset by lower sales of PREZISTA®(darunavir).
Neuroscience products sales were $6.1 billion, representing an increase of 1.5% as compared to the prior year. Strong sales of long-acting injectables INVEGA TRINZA®/TREVICTA®(paliperidone palmitate) and INVEGA SUSTENNA®/XEPLION® were partially offset by cannibalization of RISPERDAL CONSTA® (risperidone) and generic competition for CONCERTA®/methylphenidate.
Oncology products achieved sales of $9.8 billion in 2018, representing an increase of 35.6% as compared to the prior year. Contributors to the growth were strong sales of DARZALEX® (daratumumab) with continued market growth and share gain, IMBRUVICA® (ibrutinib) due to increased patient uptake globally and sales of ZYTIGA® (abiraterone acetate) driven by LATITUDE data and market growth. Additionally, sales from the launch of ERLEADA™ (apalutamide) contributed to the growth. A number of companies marketing generic pharmaceuticals have filed Abbreviated New Drug Applications (ANDAs) with the FDA, or undertaken similar regulatory processes outside of the U.S., seeking to market generic forms of ZYTIGA® prior to expiration of its applicable patents. These ANDAs include allegations of non-infringement and invalidity of the applicable patents. In October 2018, the Court issued a ruling invalidating all asserted claims of the applicable patent. Janssen has appealed the Court’s decision. In November 2018, the U.S. Court of Appeals for the Federal Circuit denied Janssen’s request for an injunction pending appeal. As a result, several generic versions of ZYTIGA® have entered the market, resulting in a decline in sales of ZYTIGA® in the United States. In 2018, the Company reported U.S. sales of $1.8 billion for ZYTIGA®. See Note 21 to the Consolidated Financial Statements for a description of legal matters regarding ZYTIGA®.
The Pulmonary Hypertension therapeutic area was established with the acquisition of Actelion Ltd on June 16, 2017. Sales in 2018 represented a full year as compared to half a year in 2017. Sales of OPSUMIT® (macitentan) and UPTRAVI® (selexipag) were positively impacted by market growth and share gains while sales of TRACLEER® (bosetan) were negatively impacted by increased use of OPSUMIT® and generics.
Cardiovascular/Metabolism/Other products sales were $5.8 billion, a decline of 7.5% as compared to the prior year. Lower sales of INVOKANA®/INVOKAMET® (canagliflozin) in the U.S. was primarily due to an increase in price discounts, higher rebates and market share decline driven by competitive pressure. Lower sales of XARELTO® (rivaroxaban) were driven by an increase in discounts and rebates, partially offset by an increase in market share.



                
 
20
                                


During 2018, the Company advanced its pipeline with several regulatory submissions and approvals for new drugs and additional indications for existing drugs as follows:
Product Name (Chemical Name)
Indication
US Approval
EU Approval
US Filing
EU Filing
DARZALEX® (daratumumab)
Frontline multiple myeloma transplant ineligible patients in combination with bortezomib, melphalan, and prednisone
Ÿ
Ÿ
 
 
erdafitinib
Treatment of locally advanced or metastatic urothelial cancer

 
 
Ÿ
 
 ERLEADA™ (apalutamide)
Treatment of non-metastatic castration-resistant prostate cancer
Ÿ
 
 
Ÿ
esketamine
Antidepressant for treatment-resistant depression in adults
 
 
Ÿ
Ÿ
IMBRUVICA®  (ibrutinib)
Treatment of Waldenstrom's macroglobulinemia used in combination with rituximab
Ÿ
 
 
Ÿ
 
Treatment for previously untreated Chronic Lymphocytic Leukemia in combination with obinutuzumab
 
 
Ÿ
Ÿ
INVOKANA®  (canagliflozin)
Reduce the risk of death in type 2 diabetes with established, or risk for, cardiovascular disease. (CANVAS/CANVAS-R )
Ÿ
Ÿ
 
 
JULUCA® (rilpivirine and dolutegravir)
Single-tablet, once-daily, two-drug regimen for the treatment of HIV-1 infection
 
Ÿ
 
 
OPSUMIT® (macitentan)
Treatment of adults with inoperable chronic thromboembolic pulmonary hypertension to improve exercise capacity and pulmonary vascular resistance
 
 
Ÿ
Ÿ
STELARA® (ustekinumab)
Treatment of adults with moderately to severely active ulcerative colitis
 
 
Ÿ
Ÿ
SYMTUZA® (darunavir/cobicistat/ emtricitabine/tenofovir alafenamide)
A complete darunavir-based single-tablet regimen for the treatment of HIV-1 infection
Ÿ
 
 
 
TREMFYA® (guselkumab)
Patient controlled injector for the treatment of adults living with moderate to severe plaque psoriasis
 
Ÿ
Ÿ
 
XARELTO® (rivaroxaban)
Treatment to reduce the risk of major cardiovascular events in people with chronic coronary or peripheral artery disease
Ÿ
 
 
 
 
For the prevention of venous thromboembolism for medically ill patients
 
 
Ÿ
 
ZYTIGA®  (abiraterone acetate)
Treatment of Hormone Naïve Metastatic Prostate Cancer
Ÿ
 
 
 

Pharmaceutical segment sales in 2017 were $36.3 billion, an increase of 8.3% from 2016, which included operational growth of 8.0% and a positive currency impact of 0.3%. U.S. sales were $21.5 billion, an increase of 6.7%. International sales were $14.8 billion, an increase of 10.8%, which included 10.1% operational growth and a positive currency impact of 0.7%. In 2017, acquisitions and divestitures had a net positive impact of 3.8% on the operational sales growth of the worldwide Pharmaceutical segment. Adjustments to previous reserve estimates, as compared to the prior year, negatively impacted the reported Pharmaceutical segment operational growth by approximately 1.8%, primarily in the Immunology and Cardiovascular/Metabolism/Other therapeutic areas.


                
 
21
                                



Medical Devices Segment
The Medical Devices segment sales in 2018 were $27.0 billion, an increase of 1.5% from 2017, which included an operational increase of 1.1% and a positive currency impact of 0.4%. U.S. sales were $12.8 billion, an increase of 0.1% as compared to the prior year. International sales were $14.2 billion, an increase of 2.8% as compared to the prior year, with an operational increase of 1.9% and a positive currency impact of 0.9%. In 2018, acquisitions and divestitures had a net negative impact of 1.5% on the worldwide operational sales growth of the Medical Devices segment as compared to 2017.
Major Medical Devices Franchise Sales:*
 
 
 
 
 
 
 
 
% Change
(Dollars in Millions)
 
2018
 
2017
 
2016
 
’18 vs. ’17
 
’17 vs. ’16
Surgery
 
$
9,901

 
9,559

 
9,296

 
3.6
 %
 
2.8

     Advanced
 
4,002

 
3,756

 
3,517

 
6.5

 
6.8

     General
 
4,557

 
4,463

 
4,362

 
2.1

 
2.3

     Specialty
 
1,342

 
1,340

 
1,417

 
0.1

 
(5.4
)
Orthopaedics
 
8,885

 
9,058

 
9,128

 
(1.9
)
 
(0.8
)
     Hips
 
1,418

 
1,394

 
1,361

 
1.7

 
2.4

     Knees
 
1,502

 
1,523

 
1,524

 
(1.4
)
 
(0.1
)
     Trauma
 
2,699

 
2,616

 
2,569

 
3.2

 
1.8

     Spine & Other
 
3,266

 
3,525

 
3,674

 
(7.3
)
 
(4.1
)
Vision
 
4,553

 
4,063

 
2,785

 
12.1

 
45.9

     Contact Lenses/Other
 
3,302

 
3,036

 
2,785

 
8.8

 
9.0

     Surgical
 
1,251

 
1,027

 
—

 
21.8

 
**
Interventional Solutions (1)
 
2,646

 
2,296

 
2,055

 
15.2

 
11.7

Diabetes Care
 
1,009

 
1,615

 
1,789

 
(37.5
)
 
(9.7
)
Diagnostics (2)
 
—

 
1

 
66

 
***
 
***
Total Medical Devices Sales
 
$
26,994

 
26,592

 
25,119

 
1.5
 %
 
5.9

(1)Previously referred to as Cardiovascular
(2)On June 30, 2014, the Company divested the Ortho-Clinical Diagnostics business (the Diagnostics Franchise) and amounts represent transitional service agreement that concluded in 2017.
* Prior year amounts have been reclassified to conform to current year presentation
**Products acquired from Abbott Medical Optics (AMO) on February 27, 2017
*** Percentage greater than 100% or not meaningful

The Surgery franchise sales were $9.9 billion in 2018, an increase of 3.6% from 2017. Growth in Advanced Surgery was primarily driven by endocutter, biosurgery and energy products. Growth in General Surgery was primarily driven by wound care products. Growth in Specialty Surgery was primarily driven by Advanced Sterilization Products.
The Orthopaedics franchise sales were $8.9 billion in 2018, a decrease of 1.9% from 2017. The decline in Spine & Other was primarily due to the Codman Neurosurgery divestiture and share loss in Spine partially offset by new product launches. The decline in knees was primarily due to competitive pressure in the U.S. partially offset by growth in Asia Pacific. Growth in hips and trauma was due to continued uptake of new products.
The Vision franchise achieved sales of $4.6 billion in 2018, an increase of 12.1% from 2017. Growth was primarily driven by strength of the astigmatism and daily disposable lenses in the OASYS® contact lenses category. Surgical growth was driven by cataract performance primarily outside the U.S.
The Interventional Solutions franchise (includes the Cerenovus business previously included in Spine and Other in Orthopaedics) sales were $2.6 billion, an increase of 15.2% from 2017. Strong growth in the electrophysiology business was driven by Atrial Fibrillation procedure growth and continued uptake of the THERMOCOOL SMARTTOUCH® Contact Force Sensing Catheter.
The Diabetes Care franchise sales were $1.0 billion, a decrease of 37.5% from 2017. The decline was primarily due to divestiture of its LifeScan business in the fiscal fourth quarter of 2018 and the Company's decision to exit the Animas insulin pump business in the fiscal fourth quarter of 2017.
The Medical Devices segment sales in 2017 were $26.6 billion, an increase of 5.9% from 2016, which included an operational increase of 5.7% and a positive currency impact of 0.2%. U.S. sales were $12.8 billion, an increase of 4.5% as compared to the prior year. International sales were $13.8 billion, an increase of 7.1% as compared to the prior year, with an

                
 
22
                                


operational increase of 6.7% and a positive currency impact of 0.4%. In 2017, acquisitions and divestitures had a net positive impact of 4.2% on the worldwide operational sales growth of the Medical Devices segment as compared to 2016.


Analysis of Consolidated Earnings Before Provision for Taxes on Income
Consolidated earnings before provision for taxes on income was $18.0 billion, $17.7 billion and $19.8 billion for the fiscal years ended 2018, 2017 and 2016, respectively. As a percent to sales, consolidated earnings before provision for taxes on income was 22.1%, 23.1%, and 27.5% in 2018, 2017 and 2016, respectively.

chart-e981d5a5e2a218e4beb.jpg
Cost of Products Sold and Selling, Marketing and Administrative Expenses:  Cost of products sold and selling, marketing and administrative expenses as a percent to sales were as follows:*
% of Sales
 
2018
 
2017
 
2016
Cost of products sold*
 
33.2
%
 
33.3

 
30.3

Percent point increase/(decrease) over the prior year
 
(0.1
)
 
3.0

 
(0.3
)
Selling, marketing and administrative expenses*
 
27.6
%
 
28.1

 
27.9

Percent point increase/(decrease) over the prior year
 
(0.5
)
 
0.2

 
(2.2
)
*Prior years amounts were reclassified to conform to current year presentation (adoption of ASU 2017-07)

In 2018, cost of products sold as a percent to sales decreased to 33.2% from 33.3% as compared to the same period a year ago primarily due to lower inventory step-up costs related to the Actelion acquisition and favorable product and segment mix driven by a higher percentage of sales from the Pharmaceutical segment. This was mostly offset by higher amortization expense primarily related to the Actelion acquisition on June 16, 2017. Intangible asset amortization expense of $4.4 billion was included in cost of products sold for 2018 as compared to $3.0 billion in 2017. There was a decrease in the percent to sales of selling, marketing and administrative expenses in 2018 as compared to the prior year, primarily due to lower costs relative to sales growth in the Pharmaceutical business and favorable segment mix.
In 2017, cost of products sold as a percent to sales increased to 33.3% from 30.3% as compared to the same period a year ago. The unfavorable increase was primarily driven by $2.3 billion of higher amortization expense and charges for inventory step-up related to the recent acquisitions, primarily Actelion. Intangible asset amortization expense of $3.0 billion was included in cost of products sold for 2017 as compared to $1.2 billion in 2016. There was an increase in the percent to sales of selling, marketing and administrative expenses in 2017 as compared to the prior year, primarily due to investments in new product launches partially offset by favorable mix.


                
 
23
                                


Research and Development Expense: Research and development expense by segment of business was as follows:*
 
 
2018
 
2017
 
2016
(Dollars in Millions)
 
Amount
 
% of Sales**
 
Amount
 
% of Sales**
 
Amount
 
% of Sales**
Consumer
 
$
565

 
4.1
%
 
586

 
4.3

 
585

 
4.4

Pharmaceutical
 
8,446

 
20.7

 
8,392

 
23.1

 
7,001

 
20.9

Medical Devices
 
1,764

 
6.5

 
1,616

 
6.1

 
1,557

 
6.2

Total research and development expense
 
$
10,775

 
13.2
%
 
10,594

 
13.9

 
9,143

 
12.7

Percent increase/(decrease) over the prior year
 
1.7
%
 
 

 
15.9

 
 

 
1.6

 
 

*Prior years amounts were reclassified to conform to current year presentation (adoption of ASU 2017-07)
**As a percent to segment sales
Research and development activities represent a significant part of the Company's business. These expenditures relate to the processes of discovering, testing and developing new products, upfront payments and milestones, improving existing products, as well as ensuring product efficacy and regulatory compliance prior to launch. The Company remains committed to investing in research and development with the aim of delivering high quality and innovative products. In 2018, worldwide costs of research and development activities increased by 1.7% compared to 2017 but decreased as a percent of sales. The decrease as a percent of sales in the Pharmaceutical segment was attributable to lower costs relative to sales growth. The increased dollar spend in the Medical Devices and Pharmaceutical segments was for investment spending to advance the pipeline. In 2017, worldwide costs of research and development activities increased by 15.9% compared to 2016. The increase as a percent of sales was primarily in the Pharmaceutical segment due to general portfolio progression as well as collaborative agreements entered into with Idorsia Ltd. and Legend Biotech. Research facilities are located in the U.S., Belgium, Brazil, China, France, Germany, India, Israel, the Netherlands, Poland, Singapore, Sweden, Switzerland and the United Kingdom with additional R&D support in over 30 other countries.

In-Process Research and Development (IPR&D): In 2018, the Company recorded an IPR&D charge of $1.1 billion. Of the $1.1 billion, a partial impairment charge of $0.8 billion related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios Biopharma Inc. The impairment charge was calculated based on updated cash flow projections discounted for the inherent risk in the asset development and reflects the impact of the phase 2b clinical trial suspension, a decrease in the probability of success factors and the ongoing analysis of asset development activities. The Company continues to evaluate information with respect to the development program and will monitor the remaining $0.9 billion intangible asset for further impairment. In addition, an impairment charge of $0.3 billion was recorded for the discontinuation of the development project for an anti-thrombin antibody associated with the 2015 acquisition of XO1 Limited.
In 2017, the Company recorded an IPR&D charge of $0.4 billion primarily for the discontinuation of certain development projects related to Novira which was acquired in 2015. The product development was canceled due to safety concerns. In 2016, the Company recorded an IPR&D charge of $29 million for the discontinuation of a development program related to Crucell.

Other (Income) Expense, Net: Other (income) expense, net is the account where the Company records gains and losses related to the sale and write-down of certain investments in equity securities held by Johnson & Johnson Innovation - JJDC, Inc. (JJDC), unrealized gains and losses on investments, gains and losses on divestitures, certain transactional currency gains and losses, acquisition-related costs, litigation accruals and settlements, as well as royalty income.
The change in other (income) expense, net for the fiscal year 2018 was an unfavorable change of $1.4 billion primarily due to litigation expense of $2.0 billion in 2018 as compared to $1.3 billion in 2017. Additionally, 2018 included unrealized losses on securities of $0.2 billion and lower realized gains of $0.4 billion related to investments in equity securities as compared to the prior year. This was partially offset by a reversal of a contingent liability of $0.2 billion and lower costs of $0.1 billion related to the Actelion and AMO acquisitions in 2018 as compared to 2017. The fiscal year of 2017 included a gain of $0.2 billion related to monetization of future royalty receivables offset by an asset impairment charge of $0.2 billion primarily related to the insulin pump business. Divestiture gains were approximately $1.2 billion in 2018 and included the LifeScan business, NIZORAL®, RoC® and certain non-strategic Pharmaceutical products. Divestiture gains were approximately $1.3 billion in 2017 and primarily included the Codman Neurosurgery and COMPEED® divestitures. Additionally, restructuring related expense in 2018 was $0.3 billion as compared to $0.4 billion 2017.
The change in other (income) expense, net for the fiscal year 2017 was a favorable change of $0.3 billion due to higher gains of $0.7 billion on the sale of assets/businesses, primarily the Codman Neurosurgery and COMPEED® divestitures, a gain of $0.2 billion related to monetization of future royalty receivables and a higher gain of $0.3 billion related to the sale of certain investments in equity securities as compared to the prior year. This was partially offset by higher litigation expense of $0.4 billion, $0.3 billion of acquisition costs related to Actelion and AMO, an asset impairment charge of $0.2 billion primarily

                
 
24
                                


related to the insulin pump business and a higher restructuring related charge of $0.2 billion as compared to the fiscal year 2016.

Interest (Income) Expense:  Interest income was higher in 2018 as compared to 2017 due to a higher average interest rate and a benefit from net investment hedging partially offset by a lower average cash, cash equivalents and marketable securities balance during the period. Cash, cash equivalents and marketable securities totaled $19.7 billion at the end of 2018, and averaged $19.0 billion as compared to the cash, cash equivalents and marketable securities total of $18.3 billion and $30.1 billion average cash balance in 2017. The decrease in the average balance of cash, cash equivalents and marketable securities was due to the use of cash for general corporate purposes, primarily the Actelion acquisition for $29.6 billion, net of cash acquired late in the fiscal second quarter of 2017.
Interest expense in 2018 was higher as compared to 2017 due to a higher average debt balance. The average debt balance was $32.5 billion in 2018 versus $30.9 billion in 2017. The total debt balance at the end of 2018 was $30.5 billion as compared to $34.6 billion at the end of 2017.
Interest income in 2017 increased slightly as compared to 2016 due to higher average interest rates partially offset by lower cash, cash equivalents and marketable securities balances during the period. Cash, cash equivalents and marketable securities totaled $18.3 billion at the end of 2017, and averaged $30.1 billion as compared to the $40.1 billion average cash balance in 2016. The decrease in the balance of cash, cash equivalents and marketable securities was due to the use of cash for general corporate purposes including acquisitions, primarily the Actelion acquisition for $29.6 billion, net of cash acquired.
Interest expense in 2017 was higher as compared to 2016. The average debt balance was $30.9 billion in 2017 versus $23.5 billion in 2016. The total debt balance at the end of 2017 was $34.6 billion as compared to $27.1 billion at the end of 2016. The higher debt balance of approximately $7.5 billion was primarily due to increased borrowings. The Company increased borrowings in February and November of 2017, capitalizing on favorable terms in the capital markets. The proceeds of the borrowings were used for general corporate purposes, including the completion of the stock repurchase program.
Income Before Tax by Segment
Income before tax by segment of business were as follows:
 
 
Income Before Tax
 
Segment Sales
 
Percent of Segment Sales
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
Consumer
 
$
2,320

 
2,524

 
13,853

 
13,602

 
16.7
%
 
18.6
Pharmaceutical
 
12,568

 
11,083

 
40,734

 
36,256

 
30.9

 
30.6
Medical Devices
 
4,397

 
5,392

 
26,994

 
26,592

 
16.3

 
20.3
Total (1)
 
19,285

 
18,999

 
81,581

 
76,450

 
23.6

 
24.9
Less: Expenses not allocated to segments (2)
 
1,286

 
1,326

 
 
 
 
 
 

 
 
Earnings before provision for taxes on income
 
$
17,999

 
17,673

 
81,581

 
76,450

 
22.1
%
 
23.1

(1) 
See Note 18 to the Consolidated Financial Statements for more details.
(2) 
Amounts not allocated to segments include interest (income) expense and general corporate (income) expense.
 
Consumer Segment: In 2018, the Consumer segment income before tax as a percent to sales was 16.7%, versus 18.6% in 2017. The decrease in the income before tax as a percent of sales in 2018 as compared to 2017 was primarily attributable to higher litigation expense of $0.3 billion in 2018 partially offset by slower increases in expenses relative to the increase in sales. Divestiture gains for the fiscal year of 2018, which included the divestitures of NIZORAL® and RoC® were comparable to fiscal year of 2017. A gain of $0.3 billion was recognized from the divestiture of NIZORAL®.
In 2017, the Consumer segment income before tax as a percent to sales was 18.6%, versus 18.3% in 2016. The increase in the income before tax as a percent of sales in 2017 as compared to 2016 was attributable to higher gains on divestitures, primarily the divestiture of COMPEED® in 2017. This was partially offset by higher selling, marketing and administrative expenses as compared to the prior year due to increased advertising and promotional spending and slightly higher amortization expense in 2017 related to acquisitions. Additionally, the fiscal year 2016 was negatively impacted by operations in Venezuela.

Pharmaceutical Segment: In 2018, the Pharmaceutical segment income before tax as a percent to sales was 30.9% versus 30.6% in 2017. The increase in the income before tax as a percent of sales was primarily due to lower inventory step-up costs related to Actelion of $0.6 billion, favorable product mix and slower increases in expenses relative to the increase in sales, a contingent liability reversal of $0.2 billion and higher divestiture gains of $0.2 billion from divestitures of certain non-strategic Pharmaceutical products. This was partially offset by higher amortization expense of $1.3 billion primarily related to the Actelion acquisition, a higher IPR&D charge of $0.7 billion and an unrealized loss on securities of $0.2 billion as compared to

                
 
25
                                


the prior year. Additionally, 2017 included a gain of $0.2 billion related to monetization of future royalty receivables and a higher gain of $0.3 billion related to the sale of certain investments in equity securities.
In 2017, the Pharmaceutical segment income before tax as a percent to sales was 30.6% versus 38.3% in 2016. The decrease in the income before tax as a percent of sales was primarily due to $2.3 billion of higher amortization expense and other costs related to the Actelion acquisition, higher research and development expense, a higher IPR&D charge of $0.4 billion related to Novira and lower gains on divestitures as compared to the prior year. Additionally, the fiscal year 2016 included a positive adjustment of $0.5 billion to previous reserve estimates. This was partially offset by a gain of $0.2 billion related to monetization of future royalty receivables, a higher gain of $0.2 billion related to the sale of certain investments in equity securities and favorable product mix in 2017.

Medical Devices Segment: In 2018, the Medical Devices segment income before tax as a percent to sales was 16.3% versus 20.3% in 2017. The decrease in the income before tax as a percent to sales was primarily due higher litigation expense of $1.7 billion in 2018 as compared to $1.1 billion in 2017 and higher investments in the business in 2018. Additionally, 2018 had lower divestiture gains of approximately $0.3 billion as compared to divestiture gains in 2017. In 2018 the Company recorded a gain of $0.5 billion related to the LifeScan divestiture. This was partially offset by lower restructuring expense of $0.2 billion in 2018 as compared to 2017. Additionally, 2017 included an asset impairment charge of $0.2 billion primarily related to the insulin pump business.
In 2017, the Medical Devices segment income before tax as a percent to sales was 20.3% versus 22.2% in 2016. The decrease in the income before tax as a percent to sales was primarily due to $0.3 billion of higher amortization expense and other acquisition costs related to AMO, $0.3 billion of higher litigation, an asset impairment charge of $0.2 billion primarily related to the insulin pump business, $0.1 billion of higher restructuring and investments in new product launches as compared to the fiscal year 2016. This was partially offset by $0.8 billion higher gains in 2017 related to divestitures, primarily the divestiture of Codman Neurosurgery.

Restructuring: In the first quarter of 2016, the Company announced restructuring actions in its Medical Devices segment. The Company has achieved approximately $0.7 billion of annualized pre-tax cost saving in 2018 and is on track to achieve the annualized pre-tax cost savings of $0.8 billion to $1.0 billion as outlined in the restructuring actions. The savings will provide the Company with added flexibility and resources to fund investment in new growth opportunities and innovative solutions for customers and patients. In 2018, the Company recorded a pre-tax charge of $462 million, of which $46 million is included in cost of products sold and $227 million is included in other (income) expense. Total project costs of approximately $2.5 billion have been recorded since the restructuring was announced. This restructuring program was completed in the fiscal fourth quarter of 2018.
In the second quarter of 2018, the Company announced plans to implement actions across its global supply chain that are intended to enable the Company to focus resources and increase investments in critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio of the future, enhance agility and drive growth. The Company expects these supply chain actions will include expanding its use of strategic collaborations, and bolstering its initiatives to reduce complexity, improving cost-competitiveness, enhancing capabilities and optimizing its network.  Discussions regarding specific future actions are ongoing and are subject to all relevant consultation requirements before they are finalized. In total, the Company expects these actions to generate approximately $0.6 to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 to $2.3 billion. The Company estimates that approximately 70% of the cumulative pre-tax costs will result in cash outlays. In 2018, the Company recorded a pre-tax charge of $238 million, of which $59 million is included in cost of products sold and $117 million is included in other (income) expense.

See Note 22 to the Consolidated Financial Statements for additional details related to the restructuring programs.

Provision for Taxes on Income:  The worldwide effective income tax rate was 15.0% in 2018, 92.6% in 2017 and 16.5% in 2016. The 2018 effective tax rate decreased by 77.6% as compared to 2017. The 2017 effective tax rate was primarily driven by a provisional tax charge of approximately $13.0 billion as a result of the Tax Cuts and Jobs Act (TCJA) recorded in the fourth quarter of 2017 and the impact of a Belgian statutory tax rate change which increased the 2017 effective rate by 3.4%. The Company also received a benefit in 2018 from a lower U.S. statutory tax rate vs. 2017 as well as favorable adjustments to the 2017 provisional TCJA tax charge partially offset by unfavorable income tax mix and the U.S. tax on global intangible low-taxed income (GILTI).
The 2017 effective tax rate increased by 76.1% as compared to 2016, primarily driven by the enactment of the Tax Cuts and Jobs Act (TCJA) in the United States in December 2017. The enactment of the TCJA resulted in a provisional tax charge in the fourth quarter of 2017, of approximately $13.0 billion or approximately 73.3 percentage point increase to the effective tax rate. See Note 8 to the Consolidated Financial Statements for additional details related to the TCJA.

                
 
26
                                


The remainder of the increase in the tax rate for 2017 was related to the remeasurement of the Company’s deferred tax assets in Belgium, as a result of changes in the Belgian statutory corporate tax rate, enacted in December 2017, offset by a tax benefit for the closure of the Company’s Animas insulin pump business.
The government in Switzerland is currently considering tax reform legislation, which could have a material impact on the Company’s effective tax rate if enacted into law.
See Note 8 to the Consolidated Financial Statements for additional details related to the TCJA and income taxes.


Liquidity and Capital Resources
Liquidity & Cash Flows
Cash and cash equivalents were $18.1 billion at the end of 2018 as compared to $17.8 billion at the end of 2017. The primary sources and uses of cash that contributed to the $0.3 billion increase were approximately $22.2 billion of cash generated from operating activities. This was partially offset by $3.2 billion net cash used by investing activities, $18.5 billion net cash used by financing activities and $0.2 billion due to the effect on exchange rate changes on cash and cash equivalents. In addition, the Company had $1.6 billion in marketable securities at the end of 2018 and $0.5 billion at the end of 2017. See Note 1 to the Consolidated Financial Statements for additional details on cash, cash equivalents and marketable securities.
Cash flow from operations of $22.2 billion was the result of $15.3 billion of net earnings and $9.2 billion of non-cash expenses and other adjustments for depreciation and amortization, stock-based compensation and assets write-downs, offset by $2.3 billion from net gains on sale of assets/businesses, deferred tax provision and accounts receivable allowances, $3.9 billion related to an increase in accounts receivable, inventories and other current and non-current assets and a decrease in other current and non-current liabilities. Additional sources of operating cash flow of $4.0 billion resulted from an increase in accounts payable and accrued liabilities. The decrease in current and non-current liabilities is primarily due to the 2018 tax payment related to TCJA.
Investing activities use of $3.2 billion was for additions to property, plant and equipment of $3.7 billion, the net purchase of investments primarily marketable securities of $1.3 billion, acquisitions, net of cash acquired of $0.9 billion (primarily the acquisitions of Zarbee's) and other uses of $0.5 billion. This was partially offset by $3.2 billion of proceeds from the disposal of assets/businesses (primarily the divestiture of LifeScan).
Financing activities use of $18.5 billion was primarily for dividends to shareholders of $9.5 billion, $5.9 billion for the repurchase of common stock, $3.9 billion for the net retirement of short and long-term debt and $0.2 billion of other financing. Financing activities also included sources of $1.0 billion of proceeds from stock options exercised/employee withholding tax on stock awards, net.
On December 17, 2018, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to $5.0 billion of the Company's shares of common stock. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Any shares acquired will be available for general corporate purposes. The Company intends to finance the share repurchase program through available cash. As of December 30, 2018, $0.9 billion has been repurchased under the program.
As of December 30, 2018, the Company's notes payable and long-term debt was in excess of cash, cash equivalents and marketable securities. As of December 30, 2018, the net debt position was $10.8 billion as compared to the prior year of $16.3 billion. There was a decrease in the net debt position due to retirement of debt. The debt balance at the end of 2018 was $30.5 billion as compared to $34.6 billion in 2017. Additionally there was a higher cash, cash equivalents and marketable securities balance at the end of 2018. In 2018, the Company continued to have access to liquidity through the commercial paper market. Additionally, as a result of the TCJA, the Company has access to its cash outside the U.S. at a significantly reduced cost. The Company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs for the next twelve months. The Company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable. The Company filed a new shelf registration on February 27, 2017 which will enable it to issue debt securities on a timely basis. For additional details on borrowings, see Note 7 to the Consolidated Financial Statements.

Financing and Market Risk
The Company uses financial instruments to manage the impact of foreign exchange rate changes on cash flows. Accordingly, the Company enters into forward foreign exchange contracts to protect the value of certain foreign currency assets and liabilities and to hedge future foreign currency transactions primarily related to product costs. Gains or losses on these contracts are offset by the gains or losses on the underlying transactions. A 10% appreciation of the U.S. Dollar from the December 30, 2018 market rates would increase the unrealized value of the Company’s forward contracts by $57 million. Conversely, a 10% depreciation of the U.S. Dollar from the December 30, 2018 market rates would decrease the unrealized value of the Company’s forward contracts by $69 million. In either scenario, the gain or loss on the forward contract would be offset by the gain or loss on the underlying transaction, and therefore, would have no impact on future anticipated earnings and cash flows.

                
 
27
                                


The Company hedges the exposure to fluctuations in currency exchange rates, and the effect on certain assets and liabilities in foreign currency, by entering into currency swap contracts. A 1% change in the spread between U.S. and foreign interest rates on the Company’s interest rate sensitive financial instruments would either increase or decrease the unrealized value of the Company’s swap contracts by approximately $226 million. In either scenario, at maturity, the gain or loss on the swap contract would be offset by the gain or loss on the underlying transaction, and therefore, would have no impact on future anticipated cash flows.
The Company does not enter into financial instruments for trading or speculative purposes. Further, the Company has a policy of only entering into contracts with parties that have at least an investment grade credit rating. The counter-parties to these contracts are major financial institutions and there is no significant concentration of exposure with any one counter-party. Management believes the risk of loss is remote. During the fiscal second quarter of 2017, the Company entered into credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements.
The Company invests in both fixed rate and floating rate interest earning securities which carry a degree of interest rate risk. The fair market value of fixed rate securities may be adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall. A 1% (100 basis points) change in spread on the Company’s interest rate sensitive investments would either increase or decrease the unrealized value of cash equivalents and current marketable securities by approximately $8 million.
The Company has access to substantial sources of funds at numerous banks worldwide. In September 2018, the Company secured a new 364-day Credit Facility. Total credit available to the Company approximates $10 billion, which expires on September 12, 2019. Interest charged on borrowings under the credit line agreement is based on either bids provided by banks, the prime rate or London Interbank Offered Rates (LIBOR), plus applicable margins. Commitment fees under the agreement are not material.
Total borrowings at the end of 2018 and 2017 were $30.5 billion and $34.6 billion, respectively. The decrease in borrowings was due to the retirement of debt in 2018. In 2018, net debt (cash and current marketable securities, net of debt) was $10.8 billion compared to net debt of $16.3 billion in 2017. Total debt represented 33.8% of total capital (shareholders’ equity and total debt) in 2018 and 36.5% of total capital in 2017. Shareholders’ equity per share at the end of 2018 was $22.44 compared to $22.43 at year-end 2017.
A summary of borrowings can be found in Note 7 to the Consolidated Financial Statements.
Contractual Obligations and Commitments
The Company’s contractual obligations are primarily for the recently enacted tax legislation, leases, debt and unfunded retirement plans. There are no other significant obligations. To satisfy these obligations, the Company will use cash from operations. The following table summarizes the Company’s contractual obligations and their aggregate maturities as of December 30, 2018 (see Notes 7, 8, 10 and 16 to the Consolidated Financial Statements for further details):

(Dollars in Millions)
 
Tax Legislation (TCJA)
 
Debt Obligations
 
Interest on
Debt Obligations
 
Unfunded
Retirement Plans
 
Operating Leases
 
Total
2019
 
$
—

 
2,636

 
949

 
92

 
223

 
3,900

2020
 
531

 
1,098

 
886

 
95

 
188

 
2,798

2021
 
812

 
1,796

 
841

 
101

 
154

 
3,704

2022
 
812

 
2,134

 
796

 
108

 
116

 
3,966

2023
 
1,522

 
1,553

 
764

 
115

 
76

 
4,030

After 2023
 
4,565

 
21,103

 
8,850

 
697

 
139

 
35,354

Total
 
$
8,242

 
30,320

 
13,086

 
1,208

 
896

 
53,752


For tax matters, see Note 8 to the Consolidated Financial Statements. For other retirement plan and post-employment medical benefit information, see Note 10 to the Consolidated Financial Statements. The table does not include activity related to business combinations.
Dividends
The Company increased its dividend in 2018 for the 56th consecutive year. Cash dividends paid were $3.54 per share in 2018 compared with dividends of $3.32 per share in 2017, and $3.15 per share in 2016.



                
 
28
                                



 
Other Information
Critical Accounting Policies and Estimates
Management’s discussion and analysis of results of operations and financial condition are based on the Company’s consolidated financial statements that have been prepared in accordance with accounting principles generally accepted in the U.S. (GAAP). The preparation of these financial statements requires that management make estimates and assumptions that affect the amounts reported for revenues, expenses, assets, liabilities and other related disclosures. Actual results may or may not differ from these estimates. The Company believes that the understanding of certain key accounting policies and estimates are essential in achieving more insight into the Company’s operating results and financial condition. These key accounting policies include revenue recognition, income taxes, legal and self-insurance contingencies, valuation of long-lived assets, assumptions used to determine the amounts recorded for pensions and other employee benefit plans and accounting for stock based awards.

Revenue Recognition: The Company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. The Company's global payment terms are typically between 30 to 90 days. Provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales. See Note 1 to the Consolidated Financial Statements for the Accounting Standards Update related to revenue which was adopted in 2018.
Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. Rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. The Company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.
Sales returns are estimated and recorded based on historical sales and returns information. Products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.
Sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. The sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. In accordance with the Company’s accounting policies, the Company generally issues credit to customers for returned goods. The Company’s sales returns reserves are accounted for in accordance with the U.S. GAAP guidance for revenue recognition when right of return exists. Sales returns reserves are recorded at full sales value. Sales returns in the Consumer and Pharmaceutical segments are almost exclusively not resalable. Sales returns for certain franchises in the Medical Devices segment are typically resalable but are not material. The Company infrequently exchanges products from inventory for returned products. The sales returns reserve for the total Company has been approximately 1.0% of annual net trade sales during the fiscal reporting years 2018, 2017 and 2016.
Promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. Continuing promotional programs include coupons and volume-based sales incentive programs. The redemption cost of consumer coupons is based on historical redemption experience by product and value. Volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. These arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. The Company also earns profit-share payments through collaborative arrangements of certain products, which are included in sales to customers. For all years presented, profit-share payments were less than 2.0% of the total revenues and are included in sales to customers.
In addition, the Company enters into collaboration arrangements that contain multiple revenue generating activities. Amounts due from collaborative partners for these arrangements are recognized as each activity is performed or delivered, based on the relative selling price. Upfront fees received as part of these arrangements are deferred and recognized over the performance period. See Note 1 to the Consolidated Financial Statements for additional disclosures on collaborations.
Reasonably likely changes to assumptions used to calculate the accruals for rebates, returns and promotions are not anticipated to have a material effect on the financial statements. The Company currently discloses the impact of changes to assumptions in the quarterly or annual filing in which there is a material financial statement impact.

                
 
29
                                



Below are tables that show the progression of accrued rebates, returns, promotions, reserve for doubtful accounts and reserve for cash discounts by segment of business for the fiscal years ended December 30, 2018 and December 31, 2017.

Consumer Segment
(Dollars in Millions)
 
Balance at
Beginning of Period
 
Accruals
 
Payments/Credits
 
Balance at
End of Period
2018
 
 

 
 

 
 

 
 

Accrued rebates (1)
 
$
186

 
836

 
(751
)
 
271

Accrued returns
 
68

 
98

 
(109
)
 
57

Accrued promotions
 
481

 
2,233

 
(2,217
)
 
497

Subtotal
 
$
735

 
3,167

 
(3,077
)
 
825

Reserve for doubtful accounts
 
31

 
10

 
(9
)
 
32

Reserve for cash discounts
 
23

 
204

 
(204
)
 
23

Total
 
$
789

 
3,381

 
(3,290
)
 
880

 
 
 
 
 
 
 
 
 
2017
 
 

 
 

 
 

 
 

Accrued rebates(1)
 
$
136

 
638

 
(588
)
 
186

Accrued returns
 
65

 
128

 
(125
)
 
68

Accrued promotions
 
358

 
2,148

 
(2,025
)
 
481

Subtotal
 
$
559

 
2,914

 
(2,738
)
 
735

Reserve for doubtful accounts
 
24

 
10

 
(3
)
 
31

Reserve for cash discounts
 
25

 
205

 
(207
)
 
23

Total
 
$
608

 
3,129

 
(2,948
)
 
789

(1) 
Includes reserve for customer rebates of $57 million at December 30, 2018 and $48 million at December 31, 2017, recorded as a contra asset.
Pharmaceutical Segment
(Dollars in Millions)
 
Balance at
Beginning of Period
 
Accruals
 
Payments/Credits(2)
 
Balance at
End of Period
2018
 
 

 
 

 
 

 
 

Accrued rebates (1)
 
$
4,862

 
22,644

 
(19,996
)
 
7,510

Accrued returns
 
362

 
385

 
(311
)
 
436

Accrued promotions
 
35

 
46

 
(68
)
 
13

Subtotal
 
$
5,259

 
23,075

 
(20,375
)
 
7,959

Reserve for doubtful accounts
 
77

 
37

 
(67
)
 
47

Reserve for cash discounts
 
55

 
860

 
(862
)
 
53

Total
 
$
5,391

 
23,972

 
(21,304
)
 
8,059

 
 
 
 
 
 
 
 
 
2017
 
 

 
 

 
 

 
 

Accrued rebates (1)
 
$
3,420

 
16,447

 
(15,005
)
 
4,862

Accrued returns
 
334

 
256

 
(228
)
 
362

Accrued promotions
 
—

 
69

 
(34
)
 
35

Subtotal
 
$
3,754

 
16,772

 
(15,267
)
 
5,259

Reserve for doubtful accounts
 
38

 
40

 
(1
)
 
77

Reserve for cash discounts
 
58

 
714

 
(717
)
 
55

Total
 
$
3,850

 
17,526

 
(15,985
)
 
5,391

(1) 
Includes reserve for customer rebates of $89 million at December 30, 2018 and $90 million at December 31, 2017, recorded as a contra asset.
(2) 
Includes adjustments

                
 
30
                                



Medical Devices Segment
(Dollars in Millions)
 
Balance at
Beginning of Period
 
Accruals
 
Payments/Credits
 
Balance at
End of Period
2018
 
 

 
 

 
 

 
 

Accrued rebates(1)
 
$
1,620

 
6,344

 
(6,746
)
 
1,218

Accrued returns
 
152

 
362

 
(400
)
 
114

Accrued promotions
 
83

 
116

 
(157
)
 
42

Subtotal
 
$
1,855

 
6,822

 
(7,303
)
 
1,374

Reserve for doubtful accounts
 
183

 
29

 
(43
)
 
169

Reserve for cash discounts
 
15

 
372

 
(387
)
 
—

Total
 
$
2,053

 
7,223

 
(7,733
)
 
1,543

 
 
 
 
 
 
 
 
 
2017
 
 

 
 

 
 

 
 

Accrued rebates(1)
 
$
1,500

 
6,407

 
(6,287
)
 
1,620

Accrued returns
 
127

 
729

 
(704
)
 
152

Accrued promotions
 
32

 
135

 
(84
)
 
83

Subtotal
 
$
1,659

 
7,271

 
(7,075
)
 
1,855

Reserve for doubtful accounts
 
190

 
27

 
(34
)
 
183

Reserve for cash discounts
 
16

 
389

 
(390
)
 
15

Total
 
$
1,865

 
7,687

 
(7,499
)
 
2,053

(1) 
Includes reserve for customer rebates of $632 million at December 30, 2018 and $501 million at December 31, 2017, recorded as a contra asset.

Income Taxes:  Income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between U.S. GAAP accounting and tax reporting, recorded as deferred tax assets or liabilities. The Company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. Future changes in tax laws and rates may affect recorded deferred tax assets and liabilities.
The Company has unrecognized tax benefits for uncertain tax positions. The Company follows U.S. GAAP, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management believes that changes in these estimates would not have a material effect on the Company's results of operations, cash flows or financial position.
The Company has recorded deferred tax liabilities on all undistributed earnings prior to December 31, 2017 from its international subsidiaries. The Company has not provided deferred taxes on the undistributed earnings subsequent to January 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. The Company intends to continue to reinvest these earnings in those international operations. If the Company decides at a later date to repatriate these earnings to the U.S., the Company would be required to provide for the net tax effects on these amounts. The Company estimates that the total tax effect of this repatriation would be approximately $0.7 billion under current enacted tax laws and regulations and at current currency exchange rates.
See Note 8 to the Consolidated Financial Statements for further information regarding income taxes.
Legal and Self Insurance Contingencies:  The Company records accruals for various contingencies, including legal proceedings and product liability claims as these arise in the normal course of business. The accruals are based on management’s judgment as to the probability of losses and, where applicable, actuarially determined estimates. The Company has self insurance through a wholly-owned captive insurance company. In addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated.
The Company follows the provisions of U.S. GAAP when recording litigation related contingencies. A liability is recorded when a loss is probable and can be reasonably estimated. The best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.
See Notes 1 and 21 to the Consolidated Financial Statements for further information regarding product liability and legal proceedings.

                
 
31
                                


Long-Lived and Intangible Assets:  The Company assesses changes in economic conditions and makes assumptions regarding estimated future cash flows in evaluating the value of the Company’s property, plant and equipment, goodwill and intangible assets. As these assumptions and estimates may change over time, it may or may not be necessary for the Company to record impairment charges.
Employee Benefit Plans:  The Company sponsors various retirement and pension plans, including defined benefit, defined contribution and termination indemnity plans, which cover most employees worldwide. These plans are based on assumptions for the discount rate, expected return on plan assets, mortality rates, expected salary increases, health care cost trend rates and attrition rates. See Note 10 to the Consolidated Financial Statements for further details on these rates and the effect a rate change to the health care cost trend would have on the Company’s results of operations.
Stock Based Compensation:  The Company recognizes compensation expense associated with the issuance of equity instruments to employees for their services. Based on the type of equity instrument, the fair value is estimated on the date of grant using either the Black-Scholes option valuation model or a combination of both the Black-Scholes option valuation model and Monte Carlo valuation model, and is expensed in the financial statements over the service period. The input assumptions used in determining fair value are the expected life, expected volatility, risk-free rate and expected dividend yield. For performance share units the fair market value is calculated for each of the three component goals at the date of grant.  The fair values for the sales and earnings per share goals of each performance share unit were estimated on the date of grant using the fair market value of the shares at the time of the award, discounted for dividends, which are not paid on the performance share units during the vesting period.  The fair value for the relative total shareholder return goal of each performance share unit was estimated on the date of grant using the Monte Carlo valuation model. See Note 17 to the Consolidated Financial Statements for additional information.
New Accounting Pronouncements
Refer to Note 1 to the Consolidated Financial Statements for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of December 30, 2018.
Economic and Market Factors
The Company is aware that its products are used in an environment where, for more than a decade, policymakers, consumers and businesses have expressed concerns about the rising cost of health care. In response to these concerns, the Company has a long-standing policy of pricing products responsibly. For the period 2008 - 2018, in the U.S., the weighted average compound annual growth rate of the Company’s net price increases for health care products (prescription and over-the-counter drugs, hospital and professional products) was below the U.S. Consumer Price Index (CPI).
The Company operates in certain countries where the economic conditions continue to present significant challenges. The Company continues to monitor these situations and take appropriate actions. Inflation rates continue to have an effect on worldwide economies and, consequently, on the way companies operate. The Company has accounted for operations in Argentina (beginning in the fiscal third quarter of 2018) and Venezuela as highly inflationary, as the prior three-year cumulative inflation rate surpassed 100%. This did not have a material impact to the Company's results in the period. In the face of increasing costs, the Company strives to maintain its profit margins through cost reduction programs, productivity improvements and periodic price increases.
In June 2016, the United Kingdom (U.K.) held a referendum in which voters approved an exit from the European Union (E.U.), commonly referred to as “Brexit” and in March 2017 the U.K. formally started the process for the U.K. to leave the E.U.  Given the lack of comparable precedent, it is unclear what financial, trade, regulatory and legal implications the withdrawal of the U.K. from the E.U. will have. Brexit creates global political and economic uncertainty, which may cause, among other consequences, volatility in exchange rates and interest rates, additional cost containment by third-party payors and changes in regulations.  However, the Company currently does not believe that these and other related effects will have a material impact on the Company’s consolidated financial position or operating results. As of December 30, 2018, the business of the Company’s U.K. subsidiaries represented less than 3% of both the Company’s consolidated assets and fiscal twelve months revenues, respectively.
The Company is exposed to fluctuations in currency exchange rates. A 1% change in the value of the U.S. Dollar as compared to all foreign currencies in which the Company had sales, income or expense in 2018 would have increased or decreased the translation of foreign sales by approximately $390 million and net income by approximately $100 million.
Governments around the world consider various proposals to make changes to tax laws, which may include increasing or decreasing existing statutory tax rates. A change in statutory tax rate in any country would result in the revaluation of the Company’s deferred tax assets and liabilities related to that particular jurisdiction in the period in which the new tax law is enacted.  This change would result in an expense or benefit recorded to the Company’s Consolidated Statement of Earnings.  The Company closely monitors these proposals as they arise in the countries where it operates. Changes to the statutory tax rate may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted. On September 28, 2018 the Swiss Parliament approved the Federal Act on Tax Reform and AHV Financing (Swiss Tax Reform). However, a referendum has been called and, as a result, a public vote on the Swiss Tax Reform

                
 
32
                                


will take place on May 19th, 2019.  If the Swiss Tax Reform passes, then the measures are expected to come into force in either January 2020 or January 2021. Prior to approval in the referendum and its subsequent cantonal implementation, the proposed Swiss Tax Reform is not enacted and therefore the Company has not reflected any of the potential impacts in its fiscal results. The Company is currently assessing the impact of the proposed Swiss Tax Reform, and when enacted, the law may have a material impact on the Company’s operating results. 
The Company faces various worldwide health care changes that may continue to result in pricing pressures that include health care cost containment and government legislation relating to sales, promotions and reimbursement of health care products.
Changes in the behavior and spending patterns of purchasers of health care products and services, including delaying medical procedures, rationing prescription medications, reducing the frequency of physician visits and foregoing health care insurance coverage, as a result of the current global economic downturn, may continue to impact the Company’s businesses.
The Company also operates in an environment increasingly hostile to intellectual property rights. Firms have filed Abbreviated New Drug Applications or Biosimilar Biological Product Applications with the FDA or otherwise challenged the coverage and/or validity of the Company's patents, seeking to market generic or biosimilar forms of many of the Company’s key pharmaceutical products prior to expiration of the applicable patents covering those products. In the event the Company is not successful in defending the patent claims challenged in the resulting lawsuits, generic or biosimilar versions of the products at issue will be introduced to the market, resulting in the potential for substantial market share and revenue losses for those products, and which may result in a non-cash impairment charge in any associated intangible asset. There is also a risk that one or more competitors could launch a generic or biosimilar version of the product at issue following regulatory approval even though one or more valid patents are in place. For further information, see the discussion on “REMICADE® Related Cases” and “Litigation Against Filers of Abbreviated New Drug Applications” in Note 21 to the Consolidated Financial Statements.
Legal Proceedings
Johnson & Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability, intellectual property, commercial and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of business.
The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. The Company has accrued for certain litigation matters and continues to monitor each related legal issue and adjust accruals for new information and further developments in accordance with Accounting Standards Codification (ASC) 450-20-25. For these and other litigation and regulatory matters currently disclosed for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions. The ability to make such estimates and judgments can be affected by various factors, including whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; or there are numerous parties involved.
In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.
See Note 21 to the Consolidated Financial Statements for further information regarding legal proceedings.
Common Stock
The Company’s Common Stock is listed on the New York Stock Exchange under the symbol JNJ. As of February 15, 2019, there were 142,029 record holders of Common Stock of the Company.

Item 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information called for by this item is incorporated herein by reference to “Item 7. Management’s Discussion and Analysis of Results of Operations and Financial Condition - Liquidity and Capital Resources - Financing and Market Risk” of this Report; and Note 1 “Summary of Significant Accounting Policies - Financial Instruments” of the Notes to Consolidated Financial Statements included in Item 8 of this Report.


                
 
33
                                

Item 8.     FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA


                
 
34
                                


JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
At December 30, 2018 and December 31, 2017
(Dollars in Millions Except Share and Per Share Amounts) (Note 1)
 
2018
 
2017
Assets
 
 
 
Current assets
 

 
 

Cash and cash equivalents (Notes 1 and 2)
$
18,107

 
17,824

Marketable securities (Notes 1 and 2)
1,580

 
472

Accounts receivable trade, less allowances for doubtful accounts $248 (2017, $291)
14,098

 
13,490

Inventories (Notes 1 and 3)
8,599

 
8,765

Prepaid expenses and other receivables
2,699

 
2,537

Assets held for sale (Note 20)
950

 
—

Total current assets
46,033

 
43,088

Property, plant and equipment, net (Notes 1 and 4)
17,035

 
17,005

Intangible assets, net (Notes 1 and 5)
47,611

 
53,228

Goodwill (Notes 1 and 5)
30,453

 
31,906

Deferred taxes on income (Note 8)
7,640

 
7,105

Other assets
4,182

 
4,971

Total assets
$
152,954

 
157,303

Liabilities and Shareholders’ Equity
 

 
 

Current liabilities
 

 
 

Loans and notes payable (Note 7)
$
2,796

 
3,906

Accounts payable
7,537

 
7,310

Accrued liabilities
7,601

 
7,304

Accrued rebates, returns and promotions
9,380

 
7,210

Accrued compensation and employee related obligations
3,098

 
2,953

Accrued taxes on income (Note 8)
818

 
1,854

Total current liabilities
31,230

 
30,537

Long-term debt (Note 7)
27,684

 
30,675

Deferred taxes on income (Note 8)
7,506

 
8,368

Employee related obligations (Notes 9 and 10)
9,951

 
10,074

Long-term taxes payable (Note 8)
8,242

 
8,472

Other liabilities
8,589

 
9,017

Total liabilities
93,202

 
97,143

Shareholders’ equity
 

 
 

Preferred stock — without par value (authorized and unissued 2,000,000 shares)
—

 
—

Common stock — par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)
3,120

 
3,120

Accumulated other comprehensive income (loss) (Note 13)
(15,222
)
 
(13,199
)
Retained earnings
106,216

 
101,793

 
94,114

 
91,714

Less: common stock held in treasury, at cost (Note 12) (457,519,000 shares and 437,318,000 shares)
34,362

 
31,554

Total shareholders’ equity
59,752

 
60,160

Total liabilities and shareholders’ equity
$
152,954

 
157,303

See Notes to Consolidated Financial Statements

                
 
35
                                


JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
(Dollars and Shares in Millions Except Per Share Amounts) (Note 1)*
 
2018
 
2017
 
2016
Sales to customers
$
81,581

 
76,450

 
71,890

Cost of products sold
27,091

 
25,439

 
21,789

Gross profit
54,490

 
51,011

 
50,101

Selling, marketing and administrative expenses
22,540

 
21,520

 
20,067

Research and development expense
10,775

 
10,594

 
9,143

In-process research and development
1,126

 
408

 
29

Interest income
(611
)
 
(385
)
 
(368
)
Interest expense, net of portion capitalized (Note 4)
1,005

 
934

 
726

Other (income) expense, net
1,405

 
(42
)
 
210

Restructuring (Note 22)
251

 
309

 
491

Earnings before provision for taxes on income
17,999

 
17,673

 
19,803

Provision for taxes on income (Note 8)
2,702

 
16,373

 
3,263

Net earnings
$
15,297

 
1,300

 
16,540

 
 
 
 
 
 
Net earnings per share (Notes 1 and 15)
 
 
 
 
 
    Basic
$
5.70

 
0.48

 
6.04

    Diluted
$
5.61

 
0.47

 
5.93

Average shares outstanding (Notes 1 and 15)
 
 
 
 
 
   Basic
2,681.5

 
2,692.0

 
2,737.3

   Diluted
2,728.7

 
2,745.3

 
2,788.9

*Prior years amounts were reclassified to conform to current year presentation (adoption of ASU 2017-07)
See Notes to Consolidated Financial Statements



                
 
36
                                


JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in Millions) (Note 1)

 
2018
 
2017
 
2016
Net earnings
$
15,297

 
1,300

 
16,540

 
 
 
 
 
 
Other comprehensive income (loss), net of tax
 
 
 
 
 
      Foreign currency translation
(1,518
)
 
1,696

 
(612
)
 
 
 
 
 
 
      Securities: (1)
 
 
 
 
 
          Unrealized holding gain (loss) arising during period
(1
)
 
159

 
(52
)
          Reclassifications to earnings
1

 
(338
)
 
(141
)
          Net change
—

 
(179
)
 
(193
)
 
 
 
 
 
 
      Employee benefit plans:
 
 
 
 
 
          Prior service credit (cost), net of amortization
(44
)
 
2

 
21

          Gain (loss), net of amortization
(56
)
 
29

 
(862
)
          Effect of exchange rates
92

 
(201
)
 
159

          Net change
(8
)
 
(170
)
 
(682
)
 
 
 
 
 
 
      Derivatives & hedges:
 
 
 
 
 
          Unrealized gain (loss) arising during period
(73
)
 
(4
)
 
(359
)
          Reclassifications to earnings
(192
)
 
359

 
110

          Net change
(265
)
 
355

 
(249
)
 
 
 
 
 
 
Other comprehensive income (loss)
(1,791
)
 
1,702

 
(1,736
)
 
 
 
 
 
 
Comprehensive income
$
13,506

 
3,002

 
14,804

 
 
 
 
 
 
(1) 2018 includes the impact from adoption of ASU 2016-01. For further details see Note 1 to the Consolidated Financial Statements
 
The tax effects in other comprehensive income for the fiscal years ended 2018, 2017 and 2016 respectively: Foreign Currency Translation $236 million in 2018 due to the enactment of the U.S. Tax Cuts and Jobs Act; Securities: $0 million, $96 million and $104 million, Employee Benefit Plans: $4 million, $83 million and $346 million, Derivatives & Hedges: $70 million, $191 million and $134 million.
 
See Notes to Consolidated Financial Statements


                
 
37
                                




JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
(Dollars in Millions) (Note 1)
 
Total
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income
 
Common Stock
Issued Amount
 
Treasury
Stock
Amount
Balance, January 3, 2016
$
71,150

 
103,879

 
(13,165
)
 
3,120

 
(22,684
)
Net earnings
16,540

 
16,540

 
 

 
 

 
 

Cash dividends paid ($3.15 per share)
(8,621
)
 
(8,621
)
 
 

 
 

 
 

Employee compensation and stock option plans
2,130

 
(1,181
)
 
 

 
 

 
3,311

Repurchase of common stock
(8,979
)
 


 
 

 
 

 
(8,979
)
Other
(66
)
 
(66
)
 
 
 
 
 
 
Other comprehensive income (loss), net of tax
(1,736
)
 
 
 
(1,736
)
 
 

 
 

Balance, January 1, 2017
70,418

 
110,551

 
(14,901
)
 
3,120

 
(28,352
)
Net earnings
1,300

 
1,300

 
 

 
 

 
 

Cash dividends paid ($3.32 per share)
(8,943
)
 
(8,943
)
 
 

 
 

 
 

Employee compensation and stock option plans
2,077

 
(1,079
)
 
 

 
 

 
3,156

Repurchase of common stock
(6,358
)
 


 
 

 
 

 
(6,358
)
Other
(36
)
 
(36
)
 
 
 
 
 
 
Other comprehensive income (loss), net of tax
1,702

 
 

 
1,702

 
 

 
 

Balance, December 31, 2017
60,160

 
101,793

 
(13,199
)
 
3,120

 
(31,554
)
Cumulative adjustment
(486
)
 
(254
)
(1 
) 
(232
)
 
 
 
 
Net earnings
15,297

 
15,297

 
 

 
 

 
 

Cash dividends paid ($3.54 per share)
(9,494
)
 
(9,494
)
 
 

 
 

 
 

Employee compensation and stock option plans
1,949

 
(1,111
)
 
 

 
 

 
3,060

Repurchase of common stock
(5,868
)
 


 
 

 
 

 
(5,868
)
Other
(15
)
 
(15
)
 
 
 
 
 
 
Other comprehensive income (loss), net of tax
(1,791
)
 
 

 
(1,791
)
 
 

 
 

Balance, December 30, 2018
$
59,752

 
106,216

 
(15,222
)
 
3,120

 
(34,362
)

(1) See Note 1 to Consolidated Financial Statements for additional details on the effect of cumulative adjustments to retained earnings.
See Notes to Consolidated Financial Statements


                
 
38
                                


JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Millions) (Note 1)
 
2018
 
2017
 
2016
Cash flows from operating activities
 

 
 

 
 
Net earnings
$
15,297

 
1,300

 
16,540

Adjustments to reconcile net earnings to cash flows from operating activities:
 

 
 

 
 
Depreciation and amortization of property and intangibles
6,929

 
5,642

 
3,754

Stock based compensation
978

 
962

 
878

Asset write-downs
1,258

 
795

 
283

Gain on sale of assets/businesses
(1,217
)
 
(1,307
)
 
(563
)
Deferred tax provision
(1,016
)
 
2,406

 
(341
)
Accounts receivable allowances
(31
)
 
17

 
(11
)
Changes in assets and liabilities, net of effects from acquisitions and divestitures:
 

 
 

 
 
Increase in accounts receivable
(1,185
)
 
(633
)
 
(1,065
)
(Increase)/Decrease in inventories
(644
)
 
581

 
(249
)
Increase in accounts payable and accrued liabilities
3,951

 
2,725

 
656

Increase in other current and non-current assets
(275
)
 
(411
)
 
(529
)
(Decrease)/Increase in other current and non-current liabilities
(1,844
)
 
8,979

 
(586
)
Net cash flows from operating activities
22,201

 
21,056

 
18,767

Cash flows from investing activities
 

 
 

 
 
Additions to property, plant and equipment
(3,670
)
 
(3,279
)
 
(3,226
)
Proceeds from the disposal of assets/businesses, net
3,203

 
1,832

 
1,267

Acquisitions, net of cash acquired (Note 20)
(899
)
 
(35,151
)
 
(4,509
)
Purchases of investments
(5,626
)
 
(6,153
)
 
(33,950
)
Sales of investments
4,289

 
28,117

 
35,780

Other (primarily intangibles)
(464
)
 
(234
)
 
(123
)
Net cash used by investing activities
(3,167
)
 
(14,868
)
 
(4,761
)
Cash flows from financing activities
 
 
 

 
 
Dividends to shareholders
(9,494
)
 
(8,943
)
 
(8,621
)
Repurchase of common stock
(5,868
)
 
(6,358
)
 
(8,979
)
Proceeds from short-term debt
80

 
869

 
111

Retirement of short-term debt
(2,479
)
 
(1,330
)
 
(2,017
)
Proceeds from long-term debt, net of issuance costs
5

 
8,992

 
12,004

Retirement of long-term debt
(1,555
)
 
(1,777
)
 
(2,223
)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net
949

 
1,062

 
1,189

Other
(148
)
 
(188
)
 
(15
)
Net cash used by financing activities
(18,510
)
 
(7,673
)
 
(8,551
)
Effect of exchange rate changes on cash and cash equivalents
(241
)
 
337

 
(215
)
Increase/(Decrease) in cash and cash equivalents
283

 
(1,148
)
 
5,240

Cash and cash equivalents, beginning of year (Note 1)
17,824

 
18,972

 
13,732

Cash and cash equivalents, end of year (Note 1)
$
18,107

 
17,824

 
18,972

 
 
 
 
 
 
Supplemental cash flow data
 

 
 

 
 

Cash paid during the year for:
 

 
 

 
 

Interest
$
1,049

 
960

 
730

Interest, net of amount capitalized
963

 
866

 
628

Income taxes
4,570

 
3,312

 
2,843

 
 
 
 
 
 

                
 
39
                                


Supplemental schedule of non-cash investing and financing activities
 

 
 

 
 

Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards
$
2,095

 
2,062

 
2,043

Conversion of debt
6

 
16

 
35

 
 
 
 
 
 
Acquisitions
 

 
 

 
 

Fair value of assets acquired
$
1,047

 
36,937

 
4,586

Fair value of liabilities assumed and noncontrolling interests
(148
)
 
(1,786
)
 
(77
)
Net cash paid for acquisitions
$
899

 
35,151

 
4,509

See Notes to Consolidated Financial Statements

                
 
40
                                



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.
Summary of Significant Accounting Policies
Principles of Consolidation
The consolidated financial statements include the accounts of Johnson & Johnson and its subsidiaries (the Company). Intercompany accounts and transactions are eliminated.
Description of the Company and Business Segments
The Company has approximately 135,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the world and its primary focus is on products related to human health and well-being.
The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. The Pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular), diabetes care (divested in the fiscal fourth quarter of 2018) and vision fields, which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

New Accounting Standards
Recently Adopted Accounting Standards
ASU 2014-09: Revenue from Contracts with Customers
On January 1, 2018, the Company adopted the new accounting standard, ASC 606, Revenue from Contracts with Customers and all the related amendments (new revenue standard) to all contracts using the modified retrospective method. The cumulative effect of initially applying the new revenue standard was recognized as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The adoption of the new revenue standard has not had a material impact to either reported Sales to customers or Net earnings. Additionally, the Company will continue to recognize revenue from product sales as goods are shipped or delivered to the customer, as control of goods transfers at the same time.

In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on the Company's Consolidated Statement of Earnings and Balance Sheet was as follows:
Statement of Earnings - For the fiscal year ended December 30, 2018
(Dollars in millions)
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Sales to customers
$
81,581

 
(35
)
 
81,546

 
 
 
 
 
 
Net earnings
15,297

 
(28
)
 
15,269

 
 
 
 
 
 
Balance Sheet - As of December 30, 2018
 
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Assets
152,954

 
23

 
152,977

 
 
 
 
 
 
Liabilities
93,202

 
4

 
93,206

 
 
 
 
 
 
Equity
$
59,752

 
19

 
59,771

 
 
 
 
 
 

The Company made a cumulative effect adjustment to the 2018 opening balance of retained earnings upon adoption of ASU 2014-09, which decreased beginning retained earnings by $47 million.
As part of the adoption of ASC 606 see Note 18 to the Consolidated Financial Statements for further disaggregation of revenue.

                
 
41
                                


ASU 2016-01: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities
The Company adopted this standard as of the beginning of the fiscal year 2018 on a modified retrospective basis. The amendments in this update supersede the guidance to classify equity securities with readily determinable fair values into different categories (that is, trading or available-for-sale) and require equity securities to be measured at fair value with changes in the fair value recognized through net earnings. The standard amends financial reporting by providing relevant information about an entity’s equity investments and reducing the number of items that are recognized in other comprehensive income.
The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 that increased retained earnings by $232 million net of tax and decreased accumulated other comprehensive income for previously unrealized gains from equity investments. For additional details see Note 6 to the Consolidated Financial Statements.
ASU 2016-16: Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory
The Company adopted this standard as of the beginning of the fiscal year 2018. This update removes the current exception in U.S. GAAP prohibiting entities from recognizing current and deferred income tax expenses or benefits related to transfer of assets, other than inventory, within the consolidated entity. The current exception to defer the recognition of any tax impact on the transfer of inventory within the consolidated entity until it is sold to a third party remains unaffected. As discussed further in Note 8 to the Consolidated Financial Statements, in the fourth fiscal quarter of 2018 the Company elected an accounting policy to treat the tax on global intangible low-taxed income (GILTI) under the deferred tax accounting model. As a result, the Company is required to record an additional deferred tax liability related to the basis difference of these intra-entity asset transfers. The Company recorded net adjustments including an increase to deferred tax assets of approximately $2.0 billion, an increase to deferred tax liabilities of approximately $1.7 billion, related to the GILTI accounting policy election in the fourth fiscal quarter of 2018, a decrease to Other Assets of approximately $0.7 billion and a decrease to retained earnings of approximately $0.4 billion. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

ASU 2017-01: Clarifying the Definition of a Business
The Company adopted this standard as of the beginning of the fiscal year 2018. This update narrows the definition of a business by providing a screen to determine when an integrated set of assets and activities is not a business. The screen specifies that an integrated set of assets and activities is not a business if substantially all of the fair value of the gross assets acquired or disposed of is concentrated in a single or a group of similar identifiable assets. This update was applied prospectively. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

ASU 2017-07: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost
The Company adopted this standard as of the beginning of the fiscal year 2018. This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost (NPBC). In addition, only the service cost component will be eligible for capitalization. The amendments in this update are required to be applied retrospectively for the presentation of the service cost component and the other components of NPBC in the Consolidated Statement of Earnings and prospectively, on and after the adoption date, for the capitalization of the service cost component of NPBC in assets. As required by the transition provisions of this update, the following table shows the impact of the adoption on the respective line items in the Consolidated Statement of Earnings for 2018 and the reclassifications to the 2017 and 2016 fiscal year Consolidated Statement of Earnings to retroactively apply classification of the service cost component and the other components of NPBC:

(Dollars In millions)
 
 
Increase (Decrease) to Net Expense
 
 
2018
2017
 
2016
Cost of products sold
 
$
51

85

 
104

Selling, marketing and administrative expenses
 
55

100

 
122

Research and development expense
 
21

40

 
48

Other (income) expense, net
 
(127
)
(225
)
 
(274
)
Earnings before provision for taxes on income
 
$
—

—

 
—







                
 
42
                                


The following table summarizes the cumulative effect adjustments made to the 2018 opening balance of retained earnings upon adoption of the new accounting standards mentioned above:
(Dollars in Millions)
 
Cumulative Effect Adjustment Increase (Decrease) to Retained Earnings
ASU 2014-09 - Revenue from Contracts with Customers
 
$
(47
)
ASU 2016-01 - Financial Instruments
 
232

ASU 2016-16 - Income Taxes: Intra-Entity Transfers
 
(439
)
Total
 
$
(254
)

ASU 2017-12: Targeted Improvements to Accounting for Hedging Activities
The Company elected to early adopt this standard as of the beginning of the fiscal second quarter of 2018. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. For additional required disclosures see Note 6 to the Consolidated Financial Statements.

Recently Issued Accounting Standards
Not Adopted as of December 30, 2018
ASU 2018-18: Collaborative Arrangements
This update clarifies the interaction between ASC 808, Collaborative Arrangements and ASC 606, Revenue from Contracts with Customers. The update clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue if the counterparty is not a customer for that transaction. This update will be effective for the Company for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2018-18 should be applied retrospectively to the date of initial application of ASC 606 and early adoption is permitted. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2018-16: Derivatives and Hedging (Topic ASC 815)
This update adds the Overnight Index Swap (OIS) rate based on the Secured Overnight Financing Rate (SOFR) as an eligible benchmark interest rate permitted in the application of hedge accounting. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted if an entity has adopted ASU 2017-12. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2018-02: Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
This update allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Job Act enacted in December 2017. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company does not expect this standard to have a material impact on the Company's consolidated financial statements.

ASU 2016-13: Financial Instruments - Credit Losses
This update introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. This update will be effective for the Company for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2016-02: Leases
This update requires the recognition of lease assets and lease liabilities on the balance sheet for all lease obligations and disclosing key information about leasing arrangements. This update requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current generally accepted accounting principles. This update will be effective for the Company for all annual periods beginning after December 15, 2018, including interim periods within those fiscal years. The Company will apply the new standard at its adoption date rather than at the earliest comparative period

                
 
43
                                


presented in the financial statements. The Company’s operating leases will result in the recognition of additional assets and the corresponding liabilities on its Consolidated Balance Sheets. The adoption of this standard will not have a material impact on the Company's consolidated financial statements.
Cash Equivalents
The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating. The Company invests its cash primarily in government securities and obligations, corporate debt securities, money market funds and reverse repurchase agreements (RRAs).
RRAs are collateralized by deposits in the form of Government Securities and Obligations for an amount not less than 102% of their value. The Company does not record an asset or liability as the Company is not permitted to sell or repledge the associated collateral. The Company has a policy that the collateral has at least an A (or equivalent) credit rating. The Company utilizes a third party custodian to manage the exchange of funds and ensure that collateral received is maintained at 102% of the value of the RRAs on a daily basis. RRAs with stated maturities of greater than three months from the date of purchase are classified as marketable securities.
Investments
Investments classified as held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income. Available-for-sale securities available for current operations are classified as current assets otherwise, they are classified as long term. Management determines the appropriate classification of its investment in debt and equity securities at the time of purchase and re-evaluates such determination at each balance sheet date. The Company reviews its investments in equity securities for impairment and adjusts these investments to fair value through earnings, as required. 
Property, Plant and Equipment and Depreciation
Property, plant and equipment are stated at cost. The Company utilizes the straight-line method of depreciation over the estimated useful lives of the assets:
Building and building equipment
20 - 30 years
Land and leasehold improvements
10 - 20 years
Machinery and equipment
2 - 13 years

The Company capitalizes certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 8 years.
The Company reviews long-lived assets to assess recoverability using undiscounted cash flows. When certain events or changes in operating or economic conditions occur, an impairment assessment may be performed on the recoverability of the carrying value of these assets. If the asset is determined to be impaired, the loss is measured based on the difference between the asset’s fair value and its carrying value. If quoted market prices are not available, the Company will estimate fair value using a discounted value of estimated future cash flows.
Revenue Recognition
The Company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. The Company's global payment terms are typically between 30 to 90 days. Provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.
Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. Rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. The Company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.
Sales returns are estimated and recorded based on historical sales and returns information. Products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.
Sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. The sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. In accordance with the Company’s accounting policies, the Company generally issues credit to

                
 
44
                                


customers for returned goods. The Company’s sales returns reserves are accounted for in accordance with the U.S. GAAP guidance for revenue recognition when right of return exists. Sales returns reserves are recorded at full sales value. Sales returns in the Consumer and Pharmaceutical segments are almost exclusively not resalable. Sales returns for certain franchises in the Medical Devices segment are typically resalable but are not material. The Company infrequently exchanges products from inventory for returned products. The sales returns reserve for the total Company has been approximately 1.0% of annual net trade sales during the fiscal reporting years 2018, 2017 and 2016.
Promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. Continuing promotional programs include coupons and volume-based sales incentive programs. The redemption cost of consumer coupons is based on historical redemption experience by product and value. Volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. These arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. The Company also earns profit-share payments through collaborative arrangements for certain products, which are included in sales to customers. For all years presented, profit-share payments were less than 2.0% of the total revenues and are included in sales to customers.
Shipping and Handling
Shipping and handling costs incurred were $1,090 million, $1,042 million and $974 million in 2018, 2017 and 2016, respectively, and are included in selling, marketing and administrative expense. The amount of revenue received for shipping and handling is less than 0.5% of sales to customers for all periods presented.
Inventories
Inventories are stated at the lower of cost or net realizable value determined by the first-in, first-out method.
Intangible Assets and Goodwill
The authoritative literature on U.S. GAAP requires that goodwill and intangible assets with indefinite lives be assessed annually for impairment. The Company completed the annual impairment test for 2018 in the fiscal fourth quarter. Future impairment tests will be performed annually in the fiscal fourth quarter, or sooner if warranted. Purchased in-process research and development is accounted for as an indefinite lived intangible asset until the underlying project is completed, at which point the intangible asset will be accounted for as a definite lived intangible asset, or abandoned, at which point the intangible asset will be written off or partially impaired.
Intangible assets that have finite useful lives continue to be amortized over their useful lives, and are reviewed for impairment when warranted by economic conditions. See Note 5 for further details on Intangible Assets and Goodwill.
Financial Instruments
As required by U.S. GAAP, all derivative instruments are recorded on the balance sheet at fair value. Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value, with Level 1 having the highest priority and Level 3 having the lowest. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.
The Company documents all relationships between hedged items and derivatives. The overall risk management strategy includes reasons for undertaking hedge transactions and entering into derivatives. The objectives of this strategy are: (1) minimize foreign currency exposure’s impact on the Company’s financial performance; (2) protect the Company’s cash flow from adverse movements in foreign exchange rates; (3) ensure the appropriateness of financial instruments; and (4) manage the enterprise risk associated with financial institutions. See Note 6 for additional information on Financial Instruments.
Product Liability
Accruals for product liability claims are recorded, on an undiscounted basis, when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on existing information and actuarially determined estimates where applicable. The accruals are adjusted periodically as additional information becomes available. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.
As a result of cost and availability factors, effective November 1, 2005, the Company ceased purchasing third-party product liability insurance. The Company has self insurance through a wholly-owned captive insurance company. In addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated.


                
 
45
                                


Research and Development
Research and development expenses are expensed as incurred in accordance with ASC 730, Research and Development. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Amounts capitalized for such payments are included in other intangibles, net of accumulated amortization.
The Company enters into collaborative arrangements, typically with other pharmaceutical or biotechnology companies, to develop and commercialize drug candidates or intellectual property. These arrangements typically involve two (or more) parties who are active participants in the collaboration and are exposed to significant risks and rewards dependent on the commercial success of the activities. These collaborations usually involve various activities by one or more parties, including research and development, marketing and selling and distribution. Often, these collaborations require upfront, milestone and royalty or profit share payments, contingent upon the occurrence of certain future events linked to the success of the asset in development. Amounts due from collaborative partners related to development activities are generally reflected as a reduction of research and development expense because the performance of contract development services is not central to the Company’s operations. In general, the income statement presentation for these collaborations is as follows:

Nature/Type of Collaboration
 
Statement of Earnings Presentation
Third-party sale of product & profit share payments received
 
Sales to customers
Royalties/milestones paid to collaborative partner (post-regulatory approval)*
 
Cost of products sold
Royalties received from collaborative partner
 
Other income (expense), net
Upfront payments & milestones paid to collaborative partner (pre-regulatory approval)
 
Research and development expense
Research and development payments to collaborative partner
 
Research and development expense
Research and development payments received from collaborative partner
 
Reduction of Research and development expense
* 
Milestones are capitalized as intangible assets and amortized to cost of products sold over the useful life.
For all years presented, there was no individual project that represented greater than 5% of the total annual consolidated research and development expense.
The Company has a number of products and compounds developed in collaboration with strategic partners including XARELTO®, co-developed with Bayer HealthCare AG and IMBRUVICA®, developed in collaboration and co-marketed with Pharmacyclics LLC, an AbbVie company.
The Company has a number of licensing arrangements for products and compounds including DARZALEX®, licensed from Genmab A/S.
 
Advertising
Costs associated with advertising are expensed in the year incurred and are included in selling, marketing and administrative expenses. Advertising expenses worldwide, which comprised television, radio, print media and Internet advertising, were $2.6 billion, $2.5 billion and $2.4 billion in 2018, 2017 and 2016, respectively.
Income Taxes
Income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between U.S. GAAP accounting and tax reporting, recorded as deferred tax assets or liabilities. The Company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. Future changes in tax laws and rates may affect recorded deferred tax assets and liabilities in the future.
The Company has unrecognized tax benefits for uncertain tax positions. The Company follows U.S. GAAP which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management believes that changes in these estimates would not have a material effect on the Company's results of operations, cash flows or financial position.
In the fourth fiscal quarter of 2018, the Company has elected to account for the GILTI tax under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred.
The Company has recorded deferred tax liabilities on all undistributed earnings prior to December 31, 2017 from its international subsidiaries. The Company has not provided deferred taxes on the undistributed earnings subsequent to January 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. The Company intends to continue to reinvest these earnings in those international operations. If the Company decides at a later date to

                
 
46
                                


repatriate these earnings to the U.S., the Company would be required to provide for the net tax effects on these amounts. The Company estimates that the total tax effect of this repatriation would be approximately $0.7 billion under current enacted tax laws and regulations and at current currency exchange rates.
See Note 8 for further information regarding income taxes.
Net Earnings Per Share
Basic earnings per share is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, rebates, allowances and incentives, product liabilities, income taxes, withholding taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates.
The Company follows the provisions of U.S. GAAP when recording litigation related contingencies. A liability is recorded when a loss is probable and can be reasonably estimated. The best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.
Annual Closing Date
The Company follows the concept of a fiscal year, which ends on the Sunday nearest to the end of the month of December. Normally each fiscal year consists of 52 weeks, but every five or six years the fiscal year consists of 53 weeks, and therefore includes additional shipping days, as was the case in 2015, and will be the case again in 2020.
Reclassification
Certain prior period amounts have been reclassified to conform to current year presentation.

2.
Cash, Cash Equivalents and Current Marketable Securities
At the end of 2018 and 2017, cash, cash equivalents and current marketable securities were comprised of:
(Dollars in Millions)
 
2018
 
 
Carrying Amount
 
 
Estimated Fair Value
 
Cash & Cash Equivalents
 
Current Marketable Securities
Cash
 
$
2,619

 
 
2,619

 
2,619

 
—

U.S. Reverse repurchase agreements
 
3,009

 
 
3,009

 
3,009

 
—

Other Reverse repurchase agreements
 
443

 
 
443

 
443

 
—

Money market funds
 
3,397

 
 
3,397

 
3,397

 
—

Time deposits(1)
 
485

 
 
485

 
485

 
—

    Subtotal
 
$
9,953

 
 
9,953

 
9,953

 
—

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gov't Securities
 
$
9,474

 
 
9,474

 
8,144

 
1,330

Corporate debt securities
 
260

 
 
260

 
10

 
250

   Subtotal available for sale(2)
 
$
9,734

 
 
9,734

 
8,154

 
1,580

 
 
 
 
 
 
 
 
 
 
Total cash, cash equivalents and current marketable securities
 


 
 
 
 
$
18,107

 
1,580


In 2018, the carrying amount was the same as the estimated fair value.
In 2017, the carrying amount was the same as the estimated fair value.

                
 
47
                                


(Dollars in Millions)
 
2017
 
 
Carrying Amount
 
 
Estimated Fair Value
 
Cash & Cash Equivalents
 
Current Marketable Securities
Cash
 
$
2,929

 
 
2,929

 
2,929

 
—

Other Sovereign Securities(1)
 
279

 
 
279

 
219

 
60

U.S. Reverse repurchase agreements
 
4,025

 
 
4,025

 
4,025

 
—

Corporate debt securities(1)
 
289

 
 
289

 
244

 
45

Money market funds
 
4,288

 
 
4,288

 
4,288

 
—

Time deposits(1)
 
1,176

 
 
1,176

 
1,175

 
1

    Subtotal
 
$
12,986

 
 
12,986

 
12,880

 
106

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gov't Securities
 
$
4,864

 
 
4,864

 
4,833

 
31

Other Sovereign Securities
 
186

 
 
186

 
80

 
106

Corporate debt securities
 
260

 
 
260

 
31

 
229

   Subtotal available for sale(2)
 
$
5,310

 
 
5,310

 
4,944

 
366

 
 
 
 
 
 
 
 
 
 
Total cash, cash equivalents and current marketable securities
 
 
 
 
 
 
$
17,824

 
472


(1) Held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings.
(2) Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.
Fair value of government securities and obligations and corporate debt securities were estimated using quoted broker prices and significant other observable inputs.

The contractual maturities of the available for sale debt securities at December 30, 2018 are as follows:
(Dollars in Millions)
 
Cost Basis
 
Fair Value
Due within one year
 
$
9,670

 
9,670

Due after one year through five years
 
64

 
64

Due after five years through ten years
 
—

 
—

Total debt securities
 
$
9,734

 
9,734


The Company invests its excess cash in both deposits with major banks throughout the world and other high-quality money market instruments. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating.

3.
Inventories
At the end of 2018 and 2017, inventories were comprised of:
(Dollars in Millions)
 
2018
 
2017
Raw materials and supplies
 
$
1,114

 
1,140

Goods in process
 
2,109

 
2,317

Finished goods
 
5,376

 
5,308

Total inventories
 
$
8,599

(1)
8,765

(1) Net of assets held for sale on the Consolidated Balance Sheet for approximately $0.2 billion related to the divestiture of the Advanced Sterilization Products business and $0.3 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.


                
 
48
                                


4.
Property, Plant and Equipment
At the end of 2018 and 2017, property, plant and equipment at cost and accumulated depreciation were:
(Dollars in Millions)
 
2018
 
2017
Land and land improvements
 
$
807

 
829

Buildings and building equipment
 
11,176

 
11,240

Machinery and equipment
 
25,992

 
25,949

Construction in progress
 
3,876

 
3,448

Total property, plant and equipment, gross
 
$
41,851

 
41,466

Less accumulated depreciation
 
24,816

 
24,461

Total property, plant and equipment, net
 
$
17,035

(1) 
17,005

(1) Net of assets held for sale on the Consolidated Balance Sheet for approximately $0.1 billion related to the divestiture of the Advanced Sterilization Products business and $0.1 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.

The Company capitalizes interest expense as part of the cost of construction of facilities and equipment. Interest expense capitalized in 2018, 2017 and 2016 was $86 million, $94 million and $102 million, respectively.
Depreciation expense, including the amortization of capitalized interest in 2018, 2017 and 2016 was $2.6 billion, $2.6 billion and $2.5 billion, respectively.
Upon retirement or other disposal of property, plant and equipment, the costs and related amounts of accumulated depreciation or amortization are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds are recorded in earnings.

5.
Intangible Assets and Goodwill
At the end of 2018 and 2017, the gross and net amounts of intangible assets were:
(Dollars in Millions)
 
2018
 
2017
Intangible assets with definite lives:
 
 

 
 

Patents and trademarks — gross
 
$
35,194

 
36,427

Less accumulated amortization
 
9,784

 
7,223

Patents and trademarks — net
 
$
25,410

 
29,204

Customer relationships and other intangibles — gross
 
$
21,334

 
20,204

Less accumulated amortization
 
8,323

 
7,463

Customer relationships and other intangibles — net
 
$
13,011

 
12,741

Intangible assets with indefinite lives:
 
 

 
 

Trademarks
 
$
6,937

 
7,082

Purchased in-process research and development(1)
 
2,253

 
4,201

Total intangible assets with indefinite lives
 
$
9,190

 
11,283

Total intangible assets — net
 
$
47,611

 
53,228

(1) The decrease was primarily attributable to the write-down of $1.1 billion related to the assets acquired in the acquisitions of Alios Biopharma Inc. (Alios) and XO1 Limited (XO1). Of the $1.1 billion, the Company recorded a partial impairment charge of $0.8 billion related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios. The impairment charge was calculated based on updated cash flow projections discounted for the inherent risk in the asset development and reflects the impact of the phase 2b clinical trial suspension, a decrease in the probability of success factors and the ongoing analysis of asset development activities. In addition, an impairment charge of $0.3 billion was recorded for the discontinuation of the development project for an anti-thrombin antibody associated with the 2015 acquisition of XO1. Additionally, $0.8 billion of IPR&D related to ERLEADA™ was reclassified to definite lived intangible assets upon commercialization.







                
 
49
                                



Goodwill as of December 30, 2018 and December 31, 2017, as allocated by segment of business, was as follows:
(Dollars in Millions)
 
Consumer
 
Pharmaceutical
 
Medical Devices
 
Total
Goodwill at January 1, 2017
 
$
8,263

 
2,840

 
11,702

 
22,805

Goodwill, related to acquisitions (1)
 
102

 
6,161

 
2,200

 
8,463

Goodwill, related to divestitures
 
(74
)
 
(1
)
 
(102
)
 
(177
)
Currency translation/other
 
584

 
109

 
122

 
815

Goodwill at December 31, 2017
 
$
8,875

 
9,109

 
13,922

 
31,906

Goodwill, related to acquisitions
 
168

 
51

 
184

 
403

Goodwill, related to divestitures
 
—

 
—

 
(1,348
)
(2) 
(1,348
)
Currency translation/other
 
(373
)
 
(97
)
 
(38
)
 
(508
)
Goodwill at December 30, 2018
 
$
8,670

 
9,063

 
12,720

 
30,453


(1) Goodwill of $6.2 billion related to the Actelion acquisition acquired in the fiscal second quarter of 2017, within the Pharmaceutical segment and $1.7 billion related to the AMO acquisition acquired in the fiscal first quarter of 2017, within the Medical Devices segment.
(2) Goodwill of $1.0 billion is related to the divestiture of the LifeScan business. Goodwill of $0.3 billion is related to the divestiture of the Advanced Sterilization Products business, which was pending and classified as assets held for sale on the Consolidated Balance Sheet as of December 30, 2018.

The weighted average amortization periods for patents and trademarks and customer relationships and other intangible assets are 11 years and 22 years, respectively. The amortization expense of amortizable assets included in cost of products sold was $4.4 billion, $3.0 billion and $1.2 billion before tax, for the fiscal years ended December 30, 2018, December 31, 2017 and January 1, 2017, respectively. The estimated amortization expense for the five succeeding years approximates $4.3 billion before tax, per year. Intangible asset write-downs are included in Other (income) expense, net.

See Note 20 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.


6.
Fair Value Measurements
The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany products and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges.
Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings. These derivatives are designated as fair value hedges. The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges. Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities.
The Company early adopted ASU 2017-12: Targeted Improvements to Accounting for Hedge Activities effective as of the beginning of fiscal second quarter of 2018.
The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. During the fiscal second quarter of 2017, the Company entered into credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of December 30, 2018, the total amount of collateral paid under the credit support agreements (CSA) amounted to $182 million net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating. Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of December 30, 2018, the Company had notional amounts outstanding for forward foreign exchange contracts, cross currency interest rate swaps and interest rate swaps of $41.1 billion, $7.3 billion, and $0.5 billion respectively. As of December 31, 2017, the Company had notional amounts outstanding for forward foreign exchange contracts, cross currency interest rate swaps and interest rate swaps of $34.5 billion, $2.3 billion, and $1.1 billion respectively.


                
 
50
                                


All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.
The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings.  Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings, and are then reclassified to earnings in the same account as the hedged transaction.
Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur. Gains and losses on net investment hedge are accounted through the currency translation account within accumulated other comprehensive income.  The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued.
During the fiscal second quarter of 2016, the Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates.
As of December 30, 2018, the balance of deferred net loss on derivatives included in accumulated other comprehensive income was $195 million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 13. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the next 12 months as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is 18 months, excluding interest rate contracts, net investment hedges and equity collar contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.

                
 
51
                                


The following table is a summary of the activity related to derivatives and hedges for the fiscal years ended December 30, 2018 and December 31, 2017:
 
December 30, 2018
December 31, 2017
(Dollars in Millions)
Sales
Cost of Products Sold
R&D Expense
Interest (Income) Expense
Other (Income) Expense
Sales
Cost of Products Sold
R&D Expense
Interest (Income) Expense
Other (Income) Expense
The effects of fair value, net investment and cash flow hedging:
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on fair value hedging relationship:
 
 
 
 
 
 
 
 
 
 
Interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
 Hedged items
$
—

—

—

5

—

—

—

—

5

—

 Derivatives designated as hedging instruments
—

—

—

(5
)
—

—

—

—

(5
)
—

 
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on net investment hedging relationship:
 
 
 
 
 
 
 
 
 
 
Cross currency interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing
—

—

—

56

—

—

—

—

—

—

   Amount of gain or (loss) recognized in AOCI
—

—

—

56

—

—

—

—

—

—

 
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on cash flow hedging relationship:
 
 
 
 
 
 
 
 
 
 
Forward foreign exchange contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) reclassified from AOCI into income (1)
47

200

(220
)
—

(24
)
(31
)
(159
)
(165
)
—

(87
)
 
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) recognized in AOCI (1)
(32
)
(17
)
(193
)
—

(4
)
49

96

(199
)
—

(60
)
 
 
 
 
 
 
 
 
 
 
 
Cross currency interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) reclassified from AOCI into income
—

—

—

133

—

—

—

—

83

—

   Amount of gain or (loss) recognized in AOCI
$
—

—

—

117

—

—

—

—

110

—


(1) Includes equity collar contracts. The equity collar contracts expired in December of 2017.

 
 
 
 
 
 
 
 
 
 
 
 
 
For the fiscal years ended December 30, 2018 and December 31, 2017, the following amounts were recorded on the Consolidated Balance Sheet
Line item in the Consolidated Balance Sheet in which the hedged item is included
 
Carrying Amount of the Hedged Liability

 
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability
(Dollars in Millions)
 
December 30, 2018
 
December 31, 2017
 
December 30, 2018
 
December 31, 2017
Current Portion of Long-term Debt
 
$
494

 
597

 
5

 
2

Long-term Debt
 
—

 
496

 
—

 
3


                
 
52
                                


The following table is the effect of derivatives not designated as hedging instrument for the fiscal years ended December 30, 2018 and December 31, 2017:
 
 
 
 
 
(Dollars in Millions)
 
Location of Gain /(Loss) Recognized in Income on Derivative
 
Gain/(Loss)
Recognized In
Income on Derivative
Derivatives Not Designated as Hedging Instruments
 
 
 
December 30, 2018
 
December 31, 2017
Foreign Exchange Contracts
 
Other (income) expense
 
(68
)
 
(5
)


The following table is the effect of net investment hedges for the fiscal years ended December 30, 2018 and December 31, 2017:
 
 
Gain/(Loss)
Recognized In
Accumulated OCI
 
Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income
 
Gain/(Loss) Reclassified From
Accumulated OCI
Into Income
(Dollars in Millions)
 
Fiscal Nine Months Ended
 
 
December 30, 2018
 
December 31, 2017
 
 
 
December 30, 2018
 
December 31, 2017
Debt
 
$
218

 
(597
)
 
Other (income) expense

 
—

 
—

Cross Currency interest rate swaps
 
$
150

 
—

 
Other (income) expense
 
—

 
—


The Company adopted ASU 2016-01: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities as of the beginning of the fiscal year 2018. This ASU amends prior guidance to classify equity investments with readily determinable market values into different categories (that is, trading or available-for-sale) and require equity investments to be measured at fair value with changes in fair value recognized through net earnings. The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 which increased retained earnings by $232 million, net of tax, and decreased accumulated other comprehensive income for previously net unrealized gains from equity investments.
The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
The following table is a summary of the activity related to equity investments as of December 30, 2018:
(Dollars in Millions)
 
December 31, 2017
 
 
 
 
 
December 30, 2018
 
 
 
 
Carrying Value
 
Changes in Fair Value Reflected in Net Income (1)
 
Sales/ Purchases/Other (2)
 
Carrying Value
 
Non Current Other Assets
Equity Investments with readily determinable value
 
$
751

 
(247
)
 
7

 
511

 
511

 
 
 
 
 
 
 
 
 
 
 
Equity Investments without readily determinable value
 
$
510

 
13

 
158

 
681

 
681

(1) Recorded in Other Income/Expense
(2) Other includes impact of currency

For equity investments without readily determinable market values, $54 million of the changes in fair value reflected in net income were the result of impairments. There were $67 million of changes in fair value reflected in net income due to changes in observable prices.


                
 
53
                                


For the fiscal years ended December 31, 2017, changes in fair value reflected within other comprehensive income due to previously unrealized gains on equity investments with readily determinable fair values net of tax was a net gain of $232 million.

Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 having the highest priority and Level 3 having the lowest.

The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company’s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company did not have any other significant financial assets or liabilities which would require revised valuations under this standard that are recognized at fair value.

The following three levels of inputs are used to measure fair value:
Level 1 — Quoted prices in active markets for identical assets and liabilities.
Level 2 — Significant other observable inputs.
Level 3 — Significant unobservable inputs.


The Company’s significant financial assets and liabilities measured at fair value as of December 30, 2018 and December 31, 2017 were as follows:
 
 
2018
 
2017
(Dollars in Millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total (1)
Derivatives designated as hedging instruments:
 
 

 
 

 
 

 
 

 
 

Assets:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
$
—

 
501

 
—

 
501

 
418

Interest rate contracts (2)(4)
 
—

 
161

 
—

 
161

 
7

Total
 
—

 
662

 
—

 
662

 
425

Liabilities:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
548

 
—

 
548

 
402

Interest rate contracts (3)(4)
 
—

 
292

 
—

 
292

 
165

Total
 
—

 
840

 
—

 
840

 
567

Derivatives not designated as hedging instruments:
 
 

 
 

 
 

 
 

 
 

Assets:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
32

 
—

 
32

 
38

Liabilities:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
32

 
—

 
32

 
38

Available For Sale Other Investments:
 
 
 
 
 
 
 
 
 
 
Equity investments(5)
 
511

 
—

 
—

 
511

 
751

Debt securities(6)
 
$
—

 
9,734

 
—

 
9,734

 
5,310




                
 
54
                                


Gross to Net Derivative Reconciliation
 
2018
 
2017
(Dollars in Millions)
 
 
 
 
Total Gross Assets
 
$
694

 
463

Credit Support Agreement (CSA)
 
(423
)
 
(76
)
Total Net Asset
 
271

 
387

 
 
 
 
 
Total Gross Liabilities
 
872

 
605

Credit Support Agreement (CSA)
 
(605
)
 
(238
)
Total Net Liabilities
 
$
267

 
367

 
 
 
 
 


(1) 
2017 assets and liabilities are all classified as Level 2 with the exception of equity investments of $751 million, which are classified as Level 1.
(2) 
Includes $6 million and $7 million of non-current assets for the fiscal years ending December 30, 2018 and December 31, 2017, respectively.
(3) 
Includes $3 million and $9 million of non-current liabilities for the fiscal years ending December 30, 2018 and December 31, 2017, respectively.
(4) 
Includes cross currency interest rate swaps and interest rate swaps.
(5) 
Classified as non-current other assets. The carrying amount of the equity investments were $511 million and $751 million as of December 30, 2018 and December 31, 2017, respectively.
(6) 
Classified as cash equivalents and current marketable securities.

See Notes 2 and 7 for financial assets and liabilities held at carrying amount on the Consolidated Balance Sheet.


                
 
55
                                


7.
Borrowings
The components of long-term debt are as follows:
(Dollars in Millions)
 
2018
  
Effective Rate %
  
2017
  
Effective Rate %
 
5.15% Debentures due 2018
 
$
—

  


  
900

  
5.18
 
1.65% Notes due 2018
 
—

 


 
597

 
1.70
 
4.75% Notes due 2019 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)
 
1,139

(2) 
5.83

  
1,192

(3) 
5.83
 
1.875% Notes due 2019
 
494

 
1.93

 
496

 
1.93
 
0.89% Notes due 2019
 
300

 
1.32

 
300

 
1.75
 
1.125% Notes due 2019
 
699

 
1.13

 
699

 
1.13
 
3% Zero Coupon Convertible Subordinated Debentures due 2020
 
51

  
3.00

  
60

  
3.00
 
2.95% Debentures due 2020
 
548

  
3.15

  
547

  
3.15
 
1.950% Notes due 2020
 
499

 
1.99

 
499

 
1.99
 
3.55% Notes due 2021
 
449

 
3.67

 
448

 
3.67
 
2.45% Notes due 2021
 
349

 
2.48

 
349

 
2.48
 
1.65% Notes due 2021
 
998

 
1.65

 
998

 
1.65
 
0.250% Notes due 2022 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)
 
1,137

(2) 
0.26

 
1,191

(3) 
0.26
 
2.25% Notes due 2022
 
996

 
2.31

 
995

 
2.31
 
6.73% Debentures due 2023
 
250

  
6.73

  
250

  
6.73
 
3.375% Notes due 2023
 
805

 
3.17

 
806

 
3.17
 
2.05% Notes due 2023
 
498

 
2.09

 
498

 
2.09
 
0.650% Notes due 2024 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)
 
851

(2) 
0.68

 
891

(3) 
0.68
 
5.50% Notes due 2024 (500MM GBP 1.2636)(2)/(500MM GBP 1.3444)(3)
 
627

(2) 
6.75

  
666

(3) 
6.75
 
2.625% Notes due 2025
 
748

 
2.63

 
747

 
2.63
 
2.45% Notes due 2026
 
1,992

 
2.47

 
1,990

 
2.47
 
2.95% Notes due 2027
 
996

 
2.96

 
995

 
2.96
 
1.150% Notes due 2028 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)
 
847

(2) 
1.21

 
887

(3) 
1.21
 
2.900% Notes due 2028
 
1,493

 
2.91

 
1,492

 
2.91
 
6.95% Notes due 2029
 
297

  
7.14

  
296

  
7.14
 
4.95% Debentures due 2033
 
498

  
4.95

  
498

  
4.95
 
4.375% Notes due 2033
 
856

 
4.24

 
856

 
4.24
 
1.650% Notes due 2035 (1.5B Euro 1.14)(2)/(1.5B Euro 1.1947)(3)
 
1,693

(2) 
1.68

 
1,774

(3) 
1.68
 
3.55% Notes due 2036
 
988

 
3.59

 
987

 
3.59
 
5.95% Notes due 2037
 
991

  
5.99

  
991

  
5.99
 
3.625% Notes due 2037
 
1,486

 
3.64

 
1,486

 
3.64
 
5.85% Debentures due 2038
 
696

  
5.85

  
696

  
5.85
 
3.400% Notes due 2038
 
990

 
3.42

 
990

 
3.42
 
4.50% Debentures due 2040
 
538

  
4.63

  
538

  
4.63
 
4.85% Notes due 2041
 
297

 
4.89

 
296

 
4.89
 
4.50% Notes due 2043
 
495

 
4.52

 
495

 
4.52
 
3.70% Notes due 2046
 
1,972

 
3.74

 
1,971

 
3.74
 
3.75% Notes due 2047
 
991

 
3.76

 
990

 
3.76
 

                
 
56
                                


3.500% Notes due 2048
 
742

 
3.52

 
742

 
3.52
 
Other
 
24

  
—

  
75

  
—
 
Subtotal
 
30,320

(4) 
3.19
%
(1) 
32,174

(4) 
3.19
(1 
) 
Less current portion
 
2,636

  
 

  
1,499

  
 
 
Total long-term debt
 
$
27,684

  
 

  
30,675

  
 
 

(1) 
Weighted average effective rate.
(2) 
Translation rate at December 30, 2018.
(3) 
Translation rate at December 31, 2017.
(4) 
The excess of the fair value over the carrying value of debt was $0.3 billion in 2018 and $2.0 billion in 2017.

Fair value of the long-term debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.(Level 2)
The Company has access to substantial sources of funds at numerous banks worldwide. In September 2018, the Company secured a new 364-day Credit Facility. Total credit available to the Company approximates $10 billion, which expires on September 12, 2019. Interest charged on borrowings under the credit line agreements is based on either bids provided by banks, the prime rate or London Interbank Offered Rates (LIBOR), plus applicable margins. Commitment fees under the agreements are not material.
Throughout 2018, the Company continued to have access to liquidity through the commercial paper market. Short-term borrowings and the current portion of long-term debt amounted to approximately $2.8 billion at the end of 2018, of which $2.6 billion is the current portion of the long term debt, and the remainder principally represents local borrowing by international subsidiaries.
Throughout 2017, the Company continued to have access to liquidity through the commercial paper market. Short-term borrowings and the current portion of long-term debt amounted to approximately $3.9 billion at the end of 2017, of which $2.3 billion was borrowed under the Commercial Paper Program, $1.5 billion is the current portion of the long-term debt, and the remainder principally represents local borrowing by international subsidiaries.

Aggregate maturities of long-term obligations commencing in 2019 are:
(Dollars in Millions)
 
 
 
 
 
 
 
 
2019
 
2020
 
2021
 
2022
 
2023
 
After 2023
$2,636
 
1,098
 
1,796
 
2,134
 
1,553
 
21,103

8.
Income Taxes
The provision for taxes on income consists of:
(Dollars in Millions)
 
2018
 
2017
 
2016
Currently payable:
 
 
 
 
 
 
U.S. taxes
 
$
1,081

 
11,969

 
1,896

U.S. taxes on international operations
 
203

 
126

 
49

International taxes
 
2,434

 
1,872

 
1,659

Total currently payable
 
3,718

 
13,967

 
3,604

Deferred:
 
 
 
 
 
 
U.S. taxes
 
(148
)
 
(1,956
)
 
294

U.S. taxes on international operations
 
1,358

 
 
 
 
International taxes
 
(2,226
)
 
4,362

 
(635
)
Total deferred
 
(1,016
)
 
2,406

 
(341
)
Provision for taxes on income
 
$
2,702

 
16,373

 
3,263


A comparison of income tax expense at the U.S. statutory rate of 21% in 2018 and 35% in 2017 and 2016, to the Company’s effective tax rate is as follows:

                
 
57
                                


(Dollars in Millions)
 
2018
 
2017
 
2016
U.S. 
 
$
5,575

 
4,865

 
7,457

International
 
12,424

 
12,808

 
12,346

Earnings before taxes on income:
 
$
17,999

 
17,673

 
19,803

Tax rates:
 
 
 
 
 
 
U.S. statutory rate
 
21.0
 %
 
35.0

 
35.0

International operations (1)
 
(3.7
)
 
(12.8
)
 
(17.2
)
Research and orphan drug tax credits
 
(1.0
)
 
(0.4
)
 
(0.4
)
U.S. state and local
 
0.8

 
0.6

 
(0.1
)
U.S. manufacturing deduction
 
—

 
(0.8
)
 
(0.6
)
U.S. tax on international income (2)
 
1.4

 
0.7

 
1.3

Tax benefits on share-based compensation
 
(1.5
)
 
(2.1
)
 
(1.8
)
U.S. tax benefit on asset/business disposals
 
0.5

 
(0.8
)
 
—

All other
 
(0.6
)
 
(0.1
)
 
0.3

TCJA and related impacts (3)
 
(1.9
)
(3) 
73.3

(4) 
—

Effective Rate
 
15.0
 %
 
92.6

 
16.5


(1) For all periods presented the Company has subsidiaries operating in Puerto Rico under various tax incentives. International operations reflects the impacts of operations in jurisdictions with statutory tax rates different than the U.S., particularly Ireland, Switzerland and Puerto Rico, which is a favorable impact on the effective tax rate as compared with the U.S. statutory rate. The 2017 amount also includes tax cost related to the revaluation of deferred tax balances related to the change in the Belgian statutory tax rate increasing the tax provision by approximately 3.4%.
(2) Includes the impact of the GILTI tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.
(3) Represents impact of adjustments to the 2017 TCJA provisional tax charge. This also includes a net tax benefit from the reduction of a deferred tax liability related to foreign withholding taxes originally accrued as part of the provisional charge. This benefit reduced the Company’s effective tax rate by approximately 11%. Further description is included below.
(4) Includes U.S. state and local taxes provisionally recorded as part TCJA provisional charge which was approximately 0.6% of the total effective tax rate.

On December 22, 2017, the United States enacted into law new U.S. tax legislation, the Tax Cuts and Jobs Act (TCJA).
This law included provisions for a comprehensive overhaul of the corporate income tax code, including a reduction of the statutory corporate tax rate from 35% to 21%, effective on January 1, 2018. This legislation also eliminated or reduced certain corporate income tax deductions as well as introduced new provisions that taxed certain foreign income not previously taxed by the United States. The TCJA also included a provision for a tax on all previously undistributed earnings of U.S. companies located in foreign jurisdictions. Undistributed earnings in the form of cash and cash equivalents were taxed at a rate of 15.5% and all other earnings are taxed at a rate of 8.0%. This tax is payable over 8 years and will not accrue interest and these payments began in 2018 and will continue through 2025. The remaining balance at the end of the fiscal year 2018 was approximately $8.2 billion.

In December 2017, the SEC provided regulatory guidance for accounting of the impacts of the TCJA, referred to as SAB 118. Under the guidance in SAB 118, the income tax effects, which the accounting under ASC 740 is incomplete, are reported as a provisional amount based on a reasonable estimate. The reasonable estimate is subject to adjustment during a "measurement period", not to exceed one year, until the accounting is complete. The estimate is also subject to the finalization of management’s analysis related to certain matters, such as developing interpretations of the provision of the TCJA, changes to certain estimates and amounts related to the earnings and profits of certain subsidiaries and the filing of tax returns.
In the fourth quarter of 2017, the Company recorded a provisional tax cost of approximately $13.0 billion which consisted primarily of the following components:

•
a $10.1 billion charge on previously undistributed foreign earnings as of December 31, 2017
•
a $4.5 billion deferred tax liability for foreign local and withholding taxes, offset by a $1.1 billion deferred tax asset for U.S. foreign tax credits, for repatriation of substantially all those earnings
•
a $0.6 billion tax benefit relating to the remeasurement of U.S. deferred tax assets and liabilities and the impact of the TCJA on unrecognized tax benefits
•
a $0.1 billion charge for U.S. state and local taxes on the repatriation of these foreign earnings

During the fourth quarter of 2018, the Company completed its full assessment and finalized the accounting for the impact of TCJA. The Company recorded net adjustments to the above components of the provisional charge of approximately $0.2 billion. These revisions were based on updated estimates and additional analysis by management as well as applying

                
 
58
                                


interpretative guidance issued by the U.S. Department of Treasury to the facts and circumstances that existed as of the TCJA enactment date. This charge was primarily related to additional deferred tax liabilities for foreign local and withholding taxes for the remaining balance of undistributed foreign earnings as of December 31, 2017 that were not provided for in the provisional charge in the fourth quarter of 2017.

The TCJA also includes provisions for a tax on global intangible low-taxed income (GILTI). GILTI is described as the excess of a U.S. shareholder’s total net foreign income over a deemed return on tangible assets, as provided by the TCJA. In January 2018, the FASB issued guidance that allows companies to elect as an accounting policy whether to record the tax effects of GILTI in the period the tax liability is generated (i.e., “period cost”) or provide for deferred tax assets and liabilities related to basis differences that exist and are expected to effect the amount of GILTI inclusion in future years upon reversal (i.e., “deferred method”). Through the third fiscal quarter of 2018, the Company had provisionally elected to treat GILTI as a period expense. Upon further analysis of this new tax provision, the Company has elected to account for GILTI under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred. As a result of this election, the Company recorded a deferred tax cost related to GILTI of approximately $1.4 billion in the fourth fiscal quarter of 2018 related to facts and circumstances that existed on the date of TCJA enactment.
As a result of the GILTI deferred tax charge and the other adjustments to the provisional amount, the Company recorded a total of $1.6 billion of adjustments to the 2017 provisional charge increasing the Company’s annual effective tax rate by approximately 9%.

During 2018, the Company reorganized the ownership structure of certain foreign subsidiaries which resulted in a reduction of certain foreign withholding taxes that it had recognized as part of the provisional TCJA tax charge in the fourth quarter of 2017. Following the completion of this restructuring in the fourth quarter 2018, and as a result of clarification by Swiss tax authorities regarding the applicability of withholding tax to repatriation of certain earnings, the Company reversed a deferred tax liability of $2.8 billion and a related deferred tax asset of $0.9 billion for U.S. foreign tax credits, for a net deferred tax benefit of $1.9 billion. As this restructuring occurred after the TCJA enactment date, the benefit is not considered an adjustment to the provisional amount recorded in 2017 under SAB118. This benefit with the SAB 118 adjustments has been reflected as “TCJA and related impacts” on the Company’s effective tax rate reconciliation.

As described in Note 1 to the Consolidated Financial Statements, in 2018 the Company adopted ASU 2016-16: Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory. This standard requires entities to recognize deferred tax assets and liabilities related to transfer of assets, other than inventory, within the consolidated entity. At the beginning of fiscal 2018, the Company recorded a net adjustment to deferred tax assets of approximately $2.0 billion. In the fourth quarter of 2018, as a result of the election to record GILTI on the deferred method, the Company recorded a GILTI deferred tax liability of $1.7 billion related to the adoption provisions of ASU 2016-16 as an adjustment to retained earnings.

The 2018 effective tax rate decreased by 77.6% compared to 2017. The 2017 effective tax rate was primarily driven by the approximately $13 billion provisional tax charge recorded in the fourth quarter of 2017 and the impact of a Belgian statutory tax rate change which increased the 2017 effective rate by 3.4%. Additional drivers of the 2018 annual effective tax were:
•
the reduction of the U.S. statutory corporate tax rate including the effects of tax elections which resulted in the acceleration of certain deductions into the 2017 tax return. The impact of these accelerated deductions decreased the annual effective tax rate by approximately 1.7%
•
the impact of the adjustments to the 2017 provisional TCJA charge, including both SAB 118 adjustments and the internal restructuring, decreased the effective tax rate by approximately 1.9%
•
GILTI tax which increased the annual effective tax rate by approximately 1.6%, which excludes the impact of the SAB 118 adjustment for the adoption of the deferred method for GILTI
•
tax benefits received from stock-based compensation during fiscal 2018 and 2017, reduced the effective tax rate by 1.5% and 2.0%, respectively
•
in the fourth quarter of 2018, the Company completed the divestiture of its LifeScan business (Note 20), which increased the Company annual effective tax rate by approximately 0.8%
•
more income in higher tax jurisdictions relative to lower tax jurisdictions as compared to 2017

The 2017 effective tax rate increased by 76.1% as compared to 2016, primarily driven by the enactment of the TCJA in the U.S. in December 2017. The enactment of the TCJA resulted in a provisional tax charge in the fourth quarter of 2017, of approximately $13.0 billion or approximately 73.3 percentage point increase to the effective tax rate.
The remainder of the increase in the tax rate for 2017 was related to the remeasurement of the Company’s deferred tax assets in Belgium, as a result of changes in the Belgian statutory corporate tax rate enacted in December 2017, offset by a tax benefit for the closure of the Company’s Animas insulin pump business.


                
 
59
                                



Temporary differences and carryforwards for 2018 and 2017 were as follows:
 
 
2018 Deferred Tax
 
2017 Deferred Tax
(Dollars in Millions)
 
Asset
 
Liability
 
Asset
 
Liability
Employee related obligations
 
$
2,398

 


 
2,259

 


Stock based compensation
 
639

 


 
507

 


Depreciation & amortization
 
1,784

 


 


 
(9
)
Non-deductible intangibles
 


 
(5,967
)
 


 
(6,506
)
International R&D capitalized for tax
 
1,282

 


 
1,307

 


Reserves & liabilities
 
1,647

 


 
1,718

 


Income reported for tax purposes
 
1,104

 


 
1,316

 


Net operating loss carryforward international
 
786

 


 
762

 


Undistributed foreign earnings
 
693

 
(2,240
)
 
1,101

 
(4,457
)
Global intangible low-taxed income
 
 
 
(2,971
)
 
 
 
 
Miscellaneous international
 
603

 
(93
)
 
755

 
(194
)
Miscellaneous U.S. 
 
469

 


 
177

 


Total deferred income taxes
 
$
11,405

 
(11,271
)
 
9,902

 
(11,166
)

The Company has wholly-owned international subsidiaries that have cumulative net losses. The Company believes that it is more likely than not that these subsidiaries will generate future taxable income sufficient to utilize these deferred tax assets.
The following table summarizes the activity related to unrecognized tax benefits:
(Dollars in Millions)
 
2018
 
2017
 
2016
Beginning of year
 
$
3,151

 
3,041

 
3,080

Increases related to current year tax positions
 
242

 
332

 
348

Increases related to prior period tax positions
 
145

 
232

 
11

Decreases related to prior period tax positions
 
(137
)
 
(416
)
(1)
(338
)
Settlements
 
(40
)
 
(2
)
 
(37
)
Lapse of statute of limitations
 
(35
)
 
(36
)
 
(23
)
End of year
 
$
3,326

 
3,151

 
3,041

(1) In 2017, $347 million of this decrease is related to the TCJA

The unrecognized tax benefits of $3.3 billion at December 30, 2018, if recognized, would affect the Company’s annual effective tax rate. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress with a number of tax authorities. The IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010-2012. The Company currently expects completion of this audit during 2019. Final conclusion of the tax audit may result in an outcome that is different than the Company’s estimates and may result in a material impact on the Company’s current and future operating results or cash flows in the period that the audit is concluded. In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that audits may be completed by tax authorities in some jurisdictions over the next twelve months.  However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.

The Company classifies liabilities for unrecognized tax benefits and related interest and penalties as long-term liabilities. Interest expense and penalties related to unrecognized tax benefits are classified as income tax expense. The Company recognized after tax interest expense of $53 million, $60 million and $7 million in 2018, 2017 and 2016, respectively. The total amount of accrued interest was $503 million and $436 million in 2018 and 2017, respectively.


                
 
60
                                


9.
Employee Related Obligations
At the end of 2018 and 2017, employee related obligations recorded on the Consolidated Balance Sheets were:
(Dollars in Millions)
 
2018
 
2017
Pension benefits
 
$
5,327

 
5,343

Postretirement benefits
 
2,283

 
2,331

Postemployment benefits
 
2,330

 
2,250

Deferred compensation
 
410

 
475

Total employee obligations
 
10,350

 
10,399

Less current benefits payable
 
399

 
325

Employee related obligations — non-current
 
$
9,951

 
10,074

Prepaid employee related obligations of $475 million and $526 million for 2018 and 2017, respectively, are included in Other assets on the Consolidated Balance Sheets.

10.
Pensions and Other Benefit Plans
The Company sponsors various retirement and pension plans, including defined benefit, defined contribution and termination indemnity plans, which cover most employees worldwide. The Company also provides post-retirement benefits, primarily health care, to all eligible U.S. retired employees and their dependents.
Many international employees are covered by government-sponsored programs and the cost to the Company is not significant.
Retirement plan benefits for employees hired before January 1, 2015 are primarily based on the employee’s compensation during the last three to five years before retirement and the number of years of service. In 2014, the Company announced that the U.S. Defined Benefit Plan was amended to adopt a new benefit formula, effective for employees hired on or after January 1, 2015. The benefits are calculated using a new formula based on employee compensation over total years of service.
International subsidiaries have plans under which funds are deposited with trustees, annuities are purchased under group contracts, or reserves are provided.
The Company does not typically fund retiree health care benefits in advance, but may do so at its discretion. The Company also has the right to modify these plans in the future.
In 2018 and 2017 the Company used December 31, 2018 and December 31, 2017, respectively, as the measurement date for all U.S. and international retirement and other benefit plans.
Net periodic benefit costs for the Company’s defined benefit retirement plans and other benefit plans for 2018, 2017 and 2016 include the following components:
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Service cost
 
$
1,283

 
1,080

 
949

 
269

 
247

 
224

Interest cost
 
996

 
927

 
927

 
148

 
159

 
158

Expected return on plan assets
 
(2,212
)
 
(2,041
)
 
(1,962
)
 
(7
)
 
(6
)
 
(6
)
Amortization of prior service cost (credit)
 
3

 
2

 
1

 
(31
)
 
(30
)
 
(34
)
Recognized actuarial losses
 
852

 
609

 
496

 
123

 
138

 
135

Curtailments and settlements
 
1

 
17

 
11

 
—

 
—

 
—

Net periodic benefit cost
 
$
923

 
594

 
422

 
502

 
508

 
477


In 2018, as per the adoption of ASU 2017-07, the service cost component of net periodic benefit cost was presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.








                
 
61
                                



Amounts expected to be recognized in net periodic benefit cost in the coming year for the Company’s defined benefit retirement plans and other post-retirement plans:
(Dollars in Millions)
 
Amortization of net transition obligation
$
—

Amortization of net actuarial losses
656

Amortization of prior service credit
27


Unrecognized gains and losses for the U.S. pension plans are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses for the other U.S. benefit plans is determined by using a 10% corridor of the greater of the market value of assets or the accumulated postretirement benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.
Prior service costs/benefits for the U.S. pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment. Prior service cost/benefit for the other U.S. benefit plans is amortized over the average remaining service to full eligibility age of plan participants at the time of the plan amendment.

The following table represents the weighted-average actuarial assumptions:
 
 
Retirement Plans
 
Other Benefit Plans
Worldwide Benefit Plans
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Net Periodic Benefit Cost
 
 
 
 
 
 
 
 
 
 
 
 
Service cost discount rate
 
3.20
%
 
3.59
 
3.98
 
3.85
 
4.63
 
4.77
Interest cost discount rate
 
3.60
%
 
3.98
 
4.24
 
3.62
 
3.94
 
4.10
Rate of increase in compensation levels
 
3.98
%
 
4.01
 
4.02
 
4.29
 
4.31
 
4.32
Expected long-term rate of return on plan assets
 
8.46
%
 
8.43
 
8.55
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Benefit Obligation
 
 
 
 
 
 
 
 
 
 
 
 
Discount rate
 
3.76
%
 
3.30
 
3.78
 
4.40
 
3.78
 
4.42
Rate of increase in compensation levels
 
3.97
%
 
3.99
 
4.02
 
4.29
 
4.30
 
4.29

The Company’s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In the fiscal year 2016, the Company changed its methodology in determining service and interest cost from the single weighted average discount rate approach to duration specific spot rates along that yield curve to the plans’ liability cash flows, which management has concluded is a more precise estimate. Prior to this change in methodology, the Company measured service and interest costs utilizing a single weighted-average discount rate derived from the yield curve used to measure the plan obligations. The Company has accounted for this change as a change in accounting estimate and, accordingly, has accounted for it on a prospective basis. This change does not impact the benefit obligation and did not have a material impact to the 2016 full year results.
The expected rates of return on plan asset assumptions represent the Company's assessment of long-term returns on diversified investment portfolios globally. The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.













                
 
62
                                



The following table displays the assumed health care cost trend rates, for all individuals:
Health Care Plans
 
2018
 
2017
Health care cost trend rate assumed for next year
 
6.12
%
 
6.33
%
Rate to which the cost trend rate is assumed to decline (ultimate trend)
 
4.55
%
 
4.55
%
Year the rate reaches the ultimate trend rate
 
2038

 
2038



A one-percentage-point change in assumed health care cost trend rates would have the following effect:
 
 
One-Percentage-
 
One-Percentage-
(Dollars in Millions)
 
Point Increase
 
Point Decrease
Health Care Plans
 
 

 
 

Total interest and service cost
 
$
28

 
(22
)
Post-retirement benefit obligation
 
$
340

 
(280
)

                
 
63
                                



The following table sets forth information related to the benefit obligation and the fair value of plan assets at year-end 2018 and 2017 for the Company’s defined benefit retirement plans and other post-retirement plans:
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
Change in Benefit Obligation
 
 
 
 
 
 
 
 
Projected benefit obligation — beginning of year
 
$
33,221

 
28,116

 
4,582

 
4,605

Service cost
 
1,283

 
1,080

 
269

 
247

Interest cost
 
996

 
927

 
148

 
159

Plan participant contributions
 
66

 
60

 
—

 
—

Amendments
 
26

 
(7
)
 
—

 
(17
)
Actuarial (gains) losses
 
(2,326
)
 
2,996

 
(119
)
 
(166
)
Divestitures & acquisitions
 
(29
)
 
201

 
—

 
88

Curtailments, settlements & restructuring
 
(21
)
 
(35
)
 
—

 
2

Benefits paid from plan
 
(1,018
)
 
(1,050
)
 
(383
)
 
(351
)
Effect of exchange rates
 
(528
)
 
933

 
(17
)
 
15

Projected benefit obligation — end of year
 
$
31,670

 
33,221

 
4,480

 
4,582

Change in Plan Assets
 
 
 
 
 
 
 
 
Plan assets at fair value — beginning of year
 
$
28,404

 
23,633

 
281

 
75

Actual return on plan assets
 
(1,269
)
 
4,274

 
—

 
12

Company contributions
 
1,140

 
664

 
282

 
545

Plan participant contributions
 
66

 
60

 
—

 
—

Settlements
 
(13
)
 
(32
)
 
—

 
—

Divestitures & acquisitions
 
(17
)
 
173

 
—

 
—

Benefits paid from plan assets
 
(1,018
)
 
(1,050
)
 
(383
)
 
(351
)
Effect of exchange rates
 
(475
)
 
682

 
—

 
—

Plan assets at fair value — end of year
 
$
26,818

 
28,404

 
180

 
281

Funded status — end of year
 
$
(4,852
)
 
(4,817
)
 
(4,300
)
 
(4,301
)
Amounts Recognized in the Company’s Balance Sheet consist of the following:
 
 
 
 
 
 
 
 
Non-current assets
 
$
475

 
526

 
—

 
—

Current liabilities
 
(98
)
 
(92
)
 
(281
)
 
(228
)
Non-current liabilities
 
(5,229
)
 
(5,251
)
 
(4,019
)
 
(4,073
)
Total recognized in the consolidated balance sheet — end of year
 
$
(4,852
)
 
(4,817
)
 
(4,300
)
 
(4,301
)
Amounts Recognized in Accumulated Other Comprehensive Income consist of the following:
 
 
 
 
 
 
 
 
Net actuarial loss
 
$
8,323

 
8,140

 
1,263

 
1,500

Prior service cost (credit)
 
2

 
(25
)
 
(106
)
 
(137
)
Unrecognized net transition obligation
 
—

 
—

 
—

 
—

Total before tax effects
 
$
8,325

 
8,115

 
1,157

 
1,363

 
 
 
 
 
 
 
 
 
Accumulated Benefit Obligations — end of year
 
$
28,533

 
29,793

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

                
 
64
                                


 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
Amounts Recognized in Net Periodic Benefit Cost and Other Comprehensive Income
 
 
 
 
 
 
 
 
Net periodic benefit cost
 
$
923

 
594

 
502

 
508

Net actuarial (gain) loss
 
1,153

 
740

 
(111
)
 
(169
)
Amortization of net actuarial loss
 
(852
)
 
(609
)
 
(123
)
 
(138
)
Prior service cost (credit)
 
26

 
(7
)
 
—

 
(17
)
Amortization of prior service (cost) credit
 
(3
)
 
(2
)
 
31

 
30

Effect of exchange rates
 
(114
)
 
256

 
(3
)
 
3

Total loss/(income) recognized in other comprehensive income, before tax
 
$
210

 
378

 
(206
)
 
(291
)
Total recognized in net periodic benefit cost and other comprehensive income
 
$
1,133

 
972

 
296

 
217


The Company plans to continue to fund its U.S. Qualified Plans to comply with the Pension Protection Act of 2006. International Plans are funded in accordance with local regulations. Additional discretionary contributions are made when deemed appropriate to meet the long-term obligations of the plans. For certain plans, funding is not a common practice, as funding provides no economic benefit. Consequently, the Company has several pension plans that are not funded.
In 2018, the Company contributed $679 million and $461 million to its U.S. and international pension plans, respectively.
The following table displays the funded status of the Company's U.S. Qualified & Non-Qualified pension plans and international funded and unfunded pension plans at December 31, 2018 and December 31, 2017, respectively:

 
U.S. Plans
International Plans
 
Qualified Plans
Non-Qualified Plans
Funded Plans
Unfunded Plans
(Dollars in Millions)
2018
2017
2018
2017
2018
2017
2018
2017
Plan Assets
$
17,725

18,681

—

—

9,093

9,723

—

—

Projected Benefit Obligation
18,609

19,652

2,176

2,257

10,467

10,863

418

449

Accumulated Benefit Obligation
16,851

17,654

1,793

1,849

9,510

9,893

379

397

Over (Under) Funded Status
 
 
 
 
 
 
 
 
Projected Benefit Obligation
$
(884
)
(971
)
(2,176
)
(2,257
)
(1,374
)
(1,140
)
(418
)
(449
)
Accumulated Benefit Obligation
874

1,027

(1,793
)
(1,849
)
(417
)
(170
)
(379
)
(397
)
Plans with accumulated benefit obligations in excess of plan assets have an accumulated benefit obligation, projected benefit obligation and plan assets of $7.5 billion, $8.8 billion and $4.3 billion, respectively, at the end of 2018, and $3.8 billion, $4.6 billion and $0.7 billion, respectively, at the end of 2017.

The following table displays the projected future benefit payments from the Company’s retirement and other benefit plans:
(Dollars in Millions)
 
2019
 
2020
 
2021
 
2022
 
2023
 
2024-2028
Projected future benefit payments
 
 
 
 
 
 
 
 
 
 
 
 
Retirement plans
 
$
1,062

 
1,104

 
1,182

 
1,257

 
1,332

 
7,679

Other benefit plans 
 
$
375

 
397

 
411

 
428

 
413

 
2,273


The following table displays the projected future minimum contributions to the unfunded retirement plans. These amounts do not include any discretionary contributions that the Company may elect to make in the future.
(Dollars in Millions)
 
2019
 
2020
 
2021
 
2022
 
2023
 
2024-2028
Projected future contributions
 
$
92

 
95

 
101

 
108

 
115

 
697




                
 
65
                                


Each pension plan is overseen by a local committee or board that is responsible for the overall administration and investment of the pension plans. In determining investment policies, strategies and goals, each committee or board considers factors including, local pension rules and regulations; local tax regulations; availability of investment vehicles (separate accounts, commingled accounts, insurance funds, etc.); funded status of the plans; ratio of actives to retirees; duration of liabilities; and other relevant factors including: diversification, liquidity of local markets and liquidity of base currency. A majority of the Company’s pension funds are open to new entrants and are expected to be on-going plans. Permitted investments are primarily liquid and/or listed, with little reliance on illiquid and non-traditional investments such as hedge funds.
The Company’s retirement plan asset allocation at the end of 2018 and 2017 and target allocations for 2019 are as follows:
 
 
Percent of
Plan Assets
 
Target
Allocation
 
 
2018
 
2017
 
2019
Worldwide Retirement Plans
 
 
 
 
 
 
Equity securities
 
71
%
 
76
%
 
70
%
Debt securities
 
29

 
24

 
30

Total plan assets
 
100
%
 
100
%
 
100
%
Determination of Fair Value of Plan Assets
The Plan has an established and well-documented process for determining fair values. Fair value is based upon quoted market prices, where available. If listed prices or quotes are not available, fair value is based upon models that primarily use, as inputs, market-based or independently sourced market parameters, including yield curves, interest rates, volatilities, equity or debt prices, foreign exchange rates and credit curves.
While the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.
Valuation Hierarchy
The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described in the table below with Level 1 having the highest priority and Level 3 having the lowest.
A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Following is a description of the valuation methodologies used for the investments measured at fair value.
•
Short-term investment funds — Cash and quoted short-term instruments are valued at the closing price or the amount held on deposit by the custodian bank. Other investments are through investment vehicles valued using the Net Asset Value (NAV) provided by the administrator of the fund. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. The NAV is a quoted price in a market that is not active and classified as Level 2.
•
Government and agency securities — A limited number of these investments are valued at the closing price reported on the major market on which the individual securities are traded. Where quoted prices are available in an active market, the investments are classified within Level 1 of the valuation hierarchy. If quoted market prices are not available for the specific security, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. When quoted market prices for a security are not available in an active market, they are classified as Level 2.
•
Debt instruments — A limited number of these investments are valued at the closing price reported on the major market on which the individual securities are traded. Where quoted prices are available in an active market, the investments are classified as Level 1. If quoted market prices are not available for the specific security, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows and are classified as Level 2. Level 3 debt instruments are priced based on unobservable inputs.
•
Equity securities — Equity securities are valued at the closing price reported on the major market on which the individual securities are traded. Substantially all common stock is classified within Level 1 of the valuation hierarchy.
•
Commingled funds — These investment vehicles are valued using the NAV provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. Assets in the Level 2 category have a quoted market price.

                
 
66
                                


•
Insurance contracts — The instruments are issued by insurance companies. The fair value is based on negotiated value and the underlying investments held in separate account portfolios as well as considering the credit worthiness of the issuer. The underlying investments are government, asset-backed and fixed income securities. In general, insurance contracts are classified as Level 3 as there are no quoted prices nor other observable inputs for pricing.
•
Other assets — Other assets are represented primarily by limited partnerships and real estate investments, as well as commercial loans and commercial mortgages that are not classified as corporate debt. Other assets that are exchange listed and actively traded are classified as Level 1, while inactively traded assets are classified as Level 2.

The following table sets forth the Retirement Plans' investments measured at fair value as of December 31, 2018 and December 31, 2017:
 
 
Quoted Prices
in Active
Markets for
Identical Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs(a)
 
Investments Measured at Net Asset Value
 
 
 
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
 
 
 
 
Total Assets
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
Short-term investment funds
 
$
122

 
429

 
529

 
427

 
—

 
—

 
—

 
—

 
651

 
856

Government and agency securities
 
—

 
—

 
3,595

 
3,094

 
—

 
—

 
—

 
—

 
3,595

 
3,094

Debt instruments
 
—

 
—

 
3,105

 
2,013

 
—

 
—

 
—

 
—

 
3,105

 
2,013

Equity securities
 
11,298

 
13,848

 
4

 
—

 
—

 
—

 
—

 
—

 
11,302

 
13,848

Commingled funds
 
—

 
—

 
2,304

 
1,780

 
133

 
57

 
5,201

 
6,158

 
7,638

 
7,995

Insurance contracts
 
—

 
—

 
—

 
—

 
193

 
199

 
—

 
—

 
193

 
199

Other assets
 
—

 
—

 
33

 
121

 
—

 
—

 
301

 
278

 
334

 
399

Investments at fair value
 
$
11,420

 
14,277

 
9,570

 
7,435

 
326

 
256

 
5,502

 
6,436

 
26,818

 
28,404


(a) The activity for the Level 3 assets is not significant for all years presented.

The Company's Other Benefit Plans are unfunded except for U.S. commingled funds (Level 2) of $72 million and $81 million and U.S. short-term investment funds (Level 2) of $108 million and $200 million at December 31, 2018 and December 31, 2017, respectively.
The fair value of Johnson & Johnson Common Stock directly held in plan assets was $876 million (3.3% of total plan assets) at December 31, 2018 and $938 million (3.3% of total plan assets) at December 31, 2017.

11.
Savings Plan
The Company has voluntary 401(k) savings plans designed to enhance the existing retirement programs covering eligible employees. The Company matches a percentage of each employee’s contributions consistent with the provisions of the plan for which he/she is eligible. Total Company matching contributions to the plans were $242 million, $214 million and $191 million in 2018, 2017 and 2016, respectively.


                
 
67
                                


12.
Capital and Treasury Stock
Changes in treasury stock were:
 
 
Treasury Stock
(Amounts in Millions Except Treasury Stock Shares in Thousands)
 
Shares
 
Amount
Balance at January 3, 2016
 
364,681

 
$
22,684

Employee compensation and stock option plans
 
(30,839
)
 
(3,311
)
Repurchase of common stock
 
79,490

 
8,979

Balance at January 1, 2017
 
413,332

 
28,352

Employee compensation and stock option plans
 
(25,508
)
 
(3,156
)
Repurchase of common stock
 
49,494

 
6,358

Balance at December 31, 2017
 
437,318

 
31,554

Employee compensation and stock option plans
 
(22,082
)
 
(3,060
)
Repurchase of common stock
 
42,283

 
5,868

Balance at December 30, 2018
 
457,519

 
$
34,362


Aggregate shares of common stock issued were approximately 3,119,843,000 shares at the end of 2018, 2017 and 2016.

Cash dividends paid were $3.54 per share in 2018, compared with dividends of $3.32 per share in 2017, and $3.15 per share in 2016.
On December 17, 2018, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to $5.0 billion of the Company's shares of common stock. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Any shares acquired will be available for general corporate purposes. The Company intends to finance the share repurchase program through available cash. As of December 30, 2018, $0.9 billion has been repurchased under the program.
On October 13, 2015, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to $10.0 billion of the Company's shares of common stock. This share repurchase program was completed as of July 2, 2017.

13.
Accumulated Other Comprehensive Income (Loss)
Components of other comprehensive income (loss) consist of the following:
(Dollars in Millions)
 
Foreign
Currency Translation
 
Gain/(Loss) On Securities
 
Employee Benefit Plans
 
Gain/
(Loss) On
Derivatives & Hedges
 
Total
Accumulated
Other
Comprehensive Income (Loss)
January 3, 2016
 
$
(8,435
)
 
604

 
(5,298
)
 
(36
)
 
(13,165
)
Net 2016 changes
 
(612
)
 
(193
)
 
(682
)
 
(249
)
 
(1,736
)
January 1, 2017
 
(9,047
)
 
411

 
(5,980
)
 
(285
)
 
(14,901
)
Net 2017 changes
 
1,696

 
(179
)
 
(170
)
 
355

 
1,702

December 31, 2017
 
(7,351
)
 
232

 
(6,150
)
 
70

 
(13,199
)
Cumulative adjustment to retained earnings
 
 
 
(232
)
(1) 
 
 
 
 
(232
)
Net 2018 changes
 
(1,518
)
 
—

 
(8
)
 
(265
)
 
(1,791
)
December 30, 2018
 
$
(8,869
)
 
—

 
(6,158
)
 
(195
)
 
(15,222
)

(1) See Note 1 to Consolidated Financial Statements for additional details on the adoption of ASU 2016-01

Amounts in accumulated other comprehensive income are presented net of the related tax impact. Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries. For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income.

Details on reclassifications out of Accumulated Other Comprehensive Income:
Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.

                
 
68
                                


Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 10 for additional details.
Gain/(Loss) On Derivatives & Hedges - reclassifications to earnings are recorded in the same account as the hedged transaction. See Note 6 for additional details.

14.
International Currency Translation
For translation of its subsidiaries operating in non-U.S. Dollar currencies, the Company has determined that the local currencies of its international subsidiaries are the functional currencies except those in highly inflationary economies, which are defined as those which have had compound cumulative rates of inflation of 100% or more during the past three years, or where a substantial portion of its cash flows are not in the local currency. Beginning in the fiscal third quarter of 2018, the Company accounted for operations in Argentina as highly inflationary. For the majority of the Company's subsidiaries the local currency is the functional currency.
In consolidating international subsidiaries, balance sheet currency effects are recorded as a component of accumulated other comprehensive income. This equity account includes the results of translating certain balance sheet assets and liabilities at current exchange rates and some accounts at historical rates, except for those located in highly inflationary economies. The translation of balance sheet accounts for highly inflationary economies are reflected in the operating results.
A rollforward of the changes during 2018, 2017 and 2016 for foreign currency translation adjustments is included in Note 13.
Net currency transaction gains and losses included in Other (income) expense were losses of $265 million, $216 million and $289 million in 2018, 2017 and 2016, respectively.

15.
Earnings Per Share
The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal years ended December 30, 2018, December 31, 2017 and January 1, 2017:
(In Millions Except Per Share Amounts)
 
2018
 
2017
 
2016
Basic net earnings per share
 
$
5.70

 
0.48

 
6.04

Average shares outstanding — basic
 
2,681.5

 
2,692.0

 
2,737.3

Potential shares exercisable under stock option plans
 
139.0

 
139.7

 
142.4

Less: shares repurchased under treasury stock method
 
(92.5
)
 
(87.3
)
 
(92.1
)
Convertible debt shares
 
0.7

 
0.9

 
1.3

Adjusted average shares outstanding — diluted
 
2,728.7

 
2,745.3

 
2,788.9

Diluted net earnings per share
 
$
5.61

 
0.47

 
5.93


The diluted net earnings per share calculation included the dilutive effect of convertible debt that is offset by the related reduction in interest expense of $1 million after-tax for 2018 and 2017, and $2 million for 2016.
The diluted net earnings per share calculation for 2018, 2017 and 2016 included all shares related to stock options, as the exercise price of all options was less than the average market value of the Company's stock.
 
16.
Rental Expense and Lease Commitments
Rentals of space, vehicles, manufacturing equipment and office and data processing equipment under operating leases were approximately $332 million, $372 million and $330 million in 2018, 2017 and 2016, respectively.
The approximate minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year at December 30, 2018 are:
(Dollars in Millions)
2019
 
2020
 
2021
 
2022
 
2023
 
After 2023
 
Total
$223
 
188
 
154
 
116
 
76
 
139
 
896
Commitments under capital leases are not significant.


                
 
69
                                


17.
Common Stock, Stock Option Plans and Stock Compensation Agreements
At December 30, 2018, the Company had 2 stock-based compensation plans. The shares outstanding are for contracts under the Company's 2005 Long-Term Incentive Plan and the 2012 Long-Term Incentive Plan. The 2005 Long-Term Incentive Plan expired April 26, 2012. All options and restricted shares granted subsequent to that date were under the 2012 Long-Term Incentive Plan. Under the 2012 Long-Term Incentive Plan, the Company may issue up to 650 million shares of common stock, plus any shares canceled, expired, forfeited, or not issued from the 2005 Long-Term Incentive Plan subsequent to April 26, 2012. Shares available for future grants under the 2012 Long-Term Incentive Plan were 351 million at the end of 2018.
The compensation cost that has been charged against income for these plans was $978 million, $962 million and $878 million for 2018, 2017 and 2016, respectively. The total income tax benefit recognized in the income statement for share-based compensation costs was $192 million, $275 million and $256 million for 2018, 2017 and 2016, respectively. An additional tax benefit of $353 million was recognized in 2016 due to the adoption of a new accounting standard for the reporting of additional tax benefits on share-based compensation. The total unrecognized compensation cost was $827 million, $798 million and $749 million for 2018, 2017 and 2016, respectively. The weighted average period for this cost to be recognized was 1.73 years, 1.76 years and 1.09 years for 2018, 2017, and 2016, respectively. Share-based compensation costs capitalized as part of inventory were insignificant in all periods.
The Company settles employee benefit equity issuances with treasury shares. Treasury shares are replenished throughout the year for the number of shares used to settle employee benefit equity issuances.
Stock Options
Stock options expire 10 years from the date of grant and vest over service periods that range from 6 months to 4 years. All options are granted at the average of the high and low prices of the Company’s Common Stock on the New York Stock Exchange on the date of grant.
The fair value of each option award was estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. For 2018, 2017 and 2016 grants, expected volatility represents a blended rate of 10-year weekly historical overall volatility rate, and a 5-week average implied volatility rate based on at-the-money traded Johnson & Johnson options with a life of 2 years. For all grants, historical data is used to determine the expected life of the option. The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant.

The average fair value of options granted was $17.98, $13.38 and $10.01, in 2018, 2017 and 2016, respectively. The fair value was estimated based on the weighted average assumptions of:
 
2018
 
2017
 
2016
Risk-free rate
2.77
%
 
2.25
%
 
1.51
%
Expected volatility
15.77
%
 
15.30
%
 
15.76
%
Expected life (in years)
7.0

 
7.0

 
7.0

Expected dividend yield
2.70
%
 
2.90
%
 
3.10
%

A summary of option activity under the Plan as of December 30, 2018, December 31, 2017 and January 1, 2017, and changes during the years ending on those dates is presented below:

                
 
70
                                


(Shares in Thousands)
 
Outstanding Shares
 
Weighted
Average Exercise Price
 
Aggregate
Intrinsic
Value
(Dollars in Millions)
Shares at January 3, 2016
 
116,517

 
$
76.41

 
$
3,065

Options granted
 
22,491

 
101.87

 
 
Options exercised
 
(22,547
)
 
65.66

 
 
Options canceled/forfeited
 
(3,006
)
 
92.83

 
 
Shares at January 1, 2017
 
113,455

 
83.16

 
3,636

Options granted
 
19,287

 
115.67

 
 
Options exercised
 
(18,975
)
 
70.87

 
 
Options canceled/forfeited
 
(2,461
)
 
101.40

 
 
Shares at December 31, 2017
 
111,306

 
90.48

 
5,480

Options granted
 
17,115

 
129.51

 
 
Options exercised
 
(16,228
)
 
75.44

 
 
Options canceled/forfeited
 
(2,541
)
 
112.90

 
 
Shares at December 30, 2018
 
109,652

 
$
98.29

 
$
3,214


The total intrinsic value of options exercised was $1,028 million, $1,060 million and $980 million in 2018, 2017 and 2016, respectively.

The following table summarizes stock options outstanding and exercisable at December 30, 2018:
(Shares in Thousands)
 
Outstanding
 
Exercisable
Exercise Price Range
 
Options
 
Average Life(1)
 
Average Exercise Price
 
Options
 
Average Exercise Price
$52.13-$65.62
 
13,466

 
1.8
 
$62.67
 
13,466

 
$62.67
$66.07-$72.54
 
12,710

 
4.0
 
$72.53
 
12,710

 
$72.53
$90.44-$100.48
 
29,162

 
5.6
 
$95.34
 
28,537

 
$95.23
$101.87-$115.67
 
37,877

 
7.6
 
$108.33
 
111

 
$108.04
$115.68-$129.51
 
16,437

 
9.1
 
$129.51
 
38

 
$129.51
 
 
109,652

 
6.2
 
$98.29
 
54,862

 
$82.03

(1) Average contractual life remaining in years.
Stock options outstanding at December 31, 2017 and January 1, 2017 were 111,306 and an average life of 6.3 years and 113,455 and an average life of 6.2 years, respectively. Stock options exercisable at December 31, 2017 and January 1, 2017 were 52,421 at an average price of $73.61 and 50,414 at an average price of $65.77, respectively.
Restricted Share Units and Performance Share Units
The Company grants restricted share units which vest over service periods that range from 6 months to 3 years. The Company also grants performance share units, which are paid in shares of Johnson & Johnson Common Stock after the end of a three-year performance period. Whether any performance share units vest, and the amount that does vest, is tied to the completion of service periods that range from 6 months to 3 years and the achievement, over a three-year period, of three equally-weighted goals that directly align with or help drive long-term total shareholder return: operational sales, adjusted operational earnings per share, and relative total shareholder return. The number of shares actually earned at the end of the three-year period will vary, based only on actual performance, from 0% to 200% of the target number of performance share units granted. In the fourth quarter of 2017, the Company modified the restricted share units that are scheduled to vest between January 1, 2018 and March 15, 2018. This modification guaranteed a minimum aggregate value, below the market value of the total expected payout amount, for all awards expected to vest during this period. The amount that was committed was not material to the Company’s overall financial position.




                
 
71
                                


A summary of the restricted share units and performance share units activity under the Plans as of December 30, 2018 is presented below:
(Shares in Thousands)
 
Outstanding Restricted Share Units
 
Outstanding Performance Share Units
Shares at December 31, 2017
 
20,161

 
2,625

Granted
 
6,074

 
1,142

Issued
 
(6,684
)
 
(1,151
)
Canceled/forfeited/adjusted
 
(1,091
)
 
(122
)
Shares at December 30, 2018
 
18,460

 
2,494

The average fair value of the restricted share units granted was $119.67, $107.69 and $92.45 in 2018, 2017 and 2016, respectively, using the fair market value at the date of grant. The fair value of restricted share units was discounted for dividends, which are not paid on the restricted share units during the vesting period. The fair value of restricted share units issued was $613.7 million, $596.5 million and $587.7 million in 2018, 2017 and 2016, respectively.
The weighted average fair value of the performance share units granted was $120.64, $114.13 and $105.30 in 2018, 2017 and 2016, calculated using the weighted average fair market value for each of the three component goals at the date of grant. 
The fair values for the sales and earnings per share goals of each performance share unit were estimated on the date of grant using the fair market value of the shares at the time of the award discounted for dividends, which are not paid on the performance share units during the vesting period.  The fair value for the relative total shareholder return goal of each performance share unit was estimated on the date of grant using the Monte Carlo valuation model. The fair value of performance share units issued was $128.8 million, $132.5 million and $127.7 million in 2018, 2017 and 2016, respectively.


                
 
72
                                


18.
Segments of Business and Geographic Areas

 
 
Sales to Customers
 
% Change
(Dollars in Millions)
 
2018
 
2017
 
2016
 
’18 vs. ’17
 
’17 vs. ’16
 
 
 
 
 
 
 
 
 
 
 
CONSUMER
 
 
 
 
 
 
 
 
 
 
Baby Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
$
422

 
449

 
488

 
(6.0
)%
 
(8.0
)
     International
 
1,436

 
1,467

 
1,513

 
(2.1
)
 
(3.0
)
     Worldwide
 
1,858

 
1,916

 
2,001

 
(3.0
)
 
(4.2
)
Beauty
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,403

 
2,335

 
2,135

 
2.9

 
9.4

     International
 
1,979

 
1,865

 
1,762

 
6.1

 
5.8

     Worldwide
 
4,382

 
4,200

 
3,897

 
4.3

 
7.8

Oral Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
637

 
616

 
648

 
3.4

 
(4.9
)
     International
 
918

 
915

 
920

 
0.3

 
(0.5
)
     Worldwide
 
1,555

 
1,531

 
1,568

 
1.6

 
(2.4
)
OTC
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,850

 
1,716

 
1,675

 
7.8

 
2.4

     International
 
2,484

 
2,410

 
2,302

 
3.1

 
4.7

     Worldwide
 
4,334

 
4,126

 
3,977

 
5.0

 
3.7

Women's Health
 
 
 
 
 
 
 
 
 
 
     U.S.
 
13

 
12

 
19

 
8.3

 
(36.8
)
     International
 
1,036

 
1,038

 
1,048

 
(0.2
)
 
(1.0
)
     Worldwide
 
1,049

 
1,050

 
1,067

 
(0.1
)
 
(1.6
)
Wound Care/Other
 
 
 
 
 
 
 
 
 
 
     U.S.
 
436

 
437

 
455

 
(0.2
)
 
(4.0
)
     International
 
239

 
342

 
342

 
(30.1
)
 
0.0

     Worldwide
 
675

 
779

 
797

 
(13.4
)
 
(2.3
)
TOTAL CONSUMER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
5,761

 
5,565

 
5,420

 
3.5

 
2.7

     International
 
8,092

 
8,037

 
7,887

 
0.7

 
1.9

     Worldwide
 
13,853

 
13,602

 
13,307

 
1.8

 
2.2

 
 
 
 
 
 
 
 
 
 
 
PHARMACEUTICAL
 
 
 
 
 
 
 
 
 
 
Immunology
 
 
 
 
 
 
 
 
 
 
     U.S.
 
9,073

 
8,871

 
8,846

 
2.3

 
0.3

     International
 
4,047

 
3,373

 
3,122

 
20.0

 
8.0

     Worldwide
 
13,120

 
12,244

 
11,968

 
7.2

 
2.3

     REMICADE®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
3,664

 
4,525

 
4,842

 
(19.0
)
 
(6.5
)
     U.S. Exports
 
436

 
563

 
782

 
(22.6
)
 
(28.0
)
     International
 
1,226

 
1,227

 
1,342

 
(0.1
)
 
(8.6
)
     Worldwide
 
5,326

 
6,315

 
6,966

 
(15.7
)
 
(9.3
)
 
 
 
 
 
 
 
 
 
 
 

                
 
73
                                


     SIMPONI / SIMPONI ARIA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,051

 
954

 
959

 
10.2

 
(0.5
)
     International
 
1,033

 
879

 
786

 
17.5

 
11.8

     Worldwide
 
2,084

 
1,833

 
1,745

 
13.7

 
5.0

     STELARA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
3,469

 
2,767

 
2,263

 
25.4

 
22.3

     International
 
1,687

 
1,244

 
969

 
35.6

 
28.4

     Worldwide
 
5,156

 
4,011

 
3,232

 
28.5

 
24.1

     TREMFAYA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
453

 
62

 
—

 
*
 
*
     International
 
91

 
1

 
—

 
*
 
*
     Worldwide
 
544

 
63

 
—

 
*
 
*
     OTHER IMMUNOLOGY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—
     International
 
10

 
22

 
25

 
(54.5
)
 
(12.0
)
     Worldwide
 
10

 
22

 
25

 
(54.5
)
 
(12.0
)
 
 
 
 
 
 
 
 
 
 
 
Infectious Diseases
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,378

 
1,358

 
1,461

 
1.5

 
(7.0
)
     International
 
1,926

 
1,796

 
1,747

 
7.2

 
2.8

     Worldwide
 
3,304

 
3,154

 
3,208

 
4.8

 
(1.7
)
     EDURANT® / rilpivirine
 
 
 
 
 
 
 
 
 
 
     U.S.
 
58

 
58

 
52

 
0.0

 
11.5

     International
 
758

 
656

 
521

 
15.5

 
25.9

     Worldwide
 
816

 
714

 
573

 
14.3

 
24.6

     PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,169

 
1,109

 
1,143

 
5.4

 
(3.0
)
     International
 
786

 
712

 
708

 
10.4

 
0.6

     Worldwide
 
1,955

 
1,821

 
1,851

 
7.4

 
(1.6
)
     OTHER INFECTIOUS DISEASES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
151

 
191

 
266

 
(20.9
)
 
(28.2
)
     International
 
382

 
428

 
518

 
(10.7
)
 
(17.4
)
     Worldwide
 
533

 
619

 
784

 
(13.9
)
 
(21.0
)
 
 
 
 
 
 
 
 
 
 
 
Neuroscience
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,574

 
2,630

 
2,628

 
(2.1
)
 
0.1

     International
 
3,503

 
3,356

 
3,457

 
4.4

 
(2.9
)
     Worldwide
 
6,077

 
5,986

 
6,085

 
1.5

 
(1.6
)
     CONCERTA® / Methylphenidate
 
 
 
 
 
 
 
 
 
 
     U.S.
 
229

 
384

 
468

 
(40.4
)
 
(17.9
)
     International
 
434

 
407

 
395

 
6.6

 
3.0

     Worldwide
 
663

 
791

 
863

 
(16.2
)
 
(8.3
)
     INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,791

 
1,590

 
1,343

 
12.6

 
18.4

     International
 
1,137

 
979

 
871

 
16.1

 
12.4

     Worldwide
 
2,928

 
2,569

 
2,214

 
14.0

 
16.0


                
 
74
                                


     RISPERDAL CONSTA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
315

 
360

 
381

 
(12.5
)
 
(5.5
)
     International
 
422

 
445

 
512

 
(5.2
)
 
(13.1
)
     Worldwide
 
737

 
805

 
893

 
(8.4
)
 
(9.9
)
     OTHER NEUROSCIENCE
 
 
 
 
 
 
 
 
 
 
     U.S.
 
239

 
296

 
436

 
(19.3
)
 
(32.1
)
     International
 
1,510

 
1,525

 
1,679

 
(1.0
)
 
(9.2
)
     Worldwide
 
1,749

 
1,821

 
2,115

 
(4.0
)
 
(13.9
)
 
 
 
 
 
 
 
 
 
 
 
Oncology
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,331

 
3,098

 
2,335

 
39.8

 
32.7

     International
 
5,513

 
4,160

 
3,472

 
32.5

 
19.8

     Worldwide
 
9,844

 
7,258

 
5,807

 
35.6

 
25.0

     DARZALEX®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,203

 
884

 
471

 
36.1

 
87.7

     International
 
822

 
358

 
101

 
*
 
*
     Worldwide
 
2,025

 
1,242

 
572

 
63.0

 
*
     IMBRUVICA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,129

 
841

 
613

 
34.2

 
37.2

     International
 
1,486

 
1,052

 
638

 
41.3

 
64.9

     Worldwide
 
2,615

 
1,893

 
1,251

 
38.1

 
51.3

     VELCADE®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—
     International
 
1,116

 
1,114

 
1,224

 
0.2

 
(9.0
)
     Worldwide
 
1,116

 
1,114

 
1,224

 
0.2

 
(9.0
)
     ZYTIGA® /abiraterone acetate
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,771

 
1,228

 
1,089

 
44.2

 
12.8

     International
 
1,727

 
1,277

 
1,171

 
35.2

 
9.1

     Worldwide
 
3,498

 
2,505

 
2,260

 
39.6

 
10.8

     OTHER ONCOLOGY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
228

 
145

 
162

 
57.2

 
(10.5
)
     International
 
362

 
359

 
338

 
0.8

 
6.2

     Worldwide
 
590

 
504

 
500

 
17.1

 
0.8

 
 
 
 
 
 
 
 
 
 
 
Pulmonary Hypertension
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,651

 
773

 
—

 
*
 
*
     International
 
922

 
554

 
—

 
66.4

 
*
     Worldwide
 
2,573

 
1,327

 
—

 
93.9

 
*
     OPSUMIT®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
700

 
320

 
—

 
*
 
*
     International
 
515

 
253

 
—

 
*
 
*
     Worldwide
 
1,215

 
573

 
—

 
*
 
*
     TRACLEER®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
268

 
161

 
—

 
66.5

 
*
     International
 
278

 
242

 
—

 
14.9

 
*
     Worldwide
 
546

 
403

 
—

 
35.5

 
*
 
 
 
 
 
 
 
 
 
 
 

                
 
75
                                


     UPTRAVI®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
598

 
238

 
—

 
*
 
*
     International
 
65

 
25

 
—

 
*
 
*
     Worldwide
 
663

 
263

 
—

 
*
 
*
     OTHER 
 
 
 
 
 
 
 
 
 
 
     U.S.
 
85

 
54

 
—

 
57.4

 
*
     International
 
64

 
34

 
—

 
88.2

 
*
     Worldwide
 
149

 
88

 
—

 
69.3

 
*
Cardiovascular / Metabolism / Other
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,279

 
4,744

 
4,855

 
(9.8
)
 
(2.3
)
     International
 
1,537

 
1,543

 
1,541

 
(0.4
)
 
0.1

     Worldwide
 
5,816

 
6,287

 
6,396

 
(7.5
)
 
(1.7
)
     XARELTO®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,477

 
2,500

 
2,288

 
(0.9
)
 
9.3

     International
 
—

 
—

 
—

 
—

 
—

     Worldwide
 
2,477

 
2,500

 
2,288

 
(0.9
)
 
9.3

     INVOKANA® / INVOKAMET®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
711

 
944

 
1,273

 
(24.7
)
 
(25.8
)
     International
 
170

 
167

 
134

 
1.8

 
24.6

     Worldwide
 
881

 
1,111

 
1,407

 
(20.7
)
 
(21.0
)
     PROCRIT® / EPREX®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
674

 
675

 
767

 
(0.1
)
 
(12.0
)
     International
 
314

 
297

 
338

 
5.7

 
(12.1
)
     Worldwide
 
988

 
972

 
1,105

 
1.6

 
(12.0
)
     OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
417

 
625

 
527

 
(33.3
)
 
18.6

     International
 
1,053

 
1,079

 
1,069

 
(2.4
)
 
0.9

     Worldwide
 
1,470

 
1,704

 
1,596

 
(13.7
)
 
6.8

TOTAL PHARMACEUTICAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
23,286

 
21,474

 
20,125

 
8.4

 
6.7

     International
 
17,448

 
14,782

 
13,339

 
18.0

 
10.8

     Worldwide
 
40,734

 
36,256

 
33,464

 
12.4

 
8.3

 
 
 
 
 
 
 
 
 
 
 
MEDICAL DEVICES
 
 
 
 
 
 
 
 
 
 
Diabetes Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
371

 
612

 
739

 
(39.4
)
 
(17.2
)
     International
 
638

 
1,003

 
1,050

 
(36.4
)
 
(4.5
)
     Worldwide
 
1,009

 
1,615

 
1,789

 
(37.5
)
 
(9.7
)
Diagnostics
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—

     International
 
—

 
1

 
66

 
*
 
*
     Worldwide
 
—

 
1

 
66

 
*
 
*
Interventional Solutions
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,283

 
1,148

 
1,031

 
11.8

 
11.3

     International
 
1,363

 
1,148

 
1,024

 
18.7

 
12.1

     Worldwide
 
2,646

 
2,296

 
2,055

 
15.2

 
11.7


                
 
76
                                


Orthopaedics
 
 
 
 
 
 
 
 
 
 
     U.S.
 
5,281

 
5,404

 
5,438

 
(2.3
)
 
(0.6
)
     International
 
3,604

 
3,654

 
3,690

 
(1.4
)
 
(1.0
)
     Worldwide
 
8,885

 
9,058

 
9,128

 
(1.9
)
 
(0.8
)
     HIPS
 
 
 
 
 
 
 
 
 
 
     U.S.
 
841

 
827

 
798

 
1.7

 
3.6

     International
 
577

 
567

 
563

 
1.8

 
0.7

     Worldwide
 
1,418

 
1,394

 
1,361

 
1.7

 
2.4

     KNEES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
911

 
948

 
943

 
(3.9
)
 
0.5

     International
 
591

 
575

 
581

 
2.8

 
(1.0
)
     Worldwide
 
1,502

 
1,523

 
1,524

 
(1.4
)
 
(0.1
)
     TRAUMA
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,599

 
1,576

 
1,545

 
1.5

 
2.0

     International
 
1,100

 
1,040

 
1,024

 
5.8

 
1.6

     Worldwide
 
2,699

 
2,616

 
2,569

 
3.2

 
1.8

     SPINE & OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,930

 
2,053

 
2,152

 
(6.0
)
 
(4.6
)
     International
 
1,336

 
1,472

 
1,522

 
(9.2
)
 
(3.3
)
     Worldwide
 
3,266

 
3,525

 
3,674

 
(7.3
)
 
(4.1
)
Surgery
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,125

 
4,085

 
4,026

 
1.0

 
1.5

     International
 
5,776

 
5,474

 
5,270

 
5.5

 
3.9

     Worldwide
 
9,901

 
9,559

 
9,296

 
3.6

 
2.8

     ADVANCED
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,657

 
1,620

 
1,524

 
2.3

 
6.3

     International
 
2,345

 
2,136

 
1,993

 
9.8

 
7.2

     Worldwide
 
4,002

 
3,756

 
3,517

 
6.5

 
6.8

     GENERAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,751

 
1,728

 
1,669

 
1.3

 
3.5

     International
 
2,806

 
2,735

 
2,693

 
2.6

 
1.6

     Worldwide
 
4,557

 
4,463

 
4,362

 
2.1

 
2.3

     SPECIALTY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
717

 
737

 
833

 
(2.7
)
 
(11.5
)
     International
 
625

 
603

 
584

 
3.6

 
3.3

     Worldwide
 
1,342

 
1,340

 
1,417

 
0.1

 
(5.4
)
Vision
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,777

 
1,575

 
1,032

 
12.8

 
52.6

     International
 
2,776

 
2,488

 
1,753

 
11.6

 
41.9

     Worldwide
 
4,553

 
4,063

 
2,785

 
12.1

 
45.9

     CONTACT LENSES / OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,237

 
1,122

 
1,032

 
10.2

 
8.7

     International
 
2,065

 
1,914

 
1,753

 
7.9

 
9.2

     Worldwide
 
3,302

 
3,036

 
2,785

 
8.8

 
9.0

 
 
 
 
 
 
 
 
 
 
 

                
 
77
                                


     SURGICAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
540

 
453

 
—

 
19.2

 
*
     International
 
711

 
574

 
—

 
23.9

 
*
     Worldwide
 
1,251

 
1,027

 
—

 
21.8

 
*
 
 
 
 
 
 
 
 
 
 
 
TOTAL MEDICAL DEVICES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
12,837

 
12,824

 
12,266

 
0.1

 
4.5

     International
 
14,157

 
13,768

 
12,853

 
2.8

 
7.1

     Worldwide
 
26,994

 
26,592

 
25,119

 
1.5

 
5.9

 
 
 
 
 
 
 
 
 
 
 
WORLDWIDE
 
 
 
 
 
 
 
 
 
 
     U.S.
 
41,884

 
39,863

 
37,811

 
5.1

 
5.4

     International
 
39,697

 
36,587

 
34,079

 
8.5

 
7.4

     Worldwide
 
$
81,581

 
76,450

 
71,890

 
6.7
 %
 
6.3

*Percentage greater than 100% or not meaningful

 
 
Income Before Tax
 
Identifiable Assets
(Dollars in Millions)
 
2018 (3)
 
2017 (4)
 
2016 (5)
 
2018
 
2017
Consumer
 
$
2,320

 
2,524

 
2,441

 
$
25,877

 
25,030

Pharmaceutical
 
12,568

 
11,083

 
12,827

 
56,636

 
59,450

Medical Devices
 
4,397

 
5,392

 
5,578

 
46,254

 
45,413

Total
 
19,285

 
18,999

 
20,846

 
128,767

 
129,893

Less: Expense not allocated to segments (1)
 
1,286

 
1,326

 
1,043

 
 
 
 
General corporate (2)
 
 
 
 
 
 
 
24,187

 
27,410

Worldwide total
 
$
17,999

 
17,673

 
19,803

 
$
152,954

 
157,303


 
 
Additions to Property,
Plant & Equipment
 
Depreciation and
Amortization
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Consumer
 
$
438

 
485

 
486

 
$
688

 
674

 
608

Pharmaceutical
 
1,012

 
936

 
927

 
3,802

 
2,416

 
886

Medical Devices
 
1,843

 
1,566

 
1,472

 
2,103

 
2,216

 
1,928

Segments total
 
3,293

 
2,987

 
2,885

 
6,593

 
5,306

 
3,422

General corporate
 
377

 
292

 
341

 
336

 
336

 
332

Worldwide total
 
$
3,670

 
3,279

 
3,226

 
$
6,929

 
5,642

 
3,754

 
 
Sales to Customers
 
Long-Lived Assets (6)
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
United States
 
$
41,884

 
39,863

 
37,811

 
$
37,117

 
38,556

Europe
 
18,753

 
17,126

 
15,770

 
51,433

 
56,677

Western Hemisphere excluding U.S. 
 
6,113

 
6,041

 
5,734

 
2,752

 
2,990

Asia-Pacific, Africa
 
14,831

 
13,420

 
12,575

 
2,733

 
2,773

Segments total
 
81,581

 
76,450

 
71,890

 
94,035

 
100,996

General corporate
 
 
 
 
 
 
 
1,064

 
1,143

Other non long-lived assets
 
 
 
 
 
 
 
57,855

 
55,164

Worldwide total
 
$
81,581

 
76,450

 
71,890

 
$
152,954

 
157,303

­
See Note 1 for a description of the segments in which the Company operates.

                
 
78
                                


Export sales are not significant. In 2018, the Company had three wholesalers distributing products for all three segments that represented approximately 14.0%, 11.0% and 11.0% of the total consolidated revenues. In 2017, the Company had two wholesalers distributing products for all three segments that represented approximately 14.0% and 10.0% of the total consolidated revenues. In 2016, the Company had two wholesalers distributing products for all three segments that represented approximately 13.5% and 10.7% of the total consolidated revenues.

(1) 
Amounts not allocated to segments include interest (income) expense and general corporate (income) expense.
(2) 
General corporate includes cash, cash equivalents and marketable securities.
(3) 
The Consumer segment includes a gain of $0.3 billion from the divestiture of NIZORAL® and litigation expense of $0.3 billion. The Pharmaceutical segment includes an in-process research and development charge of $1.1 billion related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of $0.2 billion, Actelion acquisition related costs of $0.2 billion, unrealized loss on securities of $0.2 billion and a gain of $0.2 billion from the divestiture of certain non-strategic Pharmaceutical products. The Medical Devices segment includes net litigation expense of $1.7 billion, a restructuring related charge of $0.6 billion, AMO acquisition related costs of $0.1 billion and a gain of $0.5 billion from the divestiture of the LifeScan business in the fiscal fourth quarter.
(4) 
The Pharmaceutical segment includes $0.8 billion for Actelion acquisition related costs, an in-process research and development expense of $0.4 billion and litigation expense of $0.1 billion. The Medical Devices segment includes litigation expense of $1.1 billion, a restructuring related charge of $0.8 billion, an asset impairment of $0.2 billion primarily related to the insulin pump business and $0.1 billion for AMO acquisition related costs. The Medical Devices segment includes a gain of $0.7 billion from the divestiture of Codman Neurosurgery. The Consumer segment includes a gain of $0.5 billion from the divestiture of COMPEED®.
(5) 
Includes net litigation expense of $0.8 billion and a restructuring related charge of $0.7 billion in the Medical Devices segment. The Pharmaceutical segment includes a positive adjustment of $0.5 billion to previous reserve estimates and gains from the divestitures of the controlled substance raw material and active pharmaceutical ingredient (API) business and certain anesthetic products in Europe.
(6) 
Long-lived assets include property, plant and equipment, net for 2018, and 2017 of $17,035 and $17,005, respectively, and intangible assets and goodwill, net for 2018 and 2017 of $78,064 and $85,134, respectively.


                
 
79
                                


19.
Selected Quarterly Financial Data (unaudited)
Selected unaudited quarterly financial data for the years 2018 and 2017 are summarized below:
 
 
2018
 
2017
(Dollars in Millions Except Per Share Data)
 
First Quarter (1)
 
Second Quarter (2)
 
Third Quarter (3)
 
Fourth Quarter (4)
 
First Quarter (5)
 
Second Quarter (6)
 
Third Quarter (7)
 
Fourth Quarter (8)
Segment sales to customers
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Consumer
 
$
3,398

 
3,504

 
3,415

 
3,536

 
3,228

 
3,478

 
3,356

 
3,540

Pharmaceutical
 
9,844

 
10,354

 
10,346

 
10,190

 
8,245

 
8,635

 
9,695

 
9,681

Medical Devices 
 
6,767

 
6,972

 
6,587

 
6,668

 
6,293

 
6,726

 
6,599

 
6,974

Total sales
 
20,009

 
20,830

 
20,348

 
20,394

 
17,766

 
18,839

 
19,650

 
20,195

Gross profit
 
13,395

 
13,903

 
13,759

 
13,433

 
12,357

 
12,993

 
12,725

 
12,936

Earnings before provision for taxes on income
 
5,481

 
4,973

 
4,423

 
3,122

 
5,575

 
4,748

 
4,790

 
2,560

Net earnings (loss)
 
4,367

 
3,954

 
3,934

 
3,042

 
4,422

 
3,827

 
3,764

 
(10,713
)
Basic net earnings (loss) per share
 
$
1.63

 
1.47

 
1.47

 
1.14

 
1.63

 
1.42

 
1.40

 
(3.99
)
Diluted net earnings (loss) per share
 
$
1.60

 
1.45

 
1.44

 
1.12

 
1.61

 
1.40

 
1.37

 
(3.99
)

(1)
The first quarter of 2018 includes an Actelion acquisition related cost of $92 million after-tax ($96 million before-tax) and a restructuring related charge of $81 million after-tax ($107 million before-tax).
(2) 
The second quarter of 2018 includes a litigation expense of $609 million after-tax ($703 million before-tax) and a restructuring related charge of $152 million after-tax ($176 million before-tax).
(3) 
The third quarter of 2018 includes an in-process research and development expense of $859 million after-tax ($1,126 million before-tax) related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of $184 million after and before tax, a restructuring related charge of $162 million after-tax ($190 million before-tax) and a $265 million benefit after-tax from the impact of tax legislation.
(4) 
The fourth quarter of 2018 includes a litigation expense of $1,113 million after-tax ($1,288 million before-tax), a restructuring related charge of $190 million after-tax ($227 million before-tax) and a $137 million benefit after-tax from the impact of tax legislation.
(5) 
The first quarter of 2017 includes a restructuring charge of $121 million after-tax ($161 million before-tax) and an AMO acquisition related cost of $251 million after-tax ($38 million before-tax).
(6) 
The second quarter of 2017 includes a litigation expense of $352 million after-tax ($493 million before-tax), Actelion acquisition related costs of $199 million after-tax ($213 million before-tax) a restructuring charge of $101 million after-tax ($128 million before-tax) and an asset impairment charge of $125 million after-tax ($182 million before-tax).
(7) 
The third quarter of 2017 includes a litigation expense of $97 million after-tax ($118 million before-tax), Actelion acquisition related costs of $255 million after-tax ($367 million before-tax) and a restructuring charge of $136 million after-tax ($187 million before-tax).
(8) 
The fourth quarter of 2017 includes a litigation expense of $506 million after-tax ($645 million before-tax), Actelion acquisition related costs of $313 million after-tax ($217 million before-tax), a restructuring charge of $237 million after-tax ($284 million before-tax), an in-process research and development expense of $266 million after-tax ($408 million before-tax) and an after-tax benefit of $116 million related to the insulin pump business. Additionally, the fourth quarter of 2017 includes a provisional charge of $13.6 billion for recently enacted tax legislation.


                
 
80
                                


20.
Business Combinations and Divestitures
Certain businesses were acquired for $0.9 billion in cash and $0.1 billion of liabilities assumed during 2018. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.
The 2018 acquisitions primarily included: Zarbee’s, Inc., a privately held company that is a leader in naturally-based consumer healthcare products; Medical Enterprises Distribution LLC, a privately held healthcare technology firm focused on surgical procedure innovation; BeneVir Biopharm, Inc. (BeneVir), a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies and Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution.
The excess of purchase price over the estimated fair value of tangible assets acquired amounted to $1.0 billion and has been assigned to identifiable intangible assets, with any residual recorded to goodwill.
On October 23, 2018, the Company entered into an agreement to acquire Ci:z Holdings Co., Ltd., a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately ¥230 billion, which equates to approximately $2.1 billion, using the exchange rate of 109.06 Japanese Yen to each U.S. Dollar on January 16, 2019. The acquisition was completed on January 17, 2019, through a series of transactions that included an all-cash tender offer to acquire the publicly held shares not already held by the Company for ¥5,900 per share. Upon completion of the tender offer and the related transactions, the Company acquired 89% of the outstanding shares. The Company plans to acquire the remaining shares that were not tendered in the tender offer through a share consolidation under Japanese law during the first half of 2019 and take appropriate actions to delist from the Tokyo Stock Exchange. The acquisition will include the range of brands comprising DR.CI:LABO, LABO LABO and GENOMER line of skincare products. The Company expects to treat this transaction as a business combination and will include it in the Consumer segment.
On February 13, 2019, the Company entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4 billion in cash. Additional contingent payments of up to$2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The closing is subject to antitrust clearance and other customary closing conditions. The transaction is expected to close by the end of the second quarter of 2019. The Company expects to treat this transaction as a business combination and will include it in the Medical Devices segment.
During 2017 certain businesses were acquired for $35.2 billion in cash and $1.8 billion of liabilities assumed. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.
The 2017 acquisitions primarily included: Actelion Ltd, an established leading franchise of differentiated, innovative products for pulmonary arterial hypertension (PAH); Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, which included ophthalmic products related to: cataract surgery, laser refractive surgery and consumer eye health; Neuravi Limited, a privately-held medical device company that develops and markets medical devices for neurointerventional therapy; TearScience Inc., a manufacturer of products dedicated to treating meibomian gland dysfunction; Sightbox, Inc., a privately-held company that developed a subscription vision care service that connects consumers with eye care professionals and a supply of contact lenses; Torax Medical, Inc., a privately-held medical device company that manufactures and markets the LINX™ Reflux Management System for the surgical treatment of gastroesophageal reflux disease and Megadyne Medical Products, Inc., a privately-held medical device company that develops, manufactures and markets electrosurgical tools.
The excess of purchase price over the estimated fair value of tangible assets acquired amounted to $34.4 billion and has been assigned to identifiable intangible assets, with any residual recorded to goodwill. Of this amount, approximately $1.1 billion has been identified as the value of IPR&D, primarily associated with the acquisition of Actelion Ltd. The value of the IPR&D was calculated using cash flow projections discounted for the inherent risk in the projects.
During 2017, the Company completed the acquisition of Actelion Ltd through an all cash tender offer in Switzerland for $280 per share, amounting to $29.6 billion, net of cash acquired. As part of the transaction, immediately prior to the completion of the acquisition, Actelion spun out its drug discovery operations and early-stage clinical development assets into a newly created Swiss biopharmaceutical company, Idorsia Ltd. The shares of Idorsia are listed on the SIX Swiss Exchange (SIX). In 2017 the Company held 9.9% of the shares of Idorsia and had rights to an additional 22.1% of Idorsia equity through a convertible loan with a principal amount of approximately $0.5 billion. As a result of Idorsia raising additional capital in July 2018, the Company currently holds 9.0% of the shares of Idorsia and has rights to an additional 20.8% of Idorsia equity through a convertible loan with a principal amount of approximately $0.5 billion. The convertible loan may be converted into Idorsia shares as follows: (i) up to an aggregate shareholding of 16% of Idorsia shares as a result of certain shareholders holding more than 20% of the issued Idorsia shares, and (ii) up to the balance of the remaining amount within 20 business days of the maturity date of the convertible loan, which has a 10 year term, or if Idorsia undergoes a change of control transaction. The investment in Idorsia was recorded as a cost method investment in Other assets in the Company's consolidated Balance Sheet. The Company also exercised the option acquired on ACT-132577, a product within Idorsia being developed for resistant hypertension currently in phase 2 of clinical development. The Company has also entered into an agreement to provide Idorsia

                
 
81
                                


with a Swiss franc denominated credit facility of approximately $250 million. As of December 30, 2018, Idorsia has not made any draw-downs under the credit facility. Actelion has entered into a transitional services agreement with Idorsia. Actelion has established a leading franchise of differentiated, innovative products for pulmonary arterial hypertension (PAH) that are highly complementary to the existing portfolio of the Company. The addition of Actelion’s specialty in-market medicines and late-stage products is consistent with the Company's efforts to grow in attractive and complementary therapeutic areas and serve patients with serious illnesses and significant unmet medical need.
During the fiscal second quarter of 2018, the Company finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. The following table presents the amounts recognized for assets acquired and liabilities assumed as of the acquisition date with adjustments made through the second quarter of 2018:


(Dollars in Millions)
 
Cash & Cash equivalents
469

Inventory(1)
759

Accounts Receivable
485

Other current assets
93

Property, plant and equipment
104

Goodwill
6,161

Intangible assets
25,010

Deferred Taxes
99

Other non-current assets
19

Total Assets Acquired
33,199

 
 
Current liabilities
956

Deferred Taxes
1,776

Other non-current liabilities
413

Total Liabilities Assumed
3,145

 
 
Net Assets Acquired
30,054

(1) Includes adjustment of $642 million to write-up the acquired inventory to its estimated fair value.
The adjustments made since the date of acquisition were $0.2 billion to the deferred taxes and $0.4 billion to the current liabilities with the offset to goodwill. The assets acquired are recorded in the Pharmaceutical segment. The acquisition of Actelion resulted in approximately $6.2 billion of goodwill. The goodwill is primarily attributable to synergies expected to arise from the acquisition. The goodwill is not expected to be deductible for tax purposes.

The purchase price allocation to the identifiable intangible assets is as follows:
(Dollars in Millions)
 
 
Intangible assets with definite lives:
 
 
Patents and trademarks*
 
$
24,230

Total amortizable intangibles
 
24,230

 
 
 
In-process research and development
 
780

Total intangible assets
 
$
25,010

*Includes $0.4 billion related to VALCHLOR®, one of the acquired products, which was divested in the fiscal second quarter of 2018.
The patents and trademarks acquired are comprised of developed technology with a weighted average life of 9 years and was primarily based on the patent life of the marketed products. The intangible assets with definite lives were assigned asset lives ranging from 4 to 10 years. The in-process research and development intangible assets were valued for technology programs for unapproved products.
The value of the IPR&D was calculated using probability adjusted cash flow projections discounted for the risk inherent in such projects. The discount rate applied was 9%.

                
 
82
                                


The acquisition was accounted for using the acquisition method and, accordingly, the results of operations of Actelion were reported in the Company's financial statements beginning on June 16, 2017, the date of acquisition. For the year ended December 31, 2017, total sales and a net loss for Actelion from the date of acquisition were $1.4 billion and $1.4 billion, respectively.
The following table provides pro forma results of operations for the fiscal year ended December 31, 2017 and January 1, 2017, as if Actelion had been acquired as of January 4, 2016. The pro forma results include the effect of certain purchase accounting adjustments such as the estimated changes in depreciation and amortization expense on the acquired tangible and intangible assets. However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of Actelion. Accordingly, such amounts are not necessarily indicative of the results if the acquisition had occurred on the dates indicated or which may occur in the future.
 
Unaudited Pro forma Consolidated Results
(Dollars in Millions Except Per Share Data)
2017
2016
 
 
 
Net Sales
77,681

74,339

Net Earnings
1,509

13,916

Diluted Net Earnings per Common Share
0.55

4.99


The Company recorded Actelion acquisition related costs before tax of approximately $0.2 billion and $0.8 billion in 2018 and 2017, respectively, which was recorded in Other (income)/expense and Cost of products sold.
During 2017, the Company acquired Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, for $4.3 billion, net of cash acquired. The acquisition included ophthalmic products related to: cataract surgery, laser refractive surgery and consumer eye health. The net purchase price was primarily recorded as amortizable intangible assets for $2.3 billion and goodwill for $1.7 billion. The weighted average life of total amortizable intangibles, the majority being customer relationships, is approximately 14.4 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not deductible for tax purposes. The intangible assets and goodwill amounts are based on the final purchase price allocation. The assets acquired were recorded in the Medical Devices segment.
Certain businesses were acquired for $4.5 billion in cash and $0.1 billion of liabilities assumed during 2016. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.
The 2016 acquisitions primarily included: Vogue International LLC, a privately-held company focused on the marketing, development and distribution of salon-influenced and nature inspired hair care and other personal products; NeuWave Medical, Inc., a privately-held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems; NeoStrata Company, Inc., a global leader in dermocosmetics; and the global rights for the commercialization of RHINOCORT® allergy spray outside the United States.
The excess of purchase price over the estimated fair value of tangible assets acquired amounted to $4.1 billion and has been assigned to identifiable intangible assets, with any residual recorded to goodwill.
The net purchase price for Vogue International LLC of $3.3 billion was primarily recorded as amortizable intangible assets for $2.3 billion and goodwill for $1.1 billion. The weighted average life for the $2.3 billion of total amortizable intangibles is approximately 22 years. The trademark asset values were determined to have definite lives ranging from 10 to 22 years, with the majority being 22 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is expected to be deductible for tax purposes. The assets acquired were recorded in the Consumer segment.
In 2012, the Company completed the acquisition of Synthes, Inc. for a purchase price of $20.2 billion in cash and stock. In connection with the acquisition of Synthes, Inc. the Company entered into two accelerated share repurchase (ASR) agreements.  In 2013, the Company settled the remaining liabilities under the ASR agreements. While the Company believes that the transactions under each ASR agreement and a series of related internal transactions were consummated in a tax efficient manner in accordance with applicable law, it is possible that the Internal Revenue Service could assert one or more contrary positions to challenge the transactions from a tax perspective. If challenged, an amount up to the total purchase price for the Synthes shares could be treated as subject to applicable U.S. tax at approximately the statutory rate to the Company, plus interest.
With the exception of the Actelion Ltd acquisition, supplemental pro forma information for 2018, 2017 and 2016 in accordance with U.S. GAAP standards related to business combinations, and goodwill and other intangible assets, is not provided, as the impact of the aforementioned acquisitions did not have a material effect on the Company’s results of operations, cash flows or financial position.
During 2018, the Company divested the LifeScan Inc business for approximately $2.1 billion and retained certain net liabilities. Other divestitures in 2018 included: NIZORAL®, RoC® and certain non-strategic Pharmaceutical products. In 2018, the pre-tax gains on the divestitures were approximately $1.2 billion. Additionally, in 2018, the Company accepted the binding

                
 
83
                                


offer from Fortive Corporation to acquire its Advanced Sterilization Products (ASP) business for approximately $2.7 billion, subject to customary adjustments. The transaction is expected to close in 2019. As of December 30, 2018, the assets held for sale on the Consolidated Balance Sheet were $0.2 billion of inventory, $0.1 billion of property, plant and equipment and $0.3 billion of goodwill. The Company will retain certain net receivables of approximately $0.1 billion associated with the ASP business.
In 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world’s leading manufacturing services providers for health care products and technology products. The Company is expanding a 12-year relationship with Jabil to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of employees and manufacturing sites. As of December 30, 2018, the assets held for sale on the Consolidated Balance Sheet were $0.3 billion of inventory and $0.1 billion of property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 22 to the Consolidated Financial Statements.
During 2017, the Company divestitures primarily included: the Codman Neurosurgery business, to Integra LifeSciences Holdings Corporation and the divestiture of COMPEED® to HRA Pharma. In 2017, the pre-tax gains on the divestitures were approximately $1.3 billion.
During 2016, the Company divestitures included: the controlled substance raw material and active pharmaceutical ingredient (API) business; certain anesthetic products in Europe; and certain non-strategic Consumer brands. In 2016, the pre-tax gains on the divestitures were approximately $0.6 billion.

21.
Legal Proceedings
Johnson & Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability, intellectual property, commercial, supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business.

The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. As of December 30, 2018, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions. The ability to make such estimates and judgments can be affected by various factors, including whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; or there are numerous parties involved.

In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.

PRODUCT LIABILITY

Johnson & Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.

The most significant of these cases include: the DePuy ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System; the PINNACLE® Acetabular Cup System; pelvic meshes; RISPERDAL®; XARELTO®; body powders containing talc, primarily JOHNSONS® Baby Powder; INVOKANA®; and ETHICON PHYSIOMESH® Flexible Composite Mesh. As of December 30, 2018, in the United States there were approximately 1,800 plaintiffs with direct claims in pending lawsuits

                
 
84
                                


regarding injuries allegedly due to the DePuy ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System; 10,500 with respect to the PINNACLE® Acetabular Cup System; 34,800 with respect to pelvic meshes; 13,400 with respect to RISPERDAL®; 25,600 with respect to XARELTO®; 13,000 with respect to body powders containing talc; 1,050 with respect to INVOKANA®; and 2,100 with respect to ETHICON PHYSIOMESH® Flexible Composite Mesh.

In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson & Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than 10,000 claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Québec Superior Court and the Supreme Court of British Columbia. The British Columbia order is currently the subject of an appeal. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR™ Hip-related product liability litigation.

Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson & Johnson (collectively, DePuy) relating to the PINNACLE® Acetabular Cup System used in hip replacement surgery. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States. Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial, the second remains under appeal and the third is pending decision on post-trial motions in the district court. The Company has established an accrual for product liability litigation associated with the PINNACLE® Acetabular Cup System. The Company is negotiating settlements of these cases and the related costs are reflected in the Company’s accruals.

Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson & Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Southern District of West Virginia. The Company has settled or otherwise resolved a majority of the United States cases and the costs associated with these settlements are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands and Belgium, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices. In Australia, a trial of class action issues has been completed and the parties are awaiting a decision. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh products.

Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH® Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson & Johnson alleging personal injury arising out of the use of this hernia mesh device.  Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH® Flexible Composite Mesh.

Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson & Johnson arising out of the use of RISPERDAL®, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I

                
 
85
                                


disorder and irritability associated with autism, and related compounds. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.

Claims for personal injury arising out of the use of XARELTO®, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson & Johnson; and JPI's collaboration partner for XARELTO® Bayer AG and certain of its affiliates. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania; and there are coordinated proceedings in Delaware, California and Missouri. Class action lawsuits also have been filed in Canada. The Company has established an accrual for defense costs only in connection with product liability litigation associated with XARELTO®.

Personal injury claims alleging that talc causes cancer have been made against Johnson & Johnson Consumer Inc. and Johnson & Johnson arising out of the use of body powders containing talc, primarily JOHNSONS® Baby Powder. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a verdict in July 2018 of $4.7 billion. The Company believes that it has strong grounds on appeal to overturn these verdicts. The Company has established an accrual for defense costs only in connection with product liability litigation associated with body powders containing talc.

In February 2018, a securities class action lawsuit was filed against Johnson & Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson & Johnson violated the federal securities laws by failing to adequately disclose the alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S® Baby Powder, and that purchasers of Johnson & Johnson’s shares suffered losses as a result.  Plaintiffs are seeking damages.  In October 2018, a shareholder derivative lawsuit was filed against Johnson & Johnson as the nominal defendant and its current directors as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON’S® Baby Powder, and that Johnson & Johnson has suffered damages as a result of those alleged breaches.  Plaintiff is seeking damages and an order for the Company to reform its internal policies and procedures.  In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson & Johnson Savings Plan against Johnson & Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson & Johnson stock as a Johnson & Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON’S® Baby Powder.  Plaintiffs are seeking damages and injunctive relief.  Each of these matters will be adjudicated in conjunction with the multi-district litigation referenced in the prior paragraph. In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice and the Securities and Exchange Commission. The Company is cooperating with these government inquiries and will be producing documents in response.     

Claims for personal injury have been made against a number of Johnson & Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson & Johnson, arising out of the use of INVOKANA®, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts in Pennsylvania, California and New Jersey. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.



                
 
86
                                


INTELLECTUAL PROPERTY
Certain subsidiaries of Johnson & Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company’s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.

Medical Devices
In June 2009, Rembrandt Vision Technologies, L.P. (Rembrandt) filed a patent infringement lawsuit against Johnson & Johnson Vision Care, Inc. (JJVCI) in the United States District Court for the Eastern District of Texas alleging that JJVCI's manufacture and sale of its ACUVUE® ADVANCE and ACUVUE OASYS® Hydrogel Contact Lenses infringed Rembrandt’s United States Patent No. 5,712,327 and seeking monetary relief. The case was transferred to the United States District Court for the Middle District of Florida, where a trial in May 2012 resulted in a verdict of non-infringement that was subsequently upheld on appeal. In July 2014, Rembrandt sought a new trial based on alleged new evidence, which the district court denied. In April 2016, the Court of Appeals overturned that ruling and remanded the case to the district court for a new trial. A new trial was held in August 2017, and the jury returned a verdict of non-infringement in favor of JJVCI. Rembrandt has appealed the verdict to the United States Court of Appeals for the Federal Circuit (CAFC). In February 2019, the CAFC affirmed the judgment in favor of JJVCI.

In March 2013, Medinol Ltd. (Medinol) filed a patent infringement lawsuit against Cordis Corporation (Cordis) and Johnson & Johnson in the United States District Court for the Southern District of New York alleging that Cordis’s sales of the CYPHER™ and CYPHER SELECT™ stents made in the United States since 2005 willfully infringed four of Medinol's patents directed to the geometry of articulated stents. Medinol is seeking damages and attorneys’ fees. Although Johnson & Johnson has since sold Cordis, it has retained liability for this case. After trial in January 2014, the district court dismissed the case, finding Medinol unreasonably delayed bringing its claims (the laches defense). In September 2014, the district court denied a motion by Medinol to vacate the judgment and grant it a new trial. Medinol appealed the decision to the United States Court of Appeals for the Federal Circuit. In March 2017, the United States Supreme Court held that the laches defense is not available in patent cases. In April 2018, the United States Court of Appeals for the Federal Circuit remanded the case back to the district court to reconsider Medinol’s motion for a new trial, and briefing in the district court was completed in June 2018.

In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE® Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants. MedIdea alleges infringement of United States Patent Nos. 6,558,426 (’426); 8,273,132 (’132); 8,721,730 (’730) and 9,492,280 (’280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAMTM Contact feature of the ATTUNE® posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts. A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the ’132, ’730 and ’280 patents, based on the district court’s claim construction and reserving its right to appeal that construction, leaving only the ’426 patent at issue before the district court. In January 2019, the district court stayed the case pending a decision in the Inter Partes Review proceeding on the ’426 patent (see below). In December 2017, DePuy Synthes Products, Inc. filed a Petition for Inter Partes Review with the United States Patent and Trademark Office (USPTO), seeking to invalidate the two claims of the ’426 patent asserted in the district court litigation, and in June 2018, the USPTO instituted review of those claims. A hearing trial is scheduled for March 2019, and a decision in the proceeding is due by June 2019.

In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (the ’735 patent); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (the ’284 patent), are either invalid or not infringed by Ethicon’s ENSEAL® X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the ’735 patent, the ’284 patent and United States Patent Nos. 8,323,310 (the ’310 patent); 9,084,608; 9,241,759 (the ’759 patent) and 9,113,882, and seeking damages and an injunction. Covidien filed a motion for preliminary injunction, which was denied in

                
 
87
                                


October 2017. The parties have entered joint stipulations such that only the ’735 patent, the ’310 patent and the ’759 patent remain in dispute. Trial is scheduled to begin in September 2019.

In November 2017, Board of Regents, The University of Texas System and Tissuegen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC alleging the manufacture and sale of VICRYL® Plus Antibacterial Sutures, MONOCRYL® Plus Antibacterial Sutures, PDS® Plus Antibacterial Sutures, STRATAFIX® POS® Antibacterial Sutures and STRATAFIX® MONOCRYL®Plus Antibacterial Sutures infringe plaintiffs’ United States Patent Nos. 6,596,296 and 7,033,603 directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent. UT is seeking damages and an injunction. In December 2018, Ethicon filed petitions with the USPTO, seeking Inter Partes Review (IPR) of both asserted patents. Those petitions have been stayed by the USPTO pending a decision by the U.S. Court of Appeals for the Federal Circuit in an unrelated case.

Pharmaceutical
In April 2016, MorphoSys AG, a German biotech company, filed a patent infringement lawsuit against Janssen Biotech, Inc. (JBI), Genmab U.S. Inc. and Genmab A/S (collectively, Genmab) in the United States District Court for the District of Delaware. MorphoSys alleged that JBI’s manufacture and sale of DARZALEX® (daratumumab) willfully infringed MorphoSys’ United States Patent Nos. 8,263,746, 9,200,061 and 9,785,590. MorphoSys sought money damages. JBI licenses patents and the commercial rights to DARZALEX® from Genmab. In January 2019, the district court granted summary judgment in JBI and Genmab’s favor, invalidating the asserted claims of the patents-in-suit, and the parties filed a joint stipulation of dismissal of the action.

In August 2016, Sandoz Ltd and Hexal AG (collectively, Sandoz) filed a lawsuit in the English High Court against G.D. Searle LLC, a Pfizer company (Searle) and Janssen Sciences Ireland UC (JSI) alleging that Searle’s supplementary protection certificate SPC/GB07/038 (SPC), which is exclusively licensed to JSI, is invalid and should be revoked. Janssen-Cilag Limited sells PREZISTA® (darunavir) in the United Kingdom pursuant to this license. In October 2016, Searle and JSI counterclaimed against Sandoz for threatened infringement of the SPC based on statements of its plans to launch generic darunavir in the United Kingdom. Sandoz admitted that its generic darunavir product would infringe the SPC if it is found valid. Searle and JSI are seeking an order enjoining Sandoz from marketing its generic darunavir before the expiration of the SPC. Following a trial in April 2017, the court entered a decision holding that the SPC is valid and granting a final injunction. Sandoz has appealed the court’s decision and the injunction is stayed pending the appeal. In January 2018, the court referred the issue on appeal to the Court of Justice for the European Union (CJEU) and stayed the proceedings pending the CJEU’s ruling on the issue.

In April 2018, Acerta Pharma B.V., AstraZeneca UK Ltd and AstraZeneca Pharmaceuticals LP filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Pharmacylics LLC and Abbvie Inc. (collectively, Abbvie), alleging that the manufacture and sale of IMBRUVICA® infringes U.S. Patent No. 7,459,554. Janssen Biotech, Inc., which commercializes IMBRUVICA® jointly with Abbvie, intervened in the action in November 2018. A trial is scheduled to begin in January 2021.

REMICADE® Related Cases

In August 2014, Celltrion Healthcare Co. Ltd. and Celltrion Inc. (collectively, Celltrion) filed an application with the United States Food and Drug Administration (FDA) for approval to make and sell its own infliximab biosimilar. In March 2015, Janssen Biotech, Inc. (JBI) filed a lawsuit in the United States District Court for the District of Massachusetts against Celltrion and Hospira Healthcare Corporation (Hospira), which has exclusive marketing rights for Celltrion’s infliximab biosimilar in the United States, seeking, among other things, a declaratory judgment that their biosimilar product infringes or potentially infringes several JBI patents, including United States Patent No. 6,284,471 relating to REMICADE® (infliximab) (the ’471 patent) and United States Patent No. 7,598,083 (the ’083 patent) directed to the cell culture media used to make Celltrion’s biosimilar. In August 2016, the district court granted both Celltrion’s and Hospira’s motions for summary judgment of invalidity of the ’471 patent. JBI appealed those decisions to the United States Court of Appeals for the Federal Circuit. In January 2018, the Federal Circuit dismissed the appeal as moot based on its affirmance of a decision by the USPTO’s Patent Trial and Appeal Board affirming invalidity of the ’471 patent.

In June 2016, JBI filed two additional patent infringement lawsuits asserting the ’083 patent, one against Celltrion and Hospira in the United States District Court for the District of Massachusetts and the other against HyClone Laboratories, Inc., the manufacturer of the cell culture media that Celltrion uses to make its biosimilar product, in the United States District Court for the District of Utah. On July 30, 2018 the district court granted Celltrion’s motion for summary judgment of non-infringement and entered an order dismissing the ’083 lawsuit against Celltrion and Hospira. JBI appealed to the United States Court of

                
 
88
                                


Appeals for the Federal Circuit. The litigation against HyClone in Utah is stayed pending the outcome of the Massachusetts actions.

The FDA approved the first infliximab biosimilar for sale in the United States in 2016, and a number of such products have been launched.

Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)
The following summarizes lawsuits pending against generic companies that have filed Abbreviated New Drug Applications (ANDAs) with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson & Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of generic versions of the products at issue to the market prior to the expiration of the relevant patents. The Inter Partes Review (IPR) process with the United States Patent and Trademark Office (USPTO), created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.
ZYTIGA® 
In July 2015, Janssen Biotech, Inc., Janssen Oncology, Inc. and Janssen Research & Development, LLC (collectively, Janssen) and BTG International Ltd. (BTG) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies (and certain of their affiliates and/or suppliers) who filed ANDAs seeking approval to market a generic version of ZYTIGA® 250mg before the expiration of United States Patent No. 8,822,438 (the ’438 patent). The generic companies include Amneal Pharmaceuticals, LLC and Amneal Pharmaceuticals of New York, LLC (collectively, Amneal); Apotex Inc. and Apotex Corp. (collectively, Apotex); Citron Pharma LLC (Citron); Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, Dr. Reddy’s); Mylan Pharmaceuticals Inc. and Mylan Inc. (collectively, Mylan); Par Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. (collectively, Par); Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries, Inc. (collectively, Sun); Teva Pharmaceuticals USA, Inc. (Teva); Wockhardt Bio A.G.; Wockhardt USA LLC and Wockhardt Ltd. (collectively, Wockhardt); West-Ward Pharmaceutical Corp. (West-Ward) and Hikma Pharmaceuticals, LLC (Hikma).

Janssen and BTG also initiated patent infringement lawsuits in the United States District Court for the District of New Jersey against Amerigen Pharmaceuticals Limited (Amerigen) in May 2016, and Glenmark Pharmaceuticals, Inc. (Glenmark) in June 2016, each of whom filed an ANDA seeking approval to market its generic version of ZYTIGA® before the expiration of the ’438 patent. These lawsuits have been consolidated with the lawsuit filed in July 2015.

In August 2015, Janssen and BTG filed an additional jurisdictional protective lawsuit against the Mylan defendants in the United States District Court for the Northern District of West Virginia, which has been stayed.

In August 2017, Janssen and BTG initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva, who filed an ANDA seeking approval to market a generic version of ZYTIGA® 500mg before the expiration of the ’438 patent. This lawsuit has been consolidated with the lawsuit filed in July 2015.

In February 2018, Janssen and BTG filed a patent infringement lawsuit against MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited (collectively, MSN) in United States District Court for the District of New Jersey based on its ANDA seeking approval for a generic version of ZYTIGA® prior to the expiration of the ’438 patent.

In November 2018, Janssen and BTG initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Qilu Pharmaceutical Co., Ltd. and Qilu Pharma, Inc. (collectively, Qilu), who filed an ANDA seeking approval to market a generic version of ZYTIGA® before the expiration of the ’438 patent.

In December 2017, Janssen and BTG entered into a settlement agreement with Glenmark. In January 2018, Janssen dismissed its lawsuit against Sun after it withdrew its ANDA. In April 2018, Janssen and BTG entered into a settlement agreement with Apotex.


                
 
89
                                


In October 2018, the United States District Court for the District of New Jersey issued a ruling invalidating all asserted claims of the ’438 patent. The court held that the patent claims would be infringed if the patent were valid. Janssen appealed the court’s decision.

In November 2018, the United States Court of Appeals for the Federal Circuit denied Janssen’s request for an injunction pending appeal. As a result, several generic versions of ZYTIGA® have entered the market. Janssen has appealed the decision of the United States District Court for the District of New Jersey, and the oral argument on the appeal is scheduled for March 2019.

The lawsuits against MSN and Qilu remain pending in the district courts. In each of these lawsuits, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA® before the expiration of the ’438 patent.

Several generic companies including Amerigen, Argentum Pharmaceuticals LLC (Argentum), Mylan, Wockhardt, Actavis, Amneal, Dr. Reddy’s, Sun, Teva, West-Ward and Hikma filed Petitions for Inter Partes Review (IPR) with the USPTO, seeking to invalidate the ’438 patent. In January 2018, the USPTO issued decisions finding the ’438 patent claims unpatentable, and Janssen requested rehearing. In December 2018, the USPTO denied Janssen’s request for rehearing of the IPR decisions. Janssen filed an appeal, which was consolidated with the above-mentioned appeal of the decision of the United States District Court for the District of New Jersey.

In October 2017, Janssen Inc. and Janssen Oncology, Inc. (collectively, Janssen) initiated two Notices of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) and the Minister of Health in Canada in response to Teva's filing Abbreviated New Drug Submissions (ANDS) and seeking approval to market generic versions of ZYTIGA® 250mg and ZYTIGA® 500mg before the expiration of Canadian Patent No. 2,661,422. In June 2018, the parties entered into a settlement agreement.

In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex’s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA® before the expiration of Canadian Patent No. 2,661,422. The federal court of Canada scheduled the Final Hearing for April 2019. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Apotex’s ANDS before the expiration of Janssen’s patent.

In January 2019, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex and the Minister of Health in Canada in response to Apotex’s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a film-coated generic version of ZYTIGA® before the expiration of Canadian Patent No. 2,661,422. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Apotex’s ANDS before the expiration of Janssen’s patent.


XARELTO® 
Beginning in October 2015, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of XARELTO® before expiration of Bayer’s United States Patent Nos. 7,157,456, 7,585,860 and 7,592,339 relating to XARELTO®. JPI is the exclusive sublicensee of the asserted patents. The following generic companies are named defendants: Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. (collectively, Aurobindo); Breckenridge Pharmaceutical, Inc. (Breckenridge); InvaGen Pharmaceuticals Inc. (InvaGen); Micro Labs USA Inc. and Micro Labs Ltd (collectively, Micro); Mylan Pharmaceuticals Inc. (Mylan); Prinston Pharmaceuticals, Inc.; Sigmapharm Laboratories, LLC (Sigmapharm); Torrent Pharmaceuticals, Limited and Torrent Pharma Inc. (collectively, Torrent). Trial concluded in April 2018. In July 2018 the district court entered judgment against Mylan and Sigmapharm, holding that the asserted compound patent is valid and infringed. In September 2018, the district court entered judgment against the remaining defendants. None of the defendants appealed the judgment.

Beginning in April 2017, JPI and Bayer Intellectual Property GmbH and Bayer AG (collectively, Bayer AG) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of XARELTO® before expiration of Bayer AG’s United States Patent No. 9,539,218 (’218) relating to XARELTO®. JPI is the exclusive sublicensee of the asserted patent. The following generic companies are named defendants: Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc. (Alembic); Aurobindo; Breckenridge; InvaGen; Lupin Limited and Lupin Pharmaceuticals, Inc.

                
 
90
                                


(collectively, Lupin); Micro; Mylan; Sigmapharm; Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. (collectively, Taro) and Torrent. Lupin counterclaimed for declaratory judgment of noninfringement and invalidity of United States Patent No. 9,415,053, but Lupin dismissed its counterclaims after it was provided a covenant not to sue on that patent. Aurobindo, Taro, Torrent, Micro, Breckenridge, InvaGen, Sigmapharm, Lupin and Alembic have agreed to have their cases stayed and to be bound by the outcome of any final judgment rendered against any of the other defendants. The ’218 cases have been consolidated for discovery and trial, and are currently set for trial in April 2019.

In December 2018, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. (collectively, Teva) who filed an ANDA seeking approval to market a generic version of XARELTO® before expiration of Bayer AG’s ’218 patent.

In each of these lawsuits, JPI is seeking an order enjoining the defendants from marketing their generic versions of XARELTO® before the expiration of the relevant patents.

In May 2018, Mylan filed a Petition for Inter Partes Review with the USPTO, seeking to invalidate the ’218 patent. In December 2018, the USPTO issued a decision denying institution of Mylan’s Petition for Inter Partes Review.

PREZISTA® 

In May 2018, Janssen Products, L.P. and Janssen Sciences Ireland UC (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Laurus Labs, Ltd. and Pharmaq, Inc. (collectively, DRL) who filed an ANDA seeking approval to market generic versions of PREZISTA® before the expiration of United States Patent Nos. 8,518,987; 7,126,015; and 7,595,408. Trial is scheduled to begin in May 2020.

In December 2018, Janssen initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt Ltd., and Raks Pharma Pvt. Ltd. (collectively, Amneal), who filed an ANDA seeking approval to market generic versions of PREZISTA® before the expiration of United States Patent Nos. 8,518,987; 7,126,015; and 7,595,408.

In each of these lawsuits, Janssen is seeking an order enjoining the defendants from marketing its generic versions of PREZISTA® before the expiration of the relevant patents.


INVOKANA®/INVOKAMET® 

Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey, the United States District Court for the District of Colorado and the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA® and/or INVOKAMET® before expiration of MTPC’s United States Patent Nos. 7,943,582 and/or 8,513,202 relating to INVOKANA® and INVOKAMET®. Janssen is the exclusive licensee of the asserted patents. The following generic companies are named defendants:  Apotex Inc. and Apotex Corp. (Apotex); Aurobindo Pharma USA Inc. (Aurobindo); Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.; InvaGen Pharmaceuticals, Inc. (InvaGen); Prinston Pharmaceuticals Inc.; Dr. Reddy’s Laboratories, Inc. and Dr. Reddy’s Laboratories Ltd; Hetero USA, Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited; MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.; Laurus Labs Ltd.; Indoco Remedies Ltd.; Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); Teva Pharmaceuticals USA, Inc.; and Lupin Ltd. and Lupin Pharmaceuticals, Inc.

Beginning in July 2017, Janssen and MTPC filed patent infringement lawsuits in the United States District Court for the District of New Jersey and the United States District Court for the District of Colorado against Sandoz and InvaGen, who filed ANDAs seeking approval to market generic versions of INVOKANA® and/or INVOKAMET® before expiration of MTPC’s United States Patent No. 7,943,788 (the ’788 patent) relating to INVOKANA® and INVOKAMET® and against Zydus, who filed ANDAs seeking approval to market generic versions of INVOKANA® and INVOKAMET® before expiration of the ’788 patent, MTPC's United States Patent No. 8,222,219 relating to INVOKANA® and INVOKAMET® and MTPC’s United States Patent No. 8,785,403 relating to INVOKAMET®, and against Aurobindo, who filed an ANDA seeking approval to market a generic version of INVOKANA® before expiration of the ’788 patent and the ’219 patent relating to INVOKANA®.

                
 
91
                                


Janssen is the exclusive licensee of the asserted patents. In October 2017, the Colorado lawsuits against Sandoz were dismissed. In December 2017, the Delaware lawsuits against Apotex and Teva were dismissed.

In April 2018, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Prinston, who filed an ANDA seeking approval to market a generic version of INVOKANA® before expiration of the ’788 patent relating to INVOKANA®.

In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA® and/or INVOKAMET® before the expiration of the relevant patents.

OPSUMIT® 

In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) and Amneal Pharmaceuticals LLC (Amneal), each of whom filed an ANDA seeking approval to market a generic version of OPSUMIT® before the expiration of United States Patent No. 7,094,781. In the lawsuit, Actelion is seeking an order enjoining Zydus and Amneal from marketing generic versions of OPSUMIT® before the expiration of the patent. In December 2018, the district court entered an order wherein one of the defendants, Amneal, stipulated to infringement. Trial is scheduled to commence in October 2020.

INVEGA SUSTENNA® 

In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA® before the expiration of United States Patent No. 9,439,906. In the lawsuit, Janssen is seeking an order enjoining Teva from marketing a generic version of INVEGA SUSTENNA® before the expiration of the patent.

In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Notices of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) and the Minister of Health in response to Teva's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA® before the expiration of Canadian Patent Nos. 2,309,629 and 2,655,335. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Teva’s ANDS before the expiration of these patents. The Final Hearing is scheduled to begin in September 2019.

IMBRUVICA® 

Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA® before expiration of Pharmacyclics’  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA®. JBI is the exclusive licensee of the asserted patents. The following generic companies are named defendants: Cipla Limited and Cipla USA Inc. (Cipla); Fresenius Kabi USA, LLC, Fresenius Kabi USA, Inc., and Fresenius Kabi Oncology Limited (Fresenius Kabi); Sandoz Inc. and Lek Pharmaceuticals d.d. (Sandoz); Shilpa Medicare Limited (Shilpa); Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited (Sun); Teva Pharmaceuticals USA, Inc. (Teva); and Zydus Worldwide DMCC and Cadila Healthcare Limited (Zydus). Trial is scheduled to begin in October 2020.

In October 2018, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Sun asserting newly issued United States Patent No. 10,004,746.

In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA® before the expiration of the relevant patents.

In January 2019, Pharmacyclics and JBI amended their complaints against Fresenius Kabi, Zydus, Teva and Sandoz to further allege infringement of U.S. Patent Nos. 10,106,548, and 10,125,140.

In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA® 70 mg before the

                
 
92
                                


expiration of U.S. Patent Nos. 514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140.

GOVERNMENT PROCEEDINGS
Like other companies in the pharmaceutical and medical devices industries, Johnson & Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.

Average Wholesale Price (AWP) Litigation
Johnson & Johnson and several of its pharmaceutical subsidiaries (the J&J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&J AWP Defendants were ultimately dismissed. The J&J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. Two cases remain pending. In a case brought by Illinois, trial has been scheduled for March 2019. In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson & Johnson and ALZA Corporation.

Opioids Litigation
Beginning in 2014 and continuing to the present, Johnson & Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than 1,600 lawsuits brought by certain state and local governments related to the marketing of opioids, including DURAGESIC®, NUCYNTA® and NUCYNTA® ER. To date, complaints against pharmaceutical companies, including Johnson & Johnson and JPI, have been filed in state court by the state Attorneys General in Arkansas, Florida, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma and South Dakota. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama; Arkansas; California; Connecticut; Florida; Georgia; Illinois; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Mississippi; Missouri; Nevada; New Hampshire; New Jersey; New Mexico; New York; North Carolina; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Virginia; Washington; West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. In addition, the Province of British Columbia filed suit in Canada. These actions allege a variety of claims related to opioids marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. These cases are in early stages of litigation. In October 2017, Johnson & Johnson and JPI were both served with a motion to consolidate 66 pending matters into a federal Multi District Litigation in the Southern District of Ohio. In December 2017, the MDL was approved in the Northern District of Ohio and there are over 1,400 cases that have been transferred to the MDL.

Johnson & Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson & Johnson and JPI were contacted by the Texas and Colorado Attorney General’s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. The multi-state coalition served Johnson & Johnson and JPI with subpoenas as part of the investigation. Johnson & Johnson and JPI have also received requests for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs regarding the sales, marketing, and educational strategies related to the promotion of opioids use.

Other

                
 
93
                                


In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson & Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR™ XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a qui tam case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies’ motion to dismiss with prejudice, unsealed the qui tam complaint, and denied the qui tam relators’ request for leave to file a further amended complaint. The qui tam relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court’s dismissal in part, reversed in part, and affirmed the decision to deny the relators’ request to file a third amended complaint. The relators’ remaining claims are now pending before the district court, and fact discovery is currently scheduled to close in September 2019. Additionally, DePuy filed a petition for certiorari with the United States Supreme Court, seeking review of the First Circuit’s decision. The Supreme Court denied the petition in April 2018.
Since October 2013, a group of State Attorneys General have issued Civil Investigative Demands relating to the development, sales and marketing of several of DePuy Orthopaedics, Inc.'s hip products. In July 2014, the Oregon Department of Justice, which was investigating these matters independently of the other states, announced a settlement of its ASR™ XL Hip device investigation with the State of Oregon. In December 2018, the Company, the remaining states and the District of Columbia agreed to settle all of the investigations, and on January 22, 2019, the states and the Company filed consent judgments resolving the matter.
In October 2012, Johnson & Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson & Johnson's subsidiary, Ethicon, Inc. (Ethicon). Johnson & Johnson and Ethicon have since entered into a series of tolling agreements with the 47 states and the District of Columbia participating in the multi-state investigation and have responded to Civil Investigative Demands served by certain of the participating states. The states are seeking monetary and injunctive relief. In May 2016, California and Washington filed civil complaints against Johnson & Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by Kentucky in August 2016 and by Mississippi in October 2017. Johnson & Johnson and Ethicon have entered into a new tolling agreement with the remaining 43 states and the District of Columbia.
In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson & Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex® (methoxsalen) and the Uvar Xts® and Cellex® Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson & Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson & Johnson retains OCD’s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney’s Office requested that Johnson & Johnson produce certain documents, and Johnson & Johnson is cooperating with those requests.
In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson & Johnson and Johnson & Johnson Consumer Companies, Inc. (now known as Johnson & Johnson Consumer Inc.) (JJCI). The complaint alleges that defendants failed to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S® Baby Powder and JOHNSON'S® Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief. Trial is stayed pending interlocutory appeal of a denial of JJCI's motion for summary judgment.

In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney’s Office for the Southern District of New York related to JPI’s contractual relationships with pharmacy benefit managers over the period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products. The demand was issued in connection with an investigation under the False Claims Act.

In January 2017, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Department of Justice relating to allegations concerning the sales and marketing practices of OLYSIO®. In December 2017, Johnson & Johnson and JPI were served with a whistleblower lawsuit filed in the United States District Court for the Central District of California alleging the off-label promotion of OLYSIO® and additional products, including NUCYNTA®, XARELTO®, LEVAQUIN® and REMICADE®.  At this time, the federal and state governments have declined to intervene and the lawsuit, which is related to the Civil Investigative Demand, is being prosecuted by a former company employee.  The United States

                
 
94
                                


District Court for the Central District of California dismissed the claim in April 2018. In May 2018, the relator filed a notice of appeal to the United States Court of Appeals for the Ninth Circuit.

In November 2018, a second whistleblower lawsuit was unsealed in the United States District Court for the Central District of California. The lawsuit is substantially similar to the lawsuit under appeal but is brought in the name of the original relator. The federal and state governments have declined to intervene in the second suit at this time.

In February 2017, Johnson & Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking the production of records pertaining to payments to any 501(c)(3) charitable organization that provides financial assistance to Medicare patients. Multiple pharmaceutical companies have publicly reported receipt of subpoenas and ongoing inquiries similar to this one and the one described below. The government has represented that it will not be pursuing action against the company in this matter.

Actelion Pharmaceuticals US, Inc. (Actelion US), received a subpoena in May 2016, with follow-up requests for documents from the United States Attorney's Office for the District of Massachusetts. The subpoena seeks the production of records pertaining to Actelion US’ payments to 501(c)(3) charitable organizations that provide financial assistance to Medicare patients. In December 2018, the Company and the United States Department of Justice agreed to a settlement in this matter.

In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE® or SIMPONI ARIA®.

In April and September 2017, Johnson & Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX®, OLYSIO®, REMICADE®, SIMPONI®, STELARA® and ZYTIGA®. The subpoenas also seek documents relating to Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies.

In June 2017, Johnson & Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson & Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government’s investigation.

In July 2018, Advanced Sterilization Products (ASP) received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning the pricing, quality, marketing and promotion of EvoTech ECR, Tyvek Peel Pouches, or Sterrad Cyclesure 24 biological indicators.

In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson & Johnson do Brasil Indústria e Comércio de Produtos para Saúde Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry. The United States Department of Justice and the United States Securities and Exchange Commission have made additional preliminary inquiries about the inspection in Brazil, and Johnson & Johnson do Brasil Indústria e Comércio de Produtos para Saúde Ltda. is cooperating with those requests.

From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson & Johnson to cooperate with these inquiries by producing the requested information.
GENERAL LITIGATION

In April 2016, a putative class action was filed against Johnson & Johnson, Johnson & Johnson Sales and Logistics Company, LLC and McNeil PPC, Inc. (now known as Johnson & Johnson Consumer, Inc.) in New Jersey Superior Court, Camden County on behalf of persons who reside in the state of New Jersey who purchased various McNeil over-the-counter products from December 2008 through the present. The complaint alleges violations of the New Jersey Consumer Fraud Act. Following the grant of a motion to dismiss and the filing of an amended complaint, in May 2017, the court denied a motion to dismiss the amended complaint. In December 2018, a settlement was reached and the matter has been dismissed.


                
 
95
                                


In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson & Johnson and Johnson & Johnson Consumer Companies, Inc. (now known as Johnson & Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S® Baby Powder and JOHNSON'S® Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson & Johnson's and JJCI’s motion to dismiss one of the cases. In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal. In September 2017, the plaintiff in the second case voluntarily dismissed their complaint. In March 2018, the plaintiff in the second case refiled in Illinois State Court.

In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA®) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015.

In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson & Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In June 2016, the district court denied motions to dismiss filed by JJVCI and other defendants. Discovery is ongoing. In March 2017, the plaintiffs filed a motion for class certification. The district court held a hearing on the motion for class certification in August 2018. In December 2018, the district court granted the plaintiffs motion for class certification.
In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research & Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson & Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO® as safer and more effective than less expensive alternative medications while failing to fully disclose its risks. The complaint seeks damages.
In May 2017, Lonza Sales AG (Lonza) filed a Request for Arbitration with the London Court of International Arbitration against Janssen Research & Development, LLC (Janssen R&D). Lonza alleges that Janssen R&D breached a 2005 agreement between the parties by sublicensing certain Lonza technology used in the manufacture of daratumumab without Lonza’s consent. Lonza seeks monetary damages. The arbitration hearing was held in September 2018. Post hearing briefing is complete, and the parties are awaiting a decision.
In May 2017, a purported class action was filed in the United States District Court for the Western District of Washington against LifeScan Inc., Johnson & Johnson, other diabetes test strip manufacturers and certain Pharmacy Benefit Managers (PBMs). The complaint alleges that consumers paid inflated prices for glucose monitor test strips as a consequence of undisclosed rebates and other incentives paid by manufacturers to PBMs. The complaint includes RICO, ERISA, and state consumer protection claims. The complaint seeks equitable relief and damages. In November 2017, the case was ordered transferred to United States District Court for the District of New Jersey. The LifeScan business was divested in October 2018 and Johnson & Johnson retained liability that may result from these claims prior to the closing of the divestiture.
In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson & Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania. Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE®. The complaint seeks damages and injunctive relief.

Beginning in September 2017, multiple purported class actions were filed against Johnson & Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen’s REMICADE® contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief. In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation.


                
 
96
                                


In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson & Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania. The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE®. The complaint seeks damages and injunctive relief.
 
In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson & Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.  The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health.

Andover Healthcare, Inc. (Andover) filed a Lanham act case against Johnson & Johnson Consumer Inc. in April 2017 in the United States District Court for the District of Massachusetts.  Andover asserts that the claim “not made with natural rubber latex” on COACH® Sports Wrap, BAND-AID® Brand SECURE-FLEX® Wrap and BAND-AID® Brand HURT-FREE® Wrap is false.  Andover seeks actual damages and pre-judgment interest thereon, disgorgement of profits, treble damages, attorney’s fees and injunctive relief.  In December 2018, the parties entered into a settlement agreement.

In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively “Actelion”) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.  The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER®.  TRACLEER® is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on distribution of the product.  In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in federal court in Maryland. 
 
In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research & Development, LLC, and Johnson & Johnson (collectively, Janssen) were served with a qui tam complaint filed on behalf of the United States, 28 states, and the District of Columbia.  The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA® to the government in connection with direct government sales and government-funded drug reimbursement programs.  At this time, the federal and state governments have declined to intervene.

Johnson & Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.

22. Restructuring
In the first quarter of 2016, the Company announced restructuring actions in its Medical Devices segment to better serve the needs of patients and customers in today’s evolving healthcare marketplace. The Company has undertaken actions to strengthen its go-to-market model, accelerate the pace of innovation, further prioritize key platforms and geographies, and streamline operations while maintaining high quality standards.
In 2018, the Company recorded a pre-tax charge of $462 million, of which $46 million was included in cost of products sold and $227 million was included in other (income) expense. Total project costs of $2.5 billion have been recorded since the restructuring has been announced. This restructuring program was completed in the fiscal fourth quarter of 2018.
On April 17, 2018, the Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the global supply chain restructuring strategic collaborations see Note 20 to the Consolidated Financial Statements. In 2018, the Company recorded a pre-tax charge of $238 million, of which $59 million was included in cost of products sold and $117 million was included in other (income) expense. See the following table for additional details on the restructuring programs.
In total, the Company expects the Global Supply Chain actions to generate approximately $0.6 billion to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 billion to $2.3 billion, over the 4 to 5 year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.   


                
 
97
                                


The following table summarizes the severance charges and the associated spending under these initiatives through the fiscal year ended 2018:
(Dollars in Millions)
Severance
Asset Write-offs
Other**
Total
Reserve balance, January 3, 2016
$
484

—

17

501

 
 
 
 
 
2016 activity
(104
)
—

(16
)
(120
)
 
 
 
 
 
Reserve balance, January 1, 2017
380

—

1

381

 
 
 
 
 
2017 activity
(151
)
—

37

(114
)
 
 
 
 
 
Reserve balance, December 31, 2017
229

—

38

267

 
 
 
 
 
Current year activity:
 
 
 
 
   Charges
—

132

568

700

   Cash payments
(35
)
—

(558
)
(593
)
   Settled non cash
—

(132
)
—

(132
)
Reserve balance, December 30, 2018*
$
194

—

48

242

 
 
 
 
 
*Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws.
**Other includes project expense such as salaries for employees supporting the initiative and consulting expenses.

Although the Medical Devices restructuring program was completed in 2018, the Company expects that severance charges will continue beyond that date. The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments has extended due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable. Approximately 2,375 individuals received separation payments since these restructuring announcements.

                
 
98
                                


Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Johnson & Johnson

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Johnson & Johnson and its subsidiaries (the “Company”) as of December 30, 2018 and December 31, 2017, and the related consolidated statements of earnings, of comprehensive income, of equity, and of cash flows for each of the three years in the period ended December 30, 2018 including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 30, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 30, 2018 and December 31, 2017, and the results of its operations and its cash flows for each of the three years in the period ended December 30, 2018 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 30, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.


Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.


                
 
99
                                


Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.


/s/PricewaterhouseCoopers LLP

Florham Park, New Jersey
February 20, 2019

We have served as the Company’s auditor since at least 1920. We have not been able to determine the specific year we began serving as auditor of the Company.  











                
 
100
                                


Management’s Report on Internal Control Over Financial Reporting

Under Section 404 of the Sarbanes-Oxley Act of 2002, management is required to assess the effectiveness of the Company’s internal control over financial reporting as of the end of each fiscal year and report, based on that assessment, whether the Company’s internal control over financial reporting is effective.
Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. The Company’s internal control over financial reporting is designed to provide reasonable assurance as to the reliability of the Company’s financial reporting and the preparation of external financial statements in accordance with generally accepted accounting principles.
Internal controls over financial reporting, no matter how well designed, have inherent limitations. Therefore, internal control over financial reporting determined to be effective can provide only reasonable assurance with respect to financial statement preparation and may not prevent or detect all misstatements. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
The Company’s management has assessed the effectiveness of the Company’s internal control over financial reporting as of December 30, 2018. In making this assessment, the Company used the criteria established by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in “Internal Control-Integrated Framework (2013).” These criteria are in the areas of control environment, risk assessment, control activities, information and communication, and monitoring. The Company’s assessment included extensive documenting, evaluating and testing the design and operating effectiveness of its internal controls over financial reporting.
Based on the Company’s processes and assessment, as described above, management has concluded that, as of December 30, 2018, the Company’s internal control over financial reporting was effective.
The effectiveness of the Company’s internal control over financial reporting as of December 30, 2018 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which appears herein.

/s/ Alex Gorsky
 
/s/ Joseph J. Wolk
Alex Gorsky
 
Joseph J. Wolk
Chairman, Board of Directors
 
Executive Vice President, Chief Financial Officer
Chief Executive Officer
 
 


                
 
101
                                


Shareholder Return Performance Graphs
Set forth below are line graphs comparing the cumulative total shareholder return on the Company’s Common Stock for periods of five years and ten years ending December 31, 2018, against the cumulative total return of the Standard & Poor’s 500 Stock Index, the Standard & Poor’s Pharmaceutical Index and the Standard & Poor’s Health Care Equipment Index. The graphs and tables assume that $100 was invested on December 31, 2013 and December 31, 2008 in each of the Company’s Common Stock, the Standard & Poor’s 500 Stock Index, the Standard & Poor’s Pharmaceutical Index and the Standard & Poor’s Health Care Equipment Index and that all dividends were reinvested.
5 Year Shareholder Return Performance J&J vs. Indicesjnj5yearshareholder2018.jpg
 
2013
2014
2015
2016
2017
2018
Johnson & Johnson
$100.00
$117.34
$118.69
$136.88
$170.29
$161.54
S&P 500 Index
$100.00
$113.68
$115.24
$129.02
$157.17
$150.27
S&P Pharmaceutical Index
$100.00
$122.22
$129.29
$127.27
$143.27
$154.86
S&P Healthcare Equipment Index
$100.00
$126.28
$133.82
$142.50
$186.53
$216.82
10 Year Shareholder Return Performance J&J vs. Indicesjnj10yearshareholder2018.jpg
 
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Johnson & Johnson
$100.00
$111.28
$110.63
$121.57
$134.73
$181.37
$212.81
$215.28
$248.26
$308.85
$292.99
S&P 500 Index
$100.00
$126.45
$145.49
$148.55
$172.31
$228.09
$259.29
$262.86
$294.28
$358.50
$342.75
S&P Pharmaceutical Index
$100.00
$118.62
$119.54
$140.77
$161.07
$217.82
$266.21
$281.62
$277.21
$312.06
$337.32
S&P Healthcare Equipment Index
$100.00
$128.79
$125.30
$124.30
$145.76
$186.12
$235.04
$249.08
$265.23
$347.17
$403.55

                
 
102
                                

Item 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
Not applicable.
Item 9A.
CONTROLS AND PROCEDURES
Disclosure Controls and Procedures.  At the end of the period covered by this Report, the Company evaluated the effectiveness of the design and operation of its disclosure controls and procedures. The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Alex Gorsky, Chairman and Chief Executive Officer, and Joseph J. Wolk, Executive Vice President, Chief Financial Officer, reviewed and participated in this evaluation. Based on this evaluation, Messrs. Gorsky and Wolk concluded that, as of the end of the period covered by this Report, the Company’s disclosure controls and procedures were effective
Reports on Internal Control Over Financial Reporting. The information called for by this item is incorporated herein by reference to "Management’s Report on Internal Control Over Financial Reporting", and the attestation regarding internal controls over financial reporting included in the "Report of Independent Registered Public Accounting Firm" included in Item 8 of this Report.
Changes in Internal Control Over Financial Reporting.  During the fiscal quarter ended December 30, 2018, there were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required under Rules 13a-15 and 15d-15 under the Exchange Act that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
The Company is implementing a multi-year, enterprise-wide initiative to integrate, simplify and standardize processes and systems for the human resources, information technology, procurement, supply chain and finance functions. These are enhancements to support the growth of the Company’s financial shared service capabilities and standardize financial systems. This initiative is not in response to any identified deficiency or weakness in the Company’s internal control over financial reporting. In response to this initiative, the Company has and will continue to align and streamline the design and operation of its financial control environment.
Item 9B.
OTHER INFORMATION
Not applicable.
PART III
Item 10.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
    
The information called for by this item is incorporated herein by reference to the discussion of the Audit Committee under the caption “Item 1. Election of Directors - Board Committees”; and the material under the captions “Item 1. Election of Directors” and “Stock Ownership and Section 16 Compliance – Section 16(a) Beneficial Ownership Reporting Compliance” in the Proxy Statement; and the material under the caption “Executive Officers of the Registrant” in Part I of this Report.
The Company’s Code of Business Conduct, which covers all employees (including the Chief Executive Officer, Chief Financial Officer and Controller), meets the requirements of the SEC rules promulgated under Section 406 of the Sarbanes-Oxley Act of 2002. The Code of Business Conduct is available on the Company’s website at www.jnj.com/code-of-business-conduct, and copies are available to shareholders without charge upon written request to the Secretary at the Company’s principal executive offices. Any substantive amendment to the Code of Business Conduct or any waiver of the Code granted to the Chief Executive Officer, the Chief Financial Officer or the Controller will be posted on the Company’s website at www.investor.jnj.com/gov.cfm within five business days (and retained on the website for at least one year).
In addition, the Company has adopted a Code of Business Conduct & Ethics for Members of the Board of Directors and Executive Officers. The Code of Business Conduct & Ethics for Members of the Board of Directors and Executive Officers is available on the Company’s website at www.investor.jnj.com/gov/boardconduct.cfm, and copies are available to shareholders without charge upon written request to the Secretary at the Company’s principal executive offices. Any substantive amendment to the Code or any waiver of the Code granted to any member of the Board of Directors or any executive officer will be posted

                
 
103
                                


on the Company’s website at www.investor.jnj.com/gov.cfm within five business days (and retained on the website for at least one year).
Item 11.
EXECUTIVE COMPENSATION
The information called for by this item is incorporated herein by reference to the material under the captions “Item 1. Election of Directors – Director Compensation,” and “Item 2. Compensation Committee Report,” “Compensation Discussion and Analysis” and “Executive Compensation Tables” in the Proxy Statement.
The material incorporated herein by reference to the material under the caption “Compensation Committee Report” in the Proxy Statement shall be deemed furnished, and not filed, in this Report and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, as a result of this furnishing, except to the extent that the Company specifically incorporates it by reference.
Item 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information called for by this item is incorporated herein by reference to the material under the caption “Item 1. Stock Ownership and Section 16 Compliance” in the Proxy Statement; and Note 17 “Common Stock, Stock Option Plans and Stock Compensation Agreements” of the Notes to Consolidated Financial Statements in Item 8 of this Report.
Equity Compensation Plan Information
The following table provides certain information as of December 30, 2018 concerning the shares of the Company’s Common Stock that may be issued under existing equity compensation plans.
Plan Category
Number of Securities to
be Issued Upon Exercise of
Outstanding Options and Rights
 
Weighted Average
Exercise Price of
Outstanding Options and Rights
 
Number of Securities
Remaining Available for
Future Issuance Under Equity Compensation Plans(2)(3)
Equity Compensation Plans Approved by Security Holders(1)
130,605,768

 

$82.52

 
351,079,202

Equity Compensation Plans Not Approved by Security Holders
-

 
-

 
-

Total
130,605,768

 

$82.52

 
351,079,202


(1) 
Included in this category are the following equity compensation plans which have been approved by the Company’s shareholders: 2005 Long-Term Incentive Plan and 2012 Long-Term Incentive Plan.
(2) 
This column excludes shares reflected under the column “Number of Securities to be Issued Upon Exercise of Outstanding Options and Rights.”
(3) 
The 2005 Long-Term Incentive Plan expired April 26, 2012. All options and restricted shares granted subsequent to that date were under the 2012 Long-Term Incentive Plan.
Item 13.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information called for by this item is incorporated herein by reference to the material under the captions “Item 1. Election of Directors - Director Independence” and “Related Person Transactions” in the Proxy Statement.
Item 14.
PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information called for by this item is incorporated herein by reference to the material under the caption “Item 3. Ratification of Appointment of Independent Registered Public Accounting Firm” in the Proxy Statement.

                
 
104
                                


PART IV
Item 15.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
The following documents are filed as part of this report:
1.     Financial Statements
Consolidated Balance Sheets at end of Fiscal Years 2018 and 2017
Consolidated Statements of Earnings for Fiscal Years 2018, 2017 and 2016    
Consolidated Statements of Comprehensive Income for Fiscal Years 2018, 2017 and 2016
Consolidated Statements of Equity for Fiscal Years 2018, 2017 and 2016
Consolidated Statements of Cash Flows for Fiscal Years 2018, 2017 and 2016
Notes to Consolidated Financial Statements
Report of Independent Registered Public Accounting Firm
All schedules are omitted because they are not applicable or the required information is included in the financial statements or notes.
2.     Exhibits Required to be Filed by Item 60l of Regulation S-K
The information called for by this item is incorporated herein by reference to the Exhibit Index in this Report.

Item 16. FORM 10-K SUMMARY
Registrants may voluntarily include a summary of information required by Form 10-K under this Item 16. The Company has elected not to include such summary information.


                
 
105
                                


SIGNATURES
Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: February 20, 2019
JOHNSON & JOHNSON
(Registrant)

By 
/s/  A. Gorsky
 
A. Gorsky, Chairman, Board of Directors,
and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature
 
Title
 
Date
 
 
 
 
 
/s/  A. Gorsky
 
Chairman, Board of Directors
 
February 20, 2019
A. Gorsky
 
Chief Executive Officer
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/  J. J. Wolk
 
Chief Financial Officer
 
February 20, 2019
J. J. Wolk
 
(Principal Financial Officer)
 
 
 
 
 
 
 
/s/  R. A. Kapusta
 
Controller and Chief Accounting Officer
 
February 20, 2019
R. A. Kapusta
 
(Principal Accounting Officer)
 
 
 
 
 
 
 
/s/ M. C. Beckerle
 
Director
 
February 20, 2019
M. C. Beckerle
 
 
 
 
 
 
 
 
 
/s/  D. S. Davis
 
Director
 
February 20, 2019
D. S. Davis
 
 
 
 
 
 
 
 
 
/s/  I. E. L. Davis
 
Director
 
February 20, 2019
I. E. L. Davis
 
 
 
 
 
 
 
 
 
/s/  J. A. Doudna
 
Director
 
February 20, 2019
J. A. Doudna
 
 
 
 

                
 
106
                                


Signature
 
Title
 
Date
 
 
 
 
 
/s/ M. B. McClellan
 
Director
 
February 20, 2019
M. B. McClellan
 
 
 
 
 
 
 
 
 
/s/  A. M. Mulcahy
 
Director
 
February 20, 2019
A. M. Mulcahy
 
 
 
 
 
 
 
 
 
/s/  W. D. Perez
 
Director
 
February 20, 2019
W. D. Perez
 
 
 
 
 
 
 
 
 
/s/  C. Prince
 
Director
 
February 20, 2019
C. Prince
 
 
 
 
 
 
 
 
 
/s/  A. E. Washington
 
Director
 
February 20, 2019
A. E. Washington
 
 
 
 
 
 
 
 
 
/s/  R. A. Williams
 
Director
 
February 20, 2019
R. A. Williams
 
 
 
 


                
 
107
                                


EXHIBIT INDEX

Reg. S-K
 
 
Exhibit Table
 
Description
Item No.
 
of Exhibit
 
Restated Certificate of Incorporation effective February 19, 2016 — Incorporated herein by reference to Exhibit 3(i) of the Registrant’s Form 10-K Annual Report for the fiscal year ended January 3, 2016.
 
By-Laws of the Company, as amended effective January 26, 2016 — Incorporated herein by reference to Exhibit 3.1 the Registrant’s Form 8-K Current Report filed January 26, 2016.
4(a)
 
Upon the request of the Securities and Exchange Commission, the Registrant will furnish a copy of all instruments defining the rights of holders of long-term debt of the Registrant.
 
2005 Long-Term Incentive Plan — Incorporated herein by reference to Exhibit 4 of the Registrant’s S-8 Registration Statement filed with the Commission on May 10, 2005 (file no. 333-124785).*
 
Form of Stock Option Certificate under the 2005 Long-Term Incentive Plan — Incorporated herein by reference to Exhibit 10.1 of the Registrant’s Form 8-K Current Report filed January 13, 2012.*
 
2012 Long-Term Incentive Plan — Incorporated herein by reference to Appendix A of the Registrant’s Proxy Statement filed with the Commission on March 15, 2017 .*
 
Form of Stock Option Certificate, Restricted Share Unit Certificate and Performance Share Unit Certificate under the 2012 Long-Term Incentive Plan — Incorporated herein by reference to Exhibits 10.2, 10.3 and 10.4 of the Registrant’s Form 10-Q Quarterly Report filed May 7, 2012.*
 
Global NonQualified Stock Option Award Agreement, Global Restricted Share Unit Award Agreement and Global Performance Share Unit Award Agreement under the 2012 Long-Term Incentive Plan — Incorporated herein by reference to Exhibits 10.1, 10.2 and 10.3 of the Registrant’s Form 10-Q Quarterly Report filed May 1, 2018.*
 
Johnson & Johnson Executive Incentive Plan (as amended) — Incorporated herein by reference to Exhibit 10(f) of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 31, 2000.*
 
Domestic Deferred Compensation (Certificate of Extra Compensation) Plan — Incorporated herein by reference to Exhibit 10(g) of the Registrant’s Form 10-K Annual Report for the year ended December 28, 2003.*
 
Amendments to the Certificate of Extra Compensation Plan effective as of January 1, 2009 — Incorporated herein by reference to Exhibit 10(j) of the Registrant’s Form 10-K Annual Report for the year ended December 28, 2008.*
 
2009 Certificates of Long-Term Performance Plan — Incorporated herein by reference to Exhibit 10.1 of the Registrant’s Form 10-Q Quarterly Report for the quarter ended September 27, 2009.*
 
Amended and Restated Deferred Fee Plan for Directors (Amended as of January 17, 2012) — Incorporated herein by reference to Exhibit 10(k) of the Registrant's Form 10-K Annual Report for the fiscal year ended January 1, 2012.*
 
The Johnson & Johnson Executive Income Deferral Plan (Amended and Restated Effective January 1, 2010) — Incorporated herein by reference to Exhibit 10.1 of the Registrant’s Form 10-Q Quarterly Report for the quarter ended September 30, 2012.*
 
Excess Savings Plan (Effective as of January 1, 1996) — Incorporated herein by reference to Exhibit 10(j) of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 29, 1996.*
 
Amendments to the Johnson & Johnson Excess Savings Plan effective as of January 1, 2009 — Incorporated herein by reference to Exhibit 10(p) of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 28, 2008.*
10(n)**
 
Excess Benefit Plan (Supplemental Retirement Plan) — Incorporated herein by reference to Exhibit 10(h) of the Registrant’s Form 10-K Annual Report for the fiscal year ended January 3, 1993.*
 
Amendments to the Excess Benefit Plan of Johnson & Johnson and Affiliated Companies effective as of January 1, 2009 — Incorporated herein by reference to Exhibit 10(r) of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 28, 2008.*
 
Amendment to the Excess Benefit Plan of Johnson & Johnson and Affiliated Companies, effective as of January 1, 2015 — Incorporated herein by reference to Exhibit 10(q) of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 28, 2014.*
10(q)**
 
Executive Life Plan Agreement — Incorporated herein by reference to Exhibit 10(i) of the Registrant’s Form 10-K Annual Report for the fiscal year ended January 3, 1993.*
 
Executive Life Plan Agreement Closure Letter — Incorporated herein by reference to Exhibit 10.1 of the Registrant’s Form 10-Q Quarterly Report for the quarter ended March 29, 2015.*
 
Employment Agreement for Dr. Paulus Stoffels - Incorporated herein by reference to Exhibit 10.2 of the Registrant’s Form 10-Q Quarterly Report for the quarter ended September 30, 2012.*

                
 
108
                                


Reg. S-K
 
 
Exhibit Table
 
Description
Item No.
 
of Exhibit
 
Summary of Employment Arrangements for Sandra E. Peterson — Incorporated herein by reference to Exhibit 10(t) of the Registrant's Form 10-K Annual Report for the year ended December 30, 2012.*
 
Severance Pay Plan of Johnson & Johnson and U.S. Affiliated Companies, Amended and Restated as of October 1, 2014 — Incorporated herein by reference to Exhibit 10.1 of the Registrant's Form 10-Q Quarterly Report for the quarter ended September 28, 2014.*
 
First Amendment to the Severance Pay Plan of Johnson & Johnson and U.S. Affiliated Companies (as amended and restated effective October 1, 2014) — Incorporated herein by reference to Exhibit 10.1 of the Registrant's Form 10-Q Quarterly Report for the quarter ended June 28, 2015.*
 
Second Amendment to the Severance Pay Plan of Johnson & Johnson and U.S. Affiliated Companies (as amended and restated effective October 1, 2014) — Incorporated herein by reference to Exhibit 10(x) of the Registrant's Form 10-K Annual Report for the fiscal year ended January 3, 2016.*
 
Subsidiaries - Filed with this document.
 
Consent of Independent Registered Public Accounting Firm — Filed with this document.
 
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act — Filed with this document.
 
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act — Filed with this document.
 
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act — Furnished with this document.
 
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act — Furnished with this document.
101
 
XBRL (Extensible Business Reporting Language) The following materials from this Report for the fiscal year ended December 30, 2018, formatted in Extensive Business Reporting Language (XBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Earnings, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to the Consolidated Financial Statements.
*
Management contract or compensatory plan.
**
Paper filing.
A copy of any of the Exhibits listed above will be provided without charge to any shareholder submitting a written request specifying the desired exhibit(s) to the Secretary at the principal executive offices of the Company. Pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K, the Company has not filed as exhibits to this Form 10-K certain long-term debt instruments, including indentures, under which the total amount of securities authorized does not exceed 10% of the total assets of the Company and its subsidiaries on a consolidated basis. The Company hereby agrees to furnish a copy of any such instrument to the SEC upon request.

                
 
109
                                
 EX-21 2 ex21-subsidiariesxform10xk.htm EXHIBIT 21 Exhibit

EXHIBIT 21
SUBSIDIARIES
Johnson & Johnson, a New Jersey corporation, had the U.S. and international subsidiaries shown below as of
December 30, 2018. Certain U.S. subsidiaries and international subsidiaries are not named because they were not significant in the aggregate. Johnson & Johnson is not a subsidiary of any other entity.
Name of Subsidiary
Jurisdiction of Organization
U.S. Subsidiaries:
 
Acclarent, Inc.
Delaware
Actelion Pharmaceuticals US, Inc.
Delaware
Advanced Sterilization Products Services Inc.
New Jersey
ALZA Corporation
Delaware
AMO Development, LLC
Delaware
AMO Holdings, Inc.
Delaware
AMO Manufacturing USA, LLC
Delaware
AMO Sales and Service, Inc.
Delaware
AMO USA, LLC
Delaware
AMO USA Sales Holdings, Inc.
Delaware
AMO US Holdings, Inc.
Delaware
Aragon Pharmaceuticals, Inc.
Delaware
Atrionix, Inc.
California
BeneVir BioPharm, Inc.
Delaware
BioMedical Enterprises, Inc.
Texas
Biosense Webster, Inc.
California
Centocor Research & Development, Inc.
Pennsylvania
Codman & Shurtleff, Inc.
New Jersey
Coherex Medical, Inc.
Delaware
Cordis LLC
Delaware
DePuy Products, Inc.
Indiana
DePuy Synthes Products, Inc.
Delaware
DePuy Synthes Sales, Inc.
Massachusetts
DePuy Synthes, Inc.
Delaware
Ethicon Endo-Surgery, Inc.
Ohio
Ethicon Endo-Surgery, LLC
Delaware
Ethicon US, LLC
Texas
Ethicon, Inc.
New Jersey
Heartport, Inc.
Delaware
Janssen BioPharma, Inc.
Delaware
Janssen Biotech, Inc.
Pennsylvania
Janssen-Cilag Holdings, Inc.
Nevada
Janssen-Cilag Manufacturing, LLC
Delaware
Janssen Global Services, LLC
New Jersey
Janssen Oncology, Inc.
Delaware
Janssen Ortho LLC
Delaware
Janssen Pharmaceuticals, Inc.
Pennsylvania
Janssen Research & Development, LLC
New Jersey
Janssen Scientific Affairs, LLC
New Jersey



Name of Subsidiary
Jurisdiction of Organization
JJHC, LLC
Delaware
Johnson & Johnson Consumer Inc.
New Jersey
Johnson & Johnson Finance Corporation
New Jersey
Johnson & Johnson Health and Wellness Solutions, Inc.
Michigan
Johnson & Johnson Health Care Systems Inc.
New Jersey
Johnson & Johnson Innovation - JJDC, Inc.
New Jersey
Johnson & Johnson International
New Jersey
Johnson & Johnson Japan Inc.
New Jersey
Johnson & Johnson (Middle East) Inc.
New Jersey
Johnson & Johnson Services, Inc.
New Jersey
Johnson & Johnson Surgical Vision, Inc.
Delaware
Johnson & Johnson Vision Care, Inc.
Florida
JOM Pharmaceutical Services, Inc.
Delaware
LifeScan LLC
Delaware
LifeScan Products LLC
Delaware
McNeil Consumer Pharmaceuticals Co.
New Jersey
McNeil Healthcare LLC
Delaware
McNeil MMP, LLC
New Jersey
Medical Device Business Services, Inc.
Indiana
MegaDyne Medical Products, Inc.
Utah
Mentor Texas L.P.
Delaware
Mentor Worldwide LLC
Delaware
Middlesex Assurance Company Limited
Vermont
NeoStrata Company, Inc.
Delaware
NeuWave Medical, Inc.
Delaware
OMJ Pharmaceuticals, Inc.
Delaware
OptiMedica Corporation
Delaware
Ortho Biologics LLC
Delaware
Patriot Pharmaceuticals, LLC
Pennsylvania
Pulsar Vascular, Inc.
Delaware
SterilMed, Inc.
Minnesota
Synthes USA, LLC
Delaware
Synthes, Inc.
Delaware
TearScience, Inc.
Delaware
Torax Medical, Inc.
Delaware
TriStrata, Incorporated
Delaware
Zarbee's, Inc.
Delaware
International Subsidiaries:
 
Actelion Ltd
Switzerland
Actelion Pharmaceuticals Italia S.r.l.
Italy
Actelion Pharmaceuticals Japan Ltd.
Japan
Actelion Pharmaceuticals Ltd
Switzerland
AMO Canada Company
Canada
AMO Global Holdings
Cayman Islands



Name of Subsidiary
Jurisdiction of Organization
AMO International Holdings
Ireland
Apsis
France
Beijing Dabao Cosmetics Co., Ltd.
China
Berna Rhein B.V.
Netherlands
Biosense Webster (Israel) Ltd.
Israel
Cilag AG
Switzerland
Cilag GmbH International
Switzerland
Cilag Holding AG
Switzerland
Cilag Holding Treasury Unlimited Company
Ireland
CNA Development GmbH
Switzerland
Cordis de Mexico, S.A. de C.V.
Mexico
Covagen AG
Switzerland
DePuy France
France
DePuy International Limited
United Kingdom
DePuy Ireland Unlimited Company
Ireland
DePuy Synthes Gorgan Limited
Ireland
DePuy Synthes Leto S.A.R.L.
Luxembourg
EES, S.A. de C.V.
Mexico
Ethicon Holding Sarl
Switzerland
Ethicon PR Holdings Unlimited Company
Ireland
Ethnor del Istmo, S.A.
Panama
GH Biotech Holdings Limited
Ireland
Global Investment Participation B.V.
Netherlands
GMED Healthcare BVBA
Belgium
Guangzhou Bioseal Biotech Co., Ltd.
China
Janssen Biologics B.V.
Netherlands
Janssen Biologics (Ireland)
Ireland
Janssen-Cilag A/S
Denmark
Janssen-Cilag AB
Sweden
Janssen-Cilag AG
Switzerland
Janssen-Cilag AS
Norway
Janssen-Cilag B.V.
Netherlands
Janssen-Cilag de Mexico S. de R.L. de C.V.
Mexico
Janssen-Cilag Farmaceutica Ltda.
Brazil
Janssen-Cilag Farmaceutica, Lda.
Portugal
Janssen Cilag Farmaceutica S.A.
Argentina
Janssen-Cilag GmbH
Germany
Janssen-Cilag Kft.
Hungary
Janssen-Cilag Limited
Thailand
Janssen-Cilag Limited
United Kingdom
Janssen-Cilag NV
Belgium
Janssen-Cilag OY
Finland
Janssen-Cilag Pharma GmbH
Austria
Janssen-Cilag Pharmaceutical S.A.C.I.
Greece
Janssen-Cilag Polska, Sp. z o.o.
Poland



Name of Subsidiary
Jurisdiction of Organization
Janssen-Cilag Pty Ltd
Australia
Janssen-Cilag S.A.
Colombia
Janssen-Cilag, S.A.
Spain
Janssen-Cilag, S.A. de C.V.
Mexico
Janssen-Cilag S.p.A.
Italy
Janssen de Mexico, S. de R.L. de C.V.
Mexico
Janssen Egypt
Egypt
Janssen Holding GmbH
Switzerland
Janssen Inc.
Canada
Janssen Irish Finance Company UC
Ireland
Janssen Korea Ltd.
Korea, Republic of
Janssen Pharmaceutical
Ireland
Janssen Pharmaceutical K.K.
Japan
Janssen Pharmaceutica NV
Belgium
Janssen Pharmaceutica (Proprietary) Limited
South Africa
Janssen Pharmaceutical Sciences Unlimited Company
Ireland
Janssen R&D Ireland
Ireland
Janssen Sciences Ireland UC
Ireland
J.C. General Services CVBA
Belgium
J-C Health Care Ltd.
Isreal
JJC Acquisition Company B.V.
Netherlands
Johnson & Johnson AB
Sweden
Johnson & Johnson AG
Switzerland
Johnson & Johnson Belgium Finance Company
Belgium
Johnson & Johnson (China) Investment Ltd.
China
Johnson & Johnson Consumer Holdings France
France
Johnson & Johnson Consumer NV
Belgium
Johnson & Johnson Consumer Saudi Arabia Limited
Saudi Arabia
Johnson & Johnson Consumer Services EAME Ltd.
United Kingdom
Johnson & Johnson de Argentina S.A.C. e. I.
Argentina
Johnson & Johnson de Chile S.A.
Chile
Johnson & Johnson de Colombia S.A.
Colombia
Johnson & Johnson del Ecuador S.A.
Ecuador
Johnson & Johnson del Peru S.A.
Peru
Johnson & Johnson de Mexico, S.A. de C.V.
Mexico
Johnson & Johnson de Venezuela, S.A.
Venezuela
Johnson & Johnson do Brasil Industria E Comercio de Produtos Para Saude Ltda.
Brazil
Johnson & Johnson European Treasury Company
Ireland
Johnson & Johnson Finance Limited
United Kingdom
Johnson & Johnson Financial Services GmbH
Germany
Johnson & Johnson for Export & Import LLC
Egypt
Johnson & Johnson Gesellschaft m.b.H.
Austria
Johnson & Johnson GmbH
Germany
Johnson & Johnson Group Holdings GmbH
Austria
Johnson & Johnson Hellas Commercial and Industrial S.A.
Greece



Name of Subsidiary
Jurisdiction of Organization
Johnson & Johnson Hellas Consumer Products Commercial Societe Anonyme
Greece
Johnson & Johnson Holdings GmbH
Germany
Johnson & Johnson Holdings K.K.
Japan
Johnson & Johnson Inc.
Canada
Johnson & Johnson Industrial Ltda.
Brazil
Johnson & Johnson Innovation Limited
United Kingdom
Johnson & Johnson International Financial Services Company
Ireland
Johnson & Johnson (Ireland) Limited
Ireland
Johnson & Johnson K.K.
Japan
Johnson & Johnson Korea, Ltd.
Korea
Johnson & Johnson Korea Selling & Distribution Limited Liability Company
Korea, Republic of
Johnson & Johnson Limited
United Kingdom
Johnson & Johnson Limitada
Portugal
Johnson & Johnson LLC
Russian Federation
Johnson & Johnson Luxembourg Finance Company Sarl
Luxembourg
Johnson & Johnson Management Limited
United Kingdom
Johnson & Johnson Medical
France
Johnson & Johnson Medical B.V.
Netherlands
Johnson & Johnson Medical (China) Ltd.
China
Johnson & Johnson Medical GmbH
Germany
Johnson & Johnson Medical Korea Limited
Korea, Republic of
Johnson & Johnson Medical Limited
United Kingdom
Johnson & Johnson Medical Mexico, S.A. de C.V.
Mexico
Johnson & Johnson Medical NV
Belgium
Johnson & Johnson Medical Products GmbH
Austria
Johnson and Johnson Medical (Pty) Ltd
South Africa
Johnson & Johnson Medical Pty Ltd
Australia
Johnson & Johnson Medical S.A.
Argentina
Johnson & Johnson Medical, S.C.S.
Venezuela
Johnson & Johnson Medical (Shanghai) Ltd.
China
Johnson & Johnson Medical S.p.A.
Italy
Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi
Turkey
Johnson & Johnson Medical Taiwan Ltd.
Taiwan
Johnson & Johnson Middle East FZ-LLC
United Arab Emirates
Johnson & Johnson (New Zealand) Limited
New Zealand
Johnson & Johnson Nordic AB
Sweden
Johnson & Johnson Pacific Pty. Limited
Australia
Johnson & Johnson (Philippines), Inc.
Philippines
Johnson & Johnson Poland Sp. z o.o.
Poland
Johnson & Johnson Private Limited
India
Johnson & Johnson (Proprietary) Limited
South Africa
Johnson & Johnson Pte. Ltd.
Singapore
Johnson & Johnson Pty. Limited
Australia
Johnson & Johnson Romania S.R.L.
Romania
Johnson & Johnson, S.A.
Spain



Name of Subsidiary
Jurisdiction of Organization
Johnson & Johnson, S.A. de C.V.
Mexico
Johnson & Johnson Sante Beaute France
France
Johnson & Johnson SDN. BHD.
Malaysia
Johnson & Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi
Turkey
Johnson & Johnson S.p.A.
Italy
Johnson & Johnson, s.r.o.
Czech Republic
Johnson & Johnson, s.r.o.
Slovakia
Johnson & Johnson Surgical Vision India Private Limited
India
Johnson & Johnson Swiss Finance Company Limited
United Kingdom
Johnson & Johnson Taiwan Ltd.
Taiwan
Johnson & Johnson (Thailand) Ltd.
Thailand
Johnson & Johnson UK Treasury Company Limited
United Kingdom
Johnson & Johnson Vision Care (Ireland)
Ireland
Latam International Investment Company Unlimited Company
Ireland
Latam Properties Holdings Unlimited Company
Ireland
Lifescan
France
McNeil AB
Sweden
McNeil Denmark APS
Denmark
McNeil Healthcare (UK) Limited
United Kingdom
McNeil Sweden AB
Sweden
Medos International Sarl
Switzerland
Medos Sarl
Switzerland
Mentor B.V.
Netherlands
Mentor Holding PP
France
Mentor Medical Systems B.V.
Netherlands
Neuravi Limited
Ireland
OMJ Ireland Unlimited Company
Ireland
Omrix Biopharmaceuticals Ltd.
Israel
PMC Holdings G.K.
Japan
PT. Johnson & Johnson Indonesia
Indonesia
Shanghai Johnson & Johnson Limited
China
Synthes GmbH
Switzerland
Synthes Holding AG
Switzerland
SYNTHES Medical Immobilien GmbH
Germany
Synthes Produktions GmbH
Switzerland
Turnbuckle Investment Unlimited Company
Ireland
Vania Expansion
France
Xian-Janssen Pharmaceutical Ltd.
China



 EX-23 3 ex23-pwcconsentxform10xkx2.htm EXHIBIT 23 Exhibit


EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-211250, 333-181092, 333-163857, 333-129542, and 333-124785) and Form S-3 (Nos. 333-216285 and 333-67020) of Johnson & Johnson of our report dated February 20, 2019 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Florham Park, New Jersey
February 20, 2019


 EX-31.1 4 ex311-302certofceoxform10x.htm EXHIBIT 31.1 CEO CERTIFICATION Exhibit


Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
I, Alex Gorsky, certify that:
1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 30, 2018 (the “report”) of Johnson & Johnson (the “Company”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;
4. The Company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the Company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and
5. The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.
 
 
 
 
 
/s/ Alex Gorsky
 
Alex Gorsky
 
Chief Executive Officer 
 
 
Date: February 20, 2019



 EX-31.2 5 ex312-302certofcfoxform10x.htm EXHIBIT 31.2 CFO CERTIFICATION Exhibit


Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
I, Joseph J. Wolk certify that:
1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 30, 2018 (the “report”) of Johnson & Johnson (the “Company”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;
4. The Company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the Company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and
5. The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.
 
 
 
 
 
/s/ Joseph J. Wolk
 
Joseph J. Wolk
 
Chief Financial Officer 
 
 
Date: February 20, 2019



EX-32.1 6 ex321-906certofceoxform10x.htm EXHIBIT 32.1 CEO 906 CERTIFICATION Exhibit


Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
The undersigned, Alex Gorsky, the Chief Executive Officer of Johnson & Johnson, a New Jersey corporation (the “Company”), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:

(1)
the Company's Annual Report on Form 10-K for the fiscal year ended December 30, 2018 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 
 
/s/ Alex Gorsky
 
Alex Gorsky
 
Chief Executive Officer 
 
 
Dated: February 20, 2019
This certification is being furnished to the SEC with this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.












 EX-32.2 7 ex322-906certofcfoxform10x.htm EXHIBIT 32.2 CFO CERTIFICATION 906 Exhibit


Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
The undersigned, Joseph J. Wolk, the Chief Financial Officer of Johnson & Johnson, a New Jersey corporation (the “Company”), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:

(1)
the Company's Annual Report on Form 10-K for the fiscal year ended December 30, 2018 (the “Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
/s/ Joseph J. Wolk
 
Joseph J. Wolk 
 
Chief Financial Officer 
 
 
Dated: February 20, 2019
This certification is being furnished to the SEC with this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.



 EX-101.INS 8 jnj-20181230.xml XBRL INSTANCE DOCUMENT 0000200406 2018-01-01 2018-12-30 0000200406 2018-07-01 0000200406 2019-02-15 0000200406 2017-12-31 0000200406 2018-12-30 0000200406 2017-01-02 2017-12-31 0000200406 2016-01-04 2017-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-04 2017-01-01 0000200406 us-gaap:RetainedEarningsMember 2017-01-01 0000200406 us-gaap:RetainedEarningsMember 2016-01-04 2017-01-01 0000200406 us-gaap:CommonStockMember 2016-01-03 0000200406 us-gaap:TreasuryStockMember 2016-01-03 0000200406 us-gaap:TreasuryStockMember 2018-01-01 2018-12-30 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-03 0000200406 us-gaap:CommonStockMember 2017-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-30 0000200406 us-gaap:RetainedEarningsMember 2017-01-02 2017-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-02 2017-12-31 0000200406 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-30 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 0000200406 us-gaap:TreasuryStockMember 2017-01-02 2017-12-31 0000200406 us-gaap:RetainedEarningsMember 2016-01-03 0000200406 us-gaap:CommonStockMember 2017-01-01 0000200406 us-gaap:TreasuryStockMember 2017-12-31 0000200406 us-gaap:TreasuryStockMember 2016-01-04 2017-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 0000200406 us-gaap:CommonStockMember 2018-12-30 0000200406 2017-01-01 0000200406 us-gaap:TreasuryStockMember 2017-01-01 0000200406 us-gaap:RetainedEarningsMember 2017-12-31 0000200406 us-gaap:RetainedEarningsMember 2018-12-30 0000200406 2016-01-03 0000200406 us-gaap:TreasuryStockMember 2018-12-30 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000200406 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-01-01 0000200406 us-gaap:AccountingStandardsUpdate201616Member us-gaap:RetainedEarningsMember 2018-01-01 0000200406 us-gaap:NewAccountingPronouncementMember us-gaap:RetainedEarningsMember 2018-01-01 0000200406 us-gaap:AccountingStandardsUpdate201601Member us-gaap:RetainedEarningsMember 2018-01-01 0000200406 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-12-30 0000200406 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-12-30 0000200406 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-12-30 0000200406 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-12-30 0000200406 us-gaap:AccountingStandardsUpdate201616Member 2018-01-01 0000200406 us-gaap:RetainedEarningsMember 2018-01-01 0000200406 us-gaap:SoftwareDevelopmentMember us-gaap:MaximumMember 2018-01-01 2018-12-30 0000200406 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-30 0000200406 us-gaap:SoftwareDevelopmentMember us-gaap:MinimumMember 2018-01-01 2018-12-30 0000200406 jnj:AccountingStandardsUpdate201707Member 2018-01-01 2018-12-30 0000200406 jnj:AccountingStandardsUpdate201707Member 2016-01-04 2017-01-01 0000200406 jnj:AccountingStandardsUpdate201707Member 2017-01-02 2017-12-31 0000200406 us-gaap:BuildingAndBuildingImprovementsMember us-gaap:MinimumMember 2018-01-01 2018-12-30 0000200406 us-gaap:BuildingAndBuildingImprovementsMember us-gaap:MaximumMember 2018-01-01 2018-12-30 0000200406 jnj:LandAndLeaseholdImprovementsMember us-gaap:MaximumMember 2018-01-01 2018-12-30 0000200406 jnj:LandAndLeaseholdImprovementsMember us-gaap:MinimumMember 2018-01-01 2018-12-30 0000200406 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2018-01-01 2018-12-30 0000200406 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2018-01-01 2018-12-30 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:MoneyMarketFundsMember 2017-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:SovereignDebtSecuritiesMember 2017-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:RepurchaseAgreementsMember 2017-12-31 0000200406 us-gaap:AvailableforsaleSecuritiesMember us-gaap:SovereignDebtSecuritiesMember 2017-12-31 0000200406 us-gaap:AvailableforsaleSecuritiesMember 2017-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:BankTimeDepositsMember 2017-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember 2017-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:CashMember 2017-12-31 0000200406 us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0000200406 us-gaap:AvailableforsaleSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:BankTimeDepositsMember 2018-12-30 0000200406 us-gaap:HeldtomaturitySecuritiesMember jnj:OtherReverseRepurchaseAgreementsMember 2018-12-30 0000200406 us-gaap:AvailableforsaleSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2018-12-30 0000200406 us-gaap:AvailableforsaleSecuritiesMember 2018-12-30 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:MoneyMarketFundsMember 2018-12-30 0000200406 us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasuryAndGovernmentMember 2018-12-30 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:RepurchaseAgreementsMember 2018-12-30 0000200406 us-gaap:HeldtomaturitySecuritiesMember 2018-12-30 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:CashMember 2018-12-30 0000200406 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember jnj:SupplyChainMember 2018-12-30 0000200406 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember jnj:AdvancedSterilizationProductsMember 2018-12-30 0000200406 us-gaap:OtherIntangibleAssetsMember 2018-12-30 0000200406 jnj:PatentsAndTrademarksMember 2018-12-30 0000200406 jnj:PatentsAndTrademarksMember 2017-12-31 0000200406 us-gaap:TrademarksMember 2017-12-31 0000200406 jnj:PurchasedInProcessResearchAndDevelopmentMember 2018-12-30 0000200406 us-gaap:OtherIntangibleAssetsMember 2017-12-31 0000200406 jnj:PurchasedInProcessResearchAndDevelopmentMember 2017-12-31 0000200406 us-gaap:TrademarksMember 2018-12-30 0000200406 jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember 2018-12-30 0000200406 jnj:MedicalDevicesMember 2017-01-02 2017-12-31 0000200406 jnj:ConsumerMember 2017-12-31 0000200406 jnj:PharmaceuticalMember 2017-12-31 0000200406 jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember 2017-01-01 0000200406 jnj:PharmaceuticalMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember 2017-12-31 0000200406 jnj:ConsumerMember 2017-01-01 0000200406 jnj:PharmaceuticalMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember 2017-01-01 0000200406 jnj:ConsumerMember 2018-12-30 0000200406 jnj:MedicalDevicesMember 2018-12-30 0000200406 jnj:AMOMember jnj:MedicalDevicesMember 2017-04-02 0000200406 jnj:AliosBiopharmaIncandXO1LimitedMember jnj:PurchasedInProcessResearchAndDevelopmentMember 2018-12-30 0000200406 jnj:PatentsAndTrademarksMember 2018-01-01 2018-12-30 0000200406 jnj:AdvancedSterilizationProductsMember us-gaap:GoodwillMember jnj:MedicalDevicesMember 2018-12-30 0000200406 jnj:ActelionMember jnj:PharmaceuticalMember 2017-07-02 0000200406 jnj:PurchasedInProcessResearchAndDevelopmentMember 2018-12-30 0000200406 jnj:LifeScanMember us-gaap:GoodwillMember jnj:MedicalDevicesMember 2018-12-30 0000200406 jnj:XO1Member jnj:PurchasedInProcessResearchAndDevelopmentMember 2018-01-01 2018-12-30 0000200406 us-gaap:OtherIntangibleAssetsMember 2018-01-01 2018-12-30 0000200406 jnj:AliosBiopharmaMember jnj:PurchasedInProcessResearchAndDevelopmentMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel2Member 2018-12-30 0000200406 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0000200406 us-gaap:FairValueInputsLevel1Member 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel3Member 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel1Member 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:NondesignatedMember 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel2Member 2017-12-31 0000200406 us-gaap:EquitySecuritiesMember jnj:EquityInvestmentswithoutReadilyDeterminableValueMember 2018-01-01 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember jnj:EquityInvestmentswithReadilyDeterminableValueMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember 2018-12-30 0000200406 us-gaap:InterestRateContractMember 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember 2017-12-31 0000200406 us-gaap:InterestRateContractMember 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember 2017-12-31 0000200406 us-gaap:EquitySecuritiesMember 2018-12-30 0000200406 jnj:CurrentPortionofLongtermDebtMember 2018-12-30 0000200406 jnj:CurrentPortionofLongtermDebtMember 2017-12-31 0000200406 us-gaap:LongTermDebtMember 2018-12-30 0000200406 us-gaap:LongTermDebtMember 2017-12-31 0000200406 us-gaap:EquitySecuritiesMember jnj:EquityInvestmentswithReadilyDeterminableValueMember 2017-12-31 0000200406 us-gaap:EquitySecuritiesMember jnj:EquityInvestmentswithReadilyDeterminableValueMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember jnj:EquityInvestmentswithReadilyDeterminableValueMember 2018-01-01 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember jnj:EquityInvestmentswithoutReadilyDeterminableValueMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember jnj:EquityInvestmentswithoutReadilyDeterminableValueMember 2017-12-31 0000200406 us-gaap:SaleOfSubsidiaryGainLossMember 2017-01-02 2017-12-31 0000200406 us-gaap:SaleOfSubsidiaryGainLossMember 2018-01-01 2018-12-30 0000200406 jnj:OtherIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember 2017-01-02 2017-12-31 0000200406 jnj:OtherIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember jnj:InterestIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember jnj:InterestIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:SalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jnj:OtherIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:SalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember jnj:InterestIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember jnj:InterestIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember jnj:InterestIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember jnj:OtherIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember jnj:InterestIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember jnj:OtherIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember jnj:OtherIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember jnj:OtherIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:SalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember jnj:OtherIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember jnj:OtherIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember jnj:OtherIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember jnj:InterestIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember jnj:OtherIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember jnj:InterestIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jnj:OtherIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jnj:InterestIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2017-01-02 2017-12-31 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember jnj:InterestIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-30 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember jnj:OtherIncomeExpenseNetMember 2017-01-02 2017-12-31 0000200406 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember jnj:OtherIncomeExpenseNetMember 2018-01-01 2018-12-30 0000200406 jnj:A3.500Notesdue2048Member 2017-12-31 0000200406 jnj:A2.05Notesdue2023Member 2018-12-30 0000200406 jnj:A3ZeroCouponConvertibleSubordinatedDebenturesduein2020Member 2018-12-30 0000200406 jnj:A1.65Notesdue2018Member 2017-12-31 0000200406 jnj:A4.50Debenturesdue2040Member 2018-12-30 0000200406 jnj:A4.375Notesdue2033Member 2018-12-30 0000200406 jnj:A5.95Notesdue2037Member 2017-12-31 0000200406 jnj:A1.150Notesdue2028Member 2017-12-31 0000200406 jnj:A1.650Notesdue2035Member 2018-12-30 0000200406 jnj:A2.45Notesdue2026Member 2018-12-30 0000200406 jnj:A1.950Notesdue2020Member 2017-12-31 0000200406 jnj:A4.50Debenturesdue2040Member 2017-12-31 0000200406 jnj:A3.70Notesdue2046Member 2018-12-30 0000200406 jnj:A0.650Notesdue2024Member 2018-12-30 0000200406 jnj:A2.625Notesdue2025Member 2017-12-31 0000200406 jnj:A2.95Notesdue2027Member 2018-12-30 0000200406 jnj:A1.650Notesdue2035Member 2017-12-31 0000200406 jnj:A0.89Notesdue2019Member 2017-12-31 0000200406 jnj:A1.950Notesdue2020Member 2018-12-30 0000200406 jnj:A5.85Debenturesdue2038Member 2017-12-31 0000200406 jnj:A6.73Debenturesdue2023Member 2017-12-31 0000200406 jnj:A3.55Notesdue2021Member 2017-12-31 0000200406 jnj:A2.95Debenturesdue2020Member 2018-12-30 0000200406 jnj:A3.70Notesdue2046Member 2017-12-31 0000200406 jnj:A0.250Notesdue2022Member 2018-12-30 0000200406 jnj:A1.65Notesdue2021Member 2018-12-30 0000200406 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-30 0000200406 jnj:A4.95Debenturesdue2033Member 2018-12-30 0000200406 jnj:A0.89Notesdue2019Member 2018-12-30 0000200406 jnj:A4.50Notesdue2043Member 2018-12-30 0000200406 jnj:A4.95Debenturesdue2033Member 2017-12-31 0000200406 jnj:A3.625Notesdue2037Member 2018-12-30 0000200406 jnj:A0.250Notesdue2022Member 2017-12-31 0000200406 jnj:A1.125Notesdue2019Member 2017-12-31 0000200406 jnj:A3.75Notesdue2047Member 2017-12-31 0000200406 jnj:A5.85Debenturesdue2038Member 2018-12-30 0000200406 jnj:A1.875Notesdue2019Member 2017-12-31 0000200406 jnj:A2.900Notesdue2028Member 2017-12-31 0000200406 jnj:A4.75Notesdue2019Member 2017-12-31 0000200406 jnj:A3.55Notesdue2036Member 2017-12-31 0000200406 jnj:A4.75Notesdue2019Member 2018-12-30 0000200406 jnj:A6.73Debenturesdue2023Member 2018-12-30 0000200406 jnj:A2.45Notesdue2026Member 2017-12-31 0000200406 jnj:A3.500Notesdue2048Member 2018-12-30 0000200406 jnj:A2.95Debenturesdue2020Member 2017-12-31 0000200406 jnj:A3.375Notesdue2023Member 2017-12-31 0000200406 jnj:A2.900Notesdue2028Member 2018-12-30 0000200406 jnj:A6.95Notesdue2029Member 2018-12-30 0000200406 jnj:A2.95Notesdue2027Member 2017-12-31 0000200406 jnj:A2.45Notesdue2021Member 2017-12-31 0000200406 jnj:A1.125Notesdue2019Member 2018-12-30 0000200406 jnj:A5.95Notesdue2037Member 2018-12-30 0000200406 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-12-31 0000200406 us-gaap:OtherDebtSecuritiesMember 2017-12-31 0000200406 jnj:A5.15Debenturesdue2018Member 2017-12-31 0000200406 jnj:A3.375Notesdue2023Member 2018-12-30 0000200406 jnj:A2.25Notesdue2022Member 2017-12-31 0000200406 jnj:A4.50Notesdue2043Member 2017-12-31 0000200406 jnj:A1.150Notesdue2028Member 2018-12-30 0000200406 jnj:A2.05Notesdue2023Member 2017-12-31 0000200406 jnj:A2.45Notesdue2021Member 2018-12-30 0000200406 jnj:A4.85Notesdue2041Member 2017-12-31 0000200406 us-gaap:OtherDebtSecuritiesMember 2018-12-30 0000200406 jnj:A2.625Notesdue2025Member 2018-12-30 0000200406 jnj:A2.25Notesdue2022Member 2018-12-30 0000200406 jnj:A5.50Notesdue2024Member 2018-12-30 0000200406 jnj:A6.95Notesdue2029Member 2017-12-31 0000200406 jnj:A4.85Notesdue2041Member 2018-12-30 0000200406 jnj:A4.375Notesdue2033Member 2017-12-31 0000200406 jnj:A3.55Notesdue2021Member 2018-12-30 0000200406 jnj:A3ZeroCouponConvertibleSubordinatedDebenturesduein2020Member 2017-12-31 0000200406 jnj:A3.400Notesdue2038Member 2017-12-31 0000200406 jnj:A3.55Notesdue2036Member 2018-12-30 0000200406 jnj:A1.65Notesdue2021Member 2017-12-31 0000200406 jnj:A1.875Notesdue2019Member 2018-12-30 0000200406 jnj:A3.625Notesdue2037Member 2017-12-31 0000200406 jnj:A5.50Notesdue2024Member 2017-12-31 0000200406 jnj:A3.400Notesdue2038Member 2018-12-30 0000200406 jnj:A3.75Notesdue2047Member 2018-12-30 0000200406 jnj:A0.650Notesdue2024Member 2017-12-31 0000200406 us-gaap:StateAndLocalJurisdictionMember 2017-12-31 0000200406 us-gaap:AdministrationOfTheTreasuryBelgiumMember 2018-01-01 2018-12-30 0000200406 us-gaap:StateAndLocalJurisdictionMember 2018-01-01 2018-12-30 0000200406 2018-10-01 2018-12-30 0000200406 2017-10-02 2017-12-31 0000200406 us-gaap:ForeignCountryMember 2018-01-01 2018-12-30 0000200406 us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:PensionPlansDefinedBenefitMember 2017-01-02 2017-12-31 0000200406 us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-30 0000200406 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-01-02 2017-12-31 0000200406 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-12-30 0000200406 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-01-01 0000200406 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:ShortTermInvestmentFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:DebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember 2018-12-30 0000200406 us-gaap:DebtSecuritiesMember 2018-12-30 0000200406 us-gaap:EquitySecuritiesMember 2017-12-31 0000200406 us-gaap:DebtSecuritiesMember 2017-12-31 0000200406 us-gaap:MaximumMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-30 0000200406 us-gaap:ForeignPlanMember 2018-01-01 2018-12-30 0000200406 us-gaap:DomesticPlanMember 2018-01-01 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:MinimumMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-30 0000200406 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-12-31 0000200406 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:CommingledFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-30 0000200406 jnj:UnfundedPlansMember us-gaap:ForeignPlanMember 2017-12-31 0000200406 jnj:FundedPlansMember us-gaap:ForeignPlanMember 2017-12-31 0000200406 jnj:NonQualifiedPlansMember us-gaap:DomesticPlanMember 2018-12-30 0000200406 jnj:QualifiedPlansMember us-gaap:DomesticPlanMember 2017-12-31 0000200406 jnj:FundedPlansMember us-gaap:ForeignPlanMember 2018-12-30 0000200406 jnj:UnfundedPlansMember us-gaap:ForeignPlanMember 2018-12-30 0000200406 jnj:QualifiedPlansMember us-gaap:DomesticPlanMember 2018-12-30 0000200406 jnj:NonQualifiedPlansMember us-gaap:DomesticPlanMember 2017-12-31 0000200406 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-01-04 2017-01-01 0000200406 us-gaap:PensionPlansDefinedBenefitMember 2016-01-04 2017-01-01 0000200406 jnj:October132015ShareRepurchaseProgramMember 2015-10-13 0000200406 jnj:December172018ShareRepurchaseProgramMember 2018-01-01 2018-12-30 0000200406 jnj:December172018ShareRepurchaseProgramMember 2018-12-17 0000200406 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0000200406 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-03 0000200406 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-01-04 2017-01-01 0000200406 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-30 0000200406 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-01-03 0000200406 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-30 0000200406 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 0000200406 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0000200406 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-01-01 0000200406 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-03 0000200406 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-04 2017-01-01 0000200406 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 0000200406 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-02 2017-12-31 0000200406 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-01-02 2017-12-31 0000200406 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0000200406 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-03 0000200406 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-02 2017-12-31 0000200406 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-30 0000200406 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-01-02 2017-12-31 0000200406 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-04 2017-01-01 0000200406 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-04 2017-01-01 0000200406 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-12-30 0000200406 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-01-01 0000200406 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-12-30 0000200406 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-30 0000200406 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-30 0000200406 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0000200406 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-30 0000200406 jnj:ExercisePriceRangeOneMember 2018-12-30 0000200406 jnj:ExercisePriceRangeFourMember 2018-01-01 2018-12-30 0000200406 jnj:ExercisePriceRangeThreeMember 2018-12-30 0000200406 jnj:ExercisePriceRangeFiveMember 2018-12-30 0000200406 jnj:ExercisePriceRangeFourMember 2018-12-30 0000200406 jnj:ExercisePriceRangeThreeMember 2018-01-01 2018-12-30 0000200406 jnj:ExercisePriceRangeFiveMember 2018-01-01 2018-12-30 0000200406 jnj:ExercisePriceRangeOneMember 2018-01-01 2018-12-30 0000200406 jnj:ExercisePriceRangeTwoMember 2018-12-30 0000200406 jnj:ExercisePriceRangeTwoMember 2018-01-01 2018-12-30 0000200406 jnj:A2012LongTermIncentivePlanMember 2018-12-30 0000200406 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2018-01-01 2018-12-30 0000200406 us-gaap:RestrictedStockUnitsRSUMember 2016-01-04 2017-01-01 0000200406 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-30 0000200406 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2018-01-01 2018-12-30 0000200406 us-gaap:RestrictedStockUnitsRSUMember 2017-01-02 2017-12-31 0000200406 us-gaap:PerformanceSharesMember 2017-01-02 2017-12-31 0000200406 us-gaap:RestrictedStockUnitsRSUMember us-gaap:MaximumMember 2018-01-01 2018-12-30 0000200406 us-gaap:PerformanceSharesMember us-gaap:MinimumMember 2018-01-01 2018-12-30 0000200406 us-gaap:RestrictedStockUnitsRSUMember us-gaap:MinimumMember 2018-01-01 2018-12-30 0000200406 us-gaap:PerformanceSharesMember us-gaap:MaximumMember 2018-01-01 2018-12-30 0000200406 us-gaap:PerformanceSharesMember 2016-01-04 2017-01-01 0000200406 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-30 0000200406 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-30 0000200406 us-gaap:PerformanceSharesMember 2017-12-31 0000200406 us-gaap:PerformanceSharesMember 2018-12-30 0000200406 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0000200406 us-gaap:RestrictedStockUnitsRSUMember 2018-12-30 0000200406 us-gaap:CorporateNonSegmentMember jnj:GeneralCorporateMember 2016-01-04 2017-01-01 0000200406 us-gaap:CorporateNonSegmentMember jnj:GeneralCorporateMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 us-gaap:CorporateNonSegmentMember jnj:GeneralCorporateMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:MedicalDevicesMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:PharmaceuticalMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:MedicalDevicesMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember jnj:PharmaceuticalMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember jnj:PharmaceuticalMember 2016-01-04 2017-01-01 0000200406 us-gaap:CorporateNonSegmentMember jnj:GeneralCorporateMember 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:MedicalDevicesMember 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember 2018-12-30 0000200406 us-gaap:CorporateNonSegmentMember jnj:GeneralCorporateMember 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:PharmaceuticalMember 2018-12-30 0000200406 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:PharmaceuticalMember 2017-12-31 0000200406 us-gaap:CorporateNonSegmentMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember jnj:ConsumerMember 2018-12-30 0000200406 us-gaap:CorporateNonSegmentMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:MedicalDevicesMember 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:ConsumerMember 2017-12-31 0000200406 jnj:AMOMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:SalesRevenueNetMember jnj:Wholesaler2Member 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:LifeScanMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 jnj:AMOMember jnj:MedicalDevicesMember 2017-01-02 2017-12-31 0000200406 us-gaap:SalesRevenueNetMember jnj:Wholesaler2Member 2016-01-04 2017-01-01 0000200406 us-gaap:PropertyPlantAndEquipmentMember 2018-12-30 0000200406 jnj:MedicalDevicesMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember jnj:NIZORALMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 us-gaap:SalesRevenueNetMember jnj:Wholesaler1Member 2017-01-02 2017-12-31 0000200406 us-gaap:SalesRevenueNetMember jnj:Wholesaler1Member 2018-01-01 2018-12-30 0000200406 jnj:ActelionMember jnj:PharmaceuticalMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember 2016-01-04 2017-01-01 0000200406 jnj:XO1Member 2018-01-01 2018-12-30 0000200406 jnj:ActelionMember jnj:PharmaceuticalMember 2017-01-02 2017-12-31 0000200406 us-gaap:SalesRevenueNetMember jnj:Wholesaler2Member 2018-01-01 2018-12-30 0000200406 us-gaap:OtherIntangibleAssetsMember 2017-12-31 0000200406 us-gaap:SalesRevenueNetMember 2016-01-04 2017-01-01 0000200406 us-gaap:SalesRevenueNetMember jnj:Wholesaler3Member 2018-01-01 2018-12-30 0000200406 us-gaap:PropertyPlantAndEquipmentMember 2017-12-31 0000200406 us-gaap:OtherIntangibleAssetsMember 2018-12-30 0000200406 jnj:AliosBiopharmaIncandXO1LimitedMember jnj:PharmaceuticalMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:PANCREASEMember jnj:PharmaceuticalMember 2018-01-01 2018-12-30 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember country:US jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:OralCareMember jnj:ConsumerMember country:US 2018-01-01 2018-12-30 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:ConsumerMember country:US 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember jnj:UNITEDSTATESExportsMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:BabyCareMember jnj:ConsumerMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:OTCMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember country:US jnj:DiabetesCareMember 2018-01-01 2018-12-30 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember country:US jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:BabyCareMember jnj:ConsumerMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:BeautyMember jnj:ConsumerMember country:US 2017-01-02 2017-12-31 0000200406 jnj:WomensHealthMember jnj:ConsumerMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:DiagnosticsMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:BeautyMember jnj:ConsumerMember country:US 2018-01-01 2018-12-30 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:OtherMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember country:US jnj:InterventionalSolutionsMember 2018-01-01 2018-12-30 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 country:US 2018-01-01 2018-12-30 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:OTCMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 jnj:OtherMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:OralCareMember jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:WomensHealthMember jnj:ConsumerMember country:US 2018-01-01 2018-12-30 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember jnj:UNITEDSTATESExportsMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:OtherMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US jnj:InterventionalSolutionsMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US 2017-01-02 2017-12-31 0000200406 jnj:WomensHealthMember jnj:ConsumerMember country:US 2017-01-02 2017-12-31 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:DiabetesCareMember 2016-01-04 2017-01-01 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember jnj:DiabetesCareMember 2016-01-04 2017-01-01 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:BeautyMember jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:ConsumerMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:OtherMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:BabyCareMember jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:OtherMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:BeautyMember jnj:ConsumerMember country:US 2016-01-04 2017-01-01 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:BabyCareMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:OtherMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember country:US jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember jnj:DiabetesCareMember 2018-01-01 2018-12-30 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:BabyCareMember jnj:ConsumerMember country:US 2018-01-01 2018-12-30 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember country:US jnj:VisionMember 2018-01-01 2018-12-30 0000200406 country:US 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:DiagnosticsMember 2018-01-01 2018-12-30 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:OtherMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember country:US 2018-01-01 2018-12-30 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:OralCareMember jnj:ConsumerMember country:US 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:DiabetesCareMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember country:US 2018-01-01 2018-12-30 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:BabyCareMember jnj:ConsumerMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember jnj:InterventionalSolutionsMember 2018-01-01 2018-12-30 0000200406 jnj:BeautyMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:BeautyMember jnj:ConsumerMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:DiagnosticsMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:DiagnosticsMember 2016-01-04 2017-01-01 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:OtherMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:OTCMember jnj:ConsumerMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:ConsumerMember country:US 2017-01-02 2017-12-31 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:OralCareMember jnj:ConsumerMember country:US 2017-01-02 2017-12-31 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember country:US jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:InterventionalSolutionsMember 2017-01-02 2017-12-31 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember country:US 2017-01-02 2017-12-31 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:ConsumerMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember country:US jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:OTCMember jnj:ConsumerMember country:US 2017-01-02 2017-12-31 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:DiabetesCareMember 2017-01-02 2017-12-31 0000200406 jnj:WomensHealthMember jnj:ConsumerMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:WomensHealthMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:OTCMember jnj:ConsumerMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:ConsumerMember country:US 2016-01-04 2017-01-01 0000200406 jnj:BeautyMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:BabyCareMember jnj:ConsumerMember country:US 2017-01-02 2017-12-31 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US 2016-01-04 2017-01-01 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:OralCareMember jnj:ConsumerMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:OTCMember jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:WomensHealthMember jnj:ConsumerMember country:US 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US 2018-01-01 2018-12-30 0000200406 jnj:OtherOncologyMember jnj:PharmaceuticalMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 country:US 2017-01-02 2017-12-31 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember jnj:DiabetesCareMember 2017-01-02 2017-12-31 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:OTCMember jnj:ConsumerMember country:US 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember jnj:DiagnosticsMember 2017-01-02 2017-12-31 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:BeautyMember jnj:ConsumerMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:OTCMember jnj:ConsumerMember country:US 2018-01-01 2018-12-30 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:InterventionalSolutionsMember 2018-01-01 2018-12-30 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember jnj:UNITEDSTATESExportsMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:OralCareMember jnj:ConsumerMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:BabyCareMember jnj:ConsumerMember country:US 2016-01-04 2017-01-01 0000200406 jnj:OtherMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:WomensHealthMember jnj:ConsumerMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:DiabetesCareMember 2016-01-04 2017-01-01 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember country:US jnj:InterventionalSolutionsMember 2017-01-02 2017-12-31 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:OtherMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:OtherMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US 2017-01-02 2017-12-31 0000200406 jnj:OtherInfectiousDiseasesMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember jnj:SurgeryMember 2017-01-02 2017-12-31 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:OtherMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:OtherMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:ConsumerMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:HIPSMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:OTHERNEUROSCIENCEMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember jnj:OncologyMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:OtherMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:SPINEOTHERMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:KNEESMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2017-01-02 2017-12-31 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember jnj:DiagnosticsMember 2016-01-04 2017-01-01 0000200406 jnj:TRAUMAMember jnj:MedicalDevicesMember country:US jnj:OrthopaedicsMember 2018-01-01 2018-12-30 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:OralCareMember jnj:ConsumerMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:MedicalDevicesMember country:US jnj:DiagnosticsMember 2018-01-01 2018-12-30 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember country:US jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:StelaraMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember jnj:InfectiousDiseasesMember 2018-01-01 2018-12-30 0000200406 jnj:BeautyMember jnj:ConsumerMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:CONTACTLENSESOTHERMember jnj:MedicalDevicesMember jnj:VisionMember 2018-01-01 2018-12-30 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember country:US 2016-01-04 2017-01-01 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:RISPERDALCONSTAMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2018-01-01 2018-12-30 0000200406 jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember jnj:PharmaceuticalMember country:US jnj:InfectiousDiseasesMember 2017-01-02 2017-12-31 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:CONCERTAMethylphenidateMember jnj:PharmaceuticalMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:IMBRUVICAMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember jnj:PharmaceuticalMember country:US jnj:NeuroscienceMember 2017-01-02 2017-12-31 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember jnj:InterventionalSolutionsMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:EDURANTrilpivirineMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:InfectiousDiseasesMember 2016-01-04 2017-01-01 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember country:US jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:ZYTIGAMember jnj:PharmaceuticalMember country:US jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember jnj:InterventionalSolutionsMember 2017-01-02 2017-12-31 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember country:US jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:OTCMember jnj:ConsumerMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2017-01-02 2017-12-31 0000200406 jnj:OtherMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:WomensHealthMember jnj:ConsumerMember 2017-01-02 2017-12-31 0000200406 jnj:OtherMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:OtherMember jnj:PharmaceuticalMember jnj:CardiovascularMetabolismOtherMember 2018-01-01 2018-12-30 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember us-gaap:NonUsMember 2018-01-01 2018-12-30 0000200406 jnj:XareltoMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember country:US 2016-01-04 2017-01-01 0000200406 jnj:OralCareMember jnj:ConsumerMember us-gaap:NonUsMember 2017-01-02 2017-12-31 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember us-gaap:NonUsMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember jnj:SurgeryMember 2018-01-01 2018-12-30 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:VELCADEMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2016-01-04 2017-01-01 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:UPTRAVIMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:WoundCareandOtherMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember jnj:DiagnosticsMember 2018-01-01 2018-12-30 0000200406 jnj:OtherMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:SPECIALTYMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:NeuroscienceMember 2016-01-04 2017-01-01 0000200406 jnj:ADVANCEDMember jnj:MedicalDevicesMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US jnj:DiabetesCareMember 2017-01-02 2017-12-31 0000200406 jnj:OralCareMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:BabyCareMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:OPSUMITMember jnj:PharmaceuticalMember country:US jnj:PulmonaryHypertensionMember 2018-01-01 2018-12-30 0000200406 jnj:INVOKANAINVOKAMETMember jnj:PharmaceuticalMember country:US jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember country:US jnj:DiagnosticsMember 2017-01-02 2017-12-31 0000200406 jnj:SimponiSimponiAriaMember jnj:PharmaceuticalMember country:US jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2018-01-01 2018-12-30 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2016-01-04 2017-01-01 0000200406 jnj:TRACLEERMember jnj:PharmaceuticalMember jnj:PulmonaryHypertensionMember 2017-01-02 2017-12-31 0000200406 jnj:OtherImmunologyMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:DARZALEXMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:OncologyMember 2017-01-02 2017-12-31 0000200406 jnj:PharmaceuticalMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:RemicadeMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2016-01-04 2017-01-01 0000200406 jnj:SURGICALMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:VisionMember 2016-01-04 2017-01-01 0000200406 jnj:PROCRITEPREXMember jnj:PharmaceuticalMember us-gaap:NonUsMember jnj:CardiovascularMetabolismOtherMember 2016-01-04 2017-01-01 0000200406 jnj:TremfayaMember jnj:PharmaceuticalMember jnj:ImmunologyMember 2017-01-02 2017-12-31 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 jnj:WomensHealthMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:InterventionalSolutionsMember 2016-01-04 2017-01-01 0000200406 jnj:GENERALMember jnj:MedicalDevicesMember us-gaap:NonUsMember jnj:SurgeryMember 2016-01-04 2017-01-01 0000200406 us-gaap:CorporateNonSegmentMember 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:WesternHemisphereExcludingUSMember 2017-12-31 0000200406 us-gaap:CorporateNonSegmentMember 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember us-gaap:EuropeMember 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember us-gaap:EuropeMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember jnj:AsiaPacificAfricaMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember us-gaap:EuropeMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:AsiaPacificAfricaMember 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember country:US 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:AsiaPacificAfricaMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember country:US 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember country:US 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:WesternHemisphereExcludingUSMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:WesternHemisphereExcludingUSMember 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:WesternHemisphereExcludingUSMember 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember jnj:AsiaPacificAfricaMember 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember jnj:WesternHemisphereExcludingUSMember 2018-01-01 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember country:US 2018-12-30 0000200406 us-gaap:OperatingSegmentsMember country:US 2016-01-04 2017-01-01 0000200406 us-gaap:OperatingSegmentsMember us-gaap:EuropeMember 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember us-gaap:EuropeMember 2017-01-02 2017-12-31 0000200406 us-gaap:OperatingSegmentsMember jnj:AsiaPacificAfricaMember 2016-01-04 2017-01-01 0000200406 jnj:MedicalDevicesMember 2017-01-02 2017-04-02 0000200406 2018-04-02 2018-07-01 0000200406 2018-01-01 2018-04-01 0000200406 jnj:MedicalDevicesMember 2017-07-03 2017-10-01 0000200406 2017-07-03 2017-10-01 0000200406 2017-01-02 2017-04-02 0000200406 jnj:ActelionMember 2017-07-03 2017-10-01 0000200406 2018-07-02 2018-09-30 0000200406 jnj:AMOMember 2017-01-02 2017-04-02 0000200406 2017-04-03 2017-07-02 0000200406 jnj:ActelionMember 2018-01-01 2018-04-01 0000200406 jnj:ActelionMember 2017-04-03 2017-07-02 0000200406 jnj:XO1Member 2018-07-02 2018-09-30 0000200406 jnj:MedicalDevicesMember 2017-04-03 2017-07-02 0000200406 jnj:MedicalDevicesMember 2018-01-01 2018-04-01 0000200406 jnj:MedicalDevicesMember 2018-07-02 2018-09-30 0000200406 jnj:MedicalDevicesMember 2017-10-02 2017-12-31 0000200406 jnj:ConsumerMember 2018-10-01 2018-12-30 0000200406 jnj:ConsumerMember 2017-10-02 2017-12-31 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2018-04-02 2018-07-01 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2017-10-02 2017-12-31 0000200406 jnj:PharmaceuticalMember 2017-10-02 2017-12-31 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2017-07-03 2017-10-01 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2018-01-01 2018-04-01 0000200406 jnj:PharmaceuticalMember 2018-01-01 2018-04-01 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2018-10-01 2018-12-30 0000200406 jnj:ConsumerMember 2017-07-03 2017-10-01 0000200406 jnj:ConsumerMember 2017-04-03 2017-07-02 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2018-07-02 2018-09-30 0000200406 jnj:ConsumerMember 2018-01-01 2018-04-01 0000200406 jnj:PharmaceuticalMember 2017-01-02 2017-04-02 0000200406 jnj:PharmaceuticalMember 2017-04-03 2017-07-02 0000200406 jnj:ConsumerMember 2018-07-02 2018-09-30 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2017-04-03 2017-07-02 0000200406 jnj:PharmaceuticalMember 2018-07-02 2018-09-30 0000200406 jnj:MedicalDevicesAndDiagnosticsMember 2017-01-02 2017-04-02 0000200406 jnj:ConsumerMember 2018-04-02 2018-07-01 0000200406 jnj:PharmaceuticalMember 2017-07-03 2017-10-01 0000200406 jnj:ConsumerMember 2017-01-02 2017-04-02 0000200406 jnj:PharmaceuticalMember 2018-04-02 2018-07-01 0000200406 jnj:PharmaceuticalMember 2018-10-01 2018-12-30 0000200406 jnj:ActelionMember 2017-01-02 2017-12-31 0000200406 jnj:ActelionMember 2016-01-04 2017-01-01 0000200406 jnj:ActelionMember us-gaap:IntellectualPropertyMember 2017-06-16 2017-06-16 0000200406 jnj:ActelionMember us-gaap:InProcessResearchAndDevelopmentMember 2017-06-16 2017-06-16 0000200406 jnj:ActelionMember 2017-06-16 2017-06-16 0000200406 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember jnj:LifeScanMember 2018-12-30 0000200406 jnj:ActelionMember us-gaap:MaximumMember 2017-06-16 2017-06-16 0000200406 jnj:IdorsiaMember 2017-06-16 2017-06-16 0000200406 jnj:ActelionMember 2018-01-01 2018-12-30 0000200406 jnj:ActelionMember 2018-12-30 0000200406 jnj:IdorsiaMember us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2017-06-16 2017-06-16 0000200406 jnj:ActelionMember us-gaap:MinimumMember 2017-06-16 2017-06-16 0000200406 jnj:A2016AcquisitionsMember 2017-01-01 0000200406 jnj:VogueInternationalLLCMember jnj:ConsumerMember 2016-01-04 2017-01-01 0000200406 jnj:A2017AcquisitionsMember 2017-12-31 0000200406 jnj:A2017AcquisitionsMember us-gaap:InProcessResearchAndDevelopmentMember 2017-12-31 0000200406 jnj:IdorsiaMember us-gaap:ConvertibleDebtMember 2018-12-30 0000200406 jnj:ActelionMember 2017-06-16 2017-10-01 0000200406 jnj:IdorsiaMember 2017-06-16 0000200406 jnj:VogueInternationalLLCMember us-gaap:TrademarksMember us-gaap:MinimumMember 2016-01-04 2017-01-01 0000200406 jnj:AMOMember jnj:MedicalDevicesMember 2017-01-02 2017-04-02 0000200406 jnj:ActelionMember us-gaap:SubsequentEventMember 2019-02-13 2019-02-13 0000200406 jnj:IdorsiaMember 2018-12-30 0000200406 jnj:VogueInternationalLLCMember us-gaap:TrademarksMember us-gaap:MaximumMember 2016-01-04 2017-01-01 0000200406 jnj:CizHoldingsCo.Ltd.Member 2018-10-23 0000200406 jnj:VogueInternationalLLCMember 2016-01-04 2017-01-01 0000200406 jnj:IdorsiaMember us-gaap:ConvertibleDebtMember 2017-06-16 0000200406 jnj:SynthesIncMember 2012-01-02 2012-12-30 0000200406 jnj:ActelionMember 2017-06-16 0000200406 jnj:IdorsiaMember 2018-01-01 2018-12-30 0000200406 jnj:CizHoldingsCo.Ltd.Member us-gaap:SubsequentEventMember 2019-01-17 0000200406 jnj:IdorsiaMember us-gaap:ConvertibleDebtMember 2017-06-16 2017-06-16 0000200406 jnj:AMOMember jnj:MedicalDevicesMember 2017-12-31 0000200406 jnj:ActelionMember us-gaap:SubsequentEventMember 2019-02-13 0000200406 jnj:IdorsiaMember us-gaap:LineOfCreditMember 2017-06-16 0000200406 jnj:VogueInternationalLLCMember jnj:ConsumerMember 2017-01-01 0000200406 jnj:ValchlorMember us-gaap:IntellectualPropertyMember 2018-04-02 2018-07-01 0000200406 jnj:VogueInternationalLLCMember us-gaap:TrademarksMember 2016-01-04 2017-01-01 0000200406 jnj:CizHoldingsCo.Ltd.Member 2018-10-23 2018-10-23 0000200406 jnj:A2018AcquisitionsMember us-gaap:InProcessResearchAndDevelopmentMember 2018-12-30 0000200406 jnj:TalcMember 2018-12-30 0000200406 jnj:XareltoMember 2018-12-30 0000200406 us-gaap:PendingLitigationMember 2017-12-31 0000200406 jnj:PinnacleAcetabularCupSystemMember 2018-12-30 0000200406 jnj:RisperdalMember 2018-12-30 0000200406 jnj:PhysiomeshMember 2018-12-30 0000200406 jnj:AsrMember 2018-12-30 0000200406 jnj:BabyPowderMember us-gaap:JudicialRulingMember us-gaap:DamagesFromProductDefectsMember 2018-01-01 2018-12-30 0000200406 jnj:InvokanaMember 2018-12-30 0000200406 jnj:PelvicMeshesMember 2018-12-30 0000200406 us-gaap:PendingLitigationMember 2014-12-28 0000200406 us-gaap:PendingLitigationMember 2017-10-31 0000200406 jnj:DePuyASRU.S.Member us-gaap:SettledLitigationMember 2018-12-30 0000200406 us-gaap:MaximumMember jnj:SupplyChainMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 jnj:SupplyChainMember 2018-01-01 2018-12-30 0000200406 us-gaap:CostOfSalesMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:CostOfSalesMember jnj:SupplyChainMember 2018-01-01 2018-12-30 0000200406 us-gaap:MaximumMember jnj:SupplyChainMember 2018-12-30 0000200406 jnj:OtherIncomeExpenseNetMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:MinimumMember jnj:SupplyChainMember 2018-12-30 0000200406 jnj:OtherIncomeExpenseNetMember jnj:SupplyChainMember 2018-01-01 2018-12-30 0000200406 us-gaap:MinimumMember jnj:SupplyChainMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:OtherRestructuringMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:EmployeeSeveranceMember jnj:MedicalDevicesMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:EmployeeSeveranceMember jnj:MedicalDevicesMember 2017-01-01 0000200406 us-gaap:OtherRestructuringMember jnj:MedicalDevicesMember 2016-01-03 0000200406 jnj:AssetWriteoffMember jnj:MedicalDevicesMember 2017-12-31 0000200406 us-gaap:OtherRestructuringMember jnj:MedicalDevicesMember 2017-01-02 2017-12-31 0000200406 us-gaap:OtherRestructuringMember jnj:MedicalDevicesMember 2017-12-31 0000200406 jnj:AssetWriteoffMember jnj:MedicalDevicesMember 2018-12-30 0000200406 us-gaap:OtherRestructuringMember jnj:MedicalDevicesMember 2016-01-04 2017-01-01 0000200406 us-gaap:OtherRestructuringMember jnj:MedicalDevicesMember 2017-01-01 0000200406 jnj:AssetWriteoffMember jnj:MedicalDevicesMember 2017-01-01 0000200406 us-gaap:EmployeeSeveranceMember jnj:MedicalDevicesMember 2016-01-03 0000200406 us-gaap:EmployeeSeveranceMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 jnj:AssetWriteoffMember jnj:MedicalDevicesMember 2018-01-01 2018-12-30 0000200406 us-gaap:OtherRestructuringMember jnj:MedicalDevicesMember 2018-12-30 0000200406 us-gaap:EmployeeSeveranceMember jnj:MedicalDevicesMember 2016-01-04 2017-01-01 0000200406 us-gaap:EmployeeSeveranceMember jnj:MedicalDevicesMember 2017-12-31 0000200406 jnj:AssetWriteoffMember jnj:MedicalDevicesMember 2017-01-02 2017-12-31 0000200406 jnj:MedicalDevicesMember 2016-01-03 0000200406 us-gaap:EmployeeSeveranceMember jnj:MedicalDevicesMember 2018-12-30 0000200406 jnj:AssetWriteoffMember jnj:MedicalDevicesMember 2016-01-04 2017-01-01 0000200406 jnj:AssetWriteoffMember jnj:MedicalDevicesMember 2016-01-03 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares jnj:Employee jnj:Segment iso4217:GBP iso4217:EUR jnj:StockBasedCompensationPlans iso4217:JPY xbrli:shares iso4217:JPY jnj:claim jnj:claimant jnj:patient false --12-30 FY 2018 2018-12-30 10-K 0000200406 2663138579 Yes Large Accelerated Filer 325000000000 JOHNSON & JOHNSON No Yes 2300000000 34500000000 1100000000 7300000000 41100000000 500000000 7210000000 9380000000 121000000 101000000 136000000 237000000 81000000 152000000 162000000 190000000 -116000000 125000000 251000000 199000000 255000000 313000000 92000000 400000000 0.221 0.16 0.208 49000000 126000000 203000000 -2000000 35000000 0 21000000 0.2 1358000000 1307000000 1282000000 177000000 469000000 1101000000 693000000 2800000000 2971000000 6158000000 0 278000000 6436000000 5201000000 0 301000000 5502000000 0.0410 0.0424 0.0394 0.0398 0.0362 0.0360 88000000 201000000 0 -29000000 697000000 115000000 108000000 92000000 101000000 95000000 -170000000 -1849000000 1027000000 -397000000 -417000000 -1793000000 874000000 -379000000 0 173000000 0 -17000000 2500000000 2600000000 2600000000 100000000 3000000 256000000 -3000000 -114000000 0.016 0.761 0.013 0.007 0.014 353000000 0.000 0.733 -0.019 P5Y P3Y 10399000000 10350000000 67000000 54000000 7000000 158000000 2000000000 300000000 1043000000 1326000000 1286000000 938000000 876000000 25010000000 -352000000 -97000000 -506000000 -609000000 -1113000000 1.02 135100 2 10000 -159000000 201000000 -92000000 -21000000 -2000000 44000000 862000000 -29000000 56000000 55164000000 57855000000 0.063 0.063 0.072 0.068 -0.042 -0.080 -0.030 0.078 0.094 0.058 -0.179 0.030 -0.083 0.087 0.092 0.090 0.877 0.115 0.259 0.246 0.035 0.016 0.023 0.036 0.007 0.024 0.372 0.649 0.513 0.184 0.124 0.160 -0.258 0.246 -0.210 0.005 -0.010 -0.001 0.037 0.024 0.047 -0.321 -0.092 -0.139 -0.024 -0.049 -0.005 0.000 -0.120 -0.120 -0.282 -0.174 -0.210 0.186 0.009 0.068 -0.105 0.062 0.008 -0.030 0.006 -0.016 -0.120 -0.121 -0.120 -0.055 -0.131 -0.099 -0.065 -0.280 -0.086 -0.093 -0.115 0.033 -0.054 -0.046 -0.033 -0.041 -0.005 0.118 0.050 0.223 0.284 0.241 0.020 0.016 0.018 0.000 -0.090 -0.090 -0.016 -0.368 -0.010 -0.023 -0.040 0.000 0.093 0.000 0.093 0.128 0.091 0.108 0.022 0.027 0.019 0.059 0.045 -0.172 0.113 -0.006 0.015 0.526 0.071 -0.045 0.121 -0.010 0.039 0.419 -0.097 0.117 -0.008 0.028 0.459 0.083 0.067 -0.023 0.003 -0.070 0.001 0.327 0.108 0.001 0.080 0.028 -0.029 0.198 -0.017 0.023 -0.017 -0.016 0.250 0.054 0.074 0.067 0.023 0.098 0.065 -0.030 -0.060 -0.021 0.043 0.029 0.061 -0.404 0.066 -0.162 0.102 0.079 0.088 0.361 0.630 0.000 0.155 0.143 0.013 0.026 0.021 0.017 0.018 0.017 0.342 0.413 0.381 0.126 0.161 0.140 -0.247 0.018 -0.207 -0.039 0.028 -0.014 0.050 0.078 0.031 -0.193 -0.010 -0.040 0.016 0.034 0.003 0.000 -0.545 -0.545 -0.209 -0.107 -0.139 -0.333 0.574 -0.024 0.882 -0.137 0.693 0.572 0.008 0.171 0.054 0.104 0.074 -0.001 0.057 0.016 -0.125 -0.052 -0.084 -0.190 -0.226 -0.001 -0.157 -0.027 0.036 0.001 -0.060 -0.092 -0.073 0.192 0.239 0.218 0.102 0.175 0.137 0.254 0.356 0.285 0.665 0.149 0.355 0.015 0.058 0.032 0.000 0.002 0.002 -0.001 0.083 -0.002 -0.134 -0.002 -0.301 -0.009 0.000 -0.009 0.442 0.352 0.396 0.018 0.035 0.007 0.015 0.001 -0.394 0.118 -0.023 0.010 0.128 0.028 -0.364 0.187 -0.014 0.055 0.116 -0.375 0.152 -0.019 0.036 0.121 0.124 0.084 -0.098 0.023 0.015 -0.021 0.398 0.180 -0.004 0.200 0.072 0.044 0.325 0.664 -0.075 0.072 0.048 0.015 0.356 0.939 0.051 0.085 0.033 0.033 0.10 142400000 139700000 139000000 1189000000 1062000000 949000000 1800 1050 34800 2100 10500 13400 13000 25600 0.020 0.020 0.020 13600000000 -265000000 -137000000 800000000 266000000 859000000 800000000 600000000 P5Y P4Y 800000000 600000000 2375 0.010 0.010 0.010 -122000 92100000 87300000 92500000 0.005 600000000 1400000000 1600000000 1700000000 1700000000 13000000000 200000000 8200000000 10100000000 2043000000 2062000000 2095000000 347000000 7310000000 7537000000 13490000000 14098000000 1854000000 818000000 8472000000 8242000000 7304000000 7601000000 24461000000 24816000000 195000000 -13199000000 -15222000000 P9Y P22Y P14Y4M24D 2400000000 2500000000 2600000000 878000000 962000000 978000000 291000000 248000000 1200000000 3000000000 4400000000 217000000 972000000 296000000 1133000000 283000000 182000000 795000000 200000000 1258000000 157303000000 27410000000 25030000000 45413000000 59450000000 129893000000 152954000000 23000000 24187000000 25877000000 46254000000 56636000000 152977000000 128767000000 43088000000 46033000000 0 950000000 5310000000 260000000 186000000 4864000000 9734000000 260000000 9474000000 5310000000 260000000 186000000 4864000000 9734000000 260000000 9474000000 472000000 1580000000 0 0 64000000 64000000 9734000000 9734000000 9670000000 9670000000 5310000000 0 9734000000 0 751000000 511000000 11240000000 11176000000 0.090 0.099 0.89 4.99 0.55 1100000000 280 5900 13916000000 1509000000 74339000000 77681000000 38000000 213000000 367000000 217000000 100000000 800000000 800000000 96000000 100000000 200000000 200000000 2100000000 230000000000 -184000000 -200000000 2350000000 -1400000000 1400000000 642000000 33199000000 469000000 93000000 485000000 956000000 99000000 1776000000 25010000000 759000000 3145000000 413000000 19000000 104000000 30054000000 13732000000 18972000000 17824000000 4944000000 31000000 80000000 4833000000 12880000000 1175000000 2929000000 244000000 4288000000 4025000000 219000000 18107000000 8154000000 10000000 8144000000 9953000000 443000000 485000000 2619000000 3397000000 3009000000 5240000000 -1148000000 283000000 -5000000 0 0 0 0 5000000 0 0 0 0 -5000000 0 0 0 0 5000000 0 0 0 182000000 3.15 3.15 3.32 3.32 3.54 3.54 1 1 4320000000 4320000000 3119843000 3119843000 3119843000 3120000000 3120000000 14804000000 3002000000 13506000000 0.135 0.107 0.140 0.100 0.05 0.140 0.110 0.110 3448000000 3876000000 510000000 681000000 104000000 85000000 51000000 21789000000 25439000000 27091000000 -47000000 232000000 -439000000 -254000000 -486000000 -232000000 -232000000 -254000000 1896000000 11969000000 1081000000 1659000000 1872000000 2434000000 3604000000 13967000000 3718000000 35000000 16000000 6000000 3900000000 2800000000 1000000000 750000000 750000000 1500000000 1000000000 500000000 1000000000 750000000 750000000 1500000000 1000000000 500000000 0.0319 0.0026 0.0068 0.0175 0.0113 0.0121 0.0168 0.0170 0.0165 0.0193 0.0199 0.0209 0.0231 0.0248 0.0247 0.0263 0.0291 0.0315 0.0296 0.0317 0.0342 0.0352 0.0367 0.0359 0.0364 0.0374 0.0376 0.0300 0.0424 0.0463 0.0452 0.0583 0.0489 0.0495 0.0518 0.0675 0.0585 0.0599 0.0673 0.0714 0.0000 0.0319 0.0026 0.0068 0.0132 0.0113 0.0121 0.0168 0.0165 0.0193 0.0199 0.0209 0.0231 0.0248 0.0247 0.0263 0.0291 0.0315 0.0296 0.0317 0.0342 0.0352 0.0367 0.0359 0.0364 0.0374 0.0376 0.0300 0.0424 0.0463 0.0452 0.0583 0.0489 0.0495 0.0675 0.0585 0.0599 0.0673 0.0714 0.0000 0.0025 0.00650 0.0089 0.01125 0.01150 0.0165 0.0165 0.0165 0.01875 0.0195 0.0205 0.0225 0.0245 0.0245 0.02625 0.029 0.0295 0.0295 0.03375 0.03400 0.03500 0.0355 0.0355 0.03625 0.037 0.0375 0.03 0.04375 0.045 0.045 0.0475 0.0485 0.0495 0.0515 0.055 0.0585 0.0595 0.0673 0.0695 0.00250 0.00650 0.0089 0.01125 0.01150 0.0165 0.0165 0.01875 0.0195 0.0205 0.0225 0.0245 0.0245 0.02625 0.029 0.0295 0.0295 0.03375 0.03400 0.03500 0.0355 0.0355 0.03625 0.037 0.0375 0.03 0.04375 0.045 0.045 0.0475 0.0485 0.0495 0.055 0.0585 0.0595 0.0673 0.0695 P10Y 475000000 410000000 294000000 -1956000000 -148000000 -635000000 4362000000 -2226000000 2000000 3000000 5000000 0 -341000000 2406000000 1900000000 -1016000000 1316000000 1104000000 1100000000 2000000000 2000000000 9902000000 11405000000 7105000000 7640000000 762000000 786000000 755000000 603000000 1784000000 900000000 2259000000 2398000000 507000000 639000000 1718000000 1647000000 11166000000 11271000000 6506000000 5967000000 8368000000 7506000000 194000000 93000000 9000000 4457000000 4500000000 100000000 2240000000 5343000000 5327000000 9893000000 1849000000 17654000000 397000000 29793000000 9510000000 1793000000 16851000000 379000000 28533000000 1363000000 8115000000 1157000000 8325000000 -1500000000 -8140000000 -1263000000 -8323000000 -137000000 -25000000 -106000000 2000000 0 0 0 0 12000000 4274000000 0 -1269000000 166000000 -2996000000 119000000 2326000000 -135000000 -496000000 -138000000 -609000000 -123000000 -852000000 -34000000 1000000 -30000000 2000000 -31000000 3000000 -4301000000 -4817000000 -4300000000 -4852000000 526000000 0 526000000 475000000 0 475000000 0.0442 0.0378 0.0378 0.0330 0.0440 0.0376 0.0429 0.0402 0.0430 0.0399 0.0429 0.0397 0.0477 0.0398 0.0463 0.0359 0.0385 0.0320 0.0855 0.0843 0.0846 0.0432 0.0402 0.0431 0.0401 0.0429 0.0398 4605000000 28116000000 10863000000 2257000000 19652000000 449000000 4582000000 33221000000 10467000000 2176000000 18609000000 418000000 4480000000 31670000000 351000000 1050000000 383000000 1018000000 0 60000000 0 66000000 545000000 664000000 282000000 1140000000 280000000 22000000 340000000 28000000 -656000000 -27000000 0 2273000000 7679000000 375000000 1062000000 413000000 1332000000 428000000 1257000000 411000000 1182000000 397000000 1104000000 6000000 1962000000 6000000 2041000000 7000000 2212000000 75000000 23633000000 0 1780000000 81000000 57000000 7995000000 0 0 199000000 199000000 429000000 427000000 0 856000000 0 2013000000 0 2013000000 13848000000 0 0 13848000000 0 121000000 0 399000000 200000000 0 3094000000 0 3094000000 14277000000 7435000000 256000000 28404000000 9723000000 0 18681000000 0 281000000 28404000000 0 2304000000 72000000 133000000 7638000000 0 0 193000000 193000000 122000000 529000000 0 651000000 0 3105000000 0 3105000000 11298000000 4000000 0 11302000000 0 33000000 0 334000000 108000000 0 3595000000 0 3595000000 11420000000 9570000000 326000000 26818000000 9093000000 0 17725000000 0 180000000 26818000000 -15000000 -933000000 17000000 528000000 -1140000000 -2257000000 -971000000 -449000000 -4301000000 -4817000000 -1374000000 -2176000000 -884000000 -418000000 -4300000000 -4852000000 0.0633 0.0612 158000000 927000000 159000000 927000000 148000000 996000000 477000000 422000000 508000000 594000000 502000000 923000000 3800000000 7500000000 700000000 4300000000 4600000000 8800000000 -17000000 -7000000 0 26000000 351000000 1050000000 383000000 1018000000 0 60000000 0 66000000 0 682000000 0 -475000000 1.00 0.30 0.70 0 -11000000 0 -17000000 0 -1000000 224000000 949000000 247000000 1080000000 269000000 1283000000 0 32000000 0 13000000 0.0455 0.0455 1.00 0.24 0.76 1.00 0.29 0.71 2038 2038 191000000 214000000 242000000 3754000000 332000000 608000000 1928000000 886000000 3422000000 5642000000 336000000 674000000 2216000000 2416000000 5306000000 6929000000 336000000 688000000 2103000000 3802000000 6593000000 76000000 423000000 387000000 418000000 38000000 7000000 425000000 271000000 0 0 501000000 32000000 0 0 501000000 32000000 0 161000000 0 161000000 0 662000000 0 662000000 7000000 6000000 463000000 694000000 605000000 872000000 -5000000 -68000000 83000000 0 0 0 0 0 -87000000 -159000000 -165000000 -31000000 0 0 133000000 0 0 0 0 0 -24000000 200000000 -220000000 47000000 0 0 0 0 0 0 0 56000000 0 0 0 0 367000000 597000000 496000000 402000000 38000000 165000000 567000000 267000000 494000000 0 0 0 548000000 32000000 0 0 548000000 32000000 0 292000000 0 292000000 0 840000000 0 840000000 9000000 3000000 238000000 605000000 next 12 months 2700000000 2100000000 300000000 200000000 200000000 300000000 300000000 1000000000 100000000 100000000 8621000000 8621000000 8943000000 8943000000 9494000000 9494000000 6.04 1.63 1.42 1.40 -3.99 0.48 1.63 1.47 1.47 1.14 5.70 5.93 1.61 1.40 1.37 -3.99 0.47 1.60 1.45 1.44 1.12 5.61 -215000000 337000000 -241000000 0.165 0.926 0.150 0.350 0.35 0.350 0.35 0.210 0.733 0.09 -0.776 0.11 0.006 0.034 0.017 0.018 0.021 0.015 0.006 0.008 0.000 0.000 -0.008 0.005 0.008 -0.172 -0.128 -0.037 0.020 0.015 0.003 -0.001 -0.006 -0.001 0.006 0.008 0.004 0.004 0.010 2953000000 3098000000 749000000 798000000 827000000 P1Y1M2D P1Y9M4D P1Y8M23D 256000000 275000000 192000000 -247000000 13000000 751000000 511000000 0 0 0.09 P10Y P4Y P22Y P22Y P10Y P11Y P22Y 7223000000 7463000000 9784000000 8323000000 4300000000 4300000000 4300000000 4300000000 4300000000 36427000000 20204000000 35194000000 21334000000 29204000000 12741000000 25410000000 13011000000 24230000000 2300000000 2300000000 400000000 1.1947 1.1947 1.1947 1.1947 1.1947 1.3444 1.14 1.14 1.14 1.14 1.14 1.2636 109.06 -289000000 -216000000 -265000000 600000000 1300000000 1200000000 500000000 300000000 200000000 563000000 1307000000 500000000 700000000 1217000000 22805000000 8263000000 11702000000 2840000000 1700000000 6200000000 31906000000 1700000000 8875000000 13922000000 9109000000 30453000000 6161000000 6200000000 8670000000 12720000000 9063000000 8463000000 102000000 2200000000 6161000000 403000000 168000000 184000000 51000000 815000000 584000000 122000000 109000000 -508000000 -373000000 -38000000 -97000000 200000000 177000000 74000000 102000000 1000000 1348000000 0 1348000000 0 50101000000 12357000000 12993000000 12725000000 12936000000 51011000000 13395000000 13903000000 13759000000 13433000000 54490000000 12986000000 1176000000 2929000000 289000000 4288000000 4025000000 279000000 9953000000 443000000 485000000 2619000000 3397000000 3009000000 12986000000 1176000000 2929000000 289000000 4288000000 4025000000 279000000 9953000000 443000000 485000000 2619000000 3397000000 3009000000 800000000 300000000 7457000000 4865000000 5575000000 12346000000 12808000000 12424000000 19803000000 0 20846000000 2441000000 5578000000 12827000000 5575000000 4748000000 4790000000 2560000000 17673000000 0 18999000000 2524000000 5392000000 11083000000 5481000000 4973000000 4423000000 3122000000 17999000000 0 19285000000 2320000000 4397000000 12568000000 3263000000 16373000000 2702000000 2843000000 3312000000 4570000000 656000000 2725000000 3951000000 1065000000 633000000 1185000000 249000000 -581000000 644000000 529000000 411000000 275000000 -586000000 8979000000 -1844000000 1300000 900000 700000 11283000000 4201000000 7082000000 9190000000 1100000000 2253000000 6937000000 780000000 53228000000 47611000000 4100000000 34400000000 1100000000 1000000000 102000000 94000000 86000000 726000000 934000000 1005000000 2000000 1000000 1000000 730000000 960000000 1049000000 628000000 866000000 963000000 5308000000 5376000000 8765000000 8599000000 1140000000 1114000000 2317000000 2109000000 368000000 385000000 611000000 829000000 807000000 330000000 372000000 332000000 97143000000 93202000000 4000000 93206000000 157303000000 152954000000 30537000000 31230000000 2019-09-12 2018-09-13 10000000000 250000000 800000000 493000000 118000000 645000000 1100000000 100000000 703000000 1288000000 300000000 1700000000 2300000000 597000000 900000000 1191000000 891000000 300000000 699000000 887000000 1774000000 998000000 496000000 499000000 498000000 995000000 349000000 1990000000 747000000 1492000000 547000000 995000000 806000000 990000000 742000000 448000000 987000000 1486000000 1971000000 990000000 60000000 856000000 538000000 495000000 1192000000 296000000 498000000 666000000 696000000 991000000 250000000 296000000 75000000 32174000000 500000000 1137000000 851000000 300000000 699000000 847000000 1693000000 998000000 494000000 499000000 498000000 996000000 349000000 1992000000 748000000 1493000000 548000000 996000000 805000000 990000000 742000000 449000000 988000000 1486000000 1972000000 991000000 51000000 856000000 538000000 495000000 1139000000 297000000 498000000 627000000 696000000 991000000 250000000 297000000 24000000 30320000000 500000000 1500000000 1499000000 2600000000 2636000000 21103000000 2636000000 1553000000 2134000000 1796000000 1098000000 30675000000 30675000000 27684000000 27684000000 4700000000 1600 1400 66 25949000000 25992000000 472000000 366000000 229000000 106000000 31000000 106000000 1000000 0 45000000 0 0 60000000 1580000000 1580000000 250000000 1330000000 0 0 0 0 0 0 751000000 511000000 P18M -8551000000 -7673000000 -18510000000 -4761000000 -14868000000 -3167000000 18767000000 21056000000 22201000000 16540000000 16540000000 4422000000 3827000000 3764000000 -10713000000 1300000000 1300000000 4367000000 3954000000 3934000000 3042000000 15297000000 -28000000 15269000000 15297000000 20200000000 4509000000 35151000000 899000000 4586000000 36937000000 1047000000 77000000 100000000 1786000000 1800000000 100000000 148000000 1143000000 100996000000 38556000000 2773000000 2990000000 56677000000 85134000000 17005000000 1064000000 94035000000 37117000000 2733000000 2752000000 51433000000 78064000000 17035000000 3 3 3 3 896000000 223000000 76000000 116000000 154000000 188000000 139000000 4971000000 4182000000 511000000 681000000 -700000000 -17000000 -7000000 0 26000000 -612000000 1696000000 -1518000000 -30000000 2000000 -31000000 3000000 -193000000 -179000000 0 -249000000 355000000 -265000000 236000000 -1736000000 -682000000 -249000000 -193000000 -1736000000 -612000000 1702000000 -170000000 355000000 -179000000 1702000000 1696000000 -1791000000 -8000000 -265000000 0 -1791000000 -1518000000 -291000000 378000000 -206000000 210000000 682000000 170000000 8000000 169000000 -740000000 111000000 -1153000000 346000000 -83000000 4000000 141000000 338000000 -1000000 -110000000 -359000000 192000000 -138000000 -609000000 -123000000 -852000000 -597000000 0 218000000 150000000 -359000000 -4000000 110000000 0 0 0 0 0 0 0 0 0 0 -60000000 96000000 -199000000 49000000 -73000000 117000000 0 0 0 0 56000000 0 0 0 0 0 -4000000 -17000000 -193000000 -32000000 -134000000 191000000 -70000000 -52000000 159000000 232000000 -1000000 -104000000 -96000000 0 9017000000 8589000000 -210000000 274000000 42000000 225000000 -1405000000 127000000 2331000000 2283000000 123000000 234000000 464000000 8979000000 6358000000 5868000000 900000000 0 35000000 558000000 593000000 8621000000 8943000000 9494000000 3400000000 4500000000 4509000000 3300000000 4300000000 35151000000 35200000000 29600000000 899000000 900000000 33950000000 6153000000 5626000000 3226000000 3279000000 3670000000 325000000 228000000 92000000 399000000 281000000 98000000 10074000000 4073000000 5251000000 9951000000 4019000000 5229000000 679000000 461000000 2250000000 2330000000 0 0 2000000 2000000 0 0 0 0 2537000000 2699000000 12004000000 8992000000 5000000 -15000000 -188000000 -148000000 35780000000 28117000000 4289000000 1267000000 1832000000 3203000000 111000000 869000000 80000000 3226000000 341000000 486000000 1472000000 927000000 2885000000 3279000000 292000000 485000000 1566000000 936000000 2987000000 3670000000 377000000 438000000 1843000000 1012000000 3293000000 41466000000 41851000000 17005000000 17035000000 P20Y P10Y P30Y P20Y P13Y P2Y P8Y P3Y -11000000 17000000 -31000000 2223000000 1777000000 1555000000 2017000000 1330000000 2479000000 9143000000 48000000 10594000000 40000000 10775000000 21000000 29000000 408000000 408000000 400000000 1126000000 1126000000 1100000000 2500000000 2300000000 1900000000 491000000 700000000 161000000 128000000 187000000 284000000 309000000 0 151000000 37000000 114000000 107000000 176000000 190000000 227000000 251000000 117000000 227000000 59000000 46000000 132000000 0 568000000 700000000 238000000 462000000 0 484000000 17000000 501000000 0 380000000 1000000 381000000 0 229000000 38000000 267000000 0 194000000 48000000 242000000 0 104000000 16000000 120000000 132000000 0 0 132000000 101793000000 106216000000 400000000 71890000000 71890000000 37811000000 12575000000 5734000000 15770000000 1524000000 1993000000 3517000000 2001000000 488000000 1513000000 3897000000 2135000000 1762000000 468000000 395000000 863000000 1032000000 1753000000 2785000000 471000000 101000000 572000000 52000000 521000000 573000000 1669000000 2693000000 4362000000 798000000 563000000 1361000000 613000000 638000000 1251000000 1343000000 871000000 2214000000 1273000000 134000000 1407000000 943000000 581000000 1524000000 0 0 0 3977000000 1675000000 2302000000 436000000 1679000000 2115000000 1568000000 648000000 920000000 0 25000000 25000000 266000000 518000000 784000000 527000000 0 1069000000 0 1596000000 0 162000000 338000000 500000000 1143000000 708000000 1851000000 767000000 338000000 1105000000 381000000 512000000 893000000 4842000000 782000000 1342000000 6966000000 833000000 584000000 1417000000 2152000000 1522000000 3674000000 0 0 0 959000000 786000000 1745000000 2263000000 969000000 3232000000 0 0 0 1545000000 1024000000 2569000000 0 0 0 0 0 0 0 1224000000 1224000000 1067000000 19000000 1048000000 797000000 455000000 342000000 2288000000 0 2288000000 1089000000 1171000000 2260000000 13307000000 5420000000 7887000000 25119000000 12266000000 739000000 0 1031000000 5438000000 4026000000 1032000000 12853000000 1050000000 66000000 1024000000 3690000000 5270000000 1753000000 1789000000 66000000 2055000000 9128000000 9296000000 2785000000 33464000000 20125000000 4855000000 8846000000 1461000000 2628000000 2335000000 0 13339000000 1541000000 3122000000 1747000000 3457000000 3472000000 0 6396000000 11968000000 3208000000 6085000000 5807000000 0 37811000000 34079000000 17766000000 3228000000 6293000000 8245000000 18839000000 3478000000 6726000000 8635000000 19650000000 3356000000 6599000000 9695000000 20195000000 3540000000 6974000000 9681000000 76450000000 76450000000 39863000000 13420000000 6041000000 17126000000 1620000000 2136000000 3756000000 1916000000 449000000 1467000000 4200000000 2335000000 1865000000 384000000 407000000 791000000 1122000000 1914000000 3036000000 884000000 358000000 1242000000 58000000 656000000 714000000 1728000000 2735000000 4463000000 827000000 567000000 1394000000 841000000 1052000000 1893000000 1590000000 979000000 2569000000 944000000 167000000 1111000000 948000000 575000000 1523000000 320000000 253000000 573000000 4126000000 1716000000 2410000000 296000000 1525000000 1821000000 1531000000 616000000 915000000 0 22000000 22000000 191000000 428000000 619000000 625000000 54000000 1079000000 34000000 1704000000 88000000 145000000 359000000 504000000 1109000000 712000000 1821000000 675000000 297000000 972000000 360000000 445000000 805000000 4525000000 563000000 1227000000 6315000000 737000000 603000000 1340000000 2053000000 1472000000 3525000000 453000000 574000000 1027000000 954000000 879000000 1833000000 2767000000 1244000000 4011000000 161000000 242000000 403000000 1576000000 1040000000 2616000000 62000000 1000000 63000000 238000000 25000000 263000000 0 1114000000 1114000000 1050000000 12000000 1038000000 779000000 437000000 342000000 2500000000 0 2500000000 1228000000 1277000000 2505000000 13602000000 5565000000 8037000000 26592000000 12824000000 612000000 0 1148000000 5404000000 4085000000 1575000000 13768000000 1003000000 1000000 1148000000 3654000000 5474000000 2488000000 1615000000 1000000 2296000000 9058000000 9559000000 4063000000 36256000000 21474000000 4744000000 8871000000 1358000000 2630000000 3098000000 773000000 14782000000 1543000000 3373000000 1796000000 3356000000 4160000000 554000000 6287000000 12244000000 3154000000 5986000000 7258000000 1327000000 39863000000 36587000000 20009000000 3398000000 6767000000 9844000000 20830000000 3504000000 6972000000 10354000000 20348000000 3415000000 6587000000 10346000000 20394000000 3536000000 6668000000 10190000000 81581000000 -35000000 81581000000 41884000000 14831000000 6113000000 18753000000 81546000000 1657000000 2345000000 4002000000 1858000000 422000000 1436000000 4382000000 2403000000 1979000000 229000000 434000000 663000000 1237000000 2065000000 3302000000 1203000000 822000000 2025000000 58000000 758000000 816000000 1751000000 2806000000 4557000000 841000000 577000000 1418000000 1129000000 1486000000 2615000000 1791000000 1137000000 2928000000 711000000 170000000 881000000 911000000 591000000 1502000000 700000000 515000000 1215000000 4334000000 1850000000 2484000000 239000000 1510000000 1749000000 1555000000 637000000 918000000 0 10000000 10000000 151000000 382000000 533000000 417000000 85000000 1053000000 64000000 1470000000 149000000 228000000 362000000 590000000 1169000000 786000000 1955000000 674000000 314000000 988000000 315000000 422000000 737000000 3664000000 436000000 1226000000 5326000000 717000000 625000000 1342000000 1930000000 1336000000 3266000000 540000000 711000000 1251000000 1051000000 1033000000 2084000000 3469000000 1687000000 5156000000 268000000 278000000 546000000 1599000000 1100000000 2699000000 453000000 91000000 544000000 598000000 65000000 663000000 0 1116000000 1116000000 1049000000 13000000 1036000000 675000000 436000000 239000000 2477000000 0 2477000000 1771000000 1727000000 3498000000 13853000000 5761000000 8092000000 26994000000 12837000000 371000000 0 1283000000 5281000000 4125000000 1777000000 14157000000 638000000 0 1363000000 3604000000 5776000000 2776000000 1009000000 0 2646000000 8885000000 9901000000 4553000000 40734000000 23286000000 4279000000 9073000000 1378000000 2574000000 4331000000 1651000000 17448000000 1537000000 4047000000 1926000000 3503000000 5513000000 922000000 5816000000 13120000000 3304000000 6077000000 9844000000 2573000000 41884000000 39697000000 20067000000 122000000 21520000000 100000000 22540000000 55000000 878000000 962000000 978000000 P4Y P6M P3Y P3Y P6M P3Y P6M 1091000 1142000 6074000 105.30 92.45 114.13 107.69 120.64 119.67 2625000 20161000 2494000 18460000 1151000 6684000 127700000 587700000 132500000 596500000 128800000 613700000 0.0310 0.0290 0.0270 0.1576 0.1530 0.1577 0.0151 0.0225 0.0277 650000000 351000000 50414000 52421000 65.77 73.61 980000000 1060000000 1028000000 3006000 2461000 2541000 22491000 19287000 17115000 10.01 13.38 17.98 3065000000 3636000000 5480000000 3214000000 116517000 113455000 111306000 109652000 76.41 83.16 90.48 98.29 65.66 70.87 75.44 92.83 101.40 112.90 101.87 115.67 129.51 115.68 101.87 52.13 90.44 66.07 54862000 38000 111000 13466000 28537000 12710000 113455000 111306000 109652000 16437000 37877000 13466000 29162000 12710000 129.51 115.67 65.62 100.48 72.54 2 0 P10Y P7Y P7Y P7Y 82.03 129.51 108.04 62.67 95.23 72.53 98.29 129.51 108.33 62.67 95.34 72.53 P6Y2M12D P6Y3M18D P6Y2M12D P9Y1M6D P7Y7M6D P1Y9M18D P5Y7M6D P4Y 974000000 1042000000 1090000000 3906000000 2796000000 30839000 25508000 22082000 22547000 18975000 16228000 3311000000 3156000000 3060000000 2130000000 -1181000000 3311000000 2077000000 -1079000000 3156000000 1949000000 -1111000000 3060000000 10000000000 5000000000 91714000000 94114000000 71150000000 -5298000000 -36000000 604000000 -13165000000 -8435000000 3120000000 103879000000 -22684000000 70418000000 -5980000000 -285000000 411000000 -14901000000 -9047000000 3120000000 110551000000 -28352000000 60160000000 -6150000000 70000000 232000000 -13199000000 -7351000000 3120000000 101793000000 -31554000000 59752000000 19000000 59771000000 -6158000000 -195000000 0 -15222000000 -8869000000 3120000000 106216000000 -34362000000 66000000 66000000 36000000 36000000 15000000 15000000 364681000 413332000 437318000 457519000 79490000 49494000 42283000 22684000000 28352000000 31554000000 34362000000 8979000000 8979000000 6358000000 6358000000 5868000000 5868000000 200000000 3080000000 3041000000 3151000000 3326000000 338000000 416000000 137000000 37000000 2000000 40000000 348000000 332000000 242000000 11000000 232000000 145000000 436000000 503000000 7000000 60000000 53000000 23000000 36000000 35000000 500000000 2788900000 2745300000 2728700000 2737300000 2692000000 2681500000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in treasury stock were:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Treasury Stock</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Amounts in Millions Except Treasury Stock Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at January 3, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364,681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee compensation and stock option plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30,839</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,311</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,490</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,979</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at January 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee compensation and stock option plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,508</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,156</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,494</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,358</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">437,318</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,554</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee compensation and stock option plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,082</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,060</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,283</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,868</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">457,519</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,362</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:9px;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, employee related obligations recorded on the Consolidated Balance Sheets were:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Postretirement benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,331</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Postemployment benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total employee obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,350</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current benefits payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee related obligations&#160;&#8212; non-current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,951</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10,074</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost. The Company utilizes the straight-line method of depreciation over the estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20&#160;- 30&#160;years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10&#160;- 20&#160;years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2&#160;- 13&#160;years</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Annual Closing Date</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows the concept of a fiscal year, which ends on the Sunday nearest to the end of the month of December. Normally each fiscal year consists of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52&#160;weeks, but every five or six years the fiscal year consists of 53&#160;weeks</font><font style="font-family:inherit;font-size:10pt;">, and therefore includes additional shipping days, as was the case in 2015, and will be the case again in 2020.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the funded status of the Company's U.S. Qualified &amp; Non-Qualified pension plans and international funded and unfunded pension plans at December&#160;31, 2018 and December&#160;31, 2017, respectively:</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">U.S. Plans</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">International Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Qualified Plans</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Qualified Plans</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Funded Plans</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unfunded Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,093</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected Benefit Obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,652</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,176</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,257</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,863</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated Benefit Obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,849</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,893</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Over (Under) Funded Status</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected Benefit Obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(971</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated Benefit Obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,027</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,793</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,849</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(417</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(379</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(397</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Product Liability</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accruals for product liability claims are recorded, on an undiscounted basis, when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on existing information and actuarially determined estimates where applicable. The accruals are adjusted periodically as additional information becomes available. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As a result of cost and availability factors, effective November&#160;1, 2005, the Company ceased purchasing third-party product liability insurance. The Company has self insurance through a wholly-owned captive insurance company. In addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales to Customers </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">% Change</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8217;18 vs. &#8217;17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8217;17 vs. &#8217;16</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">CONSUMER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Baby Care</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">488</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,513</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,858</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,916</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beauty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,979</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,865</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,762</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oral Care</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">637</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">915</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,531</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,568</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OTC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,675</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,484</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,410</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Women's Health</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,036</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,048</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Wound Care/Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">437</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">779</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">TOTAL CONSUMER</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,565</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,092</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,037</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,887</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">PHARMACEUTICAL</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Immunology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,073</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,871</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,047</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,373</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">REMICADE</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,525</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S. Exports</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">563</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">782</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,226</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,227</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,342</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,326</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,315</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SIMPONI / SIMPONI ARIA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,051</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">954</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,033</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,084</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,745</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">STELARA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,469</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,767</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,263</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,687</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">969</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,156</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">TREMFAYA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER IMMUNOLOGY</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Infectious Diseases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,461</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,926</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,304</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,154</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">EDURANT</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ rilpivirine</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">656</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">PREZISTA</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ PREZCOBIX</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ REZOLSTA</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ SYMTUZA</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,169</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,109</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,955</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,821</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,851</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER INFECTIOUS DISEASES</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">151</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">784</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Neuroscience</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,574</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,630</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,628</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,503</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,457</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,077</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">CONCERTA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ Methylphenidate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">INVEGA SUSTENNA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ XEPLION</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ INVEGA TRINZA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ TREVICTA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,137</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">979</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,928</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,569</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">RISPERDAL CONSTA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">512</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">893</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER NEUROSCIENCE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,510</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,679</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,749</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,821</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,115</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oncology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,331</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,098</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,160</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,472</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,258</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">DARZALEX</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">884</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,242</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">IMBRUVICA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">841</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">613</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">VELCADE</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,114</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">ZYTIGA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></font><font style="font-family:inherit;font-size:9pt;">/</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">abiraterone acetate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,771</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,727</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,505</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,260</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER ONCOLOGY</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">504</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pulmonary Hypertension</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">773</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">922</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">554</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OPSUMIT</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">253</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">TRACLEER</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">UPTRAVI</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">263</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cardiovascular / Metabolism / Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,855</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,543</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,541</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,396</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">XARELTO</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,477</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,477</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">INVOKANA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ INVOKAMET</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">711</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">881</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,407</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">PROCRIT</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ EPREX</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">972</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,105</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">527</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,053</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,079</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,069</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,470</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,596</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">TOTAL PHARMACEUTICAL</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,286</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,125</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,448</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,782</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,256</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,464</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">MEDICAL DEVICES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diabetes Care</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">371</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,009</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,789</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Interventional Solutions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,148</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,031</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,024</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,646</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,055</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Orthopaedics</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,438</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,690</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,885</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,058</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,128</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">HIPS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">841</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">827</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">577</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,394</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,361</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">KNEES</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">911</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">948</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">943</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,502</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">TRAUMA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,599</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,576</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,024</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,569</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SPINE &amp; OTHER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,053</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,152</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,472</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Surgery</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,125</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,085</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,474</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,901</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,559</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">ADVANCED</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,657</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,345</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,002</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,756</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,517</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;&#160;&#160;&#160;&#160;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">GENERAL</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,751</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,669</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,806</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,735</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,557</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,362</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SPECIALTY</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">584</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,340</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Vision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,777</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,488</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,063</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,785</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;&#160;&#160;&#160;&#160;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">CONTACT LENSES / OTHER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,237</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,065</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,036</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,785</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;&#160;&#160;&#160;&#160;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SURGICAL</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">540</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">711</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,027</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">TOTAL MEDICAL DEVICES</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,837</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,157</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,768</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,592</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">WORLDWIDE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,811</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,697</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,079</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,890</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">*Percentage greater than 100% or not meaningful</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Savings Plan</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has voluntary 401(k) savings plans designed to enhance the existing retirement programs covering eligible employees. The Company matches a percentage of each employee&#8217;s contributions consistent with the provisions of the plan for which he/she is eligible. Total Company matching contributions to the plans were </font><font style="font-family:inherit;font-size:10pt;">$242 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$214 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$191 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the projected future minimum contributions to the unfunded retirement plans. These amounts do not include any discretionary contributions that the Company may elect to make in the future.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2024-2028</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Projected future contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, the gross and net amounts of intangible assets were:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible assets with definite lives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents and trademarks&#160;&#8212; gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,194</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,427</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,784</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents and trademarks&#160;&#8212; net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">25,410</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">29,204</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships and other intangibles&#160;&#8212; gross</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,204</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,323</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,463</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships and other intangibles&#160;&#8212; net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13,011</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12,741</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible assets with indefinite lives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased in-process research and development</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,253</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets with indefinite lives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,190</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11,283</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets&#160;&#8212; net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">47,611</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">53,228</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></font><font style="font-family:inherit;font-size:9pt;">The decrease was primarily attributable to the write-down of </font><font style="font-family:inherit;font-size:9pt;">$1.1 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the assets acquired in the acquisitions of Alios Biopharma Inc. (Alios) and XO1 Limited (XO1). Of the </font><font style="font-family:inherit;font-size:9pt;">$1.1 billion</font><font style="font-family:inherit;font-size:9pt;">, the Company recorded a partial impairment charge of </font><font style="font-family:inherit;font-size:9pt;">$0.8 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios. The impairment charge was calculated based on updated cash flow projections discounted for the inherent risk in the asset development and reflects the impact of the phase 2b clinical trial suspension, a decrease in the probability of success factors and the ongoing analysis of asset development activities. In addition, an impairment charge of </font><font style="font-family:inherit;font-size:9pt;">$0.3 billion</font><font style="font-family:inherit;font-size:9pt;"> was recorded for the discontinuation of the development project for an anti-thrombin antibody associated with the 2015 acquisition of XO1. Additionally, </font><font style="font-family:inherit;font-size:9pt;">$0.8 billion</font><font style="font-family:inherit;font-size:9pt;"> of IPR&amp;D related to ERLEADA</font><font style="font-family:inherit;font-size:10pt;">&#8482;</font><font style="font-family:inherit;font-size:9pt;"> was reclassified to definite lived intangible assets upon commercialization. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Advertising</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Costs associated with advertising are expensed in the year incurred and are included in selling, marketing and administrative expenses.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contractual maturities of the available for sale debt securities at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:88.10916179337231%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost Basis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due within one year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,670</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,670</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after one year through five years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after five years through ten years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides pro forma results of operations for the fiscal year ended December 31, 2017 and January 1, 2017, as if Actelion had been acquired as of January 4, 2016. The pro forma results include the effect of certain purchase accounting adjustments such as the estimated changes in depreciation and amortization expense on the acquired tangible and intangible assets. However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of Actelion. Accordingly, such amounts are not necessarily indicative of the results if the acquisition had occurred on the dates indicated or which may occur in the future.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.92682926829268%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unaudited Pro forma Consolidated Results</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars in Millions Except Per Share Data)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,681</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,339</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,509</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,916</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted Net Earnings per Common Share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Combinations and Divestitures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain businesses were acquired for </font><font style="font-family:inherit;font-size:10pt;">$0.9 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash and </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> of liabilities assumed during 2018. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2018 acquisitions primarily included: Zarbee&#8217;s, Inc., a privately held company that is a leader in naturally-based consumer healthcare products; Medical Enterprises Distribution LLC, a privately held healthcare technology firm focused on surgical procedure innovation; BeneVir Biopharm, Inc. (BeneVir), a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies and Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of purchase price over the estimated fair value of tangible assets acquired amounted to </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> and has been assigned to identifiable intangible assets, with any residual recorded to goodwill.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 23, 2018, the Company entered into an agreement to acquire Ci:z Holdings Co., Ltd., a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">&#165;230 billion</font><font style="font-family:inherit;font-size:10pt;">, which equates to approximately </font><font style="font-family:inherit;font-size:10pt;">$2.1 billion</font><font style="font-family:inherit;font-size:10pt;">, using the exchange rate of </font><font style="font-family:inherit;font-size:10pt;">109.06</font><font style="font-family:inherit;font-size:10pt;"> Japanese Yen to each U.S. Dollar on January 16, 2019. The acquisition was completed on January 17, 2019, through a series of transactions that included an all-cash tender offer to acquire the publicly held shares not already held by the Company for </font><font style="font-family:inherit;font-size:10pt;">&#165;5,900</font><font style="font-family:inherit;font-size:10pt;"> per share. Upon completion of the tender offer and the related transactions, the Company acquired </font><font style="font-family:inherit;font-size:10pt;">89%</font><font style="font-family:inherit;font-size:10pt;"> of the outstanding shares. The Company plans to acquire the remaining shares that were not tendered in the tender offer through a share consolidation under Japanese law during the first half of 2019 and take appropriate actions to</font><font style="font-family:inherit;font-size:10pt;color:#ff0000;"> </font><font style="font-family:inherit;font-size:10pt;">delist from the Tokyo Stock Exchange. The acquisition will include the range of brands comprising DR.CI:LABO, LABO LABO and GENOMER line of skincare products. The Company expects to treat this transaction as a business combination and will include it in the Consumer segment.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 13, 2019, the Company&#160;entered into a definitive agreement to acquire Auris Health, Inc. for approximately </font><font style="font-family:inherit;font-size:10pt;">$3.4 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash. Additional contingent payments of up to</font><font style="font-family:inherit;font-size:10pt;">$2.35 billion</font><font style="font-family:inherit;font-size:10pt;">, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The closing is subject to antitrust clearance and other customary closing conditions. The transaction is expected to close by the end of the second quarter of 2019.&#160;The Company expects to treat this transaction as a business combination and will include it in the Medical Devices segment. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2017 certain businesses were acquired for </font><font style="font-family:inherit;font-size:10pt;">$35.2 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash and </font><font style="font-family:inherit;font-size:10pt;">$1.8 billion</font><font style="font-family:inherit;font-size:10pt;"> of liabilities assumed. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 acquisitions primarily included: Actelion Ltd, an established leading franchise of differentiated, innovative products for pulmonary arterial hypertension (PAH); Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, which included ophthalmic products related to: cataract surgery, laser refractive surgery and consumer eye health; Neuravi Limited, a privately-held medical device company that develops and markets medical devices for neurointerventional therapy; TearScience Inc., a manufacturer of products dedicated to treating meibomian gland dysfunction; Sightbox, Inc., a privately-held company that developed a subscription vision care service that connects consumers with eye care professionals and a supply of contact lenses; Torax Medical, Inc., a privately-held medical device company that manufactures and markets the LINX&#8482; Reflux Management System for the surgical treatment of gastroesophageal reflux disease and Megadyne Medical Products, Inc., a privately-held medical device company that develops, manufactures and markets electrosurgical tools. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of purchase price over the estimated fair value of tangible assets acquired amounted to </font><font style="font-family:inherit;font-size:10pt;">$34.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and has been assigned to identifiable intangible assets, with any residual recorded to goodwill. Of this amount, approximately </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> has been identified as the value of IPR&amp;D, primarily associated with the acquisition of Actelion Ltd. The value of the IPR&amp;D was calculated using cash flow projections discounted for the inherent risk in the projects. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2017, the Company completed the acquisition of Actelion Ltd through an all cash tender offer in Switzerland for </font><font style="font-family:inherit;font-size:10pt;">$280</font><font style="font-family:inherit;font-size:10pt;"> per share, amounting to </font><font style="font-family:inherit;font-size:10pt;">$29.6 billion</font><font style="font-family:inherit;font-size:10pt;">, net of cash acquired. As part of the transaction, immediately prior to the completion of the acquisition, Actelion&#160;spun&#160;out its drug discovery operations and early-stage clinical development assets into a newly created Swiss biopharmaceutical company, Idorsia Ltd. The shares of Idorsia are listed on the&#160;SIX Swiss Exchange&#160;(SIX).&#160;In 2017 the Company held </font><font style="font-family:inherit;font-size:10pt;">9.9%</font><font style="font-family:inherit;font-size:10pt;"> of the shares of Idorsia and had&#160;rights to an additional </font><font style="font-family:inherit;font-size:10pt;">22.1%</font><font style="font-family:inherit;font-size:10pt;"> of Idorsia equity through a convertible loan with a principal amount of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;">.&#160;As a result of Idorsia raising additional capital in July 2018, the Company&#160;currently holds </font><font style="font-family:inherit;font-size:10pt;">9.0%</font><font style="font-family:inherit;font-size:10pt;"> of the shares of Idorsia and has rights to an additional </font><font style="font-family:inherit;font-size:10pt;">20.8%</font><font style="font-family:inherit;font-size:10pt;"> of Idorsia equity through a convertible loan with a principal amount of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;">. The convertible loan may be converted into Idorsia shares as follows: (i) up to an aggregate shareholding of </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> of Idorsia shares as a result of certain shareholders holding more than </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> of the issued Idorsia shares, and (ii) up to the balance of the remaining amount within 20 business days of the maturity date of the convertible loan, which has a </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> year term, or if Idorsia undergoes a change of control transaction. The investment in Idorsia was recorded as a cost method investment in Other assets in the Company's consolidated Balance Sheet. The Company also exercised the option acquired on ACT-132577, a product within Idorsia being developed for resistant hypertension currently in phase 2 of clinical development. The Company has also entered into an agreement to provide Idorsia with a Swiss franc denominated credit facility of approximately </font><font style="font-family:inherit;font-size:10pt;">$250 million</font><font style="font-family:inherit;font-size:10pt;">. As of December 30, 2018, Idorsia has not made any draw-downs under the credit facility. Actelion has entered into a transitional services agreement with Idorsia. Actelion has established a leading franchise of differentiated, innovative products for pulmonary arterial hypertension (PAH) that are highly complementary to the existing portfolio of the Company. The addition of Actelion&#8217;s specialty in-market medicines and late-stage products is consistent with the Company's efforts to grow in attractive and complementary therapeutic areas and serve patients with serious illnesses and significant unmet medical need. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fiscal second quarter of 2018, the Company finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. The following table presents the amounts recognized for assets acquired and liabilities assumed as of the acquisition date with adjustments made through the second quarter of 2018: </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:58.92682926829268%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash &amp; Cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">469</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts Receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred Taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets Acquired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">956</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred Taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Liabilities Assumed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Assets Acquired</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Includes adjustment of </font><font style="font-family:inherit;font-size:10pt;">$642 million</font><font style="font-family:inherit;font-size:10pt;"> to write-up the acquired inventory to its estimated fair value.</font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The adjustments made since the date of acquisition were </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> to the deferred taxes and </font><font style="font-family:inherit;font-size:10pt;">$0.4 billion</font><font style="font-family:inherit;font-size:10pt;"> to the current liabilities with the offset to goodwill. The assets acquired are recorded in the Pharmaceutical segment. The acquisition of Actelion resulted in approximately </font><font style="font-family:inherit;font-size:10pt;">$6.2 billion</font><font style="font-family:inherit;font-size:10pt;"> of goodwill. The goodwill is primarily attributable to synergies expected to arise from the acquisition. The goodwill is not expected to be deductible for tax purposes. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price allocation to the identifiable intangible assets is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:54.82926829268293%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets with definite lives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents and trademarks*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total amortizable intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,230</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">25,010</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Includes </font><font style="font-family:inherit;font-size:10pt;">$0.4 billion</font><font style="font-family:inherit;font-size:10pt;"> related to </font><font style="font-family:inherit;font-size:9pt;">VALCHLOR</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, one of the acquired products, which was divested in the fiscal second quarter of 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The patents and trademarks acquired are comprised of developed technology with a weighted average life of </font><font style="font-family:inherit;font-size:10pt;">9 years</font><font style="font-family:inherit;font-size:10pt;"> and was primarily based on the patent life of the marketed products. The intangible assets with definite lives were assigned asset lives ranging from </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">10 years</font><font style="font-family:inherit;font-size:10pt;">. The in-process research and development intangible assets were valued for technology programs for unapproved products.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The value of the IPR&amp;D was calculated using probability adjusted cash flow projections discounted for the risk inherent in such projects. The discount rate applied was </font><font style="font-family:inherit;font-size:10pt;">9%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition was accounted for using the acquisition method and, accordingly, the results of operations of Actelion were reported in the Company's financial statements beginning on June 16, 2017, the date of acquisition. For the year ended December 31, 2017, total sales and a net loss for Actelion from the date of acquisition were </font><font style="font-family:inherit;font-size:10pt;">$1.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.4 billion</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides pro forma results of operations for the fiscal year ended December 31, 2017 and January 1, 2017, as if Actelion had been acquired as of January 4, 2016. The pro forma results include the effect of certain purchase accounting adjustments such as the estimated changes in depreciation and amortization expense on the acquired tangible and intangible assets. However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of Actelion. Accordingly, such amounts are not necessarily indicative of the results if the acquisition had occurred on the dates indicated or which may occur in the future.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.92682926829268%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unaudited Pro forma Consolidated Results</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars in Millions Except Per Share Data)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,681</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,339</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,509</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,916</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted Net Earnings per Common Share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded Actelion acquisition related costs before tax of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2018 and 2017, respectively, which was recorded in Other (income)/expense and Cost of products sold. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2017, the Company acquired Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, for </font><font style="font-family:inherit;font-size:10pt;">$4.3 billion</font><font style="font-family:inherit;font-size:10pt;">, net of cash acquired. The acquisition included ophthalmic products related to: cataract surgery, laser refractive surgery and consumer eye health. The net purchase price was primarily recorded as amortizable intangible assets for </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;"> and goodwill for </font><font style="font-family:inherit;font-size:10pt;">$1.7 billion</font><font style="font-family:inherit;font-size:10pt;">. The weighted average life of total amortizable intangibles, the majority being customer relationships, is approximately </font><font style="font-family:inherit;font-size:10pt;">14.4 years</font><font style="font-family:inherit;font-size:10pt;">. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not deductible for tax purposes. The intangible assets and goodwill amounts are based on the final purchase price allocation. The assets acquired were recorded in the Medical Devices segment.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain businesses were acquired for </font><font style="font-family:inherit;font-size:10pt;">$4.5 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash and </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> of liabilities assumed during 2016. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2016 acquisitions primarily included: Vogue International LLC, a privately-held company focused on the marketing, development and distribution of salon-influenced and nature inspired hair care and other personal products; NeuWave Medical, Inc., a privately-held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems; NeoStrata Company, Inc., a global leader in dermocosmetics; and the global rights for the commercialization of RHINOCORT</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> allergy spray outside the United States.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The excess of purchase price over the estimated fair value of tangible assets acquired amounted to </font><font style="font-family:inherit;font-size:10pt;">$4.1 billion</font><font style="font-family:inherit;font-size:10pt;"> and has been assigned to identifiable intangible assets, with any residual recorded to goodwill. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net purchase price for Vogue International LLC of </font><font style="font-family:inherit;font-size:10pt;">$3.3 billion</font><font style="font-family:inherit;font-size:10pt;"> was primarily recorded as amortizable intangible assets for </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;"> and goodwill for </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">. The weighted average life for the </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;"> of total amortizable intangibles is approximately </font><font style="font-family:inherit;font-size:10pt;">22 years</font><font style="font-family:inherit;font-size:10pt;">. The trademark asset values were determined to have definite lives ranging from </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">22</font><font style="font-family:inherit;font-size:10pt;"> years, with the majority being </font><font style="font-family:inherit;font-size:10pt;">22</font><font style="font-family:inherit;font-size:10pt;"> years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is expected to be deductible for tax purposes. The assets acquired were recorded in the Consumer segment. </font></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2012, the Company completed the acquisition of Synthes, Inc. for a purchase price of </font><font style="font-family:inherit;font-size:10pt;">$20.2 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash and stock. In connection with the acquisition of Synthes, Inc. the Company entered into two accelerated share repurchase (ASR) agreements.&#160;&#160;In 2013, the Company settled the remaining liabilities under the ASR agreements. While the Company believes that the transactions under each ASR agreement and a series of related internal transactions were consummated in a tax efficient manner in accordance with applicable law, it is possible that the Internal Revenue Service could assert one or more contrary positions to challenge the transactions from a tax perspective. If challenged, an amount up to the total purchase price for the Synthes shares could be treated as subject to applicable U.S. tax at approximately the statutory rate to the Company, plus interest.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With the exception of the Actelion Ltd acquisition, supplemental pro forma information for 2018, 2017 and 2016 in accordance with U.S.&#160;GAAP standards related to business combinations, and goodwill and other intangible assets, is not provided, as the impact of the aforementioned acquisitions did not have a material effect on the Company&#8217;s results of operations, cash flows or financial position.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2018, the Company divested the LifeScan Inc business for approximately </font><font style="font-family:inherit;font-size:10pt;">$2.1 billion</font><font style="font-family:inherit;font-size:10pt;"> and retained certain net liabilities. Other divestitures in 2018 included: NIZORAL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, RoC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">and certain non-strategic Pharmaceutical products. In 2018, the pre-tax gains on the divestitures were approximately </font><font style="font-family:inherit;font-size:10pt;">$1.2 billion</font><font style="font-family:inherit;font-size:10pt;">. Additionally, in 2018, the Company accepted the binding offer from Fortive Corporation to acquire its Advanced Sterilization Products (ASP) business for approximately </font><font style="font-family:inherit;font-size:10pt;">$2.7 billion</font><font style="font-family:inherit;font-size:10pt;">, subject to customary adjustments. The transaction is expected to close in 2019. As of December 30, 2018, the assets held for sale on the Consolidated Balance Sheet were </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> of inventory, </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> of property, plant and equipment and </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;"> of goodwill. The Company will retain certain net receivables of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> associated with the ASP business. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world&#8217;s leading manufacturing services providers for health care products and technology products.&#160;The Company is expanding a 12-year relationship with Jabil to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of employees and manufacturing sites. As of December 30, 2018, the assets held for sale on the Consolidated Balance Sheet were </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;"> of inventory and </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> of property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 22 to the Consolidated Financial Statements.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2017, the Company divestitures primarily included: the Codman Neurosurgery business, to Integra LifeSciences Holdings Corporation and the divestiture of COMPEED</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> to HRA Pharma. In 2017, the pre-tax gains on the divestitures were approximately </font><font style="font-family:inherit;font-size:10pt;">$1.3 billion</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2016, the Company divestitures included: the controlled substance raw material and active pharmaceutical ingredient (API) business; certain anesthetic products in Europe; and certain non-strategic Consumer brands. In 2016, the pre-tax gains on the divestitures were approximately </font><font style="font-family:inherit;font-size:10pt;">$0.6 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Equivalents</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating. The Company invests its cash primarily in government securities and obligations, corporate debt securities, money market funds and reverse repurchase agreements (RRAs).</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RRAs are collateralized by deposits in the form of Government Securities and Obligations for an amount not less than </font><font style="font-family:inherit;font-size:10pt;">102%</font><font style="font-family:inherit;font-size:10pt;"> of their value. The Company does not record an asset or liability as the Company is not permitted to sell or repledge the associated collateral. The Company has a policy that the collateral has at least an A (or equivalent) credit rating. The Company utilizes a third party custodian to manage the exchange of funds and ensure that collateral received is maintained at </font><font style="font-family:inherit;font-size:10pt;">102%</font><font style="font-family:inherit;font-size:10pt;"> of the value of the RRAs on a daily basis. RRAs with stated maturities of greater than three months from the date of purchase are classified as marketable securities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash, Cash Equivalents and Current Marketable Securities</font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, cash, cash equivalents and current marketable securities were comprised of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated Fair Value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash &amp; Cash Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current Marketable Securities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Reverse repurchase agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Reverse repurchase agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Time deposits</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;Subtotal </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gov't Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,144</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,330</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;Subtotal available for sale</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,154</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,580</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cash, cash equivalents and current marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">18,107</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,580</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, the carrying amount was the same as the estimated fair value.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2017, the carrying amount was the same as the estimated fair value.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated Fair Value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash &amp; Cash Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current Marketable Securities</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,929</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,929</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,929</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Sovereign Securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Reverse repurchase agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Time deposits</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;Subtotal </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,986</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,986</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,880</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gov't Securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,864</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,864</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Sovereign Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;Subtotal available for sale</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,310</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,310</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cash, cash equivalents and current marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of government securities and obligations and corporate debt securities were estimated using quoted broker prices and significant other observable inputs.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contractual maturities of the available for sale debt securities at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:88.10916179337231%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost Basis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due within one year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,670</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,670</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after one year through five years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after five years through ten years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash in both deposits with major banks throughout the world and other high-quality money market instruments. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Related Obligations</font></div><div style="line-height:120%;padding-top:9px;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, employee related obligations recorded on the Consolidated Balance Sheets were:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Postretirement benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,331</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Postemployment benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total employee obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,350</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current benefits payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee related obligations&#160;&#8212; non-current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,951</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10,074</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid employee related obligations of </font><font style="font-family:inherit;font-size:10pt;">$475 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$526 million</font><font style="font-family:inherit;font-size:10pt;"> for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, are included in Other assets on the Consolidated Balance Sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Other Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Components of other comprehensive income (loss) consist of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Foreign<br clear="none"/>Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain/(Loss) On Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Employee Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain/<br clear="none"/>(Loss) On<br clear="none"/>Derivatives &amp; Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total<br clear="none"/>Accumulated<br clear="none"/>Other<br clear="none"/>Comprehensive Income (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 3, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,298</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,165</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net 2016 changes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(612</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(193</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(682</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(249</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,736</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,047</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,980</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(285</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net 2017 changes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(179</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,702</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,199</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative adjustment to retained earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(232</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(232</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net 2018 changes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,518</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(265</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,791</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,869</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,158</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(195</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,222</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> See Note 1 to Consolidated Financial Statements for additional details on the adoption of ASU 2016-01</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts in accumulated other comprehensive income are presented net of the related tax impact. Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries. For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Details on reclassifications out of Accumulated Other Comprehensive Income:</font></div><div style="line-height:120%;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.</font></div><div style="line-height:120%;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 10 for additional details.</font></div><div style="line-height:120%;text-align:left;padding-left:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(Loss) On Derivatives &amp; Hedges - reclassifications to earnings are recorded in the same account as the hedged transaction. See Note 6 for additional details.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;padding-top:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of Johnson&#160;&amp; Johnson and its subsidiaries (the Company). Intercompany accounts and transactions are eliminated.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Borrowings</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of long-term debt are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.75%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective Rate %</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective Rate %</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.15%&#160;Debentures due 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.18</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65% Notes due 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">597</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.70</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.75%&#160;Notes due 2019 (1B Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(1B Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.83</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.875% Notes due 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.93</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89% Notes due 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.125% Notes due 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.13</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3% Zero Coupon Convertible Subordinated Debentures due 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.00</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.95%&#160;Debentures due 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">547</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.15</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.950% Notes due 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.55% Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">448</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.67</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.45% Notes due 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.48</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65% Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">998</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">998</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.250% Notes due 2022 (1B Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(1B Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.26</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25% Notes due 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.31</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">995</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.31</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.73%&#160;Debentures due 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.73</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.73</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.375% Notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">805</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">806</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.17</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.05% Notes due 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.09</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.650% Notes due 2024 (750MM Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(750MM Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">891</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.50%&#160;Notes due 2024 (500MM GBP 1.2636)</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(500MM GBP 1.3444)</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.625% Notes due 2025</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.63</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">747</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.63</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.45% Notes due 2026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.47</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.95% Notes due 2027</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">995</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.96</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.150% Notes due 2028 (750MM Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(750MM Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.21</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.900%&#160;Notes due 2028</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,493</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.91</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,492</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.91</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.95%&#160;Notes due 2029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.14</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95%&#160;Debentures due 2033</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.375% Notes due 2033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.650% Notes due 2035 (1.5B Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(1.5B Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,774</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.68</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.55% Notes due 2036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">988</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">987</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.59</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.95%&#160;Notes due 2037</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">991</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">991</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.99</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.625% Notes due 2037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.64</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.85%&#160;Debentures due 2038</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.85</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.400%&#160;Notes due 2038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.42</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.50%&#160;Debentures due 2040</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">538</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.63</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">538</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.63</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.85% Notes due 2041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.89</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.50% Notes due 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.52</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.70% Notes due 2046</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,971</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.74</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.75% Notes due 2047</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">991</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.76</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.75%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.500% Notes due 2048</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.52</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">30,320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">32,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,636</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,499</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">27,684</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">30,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average effective rate.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation rate at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation rate at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of the fair value over the carrying value of debt was </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of the long-term debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.(Level 2)</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has access to substantial sources of funds at numerous banks worldwide. In </font><font style="font-family:inherit;font-size:10pt;">September 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company secured a new 364-day Credit Facility. Total credit available to the Company approximates </font><font style="font-family:inherit;font-size:10pt;">$10 billion</font><font style="font-family:inherit;font-size:10pt;">, which expires on </font><font style="font-family:inherit;font-size:10pt;">September&#160;12, 2019</font><font style="font-family:inherit;font-size:10pt;">. Interest charged on borrowings under the credit line agreements is based on either bids provided by banks, the prime rate or London Interbank Offered Rates (LIBOR), plus applicable margins. Commitment fees under the agreements are not material.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Throughout </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, the Company continued to have access to liquidity through the commercial paper market. Short-term borrowings and the current portion of long-term debt amounted to approximately </font><font style="font-family:inherit;font-size:10pt;">$2.8 billion</font><font style="font-family:inherit;font-size:10pt;"> at the end of </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$2.6 billion</font><font style="font-family:inherit;font-size:10pt;"> is the current portion of the long term debt, and the remainder principally represents local borrowing by international subsidiaries. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Throughout 2017, the Company continued to have access to liquidity through the commercial paper market. Short-term borrowings and the current portion of long-term debt amounted to approximately </font><font style="font-family:inherit;font-size:10pt;">$3.9 billion</font><font style="font-family:inherit;font-size:10pt;"> at the end of 2017, of which </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;"> was borrowed under the Commercial Paper Program, </font><font style="font-family:inherit;font-size:10pt;">$1.5 billion</font><font style="font-family:inherit;font-size:10pt;"> is the current portion of the long-term debt, and the remainder principally represents local borrowing by international subsidiaries. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate maturities of long-term obligations commencing in </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;"> are:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85.546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-top:17px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">After 2023</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2,636</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,134</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,103</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Instruments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As required by U.S.&#160;GAAP, all derivative instruments are recorded on the balance sheet at fair value. Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value, with Level&#160;1 having the highest priority and Level&#160;3 having the lowest. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company documents all relationships between hedged items and derivatives. The overall risk management strategy includes reasons for undertaking hedge transactions and entering into derivatives. The objectives of this strategy are: (1)&#160;minimize foreign currency exposure&#8217;s impact on the Company&#8217;s financial performance; (2)&#160;protect the Company&#8217;s cash flow from adverse movements in foreign exchange rates; (3)&#160;ensure the appropriateness of financial instruments; and (4)&#160;manage the enterprise risk associated with financial institutions. See Note&#160;6 for additional information on Financial Instruments.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock, Stock Option Plans and Stock Compensation Agreements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> stock-based compensation plans. The shares outstanding are for contracts under the Company's 2005 Long-Term Incentive Plan and the 2012 Long-Term Incentive Plan. The 2005 Long-Term Incentive Plan expired April 26, 2012. All options and restricted shares granted subsequent to that date were under the 2012 Long-Term Incentive Plan. Under the 2012 Long-Term Incentive Plan, the Company may issue up to </font><font style="font-family:inherit;font-size:10pt;">650 million</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock, plus any shares canceled, expired, forfeited, or not issued from the 2005 Long-Term Incentive Plan subsequent to April 26, 2012. Shares available for future grants under the 2012 Long-Term Incentive Plan were </font><font style="font-family:inherit;font-size:10pt;">351 million</font><font style="font-family:inherit;font-size:10pt;"> at the end of </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation cost that has been charged against income for these plans was </font><font style="font-family:inherit;font-size:10pt;">$978 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$962 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$878 million</font><font style="font-family:inherit;font-size:10pt;"> for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total income tax benefit recognized in the income statement for share-based compensation costs was </font><font style="font-family:inherit;font-size:10pt;">$192 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$275 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$256 million</font><font style="font-family:inherit;font-size:10pt;"> for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. An additional tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$353 million</font><font style="font-family:inherit;font-size:10pt;"> was recognized in 2016 due to the adoption of a new accounting standard for the reporting of additional tax benefits on share-based compensation. The total unrecognized compensation cost was </font><font style="font-family:inherit;font-size:10pt;">$827 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$798 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$749 million</font><font style="font-family:inherit;font-size:10pt;"> for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. The weighted average period for this cost to be recognized was </font><font style="font-family:inherit;font-size:10pt;">1.73</font><font style="font-family:inherit;font-size:10pt;">&#160;years, </font><font style="font-family:inherit;font-size:10pt;">1.76</font><font style="font-family:inherit;font-size:10pt;">&#160;years and </font><font style="font-family:inherit;font-size:10pt;">1.09</font><font style="font-family:inherit;font-size:10pt;">&#160;years for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Share-based compensation costs capitalized as part of inventory were insignificant in all periods.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company settles employee benefit equity issuances with treasury shares. Treasury shares are replenished throughout the year for the number of shares used to settle employee benefit equity issuances. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Options</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options expire </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10</font><font style="font-family:inherit;font-size:10pt;">&#160;years from the date of grant and vest over service periods that range from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">6 months</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">4 years</font><font style="font-family:inherit;font-size:10pt;">. All options are granted at the average of the high and low prices of the Company&#8217;s Common Stock on the New York Stock Exchange on the date of grant. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of each option award was estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. For 2018, 2017 and 2016 grants, expected volatility represents a blended rate of 10-year weekly historical overall volatility rate, and a 5-week average implied volatility rate based on at-the-money traded Johnson&#160;&amp; Johnson options with a life of 2&#160;years. For all grants, historical data is used to determine the expected life of the option. The risk-free rate was based on the U.S.&#160;Treasury yield curve in effect at the time of grant.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The average fair value of options granted was </font><font style="font-family:inherit;font-size:10pt;">$17.98</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$13.38</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.01</font><font style="font-family:inherit;font-size:10pt;">, in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. The fair value was estimated based on the weighted average assumptions of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.3359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.77</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.76</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.70</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.90</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of option activity under the Plan as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;">, and changes during the years ending on those dates is presented below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Outstanding Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aggregate</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Intrinsic</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Dollars in Millions) </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at January 3, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,065</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,491</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,547</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options canceled/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,006</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.83</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at January 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,636</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115.67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options canceled/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,461</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,306</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,115</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options canceled/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,541</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">109,652</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">98.29</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total intrinsic value of options exercised was </font><font style="font-family:inherit;font-size:10pt;">$1,028 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1,060 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$980 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock options outstanding and exercisable at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.7265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Exercise Price Range</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Life</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$52.13-$65.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$62.67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$62.67</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$66.07-$72.54</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$72.53</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$72.53</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$90.44-$100.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$95.34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$95.23</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$101.87-$115.67</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,877</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$108.33</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$108.04</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$115.68-$129.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,437</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$129.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$129.51</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">109,652</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$98.29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">54,862</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$82.03</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;vertical-align:bottom;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> Average contractual life remaining in years.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options outstanding at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">January&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">111,306</font><font style="font-family:inherit;font-size:10pt;"> and an average life of </font><font style="font-family:inherit;font-size:10pt;">6.3</font><font style="font-family:inherit;font-size:10pt;"> years and </font><font style="font-family:inherit;font-size:10pt;">113,455</font><font style="font-family:inherit;font-size:10pt;"> and an average life of </font><font style="font-family:inherit;font-size:10pt;">6.2</font><font style="font-family:inherit;font-size:10pt;">&#160;years, respectively. Stock options exercisable at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">January&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">52,421</font><font style="font-family:inherit;font-size:10pt;"> at an average price of </font><font style="font-family:inherit;font-size:10pt;">$73.61</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">50,414</font><font style="font-family:inherit;font-size:10pt;"> at an average price of </font><font style="font-family:inherit;font-size:10pt;">$65.77</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:17px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Share Units and Performance Share Units</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grants restricted share units which vest over service periods that range from </font><font style="font-family:inherit;font-size:10pt;">6 months</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">3 years</font><font style="font-family:inherit;font-size:10pt;">. The Company also grants performance share units, which are paid in shares of Johnson &amp; Johnson Common Stock after the end of a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance period. Whether any performance share units vest, and the amount that does vest, is tied to the completion of service periods that range from </font><font style="font-family:inherit;font-size:10pt;">6 months</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">3 years</font><font style="font-family:inherit;font-size:10pt;"> and the achievement, over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year period, of three equally-weighted goals that directly align with or help drive long-term total shareholder return: operational sales, adjusted operational earnings per share, and relative total shareholder return. The number of shares actually earned at the end of the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year period will vary, based only on actual performance, from </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;"> of the target number of performance share units granted</font><font style="font-family:inherit;font-size:9pt;">. </font><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2017, the Company modified the restricted share units that are scheduled to vest between January 1, 2018 and March 15, 2018. This modification guaranteed a minimum aggregate value, below the market value of the total expected payout amount, for all awards expected to vest during this period. The amount that was committed was not material to the Company&#8217;s overall financial position. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the restricted share units and performance share units activity under the Plans as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> is presented below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:89.0625%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding Restricted Share Units</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding Performance Share Units</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,074</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,142</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled/forfeited/adjusted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,091</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,460</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,494</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The average fair value of the restricted share units granted was </font><font style="font-family:inherit;font-size:10pt;">$119.67</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$107.69</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$92.45</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, using the fair market value at the date of grant. The fair value of restricted share units was discounted for dividends, which are not paid on the restricted share units during the vesting period. The fair value of restricted share units issued was </font><font style="font-family:inherit;font-size:10pt;">$613.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$596.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$587.7 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted average fair value of the performance share units granted was </font><font style="font-family:inherit;font-size:10pt;">$120.64</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$114.13</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$105.30</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, calculated using the weighted average fair market value for each of the three component goals at the date of grant.&#160; </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values for the sales and earnings per share goals of each performance share unit were estimated on the date of grant using the fair market value of the shares at the time of the award discounted for dividends, which are not paid on the performance share units during the vesting period.&#160; The fair value for the relative total shareholder return goal of each performance share unit was estimated on the date of grant using the Monte Carlo valuation model.&#160;The fair value of performance share units issued was </font><font style="font-family:inherit;font-size:10pt;">$128.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$132.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$127.7 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Earnings Per Share</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per share is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In Millions Except Per Share Amounts)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net earnings per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average shares outstanding&#160;&#8212; basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,681.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,692.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,737.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Potential shares exercisable under stock option plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: shares repurchased under treasury stock method</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible debt shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted average shares outstanding&#160;&#8212; diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,728.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,745.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,788.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net earnings per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.93</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The diluted net earnings per share calculation included the dilutive effect of convertible debt that is offset by the related reduction in interest expense of </font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax for 2018 and 2017, and </font><font style="font-family:inherit;font-size:10pt;">$2 million</font><font style="font-family:inherit;font-size:10pt;"> for 2016.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The diluted net earnings per share calculation for 2018, 2017 and 2016 included all shares related to stock options, as the exercise price of all options was less than the average market value of the Company's stock.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany products and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings. These derivatives are designated as fair value hedges. The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges. Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company early adopted ASU 2017-12: Targeted Improvements to Accounting for Hedge Activities effective as of the beginning of fiscal second quarter of 2018.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. During the fiscal second quarter of 2017, the Company entered into credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the total amount of collateral paid under the credit support agreements (CSA) amounted to </font><font style="font-family:inherit;font-size:10pt;">$182 million</font><font style="font-family:inherit;font-size:10pt;"> net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating. Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had notional amounts outstanding for forward foreign exchange contracts, cross currency interest rate swaps and interest rate swaps of </font><font style="font-family:inherit;font-size:10pt;">$41.1 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$7.3 billion</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> respectively. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had notional amounts outstanding for forward foreign exchange contracts, cross currency interest rate swaps and interest rate swaps of </font><font style="font-family:inherit;font-size:10pt;">$34.5 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> respectively.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings.&#160; Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings, and are then reclassified to earnings in the same account as the hedged transaction.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur. Gains and losses on net investment hedge are accounted through the currency translation account within accumulated other comprehensive income.&#160; The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fiscal second quarter of 2016, the Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the balance of deferred net loss on derivatives included in accumulated other comprehensive income was </font><font style="font-family:inherit;font-size:10pt;">$195 million</font><font style="font-family:inherit;font-size:10pt;">&#160;after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note&#160;13. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the </font><font style="font-family:inherit;font-size:10pt;">next 12 months</font><font style="font-family:inherit;font-size:10pt;"> as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is </font><font style="font-family:inherit;font-size:10pt;">18 months</font><font style="font-family:inherit;font-size:10pt;">, excluding interest rate contracts, net investment hedges and equity collar contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is a summary of the activity related to derivatives and hedges for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 30, 2018</font></div></td><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of Products Sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest (Income) Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (Income) Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of Products Sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest (Income) Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (Income) Expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The effects of fair value, net investment and cash flow hedging:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain (Loss) on fair value hedging relationship:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Interest rate swaps contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;Hedged items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;Derivatives designated as hedging instruments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain (Loss) on net investment hedging relationship:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cross currency interest rate swaps contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain (Loss) on cash flow hedging relationship:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Forward foreign exchange contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(220</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(159</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(165</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(193</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(199</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(60</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cross currency interest rate swaps contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Includes equity collar contracts. The equity collar contracts expired in December of 2017.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.7265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the following amounts were recorded on the Consolidated Balance Sheet </font></div><div style="line-height:120%;padding-bottom:9px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Line item in the Consolidated Balance Sheet in which the hedged item is included</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount of the Hedged Liability</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current Portion of Long-term Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term Debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is the effect of derivatives not designated as hedging instrument for the fiscal years ended December&#160;30, 2018 and December&#160;31, 2017:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain /(Loss) Recognized in Income on Derivative</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized In</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income on Derivative</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives Not Designated as Hedging Instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ffffff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Exchange Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is the effect of net investment hedges for the fiscal years ended December&#160;30, 2018 and December&#160;31, 2017:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized In</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated OCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain/(Loss) Reclassified From</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Into Income</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Currency interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted ASU 2016-01: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities as of the beginning of the fiscal year 2018. This ASU amends prior guidance to classify equity investments with readily determinable market values into different categories (that is, trading or available-for-sale) and require equity investments to be measured at fair value with changes in fair value recognized through net earnings. The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 which increased retained earnings by </font><font style="font-family:inherit;font-size:10pt;">$232 million</font><font style="font-family:inherit;font-size:10pt;">, net of tax, and decreased accumulated other comprehensive income for previously net unrealized gains from equity investments. </font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is a summary of the activity related to equity investments as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in Fair Value Reflected in Net Income </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Sales/ Purchases/Other </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non Current Other Assets</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity Investments with readily determinable value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity Investments without readily determinable value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">Recorded in Other Income/Expense</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (2)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">Other includes impact of currency</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For equity investments without readily determinable market values, </font><font style="font-family:inherit;font-size:10pt;">$54 million</font><font style="font-family:inherit;font-size:10pt;"> of the changes in fair value reflected in net income were the result of impairments. There were </font><font style="font-family:inherit;font-size:10pt;">$67 million</font><font style="font-family:inherit;font-size:10pt;"> of changes in fair value reflected in net income due to changes in observable prices. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, changes in fair value reflected within other comprehensive income due to previously unrealized gains on equity investments with readily determinable fair values net of tax was a net gain of </font><font style="font-family:inherit;font-size:10pt;">$232 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level&#160;1 having the highest priority and Level&#160;3 having the lowest.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and subsequently converted to the U.S.&#160;Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company&#8217;s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level&#160;1 and debt securities which are classified as Level 2. The Company did not have any other significant financial assets or liabilities which would require revised valuations under this standard that are recognized at fair value.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following three levels of inputs are used to measure fair value:</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;1&#160;&#8212; Quoted prices in active markets for identical assets and liabilities.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;2&#160;&#8212; Significant other observable inputs.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;3&#160;&#8212; Significant unobservable inputs.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate contracts </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)(4) </sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">662</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">662</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">425</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate contracts </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">567</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Available For Sale Other Investments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investments</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">751</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.46875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross to Net Derivative Reconciliation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Gross Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Support Agreement (CSA)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(76</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Net Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">271</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Gross Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">872</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Support Agreement (CSA)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(605</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Net Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 assets and liabilities are all classified as Level&#160;2 with the exception of equity investments of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$751 million</font><font style="font-family:inherit;font-size:10pt;">, which are classified as Level&#160;1.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$7 million</font><font style="font-family:inherit;font-size:10pt;"> of non-current assets for the fiscal years ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9 million</font><font style="font-family:inherit;font-size:10pt;"> of non-current liabilities for the fiscal years ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes cross currency interest rate swaps and interest rate swaps.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classified as non-current other assets. The carrying amount of the equity investments were </font><font style="font-family:inherit;font-size:10pt;">$511 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$751 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup>&#160;</font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;text-indent:-24px;"><font style="font-family:inherit;font-size:10pt;">Classified as cash equivalents and current marketable securities.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Notes&#160;2 and 7 for financial assets and liabilities held at carrying amount on the Consolidated Balance Sheet.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price allocation to the identifiable intangible assets is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:54.82926829268293%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets with definite lives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents and trademarks*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total amortizable intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,230</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">25,010</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">International Currency Translation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For translation of its subsidiaries operating in non-U.S.&#160;Dollar currencies, the Company has determined that the local currencies of its international subsidiaries are the functional currencies except those in highly inflationary economies, which are defined as those which have had compound cumulative rates of inflation of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100% or more during the past three years</font><font style="font-family:inherit;font-size:10pt;">, or where a substantial portion of its cash flows are not in the local currency. Beginning in the fiscal third quarter of 2018, the Company accounted for operations in Argentina as highly inflationary. For the majority of the Company's subsidiaries the local currency is the functional currency. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In consolidating international subsidiaries, balance sheet currency effects are recorded as a component of accumulated other comprehensive income. This equity account includes the results of translating certain balance sheet assets and liabilities at current exchange rates and some accounts at historical rates, except for those located in highly inflationary economies. The translation of balance sheet accounts for highly inflationary economies are reflected in the operating results.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A rollforward of the changes during </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> for foreign currency translation adjustments is included in Note&#160;13. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net currency transaction gains and losses included in Other (income) expense were losses of </font><font style="font-family:inherit;font-size:10pt;">$265 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$216 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$289 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets and Goodwill</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, the gross and net amounts of intangible assets were:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible assets with definite lives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents and trademarks&#160;&#8212; gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,194</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,427</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,784</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents and trademarks&#160;&#8212; net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">25,410</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">29,204</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships and other intangibles&#160;&#8212; gross</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,204</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,323</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,463</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships and other intangibles&#160;&#8212; net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13,011</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12,741</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible assets with indefinite lives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased in-process research and development</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,253</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets with indefinite lives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,190</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11,283</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets&#160;&#8212; net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">47,611</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">53,228</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></font><font style="font-family:inherit;font-size:9pt;">The decrease was primarily attributable to the write-down of </font><font style="font-family:inherit;font-size:9pt;">$1.1 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the assets acquired in the acquisitions of Alios Biopharma Inc. (Alios) and XO1 Limited (XO1). Of the </font><font style="font-family:inherit;font-size:9pt;">$1.1 billion</font><font style="font-family:inherit;font-size:9pt;">, the Company recorded a partial impairment charge of </font><font style="font-family:inherit;font-size:9pt;">$0.8 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios. The impairment charge was calculated based on updated cash flow projections discounted for the inherent risk in the asset development and reflects the impact of the phase 2b clinical trial suspension, a decrease in the probability of success factors and the ongoing analysis of asset development activities. In addition, an impairment charge of </font><font style="font-family:inherit;font-size:9pt;">$0.3 billion</font><font style="font-family:inherit;font-size:9pt;"> was recorded for the discontinuation of the development project for an anti-thrombin antibody associated with the 2015 acquisition of XO1. Additionally, </font><font style="font-family:inherit;font-size:9pt;">$0.8 billion</font><font style="font-family:inherit;font-size:9pt;"> of IPR&amp;D related to ERLEADA</font><font style="font-family:inherit;font-size:10pt;">&#8482;</font><font style="font-family:inherit;font-size:9pt;"> was reclassified to definite lived intangible assets upon commercialization. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as allocated by segment of business, was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consumer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Medical Devices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill at January 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,263</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,805</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to acquisitions</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,161</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,200</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to divestitures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation/other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,109</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,906</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to divestitures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation/other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(373</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(97</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill at December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,063</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12,720</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">30,453</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> Goodwill of </font><font style="font-family:inherit;font-size:9pt;">$6.2 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the Actelion acquisition acquired in the fiscal second quarter of 2017, within the Pharmaceutical segment and </font><font style="font-family:inherit;font-size:9pt;">$1.7 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the AMO acquisition acquired in the fiscal first quarter of 2017, within the Medical Devices segment. </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font><font style="font-family:inherit;font-size:9pt;"> Goodwill of </font><font style="font-family:inherit;font-size:9pt;">$1.0 billion</font><font style="font-family:inherit;font-size:9pt;"> is related to the divestiture of the LifeScan business. Goodwill of </font><font style="font-family:inherit;font-size:9pt;">$0.3 billion</font><font style="font-family:inherit;font-size:9pt;"> is related to the divestiture of the Advanced Sterilization Products business, which was pending and classified as assets held for sale on the Consolidated Balance Sheet as of December 30, 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted average amortization periods for patents and trademarks and customer relationships and other intangible assets are </font><font style="font-family:inherit;font-size:10pt;">11 years</font><font style="font-family:inherit;font-size:10pt;">&#160;and </font><font style="font-family:inherit;font-size:10pt;">22 years</font><font style="font-family:inherit;font-size:10pt;">, respectively. The amortization expense of amortizable assets included in cost of products sold was </font><font style="font-family:inherit;font-size:10pt;">$4.4 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$3.0 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.2 billion</font><font style="font-family:inherit;font-size:10pt;"> before tax, for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">January&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. The estimated amortization expense for the five succeeding years approximates </font><font style="font-family:inherit;font-size:10pt;">$4.3 billion</font><font style="font-family:inherit;font-size:10pt;"> before tax, per year. Intangible asset write-downs are included in Other (income) expense, net.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 20 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets and Goodwill</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The authoritative literature on U.S.&#160;GAAP requires that goodwill and intangible assets with indefinite lives be assessed annually for impairment. The Company completed the annual impairment test for 2018 in the fiscal fourth quarter. Future impairment tests will be performed annually in the fiscal fourth quarter, or sooner if warranted. Purchased in-process research and development is accounted for as an indefinite lived intangible asset until the underlying project is completed, at which point the intangible asset will be accounted for as a definite lived intangible asset, or abandoned, at which point the intangible asset will be written off or partially impaired.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets that have finite useful lives continue to be amortized over their useful lives, and are reviewed for impairment when warranted by economic conditions. See Note&#160;5 for further details on Intangible Assets and Goodwill.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:5px;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for taxes on income consists of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.6341463414634%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Currently payable:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,081</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,969</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes on international operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,434</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,872</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,659</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total currently payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,718</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,604</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,956</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes on international operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,362</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(635</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,406</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Provision for taxes on income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,702</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">16,373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,263</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A comparison of income tax expense at the U.S.&#160;statutory rate of </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, to the Company&#8217;s effective tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,865</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,808</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,346</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before taxes on income:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,999</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,673</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,803</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax rates:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International operations </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and orphan drug tax credits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. state and local</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. manufacturing deduction</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. tax on international income </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefits on share-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. tax benefit on asset/business disposals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">TCJA and related impacts </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective Rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) For all periods presented the Company has subsidiaries operating in Puerto Rico under various tax incentives. International operations reflects the impacts of operations in jurisdictions with statutory tax rates different than the U.S., particularly Ireland, Switzerland and Puerto Rico, which is a favorable impact on the effective tax rate as compared with the U.S. statutory rate. The 2017 amount also includes tax cost related to the revaluation of deferred tax balances related to the change in the Belgian statutory tax rate increasing the tax provision by approximately </font><font style="font-family:inherit;font-size:8pt;">3.4%</font><font style="font-family:inherit;font-size:8pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2) Includes the impact of the GILTI tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3) Represents impact of adjustments to the 2017 TCJA provisional tax charge. This also includes a net tax benefit from the reduction of a deferred tax liability related to foreign withholding taxes originally accrued as part of the provisional charge. This benefit reduced the Company&#8217;s effective tax rate by approximately </font><font style="font-family:inherit;font-size:8pt;">11%</font><font style="font-family:inherit;font-size:8pt;">. Further description is included below.</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4) Includes U.S. state and local taxes provisionally recorded as part TCJA provisional charge which was approximately </font><font style="font-family:inherit;font-size:8pt;">0.6%</font><font style="font-family:inherit;font-size:8pt;"> of the total effective tax rate.</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the United States enacted into law new U.S. tax legislation, the Tax Cuts and Jobs Act (TCJA).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This law included provisions for a comprehensive overhaul of the corporate income tax code, including a reduction of the statutory corporate tax rate from 35% to 21%, effective on January 1, 2018. This legislation also eliminated or reduced certain corporate income tax deductions as well as introduced new provisions that taxed certain foreign income not previously taxed by the United States. The TCJA also included a provision for a tax on all previously undistributed earnings of U.S. companies located in foreign jurisdictions. Undistributed earnings in the form of cash and cash equivalents were taxed at a rate of 15.5% and all other earnings are taxed at a rate of 8.0%. This tax is payable over 8 years and will not accrue interest and these payments began in 2018 and will continue through 2025. The remaining balance at the end of the fiscal year 2018 was approximately </font><font style="font-family:inherit;font-size:10pt;">$8.2 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the SEC provided regulatory guidance for accounting of the impacts of the TCJA, referred to as SAB 118. Under the guidance in SAB 118, the income tax effects, which the accounting under ASC 740 is incomplete, are reported as a provisional amount based on a reasonable estimate. The reasonable estimate is subject to adjustment during a "measurement period", not to exceed one year, until the accounting is complete. The estimate is also subject to the finalization of management&#8217;s analysis related to certain matters, such as developing interpretations of the provision of the TCJA, changes to certain estimates and amounts related to the earnings and profits of certain subsidiaries and the filing of tax returns.</font></div><div style="line-height:120%;text-align:left;text-indent:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2017, the Company recorded a provisional tax cost of approximately </font><font style="font-family:inherit;font-size:10pt;">$13.0 billion</font><font style="font-family:inherit;font-size:10pt;"> which consisted primarily of the following components: </font></div><div style="line-height:120%;text-align:left;text-indent:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> a </font><font style="font-family:inherit;font-size:10pt;">$10.1 billion</font><font style="font-family:inherit;font-size:10pt;"> charge on previously undistributed foreign earnings as of December 31, 2017</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> a </font><font style="font-family:inherit;font-size:10pt;">$4.5 billion</font><font style="font-family:inherit;font-size:10pt;"> deferred tax liability for foreign local and withholding taxes, offset by a </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> deferred tax asset for U.S. foreign tax credits, for repatriation of substantially all those earnings</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a </font><font style="font-family:inherit;font-size:10pt;">$0.6 billion</font><font style="font-family:inherit;font-size:10pt;"> tax benefit relating to the remeasurement of U.S. deferred tax assets and liabilities and the impact of the TCJA on unrecognized tax benefits</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> charge for U.S. state and local taxes on the repatriation of these foreign earnings </font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018, the Company completed its full assessment and finalized the accounting for the impact of TCJA. The Company recorded net adjustments to the above components of the provisional charge of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;">. These revisions were based on updated estimates and additional analysis by management as well as applying interpretative guidance issued by the U.S. Department of Treasury to the </font><font style="font-family:inherit;font-size:10pt;color:#333333;">facts and circumstances that existed as of the TCJA enactment date. </font><font style="font-family:inherit;font-size:10pt;">This charge was primarily related to additional deferred tax liabilities for foreign local and withholding taxes for the remaining balance of undistributed foreign earnings as of December 31, 2017 that were not provided for in the provisional charge in the fourth quarter of 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The TCJA also includes provisions for a tax on global intangible low-taxed income (GILTI). GILTI is described as the excess of a U.S. shareholder&#8217;s total net foreign income over a deemed return on tangible assets, as provided by the TCJA. In January 2018, the FASB issued guidance that allows companies to elect as an accounting policy whether to record the tax effects of GILTI in the period the tax liability is generated (i.e., &#8220;period cost&#8221;) or provide for deferred tax assets and liabilities related to basis differences that exist and are expected to effect the amount of GILTI inclusion in future years upon reversal (i.e., &#8220;deferred method&#8221;). Through the third fiscal quarter of 2018, the Company had provisionally elected to treat GILTI as a period expense. Upon further analysis of this new tax provision, the Company has elected to account for GILTI under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred. As a result of this election, the Company recorded a deferred tax cost related to GILTI of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.4 billion</font><font style="font-family:inherit;font-size:10pt;"> in the fourth fiscal quarter of 2018 related to facts and circumstances that existed on the date of TCJA enactment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of the GILTI deferred tax charge and the other adjustments to the provisional amount, the Company recorded a total of </font><font style="font-family:inherit;font-size:10pt;">$1.6 billion</font><font style="font-family:inherit;font-size:10pt;"> of adjustments to the 2017 provisional charge increasing the Company&#8217;s annual effective tax rate by approximately </font><font style="font-family:inherit;font-size:10pt;">9%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2018, the Company reorganized the ownership structure of certain foreign subsidiaries which resulted in a reduction of certain foreign withholding taxes that it had recognized as part of the provisional TCJA tax charge in the fourth quarter of 2017. Following the completion of this restructuring in the fourth quarter 2018, and as a result of clarification by Swiss tax authorities regarding the applicability of withholding tax to repatriation of certain earnings, the Company reversed a deferred tax liability of </font><font style="font-family:inherit;font-size:10pt;">$2.8 billion</font><font style="font-family:inherit;font-size:10pt;"> and a related deferred tax asset of </font><font style="font-family:inherit;font-size:10pt;">$0.9 billion</font><font style="font-family:inherit;font-size:10pt;"> for U.S. foreign tax credits, for a net deferred tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$1.9 billion</font><font style="font-family:inherit;font-size:10pt;">. As this restructuring occurred after the TCJA enactment date, the benefit is not considered an adjustment to the provisional amount recorded in 2017 under SAB118. This benefit with the SAB 118 adjustments has been reflected as &#8220;TCJA and related impacts&#8221; on the Company&#8217;s effective tax rate reconciliation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As described in Note 1 to the Consolidated Financial Statements, in 2018 the Company adopted ASU 2016-16: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory. </font><font style="font-family:inherit;font-size:10pt;"> This standard requires entities to recognize deferred tax assets and liabilities related to transfer of assets, other than inventory, within the consolidated entity. At the beginning of fiscal 2018, the Company recorded a net adjustment to deferred tax assets of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;">. In the fourth quarter of 2018, as a result of the election to record GILTI on the deferred method, the Company recorded a GILTI deferred tax liability of </font><font style="font-family:inherit;font-size:10pt;">$1.7 billion</font><font style="font-family:inherit;font-size:10pt;"> related to the adoption provisions of ASU 2016-16 as an adjustment to retained earnings.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2018 effective tax rate decreased by </font><font style="font-family:inherit;font-size:10pt;">77.6%</font><font style="font-family:inherit;font-size:10pt;"> compared to 2017. The 2017 effective tax rate was primarily driven by the approximately </font><font style="font-family:inherit;font-size:10pt;">$13 billion</font><font style="font-family:inherit;font-size:10pt;"> provisional tax charge recorded in the fourth quarter of 2017 and the impact of a Belgian statutory tax rate change which increased the 2017 effective rate by </font><font style="font-family:inherit;font-size:10pt;">3.4%</font><font style="font-family:inherit;font-size:10pt;">. Additional drivers of the 2018 annual effective tax were:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the reduction of the U.S. statutory corporate tax rate including the effects of tax elections which resulted in the acceleration of certain deductions into the 2017 tax return. The impact of these accelerated deductions decreased the annual effective tax rate by approximately </font><font style="font-family:inherit;font-size:10pt;">1.7%</font><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of the adjustments to the 2017 provisional TCJA charge, including both SAB 118 adjustments and the internal restructuring, decreased the effective tax rate by approximately </font><font style="font-family:inherit;font-size:10pt;">1.9%</font><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GILTI tax which increased the annual effective tax rate by approximately </font><font style="font-family:inherit;font-size:10pt;">1.6%</font><font style="font-family:inherit;font-size:10pt;">, which excludes the impact of the SAB 118 adjustment for the adoption of the deferred method for GILTI</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">tax benefits received from stock-based compensation during fiscal 2018 and 2017, reduced the effective tax rate by </font><font style="font-family:inherit;font-size:10pt;">1.5%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2.0%</font><font style="font-family:inherit;font-size:10pt;">, respectively</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">in the fourth quarter of 2018, the Company completed the divestiture of its LifeScan business (Note 20), which increased the Company annual effective tax rate by approximately </font><font style="font-family:inherit;font-size:10pt;">0.8%</font><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">more income in higher tax jurisdictions relative to lower tax jurisdictions as compared to 2017</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 effective tax rate increased by </font><font style="font-family:inherit;font-size:10pt;">76.1%</font><font style="font-family:inherit;font-size:10pt;"> as compared to 2016, primarily driven by the enactment of the TCJA in the U.S. in December 2017. The enactment of the TCJA resulted in a provisional tax charge in the fourth quarter of 2017, of approximately </font><font style="font-family:inherit;font-size:10pt;">$13.0 billion</font><font style="font-family:inherit;font-size:10pt;"> or approximately </font><font style="font-family:inherit;font-size:10pt;">73.3</font><font style="font-family:inherit;font-size:10pt;"> percentage point increase to the effective tax rate. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The remainder of the increase in the tax rate for 2017 was related to the remeasurement of the Company&#8217;s deferred tax assets in Belgium, as a result of changes in the Belgian statutory corporate tax rate enacted in December 2017, offset by a tax benefit for the closure of the Company&#8217;s Animas insulin pump business. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary differences and carryforwards for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.92682926829268%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018 Deferred Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017 Deferred Tax</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liability</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee related obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,398</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,259</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">639</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">507</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation &amp; amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,967</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,506</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International R&amp;D capitalized for tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserves&#160;&amp; liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,647</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,718</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income reported for tax purposes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss carryforward international</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">762</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Undistributed foreign earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Global intangible low-taxed income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,971</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Miscellaneous international</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Miscellaneous U.S.&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">469</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11,405</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(11,271</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,902</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(11,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has wholly-owned international subsidiaries that have cumulative net losses. The Company believes that it is more likely than not that these subsidiaries will generate future taxable income sufficient to utilize these deferred tax assets.</font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to unrecognized tax benefits:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.1951219512195%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to prior period tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decreases related to prior period tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(416</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(338</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lapse of statute of limitations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">End of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,326</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,151</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,041</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;"> In 2017, </font><font style="font-family:inherit;font-size:8pt;">$347 million</font><font style="font-family:inherit;font-size:8pt;"> of this decrease is related to the TCJA</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unrecognized tax benefits of </font><font style="font-family:inherit;font-size:10pt;">$3.3 billion</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, if recognized, would affect the Company&#8217;s annual effective tax rate. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress with a number of tax authorities. The IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010-2012. The Company currently expects completion of this audit during 2019. Final conclusion of the tax audit may result in an outcome that is different than the Company&#8217;s estimates and may result in a material impact on the Company&#8217;s current and future operating results or cash flows in the period that the audit is concluded.&#160;In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that audits may be completed by tax authorities in some jurisdictions over the next twelve months.&#160; However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company classifies liabilities for unrecognized tax benefits and related interest and penalties as long-term liabilities. Interest expense and penalties related to unrecognized tax benefits are classified as income tax expense. The Company recognized after tax interest expense of </font><font style="font-family:inherit;font-size:10pt;">$53 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$60 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total amount of accrued interest was </font><font style="font-family:inherit;font-size:10pt;">$503 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$436 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between U.S. GAAP accounting and tax reporting, recorded as deferred tax assets or liabilities. The Company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. Future changes in tax laws and rates may affect recorded deferred tax assets and liabilities in the future. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has unrecognized tax benefits for uncertain tax positions. The Company follows U.S. GAAP which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management believes that changes in these estimates would not have a material effect on the Company's results of operations, cash flows or financial position.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth fiscal quarter of 2018, the Company has elected to account for the GILTI tax under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recorded deferred tax liabilities on all undistributed earnings prior to December 31, 2017 from its international subsidiaries. The Company has not provided deferred taxes on the undistributed earnings subsequent to January 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. The Company intends to continue to reinvest these earnings in those international operations. If the Company decides at a later date to repatriate these earnings to the U.S., the Company would be required to provide for the net tax effects on these amounts. The Company estimates that the total tax effect of this repatriation would be approximately $0.7 billion under current enacted tax laws and regulations and at current currency exchange rates. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, inventories were comprised of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:89.84375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials and supplies</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goods in process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,109</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,317</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,376</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,308</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total inventories</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,599</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,765</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></font><font style="font-family:inherit;font-size:9pt;">Net of assets held for sale on the Consolidated Balance Sheet for approximately </font><font style="font-family:inherit;font-size:9pt;">$0.2 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the divestiture of the Advanced Sterilization Products business and </font><font style="font-family:inherit;font-size:9pt;">$0.3 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost or net realizable value determined by the first-in, first-out method.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments</font></div><div style="line-height:120%;padding-top:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments classified as held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income. Available-for-sale securities available for current operations are classified as current assets otherwise, they are classified as long term. Management determines the appropriate classification of its investment in debt and equity securities at the time of purchase and re-evaluates such determination at each balance sheet date. The Company reviews its investments in equity securities for impairment and adjusts these investments to fair value through earnings, as required.&#160;</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Rental Expense and Lease Commitments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rentals of space, vehicles, manufacturing equipment and office and data processing equipment under operating leases were approximately </font><font style="font-family:inherit;font-size:10pt;">$332 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$372 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$330 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:5px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The approximate minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are:</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Dollars in Millions)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.7734375%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">After 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">896</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commitments under capital leases are not significant.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability, intellectual property, commercial, supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions. The ability to make such estimates and judgments can be affected by various factors, including whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; or there are numerous parties involved.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">PRODUCT LIABILITY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The most significant of these cases include: the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; the PINNACLE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Acetabular Cup System; pelvic meshes; RISPERDAL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">; XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">; body powders containing talc, primarily JOHNSONS</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Baby Powder; INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">; and ETHICON PHYSIOMESH</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">Flexible Composite Mesh. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, in the United States there were approximately </font><font style="font-family:inherit;font-size:10pt;">1,800</font><font style="font-family:inherit;font-size:10pt;"> plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; </font><font style="font-family:inherit;font-size:10pt;">10,500</font><font style="font-family:inherit;font-size:10pt;"> with respect to the PINNACLE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Acetabular Cup System; </font><font style="font-family:inherit;font-size:10pt;">34,800</font><font style="font-family:inherit;font-size:10pt;"> with respect to pelvic meshes; </font><font style="font-family:inherit;font-size:10pt;">13,400</font><font style="font-family:inherit;font-size:10pt;"> with respect to RISPERDAL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">; </font><font style="font-family:inherit;font-size:10pt;">25,600</font><font style="font-family:inherit;font-size:10pt;"> with respect to XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">; </font><font style="font-family:inherit;font-size:10pt;">13,000</font><font style="font-family:inherit;font-size:10pt;"> with respect to body powders containing talc; </font><font style="font-family:inherit;font-size:10pt;">1,050</font><font style="font-family:inherit;font-size:10pt;"> with respect to INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">;</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2,100</font><font style="font-family:inherit;font-size:10pt;"> with respect to ETHICON PHYSIOMESH</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Flexible Composite Mesh.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> XL Acetabular System and DePuy ASR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson &amp; Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than </font><font style="font-family:inherit;font-size:10pt;">10,000</font><font style="font-family:inherit;font-size:10pt;"> claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Qu&#233;bec Superior Court and the Supreme Court of British Columbia. The British Columbia order is currently the subject of an appeal. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> Hip-related product liability litigation. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson &amp; Johnson (collectively, DePuy) relating to the PINNACLE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Acetabular Cup System used in hip replacement surgery. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States. Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial, the second remains under appeal and the third is pending decision on post-trial motions in the district court. The Company has established an accrual for product liability litigation associated with the PINNACLE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Acetabular Cup System.&#160;The Company is negotiating settlements of these cases and the related costs are reflected in the Company&#8217;s accruals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson &amp; Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Southern District of West Virginia. The Company has settled or otherwise resolved a majority of the United States cases and the costs associated with these settlements are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands and Belgium, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices. In Australia, a trial of class action issues has been completed and the parties are awaiting a decision. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh products.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson &amp; Johnson alleging personal injury arising out of the use of this hernia mesh device.&#160; Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.&#160; Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">Flexible Composite Mesh.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson arising out of the use of RISPERDAL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism, and related compounds. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims for personal injury arising out of the use of XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson &amp; Johnson; and JPI's collaboration partner for XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Bayer AG and certain of its affiliates. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania; and there are coordinated proceedings in Delaware, California and Missouri. Class action lawsuits also have been filed in Canada. The Company has established an accrual for defense costs only in connection with product liability litigation associated with XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Personal injury claims alleging that talc causes cancer have been made against Johnson &amp; Johnson Consumer Inc. and Johnson &amp; Johnson arising out of the use of body powders containing talc, primarily JOHNSONS</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Baby Powder. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a verdict in July 2018 of </font><font style="font-family:inherit;font-size:10pt;">$4.7 billion</font><font style="font-family:inherit;font-size:10pt;">. The Company believes that it has strong grounds on appeal to overturn these verdicts. The Company has established an accrual for defense costs only in connection with product liability litigation associated with body powders containing talc. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, a securities class action lawsuit was filed against Johnson &amp; Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson &amp; Johnson violated the federal securities laws by failing to adequately disclose the alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Baby Powder, and that purchasers of Johnson &amp; Johnson&#8217;s shares suffered losses as a result.&#160; Plaintiffs are seeking damages.&#160; In October 2018, a shareholder derivative lawsuit was filed against Johnson &amp; Johnson as the nominal defendant and its current directors as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Baby Powder, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches.&#160; Plaintiff is seeking damages and an order for the Company to reform its internal policies and procedures.&#160; In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson &amp; Johnson Savings Plan against Johnson &amp; Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson &amp; Johnson stock as a Johnson &amp; Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">Baby Powder. &#160;Plaintiffs are seeking damages and injunctive relief. &#160;Each of these matters will be adjudicated in conjunction with the multi-district litigation referenced in the prior paragraph. In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice and the Securities and Exchange Commission. The Company is cooperating with these government inquiries and will be producing documents in response. &#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims for personal injury have been made against a number of Johnson &amp; Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson, arising out of the use of INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts in Pennsylvania, California and New Jersey. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">INTELLECTUAL PROPERTY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain subsidiaries of Johnson &amp; Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company&#8217;s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Medical Devices</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2009, Rembrandt Vision Technologies, L.P. (Rembrandt) filed a patent infringement lawsuit against Johnson &amp; Johnson Vision Care, Inc. (JJVCI) in the United States District Court for the Eastern District of Texas alleging that JJVCI's manufacture and sale of its ACUVUE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> ADVANCE and ACUVUE OASYS</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Hydrogel Contact Lenses infringed Rembrandt&#8217;s United States Patent No. 5,712,327 and seeking monetary relief. The case was transferred to the United States District Court for the Middle District of Florida, where a trial in May 2012 resulted in a verdict of non-infringement that was subsequently upheld on appeal. In July 2014, Rembrandt sought a new trial based on alleged new evidence, which the district court denied. In April 2016, the Court of Appeals overturned that ruling and remanded the case to the district court for a new trial. A new trial was held in August 2017, and the jury returned a verdict of non-infringement in favor of JJVCI. Rembrandt has appealed the verdict to the United States Court of Appeals for the Federal Circuit (CAFC). In February 2019, the CAFC affirmed the judgment in favor of JJVCI. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2013, Medinol Ltd. (Medinol) filed a patent infringement lawsuit against Cordis Corporation (Cordis) and Johnson &amp; Johnson in the United States District Court for the Southern District of New York alleging that Cordis&#8217;s sales of the CYPHER</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> and CYPHER SELECT</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> stents made in the United States since 2005 willfully infringed four of Medinol's patents directed to the geometry of articulated stents. Medinol is seeking damages and attorneys&#8217; fees. Although Johnson &amp; Johnson has since sold Cordis, it has retained liability for this case. After trial in January 2014, the district court dismissed the case, finding Medinol unreasonably delayed bringing its claims (the laches defense). In September 2014, the district court denied a motion by Medinol to vacate the judgment and grant it a new trial. Medinol appealed the decision to the United States Court of Appeals for the Federal Circuit. In March 2017, the United States Supreme Court held that the laches defense is not available in patent cases. In April 2018, the United States Court of Appeals for the Federal Circuit remanded the case back to the district court to reconsider Medinol&#8217;s motion for a new trial, and briefing in the district court was completed in June 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants. MedIdea alleges infringement of United States Patent Nos. 6,558,426 (&#8217;426); 8,273,132 (&#8217;132); 8,721,730 (&#8217;730) and 9,492,280 (&#8217;280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAM</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;"> Contact feature of the ATTUNE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts. A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the &#8217;132, &#8217;730 and &#8217;280 patents, based on the district court&#8217;s claim construction and reserving its right to appeal that construction, leaving only the &#8217;426 patent at issue before the district court. In January 2019, the district court stayed the case pending a decision in the Inter Partes Review proceeding on the &#8217;426 patent (see below). In December 2017, DePuy Synthes Products, Inc. filed a Petition for Inter Partes Review with the United States Patent and Trademark Office (USPTO), seeking to invalidate the two claims of the &#8217;426 patent asserted in the district court litigation, and in June 2018, the USPTO instituted review of those claims. A hearing trial is scheduled for March 2019, and a decision in the proceeding is due by June 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (the &#8217;735 patent); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (the &#8217;284 patent), are either invalid or not infringed by Ethicon&#8217;s ENSEAL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the &#8217;735 patent, the &#8217;284 patent and United States Patent Nos. 8,323,310 (the &#8217;310 patent); 9,084,608; 9,241,759 (the &#8217;759 patent) and 9,113,882, and seeking damages and an injunction. Covidien filed a motion for preliminary injunction, which was denied in October 2017. The parties have entered joint stipulations such that only the &#8217;735 patent, the &#8217;310 patent and the &#8217;759 patent remain in dispute. Trial is scheduled to begin in September 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2017, Board of Regents, The University of Texas System and Tissuegen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC alleging the manufacture and sale of VICRYL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Plus Antibacterial Sutures, MONOCRYL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Plus Antibacterial Sutures, PDS</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Plus Antibacterial Sutures, STRATAFIX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> POS</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Antibacterial Sutures and STRATAFIX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> MONOCRYL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">Plus Antibacterial Sutures infringe plaintiffs&#8217; United States Patent Nos. 6,596,296 and 7,033,603 directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent. UT is seeking damages and an injunction. In December 2018, Ethicon filed petitions with the USPTO, seeking Inter Partes Review (IPR) of both asserted patents. Those petitions have been stayed by the USPTO pending a decision by the U.S. Court of Appeals for the Federal Circuit in an unrelated case. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Pharmaceutical</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2016, MorphoSys AG, a German biotech company, filed a patent infringement lawsuit against Janssen Biotech, Inc. (JBI), Genmab U.S. Inc. and Genmab A/S (collectively, Genmab) in the United States District Court for the District of Delaware. MorphoSys alleged that JBI&#8217;s manufacture and sale of DARZALEX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> (daratumumab) willfully infringed MorphoSys&#8217; United States Patent Nos. 8,263,746, 9,200,061 and 9,785,590. MorphoSys sought money damages. JBI licenses patents and the commercial rights to DARZALEX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> from Genmab. In January 2019, the district court granted summary judgment in JBI and Genmab&#8217;s favor, invalidating the asserted claims of the patents-in-suit, and the parties filed a joint stipulation of dismissal of the action.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, Sandoz Ltd and Hexal AG (collectively, Sandoz) filed a lawsuit in the English High Court against G.D. Searle LLC, a Pfizer company (Searle) and Janssen Sciences Ireland UC (JSI) alleging that Searle&#8217;s supplementary protection certificate SPC/GB07/038 (SPC), which is exclusively licensed to JSI, is invalid and should be revoked. Janssen-Cilag Limited sells PREZISTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> (darunavir) in the United Kingdom pursuant to this license. In October 2016, Searle and JSI counterclaimed against Sandoz for threatened infringement of the SPC based on statements of its plans to launch generic darunavir in the United Kingdom. Sandoz admitted that its generic darunavir product would infringe the SPC if it is found valid. Searle and JSI are seeking an order enjoining Sandoz from marketing its generic darunavir before the expiration of the SPC. Following a trial in April 2017, the court entered a decision holding that the SPC is valid and granting a final injunction. Sandoz has appealed the court&#8217;s decision and the injunction is stayed pending the appeal. In January 2018, the court referred the issue on appeal to the Court of Justice for the European Union (CJEU) and stayed the proceedings pending the CJEU&#8217;s ruling on the issue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2018, Acerta Pharma B.V., AstraZeneca UK Ltd and AstraZeneca Pharmaceuticals LP filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Pharmacylics LLC and Abbvie Inc. (collectively, Abbvie), alleging that the manufacture and sale of IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> infringes U.S. Patent No. 7,459,554. Janssen Biotech, Inc., which commercializes IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> jointly with Abbvie, intervened in the action in November 2018. A trial is scheduled to begin in January 2021.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Related Cases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, Celltrion Healthcare Co. Ltd. and Celltrion Inc. (collectively, Celltrion) filed an application with the United States Food and Drug Administration (FDA) for approval to make and sell its own infliximab biosimilar. In March 2015, Janssen Biotech, Inc. (JBI) filed a lawsuit in the United States District Court for the District of Massachusetts against Celltrion and Hospira Healthcare Corporation (Hospira), which has exclusive marketing rights for Celltrion&#8217;s infliximab biosimilar in the United States, seeking, among other things, a declaratory judgment that their biosimilar product infringes or potentially infringes several JBI patents, including United States Patent No. 6,284,471 relating to REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">(infliximab) (the &#8217;471 patent) and United States Patent No. 7,598,083 (the &#8217;083 patent) directed to the cell culture media used to make Celltrion&#8217;s biosimilar. In August 2016, the district court granted both Celltrion&#8217;s and Hospira&#8217;s motions for summary judgment of invalidity of the &#8217;471 patent. JBI appealed those decisions to the United States Court of Appeals for the Federal Circuit. In January 2018, the Federal Circuit dismissed the appeal as moot based on its affirmance of a decision by the USPTO&#8217;s Patent Trial and Appeal Board affirming invalidity of the &#8217;471 patent.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, JBI filed two additional patent infringement lawsuits asserting the &#8217;083 patent, one against Celltrion and Hospira in the United States District Court for the District of Massachusetts and the other against HyClone Laboratories, Inc., the manufacturer of the cell culture media that Celltrion uses to make its biosimilar product, in the United States District Court for the District of Utah. On July 30, 2018 the district court granted Celltrion&#8217;s motion for summary judgment of non-infringement and entered an order dismissing the &#8217;083 lawsuit against Celltrion and Hospira. JBI appealed to the United States Court of Appeals for the Federal Circuit. The litigation against HyClone in Utah is stayed pending the outcome of the Massachusetts actions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The FDA approved the first infliximab biosimilar for sale in the United States in 2016, and a number of such products have been launched.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes lawsuits pending against generic companies that have filed Abbreviated New Drug Applications (ANDAs) with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson &amp; Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of generic versions of the products at issue to the market prior to the expiration of the relevant patents. The Inter Partes Review (IPR) process with the United States Patent and Trademark Office (USPTO), created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, Janssen Biotech, Inc., Janssen Oncology, Inc. and Janssen Research &amp; Development, LLC (collectively, Janssen) and BTG International Ltd. (BTG) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies (and certain of their affiliates and/or suppliers) who filed ANDAs seeking approval to market a generic version of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> 250mg before the expiration of United States Patent No. 8,822,438 (the &#8217;438 patent). The generic companies include Amneal Pharmaceuticals, LLC and Amneal Pharmaceuticals of New York, LLC (collectively, Amneal); Apotex Inc. and Apotex Corp. (collectively, Apotex); Citron Pharma LLC (Citron); Dr. Reddy&#8217;s Laboratories, Ltd. and Dr. Reddy&#8217;s Laboratories, Inc. (collectively, Dr. Reddy&#8217;s); Mylan Pharmaceuticals Inc. and Mylan Inc. (collectively, Mylan); Par Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. (collectively, Par); Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries, Inc. (collectively, Sun); Teva Pharmaceuticals USA, Inc. (Teva); Wockhardt Bio A.G.; Wockhardt USA LLC and Wockhardt Ltd. (collectively, Wockhardt); West-Ward Pharmaceutical Corp. (West-Ward) and Hikma Pharmaceuticals, LLC (Hikma). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Janssen and BTG also initiated patent infringement lawsuits in the United States District Court for the District of New Jersey against Amerigen Pharmaceuticals Limited (Amerigen) in May 2016, and Glenmark Pharmaceuticals, Inc. (Glenmark) in June 2016, each of whom filed an ANDA seeking approval to market its generic version of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the &#8217;438 patent. These lawsuits have been consolidated with the lawsuit filed in July 2015.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2015, Janssen and BTG filed an additional jurisdictional protective lawsuit against the Mylan defendants in the United States District Court for the Northern District of West Virginia, which has been stayed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, Janssen and BTG initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva, who filed an ANDA seeking approval to market a generic version of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> 500mg before the expiration of the &#8217;438 patent. This lawsuit has been consolidated with the lawsuit filed in July 2015.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, Janssen and BTG filed a patent infringement lawsuit against MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited (collectively, MSN) in United States District Court for the District of New Jersey based on its ANDA seeking approval for a generic version of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> prior to the expiration of the &#8217;438 patent. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2018, Janssen and BTG initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Qilu Pharmaceutical Co., Ltd. and Qilu Pharma, Inc. (collectively, Qilu), who filed an ANDA seeking approval to market a generic version of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the &#8217;438 patent.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, Janssen and BTG entered into a settlement agreement with Glenmark. In January 2018, Janssen dismissed its lawsuit against Sun after it withdrew its ANDA. In April 2018, Janssen and BTG entered into a settlement agreement with Apotex.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2018, the United States District Court for the District of New Jersey issued a ruling invalidating all asserted claims of the &#8217;438 patent. The court held that the patent claims would be infringed if the patent were valid. Janssen appealed the court&#8217;s decision. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2018, the United States Court of Appeals for the Federal Circuit denied Janssen&#8217;s request for an injunction pending appeal. As a result, several generic versions of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> have entered the market. Janssen has appealed the decision of the United States District Court for the District of New Jersey, and the oral argument on the appeal is scheduled for March 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The lawsuits against MSN and Qilu remain pending in the district courts. In each of these lawsuits, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the &#8217;438 patent.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Several generic companies including Amerigen, Argentum Pharmaceuticals LLC (Argentum), Mylan, Wockhardt, Actavis, Amneal, Dr. Reddy&#8217;s, Sun, Teva, West-Ward and Hikma filed Petitions for Inter Partes Review (IPR) with the USPTO, seeking to invalidate the &#8217;438 patent. In January 2018, the USPTO issued decisions finding the &#8217;438 patent claims unpatentable, and Janssen requested rehearing. In December 2018, the USPTO denied Janssen&#8217;s request for rehearing of the IPR decisions. Janssen filed an appeal, which was consolidated with the above-mentioned appeal of the decision of the United States District Court for the District of New Jersey.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2017, Janssen Inc. and Janssen Oncology, Inc. (collectively, Janssen) initiated two Notices of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) and the Minister of Health in Canada in response to Teva's filing Abbreviated New Drug Submissions (ANDS) and seeking approval to market generic versions of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">250mg and ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">500mg</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">before the expiration of Canadian Patent No. 2,661,422. In June 2018, the parties entered into a settlement agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">before the expiration of Canadian Patent No. 2,661,422. The federal court of Canada scheduled the Final Hearing for April 2019. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Apotex&#8217;s ANDS before the expiration of Janssen&#8217;s patent.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2019, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex and the Minister of Health in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a film-coated generic version of ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of Canadian Patent No. 2,661,422. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Apotex&#8217;s ANDS before the expiration of Janssen&#8217;s patent.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">B</font><font style="font-family:inherit;font-size:10pt;">eginning in October 2015, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before expiration of Bayer&#8217;s United States Patent Nos. 7,157,456, 7,585,860 and 7,592,339 relating to XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. JPI is the exclusive sublicensee of the asserted patents. The following generic companies are named defendants: Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. (collectively, Aurobindo); Breckenridge Pharmaceutical, Inc. (Breckenridge); InvaGen Pharmaceuticals Inc. (InvaGen); Micro Labs USA Inc. and Micro Labs Ltd (collectively, Micro); Mylan Pharmaceuticals Inc. (Mylan); Prinston Pharmaceuticals, Inc.; Sigmapharm Laboratories, LLC (Sigmapharm); Torrent Pharmaceuticals, Limited and Torrent Pharma Inc. (collectively, Torrent). Trial concluded in April 2018. In July 2018 the district court entered judgment against Mylan and Sigmapharm, holding that the asserted compound patent is valid and infringed. In September 2018, the district court entered judgment against the remaining defendants. None of the defendants appealed the judgment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in April 2017, JPI and Bayer Intellectual Property GmbH and Bayer AG (collectively, Bayer AG) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before expiration of Bayer AG&#8217;s United States Patent No. 9,539,218 (&#8217;218) relating to XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. JPI is the exclusive sublicensee of the asserted patent. The following generic companies are named defendants: Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc. (Alembic); Aurobindo; Breckenridge; InvaGen; Lupin Limited and Lupin Pharmaceuticals, Inc. (collectively, Lupin); Micro; Mylan; Sigmapharm; Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. (collectively, Taro) and Torrent. Lupin counterclaimed for declaratory judgment of noninfringement and invalidity of United States Patent No. 9,415,053, but Lupin dismissed its counterclaims after it was provided a covenant not to sue on that patent. Aurobindo, Taro, Torrent, Micro, Breckenridge, InvaGen, Sigmapharm, Lupin and Alembic have agreed to have their cases stayed and to be bound by the outcome of any final judgment rendered against any of the other defendants. The &#8217;218 cases have been consolidated for discovery and trial, and are currently set for trial in April 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2018, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. (collectively, Teva) who filed an ANDA seeking approval to market a generic version of XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before expiration of Bayer AG&#8217;s &#8217;218 patent. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In each of these lawsuits, JPI is seeking an order enjoining the defendants from marketing their generic versions of XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the relevant patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2018, Mylan filed a Petition for Inter Partes Review with the USPTO, seeking to invalidate the &#8217;218 patent. In December 2018, the USPTO issued a decision denying institution of Mylan&#8217;s Petition for Inter Partes Review.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PREZISTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2018, Janssen Products, L.P. and Janssen Sciences Ireland UC (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Laurus Labs, Ltd. and Pharmaq, Inc. (collectively, DRL) who filed an ANDA seeking approval to market generic versions of PREZISTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of United States Patent Nos. 8,518,987; 7,126,015; and 7,595,408. Trial is scheduled to begin in May 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2018, Janssen initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt Ltd., and Raks Pharma Pvt. Ltd. (collectively, Amneal), who filed an ANDA seeking approval to market generic versions of PREZISTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of United States Patent Nos. 8,518,987; 7,126,015; and 7,595,408. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In each of these lawsuits, Janssen is seeking an order enjoining the defendants from marketing its generic versions of PREZISTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the relevant patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">/INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research &amp; Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey, the United States District Court for the District of Colorado and the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and/or INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">before expiration of MTPC&#8217;s United States Patent Nos. 7,943,582 and/or 8,513,202 relating to INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. Janssen is the exclusive licensee of the asserted patents. The following generic companies are named defendants:&#160; Apotex Inc. and Apotex Corp. (Apotex); Aurobindo Pharma USA Inc. (Aurobindo); Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.; InvaGen Pharmaceuticals, Inc. (InvaGen); Prinston Pharmaceuticals Inc.; Dr. Reddy&#8217;s Laboratories, Inc. and Dr. Reddy&#8217;s Laboratories Ltd; Hetero USA, Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited; MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.; Laurus Labs Ltd.; Indoco Remedies Ltd.; Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); Teva Pharmaceuticals USA, Inc.; and Lupin Ltd. and Lupin Pharmaceuticals, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in July 2017, Janssen and MTPC filed patent infringement lawsuits in the United States District Court for the District of New Jersey and the United States District Court for the District of Colorado against Sandoz and InvaGen, who filed ANDAs seeking approval to market generic versions of INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and/or INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">before expiration of MTPC&#8217;s United States Patent No. 7,943,788 (the &#8217;788 patent) relating to INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">and against Zydus, who filed ANDAs seeking approval to market generic versions of INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;"> before expiration of the &#8217;788 patent, MTPC's United States Patent No. 8,222,219 relating to INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;"> and MTPC&#8217;s United States Patent No. 8,785,403 relating to INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, and against Aurobindo, who filed an ANDA seeking approval to market a generic version of INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before expiration of the &#8217;788 patent and the &#8217;219 patent relating to INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. Janssen is the exclusive licensee of the asserted patents. In October 2017, the Colorado lawsuits against Sandoz were dismissed. In December 2017, the Delaware lawsuits against Apotex and Teva were dismissed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2018, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Prinston, who filed an ANDA seeking approval to market a generic version of INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before expiration of the &#8217;788 patent relating to INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">and/or INVOKAMET</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the relevant patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">OPSUMIT</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) and Amneal Pharmaceuticals LLC (Amneal), each of whom filed an ANDA seeking approval to market a generic version of OPSUMIT</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">before the expiration of United States Patent No. 7,094,781. In the lawsuit, Actelion is seeking an order enjoining Zydus and Amneal from marketing generic versions of OPSUMIT</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the patent. In December 2018, the district court entered an order wherein one of the defendants, Amneal, stipulated to infringement. Trial is scheduled to commence in October 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">INVEGA SUSTENNA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of United States Patent No. 9,439,906. In the lawsuit, Janssen is seeking an order enjoining Teva from marketing a generic version of INVEGA SUSTENNA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of the patent. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Notices of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) and the Minister of Health in response to Teva's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> before the expiration of Canadian Patent Nos. 2,309,629 and 2,655,335. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Teva&#8217;s ANDS before the expiration of these patents. The Final Hearing is scheduled to begin in September 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">before expiration of Pharmacyclics&#8217; &#160;United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. JBI is the exclusive licensee of the asserted patents. The following generic companies are named defendants:&#160;Cipla Limited and Cipla USA Inc. (Cipla); Fresenius Kabi USA, LLC, Fresenius Kabi USA, Inc., and Fresenius Kabi Oncology Limited (Fresenius Kabi); Sandoz Inc. and Lek Pharmaceuticals d.d. (Sandoz); Shilpa Medicare Limited (Shilpa); Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited (Sun); Teva Pharmaceuticals USA, Inc. (Teva); and Zydus Worldwide DMCC and Cadila Healthcare Limited (Zydus). Trial is scheduled to begin in October 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2018, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Sun asserting newly issued United States Patent No. 10,004,746.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">before the expiration of the relevant patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2019, Pharmacyclics and JBI amended their complaints against Fresenius Kabi, Zydus, Teva and Sandoz to further allege infringement of U.S. Patent Nos. 10,106,548, and 10,125,140.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> 70 mg before the expiration of U.S. Patent Nos. 514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">GOVERNMENT PROCEEDINGS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Like other companies in the pharmaceutical and medical devices industries, Johnson &amp; Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Average Wholesale Price (AWP) Litigation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson and several of its pharmaceutical subsidiaries (the J&amp;J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&amp;J AWP Defendants were ultimately dismissed. The J&amp;J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. Two cases remain pending. In a case brought by Illinois, trial has been scheduled for March 2019. In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson &amp; Johnson and ALZA Corporation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Opioids Litigation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in 2014 and continuing to the present, Johnson &amp; Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than </font><font style="font-family:inherit;font-size:10pt;">1,600</font><font style="font-family:inherit;font-size:10pt;"> lawsuits brought by certain state and local governments related to the marketing of opioids, including DURAGESIC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, NUCYNTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and NUCYNTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> ER. To date, complaints against pharmaceutical companies, including Johnson &amp; Johnson and JPI, have been filed in state court by the state Attorneys General in Arkansas, Florida, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma and South Dakota. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama; Arkansas; California; Connecticut; Florida; Georgia; Illinois; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Mississippi; Missouri; Nevada; New Hampshire; New Jersey; New Mexico; New York; North Carolina; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Virginia; Washington; West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. In addition, the Province of British Columbia filed suit in Canada. These actions allege a variety of claims related to opioids marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. These cases are in early stages of litigation. In October 2017, Johnson &amp; Johnson and JPI were both served with a motion to consolidate </font><font style="font-family:inherit;font-size:10pt;">66</font><font style="font-family:inherit;font-size:10pt;"> pending matters into a federal Multi District Litigation in the Southern District of Ohio. In December 2017, the MDL was approved in the Northern District of Ohio and there are over </font><font style="font-family:inherit;font-size:10pt;">1,400</font><font style="font-family:inherit;font-size:10pt;"> cases that have been transferred to the MDL. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson &amp; Johnson and JPI were contacted by the Texas and Colorado Attorney General&#8217;s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. The multi-state coalition served Johnson &amp; Johnson and JPI with subpoenas as part of the investigation. Johnson &amp; Johnson and JPI have also received requests for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs regarding the sales, marketing, and educational strategies related to the promotion of opioids use.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Other</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson &amp; Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR&#8482; XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a qui tam case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies&#8217; motion to dismiss with prejudice, unsealed the qui tam complaint, and denied the qui tam relators&#8217; request for leave to file a further amended complaint. The qui tam relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court&#8217;s dismissal in part, reversed in part, and affirmed the decision to deny the relators&#8217; request to file a third amended complaint. The relators&#8217; remaining claims are now pending before the district court, and fact discovery is currently scheduled to close in September 2019. Additionally, DePuy filed a petition for certiorari with the United States Supreme Court, seeking review of the First Circuit&#8217;s decision. The Supreme Court denied the petition in April 2018.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since October 2013, a group of State Attorneys General have issued Civil Investigative Demands relating to the development, sales and marketing of several of DePuy Orthopaedics, Inc.'s hip products. In July 2014, the Oregon Department of Justice, which was investigating these matters independently of the other states, announced a settlement of its ASR&#8482; XL Hip device investigation</font><font style="font-family:inherit;font-size:10pt;color:#ff0000;"> </font><font style="font-family:inherit;font-size:10pt;">with the State of Oregon. In December 2018, the Company, the remaining states and the District of Columbia agreed to settle all of the investigations, and on January 22, 2019, the states and the Company filed consent judgments resolving the matter.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2012, Johnson &amp; Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson &amp; Johnson's subsidiary, Ethicon, Inc. (Ethicon). Johnson &amp; Johnson and Ethicon have since entered into a series of tolling agreements with the 47 states and the District of Columbia participating in the multi-state investigation and have responded to Civil Investigative Demands served by certain of the participating states. The states are seeking monetary and injunctive relief. In May 2016, California and Washington filed civil complaints against Johnson &amp; Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by Kentucky in August 2016 and by Mississippi in October 2017.&#160;Johnson &amp; Johnson and Ethicon have entered into a new tolling agreement with the remaining 43 states and the District of Columbia. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson &amp; Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> (methoxsalen) and the Uvar Xts</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and Cellex</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson &amp; Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson &amp; Johnson retains OCD&#8217;s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney&#8217;s Office requested that Johnson &amp; Johnson produce certain documents, and Johnson &amp; Johnson is cooperating with those requests. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI).&#160;The complaint alleges that defendants failed to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Baby Powder and JOHNSON'S</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief. Trial is stayed pending interlocutory appeal of a denial of JJCI's motion for summary judgment. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney&#8217;s Office for the Southern District of New York related to JPI&#8217;s contractual relationships with pharmacy benefit managers over the period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products. The demand was issued in connection with an investigation under the False Claims Act.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Department of Justice relating to allegations concerning the sales and marketing practices of OLYSIO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. In December 2017, Johnson &amp; Johnson and JPI were served with a whistleblower lawsuit filed in the United States District Court for the Central District of California alleging the off-label promotion of OLYSIO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and additional products, including NUCYNTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, LEVAQUIN</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.&#160; At this time, the federal and state governments have declined to intervene and the lawsuit, which is related to the Civil Investigative Demand, is being prosecuted by a former company employee.&#160; The United States District Court for the Central District of California dismissed the claim in April 2018. In May 2018, the relator filed a notice of appeal to the United States Court of Appeals for the Ninth Circuit.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2018, a second whistleblower lawsuit was unsealed in the United States District Court for the Central District of California. The lawsuit is substantially similar to the lawsuit under appeal but is brought in the name of the original relator. The federal and state governments have declined to intervene in the second suit at this time.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2017, Johnson &amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking the production of records pertaining to payments to any 501(c)(3) charitable organization that provides financial assistance to Medicare patients. Multiple pharmaceutical companies have publicly reported receipt of subpoenas and ongoing inquiries similar to this one and the one described below. The government has represented that it will not be pursuing action against the company in this matter.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actelion Pharmaceuticals US, Inc. (Actelion US), received a subpoena in May 2016, with follow-up requests for documents from the United States Attorney's Office for the District of Massachusetts. The subpoena seeks the production of records pertaining to Actelion US&#8217; payments to 501(c)(3) charitable organizations that provide financial assistance to Medicare patients. In December 2018, the Company and the United States Department of Justice agreed to a settlement in this matter.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> or SIMPONI ARIA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April and September 2017, Johnson &amp; Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, OLYSIO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, SIMPONI</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, STELARA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">and ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.&#160;The subpoenas also seek documents relating to&#160;Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2017, Johnson &amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson &amp; Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government&#8217;s investigation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2018, Advanced Sterilization Products (ASP) received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning the pricing, quality, marketing and promotion of EvoTech ECR, Tyvek Peel Pouches, or Sterrad Cyclesure 24 biological indicators. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson &amp; Johnson do Brasil Ind&#250;stria e Com&#233;rcio de Produtos para Sa&#250;de Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry. The United States Department of Justice and the United States Securities and Exchange Commission have made additional preliminary inquiries about the inspection in Brazil, and Johnson &amp; Johnson do Brasil Ind&#250;stria e Com&#233;rcio de Produtos para Sa&#250;de Ltda.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">is cooperating with those requests.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson &amp; Johnson to cooperate with these inquiries by producing the requested information.</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">GENERAL LITIGATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2016, a putative class action was filed against Johnson &amp; Johnson, Johnson &amp; Johnson Sales and Logistics Company, LLC and McNeil PPC, Inc. (now known as Johnson &amp; Johnson Consumer, Inc.) in New Jersey Superior Court, Camden County on behalf of persons who reside in the state of New Jersey who purchased various McNeil over-the-counter products from December 2008 through the present.&#160;The complaint alleges violations of the New Jersey Consumer Fraud Act.&#160;Following the grant of a motion to dismiss and the filing of an amended complaint, in May 2017, the court denied a motion to dismiss the amended complaint. In December 2018, a settlement was reached and the matter has been dismissed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">Baby Powder and JOHNSON'S</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson &amp; Johnson's and JJCI&#8217;s motion to dismiss one of the cases. In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal. In September 2017, the plaintiff in the second case voluntarily dismissed their complaint. In March 2018, the plaintiff in the second case refiled in Illinois State Court.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson &amp; Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In June 2016, the district court denied motions to dismiss filed by JJVCI and other defendants. Discovery is ongoing. In March 2017, the plaintiffs filed a motion for class certification. The district court held a hearing on the motion for class certification in August 2018. In December 2018, the district court granted the plaintiffs motion for class certification.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research &amp; Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> as safer and more effective than less expensive alternative medications while failing to fully disclose its risks. The complaint seeks damages.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, Lonza Sales AG (Lonza) filed a Request for Arbitration with the London Court of International Arbitration against Janssen Research &amp; Development, LLC (Janssen R&amp;D). Lonza alleges that Janssen R&amp;D breached a 2005 agreement between the parties by sublicensing certain Lonza technology used in the manufacture of daratumumab without Lonza&#8217;s consent. Lonza seeks monetary damages. The arbitration hearing was held in September 2018. Post hearing briefing is complete, and the parties are awaiting a decision.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, a purported class action was filed in the United States District Court for the Western District of Washington against LifeScan Inc., Johnson &amp; Johnson, other diabetes test strip manufacturers and certain Pharmacy Benefit Managers (PBMs). The complaint alleges that consumers paid inflated prices for glucose monitor test strips as a consequence of undisclosed rebates and other incentives paid by manufacturers to PBMs. The complaint includes RICO, ERISA, and state consumer protection claims. The complaint seeks equitable relief and damages. In November 2017, the case was ordered transferred to United States District Court for the District of New Jersey. The LifeScan business was divested in October 2018 and Johnson &amp; Johnson retained liability that may result from these claims prior to the closing of the divestiture.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania. Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. The complaint seeks damages and injunctive relief. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in September 2017, multiple purported class actions were filed against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen&#8217;s REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief. In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania. The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. The complaint seeks damages and injunctive relief.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson &amp; Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.&#160; The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Andover Healthcare, Inc. (Andover) filed a Lanham act case against Johnson &amp; Johnson Consumer Inc. in April 2017 in the United States District Court for the District of Massachusetts.&#160; Andover asserts that the claim &#8220;not made with natural rubber latex&#8221; on COACH</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Sports Wrap, BAND-AID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Brand SECURE-FLEX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Wrap and BAND-AID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Brand HURT-FREE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> Wrap is false.&#160; Andover seeks actual damages and pre-judgment interest thereon, disgorgement of profits, treble damages, attorney&#8217;s fees and injunctive relief.&#160; In December 2018, the parties entered into a settlement agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively &#8220;Actelion&#8221;) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.&#160; The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.&#160; TRACLEER</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on distribution of the product.&#160; In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in federal court in Maryland.&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:inherit;font-size:10pt;"> complaint filed on behalf of the United States, 28 states, and the District of Columbia.&#160; The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> to the government in connection with direct government sales and government-funded drug reimbursement programs.&#160; At this time, the federal and state governments have declined to intervene.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2014-09</font><font style="font-family:inherit;font-size:10pt;">: Revenue from Contracts with Customers</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2018, the Company adopted the new accounting standard, ASC 606, Revenue from Contracts with Customers and all the related amendments (new revenue standard) to all contracts using the modified retrospective method. The cumulative effect of initially applying the new revenue standard was recognized as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The adoption of the new revenue standard has not had a material impact to either reported Sales to customers or Net earnings. Additionally, the Company will continue to recognize revenue from product sales as goods are shipped or delivered to the customer, as control of goods transfers at the same time. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on the Company's Consolidated Statement of Earnings and Balance Sheet was as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Statement of Earnings - For the fiscal year ended December 30, 2018 </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of change</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales to customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,581</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,546</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,297</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,269</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet - As of December 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of change</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,954</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,977</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,752</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,771</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made a cumulative effect adjustment to the 2018 opening balance of retained earnings upon adoption of ASU 2014-09, which decreased beginning retained earnings by </font><font style="font-family:inherit;font-size:10pt;">$47 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the adoption of ASC 606 see Note 18 to the Consolidated Financial Statements for further disaggregation of revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-01</font><font style="font-family:inherit;font-size:10pt;">: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities</font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018 on a modified retrospective basis. The amendments in this update supersede the guidance to classify equity securities with readily determinable fair values into different categories (that is, trading or available-for-sale) and require equity securities to be measured at fair value with changes in the fair value recognized through net earnings. The standard amends financial reporting by providing relevant information about an entity&#8217;s equity investments and reducing the number of items that are recognized in other comprehensive income. </font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 that increased retained earnings by </font><font style="font-family:inherit;font-size:10pt;">$232 million</font><font style="font-family:inherit;font-size:10pt;"> net of tax and decreased accumulated other comprehensive income for previously unrealized gains from equity investments. For additional details see Note 6 to the Consolidated Financial Statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-16</font><font style="font-family:inherit;font-size:10pt;">: Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018. This update removes the current exception in U.S. GAAP prohibiting entities from recognizing current and deferred income tax expenses or benefits related to transfer of assets, other than inventory, within the consolidated entity. The current exception to defer the recognition of any tax impact on the transfer of inventory within the consolidated entity until it is sold to a third party remains unaffected. As discussed further in Note 8 to the Consolidated Financial Statements, in the fourth fiscal quarter of 2018 the Company elected an accounting policy to treat the tax on global intangible low-taxed income (GILTI) under the deferred tax accounting model. As a result, the Company is required to record an additional deferred tax liability related to the basis difference of these intra-entity asset transfers. The Company recorded net adjustments including an increase to deferred tax assets of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;">, an increase to deferred tax liabilities of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.7 billion</font><font style="font-family:inherit;font-size:10pt;">, related to the GILTI accounting policy election in the fourth fiscal quarter of 2018, a decrease to Other Assets of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;"> and a decrease to retained earnings of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.4 billion</font><font style="font-family:inherit;font-size:10pt;">. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2017-01</font><font style="font-family:inherit;font-size:10pt;">: Clarifying the Definition of a Business</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018. This update narrows the definition of a business by providing a screen to determine when an integrated set of assets and activities is not a business. The screen specifies that an integrated set of assets and activities is not a business if substantially all of the fair value of the gross assets acquired or disposed of is concentrated in a single or a group of similar identifiable assets. This update was applied prospectively. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2017-07</font><font style="font-family:inherit;font-size:10pt;">: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018. This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost (NPBC). In addition, only the service cost component will be eligible for capitalization. The amendments in this update are required to be applied retrospectively for the presentation of the service cost component and the other components of NPBC in the Consolidated Statement of Earnings and prospectively, on and after the adoption date, for the capitalization of the service cost component of NPBC in assets. As required by the transition provisions of this update, the following table shows the impact of the adoption on the respective line items in the Consolidated Statement of Earnings for 2018 and the reclassifications to the 2017 and 2016 fiscal year Consolidated Statement of Earnings to retroactively apply classification of the service cost component and the other components of NPBC: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase (Decrease) to Net Expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of products sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, marketing and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(225</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the cumulative effect adjustments made to the 2018 opening balance of retained earnings upon adoption of the new accounting standards mentioned above: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:75.1953125%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative Effect Adjustment Increase (Decrease) to Retained Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2014-09 - Revenue from Contracts with Customers</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-01 - Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-16 - Income Taxes: Intra-Entity Transfers</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2017-12</font><font style="font-family:inherit;font-size:10pt;">: Targeted Improvements to Accounting for Hedging Activities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company elected to early adopt this standard as of the beginning of the fiscal second quarter of 2018. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. For additional required disclosures see Note 6 to the Consolidated Financial Statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Not Adopted as of December 30, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2018-18</font><font style="font-family:inherit;font-size:10pt;">: Collaborative Arrangements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update clarifies the interaction between ASC 808, Collaborative Arrangements and ASC 606, Revenue from Contracts with Customers. The update clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue if the counterparty is not a customer for that transaction. This update will be effective for the Company for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2018-18 should be applied retrospectively to the date of initial application of ASC 606 and early adoption is permitted. The Company is currently assessing the impact of this update on the Company&#8217;s consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2018-16:</font><font style="font-family:inherit;font-size:10pt;"> Derivatives and Hedging (Topic ASC 815)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update adds the Overnight Index Swap (OIS) rate based on the Secured Overnight Financing Rate (SOFR) as an eligible benchmark interest rate permitted in the application of hedge accounting. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted if an entity has adopted ASU 2017-12. The Company is currently assessing the impact of this update on the Company&#8217;s consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2018-02</font><font style="font-family:inherit;font-size:10pt;">: Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Job Act enacted in December 2017. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company does not expect this standard to have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-13</font><font style="font-family:inherit;font-size:10pt;">: Financial Instruments - Credit Losses</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity&#8217;s current estimate of credit losses expected to be incurred over the life of the financial instrument. This update will be effective for the Company for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact of this update on the Company&#8217;s consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-02</font><font style="font-family:inherit;font-size:10pt;">: Leases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update requires the recognition of lease assets and lease liabilities on the balance sheet for all lease obligations and disclosing key information about leasing arrangements. This update requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current generally accepted accounting principles. This update will be effective for the Company for all annual periods beginning after December 15, 2018, including interim periods within those fiscal years. The Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements. The Company&#8217;s operating leases will result in the recognition of additional assets and the corresponding liabilities on its Consolidated Balance Sheets. The adoption of this standard will not have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:5px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The approximate minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are:</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Dollars in Millions)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.7734375%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">After 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">896</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pensions and Other Benefit Plans</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sponsors various retirement and pension plans, including defined benefit, defined contribution and termination indemnity plans, which cover most employees worldwide. The Company also provides post-retirement benefits, primarily health care, to all eligible U.S.&#160;retired employees and their dependents.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Many international employees are covered by government-sponsored programs and the cost to the Company is not significant.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retirement plan benefits for employees hired before January 1, 2015 are primarily based on the employee&#8217;s compensation during the last </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> years before retirement and the number of years of service. In 2014, the Company announced that the U.S. Defined Benefit Plan was amended to adopt a new benefit formula, effective for employees hired on or after January 1, 2015. The benefits are calculated using a new formula based on employee compensation over total years of service.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International subsidiaries have plans under which funds are deposited with trustees, annuities are purchased under group contracts, or reserves are provided. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company does not typically fund retiree health care benefits in advance, but may do so at its discretion. The Company also has the right to modify these plans in the future.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018 and 2017 the Company used </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, as the measurement date for all U.S.&#160;and international retirement and other benefit plans.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> include the following components:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">949</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">159</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,212</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,962</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service cost (credit)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized actuarial losses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Curtailments and settlements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">594</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">422</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">502</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">508</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">477</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, as per the adoption of ASU 2017-07, the service cost component of net periodic benefit cost was presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts expected to be recognized in net periodic benefit cost in the coming year for the Company&#8217;s defined benefit retirement plans and other post-retirement plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of net transition obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of net actuarial losses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">656</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized gains and losses for the U.S.&#160;pension plans are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses for the other U.S.&#160;benefit plans is determined by using a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> corridor of the greater of the market value of assets or the accumulated postretirement benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service costs/benefits for the U.S.&#160;pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment. Prior service cost/benefit for the other U.S.&#160;benefit plans is amortized over the average remaining service to full eligibility age of plan participants at the time of the plan amendment.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the weighted-average actuarial assumptions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.2890625%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Worldwide Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Periodic Benefit Cost</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.59</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.98</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.85</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.63</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.77</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost discount rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.10</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate of increase in compensation levels</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.98</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.01</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.02</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.31</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.32</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected long-term rate of return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Benefit Obligation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.76</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.30</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.78</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.40</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.78</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.42</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate of increase in compensation levels</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In the fiscal year 2016, the Company changed its methodology in determining service and interest cost from the single weighted average discount rate approach to duration specific spot rates along that yield curve to the plans&#8217; liability cash flows, which management has concluded is a more precise estimate. Prior to this change in methodology, the Company measured service and interest costs utilizing a single weighted-average discount rate derived from the yield curve used to measure the plan obligations. The Company has accounted for this change as a change in accounting estimate and, accordingly, has accounted for it on a prospective basis. This change does not impact the benefit obligation and did not have a material impact to the 2016 full year results.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The expected rates of return on plan asset assumptions represent the Company's assessment of long-term returns on diversified investment portfolios globally. The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the assumed health care cost trend rates, for all individuals:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.65625%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Health Care Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health care cost trend rate assumed for next year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate to which the cost trend rate is assumed to decline (ultimate trend)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year the rate reaches the ultimate trend rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2038</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2038</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A one-percentage-point change in assumed health care cost trend rates would have the following effect:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.6796875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Point Increase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Point Decrease</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Health Care Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total interest and service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-retirement benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth information related to the benefit obligation and the fair value of plan assets at year-end </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> for the Company&#8217;s defined benefit retirement plans and other post-retirement plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in Benefit Obligation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected benefit obligation&#160;&#8212; beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,221</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">159</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan participant contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amendments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actuarial (gains) losses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,326</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,996</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Divestitures&#160;&amp; acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Curtailments, settlements&#160;&amp; restructuring</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid from plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,018</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,050</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(383</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(528</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">933</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected benefit obligation&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">31,670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">33,221</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4,582</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in Plan Assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets at fair value&#160;&#8212; beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,274</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Company contributions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,140</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">664</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan participant contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Divestitures&#160;&amp; acquisitions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid from plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,018</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,050</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(383</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">682</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets at fair value&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">26,818</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">28,404</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">281</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Funded status &#8212; end of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,301</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized in the Company&#8217;s Balance Sheet consist of the following:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">526</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,229</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,251</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,073</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recognized in the consolidated balance sheet&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,301</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized in Accumulated Other Comprehensive Income consist of the following:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net actuarial loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,323</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,140</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,263</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost (credit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized net transition obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total before tax effects</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,363</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Benefit Obligations&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">28,533</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">29,793</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized in Net Periodic Benefit Cost and Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">923</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">594</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">502</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net actuarial (gain) loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,153</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(111</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(169</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost (credit)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service (cost) credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rates</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total loss/(income) recognized in other comprehensive income, before tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">378</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(206</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(291</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recognized in net periodic benefit cost and other comprehensive income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,133</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">972</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">296</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">217</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company plans to continue to fund its U.S. Qualified Plans to comply with the Pension Protection Act of 2006. International Plans are funded in accordance with local regulations. Additional discretionary contributions are made when deemed appropriate to meet the long-term obligations of the plans. For certain plans, funding is not a common practice, as funding provides no economic benefit. Consequently, the Company has several pension plans that are not funded. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, the Company contributed </font><font style="font-family:inherit;font-size:10pt;">$679 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$461 million</font><font style="font-family:inherit;font-size:10pt;"> to its U.S.&#160;and international pension plans, respectively.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the funded status of the Company's U.S. Qualified &amp; Non-Qualified pension plans and international funded and unfunded pension plans at December&#160;31, 2018 and December&#160;31, 2017, respectively:</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">U.S. Plans</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">International Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Qualified Plans</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Qualified Plans</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Funded Plans</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unfunded Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,093</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected Benefit Obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,652</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,176</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,257</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,863</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated Benefit Obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,849</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,893</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Over (Under) Funded Status</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected Benefit Obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(971</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated Benefit Obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,027</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,793</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,849</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(417</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(379</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(397</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plans with accumulated benefit obligations in excess of plan assets have an accumulated benefit obligation, projected benefit obligation and plan assets of </font><font style="font-family:inherit;font-size:10pt;">$7.5 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$8.8 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4.3 billion</font><font style="font-family:inherit;font-size:10pt;">, respectively, at the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.8 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4.6 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;">, respectively, at the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the projected future benefit payments from the Company&#8217;s retirement and other benefit plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2024-2028</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Projected future benefit payments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retirement plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,062</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,182</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,257</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,679</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other benefit plans&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,273</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the projected future minimum contributions to the unfunded retirement plans. These amounts do not include any discretionary contributions that the Company may elect to make in the future.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2024-2028</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Projected future contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each pension plan is overseen by a local committee or board that is responsible for the overall administration and investment of the pension plans. In determining investment policies, strategies and goals, each committee or board considers factors including, local pension rules and regulations; local tax regulations; availability of investment vehicles (separate accounts, commingled accounts, insurance funds, etc.); funded status of the plans; ratio of actives to retirees; duration of liabilities; and other relevant factors including: diversification, liquidity of local markets and liquidity of base currency. A majority of the Company&#8217;s pension funds are open to new entrants and are expected to be on-going plans. Permitted investments are primarily liquid and/or listed, with little reliance on illiquid and non-traditional investments such as hedge funds. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s retirement plan asset allocation at the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and target allocations for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Percent of</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Plan Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Target</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Allocation</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Worldwide Retirement Plans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Determination of Fair Value of Plan Assets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Plan has an established and well-documented process for determining fair values. Fair value is based upon quoted market prices, where available. If listed prices or quotes are not available, fair value is based upon models that primarily use, as inputs, market-based or independently sourced market parameters, including yield curves, interest rates, volatilities, equity or debt prices, foreign exchange rates and credit curves.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">While the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation Hierarchy</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described in the table below with Level&#160;1 having the highest priority and Level&#160;3 having the lowest.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A financial instrument&#8217;s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following is a description of the valuation methodologies used for the investments measured at fair value.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:9px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term investment funds</font><font style="font-family:inherit;font-size:10pt;">&#160;&#8212; Cash and quoted short-term instruments are valued at the closing price or the amount held on deposit by the custodian bank. Other investments are through investment vehicles valued using the Net Asset Value (NAV) provided by the administrator of the fund. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. The NAV is a quoted price in a market that is not active and classified as Level&#160;2.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:9px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Government and agency securities</font><font style="font-family:inherit;font-size:10pt;">&#160;&#8212; A limited number of these investments are valued at the closing price reported on the major market on which the individual securities are traded. Where quoted prices are available in an active market, the investments are classified within Level&#160;1 of the valuation hierarchy. If quoted market prices are not available for the specific security, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. When quoted market prices for a security are not available in an active market, they are classified as Level&#160;2.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:9px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt instruments</font><font style="font-family:inherit;font-size:10pt;">&#160;&#8212; A limited number of these investments are valued at the closing price reported on the major market on which the individual securities are traded. Where quoted prices are available in an active market, the investments are classified as Level&#160;1. If quoted market prices are not available for the specific security, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows and are classified as Level&#160;2. Level&#160;3 debt instruments are priced based on unobservable inputs.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:9px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity securities</font><font style="font-family:inherit;font-size:10pt;">&#160;&#8212; Equity securities are valued at the closing price reported on the major market on which the individual securities are traded. Substantially all common stock is classified within Level&#160;1 of the valuation hierarchy.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:9px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Commingled funds</font><font style="font-family:inherit;font-size:10pt;">&#160;&#8212; These investment vehicles are valued using the NAV provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. Assets in the Level&#160;2 category have a quoted market price.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:9px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Insurance contracts</font><font style="font-family:inherit;font-size:10pt;">&#160;&#8212; The instruments are issued by insurance companies. The fair value is based on negotiated value and the underlying investments held in separate account portfolios as well as considering the credit worthiness of the issuer. The underlying investments are government, asset-backed and fixed income securities. In general, insurance contracts are classified as Level&#160;3 as there are no quoted prices nor other observable inputs for pricing.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:9px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other assets</font><font style="font-family:inherit;font-size:10pt;">&#160;&#8212; Other assets are represented primarily by limited partnerships and real estate investments, as well as commercial loans and commercial mortgages that are not classified as corporate debt. Other assets that are exchange listed and actively traded are classified as Level&#160;1, while inactively traded assets are classified as Level&#160;2. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the Retirement Plans' investments measured at fair value as of December&#160;31, 2018 and December&#160;31, 2017:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted Prices</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Markets for</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Identical Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Inputs</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investments Measured at Net Asset Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total Assets</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investment funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">529</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">427</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,595</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,094</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,595</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,094</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,298</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,848</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,848</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commingled funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,304</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,995</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">301</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14,277</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,570</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">7,435</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">326</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">256</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5,502</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6,436</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">26,818</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">28,404</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">The activity for the Level 3 assets is not significant for all years presented.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's Other Benefit Plans are unfunded except for U.S.&#160;commingled funds (Level 2) of </font><font style="font-family:inherit;font-size:10pt;">$72 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$81 million</font><font style="font-family:inherit;font-size:10pt;"> and U.S. short-term investment funds (Level 2) of </font><font style="font-family:inherit;font-size:10pt;">$108 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$200 million</font><font style="font-family:inherit;font-size:10pt;"> at December&#160;31, 2018 and December&#160;31, 2017, respectively. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of Johnson&#160;&amp; Johnson Common Stock directly held in plan assets was </font><font style="font-family:inherit;font-size:10pt;">$876 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">3.3%</font><font style="font-family:inherit;font-size:10pt;"> of total plan assets) at December&#160;31, 2018 and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$938 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3.3%</font><font style="font-family:inherit;font-size:10pt;"> of total plan assets) at December&#160;31, 2017.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to current year presentation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-top:9px;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, property, plant and equipment at cost and accumulated depreciation were:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.5078125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and land improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">829</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings and building equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,176</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,240</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,949</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,876</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,448</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property, plant and equipment, gross</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,816</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,461</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property, plant and equipment, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,035</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,005</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></font><font style="font-family:inherit;font-size:9pt;">Net of assets held for sale on the Consolidated Balance Sheet for approximately </font><font style="font-family:inherit;font-size:9pt;">$0.1 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the divestiture of the Advanced Sterilization Products business and </font><font style="font-family:inherit;font-size:9pt;">$0.1 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company capitalizes interest expense as part of the cost of construction of facilities and equipment. Interest expense capitalized in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$86 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$94 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$102 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense, including the amortization of capitalized interest in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$2.6 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.6 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.5 billion</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon retirement or other disposal of property, plant and equipment, the costs and related amounts of accumulated depreciation or amortization are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds are recorded in earnings.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, Plant and Equipment and Depreciation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost. The Company utilizes the straight-line method of depreciation over the estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20&#160;- 30&#160;years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10&#160;- 20&#160;years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2&#160;- 13&#160;years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company capitalizes certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">8</font><font style="font-family:inherit;font-size:10pt;">&#160;years.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company reviews long-lived assets to assess recoverability using undiscounted cash flows. When certain events or changes in operating or economic conditions occur, an impairment assessment may be performed on the recoverability of the carrying value of these assets. If the asset is determined to be impaired, the loss is measured based on the difference between the asset&#8217;s fair value and its carrying value. If quoted market prices are not available, the Company will estimate fair value using a discounted value of estimated future cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:9px;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, property, plant and equipment at cost and accumulated depreciation were:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.5078125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and land improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">829</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings and building equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,176</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,240</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,949</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,876</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,448</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property, plant and equipment, gross</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,816</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,461</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property, plant and equipment, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,035</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,005</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></font><font style="font-family:inherit;font-size:9pt;">Net of assets held for sale on the Consolidated Balance Sheet for approximately </font><font style="font-family:inherit;font-size:9pt;">$0.1 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the divestiture of the Advanced Sterilization Products business and </font><font style="font-family:inherit;font-size:9pt;">$0.1 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Selected Quarterly Financial Data (unaudited)</font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selected unaudited quarterly financial data for the years </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> are summarized below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(Dollars in Millions Except Per Share Data)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">First Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Second Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">First Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Second Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(7)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(8)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment sales to customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,398</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,504</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,415</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,478</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,356</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,540</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,346</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,190</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,245</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,635</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,695</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,681</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Devices&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,767</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,972</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,587</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,668</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,293</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,726</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,599</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,974</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,009</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,830</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,348</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,394</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,766</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,650</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,195</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,395</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,357</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,936</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before provision for taxes on income </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,481</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,973</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,423</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,790</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,560</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,367</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,954</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,934</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,042</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,422</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,827</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,764</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,713</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net earnings (loss) per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.63</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.63</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.40</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.99</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net earnings (loss) per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.45</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.40</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.99</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The first quarter of 2018 includes an Actelion acquisition related cost of </font><font style="font-family:inherit;font-size:10pt;">$92 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$96 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$81 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$107 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The second quarter of 2018 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$609 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$703 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$152 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$176 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The third quarter of 2018 includes an in-process research and development expense of </font><font style="font-family:inherit;font-size:10pt;">$859 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$1,126 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of </font><font style="font-family:inherit;font-size:10pt;">$184 million</font><font style="font-family:inherit;font-size:10pt;"> after and before tax, a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$162 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$190 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a </font><font style="font-family:inherit;font-size:10pt;">$265 million</font><font style="font-family:inherit;font-size:10pt;"> benefit after-tax from the impact of tax legislation. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fourth quarter of 2018 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$1,113 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$1,288 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$190 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$227 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a </font><font style="font-family:inherit;font-size:10pt;">$137 million</font><font style="font-family:inherit;font-size:10pt;"> benefit after-tax from the impact of tax legislation. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The first quarter of 2017 includes a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$121 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$161 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and an AMO acquisition related cost of </font><font style="font-family:inherit;font-size:10pt;">$251 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$38 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The second quarter of 2017 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$352 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$493 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$199 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$213 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$101 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$128 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and an asset impairment charge of </font><font style="font-family:inherit;font-size:10pt;">$125 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$182 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The third quarter of 2017 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$97 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$118 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$255 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$367 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$136 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$187 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fourth quarter of 2017 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$506 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$645 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$313 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$217 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$237 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$284 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), an in-process research and development expense of </font><font style="font-family:inherit;font-size:10pt;">$266 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$408 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and an after-tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$116 million</font><font style="font-family:inherit;font-size:10pt;"> related to the insulin pump business. Additionally, the fourth quarter of 2017 includes a provisional charge of </font><font style="font-family:inherit;font-size:10pt;">$13.6 billion</font><font style="font-family:inherit;font-size:10pt;"> for recently enacted tax legislation.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses are expensed as incurred in accordance with ASC 730, Research&#160;and Development. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Amounts capitalized for such payments are included in other intangibles, net of accumulated amortization.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company enters into collaborative arrangements, typically with other pharmaceutical or biotechnology companies, to develop and commercialize drug candidates or intellectual property. These arrangements typically involve two (or more) parties who are active participants in the collaboration and are exposed to significant risks and rewards dependent on the commercial success of the activities. These collaborations usually involve various activities by one or more parties, including research and development, marketing and selling and distribution. Often, these collaborations require upfront, milestone and royalty or profit share payments, contingent upon the occurrence of certain future events linked to the success of the asset in development. Amounts due from collaborative partners related to development activities are generally reflected as a reduction of research and development expense because the performance of contract development services is not central to the Company&#8217;s operations. In general, the income statement presentation for these collaborations is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nature/Type of Collaboration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Statement of Earnings Presentation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third-party sale of product &amp; profit share payments received</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales to customers</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties/milestones paid to collaborative partner (post-regulatory approval)*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of products sold</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties received from collaborative partner</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upfront payments&#160;&amp; milestones paid to collaborative partner (pre-regulatory approval)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development payments to collaborative partner</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development payments received from collaborative partner</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reduction of Research and development expense</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:98%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Milestones are capitalized as intangible assets and amortized to cost of products sold over the useful life.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For all years presented, there was no individual project that represented greater than </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> of the total annual consolidated research and development expense.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a number of products and compounds developed in collaboration with strategic partners including XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, co-developed with Bayer HealthCare AG and IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, developed in collaboration and co-marketed with Pharmacyclics LLC, an AbbVie company.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a number of licensing arrangements for products and compounds including DARZALEX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, licensed from Genmab A/S.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of 2016, the Company announced restructuring actions in its Medical Devices segment to better serve the needs of patients and customers in today&#8217;s evolving healthcare marketplace. The Company has undertaken actions to strengthen its go-to-market model, accelerate the pace of innovation, further prioritize key platforms and geographies, and streamline operations while maintaining high quality standards. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, the Company recorded a pre-tax charge of </font><font style="font-family:inherit;font-size:10pt;">$462 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$46 million</font><font style="font-family:inherit;font-size:10pt;"> was included in cost of products sold and </font><font style="font-family:inherit;font-size:10pt;">$227 million</font><font style="font-family:inherit;font-size:10pt;"> was included in other (income) expense. Total project costs of </font><font style="font-family:inherit;font-size:10pt;">$2.5 billion</font><font style="font-family:inherit;font-size:10pt;"> have been recorded since the restructuring has been announced. This restructuring program was completed in the fiscal fourth quarter of 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 17, 2018, the Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the global supply chain restructuring strategic collaborations see Note 20 to the Consolidated Financial Statements. In 2018, the Company recorded a pre-tax charge of </font><font style="font-family:inherit;font-size:10pt;">$238 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$59 million</font><font style="font-family:inherit;font-size:10pt;"> was included in cost of products sold and </font><font style="font-family:inherit;font-size:10pt;">$117 million</font><font style="font-family:inherit;font-size:10pt;"> was included in other (income) expense. See the following table for additional details on the restructuring programs. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In total, the Company expects the Global Supply Chain actions to generate approximately </font><font style="font-family:inherit;font-size:10pt;">$0.6 billion</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;"> in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.9 billion</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;">, over the </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.&#160; &#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the severance charges and the associated spending under these initiatives through the fiscal year ended 2018:</font><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Severance</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset Write-offs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other**</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, January 3, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016 activity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, January 1, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 activity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, December 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current year activity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Charges </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Cash payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(558</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(593</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Settled non cash </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(132</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(132</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, December 30, 2018*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">*Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">**Other includes project expense such as salaries for employees supporting the initiative and consulting expenses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although the Medical Devices restructuring program was completed in 2018, the Company expects that severance charges will continue beyond that date. The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments has extended due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable. Approximately </font><font style="font-family:inherit;font-size:10pt;">2,375</font><font style="font-family:inherit;font-size:10pt;"> individuals received separation payments since these restructuring announcements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. The Company's global payment terms are typically between 30 to 90 days. Provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. Rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. The Company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns are estimated and recorded based on historical sales and returns information. Products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. The sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. In accordance with the Company&#8217;s accounting policies, the Company generally issues credit to customers for returned goods. The Company&#8217;s sales returns reserves are accounted for in accordance with the U.S.&#160;GAAP guidance for revenue recognition when right of return exists. Sales returns reserves are recorded at full sales value. Sales returns in the Consumer and Pharmaceutical segments are almost exclusively not resalable. Sales returns for certain franchises in the Medical Devices segment are typically resalable but are not material. The Company infrequently exchanges products from inventory for returned products. The sales returns reserve for the total Company has been approximately </font><font style="font-family:inherit;font-size:10pt;">1.0%</font><font style="font-family:inherit;font-size:10pt;"> of annual net trade sales during the fiscal reporting years&#160;2018,&#160;2017&#160;and&#160;2016.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. Continuing promotional programs include coupons and volume-based sales incentive programs. The redemption cost of consumer coupons is based on historical redemption experience by product and value. Volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. These arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. The Company also earns profit-share payments through collaborative arrangements for certain products, which are included in sales to customers. For all years presented, profit-share payments were less than </font><font style="font-family:inherit;font-size:10pt;">2.0%</font><font style="font-family:inherit;font-size:10pt;"> of the total revenues and are included in sales to customers.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Components of other comprehensive income (loss) consist of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Foreign<br clear="none"/>Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain/(Loss) On Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Employee Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain/<br clear="none"/>(Loss) On<br clear="none"/>Derivatives &amp; Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total<br clear="none"/>Accumulated<br clear="none"/>Other<br clear="none"/>Comprehensive Income (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 3, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,298</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,165</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net 2016 changes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(612</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(193</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(682</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(249</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,736</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,047</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,980</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(285</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net 2017 changes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(179</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,702</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,199</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative adjustment to retained earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(232</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(232</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net 2018 changes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,518</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(265</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,791</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,869</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,158</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(195</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,222</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> See Note 1 to Consolidated Financial Statements for additional details on the adoption of ASU 2016-01</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s retirement plan asset allocation at the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and target allocations for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Percent of</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Plan Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Target</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Allocation</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Worldwide Retirement Plans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the weighted-average actuarial assumptions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.2890625%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Worldwide Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Periodic Benefit Cost</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.59</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.98</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.85</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.63</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.77</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost discount rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.10</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate of increase in compensation levels</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.98</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.01</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.02</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.31</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.32</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected long-term rate of return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Benefit Obligation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.76</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.30</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.78</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.40</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.78</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.42</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate of increase in compensation levels</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is a summary of the activity related to equity investments as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in Fair Value Reflected in Net Income </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Sales/ Purchases/Other </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non Current Other Assets</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity Investments with readily determinable value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity Investments without readily determinable value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">Recorded in Other Income/Expense</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (2)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">Other includes impact of currency</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:58.92682926829268%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash &amp; Cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">469</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts Receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred Taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets Acquired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">956</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred Taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Liabilities Assumed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Assets Acquired</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Includes adjustment of </font><font style="font-family:inherit;font-size:10pt;">$642 million</font><font style="font-family:inherit;font-size:10pt;"> to write-up the acquired inventory to its estimated fair value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, cash, cash equivalents and current marketable securities were comprised of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated Fair Value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash &amp; Cash Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current Marketable Securities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Reverse repurchase agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Reverse repurchase agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">443</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Time deposits</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;Subtotal </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gov't Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,144</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,330</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;Subtotal available for sale</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,154</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,580</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cash, cash equivalents and current marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">18,107</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,580</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, the carrying amount was the same as the estimated fair value.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2017, the carrying amount was the same as the estimated fair value.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying Amount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated Fair Value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash &amp; Cash Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current Marketable Securities</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,929</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,929</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,929</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Sovereign Securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Reverse repurchase agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Time deposits</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;Subtotal </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,986</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,986</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,880</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gov't Securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,864</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,864</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Sovereign Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;Subtotal available for sale</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,310</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,310</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cash, cash equivalents and current marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:5px;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for taxes on income consists of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.6341463414634%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Currently payable:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,081</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,969</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes on international operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,434</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,872</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,659</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total currently payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,718</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,604</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,956</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. taxes on international operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,362</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(635</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,406</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Provision for taxes on income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,702</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">16,373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,263</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of long-term debt are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.75%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective Rate %</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective Rate %</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.15%&#160;Debentures due 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.18</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65% Notes due 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">597</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.70</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.75%&#160;Notes due 2019 (1B Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(1B Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.83</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.875% Notes due 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.93</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89% Notes due 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.125% Notes due 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.13</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3% Zero Coupon Convertible Subordinated Debentures due 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.00</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.95%&#160;Debentures due 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">547</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.15</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.950% Notes due 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.99</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.55% Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">448</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.67</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.45% Notes due 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.48</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65% Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">998</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">998</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.65</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.250% Notes due 2022 (1B Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(1B Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.26</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25% Notes due 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.31</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">995</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.31</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.73%&#160;Debentures due 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.73</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.73</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.375% Notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">805</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">806</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.17</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.05% Notes due 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.09</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.650% Notes due 2024 (750MM Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(750MM Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">891</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.50%&#160;Notes due 2024 (500MM GBP 1.2636)</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(500MM GBP 1.3444)</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.625% Notes due 2025</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.63</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">747</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.63</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.45% Notes due 2026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.47</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.95% Notes due 2027</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">995</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.96</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.150% Notes due 2028 (750MM Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(750MM Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.21</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.900%&#160;Notes due 2028</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,493</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.91</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,492</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.91</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.95%&#160;Notes due 2029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.14</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95%&#160;Debentures due 2033</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.375% Notes due 2033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.650% Notes due 2035 (1.5B Euro 1.14)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">/(1.5B Euro 1.1947)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,774</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.68</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.55% Notes due 2036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">988</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">987</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.59</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.95%&#160;Notes due 2037</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">991</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">991</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.99</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.625% Notes due 2037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.64</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.85%&#160;Debentures due 2038</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.85</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.400%&#160;Notes due 2038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.42</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.50%&#160;Debentures due 2040</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">538</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.63</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">538</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.63</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.85% Notes due 2041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.89</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.50% Notes due 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.52</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.70% Notes due 2046</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,971</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.74</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.75% Notes due 2047</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">991</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.76</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.75%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.500% Notes due 2048</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.52</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">30,320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">32,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,636</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,499</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">27,684</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">30,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average effective rate.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation rate at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation rate at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of the fair value over the carrying value of debt was </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary differences and carryforwards for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.92682926829268%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018 Deferred Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017 Deferred Tax</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liability</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee related obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,398</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,259</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">639</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">507</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation &amp; amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,967</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,506</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International R&amp;D capitalized for tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserves&#160;&amp; liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,647</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,718</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income reported for tax purposes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss carryforward international</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">762</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Undistributed foreign earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Global intangible low-taxed income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,971</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Miscellaneous international</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Miscellaneous U.S.&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">469</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11,405</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(11,271</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,902</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(11,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the Retirement Plans' investments measured at fair value as of December&#160;31, 2018 and December&#160;31, 2017:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted Prices</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Markets for</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Identical Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Inputs</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investments Measured at Net Asset Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total Assets</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investment funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">529</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">427</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,595</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,094</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,595</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,094</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,298</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,848</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,848</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commingled funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,304</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,995</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">301</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14,277</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,570</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">7,435</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">326</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">256</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5,502</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6,436</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">26,818</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">28,404</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">The activity for the Level 3 assets is not significant for all years presented.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is the effect of net investment hedges for the fiscal years ended December&#160;30, 2018 and December&#160;31, 2017:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized In</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated OCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain/(Loss) Reclassified From</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Into Income</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Currency interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is a summary of the activity related to derivatives and hedges for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 30, 2018</font></div></td><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of Products Sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest (Income) Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (Income) Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of Products Sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest (Income) Expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (Income) Expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The effects of fair value, net investment and cash flow hedging:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain (Loss) on fair value hedging relationship:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Interest rate swaps contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;Hedged items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;Derivatives designated as hedging instruments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain (Loss) on net investment hedging relationship:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cross currency interest rate swaps contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gain (Loss) on cash flow hedging relationship:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Forward foreign exchange contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(220</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(159</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(165</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(193</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(199</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(60</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cross currency interest rate swaps contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Includes equity collar contracts. The equity collar contracts expired in December of 2017.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.7265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate contracts </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)(4) </sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">662</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">662</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">425</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate contracts </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">567</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Available For Sale Other Investments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investments</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">751</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.46875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross to Net Derivative Reconciliation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Gross Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Support Agreement (CSA)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(76</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Net Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">271</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Gross Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">872</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Support Agreement (CSA)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(605</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Net Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 assets and liabilities are all classified as Level&#160;2 with the exception of equity investments of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$751 million</font><font style="font-family:inherit;font-size:10pt;">, which are classified as Level&#160;1.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$7 million</font><font style="font-family:inherit;font-size:10pt;"> of non-current assets for the fiscal years ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9 million</font><font style="font-family:inherit;font-size:10pt;"> of non-current liabilities for the fiscal years ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes cross currency interest rate swaps and interest rate swaps.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classified as non-current other assets. The carrying amount of the equity investments were </font><font style="font-family:inherit;font-size:10pt;">$511 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$751 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup>&#160;</font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;text-indent:-24px;"><font style="font-family:inherit;font-size:10pt;">Classified as cash equivalents and current marketable securities.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the following amounts were recorded on the Consolidated Balance Sheet </font></div><div style="line-height:120%;padding-bottom:9px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Line item in the Consolidated Balance Sheet in which the hedged item is included</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount of the Hedged Liability</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current Portion of Long-term Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term Debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In Millions Except Per Share Amounts)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net earnings per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average shares outstanding&#160;&#8212; basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,681.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,692.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,737.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Potential shares exercisable under stock option plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: shares repurchased under treasury stock method</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible debt shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted average shares outstanding&#160;&#8212; diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,728.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,745.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,788.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net earnings per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.93</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A one-percentage-point change in assumed health care cost trend rates would have the following effect:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.6796875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Point Increase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Point Decrease</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Health Care Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total interest and service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-retirement benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A comparison of income tax expense at the U.S.&#160;statutory rate of </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, to the Company&#8217;s effective tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,865</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,808</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,346</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before taxes on income:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,999</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,673</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,803</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax rates:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International operations </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and orphan drug tax credits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. state and local</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. manufacturing deduction</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. tax on international income </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefits on share-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. tax benefit on asset/business disposals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">TCJA and related impacts </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective Rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) For all periods presented the Company has subsidiaries operating in Puerto Rico under various tax incentives. International operations reflects the impacts of operations in jurisdictions with statutory tax rates different than the U.S., particularly Ireland, Switzerland and Puerto Rico, which is a favorable impact on the effective tax rate as compared with the U.S. statutory rate. The 2017 amount also includes tax cost related to the revaluation of deferred tax balances related to the change in the Belgian statutory tax rate increasing the tax provision by approximately </font><font style="font-family:inherit;font-size:8pt;">3.4%</font><font style="font-family:inherit;font-size:8pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2) Includes the impact of the GILTI tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3) Represents impact of adjustments to the 2017 TCJA provisional tax charge. This also includes a net tax benefit from the reduction of a deferred tax liability related to foreign withholding taxes originally accrued as part of the provisional charge. This benefit reduced the Company&#8217;s effective tax rate by approximately </font><font style="font-family:inherit;font-size:8pt;">11%</font><font style="font-family:inherit;font-size:8pt;">. Further description is included below.</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4) Includes U.S. state and local taxes provisionally recorded as part TCJA provisional charge which was approximately </font><font style="font-family:inherit;font-size:8pt;">0.6%</font><font style="font-family:inherit;font-size:8pt;"> of the total effective tax rate.</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the projected future benefit payments from the Company&#8217;s retirement and other benefit plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2024-2028</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Projected future benefit payments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retirement plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,062</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,182</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,257</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,679</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other benefit plans&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,273</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as allocated by segment of business, was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consumer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Medical Devices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill at January 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,263</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,805</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to acquisitions</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,161</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,200</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to divestitures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation/other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,109</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,906</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, related to divestitures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation/other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(373</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(97</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill at December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9,063</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12,720</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">30,453</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> Goodwill of </font><font style="font-family:inherit;font-size:9pt;">$6.2 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the Actelion acquisition acquired in the fiscal second quarter of 2017, within the Pharmaceutical segment and </font><font style="font-family:inherit;font-size:9pt;">$1.7 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the AMO acquisition acquired in the fiscal first quarter of 2017, within the Medical Devices segment. </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font><font style="font-family:inherit;font-size:9pt;"> Goodwill of </font><font style="font-family:inherit;font-size:9pt;">$1.0 billion</font><font style="font-family:inherit;font-size:9pt;"> is related to the divestiture of the LifeScan business. Goodwill of </font><font style="font-family:inherit;font-size:9pt;">$0.3 billion</font><font style="font-family:inherit;font-size:9pt;"> is related to the divestiture of the Advanced Sterilization Products business, which was pending and classified as assets held for sale on the Consolidated Balance Sheet as of December 30, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays the assumed health care cost trend rates, for all individuals:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.65625%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Health Care Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health care cost trend rate assumed for next year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate to which the cost trend rate is assumed to decline (ultimate trend)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year the rate reaches the ultimate trend rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2038</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2038</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, inventories were comprised of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:89.84375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials and supplies</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goods in process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,109</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,317</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,376</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,308</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total inventories</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,599</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,765</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></font><font style="font-family:inherit;font-size:9pt;">Net of assets held for sale on the Consolidated Balance Sheet for approximately </font><font style="font-family:inherit;font-size:9pt;">$0.2 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the divestiture of the Advanced Sterilization Products business and </font><font style="font-family:inherit;font-size:9pt;">$0.3 billion</font><font style="font-family:inherit;font-size:9pt;"> related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate maturities of long-term obligations commencing in </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;"> are:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85.546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-top:17px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">After 2023</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2,636</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,134</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,103</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> include the following components:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">949</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">159</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,212</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,962</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service cost (credit)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized actuarial losses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Curtailments and settlements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">594</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">422</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">502</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">508</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">477</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth information related to the benefit obligation and the fair value of plan assets at year-end </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> for the Company&#8217;s defined benefit retirement plans and other post-retirement plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in Benefit Obligation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected benefit obligation&#160;&#8212; beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,221</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">159</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan participant contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amendments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actuarial (gains) losses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,326</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,996</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Divestitures&#160;&amp; acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Curtailments, settlements&#160;&amp; restructuring</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid from plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,018</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,050</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(383</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(528</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">933</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected benefit obligation&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">31,670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">33,221</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4,582</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in Plan Assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets at fair value&#160;&#8212; beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,274</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Company contributions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,140</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">664</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan participant contributions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Divestitures&#160;&amp; acquisitions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid from plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,018</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,050</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(383</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">682</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets at fair value&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">26,818</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">28,404</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">281</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Funded status &#8212; end of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,301</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized in the Company&#8217;s Balance Sheet consist of the following:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">526</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,229</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,251</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,073</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recognized in the consolidated balance sheet&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4,301</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized in Accumulated Other Comprehensive Income consist of the following:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net actuarial loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,323</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,140</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,263</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost (credit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized net transition obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total before tax effects</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8,115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,363</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Benefit Obligations&#160;&#8212; end of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">28,533</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">29,793</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:90px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Retirement Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Benefit Plans</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized in Net Periodic Benefit Cost and Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">923</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">594</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">502</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net actuarial (gain) loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,153</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(111</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(169</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost (credit)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service (cost) credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rates</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total loss/(income) recognized in other comprehensive income, before tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">378</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(206</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(291</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recognized in net periodic benefit cost and other comprehensive income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,133</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">972</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">296</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">217</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts expected to be recognized in net periodic benefit cost in the coming year for the Company&#8217;s defined benefit retirement plans and other post-retirement plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of net transition obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of net actuarial losses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">656</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As required by the transition provisions of this update, the following table shows the impact of the adoption on the respective line items in the Consolidated Statement of Earnings for 2018 and the reclassifications to the 2017 and 2016 fiscal year Consolidated Statement of Earnings to retroactively apply classification of the service cost component and the other components of NPBC: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase (Decrease) to Net Expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of products sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, marketing and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(225</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the cumulative effect adjustments made to the 2018 opening balance of retained earnings upon adoption of the new accounting standards mentioned above: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:75.1953125%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative Effect Adjustment Increase (Decrease) to Retained Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2014-09 - Revenue from Contracts with Customers</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-01 - Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-16 - Income Taxes: Intra-Entity Transfers</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on the Company's Consolidated Statement of Earnings and Balance Sheet was as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Statement of Earnings - For the fiscal year ended December 30, 2018 </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of change</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales to customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,581</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,546</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,297</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,269</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet - As of December 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of change</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,954</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,977</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,752</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,771</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is the effect of derivatives not designated as hedging instrument for the fiscal years ended December&#160;30, 2018 and December&#160;31, 2017:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;height:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain /(Loss) Recognized in Income on Derivative</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized In</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income on Derivative</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives Not Designated as Hedging Instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ffffff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Exchange Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selected unaudited quarterly financial data for the years </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> are summarized below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(Dollars in Millions Except Per Share Data)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">First Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Second Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">First Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Second Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Third Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(7)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth Quarter </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(8)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment sales to customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,398</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,504</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,415</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,478</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,356</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,540</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,346</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,190</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,245</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,635</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,695</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,681</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Devices&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,767</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,972</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,587</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,668</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,293</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,726</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,599</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,974</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,009</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,830</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,348</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,394</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,766</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,650</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,195</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,395</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,357</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,936</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before provision for taxes on income </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,481</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,973</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,423</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,790</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,560</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,367</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,954</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,934</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,042</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,422</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,827</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,764</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,713</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net earnings (loss) per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.63</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.63</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.40</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.99</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net earnings (loss) per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.45</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.40</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.99</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The first quarter of 2018 includes an Actelion acquisition related cost of </font><font style="font-family:inherit;font-size:10pt;">$92 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$96 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$81 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$107 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The second quarter of 2018 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$609 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$703 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$152 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$176 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The third quarter of 2018 includes an in-process research and development expense of </font><font style="font-family:inherit;font-size:10pt;">$859 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$1,126 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of </font><font style="font-family:inherit;font-size:10pt;">$184 million</font><font style="font-family:inherit;font-size:10pt;"> after and before tax, a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$162 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$190 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a </font><font style="font-family:inherit;font-size:10pt;">$265 million</font><font style="font-family:inherit;font-size:10pt;"> benefit after-tax from the impact of tax legislation. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fourth quarter of 2018 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$1,113 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$1,288 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$190 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$227 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a </font><font style="font-family:inherit;font-size:10pt;">$137 million</font><font style="font-family:inherit;font-size:10pt;"> benefit after-tax from the impact of tax legislation. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The first quarter of 2017 includes a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$121 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$161 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and an AMO acquisition related cost of </font><font style="font-family:inherit;font-size:10pt;">$251 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$38 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The second quarter of 2017 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$352 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$493 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$199 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$213 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$101 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$128 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and an asset impairment charge of </font><font style="font-family:inherit;font-size:10pt;">$125 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$182 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The third quarter of 2017 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$97 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$118 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$255 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$367 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$136 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$187 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fourth quarter of 2017 includes a litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$506 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$645 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$313 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$217 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), a restructuring charge of </font><font style="font-family:inherit;font-size:10pt;">$237 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$284 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax), an in-process research and development expense of </font><font style="font-family:inherit;font-size:10pt;">$266 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax (</font><font style="font-family:inherit;font-size:10pt;">$408 million</font><font style="font-family:inherit;font-size:10pt;"> before-tax) and an after-tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$116 million</font><font style="font-family:inherit;font-size:10pt;"> related to the insulin pump business. Additionally, the fourth quarter of 2017 includes a provisional charge of </font><font style="font-family:inherit;font-size:10pt;">$13.6 billion</font><font style="font-family:inherit;font-size:10pt;"> for recently enacted tax legislation.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the severance charges and the associated spending under these initiatives through the fiscal year ended 2018:</font><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Severance</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset Write-offs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other**</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, January 3, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016 activity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, January 1, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 activity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, December 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current year activity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Charges </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Cash payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(558</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(593</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Settled non cash </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(132</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(132</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reserve balance, December 30, 2018*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">*Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">**Other includes project expense such as salaries for employees supporting the initiative and consulting expenses.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales to Customers </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Lived Assets </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,811</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,117</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,126</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,433</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,677</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Western Hemisphere excluding U.S.&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,752</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia-Pacific, Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,831</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,420</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,575</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,733</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,773</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segments total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,890</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,035</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,996</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,064</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non long-lived assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,855</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,164</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Worldwide total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">81,581</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">76,450</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">71,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">152,954</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">157,303</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;text-decoration:underline;">&#173;</font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note&#160;1 for a description of the segments in which the Company operates. </font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Export sales are not significant. In 2018, the Company had three wholesalers distributing products for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> segments that represented approximately </font><font style="font-family:inherit;font-size:10pt;">14.0%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">11.0%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11.0%</font><font style="font-family:inherit;font-size:10pt;"> of the total consolidated revenues. In 2017, the Company had two wholesalers distributing products for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> segments that represented approximately </font><font style="font-family:inherit;font-size:10pt;">14.0%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> of the total consolidated revenues. In 2016, the Company had two wholesalers distributing products for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> segments that represented approximately </font><font style="font-family:inherit;font-size:10pt;">13.5%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10.7%</font><font style="font-family:inherit;font-size:10pt;"> of the total consolidated revenues. </font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts not allocated to segments include interest (income) expense and general corporate (income) expense. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate includes cash, cash equivalents and marketable securities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Consumer segment includes a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of NIZORAL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">and litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;">. The Pharmaceutical segment includes an in-process research and development charge of </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;">, Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;">, unrealized loss on securities of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of certain non-strategic Pharmaceutical products. The Medical Devices segment includes net litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$1.7 billion</font><font style="font-family:inherit;font-size:10pt;">, a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$0.6 billion</font><font style="font-family:inherit;font-size:10pt;">, AMO acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> and a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of the LifeScan business in the fiscal fourth quarter. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Pharmaceutical segment includes </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;"> for Actelion acquisition related costs, an in-process research and development expense of </font><font style="font-family:inherit;font-size:10pt;">$0.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;">. The Medical Devices segment includes litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">, a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;">, an asset impairment of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> primarily related to the insulin pump business and </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> for AMO acquisition related costs. The Medical Devices segment includes a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of Codman Neurosurgery. The Consumer segment includes a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of COMPEED</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes net litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;"> and a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;"> in the Medical Devices segment. The Pharmaceutical segment includes a positive adjustment of </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> to previous reserve estimates and gains from the divestitures of the controlled substance raw material and active pharmaceutical ingredient (API) business and certain anesthetic products in Europe.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets include property, plant and equipment, net for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$17,035</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$17,005</font><font style="font-family:inherit;font-size:10pt;">, respectively, and intangible assets and goodwill, net for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$78,064</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$85,134</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Before Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Identifiable Assets</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018 </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017 </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016 </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,524</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,877</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,083</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,827</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,636</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,450</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Devices</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,397</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,392</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,578</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,413</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,285</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,846</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Expense not allocated to segments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,326</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,187</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Worldwide total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,999</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,673</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">19,803</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">152,954</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">157,303</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additions to Property,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plant &amp; Equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Depreciation and</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">608</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">936</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,802</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">886</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Devices</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,843</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,566</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,472</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,928</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segments total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,987</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,885</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,593</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,306</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Worldwide total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,279</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,226</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6,929</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5,642</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the restricted share units and performance share units activity under the Plans as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> is presented below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:89.0625%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding Restricted Share Units</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding Performance Share Units</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,074</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,142</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled/forfeited/adjusted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,091</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,460</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,494</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock options outstanding and exercisable at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.7265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Exercise Price Range</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Life</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$52.13-$65.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$62.67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$62.67</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$66.07-$72.54</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$72.53</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$72.53</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$90.44-$100.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$95.34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$95.23</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$101.87-$115.67</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,877</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$108.33</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$108.04</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$115.68-$129.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,437</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$129.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$129.51</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">109,652</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$98.29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">54,862</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$82.03</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;vertical-align:bottom;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> Average contractual life remaining in years.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of option activity under the Plan as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;">, and changes during the years ending on those dates is presented below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Outstanding Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aggregate</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Intrinsic</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Dollars in Millions) </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at January 3, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,065</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,491</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,547</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options canceled/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,006</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.83</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at January 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,636</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115.67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options canceled/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,461</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,306</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,115</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options canceled/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,541</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares at December 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">109,652</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">98.29</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The average fair value of options granted was </font><font style="font-family:inherit;font-size:10pt;">$17.98</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$13.38</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.01</font><font style="font-family:inherit;font-size:10pt;">, in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. The fair value was estimated based on the weighted average assumptions of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.3359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.77</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.76</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.70</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.90</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segments of Business and Geographic Areas</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales to Customers </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">% Change</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8217;18 vs. &#8217;17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8217;17 vs. &#8217;16</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">CONSUMER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Baby Care</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">488</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,513</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,858</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,916</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beauty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,979</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,865</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,762</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oral Care</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">637</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">915</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,531</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,568</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OTC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,675</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,484</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,410</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Women's Health</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,036</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,048</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Wound Care/Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">437</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">779</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">TOTAL CONSUMER</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,565</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,092</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,037</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,887</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">PHARMACEUTICAL</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Immunology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,073</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,871</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,047</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,373</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">REMICADE</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,525</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S. Exports</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">563</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">782</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,226</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,227</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,342</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,326</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,315</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SIMPONI / SIMPONI ARIA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,051</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">954</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,033</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,084</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,745</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">STELARA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,469</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,767</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,263</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,687</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">969</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,156</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">TREMFAYA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER IMMUNOLOGY</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Infectious Diseases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,461</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,926</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,304</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,154</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">EDURANT</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ rilpivirine</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">656</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">PREZISTA</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ PREZCOBIX</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ REZOLSTA</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ SYMTUZA</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,169</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,109</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,955</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,821</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,851</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER INFECTIOUS DISEASES</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">151</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">784</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Neuroscience</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,574</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,630</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,628</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,503</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,457</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,077</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">CONCERTA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ Methylphenidate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">INVEGA SUSTENNA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ XEPLION</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ INVEGA TRINZA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ TREVICTA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,137</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">979</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,928</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,569</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">RISPERDAL CONSTA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">512</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">893</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER NEUROSCIENCE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,510</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,679</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,749</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,821</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,115</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oncology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,331</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,098</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,160</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,472</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,258</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">DARZALEX</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">884</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,242</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">IMBRUVICA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">841</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">613</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">VELCADE</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,114</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">ZYTIGA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></font><font style="font-family:inherit;font-size:9pt;">/</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">abiraterone acetate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,771</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,089</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,727</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,505</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,260</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER ONCOLOGY</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">504</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pulmonary Hypertension</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">773</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">922</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">554</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OPSUMIT</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">253</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">TRACLEER</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">UPTRAVI</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">263</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cardiovascular / Metabolism / Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,855</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,543</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,541</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,396</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">XARELTO</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,477</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,477</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">INVOKANA</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ INVOKAMET</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">711</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">881</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,407</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">PROCRIT</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/ EPREX</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">972</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,105</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">OTHER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">527</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,053</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,079</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,069</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,470</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,596</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">TOTAL PHARMACEUTICAL</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,286</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,125</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,448</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,782</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,256</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,464</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">MEDICAL DEVICES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diabetes Care</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">371</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,009</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,789</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Interventional Solutions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,148</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,031</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,024</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,646</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,055</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Orthopaedics</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,438</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,690</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,885</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,058</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,128</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">HIPS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">841</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">827</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">577</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,394</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,361</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">KNEES</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">911</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">948</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">943</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,502</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">TRAUMA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,599</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,576</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,024</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,569</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SPINE &amp; OTHER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,053</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,152</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,472</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Surgery</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,125</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,085</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,474</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,901</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,559</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">ADVANCED</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,657</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,345</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,002</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,756</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,517</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;&#160;&#160;&#160;&#160;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">GENERAL</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,751</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,669</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,806</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,735</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,557</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,362</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SPECIALTY</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">584</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,340</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Vision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,777</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,488</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,063</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,785</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;&#160;&#160;&#160;&#160;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">CONTACT LENSES / OTHER</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,237</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,065</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,036</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,785</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;&#160;&#160;&#160;&#160;</sup></font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">SURGICAL</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">540</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">711</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,027</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">TOTAL MEDICAL DEVICES</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,837</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,157</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,768</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,592</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">WORLDWIDE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,811</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,697</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,079</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Worldwide </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,890</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">*Percentage greater than 100% or not meaningful</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Before Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Identifiable Assets</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018 </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017 </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016 </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,524</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,877</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,083</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,827</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,636</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,450</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Devices</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,397</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,392</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,578</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,413</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,285</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,846</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Expense not allocated to segments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,326</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,187</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Worldwide total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,999</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17,673</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">19,803</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">152,954</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">157,303</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additions to Property,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plant &amp; Equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Depreciation and</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumer</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">608</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">936</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,802</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">886</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Devices</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,843</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,566</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,472</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,928</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segments total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,987</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,885</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,593</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,306</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Worldwide total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,279</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,226</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6,929</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5,642</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales to Customers </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Lived Assets </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,811</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,117</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,126</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,433</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,677</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Western Hemisphere excluding U.S.&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,752</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia-Pacific, Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,831</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,420</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,575</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,733</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,773</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segments total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,890</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,035</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,996</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,064</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non long-lived assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,855</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,164</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Worldwide total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">81,581</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">76,450</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">71,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">152,954</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">157,303</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;text-decoration:underline;">&#173;</font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note&#160;1 for a description of the segments in which the Company operates. </font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Export sales are not significant. In 2018, the Company had three wholesalers distributing products for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> segments that represented approximately </font><font style="font-family:inherit;font-size:10pt;">14.0%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">11.0%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11.0%</font><font style="font-family:inherit;font-size:10pt;"> of the total consolidated revenues. In 2017, the Company had two wholesalers distributing products for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> segments that represented approximately </font><font style="font-family:inherit;font-size:10pt;">14.0%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> of the total consolidated revenues. In 2016, the Company had two wholesalers distributing products for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> segments that represented approximately </font><font style="font-family:inherit;font-size:10pt;">13.5%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10.7%</font><font style="font-family:inherit;font-size:10pt;"> of the total consolidated revenues. </font></div><div style="line-height:120%;padding-left:4px;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts not allocated to segments include interest (income) expense and general corporate (income) expense. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate includes cash, cash equivalents and marketable securities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Consumer segment includes a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of NIZORAL</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">and litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;">. The Pharmaceutical segment includes an in-process research and development charge of </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;">, Actelion acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;">, unrealized loss on securities of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of certain non-strategic Pharmaceutical products. The Medical Devices segment includes net litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$1.7 billion</font><font style="font-family:inherit;font-size:10pt;">, a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$0.6 billion</font><font style="font-family:inherit;font-size:10pt;">, AMO acquisition related costs of </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> and a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of the LifeScan business in the fiscal fourth quarter. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Pharmaceutical segment includes </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;"> for Actelion acquisition related costs, an in-process research and development expense of </font><font style="font-family:inherit;font-size:10pt;">$0.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;">. The Medical Devices segment includes litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">, a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;">, an asset impairment of </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> primarily related to the insulin pump business and </font><font style="font-family:inherit;font-size:10pt;">$0.1 billion</font><font style="font-family:inherit;font-size:10pt;"> for AMO acquisition related costs. The Medical Devices segment includes a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of Codman Neurosurgery. The Consumer segment includes a gain of </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> from the divestiture of COMPEED</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes net litigation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;"> and a restructuring related charge of </font><font style="font-family:inherit;font-size:10pt;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;"> in the Medical Devices segment. The Pharmaceutical segment includes a positive adjustment of </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> to previous reserve estimates and gains from the divestitures of the controlled substance raw material and active pharmaceutical ingredient (API) business and certain anesthetic products in Europe.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets include property, plant and equipment, net for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$17,035</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$17,005</font><font style="font-family:inherit;font-size:10pt;">, respectively, and intangible assets and goodwill, net for </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$78,064</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$85,134</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of the Company and Business Segments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has approximately </font><font style="font-family:inherit;font-size:10pt;">135,100</font><font style="font-family:inherit;font-size:10pt;">&#160;employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the world and its primary focus is on products related to human health and well-being.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is organized into </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women&#8217;s health and wound care markets. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. The Pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular), diabetes care (divested in the fiscal fourth quarter of 2018) and vision fields, which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. </font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shipping and Handling</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs incurred were </font><font style="font-family:inherit;font-size:10pt;">$1,090 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1,042 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$974 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, and are included in selling, marketing and administrative expense. The amount of revenue received for shipping and handling is less than </font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;"> of sales to customers for all periods presented.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;padding-top:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of Johnson&#160;&amp; Johnson and its subsidiaries (the Company). Intercompany accounts and transactions are eliminated.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of the Company and Business Segments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has approximately </font><font style="font-family:inherit;font-size:10pt;">135,100</font><font style="font-family:inherit;font-size:10pt;">&#160;employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the world and its primary focus is on products related to human health and well-being.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is organized into </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women&#8217;s health and wound care markets. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. The Pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular), diabetes care (divested in the fiscal fourth quarter of 2018) and vision fields, which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. </font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2014-09</font><font style="font-family:inherit;font-size:10pt;">: Revenue from Contracts with Customers</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2018, the Company adopted the new accounting standard, ASC 606, Revenue from Contracts with Customers and all the related amendments (new revenue standard) to all contracts using the modified retrospective method. The cumulative effect of initially applying the new revenue standard was recognized as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The adoption of the new revenue standard has not had a material impact to either reported Sales to customers or Net earnings. Additionally, the Company will continue to recognize revenue from product sales as goods are shipped or delivered to the customer, as control of goods transfers at the same time. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on the Company's Consolidated Statement of Earnings and Balance Sheet was as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Statement of Earnings - For the fiscal year ended December 30, 2018 </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Dollars in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of change</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales to customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,581</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,546</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,297</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,269</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet - As of December 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of change</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,954</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,977</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,752</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,771</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made a cumulative effect adjustment to the 2018 opening balance of retained earnings upon adoption of ASU 2014-09, which decreased beginning retained earnings by </font><font style="font-family:inherit;font-size:10pt;">$47 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the adoption of ASC 606 see Note 18 to the Consolidated Financial Statements for further disaggregation of revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-01</font><font style="font-family:inherit;font-size:10pt;">: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities</font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018 on a modified retrospective basis. The amendments in this update supersede the guidance to classify equity securities with readily determinable fair values into different categories (that is, trading or available-for-sale) and require equity securities to be measured at fair value with changes in the fair value recognized through net earnings. The standard amends financial reporting by providing relevant information about an entity&#8217;s equity investments and reducing the number of items that are recognized in other comprehensive income. </font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 that increased retained earnings by </font><font style="font-family:inherit;font-size:10pt;">$232 million</font><font style="font-family:inherit;font-size:10pt;"> net of tax and decreased accumulated other comprehensive income for previously unrealized gains from equity investments. For additional details see Note 6 to the Consolidated Financial Statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-16</font><font style="font-family:inherit;font-size:10pt;">: Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018. This update removes the current exception in U.S. GAAP prohibiting entities from recognizing current and deferred income tax expenses or benefits related to transfer of assets, other than inventory, within the consolidated entity. The current exception to defer the recognition of any tax impact on the transfer of inventory within the consolidated entity until it is sold to a third party remains unaffected. As discussed further in Note 8 to the Consolidated Financial Statements, in the fourth fiscal quarter of 2018 the Company elected an accounting policy to treat the tax on global intangible low-taxed income (GILTI) under the deferred tax accounting model. As a result, the Company is required to record an additional deferred tax liability related to the basis difference of these intra-entity asset transfers. The Company recorded net adjustments including an increase to deferred tax assets of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;">, an increase to deferred tax liabilities of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.7 billion</font><font style="font-family:inherit;font-size:10pt;">, related to the GILTI accounting policy election in the fourth fiscal quarter of 2018, a decrease to Other Assets of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;"> and a decrease to retained earnings of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.4 billion</font><font style="font-family:inherit;font-size:10pt;">. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2017-01</font><font style="font-family:inherit;font-size:10pt;">: Clarifying the Definition of a Business</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018. This update narrows the definition of a business by providing a screen to determine when an integrated set of assets and activities is not a business. The screen specifies that an integrated set of assets and activities is not a business if substantially all of the fair value of the gross assets acquired or disposed of is concentrated in a single or a group of similar identifiable assets. This update was applied prospectively. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2017-07</font><font style="font-family:inherit;font-size:10pt;">: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted this standard as of the beginning of the fiscal year 2018. This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost (NPBC). In addition, only the service cost component will be eligible for capitalization. The amendments in this update are required to be applied retrospectively for the presentation of the service cost component and the other components of NPBC in the Consolidated Statement of Earnings and prospectively, on and after the adoption date, for the capitalization of the service cost component of NPBC in assets. As required by the transition provisions of this update, the following table shows the impact of the adoption on the respective line items in the Consolidated Statement of Earnings for 2018 and the reclassifications to the 2017 and 2016 fiscal year Consolidated Statement of Earnings to retroactively apply classification of the service cost component and the other components of NPBC: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase (Decrease) to Net Expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of products sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, marketing and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(225</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the cumulative effect adjustments made to the 2018 opening balance of retained earnings upon adoption of the new accounting standards mentioned above: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:75.1953125%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative Effect Adjustment Increase (Decrease) to Retained Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2014-09 - Revenue from Contracts with Customers</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-01 - Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-16 - Income Taxes: Intra-Entity Transfers</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2017-12</font><font style="font-family:inherit;font-size:10pt;">: Targeted Improvements to Accounting for Hedging Activities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company elected to early adopt this standard as of the beginning of the fiscal second quarter of 2018. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. For additional required disclosures see Note 6 to the Consolidated Financial Statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Not Adopted as of December 30, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2018-18</font><font style="font-family:inherit;font-size:10pt;">: Collaborative Arrangements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update clarifies the interaction between ASC 808, Collaborative Arrangements and ASC 606, Revenue from Contracts with Customers. The update clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue if the counterparty is not a customer for that transaction. This update will be effective for the Company for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2018-18 should be applied retrospectively to the date of initial application of ASC 606 and early adoption is permitted. The Company is currently assessing the impact of this update on the Company&#8217;s consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2018-16:</font><font style="font-family:inherit;font-size:10pt;"> Derivatives and Hedging (Topic ASC 815)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update adds the Overnight Index Swap (OIS) rate based on the Secured Overnight Financing Rate (SOFR) as an eligible benchmark interest rate permitted in the application of hedge accounting. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted if an entity has adopted ASU 2017-12. The Company is currently assessing the impact of this update on the Company&#8217;s consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2018-02</font><font style="font-family:inherit;font-size:10pt;">: Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Job Act enacted in December 2017. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company does not expect this standard to have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-13</font><font style="font-family:inherit;font-size:10pt;">: Financial Instruments - Credit Losses</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity&#8217;s current estimate of credit losses expected to be incurred over the life of the financial instrument. This update will be effective for the Company for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact of this update on the Company&#8217;s consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">ASU 2016-02</font><font style="font-family:inherit;font-size:10pt;">: Leases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update requires the recognition of lease assets and lease liabilities on the balance sheet for all lease obligations and disclosing key information about leasing arrangements. This update requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current generally accepted accounting principles. This update will be effective for the Company for all annual periods beginning after December 15, 2018, including interim periods within those fiscal years. The Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements. The Company&#8217;s operating leases will result in the recognition of additional assets and the corresponding liabilities on its Consolidated Balance Sheets. The adoption of this standard will not have a material impact on the Company's consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Equivalents</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating. The Company invests its cash primarily in government securities and obligations, corporate debt securities, money market funds and reverse repurchase agreements (RRAs).</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RRAs are collateralized by deposits in the form of Government Securities and Obligations for an amount not less than </font><font style="font-family:inherit;font-size:10pt;">102%</font><font style="font-family:inherit;font-size:10pt;"> of their value. The Company does not record an asset or liability as the Company is not permitted to sell or repledge the associated collateral. The Company has a policy that the collateral has at least an A (or equivalent) credit rating. The Company utilizes a third party custodian to manage the exchange of funds and ensure that collateral received is maintained at </font><font style="font-family:inherit;font-size:10pt;">102%</font><font style="font-family:inherit;font-size:10pt;"> of the value of the RRAs on a daily basis. RRAs with stated maturities of greater than three months from the date of purchase are classified as marketable securities.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments</font></div><div style="line-height:120%;padding-top:2px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments classified as held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income. Available-for-sale securities available for current operations are classified as current assets otherwise, they are classified as long term. Management determines the appropriate classification of its investment in debt and equity securities at the time of purchase and re-evaluates such determination at each balance sheet date. The Company reviews its investments in equity securities for impairment and adjusts these investments to fair value through earnings, as required.&#160;</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, Plant and Equipment and Depreciation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost. The Company utilizes the straight-line method of depreciation over the estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20&#160;- 30&#160;years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10&#160;- 20&#160;years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2&#160;- 13&#160;years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company capitalizes certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">8</font><font style="font-family:inherit;font-size:10pt;">&#160;years.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company reviews long-lived assets to assess recoverability using undiscounted cash flows. When certain events or changes in operating or economic conditions occur, an impairment assessment may be performed on the recoverability of the carrying value of these assets. If the asset is determined to be impaired, the loss is measured based on the difference between the asset&#8217;s fair value and its carrying value. If quoted market prices are not available, the Company will estimate fair value using a discounted value of estimated future cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. The Company's global payment terms are typically between 30 to 90 days. Provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. Rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. The Company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns are estimated and recorded based on historical sales and returns information. Products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. The sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. In accordance with the Company&#8217;s accounting policies, the Company generally issues credit to customers for returned goods. The Company&#8217;s sales returns reserves are accounted for in accordance with the U.S.&#160;GAAP guidance for revenue recognition when right of return exists. Sales returns reserves are recorded at full sales value. Sales returns in the Consumer and Pharmaceutical segments are almost exclusively not resalable. Sales returns for certain franchises in the Medical Devices segment are typically resalable but are not material. The Company infrequently exchanges products from inventory for returned products. The sales returns reserve for the total Company has been approximately </font><font style="font-family:inherit;font-size:10pt;">1.0%</font><font style="font-family:inherit;font-size:10pt;"> of annual net trade sales during the fiscal reporting years&#160;2018,&#160;2017&#160;and&#160;2016.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. Continuing promotional programs include coupons and volume-based sales incentive programs. The redemption cost of consumer coupons is based on historical redemption experience by product and value. Volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. These arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. The Company also earns profit-share payments through collaborative arrangements for certain products, which are included in sales to customers. For all years presented, profit-share payments were less than </font><font style="font-family:inherit;font-size:10pt;">2.0%</font><font style="font-family:inherit;font-size:10pt;"> of the total revenues and are included in sales to customers.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shipping and Handling</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs incurred were </font><font style="font-family:inherit;font-size:10pt;">$1,090 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1,042 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$974 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, and are included in selling, marketing and administrative expense. The amount of revenue received for shipping and handling is less than </font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;"> of sales to customers for all periods presented.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost or net realizable value determined by the first-in, first-out method.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets and Goodwill</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The authoritative literature on U.S.&#160;GAAP requires that goodwill and intangible assets with indefinite lives be assessed annually for impairment. The Company completed the annual impairment test for 2018 in the fiscal fourth quarter. Future impairment tests will be performed annually in the fiscal fourth quarter, or sooner if warranted. Purchased in-process research and development is accounted for as an indefinite lived intangible asset until the underlying project is completed, at which point the intangible asset will be accounted for as a definite lived intangible asset, or abandoned, at which point the intangible asset will be written off or partially impaired.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets that have finite useful lives continue to be amortized over their useful lives, and are reviewed for impairment when warranted by economic conditions. See Note&#160;5 for further details on Intangible Assets and Goodwill.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Instruments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As required by U.S.&#160;GAAP, all derivative instruments are recorded on the balance sheet at fair value. Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value, with Level&#160;1 having the highest priority and Level&#160;3 having the lowest. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company documents all relationships between hedged items and derivatives. The overall risk management strategy includes reasons for undertaking hedge transactions and entering into derivatives. The objectives of this strategy are: (1)&#160;minimize foreign currency exposure&#8217;s impact on the Company&#8217;s financial performance; (2)&#160;protect the Company&#8217;s cash flow from adverse movements in foreign exchange rates; (3)&#160;ensure the appropriateness of financial instruments; and (4)&#160;manage the enterprise risk associated with financial institutions. See Note&#160;6 for additional information on Financial Instruments.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Product Liability</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accruals for product liability claims are recorded, on an undiscounted basis, when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on existing information and actuarially determined estimates where applicable. The accruals are adjusted periodically as additional information becomes available. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As a result of cost and availability factors, effective November&#160;1, 2005, the Company ceased purchasing third-party product liability insurance. The Company has self insurance through a wholly-owned captive insurance company. In addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses are expensed as incurred in accordance with ASC 730, Research&#160;and Development. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Amounts capitalized for such payments are included in other intangibles, net of accumulated amortization.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company enters into collaborative arrangements, typically with other pharmaceutical or biotechnology companies, to develop and commercialize drug candidates or intellectual property. These arrangements typically involve two (or more) parties who are active participants in the collaboration and are exposed to significant risks and rewards dependent on the commercial success of the activities. These collaborations usually involve various activities by one or more parties, including research and development, marketing and selling and distribution. Often, these collaborations require upfront, milestone and royalty or profit share payments, contingent upon the occurrence of certain future events linked to the success of the asset in development. Amounts due from collaborative partners related to development activities are generally reflected as a reduction of research and development expense because the performance of contract development services is not central to the Company&#8217;s operations. In general, the income statement presentation for these collaborations is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nature/Type of Collaboration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Statement of Earnings Presentation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third-party sale of product &amp; profit share payments received</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales to customers</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties/milestones paid to collaborative partner (post-regulatory approval)*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of products sold</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties received from collaborative partner</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upfront payments&#160;&amp; milestones paid to collaborative partner (pre-regulatory approval)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development payments to collaborative partner</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development payments received from collaborative partner</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reduction of Research and development expense</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:98%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Milestones are capitalized as intangible assets and amortized to cost of products sold over the useful life.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For all years presented, there was no individual project that represented greater than </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> of the total annual consolidated research and development expense.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a number of products and compounds developed in collaboration with strategic partners including XARELTO</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, co-developed with Bayer HealthCare AG and IMBRUVICA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, developed in collaboration and co-marketed with Pharmacyclics LLC, an AbbVie company.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a number of licensing arrangements for products and compounds including DARZALEX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, licensed from Genmab A/S.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Advertising</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Costs associated with advertising are expensed in the year incurred and are included in selling, marketing and administrative expenses. Advertising expenses worldwide, which comprised television, radio, print media and Internet advertising, were </font><font style="font-family:inherit;font-size:10pt;">$2.6 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.5 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.4 billion</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between U.S. GAAP accounting and tax reporting, recorded as deferred tax assets or liabilities. The Company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. Future changes in tax laws and rates may affect recorded deferred tax assets and liabilities in the future. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has unrecognized tax benefits for uncertain tax positions. The Company follows U.S. GAAP which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management believes that changes in these estimates would not have a material effect on the Company's results of operations, cash flows or financial position.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth fiscal quarter of 2018, the Company has elected to account for the GILTI tax under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recorded deferred tax liabilities on all undistributed earnings prior to December 31, 2017 from its international subsidiaries. The Company has not provided deferred taxes on the undistributed earnings subsequent to January 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. The Company intends to continue to reinvest these earnings in those international operations. If the Company decides at a later date to repatriate these earnings to the U.S., the Company would be required to provide for the net tax effects on these amounts. The Company estimates that the total tax effect of this repatriation would be approximately $0.7 billion under current enacted tax laws and regulations and at current currency exchange rates. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 8 for further information regarding income taxes.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Earnings Per Share</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per share is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S.&#160;requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, rebates, allowances and incentives, product liabilities, income taxes, withholding taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows the provisions of U.S.&#160;GAAP when recording litigation related contingencies. A liability is recorded when a loss is probable and can be reasonably estimated. The best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Annual Closing Date</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows the concept of a fiscal year, which ends on the Sunday nearest to the end of the month of December. Normally each fiscal year consists of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52&#160;weeks, but every five or six years the fiscal year consists of 53&#160;weeks</font><font style="font-family:inherit;font-size:10pt;">, and therefore includes additional shipping days, as was the case in 2015, and will be the case again in 2020.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to current year presentation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to unrecognized tax benefits:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.1951219512195%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Dollars in Millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to prior period tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decreases related to prior period tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(416</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(338</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lapse of statute of limitations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">End of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,326</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,151</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3,041</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;"> In 2017, </font><font style="font-family:inherit;font-size:8pt;">$347 million</font><font style="font-family:inherit;font-size:8pt;"> of this decrease is related to the TCJA</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital and Treasury Stock</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in treasury stock were:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Treasury Stock</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Amounts in Millions Except Treasury Stock Shares in Thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at January 3, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364,681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee compensation and stock option plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30,839</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,311</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,490</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,979</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at January 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee compensation and stock option plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,508</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,156</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,494</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,358</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">437,318</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,554</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee compensation and stock option plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,082</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,060</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,283</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,868</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">457,519</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,362</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate shares of common stock issued were approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3,119,843,000</font><font style="font-family:inherit;font-size:10pt;">&#160;shares at the end of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash dividends paid were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.54</font><font style="font-family:inherit;font-size:10pt;"> per share in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, compared with dividends of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.32</font><font style="font-family:inherit;font-size:10pt;"> per share in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.15</font><font style="font-family:inherit;font-size:10pt;"> per share in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 17, 2018, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$5.0 billion</font><font style="font-family:inherit;font-size:10pt;"> of the Company's shares of common stock. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Any shares acquired will be available for general corporate purposes. The Company intends to finance the share repurchase program through available cash. As of December 30, 2018, </font><font style="font-family:inherit;font-size:10pt;">$0.9 billion</font><font style="font-family:inherit;font-size:10pt;"> has been repurchased under the program.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 13, 2015, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$10.0 billion</font><font style="font-family:inherit;font-size:10pt;"> of the Company's shares of common stock. This share repurchase program was completed as of July 2, 2017.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S.&#160;requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, rebates, allowances and incentives, product liabilities, income taxes, withholding taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows the provisions of U.S.&#160;GAAP when recording litigation related contingencies. A liability is recorded when a loss is probable and can be reasonably estimated. The best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.</font></div></div> (1) See Note 1 to Consolidated Financial Statements for additional details on the effect of cumulative adjustments to retained earnings. EX-101.SCH 9 jnj-20181230.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2113100 - Disclosure - Accumulated Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Borrowings link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Borrowings - Aggregate Maturities of Long Term Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Borrowings - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Borrowings - Schedule of Long-term Debt Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Business Combinations and Divestitures link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Business Combinations and Divestitures - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - Business Combinations and Divestitures - Purchase Price Allocation of Identifiable Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Business Combinations and Divestitures - Schedule of Preliminary Amounts Recognized for Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2420405 - Disclosure - Business Combinations and Divestitures - Schedule of Pro Forma Results (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Business Combinations and Divestitures (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Capital and Treasury Stock link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Capital and Treasury Stock - Changes in Treasury Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Capital and Treasury Stock - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Capital and Treasury Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities - Cash and Cash Equivalent Composition (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities - Contractual Maturities of Available for Sale Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Schedule Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2417405 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2417406 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Restricted Share Units (Details) link:presentationLink link:calculationLink link:definitionLink 2417404 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Earnings link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Equity link:presentationLink link:calculationLink link:definitionLink 1004001 - Statement - Consolidated Statements of Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Earnings Per Share - Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Employee Related Obligations link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Employee Related Obligations - Employee Related Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Employee Related Obligations - Employee Related Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Employee Related Obligations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Employee Related Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2406408 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2406406 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 2406407 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Income Taxes - Comparison of Income Taxes at Statutory Rate and Company's Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2408406 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Income Taxes - Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Income Taxes - Temporary Differences and Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Intangible Assets and Goodwill link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Intangible Assets and Goodwill - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets and Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Intangible Assets and Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - International Currency Translation link:presentationLink link:calculationLink link:definitionLink 2414401 - Disclosure - International Currency Translation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 2421401 - Disclosure - Legal Proceedings (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Pensions and Other Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Pensions and Other Benefit Plans - Amounts Expected to be Recognized in Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Pensions and Other Benefit Plans - Assumed Health Care Cost Trend Rates (Details) link:presentationLink link:calculationLink link:definitionLink 2410412 - Disclosure - Pensions and Other Benefit Plans - Company' Retirement Plan Asset Allocation and Target Allocations (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2410406 - Disclosure - Pensions and Other Benefit Plans - Effect of One Percentage Point Change in Assumed Health Care Cost Trend Rates (Details) link:presentationLink link:calculationLink link:definitionLink 2410409 - Disclosure - Pensions and Other Benefit Plans - Information Related to the Benefit Obligation and the Fair Value of Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2410408 - Disclosure - Pensions and Other Benefit Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2410410 - Disclosure - Pensions and Other Benefit Plans - Projected Future Benefit Payments from Company's Retirement and Other Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2410411 - Disclosure - Pensions and Other Benefit Plans - Projected Future Minimum Contributions to the Company's U.S. and International Unfunded Retirement Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Pensions and Other Benefit Plans - Rates Used to Develop Actuarial Present Value of Projected Benefit Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 2410413 - Disclosure - Pensions and Other Benefit Plans - Schedule of Defined Benefit Plans Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 2410407 - Disclosure - Pensions and Other Benefit Plans - Schedule of Net Funded Status (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Pensions and Other Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Property, Plant and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment at Cost and Accumulated Depreciation (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Rental Expense and Lease Commitments link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Rental Expense and Lease Commitments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Rental Expense and Lease Commitments - Schedule of Minimum Rental Payments Under Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Rental Expense and Lease Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Restructuring link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - Restructuring - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2422403 - Disclosure - Restructuring - Summary of Severance Charges and Associated Spending (Details) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Savings Plan link:presentationLink link:calculationLink link:definitionLink 2411401 - Disclosure - Savings Plan - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Segments of Business and Geographic Areas link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Segments of Business and Geographic Areas - Sales by Segment of Business (Details) link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - Segments of Business and Geographic Areas - Schedule of Segment Reporting Information (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Segments of Business and Geographic Areas (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Selected Quarterly Financial Data (unaudited) link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Selected Quarterly Financial Data (unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401407 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2401405 - Disclosure - Summary of Significant Accounting Policies - Schedule of Adjustments for Accounting Standards Update 2017-07 (Details) link:presentationLink link:calculationLink link:definitionLink 2401406 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cumulative Effect Adjustments (Details) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Summary of Significant Accounting Policies - Schedule of Impact of Adoption (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 jnj-20181230_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 jnj-20181230_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 jnj-20181230_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Fair Value Disclosures [Abstract] Derivative [Table] Derivative [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] ASU 2016-01 - Financial Instruments Accounting Standards Update 2016-01 [Member] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Retained Earnings Retained Earnings [Member] Asset Class [Axis] Asset Class [Axis] Asset Class [Domain] Asset Class [Domain] Equity securities Equity Securities [Member] Other Investment Not Readily Marketable [Axis] Other Investment Not Readily Marketable [Axis] Other Investment Not Readily Marketable, Name [Domain] Other Investment Not Readily Marketable, Name [Domain] Equity Investments with Readily Determinable Value Equity Investments with Readily Determinable Value [Member] Equity Investments with Readily Determinable Value [Member] Equity Investments without Readily Determinable Value Equity Investments without Readily Determinable Value [Member] Equity Investments without Readily Determinable Value [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign exchange contracts Foreign Exchange Contract [Member] Cross currency interest rate swaps Cross Currency Interest Rate Contract [Member] Interest rate swaps contracts: Interest Rate Contract [Member] Derivative [Line Items] Derivative [Line Items] Equity, Fair Value Adjustment, Impairment Loss Equity, Fair Value Adjustment, Impairment Loss Equity, Fair Value Adjustment, Impairment Loss Cumulative effect adjustment Cumulative Effect of New Accounting Principle in Period of Adoption Marketable Securities, Noncurrent Marketable Securities, Noncurrent Other Assets, Noncurrent Other Assets, Noncurrent Equity, Fair Value Adjustment Equity, Fair Value Adjustment Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period Collateral paid Collateral Already Posted, Aggregate Fair Value Derivative, notional amount Derivative, Notional Amount Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax Deferred net losses (gains) on derivatives included in accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Description of Reclassification of Cash Flow Hedge Gain (Loss) Description of Reclassification of Cash Flow Hedge Gain (Loss) Maximum length of time for hedging transaction exposure Maximum Length of Time, Foreign Currency Cash Flow Hedge Cost Method Investments Cost Method Investments Equity, Fair Value Adjustment, Change in Observable Prices Equity, Fair Value Adjustment, Change in Observable Prices Equity, Fair Value Adjustment, Change in Observable Prices Unrealized holding gain (loss) arising during period Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Savings Plan [Abstract] Savings Plan. Matching contributions Defined Contribution Plan, Cost Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Supply Chain Supply Chain [Member] Supply Chain Medical Devices Medical Devices [Member] Medical Devices [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Statement, Business Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Medical Devices Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Severance Employee Severance [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of products sold Cost of Sales [Member] Other Income Expense Net Other Income Expense Net [Member] Other Income Expense Net [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Pre-tax restructuring charges Restructuring and Related Cost, Expected Cost Restructuring charges Restructuring Charges Restructuring costs incurred since announced Restructuring and Related Cost, Cost Incurred to Date Number of positions eliminated and receiving severance payments Restructuring and Related Cost, Number of Positions Eliminated, Receiving Severance Payments Restructuring and Related Cost, Number of Positions Eliminated, Receiving Severance Payments Restructuring and Related Cost, Expected Future Savings Restructuring and Related Cost, Expected Future Savings Restructuring and Related Cost, Expected Future Savings Restructuring and Related Cost, Duration of Restructuring Plan Restructuring and Related Cost, Duration of Restructuring Plan Restructuring and Related Cost, Duration of Restructuring Plan Debt Disclosure [Abstract] Borrowings Debt Disclosure [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 5.15% Debentures due 2018 5.15% Debentures due 2018 [Member] 5.15% Debentures due 2018 [Member] 1.65% Notes due 2018 1.65% Notes due 2018 [Member] 1.65% Notes due 2018 [Member] 4.75% Notes due 2019 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3) 4.75% Notes due 2019 [Member] 4.75% Notes due 2019 [Member] 1.875% Notes due 2019 1.875% Notes due 2019 [Member] 1.875% Notes due 2019 [Member] 0.89% Notes due 2019 0.89% Notes due 2019 [Member] 0.89% Notes due 2019 [Member] 1.125% Notes due 2019 1.125% Notes due 2019 [Member] 1.125% Notes due 2019 [Member] 3% Zero Coupon Convertible Subordinated Debentures due 2020 3% Zero Coupon Convertible Subordinated Debentures due in 2020 [Member] 3% Zero Coupon Convertible Subordinated Debentures due in 2020 [Member] 2.95% Debentures due 2020 2.95% Debentures due 2020 [Member] 2.95% Debentures due 2020 [Member] 1.950% Notes due 2020 1.950% Notes due 2020 [Member] 1.950% Notes due 2020 [Member] 3.55% Notes due 2021 3.55% Notes due 2021 [Member] 3.55% Notes due 2021 [Member] 2.45% Notes due 2021 2.45% Notes due 2021 [Member] 2.45% Notes due 2021 [Member] 1.65% Notes due 2021 1.65% Notes due 2021 [Member] 1.65% Notes due 2021 [Member] 0.250% Notes due 2022 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3) 0.250% Notes due 2022 [Member] 0.250% Notes due 2022 [Member] 2.25% Notes due 2022 2.25% Notes due 2022 [Member] 2.25% Notes due 2022 [Member] 6.73% Debentures due 2023 6.73% Debentures due 2023 [Member] 6.73% Debentures due 2023 [Member] 3.375% Notes due 2023 3.375% Notes due 2023 [Member] 3.375% Notes due 2023 [Member] 2.05% Notes due 2023 2.05% Notes due 2023 [Member] 2.05% Notes due 2023 [Member] 0.650% Notes due 2024 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3) 0.650% Notes due 2024 [Member] 0.650% Notes due 2024 [Member] 5.50% Notes due 2024 (500MM GBP 1.2636)(2)/(500MM GBP 1.3444)(3) 5.50% Notes due 2024 [Member] 5.50% Notes due 2024 [Member] 2.625% Notes due 2025 2.625 Notes due 2025 [Member] 2.625 Notes due 2025 [Member] 2.45% Notes due 2026 2.45% Notes due 2026 [Member] 2.45% Notes due 2026 [Member] 2.95% Notes due 2027 2.95% Notes due 2027 [Member] 2.95% Notes due 2027 [Member] 1.150% Notes due 2028 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3) 1.150% Notes due 2028 [Member] 1.150% Notes due 2028 [Member] 2.900% Notes due 2028 2.900% Notes due 2028 [Member] 2.900% Notes due 2028 [Member] 6.95% Notes due 2029 6.95% Notes due 2029 [Member] 6.95% Notes due 2029 [Member] 4.95% Debentures due 2033 4.95% Debentures due 2033 [Member] 4.95% Debentures due 2033 [Member] 4.375% Notes due 2033 4.375% Notes due 2033 [Member] 4.375% Notes due 2033 [Member] 1.650% Notes due 2035 (1.5B Euro 1.14)(2)/(1.5B Euro 1.1947)(3) 1.650% Notes due 2035 [Member] 1.650% Notes due 2035 [Member] 3.55% Notes due 2036 3.55% Notes due 2036 [Member] 3.55% Notes due 2036 [Member] 5.95% Notes due 2037 5.95% Notes due 2037 [Member] 5.95% Notes due 2037 [Member] 3.625% Notes due 2037 3.625% Notes due 2037 [Member] 3.625% Notes due 2037 [Member] 5.85% Debentures due 2038 5.85% Debentures due 2038 [Member] 5.85% Debentures due 2038 [Member] 3.400% Notes due 2038 3.400% Notes due 2038 [Member] 3.400% Notes due 2038 [Member] 4.50% Debentures due 2040 4.50% Debentures due 2040 [Member] 4.50% Debentures due 2040 [Member] 4.85% Notes due 2041 4.85% Notes due 2041 [Member] 4.85% Notes due 2041 [Member] 4.50% Notes due 2043 4.50% Notes due 2043 [Member] 4.50% Notes due 2043 [Member] 3.70% Notes due 2046 3.70% Notes due 2046 [Member] 3.70% Notes due 2046 [Member] 3.75% Notes due 2047 3.75% Notes due 2047 [Member] 3.75% Notes due 2047 [Member] 3.500% Notes due 2048 3.500% Notes due 2048 [Member] 3.500% Notes due 2048 [Member] Other Other Debt Obligations [Member] Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis] Measurement Basis [Axis] Fair Value, Disclosure Item Amounts [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying (Reported) Amount, Fair Value Disclosure Reported Value Measurement [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Borrowed under the commercial paper program Long-term Commercial Paper, Current Long-term Debt Long-term Debt Less current portion Long-term Debt, Current Maturities Total long-term debt Long-term Debt, Excluding Current Maturities Stated interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Face Amount Debt Instrument, Face Amount Foreign Currency Exchange Rate, Translation Foreign Currency Exchange Rate, Translation Property, Plant and Equipment [Abstract] Property, Plant and Equipment at Cost and Accumulated Depreciation Property, Plant and Equipment [Table Text Block] Compensation Related Costs [Abstract] Employee Related Obligations Compensation Related Costs, General [Text Block] Retirement Benefits [Abstract] 2019 Defined Benefit Plan Expected Future Benefit Contribution In Year One Defined benefit plan expected future benefit contribution in year one. 2020 Defined Benefit Plan Expected Future Benefit Contribution In Year Two Defined benefit plan expected future benefit contribution in year two. 2021 Defined Benefit Plan Expected Future Benefit Contribution In Year Three Defined benefit plan expected future benefit contribution in year three. 2022 Defined Benefit Plan Expected Future Benefit Contribution In Year Four Defined benefit plan expected future benefit contribution in year four. 2023 Defined Benefit Plan Expected Future Benefit Contribution In Year Five Defined benefit plan expected future benefit contribution in year five. 2024-2028 Defined Benefit Plan Expected Future Benefit Contribution In Five Fiscal Years Thereafter Defined benefit plan expected future benefit contribution in five fiscal years thereafter. Equity [Abstract] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Share Repurchase Program [Domain] Share Repurchase Program [Domain] December 17, 2018 Share Repurchase Program December 17, 2018 Share Repurchase Program [Member] December 17, 2018 Share Repurchase Program [Member] October 13, 2015 Share Repurchase Program October 13, 2015 Share Repurchase Program [Member] October 13, 2015 Share Repurchase Program [Member] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Cash dividends paid (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock Asset Write-offs Asset Write-off [Member] Asset Write-off [Member] Other Other Restructuring [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Reserve balance beginning Restructuring Reserve Activity during the period Restructuring Reserve, Period Increase (Decrease) Restructuring charges Cash payments Payments for Restructuring Settled non cash Restructuring Reserve, Settled without Cash Reserve balance ending Document and Entity Information [Abstract] Document And Entity Information. Document Information [Table] Document Information [Table] Document Information, Document [Axis] Document Information, Document [Axis] Document [Domain] Document [Domain] Document Information [Line Items] Document Information [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Public Float Entity Public Float Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] UNITED STATES UNITED STATES Non-US Non-US [Member] UNITED STATES Exports UNITED STATES Exports [Member] UNITED STATES Exports [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Baby Care Baby Care [Member] Baby Care [Member] Beauty Beauty [Member] Beauty [Member] Oral Care Oral Care [Member] Oral Care [Member] OTC OTC [Member] OTC [Member] Women's Health Women's Health [Member] Women's Health [Member] Wound Care and Other Wound Care and Other [Member] Wound Care and Other [Member] Remicade Remicade [Member] Remicade [Member] Simponi/Simponi Aria Simponi/Simponi Aria [Member] Simponi/Simponi Aria [Member] Stelara Stelara [Member] Stelara [Member] Tremfaya Tremfaya [Member] Tremfaya Other Immunology Other Immunology [Member] Other Immunology [Member] EDURANT/rilpivirine EDURANT/rilpivirine [Member] EDURANT/rilpivirine [Member] PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member] PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member] Other Infectious Diseases Other Infectious Diseases [Member] Other Infectious Diseases [Member] CONCERTA/Methylphenidate CONCERTA/Methylphenidate [Member] CONCERTA/Methylphenidate [Member] INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member] INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member] RISPERDAL CONSTA RISPERDAL CONSTA [Member] RISPERDAL CONSTA [Member] OTHER NEUROSCIENCE OTHER NEUROSCIENCE [Member] OTHER NEUROSCIENCE [Member] DARZALEX DARZALEX [Member] DARZALEX [Member] IMBRUVICA IMBRUVICA [Member] IMBRUVICA [Member] VELCADE VELCADE [Member] VELCADE [Member] ZYTIGA ZYTIGA [Member] ZYTIGA [Member] Other Oncology Other Oncology [Member] Other Oncology [Member] OPSUMIT OPSUMIT [Member] OPSUMIT [Member] TRACLEER TRACLEER [Member] TRACLEER [Member] UPTRAVI UPTRAVI [Member] UPTRAVI [Member] Other Other [Member] Other [Member] Xarelto Xarelto [Member] Xarelto [Member] INVOKANA/INVOKAMET INVOKANA/INVOKAMET [Member] INVOKANA/INVOKAMET [Member] PROCRIT/EPREX PROCRIT/EPREX [Member] PROCRIT/EPREX [Member] HIPS HIPS [Member] HIPS [Member] KNEES KNEES [Member] KNEES [Member] TRAUMA TRAUMA [Member] TRAUMA [Member] SPINE & OTHER SPINE & OTHER [Member] SPINE & OTHER [Member] ADVANCED ADVANCED [Member] ADVANCED [Member] GENERAL GENERAL [Member] GENERAL [Member] SPECIALTY SPECIALTY [Member] SPECIALTY [Member] CONTACT LENSES/OTHER CONTACT LENSES/OTHER [Member] CONTACT LENSES/OTHER [Member] SURGICAL SURGICAL [Member] SURGICAL [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Segments [Axis] Consumer Consumer [Member] Consumer. Pharmaceutical Pharmaceutical [Member] Pharmaceutical. Subsegments [Axis] Subsegments [Axis] Subsegments [Domain] Subsegments [Domain] Immunology Immunology [Member] Immunology [Member] Infectious Diseases Infectious Diseases [Member] Infectious Diseases [Member] Neuroscience Neuroscience [Member] Neuroscience [Member] Oncology Oncology [Member] Oncology [Member] Pulmonary Hypertension Pulmonary Hypertension [Member] Pulmonary Hypertension [Member] Cardiovascular/Metabolism/Other Cardiovascular/Metabolism/Other [Member] Cardiovascular/Metabolism/Other [Member] Diabetes Care Diabetes Care [Member] Diabetes Care [Member] Diagnostics Diagnostics [Member] Diagnostics [Member] Interventional Solutions Interventional Solutions [Member] Interventional Solutions [Member] Orthopaedics Orthopaedics [Member] Orthopaedics [Member] Surgery Surgery [Member] Surgery [Member] Vision Vision [Member] Vision[Member] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Domain] Subsegments Consolidation Items [Domain] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Sales to Customers Revenue from Contract with Customer, Excluding Assessed Tax Percentage Change In Sales By Segment Of Business Percentage Change In Sales By Segment Of Business Percentage change in sales by segment of business. Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Intangible Assets and Goodwill Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block] Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block] Goodwill Schedule of Goodwill [Table Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Stock Option Activity Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of Options Outstanding Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Summary of Restricted Share Units Share-based Compensation, Activity [Table Text Block] Intangible Assets and Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Retirement plans Pension Plan [Member] Defined Benefit Plan, Asset Categories [Axis] Defined Benefit Plan, Asset Categories [Axis] Plan Asset Categories [Domain] Plan Asset Categories [Domain] Short-term investment funds Short Term Investment Funds [Member] Short term investment funds. Government and agency securities US Government Corporations and Agencies Securities [Member] Debt instruments Debt Securities [Member] Commingled funds Commingled Funds [Member] Commingled funds. Insurance contracts Insurance Contracts [Member] Insurance contracts. Other assets Other Assets [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Plan Assets Defined Benefit Plan, Fair Value of Plan Assets Investments Measured at Net Asset Value Defined Benefit Plan, Alternative Investments, Fair Value of Plan Assets Defined Benefit Plan, Alternative Investments, Fair Value of Plan Assets Schedule of New Accounting Pronouncements Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Estimated Useful Lives of Assets Estimated Useful Lives Of Assets [Table Text Block] Estimated useful lives of the assets. Statement of Cash Flows [Abstract] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Net Income (Loss) Attributable to Parent Adjustments to reconcile net earnings to cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization of property and intangibles Depreciation, Depletion and Amortization Stock based compensation Share-based Compensation Asset write-downs Asset Impairment Charges Gain on sale of assets/businesses Gain (Loss) on Sale of Assets and Asset Impairment Charges Deferred tax provision Deferred Income Tax Expense (Benefit) Accounts receivable allowances Provision for Doubtful Accounts Changes in assets and liabilities, net of effects from acquisitions and divestitures: Increase (Decrease) in Operating Capital [Abstract] Increase in accounts receivable Increase (Decrease) in Accounts Receivable (Increase)/Decrease in inventories Increase (Decrease) in Inventories Increase in accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase in other current and non-current assets Increase (Decrease) in Other Operating Assets (Decrease)/Increase in other current and non-current liabilities Increase (Decrease) in Other Operating Liabilities Net cash flows from operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Additions to property, plant and equipment Payments to Acquire Property, Plant, and Equipment Proceeds from the disposal of assets/businesses, net Proceeds from Sale of Productive Assets Acquisitions, net of cash acquired (Note 20) Payments to Acquire Businesses, Net of Cash Acquired Purchases of investments Payments to Acquire Investments Sales of investments Proceeds from Sale, Maturity and Collection of Investments Other (primarily intangibles) Payments for (Proceeds from) Other Investing Activities Net cash used by investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Dividends to shareholders Payments of Ordinary Dividends Repurchase of common stock Proceeds from short-term debt Proceeds from Short-term Debt Retirement of short-term debt Repayments of Short-term Debt Proceeds from long-term debt, net of issuance costs Proceeds from Issuance of Long-term Debt Retirement of long-term debt Repayments of Long-term Debt Proceeds from the exercise of stock options/employee withholding tax on stock awards, net Proceeds From The Exercise Of Stock Options And Excess Tax Benefits Proceeds From The Exercise Of Stock Options And Excess Tax Benefits Other Proceeds from (Payments for) Other Financing Activities Net cash used by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Increase/(Decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of year (Note 1) Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of year (Note 1) Supplemental cash flow data Supplemental Cash Flow Information [Abstract] Cash paid during the year for: Cash Paid During The Year [Abstract] Cash Paid During The Year [Abstract] Interest Interest Paid Interest, net of amount capitalized Interest Paid, Net Income taxes Income Taxes Paid Supplemental schedule of non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards Treasury Stock Issued For Employee Compensation And Stock Option Plans Net Of Cash Proceeds Treasury stock issued for employee compensation and stock option plans, net of cash proceeds. Conversion of debt Debt Conversion, Converted Instrument, Amount Acquisitions Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) [Abstract] Fair value of assets acquired Noncash or Part Noncash Acquisition, Value of Assets Acquired Fair value of liabilities assumed and noncontrolling interests Noncash or Part Noncash Acquisition, Value of Liabilities Assumed Net cash paid for acquisitions Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) Statement of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents (Notes 1 and 2) Marketable securities (Notes 1 and 2) Available-for-sale Securities, Current Accounts receivable trade, less allowances for doubtful accounts $248 (2017, $291) Accounts Receivable, Net, Current Inventories (Notes 1 and 3) Inventory, Net Prepaid expenses and other receivables Prepaid Expense and Other Assets, Current Assets held for sale (Note 20) Assets Held-for-sale, Not Part of Disposal Group, Current, Other Total current assets Assets, Current Property, plant and equipment, net (Notes 1 and 4) Property, Plant and Equipment, Net Intangible assets, net (Notes 1 and 5) Intangible Assets, Net (Excluding Goodwill) Goodwill (Notes 1 and 5) Goodwill Deferred taxes on income (Note 8) Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Other assets Total assets Assets Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Loans and notes payable (Note 7) Short-term Debt Accounts payable Accounts Payable, Current Accrued liabilities Accrued Liabilities, Current Accrued rebates, returns and promotions Accrued Rebates Returns And Promotions Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs. Accrued compensation and employee related obligations Employee-related Liabilities, Current Accrued taxes on income (Note 8) Accrued Income Taxes, Current Total current liabilities Liabilities, Current Long-term debt (Note 7) Deferred taxes on income (Note 8) Deferred Tax Liabilities, Net, Noncurrent Employee related obligations (Notes 9 and 10) Liability, Defined Benefit Plan, Noncurrent Long-term taxes payable (Note 8) Accrued Income Taxes, Noncurrent Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Shareholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock — without par value (authorized and unissued 2,000,000 shares) Preferred Stock, Value, Issued Common stock — par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) Common Stock, Value, Issued Accumulated other comprehensive income (loss) (Note 13) Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Stockholders' Equity before Treasury Stock Stockholders' Equity before Treasury Stock Less: common stock held in treasury, at cost (Note 12) (457,519,000 shares and 437,318,000 shares) Treasury Stock, Value Total shareholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and shareholders’ equity Liabilities and Equity Allowances for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Preferred par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Common stock, par value per share (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Treasury stock, shares Treasury Stock, Shares Retirement Plans Other Benefit Plans Other Postretirement Benefits Plan [Member] Components of net periodic benefit cost Defined Benefit Plan [Abstract] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization of prior service cost (credit) Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Recognized actuarial losses Defined Benefit Plan, Amortization of Gain (Loss) Curtailments and settlements Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Axis] Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] $52.13-$65.62 Exercise Price Range One Member Exercise price range. $66.07-$72.54 Exercise Price Range Two [Member] Exercise Price Range. $90.44-$100.48 Exercise Price Range Three [Member] Exercise Price Range. $101.87-$115.67 Exercise Price Range Four [Member] Exercise Price Range. $115.68-$129.51 Exercise Price Range Five [Member] Exercise Price Range. Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Stock options outstanding and exercisable Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Abstract] Share based compensation shares authorized under stock option plans by exercise price range. Price Range, Minimum (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Price Range, Maximum (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Outstanding number of Options (in shares) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Outstanding, Average Life Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Outstanding Average Exercise Price (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Exercisable number of Options (in shares) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Exercisable, Average Exercise Price (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Accounting Standards Update 2017-07 Accounting Standards Update 2017-07 [Member] Accounting Standards Update 2017-07 [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Cost of products sold Cost of Goods and Services Sold Selling, marketing and administrative expenses Selling, General and Administrative Expense Research and development expense Research and Development Expense (Excluding Acquired in Process Cost) Other (income) expense, net Other Nonoperating Income (Expense) Earnings before provision for taxes on income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Actelion Actelion [Member] Actelion Business Acquisition [Line Items] Business Acquisition [Line Items] Cash & Cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Inventory(1) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Accounts Receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Goodwill Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Deferred Taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Noncurrent Other non-current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Total Assets Acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Deferred Taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Other non-current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Total Liabilities Assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Net Assets Acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Sales Sales [Member] Cost of Products Sold R&D Expense Research and Development Expense [Member] Interest (Income) Expense Interest Income Expense Net Member Interest Income Expense Net Member. Other (Income) Expense Cross currency interest rate swaps contracts: Forward foreign exchange contracts: Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Value Hedging Fair Value Hedging [Member] Cash Flow Hedging Cash Flow Hedging [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Unrealized gain (loss) arising during period Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Weighted average assumptions of fair value of options Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Risk-free rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Employee-related Liabilities [Abstract] Employee-related Liabilities [Abstract] Pension benefits Liability, Defined Benefit Pension Plan Postretirement benefits Liability, Other Postretirement Defined Benefit Plan Postemployment benefits Postemployment Benefits Liability Deferred compensation Deferred Compensation Liability, Current and Noncurrent Total employee obligations Employee Obligations Total employee obligations current and non current. Less current benefits payable Liability, Defined Benefit Plan, Current Employee related obligations — non-current Cash and Cash Equivalents [Abstract] Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Investments by Category [Axis] Investments by Category [Axis] Marketable Securities and Investments Held at Cost [Domain] Marketable Securities and Investments Held at Cost [Domain] Held-to-maturity Securities Held-to-maturity Securities [Member] Available-for-sale Securities Available-for-sale Securities [Member] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Cash Cash [Member] Gov't Securities US Treasury and Government [Member] Other Sovereign Securities(1) Sovereign Debt Securities [Member] U.S. Reverse repurchase agreements Repurchase Agreements [Member] Other Reverse repurchase agreements Other Reverse Repurchase Agreements [Member] Other Reverse Repurchase Agreements [Member] Corporate debt securities(1) Corporate Debt Securities [Member] Money market funds Money Market Funds [Member] Time deposits(1) Bank Time Deposits [Member] Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Cash, Cash Equivalents, and Short-term Investments [Abstract] Cash, Cash Equivalents, and Short-term Investments [Abstract] Carrying Amount Held-to-maturity Securities Estimated Fair Value Held-to-maturity Securities, Fair Value Cash & Cash Equivalents Current Marketable Securities Marketable Securities, Current Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities Available-for-sale Securities Income Tax Disclosure [Abstract] Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Comparison of Income Taxes at Statutory Rate and Company's Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Temporary Differences and Carryforwards Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Summary of Activity Related to Unrecognized Tax Benefits Summary of Income Tax Contingencies [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Foreign Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Gain/(Loss) On Securities Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Employee Benefit Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Gain/ (Loss) On Derivatives & Hedges Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Beginning Balance Net change Other Comprehensive Income (Loss), Net of Tax Cumulative adjustment Cumulative Effect on Retained Earnings, Net of Tax Ending Balance Capital and Treasury Stock Treasury Stock [Text Block] Common Stock, Stock Option Plans and Stock Compensation Agreements Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Earnings Per Share [Abstract] Earnings Per Share Earnings Per Share [Text Block] Schedule of Long-term Debt Instruments Schedule of Long-term Debt Instruments [Table Text Block] Aggregate Maturities of Long Term Obligations Schedule of Maturities of Long-term Debt [Table Text Block] Employee Related Obligations Employee Related Obligations [Table Text Block] Employee related obligations. Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Intellectual Property Intellectual Property [Member] Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In Process Research and Development In Process Research and Development [Member] Finite-lived Intangible Assets Acquired Finite-lived Intangible Assets Acquired Indefinite-lived Intangible Assets Acquired Indefinite-lived Intangible Assets Acquired Finite-lived and Indefinite-lived Intangible Assets Acquired Finite-lived and Indefinite-lived Intangible Assets Acquired Finite-lived and Indefinite-lived Intangible Assets Acquired Statement of Comprehensive Income [Abstract] Other Comprehensive Income (Loss), net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract] Reclassifications to earnings Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Net change Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Employee benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract] Prior service credit (cost), net of amortization Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax Gain (loss), net of amortization Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax Effect of exchange rates Other comprehensive income (loss), pension and other, effects of exchange rate net of tax other comprehensive income loss, pension and other , effects of exchange rate net of tax Net change Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Derivatives & hedges Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent [Abstract] Reclassifications to earnings Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Net change Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Other comprehensive income (loss) Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Wholesaler 1 Wholesaler 1 [Member] Wholesaler 1 [Member] Wholesaler 2 Wholesaler 2 [Member] Wholesaler 2 [Member] Wholesaler 3 Wholesaler 3 [Member] Wholesaler 3 [Member] Corporate, Non-Segment Corporate, Non-Segment [Member] Operating Segments Operating Segments [Member] United States Europe Europe [Member] Western Hemisphere excluding U.S. Western Hemisphere, excluding U.S. [Member] Western Hemisphere, excluding U.S. [Member] Asia-Pacific, Africa Asia-Pacific, Africa [Member] Asia-Pacific, Africa [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales Revenue, Net Sales Revenue, Net [Member] Indefinite-lived Intangible Assets [Axis] Purchased in-process research and development(1) Purchased In-Process Research And Development [Member] Purchased In-Process Research And Development [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] NIZORAL NIZORAL [Member] NIZORAL [Member] PANCREASE PANCREASE [Member] PANCREASE [Member] LifeScan LifeScan [Member] LifeScan [Member] Alios Biopharma Inc and XO1 Limited Alios Biopharma Inc and XO1 Limited [Member] Alios Biopharma Inc and XO1 Limited [Member] XO1 XO1 [Member] XO1 [Member] AMO AMO [Member] AMO Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment Property, Plant and Equipment [Member] Other Intangible Assets Other Intangible Assets [Member] General Corporate General Corporate [Member] General corporate member. Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Concentration risk (as a percent) Concentration Risk, Percentage Long-Lived Assets Long-Lived Assets Other Non Long Lived Assets Other Non Long Lived Assets Other non long lived assets. Identifiable Assets Gain (Loss) on Disposition of Assets Gain (Loss) on Disposition of Assets Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Number of segments Number of Operating Segments Acquisition related costs Business Combination, Acquisition Related Costs Unrealized loss on securities Unrealized Loss on Securities After Tax Restructuring Charge After Tax Restructuring Charge After Tax Restructuring Charge In-process research and development Research and Development in Process Litigation expense Litigation Settlement, Expense Restructuring Charge, Net of Accrual Adjustment Restructuring Charge, Net of Accrual Adjustment Restructuring Charge, Net of Accrual Adjustment Gain from divestiture Positive adjustment Valuation Allowances and Reserves, Additions for Adjustments Reconciliation of basic net earnings per share to diluted net earnings per share Earnings Per Share Reconciliation [Abstract] Basic net earnings per share (in dollars per share) Earnings Per Share, Basic Average shares outstanding — basic (in shares) Weighted Average Number of Shares Outstanding, Basic Potential shares exercisable under stock option plans (in shares) Potential Shares Exercisable Under Stock Option Plans Potential Shares Exercisable Under Stock Option Plans Less: shares repurchased under treasury stock method (in shares) Shares Which Could Be Repurchased Under Treasury Stock Method Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period. Convertible debt shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Diluted net earnings per share (in dollars per share) Earnings Per Share, Diluted Cash, Cash Equivalents and Current Marketable Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] Health care cost trend rate assumed for next year Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Rate to which the cost trend rate is assumed to decline (ultimate trend) Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Year the rate reaches the ultimate trend rate Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate Components of Deferred Tax Assets and Liabilities [Abstract] Components of Deferred Tax Assets and Liabilities [Abstract] Deferred Tax Assets, Employee related obligations Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Deferred Tax Assets, Stock based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Deferred Tax Assets, Property, Plant and Equipment Deferred Tax Assets, Property, Plant and Equipment Deferred Tax Assets, International R&D capitalized for tax Deferred Tax Assets International Research And Development Capitalized Deferred tax assets international research and development capitalized. Deferred Tax Assets, Reserves & liabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Deferred Tax Assets, Income reported for tax purposes Deferred Tax Assets, Deferred Income Deferred Tax Assets, Net operating loss carryforward international Deferred Tax Assets, Operating Loss Carryforwards, Foreign Deferred Tax Assets, Undistributed Foreign Earnings Deferred Tax Assets, Undistributed Foreign Earnings Deferred Tax Assets, Undistributed Foreign Earnings Deferred Tax Liabilities, Non-deductible intangibles Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Undistributed Foreign Earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Deferred Tax Liability, Global Intangible Low-Taxed Income Deferred Tax Liability, Global Intangible Low-Taxed Income Deferred Tax Liability, Global Intangible Low-Taxed Income Deferred Tax Assets, Miscellaneous international Deferred Tax Assets, Other Deferred Tax Assets Other Domestic Deferred Tax Assets Other Domestic Deferred tax assets other domestic. Deferred Tax Assets, Total deferred income taxes Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Liabilities, Depreciation Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Miscellaneous international Deferred Tax Liabilities, Other Deferred Tax Liabilities, Total deferred income taxes Deferred Tax Liabilities, Net Equity Components [Axis] Treasury Stock Treasury Stock [Member] Changes in Treasury Stock Shares Outstanding [Roll Forward] Changes in Treasury Stock Shares Outstanding [Roll Forward] Changes in Treasury Stock Shares Outstanding [Roll Forward] Treasury Stock, Balance, Shares Employee compensation and stock option plans, Shares Stock Issued During Period, Shares, Other Repurchase of common stock, Shares Treasury Stock, Shares, Acquired Treasury Stock, Ending Balance, Shares Changes in treasury stock Changes In Treasury Stock [Roll Forward] Changes in treasury stock. Treasury Stock, Balance Employee compensation and stock option plans related to treasury stock Stock Issued During Period, Value, Other Repurchase of common stock, Amounts Treasury Stock, Value, Acquired, Cost Method Treasury Stock, Ending Balance Property, Plant and Equipment, Net [Abstract] Property, Plant and Equipment, Net [Abstract] Land and land improvements Land Buildings and building equipment Buildings and Improvements, Gross Machinery and equipment Machinery and Equipment, Gross Construction in progress Construction in Progress, Gross Total property, plant and equipment, gross Property, Plant and Equipment, Gross Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property, plant and equipment, net Segments of Business and Geographic Areas Segment Reporting Disclosure [Text Block] Concentration of Credit Risk [Table] Concentration of Credit Risk [Table] Concentration of Credit Risk [Table] ASU 2014-09 - Revenue from Contracts with Customers Accounting Standards Update 2014-09 [Member] ASU 2016-16 - Income Taxes: Intra-Entity Transfers Accounting Standards Update 2016-16 [Member] Prospective Adoption of New Accounting Pronouncements [Axis] Prospective Adoption of New Accounting Pronouncements [Axis] Accounting Guidance [Domain] Accounting Guidance [Domain] Customers Collection Patterns [Axis] Customers Collection Patterns [Axis] Customers Collection Patterns [Axis] Customers Collection Patterns [Domain] Customers Collection Patterns [Domain] Customers Collection Patterns [Domain] Property, Plant and Equipment, Type [Axis] Software Development Software Development [Member] Concentration of Credit Risk [Line Items] Concentration of Credit Risk [Line Items] Concentration of credit risk. Number of employees Number Of Employees Engaged In Company Activities Worldwide Number of employees engaged in company activities worldwide. Number of business segments Number of Reportable Segments Excess tax benefits Effective Income Tax Rate Reconciliation Share-based Compensation Excess Tax Benefit Amount Effective Income Tax Rate Reconciliation Share-based Compensation Excess Tax Benefit Amount Deferred taxes, net Deferred Tax Assets, Net, Noncurrent GILTI, deferred tax liability Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Global Intangible Low-Taxed Income, Liability, Provisional Income Tax Expense Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Global Intangible Low-Taxed Income, Liability, Provisional Income Tax Expense Deferred taxes on income Minimum reverse repurchase agreement collateral (as a percent) Minimum Collateral Value as a Percent, Reverse Repurchase Agreement Minimum Collateral Value as a Percent, Reverse Repurchase Agreement Estimated useful lives of the assets Property, Plant and Equipment, Useful Life Sales return reserve (as a percent) Sales Return Reserve Sales return reserve Percentage of profit share payments (less than) Profit Loss Percent To Sales Profit loss percent to sales. Shipping and handling costs Shipping, Handling and Transportation Costs Shipping and handling costs as a percent of sales Shipping and Handling Costs as a Percent of Sales Shipping and Handling Costs as a Percent of Sales Advertising expense Advertising Expense Provisional toll tax charge Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense Deferred tax liability foreign taxes Deferred tax asset offset Deferred Tax Assets, Gross Debt securities Percent of Plan Assets Defined Benefit Plan, Actual Plan Asset Allocations Target Allocation Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Leases, Operating [Abstract] Rental Expense and Lease Commitments [Abstract] Rental Expense and Lease Commitments [Abstract] Minimum rental payments under operating leases Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2019 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2020 Operating Leases, Future Minimum Payments, Due in Two Years 2021 Operating Leases, Future Minimum Payments, Due in Three Years 2022 Operating Leases, Future Minimum Payments, Due in Four Years 2023 Operating Leases, Future Minimum Payments, Due in Five Years After 2023 Operating Leases, Future Minimum Payments, Due Thereafter Total Operating Leases, Future Minimum Payments Due Interest expense convertible debt Interest on Convertible Debt, Net of Tax Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Building and building equipment Building and Building Improvements [Member] Land And Leasehold Improvements Land And Leasehold Improvements [Member] Land and leasehold improvements. Machinery and Equipment Machinery and Equipment [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Securities Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax Employee benefits Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Derivatives & hedges Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Inventory Disclosure [Abstract] Inventories Inventory Disclosure [Text Block] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Other benefit plans 2019 Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months 2020 Defined Benefit Plan, Expected Future Benefit Payment, Year Two 2021 Defined Benefit Plan, Expected Future Benefit Payment, Year Three 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year Four 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Five 2024-2028 Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter Prepaid employee related obligations Assets for Plan Benefits, Defined Benefit Plan Cost Basis Available-for-sale Securities, Debt Maturities, Single Maturity Date, Amortized Cost Basis [Abstract] Due within one year Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis Due after one year through five years Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis Due after five years through ten years Available-for-sale Securities, Debt Maturities, Year Six Through Ten, Amortized Cost Basis Total debt securities Available-for-sale Securities, Debt Maturities, Single Maturity Date, Amortized Cost Basis Fair Value Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract] Due within one year Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Due after one year through five years Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value Due after five years through ten years Available-for-sale Securities, Debt Maturities, Year Six Through Ten, Fair Value Total debt securities Available-for-sale Securities, Debt Maturities, Single Maturity Date Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table] Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table] Alios Biopharma Alios Biopharma [Member] Alios Biopharma [Member] Patents And Trademarks Patents And Trademarks [Member] Patents And Trademarks [Member] Customer relationships and other intangible assets Purchased in-process research and development Trademarks Trademarks [Member] Finite-Lived And Indefinite-Lived Intangible Assets [Line Items] Finite-Lived And Indefinite-Lived Intangible Assets [Line Items] Finite-Lived And Indefinite-Lived Intangible Assets [Line Items] Intangible assets and Goodwill Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible assets with definite lives: Finite-Lived Intangible Assets, Net [Abstract] Finite lived intangible assets gross Finite-Lived Intangible Assets, Gross Less accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Finite lived intangible assets net Finite-Lived Intangible Assets, Net Intangible assets with indefinite lives: Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Indefinite lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Total intangible assets - net Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Reclassified to definite lived intangible assets upon commercialization Reclassified To Finite-Lived Intangible Assets Reclassified To Finite-Lived Intangible Assets Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] 2012 Long-Term Incentive Plan 2012 Long-Term Incentive Plan [Member] 2012 Long-Term Incentive Plan [Member] Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Employee Stock Option Employee Stock Option [Member] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Performance Shares Performance Shares [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of stock-based compensation plans Number Of Stock Based Compensation Plans Number of stock-based compensation plans. Number of shares authorized for issuance under long-term incentive plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares available for future grants under long-term incentive plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Compensation cost charged for Long term incentive plan Allocated Share-based Compensation Expense Total income tax benefit recognized Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Total compensation cost not yet recognized for option Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted average period for total compensation cost not yet recognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Stock options expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Average fair value of option granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Total intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Stock options outstanding (in shares) Stock option average life Stock options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Stock options average price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Vesting percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Average fair value of RSU's and PSU's granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Fair Value of RSU or PSU units settled Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Foreign Currency Translation [Abstract] Foreign currency transaction gain (loss), before tax Foreign Currency Transaction Gain (Loss), before Tax Inventory, Current [Table] Inventory, Current [Table] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Discontinued Operations, Held-for-sale or Disposed of by Sale Discontinued Operations, Held-for-sale or Disposed of by Sale [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] AdvancedSterilizationProducts AdvancedSterilizationProducts [Member] AdvancedSterilizationProducts [Member] Inventory [Axis] Inventory [Axis] Inventory [Domain] Inventory [Domain] Inventory [Line Items] Inventory [Line Items] Disposal Group, Including Discontinued Operation, Inventory, Current Disposal Group, Including Discontinued Operation, Inventory, Current Summary of Inventories Inventory, Net [Abstract] Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Goods in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Balance without adoption of ASC 606 Calculated under Revenue Guidance in Effect before Topic 606 [Member] Effect of change Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Sales to customers Net earnings Assets Liabilities Equity Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Qualified Plans Qualified Plans [Member] Qualified plans. Non-Qualified Plans Non Qualified Plans [Member] Non qualified plans. Funded Plans Funded Plans [Member] Funded plans. Unfunded Plans Unfunded Plans [Member] Unfunded plans. Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] U.S. Plans Domestic Plan [Member] International Plans Foreign Plan [Member] Projected Benefit Obligation Defined Benefit Plan, Benefit Obligation Accumulated Benefit Obligation Defined Benefit Plan, Accumulated Benefit Obligation Projected Benefit Obligation Defined Benefit Plan, Funded (Unfunded) Status of Plan Accumulated Benefit Obligation Defined Benefit Plan Over (Under) Funded Status ABO Defined benefit plan over (under) funded status ABO Schedule of Preliminary Amounts Recognized for Assets Acquired and Liabilities Assumed Schedule of Business Acquisitions, by Acquisition [Table Text Block] Purchase Price Allocation of Identifiable Intangible Assets Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Schedule of Pro Forma Results Business Acquisition, Pro Forma Information [Table Text Block] Selected Quarterly Financial Information [Abstract] Med Devices Medical Devices and Diagnostics [Member] Medical Devices and Diagnostics. Summary of Selected Quarterly Financial Data (unaudited) Sales Revenue, Goods, Net [Abstract] Gross profit Gross Profit Restructuring charge, after tax Litigation income (expense) net after-tax Litigation Income (Expense) Net After Tax Litigation Income (Expense) Net After Tax. Acquisition related costs after tax Business Combination, Acquisition Related Costs, After-tax Business Combination, Acquisition Related Costs, After-tax In-process research and development, after tax Research And Development In Process, after Tax Research And Development In Process, after Tax Asset impairment benefit Asset Impairment Charges (Benefit) Asset Impairment Charges (Benefit) asset impairment charge after-tax asset impairment charge after-tax asset impairment charge after-tax Asset Impairment Charges Provisional charge Provisional Income Tax Expense (Benefit) Provisional Income Tax Expense (Benefit) Commitments and Contingencies Disclosure [Abstract] Product Liability Contingencies [Table] Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case [Domain] DePuy ASR U.S. DePuy ASR U.S. [Member] DePuy ASR U.S. [Member] Baby Powder Baby Powder [Member] Baby Powder [Member] Risperdal Risperdal [Member] Risperdal. Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Pending Litigation Pending Litigation [Member] Settled Litigation Settled Litigation [Member] Judicial Ruling Judicial Ruling [Member] ASR ASR [Member] ASR. Pinnacle Acetabular Cup System Pinnacle Acetabular Cup System [Member] Pinnacle Acetabular cup system. Pelvic Meshes Pelvic Meshes [Member] Pelvic meshes. Invokana Invokana [Member] Invokana [Member] Physiomesh Physiomesh [Member] Physiomesh [Member] Talc Talc [Member] Talc [Member] Litigation Settlement By Companies [Axis] Litigation Settlement By Companies [Axis] Litigation settlement by companies. Litigation Settlement By Companies [Domain] Litigation Settlement By Companies [Domain] Litigation settlement by companies. Loss Contingencies by Nature of Contingency [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Damages from Product Defects Damages from Product Defects [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of plaintiffs Product Liability Contingency Number Of Claimant Product liability contingency number of claimant. Number of patients in settlement Number of patients in settlement Number of patients in settlement Loss Contingency, Damages Sought, Value Loss Contingency, Damages Sought, Value Pending claims Loss Contingency, Pending Claims, Number Increase in effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Currently payable: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] U.S. taxes Current Federal Tax Expense (Benefit) U.S. taxes on international operations Current Federal Tax Expense (Benefit), Foreign Operations Current Federal Tax Expense (Benefit), Foreign Operations International taxes Current Foreign Tax Expense (Benefit) Total currently payable Current Income Tax Expense (Benefit) Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] U.S. taxes Deferred Federal Income Tax Expense (Benefit) U.S. taxes on international operations Deferred Federal Tax Expense (Benefit), Foreign Operations Deferred Federal Tax Expense (Benefit), Foreign Operations International taxes Deferred Foreign Income Tax Expense (Benefit) Total deferred Provision for taxes on income Income Tax Expense (Benefit) Schedule of Sales by Segment of Business Sales By Segment Of Business [Table Text Block] Sales by segment of business. Schedule of Segment Reporting Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Rentals under operating leases Operating Leases, Rent Expense Change in Benefit Obligation Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Projected benefit obligation - beginning of year Service cost Interest cost Plan participant contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Amendments Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Actuarial (gains) losses Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Divestitures & acquisitions Defined Benefit Plan, Benefit Obligation, Business Combination and Divestiture, Increase (Decrease) Defined Benefit Plan, Benefit Obligation, Business Combination and Divestiture, Increase (Decrease) Curtailments, settlements & restructuring Curtailments And Settlements And Restructuring The amount of increase or decrease related to curtailments, settlements and restructuring. Benefits paid from plan Defined Benefit Plan, Benefit Obligation, Benefits Paid Effect of exchange rates Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Projected benefit obligation - end of year Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Plan assets at fair value — beginning of year Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Company contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Plan participant contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Settlements Defined Benefit Plan, Plan Assets, Payment for Settlement Divestitures & acquisitions Defined Benefit Plan, Plan Assets, Business Combination and Divestiture, Increase (Decrease) Defined Benefit Plan, Plan Assets, Business Combination and Divestiture, Increase (Decrease) Benefits paid from plan assets Defined Benefit Plan, Plan Assets, Benefits Paid Effect of exchange rates Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Plan assets at fair value - End of year Funded status - end of year Amounts Recognized in the Company’s Balance Sheet consist of the following: Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Non-current assets Current liabilities Non-current liabilities Total recognized in the consolidated balance sheet — end of year Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract] Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract] Net actuarial loss Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Prior service cost (credit) Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax Unrecognized net transition obligation Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Transition Asset (Obligation), before Tax Total before tax effects Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax [Abstract] Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax [Abstract] Net periodic benefit cost Net actuarial (gain) loss Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Amortization of net actuarial loss Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Prior service cost (credit) Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax Amortization of prior service (cost) credit Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Effect of exchange rates Effect Of Exchange Rates Effect Of Exchange Rates. Total loss/(income) recognized in other comprehensive income, before tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Total recognized in net periodic benefit cost and other comprehensive income Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax Income Statement [Abstract] Cost of products sold Cost of Goods Sold Gross profit Interest income Investment Income, Interest Interest expense, net of portion capitalized (Note 4) Interest Expense Other (income) expense, net Restructuring (Note 22) Earnings before provision for taxes on income Provision for taxes on income (Note 8) Net earnings Net earnings per share (Notes 1 and 15) Basic (in dollars per share) Diluted (in dollars per share) Average shares outstanding (Notes 1 and 15) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Diluted (in shares) Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Administration of the Treasury, Belgium Administration of the Treasury, Belgium [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Foreign Tax Authority Foreign Tax Authority [Member] State and Local Jurisdiction State and Local Jurisdiction [Member] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Comparison Of Income Tax Expense At Statutory Rate And Company's Tax Rate Abstract Comparison Of Income Tax Expense At Statutory Rate And Company's Tax Rate Abstract Comparison of income tax expense at the Statutory rate and Company's tax rate. U.S. Income (Loss) from Continuing Operations before Income Taxes, Domestic International Income (Loss) from Continuing Operations before Income Taxes, Foreign Tax Rates: Effective Income Tax Rate Reconciliation, Percent [Abstract] U.S. statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent International operations (1) Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Research and orphan drug tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent U.S. state and local Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent U.S. manufacturing deduction Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent U.S. tax on international income (2) Effective Income Tax Rate Reconciliation Related To Domestic Tax On International Income Effective income tax rate reconciliation related to domestic tax on international income. Tax benefits on share-based compensation Effective Income Tax Rate Reconciliation, Deduction, Other, Percent U.S. tax benefit on asset/business disposals Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent All other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent TCJA and related impacts (3) Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Percent Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent Statement of Stockholders' Equity [Abstract] Summary of unrecognized tax benefits Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Beginning of year Unrecognized Tax Benefits Increases related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Increases related to prior period tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Decreases related to prior period tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Lapse of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations End of year Unrecognized tax benefits decrease from TCJA Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions, Tax Cuts and Jobs Act 2017 Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions, Tax Cuts and Jobs Act 2017 Excess of fair value over carrying value of debt Excess Of Fair Value Over Carrying Value Of Debt Excess of fair value over carrying value of debt. Line of Credit Facility, Initiation Date Line of Credit Facility, Initiation Date Borrowing capacity under credit facility Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Expiration Date Line of Credit Facility, Expiration Date Short-term borrowings and the current portion of long-term debt Debt, Current Current portion of long term debt Accumulated Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Effect of one percentage point change in assumed health care cost trend rates Defined Benefit Plan, Effect of One-Percentage Point Change in Assumed Health Care Cost Trend Rate [Abstract] Effect of one percentage point increase on total interest and service cost Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components Effect of one percentage point decrease on total interest and service cost Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components Effect of one percentage point increase on post-retirement benefit obligation Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation Effect of one percentage point decrease on post-retirement benefit obligation Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Shares, Beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Shares, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Shares, issued Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Shares, canceled/forfieted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Shares, canceled/forfeited/adjusted Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Canceled, Forfeited and Adjusted During the Period Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Canceled, Forfeited and Adjusted During the Period Shares, Ending balance Adjustments for New Accounting Pronouncement Adjustments for New Accounting Pronouncement [Member] Principles of Consolidation Consolidation, Policy [Policy Text Block] Description of the Company And Business Segments Segment Reporting, Policy [Policy Text Block] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Investments Investment, Policy [Policy Text Block] Property, Plant and Equipment and Depreciation Property, Plant and Equipment, Policy [Policy Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Shipping and Handling Shipping and Handling Cost, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Intangible Assets and Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Financial Instruments Derivatives, Policy [Policy Text Block] Product Liability Product Liability [Policy Text Block] Product liability. Research and Development Research and Development Expense, Policy [Policy Text Block] Advertising Advertising Costs, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Net Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Annual Closing Date Fiscal Period [Policy Text Block] Fiscal period policy. Reclassification Reclassification, Policy [Policy Text Block] Summary of option activity under the Plan Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Outstanding Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Options outstanding beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Options canceled/forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Options outstanding end of period Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Options exercise price beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Options granted, average exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options exercised, average exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options canceled/forfeited, average exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Options exercise price end of period Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Pension and Other Postretirement Benefit Plans, Amounts that Will be Amortized from Accumulated Other Comprehensive Income (Loss) in Next Fiscal Year [Abstract] Defined Benefit Plan, Expected Amortization, Next Fiscal Year [Abstract] Amortization of net transition obligation Defined Benefit Plan, Expected Amortization of Transition Asset (Obligation), Next Fiscal Year Amortization of net actuarial losses Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year Amortization of prior service credit Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year Statement [Table] Statement [Table] Common Stock Issued Amount Common Stock [Member] Treasury Stock Amount Statement [Line Items] Statement [Line Items] Cash dividends paid Dividends, Common Stock, Cash Employee compensation and stock option plans Stock Issued During Period, Value, Treasury Stock Reissued Repurchase of common stock Other Stockholders' Equity, Other Other comprehensive income (loss), net of tax Net Sales Business Acquisition, Pro Forma Revenue Net Earnings Business Acquisition, Pro Forma Net Income (Loss) Diluted Net Earnings per Common Share Business Acquisition, Pro Forma Earnings Per Share, Diluted Summary of Inventories Schedule of Inventory, Current [Table Text Block] Business Combinations and Divestitures Business Combination Disclosure [Text Block] Legal Proceedings Legal Matters and Contingencies [Text Block] Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Line Items] TCJA, provisional liability Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Liability Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Liability Provisional tax cost Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Income Tax Expense (Benefit) Remeasurement of deferred tax assets and liabilities Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense GILTI, deferred tax cost Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Global Intangible Low-Taxed Income, Deferred Income Tax Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Global Intangible Low-Taxed Income, Deferred Income Tax Increase (decrease) in effective tax rate (as a percent) Deferred tax liability, repatriation of foreign earnings Deferred Tax Liabilities, Repatriation Of Foreign Earnings Deferred Tax Liabilities, Repatriation Of Foreign Earnings Deferred tax asset, foreign tax credits Deferred Tax Assets, Tax Credit Carryforwards, Foreign Net deferred tax benefit Deferred tax assets, net Deferred Tax Assets, Net Effective income tax rate reconciliation, deduction Effective Income Tax Rate Reconciliation, Deduction, Percent Effective income tax rate reconciliation, TCJA Effective income tax rate reconciliation, GILTI Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Percent Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Percent Effective income tax rate reconciliation, stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Percent Effective income tax rate reconciliation, divestiture of business Effective Income Tax Rate Reconciliation, Disposition of Business, Percent Increase in effective tax rate from prior period (as a percent) Effective Income Tax Rate Reconciliation, Increase (Decrease) from Prior Period, Percent Effective Income Tax Rate Reconciliation, Increase (Decrease) from Prior Period, Percent Unrecognized tax benefits Unrecognized tax benefits, interest on income tax expense Unrecognized Tax Benefits, Interest on Income Taxes Expense Unrecognized tax benefits, interest on income taxes accrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued Other Investment Not Readily Marketable [Table] Other Investment Not Readily Marketable [Table] Other Investment Not Readily Marketable [Line Items] Other Investment Not Readily Marketable [Line Items] Equity Investment [Roll Forward] Equity Investment [Roll Forward] Equity Investment [Roll Forward] Changes in Treasury Stock Changes In Treasury Stock [Table Text Block] Changes in treasury stock. Pensions and Other Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Line of Credit Line of Credit [Member] Convertible Debt Convertible Debt [Member] 2018 Acquisitions 2018 Acquisitions [Member] 2018 Acquisitions Ci:z Holdings Co. Ltd. Ci:z Holdings Co. Ltd. [Member] Ci:z Holdings Co. Ltd. [Member] 2017 Acquisitions 2017 Acquisitions [Member] 2017 Acquisitions [Member] 2016 Acquisitions 2016 Acquisitions [Member] 2016 Acquisitions Vogue International LLC Vogue International LLC [Member] Vogue International LLC [Member] Valchlor Valchlor [Member] Valchlor Idorsia Idorsia [Member] Idorsia [Member] Synthes, Inc Synthes, Inc [Member] Synthes, Inc. Long-term Debt Debt Instrument, Restrictive Covenants, Shareholder Ownership Threshold, Percent Debt Instrument, Restrictive Covenants, Shareholder Ownership Threshold, Percent Debt Instrument, Restrictive Covenants, Shareholder Ownership Threshold, Percent Debt Instrument, Term Debt Instrument, Term Line of Credit Facility, Maximum Borrowing Capacity Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Goodwill, Subsequent Recognition of Deferred Tax Asset Goodwill, Subsequent Recognition of Deferred Tax Asset Business Combination, Initial Accounting Incomplete, Adjustment, Current Liabilities Business Combination, Initial Accounting Incomplete, Adjustment, Current Liabilities Business Combination, Initial Accounting Incomplete, Adjustment, Current Liabilities Acquisition payments Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Convertible Note, Equity Interest, Percentage Convertible Note, Equity Interest, Percentage Convertible Note, Equity Interest, Percentage Acquisition price (in dollars per share) Business Acquisition, Share Price Business Combination, Consideration Transferred Business Combination, Consideration Transferred Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Finite-Lived Intangible Asset, Useful Life Finite-Lived Intangible Asset, Useful Life Fair Value Inputs, Discount Rate Fair Value Inputs, Discount Rate Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Business Acquisition, Goodwill, Expected Tax Deductible Amount Business Acquisition, Goodwill, Expected Tax Deductible Amount Liabilities assumed Contingent consideration Business Combination, Contingent Consideration, Liability Purchase price over fair value of assets acquired Intangible Assets, Net (Including Goodwill) Purchase price Gain on divestitures, pre-tax Disposal Group, Including Discontinued Operation, Consideration Disposal Group, Including Discontinued Operation, Consideration Disposal Group, Including Discontinued Operation, Inventory Disposal Group, Including Discontinued Operation, Inventory Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Disposal Group, Including Discontinued Operation, Goodwill Disposal Group, Including Discontinued Operation, Goodwill Disposal Group, Including Discontinued Operation, Receivables Retained Disposal Group, Including Discontinued Operation, Receivables Retained Disposal Group, Including Discontinued Operation, Receivables Retained Net Periodic Benefit Cost Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Service cost discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Interest cost discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Interest Cost, Discount Rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Interest Cost, Discount Rate Rate of increase in compensation levels Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Expected long-term rate of return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Benefit Obligation Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Rate of increase in compensation levels Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Property, Plant and Equipment Property, Plant and Equipment Disclosure [Text Block] Schedule of Minimum Rental Payments Under Operating Leases Lessee, Operating Lease, Disclosure [Table Text Block] Rental Expense and Lease Commitments Leases of Lessee Disclosure [Text Block] Components of Accumulated Other Comprehensive Income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Aggregate maturities of long-term obligations Long-term Debt, Fiscal Year Maturity [Abstract] 2019 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2020 Long-term Debt, Maturities, Repayments of Principal in Year Two 2021 Long-term Debt, Maturities, Repayments of Principal in Year Three 2022 Long-term Debt, Maturities, Repayments of Principal in Year Four 2023 Long-term Debt, Maturities, Repayments of Principal in Year Five After 2023 Long-term Debt, Maturities, Repayments of Principal after Year Five Cash and Cash Equivalent Composition Cash, Cash Equivalents and Investments [Table Text Block] Contractual Maturities of Available for Sale Securities Available-for-sale Securities [Table Text Block] Sale of Subsidiary Gain (Loss) Sale of Subsidiary Gain (Loss) [Member] Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Current Portion of Long-term Debt Current Portion of Long-term Debt [Member] Current Portion of Long-term Debt [Member] Long-term Debt Long-term Debt [Member] Derivative Liability Derivative Liability Deferred (Gain) Loss on Discontinuation of Fair Value Hedge Deferred (Gain) Loss on Discontinuation of Fair Value Hedge Selected Quarterly Financial Data (unaudited) Quarterly Financial Information [Text Block] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill beginning of period Goodwill, related to acquisitions (1) Goodwill, Acquired During Period Goodwill, related to divestitures Goodwill, Written off Related to Sale of Business Unit Currency translation/other Goodwill, Other Increase (Decrease) Goodwill end of period Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Equity Securities Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative Asset, Fair Value, Gross Asset Derivative Asset, Fair Value, Gross Asset Derivative Asset, Fair Value, Gross Liability Derivative Asset, Fair Value, Gross Liability Financial assets and liabilities at fair value Derivative Instrument Detail [Abstract] Derivative assets Derivative Asset Derivative liabilities Equity method investments, fair market disclosure Equity Method Investments, Fair Value Disclosure Debt securities Available-for-sale Securities, Debt Securities Non-current assets included in interest rate contracts Derivative Asset, Noncurrent Non-current liabilities included in interest rate contracts Derivative Liability, Noncurrent Equity investments Available-for-sale Securities, Equity Securities Derivative Liability, Fair Value, Gross Liability Derivative Liability, Fair Value, Gross Liability Derivative Liability, Fair Value, Gross Asset Derivative Liability, Fair Value, Gross Asset Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Long Lived Assets Held-for-sale by Asset Type [Axis] Long Lived Assets Held-for-sale by Asset Type [Axis] Long Lived Assets Held-for-sale, Name [Domain] Long Lived Assets Held-for-sale, Name [Domain] Goodwill Goodwill [Member] Divestiture By Name [Axis] Divestiture By Name [Axis] Divestiture By Name [Axis] Divestiture By Name [Domain] Divestiture By Name [Domain] Divestiture By Name [Domain] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets (Excluding Goodwill) Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Intangible assets useful life Amortization expense of amortizable intangible assets Amortization of Intangible Assets Finite lived intangibles, amortization expense next twelve months Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Finite lived intangibles, amortization expense, year two Finite-Lived Intangible Assets, Amortization Expense, Year Two Finite lived intangibles, amortization expense, year three Finite-Lived Intangible Assets, Amortization Expense, Year Three Finite lived intangibles, amortization expense, year four Finite-Lived Intangible Assets, Amortization Expense, Year Four Finite lived intangibles, amortization expense, year five Finite-Lived Intangible Assets, Amortization Expense, Year Five Restructuring Restructuring and Related Activities Disclosure [Text Block] Income Taxes Income Tax Disclosure [Text Block] International Currency Transalation Foreign Currency Disclosure [Text Block] Summary of Severance Charges and Associated Spending Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Components of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Amounts Expected to be Recognized in Net Periodic Benefit Cost Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block] Rates Used to Develop Actuarial Present Value of Projected Benefit Obligation Schedule of Assumptions Used [Table Text Block] Assumed Health Care Cost Trend Rates Schedule of Health Care Cost Trend Rates [Table Text Block] Effect of One Percentage Point Change in Assumed Health Care Cost Trend Rates Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block] Schedule of Net Funded Status Schedule of Net Funded Status [Table Text Block] Information Related to the Benefit Obligation and the Fair Value of Plan Assets Information Related To Benefit Obligation And Fair Value Of Plan Assets [Table Text Block] Information related to the benefit obligation and the fair value of plan assets. Projected Future Benefit Payments from Company's Retirement and Other Benefit Plans Schedule of Expected Benefit Payments [Table Text Block] Projected Future Minimum Contributions to the Company's U.S. and International Unfunded Retirement Plans Schedule Of Estimated Future Employer Contributions [Table Text Block] Schedule of estimated future employer contributions. Company' Retirement Plan Asset Allocation and Target Allocations Schedule of Allocation of Plan Assets [Table Text Block] Schedule of Defined Benefit Plans Disclosures Schedule of Defined Benefit Plans Disclosures [Table Text Block] Summary of Derivative Activity Derivative Instruments, Gain (Loss) [Table Text Block] Schedule of Derivatives Recorded in Consolidated Balance Sheets Schedule of Derivative Liabilities at Fair Value [Table Text Block] Schedule of Effect of Derivatives not Designated as Hedging Instruments Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Schedule of Effect of Net Investment Hedges Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Summary of Activity Related to Equity Investments Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Financial Assets and Liabilities at Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Summary of Selected Quarterly Financial Data (unaudited) Quarterly Financial Information [Table Text Block] Less: Expense not allocated to segments Expense Not Allocated To Segments Expense not allocated to segments. Additions to Property, Plant & Equipment Property, Plant and Equipment, Additions Depreciation and Amortization Savings Plan Savings Plan [Text Block] Savings Plan. Defined Benefit Plan, Asset Categories [Axis] Short-term Investments Short-term Investments [Member] Retirement plan benefits Employee compensation Period Employee Compensation Period Employee Compensation Period. Percentage of corridor of greater of market value of assets Percentage Of Corridor Of Greater Of Market Value Of Assets Percentage of corridor of greater of market value of assets. Contribution to pension plans Payment for Pension Benefits Accumulated benefit obligation unfunded plans Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation Projected benefit obligation, unfunded plans Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation Plan Assets Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Fair Value of Plan Assets Fair value of company's common stock directly held in plan assets Fair Value Of Company's Common Stock Directly Held In Plan Assets Fair value of company's common stock directly held in plan assets. Percentage of company's common stock to plan asset Percentage Of Company's Common Stock To Plan Asset Percentage of the company's common stock to the total plan asset. Interest expense capitalized Interest Costs Capitalized Depreciation expense, including the amortization of capitalized interest Depreciation Expense Including Amortization Of Capitalized Interest Depreciation expense including the amortization of capitalized interest. EX-101.PRE 13 jnj-20181230_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 chart-07e0e4edcb372a3b7d2a01.jpg begin 644 chart-07e0e4edcb372a3b7d2a01.jpg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end GRAPHIC 15 chart-41ca3965692af9c6bb7a01.jpg begin 644 chart-41ca3965692af9c6bb7a01.jpg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end GRAPHIC 16 chart-906465fb51727442c0ba01.jpg begin 644 chart-906465fb51727442c0ba01.jpg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end GRAPHIC 17 chart-cc2b3d8be061d530eafa01.jpg begin 644 chart-cc2b3d8be061d530eafa01.jpg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end GRAPHIC 18 chart-e981d5a5e2a218e4beb.jpg begin 644 chart-e981d5a5e2a218e4beb.jpg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chart-e7661660c6305f08a59.jpg begin 644 chart-e7661660c6305f08a59.jpg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end GRAPHIC 20 jnj5yearshareholder2018.jpg begin 644 jnj5yearshareholder2018.jpg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end GRAPHIC 21 jnj10yearshareholder2018.jpg begin 644 jnj10yearshareholder2018.jpg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ƨN?[OZ[=S6 M$H*E;R=]5OKTM=]+6_S.PM-)F2ZMXT\):19:&VP?:-6"_:X)W$AR3P".. M!6+I6CZ38>*O%-O=6:75G86TDD<)CXD?6+J[= MIEG&GBU965A@@-(?EV@CMGC@9J.XU_2?^$B\5W$5WN@U&R>.V;RW&]V"\8(R M.0>N!6:4_/9]]]#>4J=UMI)=5MK]RVT^\Y?6=7_MBY27[!8V(1=HCLH!$IYZ MGU-;NEL;+X8:M=6I*3W-XEM(Z]1'MSC/H22#7)5O>&]5=<\9!_SQ@],H^Y9?UJ<-.I^\YI/O^5C&M;J>QNXKJTD:*:%@Z.O M52*ZGP=%<:YXOFUB]B:[:S1KR58HAF20?= 51U+8. .<4ZWL?!>EW0OI=>N- M42%@\=E%9-$SG/ +-QCUZ?TI]_XS>31[NZL[N2#5]4N]]P8"RF"%!A$#W]6^9:U33]4U7X>RW6K65S;WNF7;R SQ, MA>*4Y;&1SACGV%4+R1K#X5Z;':DJNHW4*&'4#GG/IV)J+2M9TJ/3[GP_K@EN-+:X\VWN[88DA;I MN ;L1U&,]>*GEDM+=G_7YFG/"5I7ULUK^#_0A\.:%<71@U&QU[2=/N(YOW27 M5ULD# \';M.1_.M?PY;7EG\88H=4ECENUFD,TD0PK,8V)(X'KZ"JEMI_@W3) MUO)_$5SJ8B8,MM;6+1,Q!'\3G&/7H?2DTKQ-:R_$Q-?U ?8[=Y'=QR^S,94= M!D]NU.3?\]*R;:^FL-4COK-RDL, MOF1L/7-;/C&]TG5KZ#5=*<)-=Q[KRV",/*E[G)&#GV],]Z:BU)7U7ZA*<)0D MHI)_FOF^_P#6ASM%%%;G&%%%% !74_#7_DH6F?\ ;7_T4],?6!1110 4444 %%%% !1110!SNM?\ M(\>&?^WK_P!%BNBKG=:_Y'CPS_V]?^BQ714 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%!(526. .23VK$U#QEH&FY%QJ43N/X( M3YA^GRYQ^- &W65KOB33O#UMYE_-^\89CA3EW^@_J>*X_4?B9+??Z)X9L)FN M)#M22106_!!G)^OY5+H7P^EN;G^T_%LS7-PYW?9R^>?]MN_T''\J ,UI/$?Q M%N"L0^P:0&Y/.T_7NY]NGTKN= \,:;XZ8C]Y<21-/T] MFA@RD2@+%$N..F !T%4M-_M.XN#=7S"&%EPMOC]35*-U\M M6%%%5(]5T^;5)M-AO[:2_@022VJS*98U/1F3.0#D M_$AMK&![B41+N8JHR<#UXKE_"WC74_$.K^)+'6O#UUH%II4IBAOKARJSKEAN M!90!PH;()'S#\>"\/:U:?#30+W1-&U>Y\337%R\QN[U2(H\@#:HR2W3DY ). M:N%.4W:*,JM:%)7FSK-1\73>//@W+K?@K5AX=N+H[8+G40$\LH^&7@-U (!4 M$\UQ?B+Q,GB;PCIOA[5[*WUV[MUC,U]/#_K)P,%XT&,9R>HY!Y4=*O:5X/\ M$?C.2.YU!S:6*C$;R)M55](XQ@ ?D/>O3O#O@S1_#:!K*#S+G&&N9OF<_3T' MTK?EITOBU9Q\]?$?![L>_4\VT_X<^)?$#1W&LW!M(\ *;EB\@7T"=OH2*[C1 M_ACX?TO:]Q"VH3#^*Y.5_!1Q^>:["BHE7G+38UIX.E#5J[\QL44<$2QPHL<: MC"J@P!^%.HHK [ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M*JZG:I?:3=VDQ81W$#Q,5/(#*0<>_-6J9-_J)/\ =/\ *FMQ/5'FO_"K=%_Y M^K__ +^)_P#$4?\ "K=%_P"?J_\ ^_B?_$5VE>>>'M4UN7X8^(KRRN7N-4@N M]2%H]RY?:4E?8OS=A@ #I^%=#K35]=E?[K?YGGK"TG;W=W;\R_\ \*MT7_GZ MO_\ OXG_ ,11_P *MT7_ )^K_P#[^)_\17*_">[N]2UN*^T7Q%KVN:+-I^=1 M?62Q6&\R,)"2!R 7W!25 VY)XKNOB)=7%C\-O$%U93R6]Q#82O'+$Y1T8*<$ M$<@^].=6<(W;_K^OP".%HRERJ)G_ /"K=%_Y^K__ +^)_P#$4?\ "K=%_P"? MJ_\ ^_B?_$5U6F.TFDV;R,69H$+,QR2=HYJU52J33:N0J%%J_*<7_P *MT7_ M )^K_P#[^)_\11_PJW1?^?J__P"_B?\ Q%=I12]K/N/ZO2_E.+_X5;HO_/U? M_P#?Q/\ XBC_ (5;HO\ S]7_ /W\3_XBNTHH]K/N'U>E_*<7_P *MT7_ )^K M_P#[^)_\11_PJW1?^?J__P"_B?\ Q%=I11[6?E_*<7_ ,*MT7_GZO\ _OXG_P 11_PJW1?^ M?J__ ._B?_$5VE%'M9]P^KTOY3B_^%6Z+_S]7_\ W\3_ .(H_P"%6Z+_ ,_5 M_P#]_$_^(K0\8W/B>.R6W\)VUJLDTVGJ[[?\'_(KZK2T]U:D M/_"K=%_Y^K__ +^)_P#$4?\ "K=%_P"?J_\ ^_B?_$51\'W_ (GF^)NMV_BJ MXA4_V=;SPV%JY:&T5I) %R<;WPOS/CD\#@"N]N?/%I-]C$9N-A\H2DA"V.,D M9.,]<4>UGRWO_6POJU'FM8Y#_A5NB_\ /U?_ /?Q/_B*/^%6Z+_S]7__ '\3 M_P"(KA+F:_\ "_C/1+ ^/M3U/Q?=7<)O],N9MNGF&0DR;%955,#[H4EB<87G MC4\<:QJ%MXDU]#J=]::E;P6C>'+*WN'07;LWSXB!Q-E_E8$-A?3K0JL]->MO M^&[_ /#C^JTKVL=/_P *MT7_ )^K_P#[^)_\16GX<\!:7HNOVVH6L]X\L.[: MLCJ5.5*\X4=C5?2[NX\0>,;FZBN)8]-T=39B.*0B.XNC@REA_$(QM4=MQ?N* MZ^T_X^D_'^5#J3<=6.%"DIIJ.QIT445RGH!145S=065K+=7D\=O;PH7EEE<* MB*!DDD\ #UKCO"OQ=\'>,_$%SHVA:GYEY#DQB2,QBY4 $M&3][&3QP>"0".: M%J[(-E=G;45D:SXKT3P_J&FV.KWZ6]UJL_D6<6QF:9^.,*#@'? UG!=>*=1%C#<2&.(^5)(68#)X12>G?I1?2X=;&_17->&/B%X6\8V-[> M>'M62YMK#'VF5XI(5B!!.29%7C )SVQ4'AOXH^#/%VKR:7X>UV&[O8P28?+> M,N!U*EU ?IGY<\<]*.MA75KG64444#.=UK_D>/#/_;U_Z+%=%7.ZU_R/'AG_ M +>O_18KHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***9+-%;QF2>1(D'5G M8 #\30 ^BN;U#Q_X>T_(^V_:G'\-LN_/X_=_6N=F^)>H:A*8?#VBO*_9G!D/ M_?*]/SH ]&JE?ZQIVF+G4+V"WXSM=P&/T'4UP?\ 97C[7^;V\_L^%OX?,$?' MT3G\ZN6'PKL4;S-5OY[IR]?L578OYGG]* MRO\ A+?&.O<:'I/V>-ONR>7N_P#'WPOZ5VFG^&-%TO!LM.@1QT=EWL/^!-DU M=NKZVLE#74RQ@] >2?PII-[";25V>?#P'XDUHAO$.M;4//E[S)C_ (#PH_"M MO3_AKH-GAKA)KUQWF? _)M,U#1SJ-R&ENY%@P,PKT)]?\BK\$$=M L,"!(U& !1HM1/F MDVGHBKI>G?V?&^^9II92&D=CU-7J*Y_QOXPLO GA.YU_4X+BXM[=D4QVZ@L2 MS!1U( '/7-2VV[LN,5%61T%8>N>-/#WAO5M-TS6]3CM+S5)/+M(F1CYC9 Z@ M$+R0,M@5SGBRW\2^/_ VBW_P[UPZ#),UPI1FA9<[3M#DQ MRW_B*]A\F98Y\P)]T$^@)V#.,].V:S;WQ)XJ\?W3V.E0/%:GAH8#A0/^FCGK M^@]JZKPW\*;#3]EQKKK?7 Y$*\1*?YM^.![5T^RA3UJ/Y'"\15K.U!:=V@^IR:Z MV.-(HUCB1411A548 'H!3JB=:37+'1&M+"0@^>?O2[L****P.P**** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9-_J)/]T_RI], MF_U$G^Z?Y4">QYMXF\7ZUX7\2(K^&=1UG1)[4&.31[0SSQSAOF5QN "[<$'' M7U[C'!4[>^,8)XKUZBM;?U\ M[_Y'/S?U\K?UYG@=ZFO77B-=;\">%?%.@Z*987UNP,26*M6T77?!]SX-U.74KYY+6SO;6VQ9>0_P!UWE+D*P4G(Z9& M.,\>M44>&V\(W/@K5[ M'69S&MQ?7%N%L;9U<%Y8YMQW8P2H')KT/Q+?:AIWA^0Z-;27>HRE8+8*A8*[ MG:)'QT1<[B3V'O6Q10U=687UOV/'_$WA*/2[@V,^CWVK6B:$T&E206SSF._+ MEGD)4'RI')1O-)7H?FXKUKP['=PZ=IT>IN)+U+=%N'!SND"?,?SS4U36G_'T MGX_RHV3_ *[O]?R'>\E_7;_+[[FG1116)TG,?$?PU=>,/AWJ^A:=.MO=7D($ M3L2%+!@P4D= =N#[&O"_A]JUCIWQ+@TGXE>%7TW68KZ&+3KRUD98+:<6\<8B M.QL$,JQ]V&6' '-?0GBK1;CQ#X8O=+LM5NM(N;A,17UH[+)"P(((VD$CCD9& M1D5XYX3^&?C+5O&3GQY>6C6>D:G;WS30Q2E]1GCMT1&#N "F!\Q')8,,=P4] M*GW?G^G^03UA]_XK]3$\9>#]3T'XS>"-:\0ZY+JNI:MK;?+TBMH$DC\N-!CL M')/09/3J3WOQ4\+^-/$7Q \)7?A.PL);;1VDN3<:C-M@28XVAU5O,.-@QM!Y M//&:V?B#X$U/Q7XR\&:MIT]I%!H-\UQ,88=*_P"%+7>GQI#-'<6\"B, $HZQ;A].3^?O75:1\'I[GPSXKC\9:G%< MZSXK8/=S6<9$5MM.8Q&&P6"GGG&< =LFKH/PP\776O>&9/'>K:5<:;X43&G1 MZ>LGF7+ *TQ<8! 53QGICWJH:25][Q?W;_UYDRU3MM[R^^UCUZHYYA;VTDS M*SB-"Y5!EC@9P!W-244AG#WFOIJ'C'09(-/OU,/VC*2P[&?,?\.3@XQS73_V MK+_T";__ +YC_P#BZSM:_P"1X\,_]O7_ *+%=%0!G?VK+_T";_\ [YC_ /BZ M/[5E_P"@3?\ _?,?_P 76C10!G?VK+_T";__ +YC_P#BZ/[5E_Z!-_\ ]\Q_ M_%UHT4 9W]JR_P#0)O\ _OF/_P"+H_M67_H$W_\ WS'_ /%UHT4 9W]JR_\ M0)O_ /OF/_XNC^U9?^@3?_\ ?,?_ ,76C10!G?VK+_T";_\ [YC_ /BZ/[5E M_P"@3?\ _?,?_P 76C10!G?VK+_T";__ +YC_P#BZ/[5E_Z!-_\ ]\Q__%UH MT4 9W]JR_P#0)O\ _OF/_P"+H_M67_H$W_\ WS'_ /%UHT4 9W]JR_\ 0)O_ M /OF/_XNC^U9?^@3?_\ ?,?_ ,76C10!G?VK+_T";_\ [YC_ /BZ/[5E_P"@ M3?\ _?,?_P 76C03@9/ H SO[5E_Z!-__P!\Q_\ Q=']JR_] F__ .^8_P#X MNH[WQ/HFGY^UZG;*PZJK[V'X+DUSU[\4M&@R+.&YNV[$*$4_B>?TH Z7^U9? M^@3?_P#?,?\ \71_:LO_ $";_P#[YC_^+KA_^$]\3:MQH>A81NC^6TN/^!<" ME&E?$/4V$EQ?_8\]%,P3'X(#0!V_]JR_] F__P"^8_\ XNC^U9?^@3?_ /?, M?_Q=<0/!7C.0%9O$AV^GVR9L_I0?AYXAE4>?XA)(Z#S)&Q^= ';_ -JR_P#0 M)O\ _OF/_P"+I&UAT7<^EWRCU(C'_L]<5_PJ^^D?,VOL<]3Y3$_^A4)\(T&? M,UEF]-MMC_V8T =>_B.*/'F65RN>FYHAG_Q^H6\76*,0\4BD=0981_[4KG%^ M$MF%&_5)R>Y$8%3K\*-(#?/>WI'H&0?^RT :S>.M(49+?E/ ?_:E1-\0M%3J M9/P>(_R>JB?"S0ESNFOG_P!Z5?Z+4R_#/P\H&4N&QZS=?RH 5OB3H2D@_:./ M0(?_ &:HC\4- '\-X?\ MD/\:MI\.O#2MDV+M[&=_P"AJ5/ 7AE!@:6I_P!Z M5S_-J ,X_%+01_RRO3_VR7_XJJEY\5K$*%TW3KB>0\#S2$'Z9)KHU\&^'4QC M2;?Y?4$_SIT#>'=(DQ:1V=NY."8(QG\2!32;V)R.8T_PIHFGX)\.ZA=./X[G M8^?PW[?TK8/B"STY?(&FW%N%_P"6:+$-OX!ZL6FC3Q727%WJ$T[JDEM1-:Z7>2*WW20N#^1)_2F0: MKJGG9N=*D,)' B W _\ F%;2J%4!0 !T '2EI75K6'RR;3;.4DMKNZF9KV+ M59$+9"*L8 '_ 'WC]*TI)XYEC$^AWLOE#"ETC/\ [/6S33(@D"%U#L,A2>3^ M%#G)@J<%T,Y-1:)=L>C7J+Z*D8'_ *'3O[5E_P"@3?\ _?,?_P 75%O&_AY? M&Z^$6U!1K;P^&[R*SM;83+JS$ M^4Y(4XQMQCYB =Q.5/'I)H=!_:LO_0)O_P#OF/\ ^+JA;^+[2_-Y'I=M+?SV M3%)X;>6%VB<9^1@'.T\=#6?H=OXZ3XD:W-KMY92>%6C TV"-5$B/E>20N>F_ M.XGG&.*=HWA+PG\.)M7U>R L/[4E$MT\TQ8$@L0J@^[-P.>:-Q-I*[,/1-?U M[XB?#S5;3Q%X9U;PY<7?FVBM ,,$*\.-Y4]R.F#CKSQ/H,^F?#+P-8Z!JKZA M=QVZL%>Z6,O("Q. F\_*,X YP.]9OB'XKSW,AL_"T#+N.T7$B9=C_LIV_'/T M%5=$^&FKZ[<_VAXHN9;=9#N97;=/)]<_=_')]JZ5145S5'8X98MS?)07,^_0 MCUCXB:WXCN/[.\,6TUM&_"B$;IG'U'W1].GK3M!^',WG?:?$UG?2\[O(@V?- M_O.6!_+\Z]1T?0=-T&U\C2[5(%/WF RS^Y;J:T*)5K+EIJR"&$YGSUWS/\#& MLIXM.M5MK#0;NWA7HD<<8'_H?7WJQ_:LO_0)O_\ OF/_ .+K1HKF.Y))61G? MVK+_ - F_P#^^8__ (NC^U9?^@3?_P#?,?\ \76C10,SO[5E_P"@3?\ _?,? M_P 71_:LO_0)O_\ OF/_ .+K1HH SO[5E_Z!-_\ ]\Q__%T?VK+_ - F_P#^ M^8__ (NM&B@#._M67_H$W_\ WS'_ /%T?VK+_P! F_\ ^^8__BZT:* ,[^U9 M?^@3?_\ ?,?_ ,71_:LO_0)O_P#OF/\ ^+K1HH SO[5E_P"@3?\ _?,?_P 7 M1_:LO_0)O_\ OF/_ .+K1HH SO[5E_Z!-_\ ]\Q__%T?VK+_ - F_P#^^8__ M (NM&B@#._M67_H$W_\ WS'_ /%T?VK+_P! F_\ ^^8__BZT:* ,[^U9?^@3 M?_\ ?,?_ ,71_:LO_0)O_P#OF/\ ^+K1HH SO[5E_P"@3?\ _?,?_P 71_:L MO_0)O_\ OF/_ .+K1HH SO[5E_Z!-_\ ]\Q__%T?VK+_ - F_P#^^8__ (NM M&B@#._M67_H$W_\ WS'_ /%T?VK+_P! F_\ ^^8__BZT:* ,[^U9?^@3?_\ M?,?_ ,71_:LO_0)O_P#OF/\ ^+K1HH SO[5E_P"@3?\ _?,?_P 71_:LO_0) MO_\ OF/_ .+K1HH SO[5E_Z!-_\ ]\Q__%T?VK+_ - F_P#^^8__ (NM&B@# M._M67_H$W_\ WS'_ /%T?VK+_P! F_\ ^^8__BZT:* ,[^U9?^@3?_\ ?,?_ M ,71_:LO_0)O_P#OF/\ ^+K1HH SO[5E_P"@3?\ _?,?_P 71_:LO_0)O_\ MOF/_ .+K1HH SO[5E_Z!-_\ ]\Q__%T?VK+_ - F_P#^^8__ (NM&B@#._M6 M7_H$W_\ WS'_ /%T?VK+_P! F_\ ^^8__BZT:* ,[^U9?^@3?_\ ?,?_ ,71 M_:LO_0)O_P#OF/\ ^+K1HH SO[5E_P"@3?\ _?,?_P 71_:LO_0)O_\ OF/_ M .+K1HH SO[5E_Z!-_\ ]\Q__%T?VK+_ - F_P#^^8__ (NM&B@#._M67_H$ MW_\ WS'_ /%T?VK+_P! F_\ ^^8__BZT:* ,[^U9?^@3?_\ ?,?_ ,71_:LO M_0)O_P#OF/\ ^+K1HH SO[5E_P"@3?\ _?,?_P 71_:LO_0)O_\ OF/_ .+K M1HH SO[5E_Z!-_\ ]\Q__%T?VK+_ - F_P#^^8__ (NM&B@#._M67_H$W_\ MWS'_ /%T?VK+_P! F_\ ^^8__BZT:* ,[^U9?^@3?_\ ?,?_ ,71_:LO_0)O M_P#OF/\ ^+K1HH SO[5E_P"@3?\ _?,?_P 71_:LO_0)O_\ OF/_ .+K1HH MSO[5E_Z!-_\ ]\Q__%U)!J,DTRQMIUY$&_CD";1]<,35VB@ HHHH **** "B MBB@ HHHH *9-_J)/]T_RI],F_P!1)_NG^5 GL>/?%36FL=6T>PU;7M1\.>'; MI)#![":TUQV\/>/#XJT Q$74=[?K> M7%O.<;"LB#[I (VG&.HSGB_XQUKQ!H.K6UU#H4NO>&Y+=X;VUL8A)=)(6&'V M'_6+CY=HQC+$]!7+>&-)CU?XCZ;KWACP5>>$+"Q@EBOI+RU6S:[W+\L:P*<$ M D-O]L=A6L=_O_K_ "^74PEM_7]?UV,OQIJ6KW/Q$UC3+?Q%KMGKL"P/X>TW M3,_9KE2 2TP ((#;MQ:_-?T_RZ)RT=_7\G_EI\S:OM#O_ (?Z_P"'[G3O&.O:K_:.HQV4^G:Q>"Y$ MT;_>9 0"I3&XD=OR/J$\RV]O)-(<)&I=CZ #- ME.5U!VW_ *_X?YD:.2/"?!.K>'-=O=,;5_BAXDAUZ[E$[:^/M:TU?$6K:'IFA1PQ1C29_(>>>1-[,[=PHP-OOG M([Y>HZIJOBCPBO@:/P)JFD:A(L4$L_V-8M.M"CJ7>.0,00,$J ,GC%:>H7^J M> /'FLZB/#VKZ[IFN1PRQMI4'GO#/$FQE=>P88.[\.>P^6WEK_7]=?,K6[[_ M -?UZ&-;>(/$7B>RT/P?-J]Q97\E_>VFIZI9KY-]4\(7^KWNL6D=G%J%C&+ M+0_&$VD7%[?QW][=ZGI=FWF3+'=D<(/XV3:F0.O/UKI_!@U+Q#XWU3Q??Z1> MZ/:26<6GV-MJ">7.RJS.[LG\(+$ #)SC-.-[J^_7[O\ .VWGYBE;E=MNGW_Y M?A8[VBBBF2%%%% !1110 4444 %%%% !1110 4444 "9&(+8' !49XK,\*SZ]JOP6TR;3+U&UNYTU#'=WK%P) M"/OL<$DCKR#D@9KL+Y2^GW"H"S-$P R2<&N-\+0>(-+^">EQ:191KKEMIT? MEVE^C("XZHPRI4D9 R1@D9XJ>DK^7ZE?RV\_T.4T"Z.B_%?3_#^B^-]6U^Z_ M>IKEIJUQNCC"ID-#N PVX_=3=QU( Y]D/3BO+KW5-0^(FK:':6WA+6]&;2]2 MBOKF^U:U$"1+'DE8CN)"T;PY96]PZ"[=F^?$0.)LO\ MK AL+Z=:ZW4[*ZD^+F@7D=M,UK%IEXDDZQDHC,T6T%N@)P<#O@UK^)[^_L-! MF;1K62ZU"9E@ME5"RH[G:'?'1%SN)/8>]+[*?K^;*O[S^7IT,W2[NX\0>,;F MZBN)8]-T=39B.*0B.XNC@REA_$(QM4=MQ?N*Z^T_X^D_'^5>,^)O"4>EW!L9 M]'OM6M$T)H-*D@MGG,=^7+/(2H/E2.2C>:2O0_-Q7K7AV.[AT[3H]3<27J6Z M+<.#G=($^8_GFGO'^N[_ ,K^2:%M)?UV_KU3-^BBBL3I"BBB@ HHHH **** M"BBB@#G=:_Y'CPS_ -O7_HL5T5<[K7_(\>&?^WK_ -%BNBH **** "BBB@ H MHHH **** "BFO(D8!D=4!. 6.,GTKEO&/Q(\.^!;[2[3Q!/+')J:R=7^-VI)XDTS1-*T!C-J;;87 ,O?';&<=_04 >S5#ZNK.]UA=T'E *BJ20-Q3GJI]<=\"IKK3]"TWX MB:;X2\1ZQ?2ZMJ47FQF"WS& =V 9&).3M;^'''.* /2;WQ_X=LLC[=Y[#^&! M"^?QZ?K6!<_%5)'\O2=)FF8_=,KX/_?*Y_G4"K\/=%\?67@^Y22;6KN'S8EF M#NI&&."1\H)"L<8[>XSTL?BKPIIGC.'P=;W%O;:S-"9DLXH2H*X+8R!MS@$X MSG S0!S?]K?$'6?^/2Q^PQMW\H1\?63G\J/^%?\ B+5N==UWY3_!O:7'X' ' MX5V'_"7Z!_PEW_"+_P!IP_VUY7G?8^=VW&>N,9QSC.<)=%?Q*_A]-3 MMCJ\<0F:R#CS AYSCZ$''H0: .?LOA=HEO@W&M%T[ M!M-,MD8=',89A_P(Y-2QZUII6,VHS:?#>V\E[ H>6V653)&IZ%ESD ^IH LT5$EU!)<26\<\;S1 &2-7!9 M >F1U&:D#J690P++U /(H 6BC-% !1141N81%))YJE(P2Y4YVX^E KI$M%9$ M7B&&YNDAM;>>4,P!<+P/>I+]-7EN2EB\,,&!\[,=&\,>$9_$M_ M<^;ID*JPEML2^9N8*NW!P*O"%B-7>Y2.2"WD)1MC'E MBGWCCT'UZ"I*;2W.\J.>Y@M45KF:.%68(ID<*"QZ#GO7E?CKQ;>Z[\/[ >&O M$]GX>'_!4VFQ>(;MK=]3F, M-N%B9\D8R3@< ;EY]ZH^,?&&L^'?$_AW3=*\,W.KVVJ7!CNKJ(G%JN5&3@$# MABW.!A?RXW6_B7I^KFW\_P +6=V;202V[WQ$IB<=&4;>#[@TT_$3QGJV1IEF M%ST^RVC2']=U:+#5.NA@\?1V5WZ([3Q%IOC>Y^(&@WGA[5K6V\/0 _VE:RK\ M\O/./E. M^>,^Q?$O6/OOJ$:MUS,MN/RR/Y4Z/X4^([Y_,U&_MD/J\K2-_+^M/V,5\4T+ MZW4E\%-_/0[B[O/ UIXB&O7,NE?VND7D_:U*O,$],KD]./IQ4%U\5/#-OGRI MKBZQ_P \8",_]]8K$M?@S;K@WNL2R>HAA"?J2?Y5M6OPK\,V^/-AN+K_ *[3 MD?\ H.*+4%U;#FQDMHI&#J?QC4P.FCZ:RR'[LERPPO\ P$=?SK'T_P )>)_' M-VM_K=Q)!;MR)K@I67A/0-/=7M-(M$=3E7:,,P/L3DUKT>VC! M?NU87U6I4=Z\KKLMC"\/>#](\-Q@V-OON,8:YE^:0_CV'L,5NT45SN3D[L[H MPC!6BK(****104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4R;_42?[I_E3Z9-_J)/]T_RH$]C)HK@?B!X MEU&RU[2?#^FZ[8^&AJ$4LSZO>QK)MV%0(XU)K7Q; MK4&F>([+2)=)-N+#0Y;-99-9W@'Y6/S6/)=R-K\'E>Q%).ZNO+\?Z^74;C9V?]6_KY]#N:*\TE;QQ MX*UC2+C6_%D'B33=0OH[":"33([5XC(<*Z&,G)!'(/&,_4>BWDC16,\D9PR1 MLRGT(%#DE%R["LW)1)J*\E\,Z9\2_$?A#3]VRSK;/H=N5!(R%+CG M'OC\*L0_$NY%GX/U;6KJ#3;.\6]_M4(F8V,*D94D%L;ER #DY YJGIN"5]CU M*BN7M/B3X0OO#%SXAMM=MVTRU;;-,RLA1NR[" V3V&,GMFI_"_CWPSXT\_\ MX1K58[UK?'FIY;QLH/0[7 )'N!BCR%TN=#17,:;\1O"FL7D]KINK"XFMK9KN M94@E_=Q*<$D[< _[/7VJ*U^*'@N\UA-+@U^V-V\(G".KHNS9OY=@%!V\D$Y' M.1Q2NAV9UE%<]X8\>>&O&4ES'X;U6.]>UQYR!'0J#T(# 9''49%=#3$%%%% M!1110 4444 %%%% !1110 45SGB_7M6T>T2'P]H<^J7]RCF*0X6VM]N,M,Y( M(&&R%&2VT@8ZUGZ'KOB+4?@_I^L:?;QZIKUS8QR(DI6)'D; +-T SD@8R!@ MS;38[9XR^?WD;(U0:)XL>(+"_T]UCN+G1(K)8TB@D(_US\F-UOS*64M@_<&PJ0>>:>SL_Z_KR!*^QZ?4UI_Q])^ M/\JY:TU6\U?QG+!93>5IFEP[+Q0JMYURX!$>[J/+7!.,9+KZ$5U-I_Q])^/\ MJ3V"/Q(TZ***Q.H**** "BBB@ HHHH **** .=UK_D>/#/\ V]?^BQ715SNM M?\CQX9_[>O\ T6*Z*@ HHHH ***YJX^(GA6&WN98=9MKQK9F22*S<3.'7JN% MSS]: .EID\\5M;R3W,J10QJ7>21@JHHY))/05X]8_&O4/&'AV[_X1C0)['46 M$D,!N#YFU]ORN%"\\D?ECFJMEX4^(OBSP4VE_$#4UBAF4K,\DBQ97.1D(!D_ M44 >B>+OB-H'@_PO)K=U=+>Q*JM'%9R)(\H8@ KSC'/7.*X3Q9\7=5UCPC;3 M?#2UD34+HQR!KR-,A",E54D@MG R>,9QV-:GA/X4^%M*L8-*>_EU(0H?W>=J MMSDYQUY)Z$?2NKM3;:5(UOH/A_R]AV%Q'MSCU.,G\35*$F9NI!*]SS7Q+X.\ M8_%?3=/AU]#IJ6TBS?N_W*!\8. ^#VKJ[7X0V%Q+%<>(KHW\T;;UP@^5O M7>*S.,S>8EK-_:OB2UF:08*-./E^@R M334+H3J6=FOF6;#P[X=T_:+2QL]XX#/AV_-LFMAGBBV[V1,#Y+.R3 )3/7![5 R:7<:A#=,MG+>1 K#,0K2(#U"MU&?:L*W\2^#K6VE@ MBU2V$"XI4D35+/S\G]P>VVLU]YNW%AHW]L MQ:G=6MC_ &E#&8XKN2-/.1#G*ASR!R>/(FLK)]2AB,2W^Q2Z) MW&[\2/H3ZUG76M>#[V;S;G5+%WQC/VG'\C3H]=\(QV;6D>J6 AD.64W Y/U) M]J7)ILRO:Z[JWJ31Z'X8E\6CQ#%;6+ZVT7DBZ5P9"N,8Z]<<9QG''2HCX8\* M6GC:7Q0]M:Q:])"(7N6F(8K@#[I.,X &<9P,9I(+WP?;S++#JFFJZG*G[#?"]EXRN_&\$*+ MJEU$(I;KSB4(P%R%SM!(51GV]SF#1_!WA:Q^(.H>+-,D+:QJ47ES#S\ICY22 MJ^IV+GZ=N:TUU;PLUJ+-=4TQHB>(Q=H>?SI;>X\-6LPE@O=/20=&^TJ$_&6N>,H=4NI'UPY>.63=&I)W': ,GD<>@R!6[+<^&9I6DEN].9V.23< M)S^M2-J7A[[,L+W^FF&/D*TZ8'ZT"/">DZ+XZ\1ZWIVHZA=3 M:U)YTD<_^KB^8G [GDX&>@XJMX4\!:IX8\5>(M7L;VX;^W+GSG2[D#K'\S'C MU^]C)'0 5T\WC?PM8+M.K6H4=H 7'_C@-95S\6?#D&?)^UW/IY<./_0B*M0E M?W8F4JM-*TZGW%;PQ\*8?#FJZU>R:]J%[_:]S]HDBE/RH,X''%8]S\9H%R+/1Y']#+.%_0 MUE2_%O7KI_+L-/M4)Z (\C?S_I5>PJM69F\9AHNZ=V=A\/O #^!(-5C?7KW5 MAJ%T9U-SQY/7@(KW6#>W+3K+<##0Y&,#); M)[D]SV%<;_;WQ'U3_CWAO8T/3R[,(/\ OHK_ %I?^$5^(>J?\?ES=(I[37W' M_?(8X_*CV%OBD@^N7^"#?R.K\$>#)/ /A>_TS5/%MSJ+WWWKA=@=L_*?FY/4FLCP_XONO M#_PVN_#AU75-2U&=)EBU6=]CVY<$*5Y8_*>>O7/3BO2K;X5>&8,>;%V\%^&[3'E:-:''_/6/S/\ T+-%Z"Z-ARXR6[2/#]%\8>*-,^'D MGAH:I+@QTXKZ&M[.VM%Q:V\4(](T"_RJ:E[6FMH#^KUI+W MJC^2L>#:3\,_%J>&X="6*6+2HU*+;75V#&06+'* GN2>E;5E\&=0V*MUJ5I; MJ %A1GP/QVUZ_11]8FMK(/J-)N\VWZL\[M?@[I4>/MFHWUP3IYG8?Q32L?TSC]*ZJBH=:H]V;1PM".T49]KH&D6./LFEV<)_O) H M/YXS6A116;;>YNHI;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)O M]1)_NG^5/IDW^HD_W3_*@3V/*OB)KNE:9?6EKXW\/QWGA6>%C)J+VYN!:W&= MJAE )0%20&&22P Q@UR?@.'PY_PL2RF^$/\ :']A>3*NL[C.+,L%/EX\[YC+ MN(Z?P_C7M=%:I69S-W5CYTN-8T^"-KFZNM3MOBO9W3LL)MIYFN3N;; J@;/) M9", $<<\]]B:[U/QQH7A*U\1:CJ5AK!\1307K6T7V.:R<0RL(XSCH%*_-R2# MRS):U76 M-0,Z6[D8+JN -V..<_G@UUNH?\@VZ_ZXO_(U8HHDN:+B).TN8\:\!?#"/6?A MYHMW/XP\6PQ75FC/96^J[+<*1R@3;PO;&:Z'7=!TRQ\VIX3XWO9-'\8>)Y[?R;*W.HZ9)G:WJ^N0W&BMMO]3C\M9G$ MR[Q NU=L8)QMP,'=]:]MHJ8JS_KM8J4KJW];W/-? D$4/P'G\I%0R6]\[D#[ MS%Y.3^0K(NM,L9?A+\-K62SA>![_ $UFB:,%6+*2V1WR2<^N37L-%-*SO_A_ M\E8G*_X_B<3Y2)\> ZHJLWAT[F Y.+@8S7;444UI%+U_%M_J)ZN_];)!1110 M 4444 %%%% !1110 4444 5]0_Y!MU_UQ?\ D:X+PQXFLO!_P T?7-3#-!:Z M;$=B?>D8X"J/MNMOPO_F--:7Z?\#_(\6\'_$/PCKOBFRU?Q-XC MCO/$5PPM].T^&SN!;Z>)"%V(2F&D;.&D/T&%'/J;ZK9:O9ZQ:Z?&FHS61>VN M+1P45Y-@;RR6&,$,.1DDKX:\+3>);K6 MKMQ%_P (Y?3RM:Z(=_[UR&55^0%@"2Q!(.,\CV_Q:NDZ1ID6KSZ1:7^J6NRW MTPRP*TIF8[8T1B,K\Q!)'09/:NGHHMI;^OZ^\&];GC.NP'PI/+INI:Y>V&S1 M9+RRGM[EX#?ZF\A:5OE/[U]VS$9###?=KV#P[)=S:=ITFIH([U[=&N$ QMD* M?,/SS4U36G_'TGX_RHVBU_77_.WR0[WDG_73_A_5LTZ***Q.DIZMJUCH6D76 MJ:M<+;65I&99I6!(51[#D_0<_\ $OFO8]JW M8V*__ 6*MN Y!7!SD@5UGCKPK'XU\#ZGX>EN#;?;8@JS!=VQE8,I([C*C(]* M\)\&ZSJ_@OXD?V/\1M$TW5UEU6"SBUJ*-6-I=>1&(RF5& 4$?("G@G)QBB&L M[,):0NOZ_K4]M\2?$30O"_B71M OY)9=2UB=8H(+<*QC#' =\D;5SQGDG!P# M@TOC/Q_I7@G[##?6]_J%_J#E+33]-M_.N)MO+%5R.!D=_IFO&/&G@&R\'_%K MP+J"WESJ&IZQKTD]W=W+DD@21;$49.%4-CN??& .MUHN_P"UQX=63)1-#D* MC@'][DBB/O1CYM_@KA+1OT7XNQW7A_XB>'O$7A.[\06]S):VEAO%]'=Q^7+: M,@RRR+S@@>F?:LCPQ\8_#WB?7+72TLM6TR6_1I-/EU.T\F.^4=3$VX[N.>.AY4?P6>V&)UN[54"C^$ MK#N[?2B'O6?1\J_\"7Z!+W;QZKF_"WY]3WJBBHYWDCMI'@B\Z54)2/=MWG' MR>F?6@#!UK_D>/#/_;U_Z+%="S!5+,0 !DDGI7FGBK4O%T_B7PT-.T%;6Z-S M*A+7<.,X&5 !P%&UK;@NV/J/ESCG&< MUQ%C&% P0.N.*=X?T3P'X0 MFD81MA.*T$^''B&67S-1L;BX)ZE;R)3^9)K3MO #08\W MPG=W/KYFKQ#_ -!457[B/6YFWC)[)(KW7Q#TZ NFAVEQ:V_&V)(TA[=RI-5K MCXH74NGK:+ID+HIR#<2NYS]1M]:ZBV\/"TQY7P[MVQ_SUU%)/_0LUK6UQJ]E MC['X'M[?'3RKV%*?]H*?Z"MJR\4:YJ$+2V?ACS$5VC8 M_P!H(,,IP1R*L_VUXE_Z%/\ \J4?^%3[>IW-/J=#^4YG_A3>G_\ 05N?^_:T M?\*;T_\ Z"MS_P!^UKIO[:\2_P#0I_\ E2C_ ,*/[:\2_P#0I_\ E2C_ ,*? MMZO<7U/#_P IRS_!JT./+UB=?7="#_44W_A3-O\ ]!J3_P !Q_\ %5U?]M>) M?^A3_P#*E'_A1_;7B7_H4_\ RI1_X4?6*O<7U+#_ ,OYG*?\*9M_^@U)_P" MX_\ BJ8_P70M^[UUE'HUIG_V<5UW]M>)?^A3_P#*E'_A1_;7B7_H4_\ RI1_ MX4?6*O_P#)/_[.C_A2_P#U'O\ R3_^SKL/[:\2 M_P#0I_\ E2C_ ,*/[:\2_P#0I_\ E2C_ ,*/K%7N+ZCA_P"7\7_F<6WP8F#' M9K<97L3;$'_T*A?@Q,6&_6XP.Y%L3_[-7:?VUXE_Z%/_ ,J4?^%5I_%.N6UY M;6L_AC;-=%A"O]H(=VT9/(&!QZT_K-7N'U'#_P OXLQ;;X.:6F/M>I7)?^A3_P#*E'_A2*.BHKG?[:\2_P#0I_\ E2C_ ,*/[:\2 M_P#0I_\ E2C_ ,* .BHKG?[:\2_]"G_Y4H_\*/[:\2_]"G_Y4H_\* .BHKG? M[:\2_P#0I_\ E2C_ ,*K67BG7-1B>2S\,>8B2-&Q_M!!AAU'(H ZNBN=_MKQ M+_T*?_E2C_PH_MKQ+_T*?_E2C_PH Z*BN=_MKQ+_ -"G_P"5*/\ PH_MKQ+_ M -"G_P"5*/\ PH Z*BN=_MKQ+_T*?_E2C_PH_MKQ+_T*?_E2C_PH Z*BN=_M MKQ+_ -"G_P"5*/\ PH_MKQ+_ -"G_P"5*/\ PH Z*BN=_MKQ+_T*?_E2C_PH M_MKQ+_T*?_E2C_PH Z*BN5G\4:Y;7=M;3>&-LUT6$*_V@AW%1D\XP./6K']M M>)?^A3_\J4?^% '145SO]M>)?^A3_P#*E'_A1_;7B7_H4_\ RI1_X4 =%17. M_P!M>)?^A3_\J4?^%']M>)?^A3_\J4?^% '145SO]M>)?^A3_P#*E'_A1_;7 MB7_H4_\ RI1_X4 =%17._P!M>)?^A3_\J4?^%']M>)?^A3_\J4?^% '145SO M]M>)?^A3_P#*E'_A1_;7B7_H4_\ RI1_X4 =%17*67BG7-0CD>S\,>8L4K1. M?[0089>HY%6?[:\2_P#0I_\ E2C_ ,* .BHKG?[:\2_]"G_Y4H_\*/[:\2_] M"G_Y4H_\* .BHKG?[:\2_P#0I_\ E2C_ ,*/[:\2_P#0I_\ E2C_ ,* .BHK MG?[:\2_]"G_Y4H_\*/[:\2_]"G_Y4H_\* .BHKG?[:\2_P#0I_\ E2C_ ,*/ M[:\2_P#0I_\ E2C_ ,* .BHKG?[:\2_]"G_Y4H_\*KW'BC7+6YM[>?POMEN6 M*Q+_ &@AW$#)Z#CCUH ZJBN=_MKQ+_T*?_E2C_PH_MKQ+_T*?_E2C_PH Z*B MN=_MKQ+_ -"G_P"5*/\ PH_MKQ+_ -"G_P"5*/\ PH Z*BN=_MKQ+_T*?_E2 MC_PH_MKQ+_T*?_E2C_PH Z*BN=_MKQ+_ -"G_P"5*/\ PH_MKQ+_ -"G_P"5 M*/\ PH Z*BN=_MKQ+_T*?_E2C_PH_MKQ+_T*?_E2C_PH Z*BN=_MKQ+_ -"G M_P"5*/\ PJM9^*=&/,$,K0R?\3!!M=>HY% '5T5SO]M>)?^A3_P#* ME'_A1_;7B7_H4_\ RI1_X4 =%17._P!M>)?^A3_\J4?^%']M>)?^A3_\J4?^ M% '145SO]M>)?^A3_P#*E'_A1_;7B7_H4_\ RI1_X4 =%17._P!M>)?^A3_\ MJ4?^%']M>)?^A3_\J4?^% '145SO]M>)?^A3_P#*E'_A1_;7B7_H4_\ RI1_ MX4 =%17*7'BC7+2XMX;CPQLDN7*1+_:"'<0,XX'''K5G^VO$O_0I_P#E2C_P MH Z*BN=_MKQ+_P!"G_Y4H_\ "C^VO$O_ $*?_E2C_P * .BHKG?[:\2_]"G_ M .5*/_"C^VO$O_0I_P#E2C_PH Z*BN=_MKQ+_P!"G_Y4H_\ "C^VO$O_ $*? M_E2C_P * .BHKG?[:\2_]"G_ .5*/_"C^VO$O_0I_P#E2C_PH Z*BN=_MKQ+ M_P!"G_Y4H_\ "C^VO$O_ $*?_E2C_P * .BHKE+3Q1KE]YWV7PQYGD3-!)_Q M,$&UUZCD<_7I5G^VO$O_ $*?_E2C_P * .BHKG?[:\2_]"G_ .5*/_"C^VO$ MO_0I_P#E2C_PH Z*BN=_MKQ+_P!"G_Y4H_\ "C^VO$O_ $*?_E2C_P * .BH MKG?[:\2_]"G_ .5*/_"C^VO$O_0I_P#E2C_PH Z*BN=_MKQ+_P!"G_Y4H_\ M"C^VO$O_ $*?_E2C_P * .BHKG?[:\2_]"G_ .5*/_"B'Q)J46IVEKJ^A-8I M=N8XY%NTE^;&>0.U '14444 %%%% !1110 4444 %,F_U$G^Z?Y4^F3?ZB3_ M '3_ "H$]CROX@>)=1LM>TGP_INNV/AH:A%+,^KWL:R;=A4".-7(0LQ;N>G3 MFKOART\%C)J+VYN!:W&=JAE )0%20&&22P Q@UR?@.'PY_PL2RF M^$/]H?V%Y,JZSN,XLRP4^7CSOF,NXCI_#^-:Q>OW_P!6Z?\ #=S"2T_K\RSX MS\:>)K7Q;K4&F>([+2)=)-N+#0Y;-99-9W@'Y6/S6/)=R-K\'E>Q%>6W&L:?!&US=76IVWQ7L[IV6 M$VT\S7)W-M@50-GDLA& "..>>^Q-=ZGXXT+PE:^(M1U*PU@^(IH+UK:+['-9 M.(96$<9QT"E?FY)!Y.:4=8I>:_-=?GKV\KZN2L[^OY/_ "T[^9U$K>./!6L: M1<:WXL@\2:;J%]'8302:9':O$9#A70QDY((Y!XQGZCT'4YGM])O)H6VR1P.Z M-C."%)%_!C2=3:\W:YJCI:Q7'E(/WDDQ0-MQMX7)Z8XZ&L/P= M\&_ >J_#O2-3O]"\V\N=/CFEE^V3KN+O&/B+4M/\):M!X> MTO2)OL\NI/9K.,[WA3QK<>-->GGT2S8>%X8-J:A<0/&UW/NQ^ZR1\B@$$ ME6UNESY*R^ M6))E0G:P(/#5F1>$/B*DR-+\4?,16!9/^$?MQN'<9W<4?&O['_PK2;^U/^/+ M[;:?:.O^K\]-WW>>F>G-<#8WG[.^GZA;WED_EW-O*LL3XU [74Y!P>#R.]$/ MB^?Z+H-I\NG;_/J>M>)?B%X5\'WEO:^(]8BL[BX&Z.+8[MC.,D(#M&>YP#@^ MAJQ9>,] U&]@M;+45FFN+B:VB"QOAY(1F0!L8X!!SG![$UQ4_B+1O 7Q*\0W MGBU9K=-;6W?3[T6KS+,BQA6A!4$@AAG;[@^E<5X>U>R\.II/B6ZL)],T2S\2 M:G'.GDDFQ66,! R*"1@C! Z=*(ROO_6J5OQ$XZ77]:-_H>P>)/$MC%I>LV]O MKO\ 9-WIBPFYNOL;3_9O,(*_(1A]PXXSC-)KOQ'\)^&9[B#7=8CM9K;R_-1H MI&;]X"5P%4[LA3TSCOBO+];UB'7]-^)&I6<4\=K/'II@:>,QM*F1A]IY ;J, MX.,'O6W<^*M \(?&;Q'J/B5'MXFL+**/4!:M*L)*L3&2@)4OC(XP=A]!2NU: M^G_##LK/K_2_S/3]'UG3]?TF#4]&NX[RSN%W1RQG@^Q'4$="#R#P:NUPOPJA M9M)UC4X+*33]-U75);O3[:5-A$)51OV_PABI8#T.>]=U5]B.K"BBB@ HHHH M**** .<\7Z]JVCVB0^'M#GU2_N4_3XYVB:X7C2=U!QD*I;'Z5Y%!>^!?$>N^'[;X8Z9;PZO9ZC#/=36FF-;M;6Z@^:)'*+D M$?)@DY)KT?6Y+;Q;X8\2Z+I,XDNDAFL905*^7,T60N2 #]Y>1DN>/-$TK2O&>O:U9W>DZA-#]JT9+)8Q9PSL K)*/F M9EW+D-QUY/!J]XN\6:W8:IXGGLM2-E%X=@M)8++R8W6_,IR=Y92V"?D&PJ0> M>:P+OQG;>,O!ND^!-/AO/^$D>6UM]1LWM60V:PNAE=V(V[1LXP2>1QVKTGQB MVE:;8KK=UI%G?ZK RPZ:98%:4SNV(T1B,KEB"2.@R>U.5EK':^GII;U"-_M+ M6VOW_@+::K>:OXSE@LIO*TS2X=EXH56\ZY< B/=U'EK@G&,EU]"*ZFT_X^D_ M'^5>)Z[ ?"D\NFZEKE[8;-%DO+*>WN7@-_J;R%I6^4_O7W;,1D,,-]VO8/#L MEW-IVG2:F@CO7MT:X0#&V0I\P_/-&\?Z[O\ R^ZP6M)?UV_S^^YOT445B=)D M>*O#5AXP\,7NA:N'^R7B;7:,@.A!!#*2",@@'H:\N\%_!;5-/\5/<>+==N-2 MT[2KR&XTZ+R8XQM=K11TMYW'_ )6."T'X3:5IO@W6=#U> MZGU:?7W>75+^0"-YY&_B4#(7!Y YP?6LWPW\'9],UW1KWQ'XJN-?MO#T931[ M-[1(%MN, L5),A "X)QR!]*]/HHV=U_7_#=!;JW]>?WA17E.L_&>_35]>MO" M'@RY\06?AT$:E>F]2V6-UW;@BE6+@;3TYX/&,$ZFI_/ NC>(-%LKC5+C M7IA;Z;IP81R2RY(*L3D*%(P3R,X]#T=G_5MSMKG3(+K4[*_E+^ M=9>9Y6#Q\ZX.?PJY7G6C?%ZTDM?$*>+M)F\.ZIX=B$][8O.L^8R,J8W7 )O"ESX?M_$"%]'NY+M)EN>X#* #&2"N <\D?6A M:NR$W979Z=17E7B'XSWECX@UVP\,^#[C7K7P[&'U6\%ZD A/).U2I+@!3TYX M/&!D^@^&O$-CXK\-6.N:47-I>Q"1 X 9>Q5@"1D$$'D\BA:KF0WH[,U**** M"BBB@ HHKE_B#X[L/A[X8;5K^":ZDDD$%K:PCYIY6!*KGL.#D\X'0$X!5[#2 MN=117G7AOXI7UYXXA\*>,?"D_AG4[RW^T6(-XETDZC<6!90 I 4G'/0YQQG* MO_CH;:;4-1LO"EW?>%-,O!9WFN1W2#:^0I*0XRZY(YR.O:GU2_KM^>@CT_3M M-@TNW>&V+E7E:4[SDY8Y-6Z\[\2?%2:T\0P:%X*\.R^*M1:R&H3)%=I;I# ? MNG-8X;ATDD^S1V \YKG./*].V<_P!WG&>* M/Z_3\]/4.O\ 7K^6OH>AT5P/A'XF7&L^+)O"WBKP[-X9UP0"Y@MI+I;A+B+U M5U &1SQ['G(('?4["N%%%%(84444 %%%>4ZS\9[]-7UZV\(>#+GQ!9^'01J5 MZ;U+98W7=N"*58N!M/3G@\8P2KH=FSU:J=UID%WJ-E>RE_-LRYBP>/F&#G\* MXG4_C!I,'@71O$&BV5QJEQKTPM]-TX,(Y)9N:O>!_B$WB MG5M4T+6=&ET'7]*VM!]&C74'DCD-S?13_) ZJ6\L#!WGCG!&"<1W:0K;<9(52"9" #D#'(/UJ;JR?Q"6(L,$ ]B.Q!R#[BM&J::=F2FFKH****0PHHHH **Y?X@^.[#X> M^&&U:_@FNI))!!:VL(^:>5@2JY[#@Y/.!T!. <+PW\4KZ\\<0^%/&/A2?PSJ M=Y;_ &BQ!O$NDG4;BP+* %("DXYZ'..,BUV_KJ#T5V>BU3TW3(-*@DBM2Y62 M5I6WG/S,U16^>Z)&55!U).1]!R< 4KKEYNG]?GT[CL^;E MZ_U_3['245R_A#QQ:^)?AW:>+=0CBTBVFC>659K@,D*JY7)G/!XQ@G4U/XP:3!X%T;Q!HME<:I<:],+?3=.#".267)!5B1G' MKFCI?T_';[P>CL_ZMN=O*=6U M30M9T:70=?TK:US823K.-C#*NLB@!AR,\=QUJE'\7M'O?BS:>!]&C74'DCD- MS?13_) ZJ6\L#!WGCG!&"<@T5Y3K/QGOTU?7K;PAX,N?$ M%GX=!&I7IO4MEC==VX(I5BX&T].>#QC!/?\ A7Q-8>,?"]EKVD&3[)>(602+ MAE()#*1Z@@CC(XI+570WH[,UZ*** "BBB@ HHKE_B#X[L/A[X8;5K^":ZDDD M$%K:PCYIY6!*KGL.#D\X'0$X!5[#2N=117G7AOXI7UYXXA\*>,?"D_AG4[RW M^T6(-XETDZC<6!90 I 4G'/0YQQG*O\ XZ&VFU#4;+PI=WWA33+P6=YKD=T@ MVOD*2D.,NN2.LH?@_:>.[_3)H_M MA\N'3X)/-=Y2[(J!B!UVY)QP,\'H3:_E^H;V\ST6BN \(_$RZUKQA/X5\4^& MYO#>M+;"[A@>[2Y6:+U#J!@^V#T/IBN_IV%>X4444AA1110 445Y3K/QGOTU M?7K;PAX,N?$%GX=!&I7IO4MEC==VX(I5BX&T].>#QC!*NAV;/5JJ76FP7E[9 MW4I?S+-V>/:>,D8.:XC4_C!I,'@71O$&BV5QJEQKTPM]-TX,(Y)9N:O>!_B$WBG5M4T+6=&ET'7]*VM!]&C74'DCD-S?13_) ZJ6\L#!WGCG!&"<#[[7M1&]+9/W<(;:9I#PJ X.,GO@X&3VJ6TH\W0I)N7+U-^BN> M\!^*_P#A-_!&G^(?L?V'[:K-]G\WS-FUROWL#/W<]!70U333LR4TU=!1112& M%%%% !17+_$'QW8?#WPPVK7\$UU))((+6UA'S3RL"57/8<')YP.@)P#A>&_B ME?7GCB'PIXQ\*3^&=3O+?[18@WB723J-Q8%E "D!2<<]#G'&1:[?UU!Z*[/1 M:IZ=ID&F+<+;%R+B=[A]YS\S=<>W%>8W_P =#;3:AJ-EX4N[[PIIEX+.\UR. MZ0;7R%)2'&77)'.1U[5VWBKQYH7A'PD?$&IWD?V:2(/:HK?/=$C*J@ZDG(^@ MY. *5UR\W3^OSZ=QV?-R]?Z_I]CI**Y/PQX[B\0?"^/QG8]-HHHI#"BBB@ HHHH **\Z\1_%.]L_&T_A3P;X5N/$VJ65O] MHO@+Q+6.!2%*@,P.XX8<<=1C)SBC'\==+NO EAK6G:3=7.K7][_9T.B[PLGV MK +(7(QM&1\V/XAD Y %JKK^NGY@]'9_UU_(](N]-@O;JTN)B^^TD,D>TX&2 M,_%FT\#Z-&NH/)'(;F^BG^2!U4MY8&#O/'.",$XY((#M=I+J*^C?8]!HK@O M&'Q+GT3Q,GAOPOX>F\2:V+8WEQ;1W*VZ6\ _B+L""2<87'?Z [?@3Q?%XZ\' MV>O06-S8"X!#07"G*L.#M; WKGHPZ^@.0$M5=#>CLSHJ*** "BBB@ HHK'\5 M^)]/\&^%[W7M8,GV2S0,ZQ+N=R2%"J..22!R0/4BDVDKL:3;LC8HKRG1_C-J M#ZWH-KXN\&7'A^R\0@#3;W[:Y'=(-KY"DI#C+KDCG(Z]J>SU_K_(7]?UW/3[#38--%S]G+G[ M3$?"1\0:G>1_9I(@]JBM\]T2,JJ#J2L><2%#^^90. "W3VH[^0=O,[2BO) M1\7O%-IXYT;PQKGP[-A=ZK(-HCUN*X:.+=AI2L:'"@9/)&=IYX->M4[:7#K8 M****0!1110 445YUXC^*=[9^-I_"G@WPK<>)M4LK?[1? 7B6L<"D*5 9@=QP MPXXZC&3G"N.QZ+5.]TR"^NK2><1_'72[KP)8:UIVDW5S MJU_>_P!G0Z+O"R?:L LA.XZU5G>Q-]+G:45Y]'\7M'O?BS:>!]&C74'DCD-S? M13_) ZJ6\L#!WGCG!&"<-CX4\)^%I_$FJPVAO+N-;Q+988^ M,8+ [CR...HQDG FZLGW_K]"K:M=CT2BN:\ ^-['X@>$H-SB9_P!@E_O)^9H^P2_WD_,UH44SB9_V"7^\GYFC[!+_>3\S6A11S,/9Q,_[!+_ 'D_,UA> M%?!^SY939YASLZG./7C/I76T4SB9_V"7^\GYFC[!+_ 'D_,UH44SB9_P!@E_O)^9H^P2_WD_,UH44SB9_V"7^\GYFI(+22*978K@>A]JN44)O"D/@3Q-\'M$@EWP6=](DD[?*))6>,LV">,L3@?05V4_P)TF3Q/J M&OVOBOQ98:CJ$C//+9:BD1(8YV9$>=HP 2> /2MR_\ A?I.K>#+?P]K.I:Q MJ)M)O/M]4NKS?>PR9)#++CJ,X&1C&/2B'NVEUNF_ET_KJ.6MX]+-?>M_ZZ'A M?QF26?XD>/C9ABD6A6GVC:>_GVY&>?2NM\[M6C9#G*A8=QZ M\CI7I/A_X6^'=!TW5;247>L2:R-NH7>JS^=/&/@YX> M\,:Y:ZHE[JVIRV"-'I\6IW?G1V*GJ(EVC;QQSG\^:(>[9=FG]S;M^(I>]=^3 M7WI+]#RF]TK5/%WB+XJ7_@S5E\.65NK6VH6QB$O]I.BR;F+-_J@V&Y7U^M>O M_![4['5OA+H-SI=A_9]NL!B%ON+!61BK$$\D%@3D\\U1\1_!7P[XAUN^U.._ MUG1Y-339J$.EWGDQ7O\ UT4JUTK2+9;6RM(Q'#$ MF2%4>YY)[DGDGDT0TA9^7X7_ UT70):RNO/\;?Y;ERBBB@ HHHH *IZMJUC MH6D7.J:O!5RN8\>^ ]/^(>@QZ1K%[J%K:K,)F% MC*J&0@$ -N5@1SG&.H%*5[:#5KZGGW@O3]5^)7Q ;XEZO:R6&E6=N]MX?M). M))%(8>;+*XE'.YX\9R3SP1[8HE%6<5LU;\;W_,%)W4GNG?\&K' ?!!)K?X MO:C%?DK.WABP8*YY8"&#WYQ7-Z-X?&O_ 'UJ6/4['3GM?%,EYIS:A]CC)!./<Y%N\D/_/-OE(*_ MA[=*GG^&'A:?X>?\(4; II 7Y0CD2*^<^:&_OYYR>.V,<53DWKV_^2YK_A]X MHI+1]=__ 'E_KR/)[>Z\4ZQ^U!X4O/$NCPZ/=+ILF;.&[6Y*1!)1O=EX^9F M.!SCBOH:N.\'?#+1O!NHSZE!=ZEJVIS1B$W^K7/GS)$,8C4X "\#MGWQ@5V- M-VLEZ_BVQ:MW?E^""BBBI&%%%% !7EWQ6\9WLL@^'_@J+[;XFUB(I+M/R6%N MPPTCM_"<'CTZ_P!T-ZC7E\_P)TF3Q/J&OVOBOQ98:CJ$C//+9:BD1(8YV9$> M=HP 2> /2I:N[/8I.RNMSC?$WA2'P)XF^#VB02[X+.^D22=OE$DK/&6;!/& M6)P/H*W=/MA?_M5>)X$+"%O#Z17!4]"WE8^AP?2NQO\ X7Z3JW@RW\/:SJ6L M:B;2;S[?5+J\WWL,F20RRXZC.!D8QCTJYX-^'^D^"3>S6,]]J%_?N&N]1U*? MSKB;'W0S8' ^GUS5[OWO[S_\"5OZ^1&VWDON=[GE%MX1T;P3^TUX/TCP[:+; M6R:-*S$G+RN1/EW;JS']. , 5)X!=(/^%T)>'!2[N'D5FYV[9N?I[UZK>^! M-,O_ (BZ?XSFGNUU'3[5K6*)77R64[^6&W=GYST8=JQO$WP;\/>)]=NM4DO- M6TR2_14U"'3;OR8K]1T$JX.[CCC'Y\U$KRCROJFOO=RU92YET<7]RLRO\ $E M3X(:#Y^EE\_\CQ_PM)''^R%XL2!M(UCX)Z;KNO6INM1TGPDZVRRG*1L;;._;W88X)R!U S@C M=U#X&^%=1UNXO'GU6&RN[D75UH\%YLLKB4<[GCQG)//!'MBNYU72+;5_#]YH M\VZ*UO+9[5_)PI1&4J=O! (!XXHE>4'W:7X)K\;CBTIKM=O[VG^AYA\,?">E M^-/V=_#VD:]')+9%C*\<;E/,V3N0I(YP>^,'W%4O@7:V]CX\^)5K901V]O!J MXCBBB4*J*'E X [5ZCX2\,67@SPM9Z#IX96G7^Z&X[Q-X4A\">)O@]HD$N^"SOI$DG;Y1)*SQEFP3QEB<# MZ"NRG^!.DR>)]0U^U\5^++#4=0D9YY;+44B)#'.S(CSM& "3P!Z5N7_ ,+] M)U;P9;^'M9U+6-1-I-Y]OJEU>;[V&3)(99<=1G R,8QZ40]VTNMTW\NG]=1R MUO'I9K[UO_70X[3[87_[57B>!"PA;P^D5P5/0MY6/H<'TK%MO".C>"?VFO!^ MD>';1;:V31I68DY>5R)\N[=68_IP!@ "O5_!OP_TGP2;V:QGOM0O[]PUWJ.I M3^=<38^Z&; X'T^N:=>^!-,O_B+I_C.:>[74=/M6M8HE=?)93OY8;=V?G/1A MVIQ]WE\KW^?-^K%+WE+SM;\/\CE/BMXSO99!\/\ P5%]M\3:Q$4EVGY+"W88 M:1V_A.#QZ=?[H;L? WA.W\$>"M.\/VLGFBTCQ)+C'F2$EG;';+$\=AQ7'S_ MG29/$^H:_:^*_%EAJ.H2,\\MEJ*1$ACG9D1YVC !)X ]*[SP[HG_".Z'#IO M]IZCJGE%C]JU.X\Z=\DGYGP,XS@<=*4=(Z[O^K?():O39?UP Y)X%7*YCQ[X#T_XAZ#'I&L7NH6 MMJLPF86,JH9" 0 VY6!'.<8Z@4I7MH-6OJ>?>"]/U7XE?$!OB7J]K)8:59V[ MVWA^TDXDD4AAYS<\9W-]5Z=_P:L86 MI>!M(UCX)Z;KNO6INM1TGPDZVRRG*1L;;._;W88X)R!U S@C4^#.L:9HOP+\ M-2ZQJ-I81R^9'&]U.L2NYE?"@L1D\'BO0M5TBVU?P_>:/-NBM;RV>U?R<*41 ME*G;P0" >.*YG_A57AR3X9Q>!KM;FZTN 'RI99 )D;<6#AE &X%CCC'8@C.; ME*[DUU:_-M_F2H^[%/I?\E;\CA[".\\*_M.Q)XDNUUVY\0Z>ZV-V(O):Q169 MO*V D%<)C=U)Y_O9]LKB?"?PKT7PGKDFM?;M5UK56B$,=[K%U]HDAC_NH<# M_7L."<]M2T45'M_FPU7?%;QG>RR#X?\ @J+[;XFU MB(I+M/R6%NPPTCM_"<'CTZ_W0WJ->7S_ )TF3Q/J&OVOBOQ98:CJ$C//+9: MBD1(8YV9$>=HP 2> /2I:N[/8I.RNMSC?$WA2'P)XF^#VB02[X+.^D22=OE M$DK/&6;!/&6)P/H*W=/MA?\ [57B>!"PA;P^D5P5/0MY6/H<'TKL;_X7Z3JW M@RW\/:SJ6L:B;2;S[?5+J\WWL,F20RRXZC.!D8QCTJYX-^'^D^"3>S6,]]J% M_?N&N]1U*?SKB;'W0S8' ^GUS5[OWO[S_P# E;^OD1MMY+[G>YY1;>$=&\$_ MM->#](\.VBVULFC2LQ)R\KD3Y=VZLQ_3@# %4?BKXZ\.:UXTUW2O$>H_9K; MP_I]Q#IUDT$C_:]0DB*^8=JE0$SA=V,$YZ5[/>^!-,O_ (BZ?XSFGNUU'3[5 MK6*)77R64[^6&W=GYST8=JVM8TR'6]#OM*NVD2"^MY+>1HR P5U*D@D$9P?0 MU$KRBOG^+?\ G_5BXV4[KR_!*YYS^SQK>GZE\(]/L;*X\VYTW?%=IL8>6S.S M 9(P>"#QFO4JQO"7ABR\&>%K/0=+EGEM;-6$;W#*SG+%CDJ .I/:MFM9M2DV MC*":C9A1114%A1110!3U;5K'0M(N=4U>Y2ULK6,R33/T51^I/8 MGZK\2OB WQ+U>UDL-*L[=[;P_:2<22*0P\YN>,[F^N1CA03Z#X]\!Z?\0]!C MTC6+W4+6U683,+&54,A ( ;:H)+8KM*A3&$ P!T'; I)7;O\ONW&WI9?/_ "/'_"TD5?58;*[N1=76CP7FRRN)1SN>/&V*[G5=(MM7\/WF MCS;HK6\MGM7\G"E$92IV\$ @'CBB5Y0?=I?@FOQN.+2FNUV_O:?Z'DW@>SMM M2_93M;"^UNWT*WN[26"34+@@)"&G8'.64ZTK4_@]J?@63P]XOU37 M-/U2YCT^>QN[@26\B/MP\"=(QW&"2,CYB"<^L:7\/]#TWX>IX+DCFO\ 1Q$T M3+=.-[JS%CED"X.3P1@C K"\-?!7P[X^,X] Q'D5SX%E^'OB;X66NH7 FO;K6) M;F_N-WRF=VA^4$^@ &>Y!/?%>H^(?@MI/B'QK-XJD\1^)+#4Y%"H]A>I%Y*A M=NU#Y991C/&>Y]:M3?"/2;[PL^BZSK7B#5R+H7=OJ%_?^9=6D@ ,4FT;1QT M((R:(>ZU/K=?=V_7U'+5./2S^]K!"PA;P^D5P5/0MY6/H<' MTK%MO".C>"?VFO!^D>';1;:V31I68DY>5R)\N[=68_IP!@ "O5_!OP_TGP2; MV:QGOM0O[]PUWJ.I3^=<38^Z&; X'T^N:=>^!-,O_B+I_C.:>[74=/M6M8HE M=?)93OY8;=V?G/1AVIQ]WE\KW^?-^K%+WE+SM;\/\CR"7PU>^(_VH?%>GKKN MIZ$CZ=%,9].F$4TJA(@H#X)"Y.3CKC%=W\#/%&K>)O MRNOW7VV[TO4);#[6 M?O3J@4AF]3\V,]3@$Y.2=CQA\,-&\8ZM;:M->:GI&J6\9A6_TFY\B9HSG*,< M'*\GMGGKCBMKPMX6TKP;X=M]%T&W,%G!DC5]K? MCO\ =H$]97_K:UOO-BBBB@ HHHH *9//%;6\D]Q(D4,2EY)'8*J*!DDD] !3 MZQ?%WABV\8^%[O0K^[O+2VNP%EDLY DA4$';D@C!Q@\''LUTOQIXRCM;.19([+^U5%N<-N*E%C VDYR.^ M33]0^!OA74=;N+QY]5ALKNY%U=:/!>;+*XE'.YX\9R3SP1[8H<5RN*V:M^*= M_P"O(.;52?1W_/3\?S,+4O VD:Q\$]-UW7K4W6HZ3X2=;993E(V-MG?M[L,< M$Y Z@9P1T'P((7X(>'RQP!'*23V_>O7;:KI%MJ_A^\T>;=%:WEL]J_DX4HC* M5.W@@$ \<50\,^$K'PIX-M_#6FS7+V=O&\:23,K288DDDA0,Y8]JN4F^=KKM M^+_4E1T@GTW^Y?Y'G'PC>UQ=MI^G9.1' F.GU&S\0?6O9 M*Y[P1X,T[P#X8BT+1I;F:VCD>0/=,K2$L(_$EAJPO4B\E0NW:A\LLHQGC/<^M2U?3H-.V MIY=<^!9?A[XF^%EKJ%P)KVZUB6YO[C=\IG=H?E!/H !GN03WQ79Z?;"__:J\ M3P(6$+>'TBN"IZ%O*Q]#@^E=1-\(])OO"SZ+K.M>(-7(NA=V^H7]_P"9=6D@ M ,4FT;1QT((R:U?!OP_TGP2;V:QGOM0O[]PUWJ.I3^=<38^Z&; X'T^N:O1 MZ/97_%6M\O\ (G7=;Z?@[W^9Y1;>$=&\$_M->#](\.VBVULFC2LQ)R\KD3Y= MVZLQ_3@# %6=^!-,O_ (BZ?XSFGNUU'3[5K6*)77R64[^6&W=GYST8=JSO%GPIT3Q5 MKR:X+[5M%U41&"2\T>[\B2:/^Z_!!'X ]CD 8EW:5_/\;_YE:7=NMOPM?\C! M_9WO;2;X8FQMK(6L^FWTMM=NKEUN)1@F4$^H(X]N.,5ZK6-X3\*:3X*\.V^B MZ! 8;2')RS;GD8]78]V/Y=@ !6S5R=V1%604445)04444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % *%%% !1110!__V0$! end XML 22 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 30, 2018
Feb. 15, 2019
Jul. 01, 2018
Document Information [Line Items]      
Entity Registrant Name JOHNSON & JOHNSON    
Entity Central Index Key 0000200406    
Current Fiscal Year End Date --12-30    
Entity Filer Category Large Accelerated Filer    
Document Type 10-K    
Document Period End Date Dec. 30, 2018    
Document Fiscal Year Focus 2018    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Common Stock, Shares Outstanding   2,663,138,579  
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Public Float     $ 325,000,000,000
XML 23 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents (Notes 1 and 2) $ 18,107 $ 17,824
Marketable securities (Notes 1 and 2) 1,580 472
Accounts receivable trade, less allowances for doubtful accounts $248 (2017, $291) 14,098 13,490
Inventories (Notes 1 and 3) 8,599 8,765
Prepaid expenses and other receivables 2,699 2,537
Assets held for sale (Note 20) 950 0
Total current assets 46,033 43,088
Property, plant and equipment, net (Notes 1 and 4) 17,035 17,005
Intangible assets, net (Notes 1 and 5) 47,611 53,228
Goodwill (Notes 1 and 5) 30,453 31,906
Deferred taxes on income (Note 8) 7,640 7,105
Other assets 4,182 4,971
Total assets 152,954 157,303
Current liabilities:    
Loans and notes payable (Note 7) 2,796 3,906
Accounts payable 7,537 7,310
Accrued liabilities 7,601 7,304
Accrued rebates, returns and promotions 9,380 7,210
Accrued compensation and employee related obligations 3,098 2,953
Accrued taxes on income (Note 8) 818 1,854
Total current liabilities 31,230 30,537
Long-term debt (Note 7) 27,684 30,675
Deferred taxes on income (Note 8) 7,506 8,368
Employee related obligations (Notes 9 and 10) 9,951 10,074
Long-term taxes payable (Note 8) 8,242 8,472
Other liabilities 8,589 9,017
Total liabilities 93,202 97,143
Shareholders' equity:    
Preferred stock — without par value (authorized and unissued 2,000,000 shares) 0 0
Common stock — par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) 3,120 3,120
Accumulated other comprehensive income (loss) (Note 13) (15,222) (13,199)
Retained earnings 106,216 101,793
Stockholders' Equity before Treasury Stock 94,114 91,714
Less: common stock held in treasury, at cost (Note 12) (457,519,000 shares and 437,318,000 shares) 34,362 31,554
Total shareholders’ equity 59,752 60,160
Total liabilities and shareholders’ equity $ 152,954 $ 157,303
XML 24 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Current assets:    
Allowances for doubtful accounts $ 248 $ 291
Shareholders' equity:    
Preferred par value $ 0 $ 0
Preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value per share (in dollars per share) $ 1 $ 1
Common stock, shares authorized (in shares) 4,320,000,000 4,320,000,000
Common stock, shares issued (in shares) 3,119,843,000 3,119,843,000
Treasury stock, shares 457,519,000 437,318,000
XML 25 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Income Statement [Abstract]      
Sales to customers $ 81,581 $ 76,450 $ 71,890
Cost of products sold 27,091 25,439 21,789
Gross profit 54,490 51,011 50,101
Selling, marketing and administrative expenses 22,540 21,520 20,067
Research and development expense 10,775 10,594 9,143
In-process research and development 1,126 408 29
Interest income (611) (385) (368)
Interest expense, net of portion capitalized (Note 4) 1,005 934 726
Other (income) expense, net 1,405 (42) 210
Restructuring (Note 22) 251 309 491
Earnings before provision for taxes on income 17,999 17,673 19,803
Provision for taxes on income (Note 8) 2,702 16,373 3,263
Net earnings $ 15,297 $ 1,300 $ 16,540
Net earnings per share (Notes 1 and 15)      
Basic (in dollars per share) $ 5.70 $ 0.48 $ 6.04
Diluted (in dollars per share) $ 5.61 $ 0.47 $ 5.93
Average shares outstanding (Notes 1 and 15)      
Basic (in shares) 2,681.5 2,692.0 2,737.3
Diluted (in shares) 2,728.7 2,745.3 2,788.9
XML 26 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Statement of Comprehensive Income [Abstract]      
Net earnings $ 15,297 $ 1,300 $ 16,540
Other Comprehensive Income (Loss), net of tax      
Foreign currency translation (1,518) 1,696 (612)
Securities      
Unrealized holding gain (loss) arising during period (1) 159 (52)
Reclassifications to earnings 1 (338) (141)
Net change 0 (179) (193)
Employee benefit plans      
Prior service credit (cost), net of amortization (44) 2 21
Gain (loss), net of amortization (56) 29 (862)
Effect of exchange rates 92 (201) 159
Net change (8) (170) (682)
Derivatives & hedges      
Unrealized gain (loss) arising during period (73) (4) (359)
Reclassifications to earnings (192) 359 110
Net change (265) 355 (249)
Other comprehensive income (loss) (1,791) 1,702 (1,736)
Comprehensive income $ 13,506 $ 3,002 $ 14,804
XML 27 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Statement of Comprehensive Income [Abstract]      
Foreign currency translation $ 236    
Securities 0 $ (96) $ (104)
Employee benefits 4 (83) 346
Derivatives & hedges $ (70) $ 191 $ (134)
XML 28 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Retained Earnings
Accumulated Other Comprehensive Income
Common Stock Issued Amount
Treasury Stock Amount
Beginning Balance at Jan. 03, 2016 $ 71,150 $ 103,879 $ (13,165) $ 3,120 $ (22,684)
Net earnings 16,540 16,540      
Cash dividends paid (8,621) (8,621)      
Employee compensation and stock option plans 2,130 (1,181)     3,311
Repurchase of common stock (8,979)       (8,979)
Other (66) (66)      
Other comprehensive income (loss), net of tax (1,736)   (1,736)    
Ending Balance at Jan. 01, 2017 70,418 110,551 (14,901) 3,120 (28,352)
Net earnings 1,300 1,300      
Cash dividends paid (8,943) (8,943)      
Employee compensation and stock option plans 2,077 (1,079)     3,156
Repurchase of common stock (6,358)       (6,358)
Other (36) (36)      
Other comprehensive income (loss), net of tax 1,702   1,702    
Ending Balance at Dec. 31, 2017 60,160 101,793 (13,199) 3,120 (31,554)
Cumulative adjustment [1] (486) (254) (232)    
Net earnings 15,297 15,297      
Cash dividends paid (9,494) (9,494)      
Employee compensation and stock option plans 1,949 (1,111)     3,060
Repurchase of common stock (5,868)       (5,868)
Other (15) (15)      
Other comprehensive income (loss), net of tax (1,791)   (1,791)    
Ending Balance at Dec. 30, 2018 $ 59,752 $ 106,216 $ (15,222) $ 3,120 $ (34,362)
[1] (1) See Note 1 to Consolidated Financial Statements for additional details on the effect of cumulative adjustments to retained earnings.
XML 29 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Equity (Parenthetical) - $ / shares
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Statement of Stockholders' Equity [Abstract]      
Cash dividends paid (in dollars per share) $ 3.54 $ 3.32 $ 3.15
XML 30 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Cash flows from operating activities      
Net earnings $ 15,297 $ 1,300 $ 16,540
Adjustments to reconcile net earnings to cash flows from operating activities:      
Depreciation and amortization of property and intangibles 6,929 5,642 3,754
Stock based compensation 978 962 878
Asset write-downs 1,258 795 283
Gain on sale of assets/businesses (1,217) (1,307) (563)
Deferred tax provision (1,016) 2,406 (341)
Accounts receivable allowances (31) 17 (11)
Changes in assets and liabilities, net of effects from acquisitions and divestitures:      
Increase in accounts receivable (1,185) (633) (1,065)
(Increase)/Decrease in inventories (644) 581 (249)
Increase in accounts payable and accrued liabilities 3,951 2,725 656
Increase in other current and non-current assets (275) (411) (529)
(Decrease)/Increase in other current and non-current liabilities (1,844) 8,979 (586)
Net cash flows from operating activities 22,201 21,056 18,767
Cash flows from investing activities      
Additions to property, plant and equipment (3,670) (3,279) (3,226)
Proceeds from the disposal of assets/businesses, net 3,203 1,832 1,267
Acquisitions, net of cash acquired (Note 20) (899) (35,151) (4,509)
Purchases of investments (5,626) (6,153) (33,950)
Sales of investments 4,289 28,117 35,780
Other (primarily intangibles) (464) (234) (123)
Net cash used by investing activities (3,167) (14,868) (4,761)
Cash flows from financing activities      
Dividends to shareholders (9,494) (8,943) (8,621)
Repurchase of common stock (5,868) (6,358) (8,979)
Proceeds from short-term debt 80 869 111
Retirement of short-term debt (2,479) (1,330) (2,017)
Proceeds from long-term debt, net of issuance costs 5 8,992 12,004
Retirement of long-term debt (1,555) (1,777) (2,223)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net 949 1,062 1,189
Other (148) (188) (15)
Net cash used by financing activities (18,510) (7,673) (8,551)
Effect of exchange rate changes on cash and cash equivalents (241) 337 (215)
Increase/(Decrease) in cash and cash equivalents 283 (1,148) 5,240
Cash and cash equivalents, beginning of year (Note 1) 17,824 18,972 13,732
Cash and cash equivalents, end of year (Note 1) 18,107 17,824 18,972
Cash paid during the year for:      
Interest 1,049 960 730
Interest, net of amount capitalized 963 866 628
Income taxes 4,570 3,312 2,843
Supplemental schedule of non-cash investing and financing activities      
Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards 2,095 2,062 2,043
Conversion of debt 6 16 35
Acquisitions      
Fair value of assets acquired 1,047 36,937 4,586
Fair value of liabilities assumed and noncontrolling interests (148) (1,786) (77)
Net cash paid for acquisitions $ 899 $ 35,151 $ 4,509
XML 31 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 30, 2018
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies
Principles of Consolidation
The consolidated financial statements include the accounts of Johnson & Johnson and its subsidiaries (the Company). Intercompany accounts and transactions are eliminated.
Description of the Company and Business Segments
The Company has approximately 135,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the world and its primary focus is on products related to human health and well-being.
The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. The Pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular), diabetes care (divested in the fiscal fourth quarter of 2018) and vision fields, which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

New Accounting Standards
Recently Adopted Accounting Standards
ASU 2014-09: Revenue from Contracts with Customers
On January 1, 2018, the Company adopted the new accounting standard, ASC 606, Revenue from Contracts with Customers and all the related amendments (new revenue standard) to all contracts using the modified retrospective method. The cumulative effect of initially applying the new revenue standard was recognized as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The adoption of the new revenue standard has not had a material impact to either reported Sales to customers or Net earnings. Additionally, the Company will continue to recognize revenue from product sales as goods are shipped or delivered to the customer, as control of goods transfers at the same time.

In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on the Company's Consolidated Statement of Earnings and Balance Sheet was as follows:
Statement of Earnings - For the fiscal year ended December 30, 2018
(Dollars in millions)
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Sales to customers
$
81,581

 
(35
)
 
81,546

 
 
 
 
 
 
Net earnings
15,297

 
(28
)
 
15,269

 
 
 
 
 
 
Balance Sheet - As of December 30, 2018
 
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Assets
152,954

 
23

 
152,977

 
 
 
 
 
 
Liabilities
93,202

 
4

 
93,206

 
 
 
 
 
 
Equity
$
59,752

 
19

 
59,771

 
 
 
 
 
 


The Company made a cumulative effect adjustment to the 2018 opening balance of retained earnings upon adoption of ASU 2014-09, which decreased beginning retained earnings by $47 million.
As part of the adoption of ASC 606 see Note 18 to the Consolidated Financial Statements for further disaggregation of revenue.
ASU 2016-01: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities
The Company adopted this standard as of the beginning of the fiscal year 2018 on a modified retrospective basis. The amendments in this update supersede the guidance to classify equity securities with readily determinable fair values into different categories (that is, trading or available-for-sale) and require equity securities to be measured at fair value with changes in the fair value recognized through net earnings. The standard amends financial reporting by providing relevant information about an entity’s equity investments and reducing the number of items that are recognized in other comprehensive income.
The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 that increased retained earnings by $232 million net of tax and decreased accumulated other comprehensive income for previously unrealized gains from equity investments. For additional details see Note 6 to the Consolidated Financial Statements.
ASU 2016-16: Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory
The Company adopted this standard as of the beginning of the fiscal year 2018. This update removes the current exception in U.S. GAAP prohibiting entities from recognizing current and deferred income tax expenses or benefits related to transfer of assets, other than inventory, within the consolidated entity. The current exception to defer the recognition of any tax impact on the transfer of inventory within the consolidated entity until it is sold to a third party remains unaffected. As discussed further in Note 8 to the Consolidated Financial Statements, in the fourth fiscal quarter of 2018 the Company elected an accounting policy to treat the tax on global intangible low-taxed income (GILTI) under the deferred tax accounting model. As a result, the Company is required to record an additional deferred tax liability related to the basis difference of these intra-entity asset transfers. The Company recorded net adjustments including an increase to deferred tax assets of approximately $2.0 billion, an increase to deferred tax liabilities of approximately $1.7 billion, related to the GILTI accounting policy election in the fourth fiscal quarter of 2018, a decrease to Other Assets of approximately $0.7 billion and a decrease to retained earnings of approximately $0.4 billion. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

ASU 2017-01: Clarifying the Definition of a Business
The Company adopted this standard as of the beginning of the fiscal year 2018. This update narrows the definition of a business by providing a screen to determine when an integrated set of assets and activities is not a business. The screen specifies that an integrated set of assets and activities is not a business if substantially all of the fair value of the gross assets acquired or disposed of is concentrated in a single or a group of similar identifiable assets. This update was applied prospectively. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

ASU 2017-07: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost
The Company adopted this standard as of the beginning of the fiscal year 2018. This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost (NPBC). In addition, only the service cost component will be eligible for capitalization. The amendments in this update are required to be applied retrospectively for the presentation of the service cost component and the other components of NPBC in the Consolidated Statement of Earnings and prospectively, on and after the adoption date, for the capitalization of the service cost component of NPBC in assets. As required by the transition provisions of this update, the following table shows the impact of the adoption on the respective line items in the Consolidated Statement of Earnings for 2018 and the reclassifications to the 2017 and 2016 fiscal year Consolidated Statement of Earnings to retroactively apply classification of the service cost component and the other components of NPBC:

(Dollars In millions)
 
 
Increase (Decrease) to Net Expense
 
 
2018
2017
 
2016
Cost of products sold
 
$
51

85

 
104

Selling, marketing and administrative expenses
 
55

100

 
122

Research and development expense
 
21

40

 
48

Other (income) expense, net
 
(127
)
(225
)
 
(274
)
Earnings before provision for taxes on income
 
$
—

—

 
—






The following table summarizes the cumulative effect adjustments made to the 2018 opening balance of retained earnings upon adoption of the new accounting standards mentioned above:
(Dollars in Millions)
 
Cumulative Effect Adjustment Increase (Decrease) to Retained Earnings
ASU 2014-09 - Revenue from Contracts with Customers
 
$
(47
)
ASU 2016-01 - Financial Instruments
 
232

ASU 2016-16 - Income Taxes: Intra-Entity Transfers
 
(439
)
Total
 
$
(254
)


ASU 2017-12: Targeted Improvements to Accounting for Hedging Activities
The Company elected to early adopt this standard as of the beginning of the fiscal second quarter of 2018. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. For additional required disclosures see Note 6 to the Consolidated Financial Statements.

Recently Issued Accounting Standards
Not Adopted as of December 30, 2018
ASU 2018-18: Collaborative Arrangements
This update clarifies the interaction between ASC 808, Collaborative Arrangements and ASC 606, Revenue from Contracts with Customers. The update clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue if the counterparty is not a customer for that transaction. This update will be effective for the Company for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2018-18 should be applied retrospectively to the date of initial application of ASC 606 and early adoption is permitted. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2018-16: Derivatives and Hedging (Topic ASC 815)
This update adds the Overnight Index Swap (OIS) rate based on the Secured Overnight Financing Rate (SOFR) as an eligible benchmark interest rate permitted in the application of hedge accounting. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted if an entity has adopted ASU 2017-12. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2018-02: Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
This update allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Job Act enacted in December 2017. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company does not expect this standard to have a material impact on the Company's consolidated financial statements.

ASU 2016-13: Financial Instruments - Credit Losses
This update introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. This update will be effective for the Company for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2016-02: Leases
This update requires the recognition of lease assets and lease liabilities on the balance sheet for all lease obligations and disclosing key information about leasing arrangements. This update requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current generally accepted accounting principles. This update will be effective for the Company for all annual periods beginning after December 15, 2018, including interim periods within those fiscal years. The Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements. The Company’s operating leases will result in the recognition of additional assets and the corresponding liabilities on its Consolidated Balance Sheets. The adoption of this standard will not have a material impact on the Company's consolidated financial statements.
Cash Equivalents
The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating. The Company invests its cash primarily in government securities and obligations, corporate debt securities, money market funds and reverse repurchase agreements (RRAs).
RRAs are collateralized by deposits in the form of Government Securities and Obligations for an amount not less than 102% of their value. The Company does not record an asset or liability as the Company is not permitted to sell or repledge the associated collateral. The Company has a policy that the collateral has at least an A (or equivalent) credit rating. The Company utilizes a third party custodian to manage the exchange of funds and ensure that collateral received is maintained at 102% of the value of the RRAs on a daily basis. RRAs with stated maturities of greater than three months from the date of purchase are classified as marketable securities.
Investments
Investments classified as held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income. Available-for-sale securities available for current operations are classified as current assets otherwise, they are classified as long term. Management determines the appropriate classification of its investment in debt and equity securities at the time of purchase and re-evaluates such determination at each balance sheet date. The Company reviews its investments in equity securities for impairment and adjusts these investments to fair value through earnings, as required. 
Property, Plant and Equipment and Depreciation
Property, plant and equipment are stated at cost. The Company utilizes the straight-line method of depreciation over the estimated useful lives of the assets:
Building and building equipment
20 - 30 years
Land and leasehold improvements
10 - 20 years
Machinery and equipment
2 - 13 years


The Company capitalizes certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 8 years.
The Company reviews long-lived assets to assess recoverability using undiscounted cash flows. When certain events or changes in operating or economic conditions occur, an impairment assessment may be performed on the recoverability of the carrying value of these assets. If the asset is determined to be impaired, the loss is measured based on the difference between the asset’s fair value and its carrying value. If quoted market prices are not available, the Company will estimate fair value using a discounted value of estimated future cash flows.
Revenue Recognition
The Company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. The Company's global payment terms are typically between 30 to 90 days. Provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.
Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. Rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. The Company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.
Sales returns are estimated and recorded based on historical sales and returns information. Products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.
Sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. The sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. In accordance with the Company’s accounting policies, the Company generally issues credit to customers for returned goods. The Company’s sales returns reserves are accounted for in accordance with the U.S. GAAP guidance for revenue recognition when right of return exists. Sales returns reserves are recorded at full sales value. Sales returns in the Consumer and Pharmaceutical segments are almost exclusively not resalable. Sales returns for certain franchises in the Medical Devices segment are typically resalable but are not material. The Company infrequently exchanges products from inventory for returned products. The sales returns reserve for the total Company has been approximately 1.0% of annual net trade sales during the fiscal reporting years 2018, 2017 and 2016.
Promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. Continuing promotional programs include coupons and volume-based sales incentive programs. The redemption cost of consumer coupons is based on historical redemption experience by product and value. Volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. These arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. The Company also earns profit-share payments through collaborative arrangements for certain products, which are included in sales to customers. For all years presented, profit-share payments were less than 2.0% of the total revenues and are included in sales to customers.
Shipping and Handling
Shipping and handling costs incurred were $1,090 million, $1,042 million and $974 million in 2018, 2017 and 2016, respectively, and are included in selling, marketing and administrative expense. The amount of revenue received for shipping and handling is less than 0.5% of sales to customers for all periods presented.
Inventories
Inventories are stated at the lower of cost or net realizable value determined by the first-in, first-out method.
Intangible Assets and Goodwill
The authoritative literature on U.S. GAAP requires that goodwill and intangible assets with indefinite lives be assessed annually for impairment. The Company completed the annual impairment test for 2018 in the fiscal fourth quarter. Future impairment tests will be performed annually in the fiscal fourth quarter, or sooner if warranted. Purchased in-process research and development is accounted for as an indefinite lived intangible asset until the underlying project is completed, at which point the intangible asset will be accounted for as a definite lived intangible asset, or abandoned, at which point the intangible asset will be written off or partially impaired.
Intangible assets that have finite useful lives continue to be amortized over their useful lives, and are reviewed for impairment when warranted by economic conditions. See Note 5 for further details on Intangible Assets and Goodwill.
Financial Instruments
As required by U.S. GAAP, all derivative instruments are recorded on the balance sheet at fair value. Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value, with Level 1 having the highest priority and Level 3 having the lowest. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.
The Company documents all relationships between hedged items and derivatives. The overall risk management strategy includes reasons for undertaking hedge transactions and entering into derivatives. The objectives of this strategy are: (1) minimize foreign currency exposure’s impact on the Company’s financial performance; (2) protect the Company’s cash flow from adverse movements in foreign exchange rates; (3) ensure the appropriateness of financial instruments; and (4) manage the enterprise risk associated with financial institutions. See Note 6 for additional information on Financial Instruments.
Product Liability
Accruals for product liability claims are recorded, on an undiscounted basis, when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on existing information and actuarially determined estimates where applicable. The accruals are adjusted periodically as additional information becomes available. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.
As a result of cost and availability factors, effective November 1, 2005, the Company ceased purchasing third-party product liability insurance. The Company has self insurance through a wholly-owned captive insurance company. In addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated.

Research and Development
Research and development expenses are expensed as incurred in accordance with ASC 730, Research and Development. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Amounts capitalized for such payments are included in other intangibles, net of accumulated amortization.
The Company enters into collaborative arrangements, typically with other pharmaceutical or biotechnology companies, to develop and commercialize drug candidates or intellectual property. These arrangements typically involve two (or more) parties who are active participants in the collaboration and are exposed to significant risks and rewards dependent on the commercial success of the activities. These collaborations usually involve various activities by one or more parties, including research and development, marketing and selling and distribution. Often, these collaborations require upfront, milestone and royalty or profit share payments, contingent upon the occurrence of certain future events linked to the success of the asset in development. Amounts due from collaborative partners related to development activities are generally reflected as a reduction of research and development expense because the performance of contract development services is not central to the Company’s operations. In general, the income statement presentation for these collaborations is as follows:

Nature/Type of Collaboration
 
Statement of Earnings Presentation
Third-party sale of product & profit share payments received
 
Sales to customers
Royalties/milestones paid to collaborative partner (post-regulatory approval)*
 
Cost of products sold
Royalties received from collaborative partner
 
Other income (expense), net
Upfront payments & milestones paid to collaborative partner (pre-regulatory approval)
 
Research and development expense
Research and development payments to collaborative partner
 
Research and development expense
Research and development payments received from collaborative partner
 
Reduction of Research and development expense
* 
Milestones are capitalized as intangible assets and amortized to cost of products sold over the useful life.
For all years presented, there was no individual project that represented greater than 5% of the total annual consolidated research and development expense.
The Company has a number of products and compounds developed in collaboration with strategic partners including XARELTO®, co-developed with Bayer HealthCare AG and IMBRUVICA®, developed in collaboration and co-marketed with Pharmacyclics LLC, an AbbVie company.
The Company has a number of licensing arrangements for products and compounds including DARZALEX®, licensed from Genmab A/S.
 
Advertising
Costs associated with advertising are expensed in the year incurred and are included in selling, marketing and administrative expenses. Advertising expenses worldwide, which comprised television, radio, print media and Internet advertising, were $2.6 billion, $2.5 billion and $2.4 billion in 2018, 2017 and 2016, respectively.
Income Taxes
Income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between U.S. GAAP accounting and tax reporting, recorded as deferred tax assets or liabilities. The Company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. Future changes in tax laws and rates may affect recorded deferred tax assets and liabilities in the future.
The Company has unrecognized tax benefits for uncertain tax positions. The Company follows U.S. GAAP which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management believes that changes in these estimates would not have a material effect on the Company's results of operations, cash flows or financial position.
In the fourth fiscal quarter of 2018, the Company has elected to account for the GILTI tax under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred.
The Company has recorded deferred tax liabilities on all undistributed earnings prior to December 31, 2017 from its international subsidiaries. The Company has not provided deferred taxes on the undistributed earnings subsequent to January 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. The Company intends to continue to reinvest these earnings in those international operations. If the Company decides at a later date to repatriate these earnings to the U.S., the Company would be required to provide for the net tax effects on these amounts. The Company estimates that the total tax effect of this repatriation would be approximately $0.7 billion under current enacted tax laws and regulations and at current currency exchange rates.
See Note 8 for further information regarding income taxes.
Net Earnings Per Share
Basic earnings per share is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, rebates, allowances and incentives, product liabilities, income taxes, withholding taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates.
The Company follows the provisions of U.S. GAAP when recording litigation related contingencies. A liability is recorded when a loss is probable and can be reasonably estimated. The best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.
Annual Closing Date
The Company follows the concept of a fiscal year, which ends on the Sunday nearest to the end of the month of December. Normally each fiscal year consists of 52 weeks, but every five or six years the fiscal year consists of 53 weeks, and therefore includes additional shipping days, as was the case in 2015, and will be the case again in 2020.
Reclassification
Certain prior period amounts have been reclassified to conform to current year presentation.
XML 32 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash, Cash Equivalents and Current Marketable Securities
 12 Months Ended
Dec. 30, 2018
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Current Marketable Securities
Cash, Cash Equivalents and Current Marketable Securities
At the end of 2018 and 2017, cash, cash equivalents and current marketable securities were comprised of:
(Dollars in Millions)
 
2018
 
 
Carrying Amount
 
 
Estimated Fair Value
 
Cash & Cash Equivalents
 
Current Marketable Securities
Cash
 
$
2,619

 
 
2,619

 
2,619

 
—

U.S. Reverse repurchase agreements
 
3,009

 
 
3,009

 
3,009

 
—

Other Reverse repurchase agreements
 
443

 
 
443

 
443

 
—

Money market funds
 
3,397

 
 
3,397

 
3,397

 
—

Time deposits(1)
 
485

 
 
485

 
485

 
—

    Subtotal
 
$
9,953

 
 
9,953

 
9,953

 
—

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gov't Securities
 
$
9,474

 
 
9,474

 
8,144

 
1,330

Corporate debt securities
 
260

 
 
260

 
10

 
250

   Subtotal available for sale(2)
 
$
9,734

 
 
9,734

 
8,154

 
1,580

 
 
 
 
 
 
 
 
 
 
Total cash, cash equivalents and current marketable securities
 


 
 
 
 
$
18,107

 
1,580



In 2018, the carrying amount was the same as the estimated fair value.
In 2017, the carrying amount was the same as the estimated fair value.
(Dollars in Millions)
 
2017
 
 
Carrying Amount
 
 
Estimated Fair Value
 
Cash & Cash Equivalents
 
Current Marketable Securities
Cash
 
$
2,929

 
 
2,929

 
2,929

 
—

Other Sovereign Securities(1)
 
279

 
 
279

 
219

 
60

U.S. Reverse repurchase agreements
 
4,025

 
 
4,025

 
4,025

 
—

Corporate debt securities(1)
 
289

 
 
289

 
244

 
45

Money market funds
 
4,288

 
 
4,288

 
4,288

 
—

Time deposits(1)
 
1,176

 
 
1,176

 
1,175

 
1

    Subtotal
 
$
12,986

 
 
12,986

 
12,880

 
106

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gov't Securities
 
$
4,864

 
 
4,864

 
4,833

 
31

Other Sovereign Securities
 
186

 
 
186

 
80

 
106

Corporate debt securities
 
260

 
 
260

 
31

 
229

   Subtotal available for sale(2)
 
$
5,310

 
 
5,310

 
4,944

 
366

 
 
 
 
 
 
 
 
 
 
Total cash, cash equivalents and current marketable securities
 
 
 
 
 
 
$
17,824

 
472


(1) Held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings.
(2) Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.
Fair value of government securities and obligations and corporate debt securities were estimated using quoted broker prices and significant other observable inputs.

The contractual maturities of the available for sale debt securities at December 30, 2018 are as follows:
(Dollars in Millions)
 
Cost Basis
 
Fair Value
Due within one year
 
$
9,670

 
9,670

Due after one year through five years
 
64

 
64

Due after five years through ten years
 
—

 
—

Total debt securities
 
$
9,734

 
9,734



The Company invests its excess cash in both deposits with major banks throughout the world and other high-quality money market instruments. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating.
XML 33 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories
 12 Months Ended
Dec. 30, 2018
Inventory Disclosure [Abstract]  
Inventories
Inventories
At the end of 2018 and 2017, inventories were comprised of:
(Dollars in Millions)
 
2018
 
2017
Raw materials and supplies
 
$
1,114

 
1,140

Goods in process
 
2,109

 
2,317

Finished goods
 
5,376

 
5,308

Total inventories
 
$
8,599

(1)
8,765


(1) Net of assets held for sale on the Consolidated Balance Sheet for approximately $0.2 billion related to the divestiture of the Advanced Sterilization Products business and $0.3 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.
XML 34 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property, Plant and Equipment
 12 Months Ended
Dec. 30, 2018
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Property, Plant and Equipment
At the end of 2018 and 2017, property, plant and equipment at cost and accumulated depreciation were:
(Dollars in Millions)
 
2018
 
2017
Land and land improvements
 
$
807

 
829

Buildings and building equipment
 
11,176

 
11,240

Machinery and equipment
 
25,992

 
25,949

Construction in progress
 
3,876

 
3,448

Total property, plant and equipment, gross
 
$
41,851

 
41,466

Less accumulated depreciation
 
24,816

 
24,461

Total property, plant and equipment, net
 
$
17,035

(1) 
17,005

(1) Net of assets held for sale on the Consolidated Balance Sheet for approximately $0.1 billion related to the divestiture of the Advanced Sterilization Products business and $0.1 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.

The Company capitalizes interest expense as part of the cost of construction of facilities and equipment. Interest expense capitalized in 2018, 2017 and 2016 was $86 million, $94 million and $102 million, respectively.
Depreciation expense, including the amortization of capitalized interest in 2018, 2017 and 2016 was $2.6 billion, $2.6 billion and $2.5 billion, respectively.
Upon retirement or other disposal of property, plant and equipment, the costs and related amounts of accumulated depreciation or amortization are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds are recorded in earnings.
XML 35 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets and Goodwill
 12 Months Ended
Dec. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill
Intangible Assets and Goodwill
At the end of 2018 and 2017, the gross and net amounts of intangible assets were:
(Dollars in Millions)
 
2018
 
2017
Intangible assets with definite lives:
 
 

 
 

Patents and trademarks — gross
 
$
35,194

 
36,427

Less accumulated amortization
 
9,784

 
7,223

Patents and trademarks — net
 
$
25,410

 
29,204

Customer relationships and other intangibles — gross
 
$
21,334

 
20,204

Less accumulated amortization
 
8,323

 
7,463

Customer relationships and other intangibles — net
 
$
13,011

 
12,741

Intangible assets with indefinite lives:
 
 

 
 

Trademarks
 
$
6,937

 
7,082

Purchased in-process research and development(1)
 
2,253

 
4,201

Total intangible assets with indefinite lives
 
$
9,190

 
11,283

Total intangible assets — net
 
$
47,611

 
53,228


(1) The decrease was primarily attributable to the write-down of $1.1 billion related to the assets acquired in the acquisitions of Alios Biopharma Inc. (Alios) and XO1 Limited (XO1). Of the $1.1 billion, the Company recorded a partial impairment charge of $0.8 billion related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios. The impairment charge was calculated based on updated cash flow projections discounted for the inherent risk in the asset development and reflects the impact of the phase 2b clinical trial suspension, a decrease in the probability of success factors and the ongoing analysis of asset development activities. In addition, an impairment charge of $0.3 billion was recorded for the discontinuation of the development project for an anti-thrombin antibody associated with the 2015 acquisition of XO1. Additionally, $0.8 billion of IPR&D related to ERLEADA™ was reclassified to definite lived intangible assets upon commercialization.







Goodwill as of December 30, 2018 and December 31, 2017, as allocated by segment of business, was as follows:
(Dollars in Millions)
 
Consumer
 
Pharmaceutical
 
Medical Devices
 
Total
Goodwill at January 1, 2017
 
$
8,263

 
2,840

 
11,702

 
22,805

Goodwill, related to acquisitions (1)
 
102

 
6,161

 
2,200

 
8,463

Goodwill, related to divestitures
 
(74
)
 
(1
)
 
(102
)
 
(177
)
Currency translation/other
 
584

 
109

 
122

 
815

Goodwill at December 31, 2017
 
$
8,875

 
9,109

 
13,922

 
31,906

Goodwill, related to acquisitions
 
168

 
51

 
184

 
403

Goodwill, related to divestitures
 
—

 
—

 
(1,348
)
(2) 
(1,348
)
Currency translation/other
 
(373
)
 
(97
)
 
(38
)
 
(508
)
Goodwill at December 30, 2018
 
$
8,670

 
9,063

 
12,720

 
30,453



(1) Goodwill of $6.2 billion related to the Actelion acquisition acquired in the fiscal second quarter of 2017, within the Pharmaceutical segment and $1.7 billion related to the AMO acquisition acquired in the fiscal first quarter of 2017, within the Medical Devices segment.
(2) Goodwill of $1.0 billion is related to the divestiture of the LifeScan business. Goodwill of $0.3 billion is related to the divestiture of the Advanced Sterilization Products business, which was pending and classified as assets held for sale on the Consolidated Balance Sheet as of December 30, 2018.

The weighted average amortization periods for patents and trademarks and customer relationships and other intangible assets are 11 years and 22 years, respectively. The amortization expense of amortizable assets included in cost of products sold was $4.4 billion, $3.0 billion and $1.2 billion before tax, for the fiscal years ended December 30, 2018, December 31, 2017 and January 1, 2017, respectively. The estimated amortization expense for the five succeeding years approximates $4.3 billion before tax, per year. Intangible asset write-downs are included in Other (income) expense, net.

See Note 20 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.
XML 36 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements
 12 Months Ended
Dec. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany products and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges.
Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings. These derivatives are designated as fair value hedges. The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges. Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities.
The Company early adopted ASU 2017-12: Targeted Improvements to Accounting for Hedge Activities effective as of the beginning of fiscal second quarter of 2018.
The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. During the fiscal second quarter of 2017, the Company entered into credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of December 30, 2018, the total amount of collateral paid under the credit support agreements (CSA) amounted to $182 million net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating. Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of December 30, 2018, the Company had notional amounts outstanding for forward foreign exchange contracts, cross currency interest rate swaps and interest rate swaps of $41.1 billion, $7.3 billion, and $0.5 billion respectively. As of December 31, 2017, the Company had notional amounts outstanding for forward foreign exchange contracts, cross currency interest rate swaps and interest rate swaps of $34.5 billion, $2.3 billion, and $1.1 billion respectively.

All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.
The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings.  Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings, and are then reclassified to earnings in the same account as the hedged transaction.
Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur. Gains and losses on net investment hedge are accounted through the currency translation account within accumulated other comprehensive income.  The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued.
During the fiscal second quarter of 2016, the Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates.
As of December 30, 2018, the balance of deferred net loss on derivatives included in accumulated other comprehensive income was $195 million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 13. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the next 12 months as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is 18 months, excluding interest rate contracts, net investment hedges and equity collar contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.
The following table is a summary of the activity related to derivatives and hedges for the fiscal years ended December 30, 2018 and December 31, 2017:
 
December 30, 2018
December 31, 2017
(Dollars in Millions)
Sales
Cost of Products Sold
R&D Expense
Interest (Income) Expense
Other (Income) Expense
Sales
Cost of Products Sold
R&D Expense
Interest (Income) Expense
Other (Income) Expense
The effects of fair value, net investment and cash flow hedging:
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on fair value hedging relationship:
 
 
 
 
 
 
 
 
 
 
Interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
 Hedged items
$
—

—

—

5

—

—

—

—

5

—

 Derivatives designated as hedging instruments
—

—

—

(5
)
—

—

—

—

(5
)
—

 
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on net investment hedging relationship:
 
 
 
 
 
 
 
 
 
 
Cross currency interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing
—

—

—

56

—

—

—

—

—

—

   Amount of gain or (loss) recognized in AOCI
—

—

—

56

—

—

—

—

—

—

 
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on cash flow hedging relationship:
 
 
 
 
 
 
 
 
 
 
Forward foreign exchange contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) reclassified from AOCI into income (1)
47

200

(220
)
—

(24
)
(31
)
(159
)
(165
)
—

(87
)
 
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) recognized in AOCI (1)
(32
)
(17
)
(193
)
—

(4
)
49

96

(199
)
—

(60
)
 
 
 
 
 
 
 
 
 
 
 
Cross currency interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) reclassified from AOCI into income
—

—

—

133

—

—

—

—

83

—

   Amount of gain or (loss) recognized in AOCI
$
—

—

—

117

—

—

—

—

110

—


(1) Includes equity collar contracts. The equity collar contracts expired in December of 2017.

 
 
 
 
 
 
 
 
 
 
 
 
 

For the fiscal years ended December 30, 2018 and December 31, 2017, the following amounts were recorded on the Consolidated Balance Sheet
Line item in the Consolidated Balance Sheet in which the hedged item is included
 
Carrying Amount of the Hedged Liability

 
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability
(Dollars in Millions)
 
December 30, 2018
 
December 31, 2017
 
December 30, 2018
 
December 31, 2017
Current Portion of Long-term Debt
 
$
494

 
597

 
5

 
2

Long-term Debt
 
—

 
496

 
—

 
3


The following table is the effect of derivatives not designated as hedging instrument for the fiscal years ended December 30, 2018 and December 31, 2017:
 
 
 
 
 
(Dollars in Millions)
 
Location of Gain /(Loss) Recognized in Income on Derivative
 
Gain/(Loss)
Recognized In
Income on Derivative
Derivatives Not Designated as Hedging Instruments
 
 
 
December 30, 2018
 
December 31, 2017
Foreign Exchange Contracts
 
Other (income) expense
 
(68
)
 
(5
)



The following table is the effect of net investment hedges for the fiscal years ended December 30, 2018 and December 31, 2017:
 
 
Gain/(Loss)
Recognized In
Accumulated OCI
 
Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income
 
Gain/(Loss) Reclassified From
Accumulated OCI
Into Income
(Dollars in Millions)
 
Fiscal Nine Months Ended
 
 
December 30, 2018
 
December 31, 2017
 
 
 
December 30, 2018
 
December 31, 2017
Debt
 
$
218

 
(597
)
 
Other (income) expense

 
—

 
—

Cross Currency interest rate swaps
 
$
150

 
—

 
Other (income) expense
 
—

 
—



The Company adopted ASU 2016-01: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities as of the beginning of the fiscal year 2018. This ASU amends prior guidance to classify equity investments with readily determinable market values into different categories (that is, trading or available-for-sale) and require equity investments to be measured at fair value with changes in fair value recognized through net earnings. The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 which increased retained earnings by $232 million, net of tax, and decreased accumulated other comprehensive income for previously net unrealized gains from equity investments.
The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
The following table is a summary of the activity related to equity investments as of December 30, 2018:
(Dollars in Millions)
 
December 31, 2017
 
 
 
 
 
December 30, 2018
 
 
 
 
Carrying Value
 
Changes in Fair Value Reflected in Net Income (1)
 
Sales/ Purchases/Other (2)
 
Carrying Value
 
Non Current Other Assets
Equity Investments with readily determinable value
 
$
751

 
(247
)
 
7

 
511

 
511

 
 
 
 
 
 
 
 
 
 
 
Equity Investments without readily determinable value
 
$
510

 
13

 
158

 
681

 
681

(1) Recorded in Other Income/Expense
(2) Other includes impact of currency

For equity investments without readily determinable market values, $54 million of the changes in fair value reflected in net income were the result of impairments. There were $67 million of changes in fair value reflected in net income due to changes in observable prices.

For the fiscal years ended December 31, 2017, changes in fair value reflected within other comprehensive income due to previously unrealized gains on equity investments with readily determinable fair values net of tax was a net gain of $232 million.

Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 having the highest priority and Level 3 having the lowest.

The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company’s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company did not have any other significant financial assets or liabilities which would require revised valuations under this standard that are recognized at fair value.

The following three levels of inputs are used to measure fair value:
Level 1 — Quoted prices in active markets for identical assets and liabilities.
Level 2 — Significant other observable inputs.
Level 3 — Significant unobservable inputs.


The Company’s significant financial assets and liabilities measured at fair value as of December 30, 2018 and December 31, 2017 were as follows:
 
 
2018
 
2017
(Dollars in Millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total (1)
Derivatives designated as hedging instruments:
 
 

 
 

 
 

 
 

 
 

Assets:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
$
—

 
501

 
—

 
501

 
418

Interest rate contracts (2)(4)
 
—

 
161

 
—

 
161

 
7

Total
 
—

 
662

 
—

 
662

 
425

Liabilities:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
548

 
—

 
548

 
402

Interest rate contracts (3)(4)
 
—

 
292

 
—

 
292

 
165

Total
 
—

 
840

 
—

 
840

 
567

Derivatives not designated as hedging instruments:
 
 

 
 

 
 

 
 

 
 

Assets:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
32

 
—

 
32

 
38

Liabilities:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
32

 
—

 
32

 
38

Available For Sale Other Investments:
 
 
 
 
 
 
 
 
 
 
Equity investments(5)
 
511

 
—

 
—

 
511

 
751

Debt securities(6)
 
$
—

 
9,734

 
—

 
9,734

 
5,310



Gross to Net Derivative Reconciliation
 
2018
 
2017
(Dollars in Millions)
 
 
 
 
Total Gross Assets
 
$
694

 
463

Credit Support Agreement (CSA)
 
(423
)
 
(76
)
Total Net Asset
 
271

 
387

 
 
 
 
 
Total Gross Liabilities
 
872

 
605

Credit Support Agreement (CSA)
 
(605
)
 
(238
)
Total Net Liabilities
 
$
267

 
367

 
 
 
 
 


(1) 
2017 assets and liabilities are all classified as Level 2 with the exception of equity investments of $751 million, which are classified as Level 1.
(2) 
Includes $6 million and $7 million of non-current assets for the fiscal years ending December 30, 2018 and December 31, 2017, respectively.
(3) 
Includes $3 million and $9 million of non-current liabilities for the fiscal years ending December 30, 2018 and December 31, 2017, respectively.
(4) 
Includes cross currency interest rate swaps and interest rate swaps.
(5) 
Classified as non-current other assets. The carrying amount of the equity investments were $511 million and $751 million as of December 30, 2018 and December 31, 2017, respectively.
(6) 
Classified as cash equivalents and current marketable securities.

See Notes 2 and 7 for financial assets and liabilities held at carrying amount on the Consolidated Balance Sheet.
XML 37 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Borrowings
 12 Months Ended
Dec. 30, 2018
Debt Disclosure [Abstract]  
Borrowings
Borrowings
The components of long-term debt are as follows:
(Dollars in Millions)
 
2018
  
Effective Rate %
  
2017
  
Effective Rate %
 
5.15% Debentures due 2018
 
$
—

  


  
900

  
5.18
 
1.65% Notes due 2018
 
—

 


 
597

 
1.70
 
4.75% Notes due 2019 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)
 
1,139

(2) 
5.83

  
1,192

(3) 
5.83
 
1.875% Notes due 2019
 
494

 
1.93

 
496

 
1.93
 
0.89% Notes due 2019
 
300

 
1.32

 
300

 
1.75
 
1.125% Notes due 2019
 
699

 
1.13

 
699

 
1.13
 
3% Zero Coupon Convertible Subordinated Debentures due 2020
 
51

  
3.00

  
60

  
3.00
 
2.95% Debentures due 2020
 
548

  
3.15

  
547

  
3.15
 
1.950% Notes due 2020
 
499

 
1.99

 
499

 
1.99
 
3.55% Notes due 2021
 
449

 
3.67

 
448

 
3.67
 
2.45% Notes due 2021
 
349

 
2.48

 
349

 
2.48
 
1.65% Notes due 2021
 
998

 
1.65

 
998

 
1.65
 
0.250% Notes due 2022 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)
 
1,137

(2) 
0.26

 
1,191

(3) 
0.26
 
2.25% Notes due 2022
 
996

 
2.31

 
995

 
2.31
 
6.73% Debentures due 2023
 
250

  
6.73

  
250

  
6.73
 
3.375% Notes due 2023
 
805

 
3.17

 
806

 
3.17
 
2.05% Notes due 2023
 
498

 
2.09

 
498

 
2.09
 
0.650% Notes due 2024 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)
 
851

(2) 
0.68

 
891

(3) 
0.68
 
5.50% Notes due 2024 (500MM GBP 1.2636)(2)/(500MM GBP 1.3444)(3)
 
627

(2) 
6.75

  
666

(3) 
6.75
 
2.625% Notes due 2025
 
748

 
2.63

 
747

 
2.63
 
2.45% Notes due 2026
 
1,992

 
2.47

 
1,990

 
2.47
 
2.95% Notes due 2027
 
996

 
2.96

 
995

 
2.96
 
1.150% Notes due 2028 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)
 
847

(2) 
1.21

 
887

(3) 
1.21
 
2.900% Notes due 2028
 
1,493

 
2.91

 
1,492

 
2.91
 
6.95% Notes due 2029
 
297

  
7.14

  
296

  
7.14
 
4.95% Debentures due 2033
 
498

  
4.95

  
498

  
4.95
 
4.375% Notes due 2033
 
856

 
4.24

 
856

 
4.24
 
1.650% Notes due 2035 (1.5B Euro 1.14)(2)/(1.5B Euro 1.1947)(3)
 
1,693

(2) 
1.68

 
1,774

(3) 
1.68
 
3.55% Notes due 2036
 
988

 
3.59

 
987

 
3.59
 
5.95% Notes due 2037
 
991

  
5.99

  
991

  
5.99
 
3.625% Notes due 2037
 
1,486

 
3.64

 
1,486

 
3.64
 
5.85% Debentures due 2038
 
696

  
5.85

  
696

  
5.85
 
3.400% Notes due 2038
 
990

 
3.42

 
990

 
3.42
 
4.50% Debentures due 2040
 
538

  
4.63

  
538

  
4.63
 
4.85% Notes due 2041
 
297

 
4.89

 
296

 
4.89
 
4.50% Notes due 2043
 
495

 
4.52

 
495

 
4.52
 
3.70% Notes due 2046
 
1,972

 
3.74

 
1,971

 
3.74
 
3.75% Notes due 2047
 
991

 
3.76

 
990

 
3.76
 
3.500% Notes due 2048
 
742

 
3.52

 
742

 
3.52
 
Other
 
24

  
—

  
75

  
—
 
Subtotal
 
30,320

(4) 
3.19
%
(1) 
32,174

(4) 
3.19
(1 
) 
Less current portion
 
2,636

  
 

  
1,499

  
 
 
Total long-term debt
 
$
27,684

  
 

  
30,675

  
 
 

(1) 
Weighted average effective rate.
(2) 
Translation rate at December 30, 2018.
(3) 
Translation rate at December 31, 2017.
(4) 
The excess of the fair value over the carrying value of debt was $0.3 billion in 2018 and $2.0 billion in 2017.

Fair value of the long-term debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.(Level 2)
The Company has access to substantial sources of funds at numerous banks worldwide. In September 2018, the Company secured a new 364-day Credit Facility. Total credit available to the Company approximates $10 billion, which expires on September 12, 2019. Interest charged on borrowings under the credit line agreements is based on either bids provided by banks, the prime rate or London Interbank Offered Rates (LIBOR), plus applicable margins. Commitment fees under the agreements are not material.
Throughout 2018, the Company continued to have access to liquidity through the commercial paper market. Short-term borrowings and the current portion of long-term debt amounted to approximately $2.8 billion at the end of 2018, of which $2.6 billion is the current portion of the long term debt, and the remainder principally represents local borrowing by international subsidiaries.
Throughout 2017, the Company continued to have access to liquidity through the commercial paper market. Short-term borrowings and the current portion of long-term debt amounted to approximately $3.9 billion at the end of 2017, of which $2.3 billion was borrowed under the Commercial Paper Program, $1.5 billion is the current portion of the long-term debt, and the remainder principally represents local borrowing by international subsidiaries.

Aggregate maturities of long-term obligations commencing in 2019 are:
(Dollars in Millions)
 
 
 
 
 
 
 
 
2019
 
2020
 
2021
 
2022
 
2023
 
After 2023
$2,636
 
1,098
 
1,796
 
2,134
 
1,553
 
21,103
XML 38 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
 12 Months Ended
Dec. 30, 2018
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
The provision for taxes on income consists of:
(Dollars in Millions)
 
2018
 
2017
 
2016
Currently payable:
 
 
 
 
 
 
U.S. taxes
 
$
1,081

 
11,969

 
1,896

U.S. taxes on international operations
 
203

 
126

 
49

International taxes
 
2,434

 
1,872

 
1,659

Total currently payable
 
3,718

 
13,967

 
3,604

Deferred:
 
 
 
 
 
 
U.S. taxes
 
(148
)
 
(1,956
)
 
294

U.S. taxes on international operations
 
1,358

 
 
 
 
International taxes
 
(2,226
)
 
4,362

 
(635
)
Total deferred
 
(1,016
)
 
2,406

 
(341
)
Provision for taxes on income
 
$
2,702

 
16,373

 
3,263



A comparison of income tax expense at the U.S. statutory rate of 21% in 2018 and 35% in 2017 and 2016, to the Company’s effective tax rate is as follows:
(Dollars in Millions)
 
2018
 
2017
 
2016
U.S. 
 
$
5,575

 
4,865

 
7,457

International
 
12,424

 
12,808

 
12,346

Earnings before taxes on income:
 
$
17,999

 
17,673

 
19,803

Tax rates:
 
 
 
 
 
 
U.S. statutory rate
 
21.0
 %
 
35.0

 
35.0

International operations (1)
 
(3.7
)
 
(12.8
)
 
(17.2
)
Research and orphan drug tax credits
 
(1.0
)
 
(0.4
)
 
(0.4
)
U.S. state and local
 
0.8

 
0.6

 
(0.1
)
U.S. manufacturing deduction
 
—

 
(0.8
)
 
(0.6
)
U.S. tax on international income (2)
 
1.4

 
0.7

 
1.3

Tax benefits on share-based compensation
 
(1.5
)
 
(2.1
)
 
(1.8
)
U.S. tax benefit on asset/business disposals
 
0.5

 
(0.8
)
 
—

All other
 
(0.6
)
 
(0.1
)
 
0.3

TCJA and related impacts (3)
 
(1.9
)
(3) 
73.3

(4) 
—

Effective Rate
 
15.0
 %
 
92.6

 
16.5



(1) For all periods presented the Company has subsidiaries operating in Puerto Rico under various tax incentives. International operations reflects the impacts of operations in jurisdictions with statutory tax rates different than the U.S., particularly Ireland, Switzerland and Puerto Rico, which is a favorable impact on the effective tax rate as compared with the U.S. statutory rate. The 2017 amount also includes tax cost related to the revaluation of deferred tax balances related to the change in the Belgian statutory tax rate increasing the tax provision by approximately 3.4%.
(2) Includes the impact of the GILTI tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.
(3) Represents impact of adjustments to the 2017 TCJA provisional tax charge. This also includes a net tax benefit from the reduction of a deferred tax liability related to foreign withholding taxes originally accrued as part of the provisional charge. This benefit reduced the Company’s effective tax rate by approximately 11%. Further description is included below.
(4) Includes U.S. state and local taxes provisionally recorded as part TCJA provisional charge which was approximately 0.6% of the total effective tax rate.

On December 22, 2017, the United States enacted into law new U.S. tax legislation, the Tax Cuts and Jobs Act (TCJA).
This law included provisions for a comprehensive overhaul of the corporate income tax code, including a reduction of the statutory corporate tax rate from 35% to 21%, effective on January 1, 2018. This legislation also eliminated or reduced certain corporate income tax deductions as well as introduced new provisions that taxed certain foreign income not previously taxed by the United States. The TCJA also included a provision for a tax on all previously undistributed earnings of U.S. companies located in foreign jurisdictions. Undistributed earnings in the form of cash and cash equivalents were taxed at a rate of 15.5% and all other earnings are taxed at a rate of 8.0%. This tax is payable over 8 years and will not accrue interest and these payments began in 2018 and will continue through 2025. The remaining balance at the end of the fiscal year 2018 was approximately $8.2 billion.

In December 2017, the SEC provided regulatory guidance for accounting of the impacts of the TCJA, referred to as SAB 118. Under the guidance in SAB 118, the income tax effects, which the accounting under ASC 740 is incomplete, are reported as a provisional amount based on a reasonable estimate. The reasonable estimate is subject to adjustment during a "measurement period", not to exceed one year, until the accounting is complete. The estimate is also subject to the finalization of management’s analysis related to certain matters, such as developing interpretations of the provision of the TCJA, changes to certain estimates and amounts related to the earnings and profits of certain subsidiaries and the filing of tax returns.
In the fourth quarter of 2017, the Company recorded a provisional tax cost of approximately $13.0 billion which consisted primarily of the following components:

•
a $10.1 billion charge on previously undistributed foreign earnings as of December 31, 2017
•
a $4.5 billion deferred tax liability for foreign local and withholding taxes, offset by a $1.1 billion deferred tax asset for U.S. foreign tax credits, for repatriation of substantially all those earnings
•
a $0.6 billion tax benefit relating to the remeasurement of U.S. deferred tax assets and liabilities and the impact of the TCJA on unrecognized tax benefits
•
a $0.1 billion charge for U.S. state and local taxes on the repatriation of these foreign earnings

During the fourth quarter of 2018, the Company completed its full assessment and finalized the accounting for the impact of TCJA. The Company recorded net adjustments to the above components of the provisional charge of approximately $0.2 billion. These revisions were based on updated estimates and additional analysis by management as well as applying interpretative guidance issued by the U.S. Department of Treasury to the facts and circumstances that existed as of the TCJA enactment date. This charge was primarily related to additional deferred tax liabilities for foreign local and withholding taxes for the remaining balance of undistributed foreign earnings as of December 31, 2017 that were not provided for in the provisional charge in the fourth quarter of 2017.

The TCJA also includes provisions for a tax on global intangible low-taxed income (GILTI). GILTI is described as the excess of a U.S. shareholder’s total net foreign income over a deemed return on tangible assets, as provided by the TCJA. In January 2018, the FASB issued guidance that allows companies to elect as an accounting policy whether to record the tax effects of GILTI in the period the tax liability is generated (i.e., “period cost”) or provide for deferred tax assets and liabilities related to basis differences that exist and are expected to effect the amount of GILTI inclusion in future years upon reversal (i.e., “deferred method”). Through the third fiscal quarter of 2018, the Company had provisionally elected to treat GILTI as a period expense. Upon further analysis of this new tax provision, the Company has elected to account for GILTI under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred. As a result of this election, the Company recorded a deferred tax cost related to GILTI of approximately $1.4 billion in the fourth fiscal quarter of 2018 related to facts and circumstances that existed on the date of TCJA enactment.
As a result of the GILTI deferred tax charge and the other adjustments to the provisional amount, the Company recorded a total of $1.6 billion of adjustments to the 2017 provisional charge increasing the Company’s annual effective tax rate by approximately 9%.

During 2018, the Company reorganized the ownership structure of certain foreign subsidiaries which resulted in a reduction of certain foreign withholding taxes that it had recognized as part of the provisional TCJA tax charge in the fourth quarter of 2017. Following the completion of this restructuring in the fourth quarter 2018, and as a result of clarification by Swiss tax authorities regarding the applicability of withholding tax to repatriation of certain earnings, the Company reversed a deferred tax liability of $2.8 billion and a related deferred tax asset of $0.9 billion for U.S. foreign tax credits, for a net deferred tax benefit of $1.9 billion. As this restructuring occurred after the TCJA enactment date, the benefit is not considered an adjustment to the provisional amount recorded in 2017 under SAB118. This benefit with the SAB 118 adjustments has been reflected as “TCJA and related impacts” on the Company’s effective tax rate reconciliation.

As described in Note 1 to the Consolidated Financial Statements, in 2018 the Company adopted ASU 2016-16: Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory. This standard requires entities to recognize deferred tax assets and liabilities related to transfer of assets, other than inventory, within the consolidated entity. At the beginning of fiscal 2018, the Company recorded a net adjustment to deferred tax assets of approximately $2.0 billion. In the fourth quarter of 2018, as a result of the election to record GILTI on the deferred method, the Company recorded a GILTI deferred tax liability of $1.7 billion related to the adoption provisions of ASU 2016-16 as an adjustment to retained earnings.

The 2018 effective tax rate decreased by 77.6% compared to 2017. The 2017 effective tax rate was primarily driven by the approximately $13 billion provisional tax charge recorded in the fourth quarter of 2017 and the impact of a Belgian statutory tax rate change which increased the 2017 effective rate by 3.4%. Additional drivers of the 2018 annual effective tax were:
•
the reduction of the U.S. statutory corporate tax rate including the effects of tax elections which resulted in the acceleration of certain deductions into the 2017 tax return. The impact of these accelerated deductions decreased the annual effective tax rate by approximately 1.7%
•
the impact of the adjustments to the 2017 provisional TCJA charge, including both SAB 118 adjustments and the internal restructuring, decreased the effective tax rate by approximately 1.9%
•
GILTI tax which increased the annual effective tax rate by approximately 1.6%, which excludes the impact of the SAB 118 adjustment for the adoption of the deferred method for GILTI
•
tax benefits received from stock-based compensation during fiscal 2018 and 2017, reduced the effective tax rate by 1.5% and 2.0%, respectively
•
in the fourth quarter of 2018, the Company completed the divestiture of its LifeScan business (Note 20), which increased the Company annual effective tax rate by approximately 0.8%
•
more income in higher tax jurisdictions relative to lower tax jurisdictions as compared to 2017

The 2017 effective tax rate increased by 76.1% as compared to 2016, primarily driven by the enactment of the TCJA in the U.S. in December 2017. The enactment of the TCJA resulted in a provisional tax charge in the fourth quarter of 2017, of approximately $13.0 billion or approximately 73.3 percentage point increase to the effective tax rate.
The remainder of the increase in the tax rate for 2017 was related to the remeasurement of the Company’s deferred tax assets in Belgium, as a result of changes in the Belgian statutory corporate tax rate enacted in December 2017, offset by a tax benefit for the closure of the Company’s Animas insulin pump business.


Temporary differences and carryforwards for 2018 and 2017 were as follows:
 
 
2018 Deferred Tax
 
2017 Deferred Tax
(Dollars in Millions)
 
Asset
 
Liability
 
Asset
 
Liability
Employee related obligations
 
$
2,398

 


 
2,259

 


Stock based compensation
 
639

 


 
507

 


Depreciation & amortization
 
1,784

 


 


 
(9
)
Non-deductible intangibles
 


 
(5,967
)
 


 
(6,506
)
International R&D capitalized for tax
 
1,282

 


 
1,307

 


Reserves & liabilities
 
1,647

 


 
1,718

 


Income reported for tax purposes
 
1,104

 


 
1,316

 


Net operating loss carryforward international
 
786

 


 
762

 


Undistributed foreign earnings
 
693

 
(2,240
)
 
1,101

 
(4,457
)
Global intangible low-taxed income
 
 
 
(2,971
)
 
 
 
 
Miscellaneous international
 
603

 
(93
)
 
755

 
(194
)
Miscellaneous U.S. 
 
469

 


 
177

 


Total deferred income taxes
 
$
11,405

 
(11,271
)
 
9,902

 
(11,166
)


The Company has wholly-owned international subsidiaries that have cumulative net losses. The Company believes that it is more likely than not that these subsidiaries will generate future taxable income sufficient to utilize these deferred tax assets.
The following table summarizes the activity related to unrecognized tax benefits:
(Dollars in Millions)
 
2018
 
2017
 
2016
Beginning of year
 
$
3,151

 
3,041

 
3,080

Increases related to current year tax positions
 
242

 
332

 
348

Increases related to prior period tax positions
 
145

 
232

 
11

Decreases related to prior period tax positions
 
(137
)
 
(416
)
(1)
(338
)
Settlements
 
(40
)
 
(2
)
 
(37
)
Lapse of statute of limitations
 
(35
)
 
(36
)
 
(23
)
End of year
 
$
3,326

 
3,151

 
3,041


(1) In 2017, $347 million of this decrease is related to the TCJA

The unrecognized tax benefits of $3.3 billion at December 30, 2018, if recognized, would affect the Company’s annual effective tax rate. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress with a number of tax authorities. The IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010-2012. The Company currently expects completion of this audit during 2019. Final conclusion of the tax audit may result in an outcome that is different than the Company’s estimates and may result in a material impact on the Company’s current and future operating results or cash flows in the period that the audit is concluded. In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that audits may be completed by tax authorities in some jurisdictions over the next twelve months.  However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.

The Company classifies liabilities for unrecognized tax benefits and related interest and penalties as long-term liabilities. Interest expense and penalties related to unrecognized tax benefits are classified as income tax expense. The Company recognized after tax interest expense of $53 million, $60 million and $7 million in 2018, 2017 and 2016, respectively. The total amount of accrued interest was $503 million and $436 million in 2018 and 2017, respectively.
XML 39 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Related Obligations
 12 Months Ended
Dec. 30, 2018
Compensation Related Costs [Abstract]  
Employee Related Obligations
Employee Related Obligations
At the end of 2018 and 2017, employee related obligations recorded on the Consolidated Balance Sheets were:
(Dollars in Millions)
 
2018
 
2017
Pension benefits
 
$
5,327

 
5,343

Postretirement benefits
 
2,283

 
2,331

Postemployment benefits
 
2,330

 
2,250

Deferred compensation
 
410

 
475

Total employee obligations
 
10,350

 
10,399

Less current benefits payable
 
399

 
325

Employee related obligations — non-current
 
$
9,951

 
10,074


Prepaid employee related obligations of $475 million and $526 million for 2018 and 2017, respectively, are included in Other assets on the Consolidated Balance Sheets.
XML 40 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans
 12 Months Ended
Dec. 30, 2018
Retirement Benefits [Abstract]  
Pensions and Other Benefit Plans
Pensions and Other Benefit Plans
The Company sponsors various retirement and pension plans, including defined benefit, defined contribution and termination indemnity plans, which cover most employees worldwide. The Company also provides post-retirement benefits, primarily health care, to all eligible U.S. retired employees and their dependents.
Many international employees are covered by government-sponsored programs and the cost to the Company is not significant.
Retirement plan benefits for employees hired before January 1, 2015 are primarily based on the employee’s compensation during the last three to five years before retirement and the number of years of service. In 2014, the Company announced that the U.S. Defined Benefit Plan was amended to adopt a new benefit formula, effective for employees hired on or after January 1, 2015. The benefits are calculated using a new formula based on employee compensation over total years of service.
International subsidiaries have plans under which funds are deposited with trustees, annuities are purchased under group contracts, or reserves are provided.
The Company does not typically fund retiree health care benefits in advance, but may do so at its discretion. The Company also has the right to modify these plans in the future.
In 2018 and 2017 the Company used December 31, 2018 and December 31, 2017, respectively, as the measurement date for all U.S. and international retirement and other benefit plans.
Net periodic benefit costs for the Company’s defined benefit retirement plans and other benefit plans for 2018, 2017 and 2016 include the following components:
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Service cost
 
$
1,283

 
1,080

 
949

 
269

 
247

 
224

Interest cost
 
996

 
927

 
927

 
148

 
159

 
158

Expected return on plan assets
 
(2,212
)
 
(2,041
)
 
(1,962
)
 
(7
)
 
(6
)
 
(6
)
Amortization of prior service cost (credit)
 
3

 
2

 
1

 
(31
)
 
(30
)
 
(34
)
Recognized actuarial losses
 
852

 
609

 
496

 
123

 
138

 
135

Curtailments and settlements
 
1

 
17

 
11

 
—

 
—

 
—

Net periodic benefit cost
 
$
923

 
594

 
422

 
502

 
508

 
477



In 2018, as per the adoption of ASU 2017-07, the service cost component of net periodic benefit cost was presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.








Amounts expected to be recognized in net periodic benefit cost in the coming year for the Company’s defined benefit retirement plans and other post-retirement plans:
(Dollars in Millions)
 
Amortization of net transition obligation
$
—

Amortization of net actuarial losses
656

Amortization of prior service credit
27



Unrecognized gains and losses for the U.S. pension plans are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses for the other U.S. benefit plans is determined by using a 10% corridor of the greater of the market value of assets or the accumulated postretirement benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.
Prior service costs/benefits for the U.S. pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment. Prior service cost/benefit for the other U.S. benefit plans is amortized over the average remaining service to full eligibility age of plan participants at the time of the plan amendment.

The following table represents the weighted-average actuarial assumptions:
 
 
Retirement Plans
 
Other Benefit Plans
Worldwide Benefit Plans
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Net Periodic Benefit Cost
 
 
 
 
 
 
 
 
 
 
 
 
Service cost discount rate
 
3.20
%
 
3.59
 
3.98
 
3.85
 
4.63
 
4.77
Interest cost discount rate
 
3.60
%
 
3.98
 
4.24
 
3.62
 
3.94
 
4.10
Rate of increase in compensation levels
 
3.98
%
 
4.01
 
4.02
 
4.29
 
4.31
 
4.32
Expected long-term rate of return on plan assets
 
8.46
%
 
8.43
 
8.55
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Benefit Obligation
 
 
 
 
 
 
 
 
 
 
 
 
Discount rate
 
3.76
%
 
3.30
 
3.78
 
4.40
 
3.78
 
4.42
Rate of increase in compensation levels
 
3.97
%
 
3.99
 
4.02
 
4.29
 
4.30
 
4.29


The Company’s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In the fiscal year 2016, the Company changed its methodology in determining service and interest cost from the single weighted average discount rate approach to duration specific spot rates along that yield curve to the plans’ liability cash flows, which management has concluded is a more precise estimate. Prior to this change in methodology, the Company measured service and interest costs utilizing a single weighted-average discount rate derived from the yield curve used to measure the plan obligations. The Company has accounted for this change as a change in accounting estimate and, accordingly, has accounted for it on a prospective basis. This change does not impact the benefit obligation and did not have a material impact to the 2016 full year results.
The expected rates of return on plan asset assumptions represent the Company's assessment of long-term returns on diversified investment portfolios globally. The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.













The following table displays the assumed health care cost trend rates, for all individuals:
Health Care Plans
 
2018
 
2017
Health care cost trend rate assumed for next year
 
6.12
%
 
6.33
%
Rate to which the cost trend rate is assumed to decline (ultimate trend)
 
4.55
%
 
4.55
%
Year the rate reaches the ultimate trend rate
 
2038

 
2038




A one-percentage-point change in assumed health care cost trend rates would have the following effect:
 
 
One-Percentage-
 
One-Percentage-
(Dollars in Millions)
 
Point Increase
 
Point Decrease
Health Care Plans
 
 

 
 

Total interest and service cost
 
$
28

 
(22
)
Post-retirement benefit obligation
 
$
340

 
(280
)


The following table sets forth information related to the benefit obligation and the fair value of plan assets at year-end 2018 and 2017 for the Company’s defined benefit retirement plans and other post-retirement plans:
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
Change in Benefit Obligation
 
 
 
 
 
 
 
 
Projected benefit obligation — beginning of year
 
$
33,221

 
28,116

 
4,582

 
4,605

Service cost
 
1,283

 
1,080

 
269

 
247

Interest cost
 
996

 
927

 
148

 
159

Plan participant contributions
 
66

 
60

 
—

 
—

Amendments
 
26

 
(7
)
 
—

 
(17
)
Actuarial (gains) losses
 
(2,326
)
 
2,996

 
(119
)
 
(166
)
Divestitures & acquisitions
 
(29
)
 
201

 
—

 
88

Curtailments, settlements & restructuring
 
(21
)
 
(35
)
 
—

 
2

Benefits paid from plan
 
(1,018
)
 
(1,050
)
 
(383
)
 
(351
)
Effect of exchange rates
 
(528
)
 
933

 
(17
)
 
15

Projected benefit obligation — end of year
 
$
31,670

 
33,221

 
4,480

 
4,582

Change in Plan Assets
 
 
 
 
 
 
 
 
Plan assets at fair value — beginning of year
 
$
28,404

 
23,633

 
281

 
75

Actual return on plan assets
 
(1,269
)
 
4,274

 
—

 
12

Company contributions
 
1,140

 
664

 
282

 
545

Plan participant contributions
 
66

 
60

 
—

 
—

Settlements
 
(13
)
 
(32
)
 
—

 
—

Divestitures & acquisitions
 
(17
)
 
173

 
—

 
—

Benefits paid from plan assets
 
(1,018
)
 
(1,050
)
 
(383
)
 
(351
)
Effect of exchange rates
 
(475
)
 
682

 
—

 
—

Plan assets at fair value — end of year
 
$
26,818

 
28,404

 
180

 
281

Funded status — end of year
 
$
(4,852
)
 
(4,817
)
 
(4,300
)
 
(4,301
)
Amounts Recognized in the Company’s Balance Sheet consist of the following:
 
 
 
 
 
 
 
 
Non-current assets
 
$
475

 
526

 
—

 
—

Current liabilities
 
(98
)
 
(92
)
 
(281
)
 
(228
)
Non-current liabilities
 
(5,229
)
 
(5,251
)
 
(4,019
)
 
(4,073
)
Total recognized in the consolidated balance sheet — end of year
 
$
(4,852
)
 
(4,817
)
 
(4,300
)
 
(4,301
)
Amounts Recognized in Accumulated Other Comprehensive Income consist of the following:
 
 
 
 
 
 
 
 
Net actuarial loss
 
$
8,323

 
8,140

 
1,263

 
1,500

Prior service cost (credit)
 
2

 
(25
)
 
(106
)
 
(137
)
Unrecognized net transition obligation
 
—

 
—

 
—

 
—

Total before tax effects
 
$
8,325

 
8,115

 
1,157

 
1,363

 
 
 
 
 
 
 
 
 
Accumulated Benefit Obligations — end of year
 
$
28,533

 
29,793

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
Amounts Recognized in Net Periodic Benefit Cost and Other Comprehensive Income
 
 
 
 
 
 
 
 
Net periodic benefit cost
 
$
923

 
594

 
502

 
508

Net actuarial (gain) loss
 
1,153

 
740

 
(111
)
 
(169
)
Amortization of net actuarial loss
 
(852
)
 
(609
)
 
(123
)
 
(138
)
Prior service cost (credit)
 
26

 
(7
)
 
—

 
(17
)
Amortization of prior service (cost) credit
 
(3
)
 
(2
)
 
31

 
30

Effect of exchange rates
 
(114
)
 
256

 
(3
)
 
3

Total loss/(income) recognized in other comprehensive income, before tax
 
$
210

 
378

 
(206
)
 
(291
)
Total recognized in net periodic benefit cost and other comprehensive income
 
$
1,133

 
972

 
296

 
217



The Company plans to continue to fund its U.S. Qualified Plans to comply with the Pension Protection Act of 2006. International Plans are funded in accordance with local regulations. Additional discretionary contributions are made when deemed appropriate to meet the long-term obligations of the plans. For certain plans, funding is not a common practice, as funding provides no economic benefit. Consequently, the Company has several pension plans that are not funded.
In 2018, the Company contributed $679 million and $461 million to its U.S. and international pension plans, respectively.
The following table displays the funded status of the Company's U.S. Qualified & Non-Qualified pension plans and international funded and unfunded pension plans at December 31, 2018 and December 31, 2017, respectively:

 
U.S. Plans
International Plans
 
Qualified Plans
Non-Qualified Plans
Funded Plans
Unfunded Plans
(Dollars in Millions)
2018
2017
2018
2017
2018
2017
2018
2017
Plan Assets
$
17,725

18,681

—

—

9,093

9,723

—

—

Projected Benefit Obligation
18,609

19,652

2,176

2,257

10,467

10,863

418

449

Accumulated Benefit Obligation
16,851

17,654

1,793

1,849

9,510

9,893

379

397

Over (Under) Funded Status
 
 
 
 
 
 
 
 
Projected Benefit Obligation
$
(884
)
(971
)
(2,176
)
(2,257
)
(1,374
)
(1,140
)
(418
)
(449
)
Accumulated Benefit Obligation
874

1,027

(1,793
)
(1,849
)
(417
)
(170
)
(379
)
(397
)

Plans with accumulated benefit obligations in excess of plan assets have an accumulated benefit obligation, projected benefit obligation and plan assets of $7.5 billion, $8.8 billion and $4.3 billion, respectively, at the end of 2018, and $3.8 billion, $4.6 billion and $0.7 billion, respectively, at the end of 2017.

The following table displays the projected future benefit payments from the Company’s retirement and other benefit plans:
(Dollars in Millions)
 
2019
 
2020
 
2021
 
2022
 
2023
 
2024-2028
Projected future benefit payments
 
 
 
 
 
 
 
 
 
 
 
 
Retirement plans
 
$
1,062

 
1,104

 
1,182

 
1,257

 
1,332

 
7,679

Other benefit plans 
 
$
375

 
397

 
411

 
428

 
413

 
2,273



The following table displays the projected future minimum contributions to the unfunded retirement plans. These amounts do not include any discretionary contributions that the Company may elect to make in the future.
(Dollars in Millions)
 
2019
 
2020
 
2021
 
2022
 
2023
 
2024-2028
Projected future contributions
 
$
92

 
95

 
101

 
108

 
115

 
697




Each pension plan is overseen by a local committee or board that is responsible for the overall administration and investment of the pension plans. In determining investment policies, strategies and goals, each committee or board considers factors including, local pension rules and regulations; local tax regulations; availability of investment vehicles (separate accounts, commingled accounts, insurance funds, etc.); funded status of the plans; ratio of actives to retirees; duration of liabilities; and other relevant factors including: diversification, liquidity of local markets and liquidity of base currency. A majority of the Company’s pension funds are open to new entrants and are expected to be on-going plans. Permitted investments are primarily liquid and/or listed, with little reliance on illiquid and non-traditional investments such as hedge funds.
The Company’s retirement plan asset allocation at the end of 2018 and 2017 and target allocations for 2019 are as follows:
 
 
Percent of
Plan Assets
 
Target
Allocation
 
 
2018
 
2017
 
2019
Worldwide Retirement Plans
 
 
 
 
 
 
Equity securities
 
71
%
 
76
%
 
70
%
Debt securities
 
29

 
24

 
30

Total plan assets
 
100
%
 
100
%
 
100
%

Determination of Fair Value of Plan Assets
The Plan has an established and well-documented process for determining fair values. Fair value is based upon quoted market prices, where available. If listed prices or quotes are not available, fair value is based upon models that primarily use, as inputs, market-based or independently sourced market parameters, including yield curves, interest rates, volatilities, equity or debt prices, foreign exchange rates and credit curves.
While the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.
Valuation Hierarchy
The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described in the table below with Level 1 having the highest priority and Level 3 having the lowest.
A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Following is a description of the valuation methodologies used for the investments measured at fair value.
•
Short-term investment funds — Cash and quoted short-term instruments are valued at the closing price or the amount held on deposit by the custodian bank. Other investments are through investment vehicles valued using the Net Asset Value (NAV) provided by the administrator of the fund. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. The NAV is a quoted price in a market that is not active and classified as Level 2.
•
Government and agency securities — A limited number of these investments are valued at the closing price reported on the major market on which the individual securities are traded. Where quoted prices are available in an active market, the investments are classified within Level 1 of the valuation hierarchy. If quoted market prices are not available for the specific security, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. When quoted market prices for a security are not available in an active market, they are classified as Level 2.
•
Debt instruments — A limited number of these investments are valued at the closing price reported on the major market on which the individual securities are traded. Where quoted prices are available in an active market, the investments are classified as Level 1. If quoted market prices are not available for the specific security, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows and are classified as Level 2. Level 3 debt instruments are priced based on unobservable inputs.
•
Equity securities — Equity securities are valued at the closing price reported on the major market on which the individual securities are traded. Substantially all common stock is classified within Level 1 of the valuation hierarchy.
•
Commingled funds — These investment vehicles are valued using the NAV provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. Assets in the Level 2 category have a quoted market price.
•
Insurance contracts — The instruments are issued by insurance companies. The fair value is based on negotiated value and the underlying investments held in separate account portfolios as well as considering the credit worthiness of the issuer. The underlying investments are government, asset-backed and fixed income securities. In general, insurance contracts are classified as Level 3 as there are no quoted prices nor other observable inputs for pricing.
•
Other assets — Other assets are represented primarily by limited partnerships and real estate investments, as well as commercial loans and commercial mortgages that are not classified as corporate debt. Other assets that are exchange listed and actively traded are classified as Level 1, while inactively traded assets are classified as Level 2.

The following table sets forth the Retirement Plans' investments measured at fair value as of December 31, 2018 and December 31, 2017:
 
 
Quoted Prices
in Active
Markets for
Identical Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs(a)
 
Investments Measured at Net Asset Value
 
 
 
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
 
 
 
 
Total Assets
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
Short-term investment funds
 
$
122

 
429

 
529

 
427

 
—

 
—

 
—

 
—

 
651

 
856

Government and agency securities
 
—

 
—

 
3,595

 
3,094

 
—

 
—

 
—

 
—

 
3,595

 
3,094

Debt instruments
 
—

 
—

 
3,105

 
2,013

 
—

 
—

 
—

 
—

 
3,105

 
2,013

Equity securities
 
11,298

 
13,848

 
4

 
—

 
—

 
—

 
—

 
—

 
11,302

 
13,848

Commingled funds
 
—

 
—

 
2,304

 
1,780

 
133

 
57

 
5,201

 
6,158

 
7,638

 
7,995

Insurance contracts
 
—

 
—

 
—

 
—

 
193

 
199

 
—

 
—

 
193

 
199

Other assets
 
—

 
—

 
33

 
121

 
—

 
—

 
301

 
278

 
334

 
399

Investments at fair value
 
$
11,420

 
14,277

 
9,570

 
7,435

 
326

 
256

 
5,502

 
6,436

 
26,818

 
28,404



(a) The activity for the Level 3 assets is not significant for all years presented.

The Company's Other Benefit Plans are unfunded except for U.S. commingled funds (Level 2) of $72 million and $81 million and U.S. short-term investment funds (Level 2) of $108 million and $200 million at December 31, 2018 and December 31, 2017, respectively.
The fair value of Johnson & Johnson Common Stock directly held in plan assets was $876 million (3.3% of total plan assets) at December 31, 2018 and $938 million (3.3% of total plan assets) at December 31, 2017.
XML 41 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Savings Plan
 12 Months Ended
Dec. 30, 2018
Savings Plan [Abstract]  
Savings Plan
Savings Plan
The Company has voluntary 401(k) savings plans designed to enhance the existing retirement programs covering eligible employees. The Company matches a percentage of each employee’s contributions consistent with the provisions of the plan for which he/she is eligible. Total Company matching contributions to the plans were $242 million, $214 million and $191 million in 2018, 2017 and 2016, respectively.
XML 42 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital and Treasury Stock
 12 Months Ended
Dec. 30, 2018
Equity [Abstract]  
Capital and Treasury Stock
Capital and Treasury Stock
Changes in treasury stock were:
 
 
Treasury Stock
(Amounts in Millions Except Treasury Stock Shares in Thousands)
 
Shares
 
Amount
Balance at January 3, 2016
 
364,681

 
$
22,684

Employee compensation and stock option plans
 
(30,839
)
 
(3,311
)
Repurchase of common stock
 
79,490

 
8,979

Balance at January 1, 2017
 
413,332

 
28,352

Employee compensation and stock option plans
 
(25,508
)
 
(3,156
)
Repurchase of common stock
 
49,494

 
6,358

Balance at December 31, 2017
 
437,318

 
31,554

Employee compensation and stock option plans
 
(22,082
)
 
(3,060
)
Repurchase of common stock
 
42,283

 
5,868

Balance at December 30, 2018
 
457,519

 
$
34,362



Aggregate shares of common stock issued were approximately 3,119,843,000 shares at the end of 2018, 2017 and 2016.

Cash dividends paid were $3.54 per share in 2018, compared with dividends of $3.32 per share in 2017, and $3.15 per share in 2016.
On December 17, 2018, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to $5.0 billion of the Company's shares of common stock. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Any shares acquired will be available for general corporate purposes. The Company intends to finance the share repurchase program through available cash. As of December 30, 2018, $0.9 billion has been repurchased under the program.
On October 13, 2015, the Company announced that its Board of Directors approved a share repurchase program, authorizing the Company to purchase up to $10.0 billion of the Company's shares of common stock. This share repurchase program was completed as of July 2, 2017.
XML 43 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accumulated Other Comprehensive Income (Loss)
 12 Months Ended
Dec. 30, 2018
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Components of other comprehensive income (loss) consist of the following:
(Dollars in Millions)
 
Foreign
Currency Translation
 
Gain/(Loss) On Securities
 
Employee Benefit Plans
 
Gain/
(Loss) On
Derivatives & Hedges
 
Total
Accumulated
Other
Comprehensive Income (Loss)
January 3, 2016
 
$
(8,435
)
 
604

 
(5,298
)
 
(36
)
 
(13,165
)
Net 2016 changes
 
(612
)
 
(193
)
 
(682
)
 
(249
)
 
(1,736
)
January 1, 2017
 
(9,047
)
 
411

 
(5,980
)
 
(285
)
 
(14,901
)
Net 2017 changes
 
1,696

 
(179
)
 
(170
)
 
355

 
1,702

December 31, 2017
 
(7,351
)
 
232

 
(6,150
)
 
70

 
(13,199
)
Cumulative adjustment to retained earnings
 
 
 
(232
)
(1) 
 
 
 
 
(232
)
Net 2018 changes
 
(1,518
)
 
—

 
(8
)
 
(265
)
 
(1,791
)
December 30, 2018
 
$
(8,869
)
 
—

 
(6,158
)
 
(195
)
 
(15,222
)


(1) See Note 1 to Consolidated Financial Statements for additional details on the adoption of ASU 2016-01

Amounts in accumulated other comprehensive income are presented net of the related tax impact. Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries. For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income.

Details on reclassifications out of Accumulated Other Comprehensive Income:
Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.
Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 10 for additional details.
Gain/(Loss) On Derivatives & Hedges - reclassifications to earnings are recorded in the same account as the hedged transaction. See Note 6 for additional details.
XML 44 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
International Currency Translation
 12 Months Ended
Dec. 30, 2018
Foreign Currency Translation [Abstract]  
International Currency Transalation
International Currency Translation
For translation of its subsidiaries operating in non-U.S. Dollar currencies, the Company has determined that the local currencies of its international subsidiaries are the functional currencies except those in highly inflationary economies, which are defined as those which have had compound cumulative rates of inflation of 100% or more during the past three years, or where a substantial portion of its cash flows are not in the local currency. Beginning in the fiscal third quarter of 2018, the Company accounted for operations in Argentina as highly inflationary. For the majority of the Company's subsidiaries the local currency is the functional currency.
In consolidating international subsidiaries, balance sheet currency effects are recorded as a component of accumulated other comprehensive income. This equity account includes the results of translating certain balance sheet assets and liabilities at current exchange rates and some accounts at historical rates, except for those located in highly inflationary economies. The translation of balance sheet accounts for highly inflationary economies are reflected in the operating results.
A rollforward of the changes during 2018, 2017 and 2016 for foreign currency translation adjustments is included in Note 13.
Net currency transaction gains and losses included in Other (income) expense were losses of $265 million, $216 million and $289 million in 2018, 2017 and 2016, respectively.
XML 45 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share
 12 Months Ended
Dec. 30, 2018
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share
The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal years ended December 30, 2018, December 31, 2017 and January 1, 2017:
(In Millions Except Per Share Amounts)
 
2018
 
2017
 
2016
Basic net earnings per share
 
$
5.70

 
0.48

 
6.04

Average shares outstanding — basic
 
2,681.5

 
2,692.0

 
2,737.3

Potential shares exercisable under stock option plans
 
139.0

 
139.7

 
142.4

Less: shares repurchased under treasury stock method
 
(92.5
)
 
(87.3
)
 
(92.1
)
Convertible debt shares
 
0.7

 
0.9

 
1.3

Adjusted average shares outstanding — diluted
 
2,728.7

 
2,745.3

 
2,788.9

Diluted net earnings per share
 
$
5.61

 
0.47

 
5.93



The diluted net earnings per share calculation included the dilutive effect of convertible debt that is offset by the related reduction in interest expense of $1 million after-tax for 2018 and 2017, and $2 million for 2016.
The diluted net earnings per share calculation for 2018, 2017 and 2016 included all shares related to stock options, as the exercise price of all options was less than the average market value of the Company's stock.
XML 46 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Rental Expense and Lease Commitments
 12 Months Ended
Dec. 30, 2018
Leases, Operating [Abstract]  
Rental Expense and Lease Commitments
Rental Expense and Lease Commitments
Rentals of space, vehicles, manufacturing equipment and office and data processing equipment under operating leases were approximately $332 million, $372 million and $330 million in 2018, 2017 and 2016, respectively.
The approximate minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year at December 30, 2018 are:
(Dollars in Millions)
2019
 
2020
 
2021
 
2022
 
2023
 
After 2023
 
Total
$223
 
188
 
154
 
116
 
76
 
139
 
896

Commitments under capital leases are not significant.
XML 47 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock, Stock Option Plans and Stock Compensation Agreements
 12 Months Ended
Dec. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Common Stock, Stock Option Plans and Stock Compensation Agreements
Common Stock, Stock Option Plans and Stock Compensation Agreements
At December 30, 2018, the Company had 2 stock-based compensation plans. The shares outstanding are for contracts under the Company's 2005 Long-Term Incentive Plan and the 2012 Long-Term Incentive Plan. The 2005 Long-Term Incentive Plan expired April 26, 2012. All options and restricted shares granted subsequent to that date were under the 2012 Long-Term Incentive Plan. Under the 2012 Long-Term Incentive Plan, the Company may issue up to 650 million shares of common stock, plus any shares canceled, expired, forfeited, or not issued from the 2005 Long-Term Incentive Plan subsequent to April 26, 2012. Shares available for future grants under the 2012 Long-Term Incentive Plan were 351 million at the end of 2018.
The compensation cost that has been charged against income for these plans was $978 million, $962 million and $878 million for 2018, 2017 and 2016, respectively. The total income tax benefit recognized in the income statement for share-based compensation costs was $192 million, $275 million and $256 million for 2018, 2017 and 2016, respectively. An additional tax benefit of $353 million was recognized in 2016 due to the adoption of a new accounting standard for the reporting of additional tax benefits on share-based compensation. The total unrecognized compensation cost was $827 million, $798 million and $749 million for 2018, 2017 and 2016, respectively. The weighted average period for this cost to be recognized was 1.73 years, 1.76 years and 1.09 years for 2018, 2017, and 2016, respectively. Share-based compensation costs capitalized as part of inventory were insignificant in all periods.
The Company settles employee benefit equity issuances with treasury shares. Treasury shares are replenished throughout the year for the number of shares used to settle employee benefit equity issuances.
Stock Options
Stock options expire 10 years from the date of grant and vest over service periods that range from 6 months to 4 years. All options are granted at the average of the high and low prices of the Company’s Common Stock on the New York Stock Exchange on the date of grant.
The fair value of each option award was estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. For 2018, 2017 and 2016 grants, expected volatility represents a blended rate of 10-year weekly historical overall volatility rate, and a 5-week average implied volatility rate based on at-the-money traded Johnson & Johnson options with a life of 2 years. For all grants, historical data is used to determine the expected life of the option. The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant.

The average fair value of options granted was $17.98, $13.38 and $10.01, in 2018, 2017 and 2016, respectively. The fair value was estimated based on the weighted average assumptions of:
 
2018
 
2017
 
2016
Risk-free rate
2.77
%
 
2.25
%
 
1.51
%
Expected volatility
15.77
%
 
15.30
%
 
15.76
%
Expected life (in years)
7.0

 
7.0

 
7.0

Expected dividend yield
2.70
%
 
2.90
%
 
3.10
%


A summary of option activity under the Plan as of December 30, 2018, December 31, 2017 and January 1, 2017, and changes during the years ending on those dates is presented below:
(Shares in Thousands)
 
Outstanding Shares
 
Weighted
Average Exercise Price
 
Aggregate
Intrinsic
Value
(Dollars in Millions)
Shares at January 3, 2016
 
116,517

 
$
76.41

 
$
3,065

Options granted
 
22,491

 
101.87

 
 
Options exercised
 
(22,547
)
 
65.66

 
 
Options canceled/forfeited
 
(3,006
)
 
92.83

 
 
Shares at January 1, 2017
 
113,455

 
83.16

 
3,636

Options granted
 
19,287

 
115.67

 
 
Options exercised
 
(18,975
)
 
70.87

 
 
Options canceled/forfeited
 
(2,461
)
 
101.40

 
 
Shares at December 31, 2017
 
111,306

 
90.48

 
5,480

Options granted
 
17,115

 
129.51

 
 
Options exercised
 
(16,228
)
 
75.44

 
 
Options canceled/forfeited
 
(2,541
)
 
112.90

 
 
Shares at December 30, 2018
 
109,652

 
$
98.29

 
$
3,214



The total intrinsic value of options exercised was $1,028 million, $1,060 million and $980 million in 2018, 2017 and 2016, respectively.

The following table summarizes stock options outstanding and exercisable at December 30, 2018:
(Shares in Thousands)
 
Outstanding
 
Exercisable
Exercise Price Range
 
Options
 
Average Life(1)
 
Average Exercise Price
 
Options
 
Average Exercise Price
$52.13-$65.62
 
13,466

 
1.8
 
$62.67
 
13,466

 
$62.67
$66.07-$72.54
 
12,710

 
4.0
 
$72.53
 
12,710

 
$72.53
$90.44-$100.48
 
29,162

 
5.6
 
$95.34
 
28,537

 
$95.23
$101.87-$115.67
 
37,877

 
7.6
 
$108.33
 
111

 
$108.04
$115.68-$129.51
 
16,437

 
9.1
 
$129.51
 
38

 
$129.51
 
 
109,652

 
6.2
 
$98.29
 
54,862

 
$82.03


(1) Average contractual life remaining in years.
Stock options outstanding at December 31, 2017 and January 1, 2017 were 111,306 and an average life of 6.3 years and 113,455 and an average life of 6.2 years, respectively. Stock options exercisable at December 31, 2017 and January 1, 2017 were 52,421 at an average price of $73.61 and 50,414 at an average price of $65.77, respectively.
Restricted Share Units and Performance Share Units
The Company grants restricted share units which vest over service periods that range from 6 months to 3 years. The Company also grants performance share units, which are paid in shares of Johnson & Johnson Common Stock after the end of a three-year performance period. Whether any performance share units vest, and the amount that does vest, is tied to the completion of service periods that range from 6 months to 3 years and the achievement, over a three-year period, of three equally-weighted goals that directly align with or help drive long-term total shareholder return: operational sales, adjusted operational earnings per share, and relative total shareholder return. The number of shares actually earned at the end of the three-year period will vary, based only on actual performance, from 0% to 200% of the target number of performance share units granted. In the fourth quarter of 2017, the Company modified the restricted share units that are scheduled to vest between January 1, 2018 and March 15, 2018. This modification guaranteed a minimum aggregate value, below the market value of the total expected payout amount, for all awards expected to vest during this period. The amount that was committed was not material to the Company’s overall financial position.



A summary of the restricted share units and performance share units activity under the Plans as of December 30, 2018 is presented below:
(Shares in Thousands)
 
Outstanding Restricted Share Units
 
Outstanding Performance Share Units
Shares at December 31, 2017
 
20,161

 
2,625

Granted
 
6,074

 
1,142

Issued
 
(6,684
)
 
(1,151
)
Canceled/forfeited/adjusted
 
(1,091
)
 
(122
)
Shares at December 30, 2018
 
18,460

 
2,494


The average fair value of the restricted share units granted was $119.67, $107.69 and $92.45 in 2018, 2017 and 2016, respectively, using the fair market value at the date of grant. The fair value of restricted share units was discounted for dividends, which are not paid on the restricted share units during the vesting period. The fair value of restricted share units issued was $613.7 million, $596.5 million and $587.7 million in 2018, 2017 and 2016, respectively.
The weighted average fair value of the performance share units granted was $120.64, $114.13 and $105.30 in 2018, 2017 and 2016, calculated using the weighted average fair market value for each of the three component goals at the date of grant. 
The fair values for the sales and earnings per share goals of each performance share unit were estimated on the date of grant using the fair market value of the shares at the time of the award discounted for dividends, which are not paid on the performance share units during the vesting period.  The fair value for the relative total shareholder return goal of each performance share unit was estimated on the date of grant using the Monte Carlo valuation model. The fair value of performance share units issued was $128.8 million, $132.5 million and $127.7 million in 2018, 2017 and 2016, respectively.
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segments of Business and Geographic Areas
 12 Months Ended
Dec. 30, 2018
Segment Reporting [Abstract]  
Segments of Business and Geographic Areas
Segments of Business and Geographic Areas

 
 
Sales to Customers
 
% Change
(Dollars in Millions)
 
2018
 
2017
 
2016
 
’18 vs. ’17
 
’17 vs. ’16
 
 
 
 
 
 
 
 
 
 
 
CONSUMER
 
 
 
 
 
 
 
 
 
 
Baby Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
$
422

 
449

 
488

 
(6.0
)%
 
(8.0
)
     International
 
1,436

 
1,467

 
1,513

 
(2.1
)
 
(3.0
)
     Worldwide
 
1,858

 
1,916

 
2,001

 
(3.0
)
 
(4.2
)
Beauty
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,403

 
2,335

 
2,135

 
2.9

 
9.4

     International
 
1,979

 
1,865

 
1,762

 
6.1

 
5.8

     Worldwide
 
4,382

 
4,200

 
3,897

 
4.3

 
7.8

Oral Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
637

 
616

 
648

 
3.4

 
(4.9
)
     International
 
918

 
915

 
920

 
0.3

 
(0.5
)
     Worldwide
 
1,555

 
1,531

 
1,568

 
1.6

 
(2.4
)
OTC
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,850

 
1,716

 
1,675

 
7.8

 
2.4

     International
 
2,484

 
2,410

 
2,302

 
3.1

 
4.7

     Worldwide
 
4,334

 
4,126

 
3,977

 
5.0

 
3.7

Women's Health
 
 
 
 
 
 
 
 
 
 
     U.S.
 
13

 
12

 
19

 
8.3

 
(36.8
)
     International
 
1,036

 
1,038

 
1,048

 
(0.2
)
 
(1.0
)
     Worldwide
 
1,049

 
1,050

 
1,067

 
(0.1
)
 
(1.6
)
Wound Care/Other
 
 
 
 
 
 
 
 
 
 
     U.S.
 
436

 
437

 
455

 
(0.2
)
 
(4.0
)
     International
 
239

 
342

 
342

 
(30.1
)
 
0.0

     Worldwide
 
675

 
779

 
797

 
(13.4
)
 
(2.3
)
TOTAL CONSUMER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
5,761

 
5,565

 
5,420

 
3.5

 
2.7

     International
 
8,092

 
8,037

 
7,887

 
0.7

 
1.9

     Worldwide
 
13,853

 
13,602

 
13,307

 
1.8

 
2.2

 
 
 
 
 
 
 
 
 
 
 
PHARMACEUTICAL
 
 
 
 
 
 
 
 
 
 
Immunology
 
 
 
 
 
 
 
 
 
 
     U.S.
 
9,073

 
8,871

 
8,846

 
2.3

 
0.3

     International
 
4,047

 
3,373

 
3,122

 
20.0

 
8.0

     Worldwide
 
13,120

 
12,244

 
11,968

 
7.2

 
2.3

     REMICADE®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
3,664

 
4,525

 
4,842

 
(19.0
)
 
(6.5
)
     U.S. Exports
 
436

 
563

 
782

 
(22.6
)
 
(28.0
)
     International
 
1,226

 
1,227

 
1,342

 
(0.1
)
 
(8.6
)
     Worldwide
 
5,326

 
6,315

 
6,966

 
(15.7
)
 
(9.3
)
 
 
 
 
 
 
 
 
 
 
 
     SIMPONI / SIMPONI ARIA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,051

 
954

 
959

 
10.2

 
(0.5
)
     International
 
1,033

 
879

 
786

 
17.5

 
11.8

     Worldwide
 
2,084

 
1,833

 
1,745

 
13.7

 
5.0

     STELARA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
3,469

 
2,767

 
2,263

 
25.4

 
22.3

     International
 
1,687

 
1,244

 
969

 
35.6

 
28.4

     Worldwide
 
5,156

 
4,011

 
3,232

 
28.5

 
24.1

     TREMFAYA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
453

 
62

 
—

 
*
 
*
     International
 
91

 
1

 
—

 
*
 
*
     Worldwide
 
544

 
63

 
—

 
*
 
*
     OTHER IMMUNOLOGY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—
     International
 
10

 
22

 
25

 
(54.5
)
 
(12.0
)
     Worldwide
 
10

 
22

 
25

 
(54.5
)
 
(12.0
)
 
 
 
 
 
 
 
 
 
 
 
Infectious Diseases
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,378

 
1,358

 
1,461

 
1.5

 
(7.0
)
     International
 
1,926

 
1,796

 
1,747

 
7.2

 
2.8

     Worldwide
 
3,304

 
3,154

 
3,208

 
4.8

 
(1.7
)
     EDURANT® / rilpivirine
 
 
 
 
 
 
 
 
 
 
     U.S.
 
58

 
58

 
52

 
0.0

 
11.5

     International
 
758

 
656

 
521

 
15.5

 
25.9

     Worldwide
 
816

 
714

 
573

 
14.3

 
24.6

     PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,169

 
1,109

 
1,143

 
5.4

 
(3.0
)
     International
 
786

 
712

 
708

 
10.4

 
0.6

     Worldwide
 
1,955

 
1,821

 
1,851

 
7.4

 
(1.6
)
     OTHER INFECTIOUS DISEASES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
151

 
191

 
266

 
(20.9
)
 
(28.2
)
     International
 
382

 
428

 
518

 
(10.7
)
 
(17.4
)
     Worldwide
 
533

 
619

 
784

 
(13.9
)
 
(21.0
)
 
 
 
 
 
 
 
 
 
 
 
Neuroscience
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,574

 
2,630

 
2,628

 
(2.1
)
 
0.1

     International
 
3,503

 
3,356

 
3,457

 
4.4

 
(2.9
)
     Worldwide
 
6,077

 
5,986

 
6,085

 
1.5

 
(1.6
)
     CONCERTA® / Methylphenidate
 
 
 
 
 
 
 
 
 
 
     U.S.
 
229

 
384

 
468

 
(40.4
)
 
(17.9
)
     International
 
434

 
407

 
395

 
6.6

 
3.0

     Worldwide
 
663

 
791

 
863

 
(16.2
)
 
(8.3
)
     INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,791

 
1,590

 
1,343

 
12.6

 
18.4

     International
 
1,137

 
979

 
871

 
16.1

 
12.4

     Worldwide
 
2,928

 
2,569

 
2,214

 
14.0

 
16.0

     RISPERDAL CONSTA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
315

 
360

 
381

 
(12.5
)
 
(5.5
)
     International
 
422

 
445

 
512

 
(5.2
)
 
(13.1
)
     Worldwide
 
737

 
805

 
893

 
(8.4
)
 
(9.9
)
     OTHER NEUROSCIENCE
 
 
 
 
 
 
 
 
 
 
     U.S.
 
239

 
296

 
436

 
(19.3
)
 
(32.1
)
     International
 
1,510

 
1,525

 
1,679

 
(1.0
)
 
(9.2
)
     Worldwide
 
1,749

 
1,821

 
2,115

 
(4.0
)
 
(13.9
)
 
 
 
 
 
 
 
 
 
 
 
Oncology
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,331

 
3,098

 
2,335

 
39.8

 
32.7

     International
 
5,513

 
4,160

 
3,472

 
32.5

 
19.8

     Worldwide
 
9,844

 
7,258

 
5,807

 
35.6

 
25.0

     DARZALEX®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,203

 
884

 
471

 
36.1

 
87.7

     International
 
822

 
358

 
101

 
*
 
*
     Worldwide
 
2,025

 
1,242

 
572

 
63.0

 
*
     IMBRUVICA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,129

 
841

 
613

 
34.2

 
37.2

     International
 
1,486

 
1,052

 
638

 
41.3

 
64.9

     Worldwide
 
2,615

 
1,893

 
1,251

 
38.1

 
51.3

     VELCADE®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—
     International
 
1,116

 
1,114

 
1,224

 
0.2

 
(9.0
)
     Worldwide
 
1,116

 
1,114

 
1,224

 
0.2

 
(9.0
)
     ZYTIGA® /abiraterone acetate
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,771

 
1,228

 
1,089

 
44.2

 
12.8

     International
 
1,727

 
1,277

 
1,171

 
35.2

 
9.1

     Worldwide
 
3,498

 
2,505

 
2,260

 
39.6

 
10.8

     OTHER ONCOLOGY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
228

 
145

 
162

 
57.2

 
(10.5
)
     International
 
362

 
359

 
338

 
0.8

 
6.2

     Worldwide
 
590

 
504

 
500

 
17.1

 
0.8

 
 
 
 
 
 
 
 
 
 
 
Pulmonary Hypertension
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,651

 
773

 
—

 
*
 
*
     International
 
922

 
554

 
—

 
66.4

 
*
     Worldwide
 
2,573

 
1,327

 
—

 
93.9

 
*
     OPSUMIT®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
700

 
320

 
—

 
*
 
*
     International
 
515

 
253

 
—

 
*
 
*
     Worldwide
 
1,215

 
573

 
—

 
*
 
*
     TRACLEER®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
268

 
161

 
—

 
66.5

 
*
     International
 
278

 
242

 
—

 
14.9

 
*
     Worldwide
 
546

 
403

 
—

 
35.5

 
*
 
 
 
 
 
 
 
 
 
 
 
     UPTRAVI®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
598

 
238

 
—

 
*
 
*
     International
 
65

 
25

 
—

 
*
 
*
     Worldwide
 
663

 
263

 
—

 
*
 
*
     OTHER 
 
 
 
 
 
 
 
 
 
 
     U.S.
 
85

 
54

 
—

 
57.4

 
*
     International
 
64

 
34

 
—

 
88.2

 
*
     Worldwide
 
149

 
88

 
—

 
69.3

 
*
Cardiovascular / Metabolism / Other
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,279

 
4,744

 
4,855

 
(9.8
)
 
(2.3
)
     International
 
1,537

 
1,543

 
1,541

 
(0.4
)
 
0.1

     Worldwide
 
5,816

 
6,287

 
6,396

 
(7.5
)
 
(1.7
)
     XARELTO®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,477

 
2,500

 
2,288

 
(0.9
)
 
9.3

     International
 
—

 
—

 
—

 
—

 
—

     Worldwide
 
2,477

 
2,500

 
2,288

 
(0.9
)
 
9.3

     INVOKANA® / INVOKAMET®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
711

 
944

 
1,273

 
(24.7
)
 
(25.8
)
     International
 
170

 
167

 
134

 
1.8

 
24.6

     Worldwide
 
881

 
1,111

 
1,407

 
(20.7
)
 
(21.0
)
     PROCRIT® / EPREX®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
674

 
675

 
767

 
(0.1
)
 
(12.0
)
     International
 
314

 
297

 
338

 
5.7

 
(12.1
)
     Worldwide
 
988

 
972

 
1,105

 
1.6

 
(12.0
)
     OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
417

 
625

 
527

 
(33.3
)
 
18.6

     International
 
1,053

 
1,079

 
1,069

 
(2.4
)
 
0.9

     Worldwide
 
1,470

 
1,704

 
1,596

 
(13.7
)
 
6.8

TOTAL PHARMACEUTICAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
23,286

 
21,474

 
20,125

 
8.4

 
6.7

     International
 
17,448

 
14,782

 
13,339

 
18.0

 
10.8

     Worldwide
 
40,734

 
36,256

 
33,464

 
12.4

 
8.3

 
 
 
 
 
 
 
 
 
 
 
MEDICAL DEVICES
 
 
 
 
 
 
 
 
 
 
Diabetes Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
371

 
612

 
739

 
(39.4
)
 
(17.2
)
     International
 
638

 
1,003

 
1,050

 
(36.4
)
 
(4.5
)
     Worldwide
 
1,009

 
1,615

 
1,789

 
(37.5
)
 
(9.7
)
Diagnostics
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—

     International
 
—

 
1

 
66

 
*
 
*
     Worldwide
 
—

 
1

 
66

 
*
 
*
Interventional Solutions
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,283

 
1,148

 
1,031

 
11.8

 
11.3

     International
 
1,363

 
1,148

 
1,024

 
18.7

 
12.1

     Worldwide
 
2,646

 
2,296

 
2,055

 
15.2

 
11.7

Orthopaedics
 
 
 
 
 
 
 
 
 
 
     U.S.
 
5,281

 
5,404

 
5,438

 
(2.3
)
 
(0.6
)
     International
 
3,604

 
3,654

 
3,690

 
(1.4
)
 
(1.0
)
     Worldwide
 
8,885

 
9,058

 
9,128

 
(1.9
)
 
(0.8
)
     HIPS
 
 
 
 
 
 
 
 
 
 
     U.S.
 
841

 
827

 
798

 
1.7

 
3.6

     International
 
577

 
567

 
563

 
1.8

 
0.7

     Worldwide
 
1,418

 
1,394

 
1,361

 
1.7

 
2.4

     KNEES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
911

 
948

 
943

 
(3.9
)
 
0.5

     International
 
591

 
575

 
581

 
2.8

 
(1.0
)
     Worldwide
 
1,502

 
1,523

 
1,524

 
(1.4
)
 
(0.1
)
     TRAUMA
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,599

 
1,576

 
1,545

 
1.5

 
2.0

     International
 
1,100

 
1,040

 
1,024

 
5.8

 
1.6

     Worldwide
 
2,699

 
2,616

 
2,569

 
3.2

 
1.8

     SPINE & OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,930

 
2,053

 
2,152

 
(6.0
)
 
(4.6
)
     International
 
1,336

 
1,472

 
1,522

 
(9.2
)
 
(3.3
)
     Worldwide
 
3,266

 
3,525

 
3,674

 
(7.3
)
 
(4.1
)
Surgery
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,125

 
4,085

 
4,026

 
1.0

 
1.5

     International
 
5,776

 
5,474

 
5,270

 
5.5

 
3.9

     Worldwide
 
9,901

 
9,559

 
9,296

 
3.6

 
2.8

     ADVANCED
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,657

 
1,620

 
1,524

 
2.3

 
6.3

     International
 
2,345

 
2,136

 
1,993

 
9.8

 
7.2

     Worldwide
 
4,002

 
3,756

 
3,517

 
6.5

 
6.8

     GENERAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,751

 
1,728

 
1,669

 
1.3

 
3.5

     International
 
2,806

 
2,735

 
2,693

 
2.6

 
1.6

     Worldwide
 
4,557

 
4,463

 
4,362

 
2.1

 
2.3

     SPECIALTY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
717

 
737

 
833

 
(2.7
)
 
(11.5
)
     International
 
625

 
603

 
584

 
3.6

 
3.3

     Worldwide
 
1,342

 
1,340

 
1,417

 
0.1

 
(5.4
)
Vision
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,777

 
1,575

 
1,032

 
12.8

 
52.6

     International
 
2,776

 
2,488

 
1,753

 
11.6

 
41.9

     Worldwide
 
4,553

 
4,063

 
2,785

 
12.1

 
45.9

     CONTACT LENSES / OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,237

 
1,122

 
1,032

 
10.2

 
8.7

     International
 
2,065

 
1,914

 
1,753

 
7.9

 
9.2

     Worldwide
 
3,302

 
3,036

 
2,785

 
8.8

 
9.0

 
 
 
 
 
 
 
 
 
 
 
     SURGICAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
540

 
453

 
—

 
19.2

 
*
     International
 
711

 
574

 
—

 
23.9

 
*
     Worldwide
 
1,251

 
1,027

 
—

 
21.8

 
*
 
 
 
 
 
 
 
 
 
 
 
TOTAL MEDICAL DEVICES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
12,837

 
12,824

 
12,266

 
0.1

 
4.5

     International
 
14,157

 
13,768

 
12,853

 
2.8

 
7.1

     Worldwide
 
26,994

 
26,592

 
25,119

 
1.5

 
5.9

 
 
 
 
 
 
 
 
 
 
 
WORLDWIDE
 
 
 
 
 
 
 
 
 
 
     U.S.
 
41,884

 
39,863

 
37,811

 
5.1

 
5.4

     International
 
39,697

 
36,587

 
34,079

 
8.5

 
7.4

     Worldwide
 
$
81,581

 
76,450

 
71,890

 
6.7
 %
 
6.3

*Percentage greater than 100% or not meaningful

 
 
Income Before Tax
 
Identifiable Assets
(Dollars in Millions)
 
2018 (3)
 
2017 (4)
 
2016 (5)
 
2018
 
2017
Consumer
 
$
2,320

 
2,524

 
2,441

 
$
25,877

 
25,030

Pharmaceutical
 
12,568

 
11,083

 
12,827

 
56,636

 
59,450

Medical Devices
 
4,397

 
5,392

 
5,578

 
46,254

 
45,413

Total
 
19,285

 
18,999

 
20,846

 
128,767

 
129,893

Less: Expense not allocated to segments (1)
 
1,286

 
1,326

 
1,043

 
 
 
 
General corporate (2)
 
 
 
 
 
 
 
24,187

 
27,410

Worldwide total
 
$
17,999

 
17,673

 
19,803

 
$
152,954

 
157,303


 
 
Additions to Property,
Plant & Equipment
 
Depreciation and
Amortization
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Consumer
 
$
438

 
485

 
486

 
$
688

 
674

 
608

Pharmaceutical
 
1,012

 
936

 
927

 
3,802

 
2,416

 
886

Medical Devices
 
1,843

 
1,566

 
1,472

 
2,103

 
2,216

 
1,928

Segments total
 
3,293

 
2,987

 
2,885

 
6,593

 
5,306

 
3,422

General corporate
 
377

 
292

 
341

 
336

 
336

 
332

Worldwide total
 
$
3,670

 
3,279

 
3,226

 
$
6,929

 
5,642

 
3,754


 
 
Sales to Customers
 
Long-Lived Assets (6)
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
United States
 
$
41,884

 
39,863

 
37,811

 
$
37,117

 
38,556

Europe
 
18,753

 
17,126

 
15,770

 
51,433

 
56,677

Western Hemisphere excluding U.S. 
 
6,113

 
6,041

 
5,734

 
2,752

 
2,990

Asia-Pacific, Africa
 
14,831

 
13,420

 
12,575

 
2,733

 
2,773

Segments total
 
81,581

 
76,450

 
71,890

 
94,035

 
100,996

General corporate
 
 
 
 
 
 
 
1,064

 
1,143

Other non long-lived assets
 
 
 
 
 
 
 
57,855

 
55,164

Worldwide total
 
$
81,581

 
76,450

 
71,890

 
$
152,954

 
157,303

­
See Note 1 for a description of the segments in which the Company operates.
Export sales are not significant. In 2018, the Company had three wholesalers distributing products for all three segments that represented approximately 14.0%, 11.0% and 11.0% of the total consolidated revenues. In 2017, the Company had two wholesalers distributing products for all three segments that represented approximately 14.0% and 10.0% of the total consolidated revenues. In 2016, the Company had two wholesalers distributing products for all three segments that represented approximately 13.5% and 10.7% of the total consolidated revenues.

(1) 
Amounts not allocated to segments include interest (income) expense and general corporate (income) expense.
(2) 
General corporate includes cash, cash equivalents and marketable securities.
(3) 
The Consumer segment includes a gain of $0.3 billion from the divestiture of NIZORAL® and litigation expense of $0.3 billion. The Pharmaceutical segment includes an in-process research and development charge of $1.1 billion related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of $0.2 billion, Actelion acquisition related costs of $0.2 billion, unrealized loss on securities of $0.2 billion and a gain of $0.2 billion from the divestiture of certain non-strategic Pharmaceutical products. The Medical Devices segment includes net litigation expense of $1.7 billion, a restructuring related charge of $0.6 billion, AMO acquisition related costs of $0.1 billion and a gain of $0.5 billion from the divestiture of the LifeScan business in the fiscal fourth quarter.
(4) 
The Pharmaceutical segment includes $0.8 billion for Actelion acquisition related costs, an in-process research and development expense of $0.4 billion and litigation expense of $0.1 billion. The Medical Devices segment includes litigation expense of $1.1 billion, a restructuring related charge of $0.8 billion, an asset impairment of $0.2 billion primarily related to the insulin pump business and $0.1 billion for AMO acquisition related costs. The Medical Devices segment includes a gain of $0.7 billion from the divestiture of Codman Neurosurgery. The Consumer segment includes a gain of $0.5 billion from the divestiture of COMPEED®.
(5) 
Includes net litigation expense of $0.8 billion and a restructuring related charge of $0.7 billion in the Medical Devices segment. The Pharmaceutical segment includes a positive adjustment of $0.5 billion to previous reserve estimates and gains from the divestitures of the controlled substance raw material and active pharmaceutical ingredient (API) business and certain anesthetic products in Europe.
(6) 
Long-lived assets include property, plant and equipment, net for 2018, and 2017 of $17,035 and $17,005, respectively, and intangible assets and goodwill, net for 2018 and 2017 of $78,064 and $85,134, respectively.
XML 49 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Selected Quarterly Financial Data (unaudited)
 12 Months Ended
Dec. 30, 2018
Selected Quarterly Financial Information [Abstract]  
Selected Quarterly Financial Data (unaudited)
Selected Quarterly Financial Data (unaudited)
Selected unaudited quarterly financial data for the years 2018 and 2017 are summarized below:
 
 
2018
 
2017
(Dollars in Millions Except Per Share Data)
 
First Quarter (1)
 
Second Quarter (2)
 
Third Quarter (3)
 
Fourth Quarter (4)
 
First Quarter (5)
 
Second Quarter (6)
 
Third Quarter (7)
 
Fourth Quarter (8)
Segment sales to customers
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Consumer
 
$
3,398

 
3,504

 
3,415

 
3,536

 
3,228

 
3,478

 
3,356

 
3,540

Pharmaceutical
 
9,844

 
10,354

 
10,346

 
10,190

 
8,245

 
8,635

 
9,695

 
9,681

Medical Devices 
 
6,767

 
6,972

 
6,587

 
6,668

 
6,293

 
6,726

 
6,599

 
6,974

Total sales
 
20,009

 
20,830

 
20,348

 
20,394

 
17,766

 
18,839

 
19,650

 
20,195

Gross profit
 
13,395

 
13,903

 
13,759

 
13,433

 
12,357

 
12,993

 
12,725

 
12,936

Earnings before provision for taxes on income
 
5,481

 
4,973

 
4,423

 
3,122

 
5,575

 
4,748

 
4,790

 
2,560

Net earnings (loss)
 
4,367

 
3,954

 
3,934

 
3,042

 
4,422

 
3,827

 
3,764

 
(10,713
)
Basic net earnings (loss) per share
 
$
1.63

 
1.47

 
1.47

 
1.14

 
1.63

 
1.42

 
1.40

 
(3.99
)
Diluted net earnings (loss) per share
 
$
1.60

 
1.45

 
1.44

 
1.12

 
1.61

 
1.40

 
1.37

 
(3.99
)

(1)
The first quarter of 2018 includes an Actelion acquisition related cost of $92 million after-tax ($96 million before-tax) and a restructuring related charge of $81 million after-tax ($107 million before-tax).
(2) 
The second quarter of 2018 includes a litigation expense of $609 million after-tax ($703 million before-tax) and a restructuring related charge of $152 million after-tax ($176 million before-tax).
(3) 
The third quarter of 2018 includes an in-process research and development expense of $859 million after-tax ($1,126 million before-tax) related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of $184 million after and before tax, a restructuring related charge of $162 million after-tax ($190 million before-tax) and a $265 million benefit after-tax from the impact of tax legislation.
(4) 
The fourth quarter of 2018 includes a litigation expense of $1,113 million after-tax ($1,288 million before-tax), a restructuring related charge of $190 million after-tax ($227 million before-tax) and a $137 million benefit after-tax from the impact of tax legislation.
(5) 
The first quarter of 2017 includes a restructuring charge of $121 million after-tax ($161 million before-tax) and an AMO acquisition related cost of $251 million after-tax ($38 million before-tax).
(6) 
The second quarter of 2017 includes a litigation expense of $352 million after-tax ($493 million before-tax), Actelion acquisition related costs of $199 million after-tax ($213 million before-tax) a restructuring charge of $101 million after-tax ($128 million before-tax) and an asset impairment charge of $125 million after-tax ($182 million before-tax).
(7) 
The third quarter of 2017 includes a litigation expense of $97 million after-tax ($118 million before-tax), Actelion acquisition related costs of $255 million after-tax ($367 million before-tax) and a restructuring charge of $136 million after-tax ($187 million before-tax).
(8) 
The fourth quarter of 2017 includes a litigation expense of $506 million after-tax ($645 million before-tax), Actelion acquisition related costs of $313 million after-tax ($217 million before-tax), a restructuring charge of $237 million after-tax ($284 million before-tax), an in-process research and development expense of $266 million after-tax ($408 million before-tax) and an after-tax benefit of $116 million related to the insulin pump business. Additionally, the fourth quarter of 2017 includes a provisional charge of $13.6 billion for recently enacted tax legislation.
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations and Divestitures
 12 Months Ended
Dec. 30, 2018
Business Combinations [Abstract]  
Business Combinations and Divestitures
Business Combinations and Divestitures
Certain businesses were acquired for $0.9 billion in cash and $0.1 billion of liabilities assumed during 2018. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.
The 2018 acquisitions primarily included: Zarbee’s, Inc., a privately held company that is a leader in naturally-based consumer healthcare products; Medical Enterprises Distribution LLC, a privately held healthcare technology firm focused on surgical procedure innovation; BeneVir Biopharm, Inc. (BeneVir), a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies and Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution.
The excess of purchase price over the estimated fair value of tangible assets acquired amounted to $1.0 billion and has been assigned to identifiable intangible assets, with any residual recorded to goodwill.
On October 23, 2018, the Company entered into an agreement to acquire Ci:z Holdings Co., Ltd., a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately ¥230 billion, which equates to approximately $2.1 billion, using the exchange rate of 109.06 Japanese Yen to each U.S. Dollar on January 16, 2019. The acquisition was completed on January 17, 2019, through a series of transactions that included an all-cash tender offer to acquire the publicly held shares not already held by the Company for ¥5,900 per share. Upon completion of the tender offer and the related transactions, the Company acquired 89% of the outstanding shares. The Company plans to acquire the remaining shares that were not tendered in the tender offer through a share consolidation under Japanese law during the first half of 2019 and take appropriate actions to delist from the Tokyo Stock Exchange. The acquisition will include the range of brands comprising DR.CI:LABO, LABO LABO and GENOMER line of skincare products. The Company expects to treat this transaction as a business combination and will include it in the Consumer segment.
On February 13, 2019, the Company entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4 billion in cash. Additional contingent payments of up to$2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The closing is subject to antitrust clearance and other customary closing conditions. The transaction is expected to close by the end of the second quarter of 2019. The Company expects to treat this transaction as a business combination and will include it in the Medical Devices segment.
During 2017 certain businesses were acquired for $35.2 billion in cash and $1.8 billion of liabilities assumed. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.
The 2017 acquisitions primarily included: Actelion Ltd, an established leading franchise of differentiated, innovative products for pulmonary arterial hypertension (PAH); Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, which included ophthalmic products related to: cataract surgery, laser refractive surgery and consumer eye health; Neuravi Limited, a privately-held medical device company that develops and markets medical devices for neurointerventional therapy; TearScience Inc., a manufacturer of products dedicated to treating meibomian gland dysfunction; Sightbox, Inc., a privately-held company that developed a subscription vision care service that connects consumers with eye care professionals and a supply of contact lenses; Torax Medical, Inc., a privately-held medical device company that manufactures and markets the LINX™ Reflux Management System for the surgical treatment of gastroesophageal reflux disease and Megadyne Medical Products, Inc., a privately-held medical device company that develops, manufactures and markets electrosurgical tools.
The excess of purchase price over the estimated fair value of tangible assets acquired amounted to $34.4 billion and has been assigned to identifiable intangible assets, with any residual recorded to goodwill. Of this amount, approximately $1.1 billion has been identified as the value of IPR&D, primarily associated with the acquisition of Actelion Ltd. The value of the IPR&D was calculated using cash flow projections discounted for the inherent risk in the projects.
During 2017, the Company completed the acquisition of Actelion Ltd through an all cash tender offer in Switzerland for $280 per share, amounting to $29.6 billion, net of cash acquired. As part of the transaction, immediately prior to the completion of the acquisition, Actelion spun out its drug discovery operations and early-stage clinical development assets into a newly created Swiss biopharmaceutical company, Idorsia Ltd. The shares of Idorsia are listed on the SIX Swiss Exchange (SIX). In 2017 the Company held 9.9% of the shares of Idorsia and had rights to an additional 22.1% of Idorsia equity through a convertible loan with a principal amount of approximately $0.5 billion. As a result of Idorsia raising additional capital in July 2018, the Company currently holds 9.0% of the shares of Idorsia and has rights to an additional 20.8% of Idorsia equity through a convertible loan with a principal amount of approximately $0.5 billion. The convertible loan may be converted into Idorsia shares as follows: (i) up to an aggregate shareholding of 16% of Idorsia shares as a result of certain shareholders holding more than 20% of the issued Idorsia shares, and (ii) up to the balance of the remaining amount within 20 business days of the maturity date of the convertible loan, which has a 10 year term, or if Idorsia undergoes a change of control transaction. The investment in Idorsia was recorded as a cost method investment in Other assets in the Company's consolidated Balance Sheet. The Company also exercised the option acquired on ACT-132577, a product within Idorsia being developed for resistant hypertension currently in phase 2 of clinical development. The Company has also entered into an agreement to provide Idorsia with a Swiss franc denominated credit facility of approximately $250 million. As of December 30, 2018, Idorsia has not made any draw-downs under the credit facility. Actelion has entered into a transitional services agreement with Idorsia. Actelion has established a leading franchise of differentiated, innovative products for pulmonary arterial hypertension (PAH) that are highly complementary to the existing portfolio of the Company. The addition of Actelion’s specialty in-market medicines and late-stage products is consistent with the Company's efforts to grow in attractive and complementary therapeutic areas and serve patients with serious illnesses and significant unmet medical need.
During the fiscal second quarter of 2018, the Company finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. The following table presents the amounts recognized for assets acquired and liabilities assumed as of the acquisition date with adjustments made through the second quarter of 2018:


(Dollars in Millions)
 
Cash & Cash equivalents
469

Inventory(1)
759

Accounts Receivable
485

Other current assets
93

Property, plant and equipment
104

Goodwill
6,161

Intangible assets
25,010

Deferred Taxes
99

Other non-current assets
19

Total Assets Acquired
33,199

 
 
Current liabilities
956

Deferred Taxes
1,776

Other non-current liabilities
413

Total Liabilities Assumed
3,145

 
 
Net Assets Acquired
30,054

(1) Includes adjustment of $642 million to write-up the acquired inventory to its estimated fair value.
The adjustments made since the date of acquisition were $0.2 billion to the deferred taxes and $0.4 billion to the current liabilities with the offset to goodwill. The assets acquired are recorded in the Pharmaceutical segment. The acquisition of Actelion resulted in approximately $6.2 billion of goodwill. The goodwill is primarily attributable to synergies expected to arise from the acquisition. The goodwill is not expected to be deductible for tax purposes.

The purchase price allocation to the identifiable intangible assets is as follows:
(Dollars in Millions)
 
 
Intangible assets with definite lives:
 
 
Patents and trademarks*
 
$
24,230

Total amortizable intangibles
 
24,230

 
 
 
In-process research and development
 
780

Total intangible assets
 
$
25,010


*Includes $0.4 billion related to VALCHLOR®, one of the acquired products, which was divested in the fiscal second quarter of 2018.
The patents and trademarks acquired are comprised of developed technology with a weighted average life of 9 years and was primarily based on the patent life of the marketed products. The intangible assets with definite lives were assigned asset lives ranging from 4 to 10 years. The in-process research and development intangible assets were valued for technology programs for unapproved products.
The value of the IPR&D was calculated using probability adjusted cash flow projections discounted for the risk inherent in such projects. The discount rate applied was 9%.
The acquisition was accounted for using the acquisition method and, accordingly, the results of operations of Actelion were reported in the Company's financial statements beginning on June 16, 2017, the date of acquisition. For the year ended December 31, 2017, total sales and a net loss for Actelion from the date of acquisition were $1.4 billion and $1.4 billion, respectively.
The following table provides pro forma results of operations for the fiscal year ended December 31, 2017 and January 1, 2017, as if Actelion had been acquired as of January 4, 2016. The pro forma results include the effect of certain purchase accounting adjustments such as the estimated changes in depreciation and amortization expense on the acquired tangible and intangible assets. However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of Actelion. Accordingly, such amounts are not necessarily indicative of the results if the acquisition had occurred on the dates indicated or which may occur in the future.
 
Unaudited Pro forma Consolidated Results
(Dollars in Millions Except Per Share Data)
2017
2016
 
 
 
Net Sales
77,681

74,339

Net Earnings
1,509

13,916

Diluted Net Earnings per Common Share
0.55

4.99



The Company recorded Actelion acquisition related costs before tax of approximately $0.2 billion and $0.8 billion in 2018 and 2017, respectively, which was recorded in Other (income)/expense and Cost of products sold.
During 2017, the Company acquired Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, for $4.3 billion, net of cash acquired. The acquisition included ophthalmic products related to: cataract surgery, laser refractive surgery and consumer eye health. The net purchase price was primarily recorded as amortizable intangible assets for $2.3 billion and goodwill for $1.7 billion. The weighted average life of total amortizable intangibles, the majority being customer relationships, is approximately 14.4 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not deductible for tax purposes. The intangible assets and goodwill amounts are based on the final purchase price allocation. The assets acquired were recorded in the Medical Devices segment.
Certain businesses were acquired for $4.5 billion in cash and $0.1 billion of liabilities assumed during 2016. These acquisitions were accounted for using the acquisition method and, accordingly, results of operations have been included in the financial statements from their respective dates of acquisition.
The 2016 acquisitions primarily included: Vogue International LLC, a privately-held company focused on the marketing, development and distribution of salon-influenced and nature inspired hair care and other personal products; NeuWave Medical, Inc., a privately-held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems; NeoStrata Company, Inc., a global leader in dermocosmetics; and the global rights for the commercialization of RHINOCORT® allergy spray outside the United States.
The excess of purchase price over the estimated fair value of tangible assets acquired amounted to $4.1 billion and has been assigned to identifiable intangible assets, with any residual recorded to goodwill.
The net purchase price for Vogue International LLC of $3.3 billion was primarily recorded as amortizable intangible assets for $2.3 billion and goodwill for $1.1 billion. The weighted average life for the $2.3 billion of total amortizable intangibles is approximately 22 years. The trademark asset values were determined to have definite lives ranging from 10 to 22 years, with the majority being 22 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is expected to be deductible for tax purposes. The assets acquired were recorded in the Consumer segment.
In 2012, the Company completed the acquisition of Synthes, Inc. for a purchase price of $20.2 billion in cash and stock. In connection with the acquisition of Synthes, Inc. the Company entered into two accelerated share repurchase (ASR) agreements.  In 2013, the Company settled the remaining liabilities under the ASR agreements. While the Company believes that the transactions under each ASR agreement and a series of related internal transactions were consummated in a tax efficient manner in accordance with applicable law, it is possible that the Internal Revenue Service could assert one or more contrary positions to challenge the transactions from a tax perspective. If challenged, an amount up to the total purchase price for the Synthes shares could be treated as subject to applicable U.S. tax at approximately the statutory rate to the Company, plus interest.
With the exception of the Actelion Ltd acquisition, supplemental pro forma information for 2018, 2017 and 2016 in accordance with U.S. GAAP standards related to business combinations, and goodwill and other intangible assets, is not provided, as the impact of the aforementioned acquisitions did not have a material effect on the Company’s results of operations, cash flows or financial position.
During 2018, the Company divested the LifeScan Inc business for approximately $2.1 billion and retained certain net liabilities. Other divestitures in 2018 included: NIZORAL®, RoC® and certain non-strategic Pharmaceutical products. In 2018, the pre-tax gains on the divestitures were approximately $1.2 billion. Additionally, in 2018, the Company accepted the binding offer from Fortive Corporation to acquire its Advanced Sterilization Products (ASP) business for approximately $2.7 billion, subject to customary adjustments. The transaction is expected to close in 2019. As of December 30, 2018, the assets held for sale on the Consolidated Balance Sheet were $0.2 billion of inventory, $0.1 billion of property, plant and equipment and $0.3 billion of goodwill. The Company will retain certain net receivables of approximately $0.1 billion associated with the ASP business.
In 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world’s leading manufacturing services providers for health care products and technology products. The Company is expanding a 12-year relationship with Jabil to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of employees and manufacturing sites. As of December 30, 2018, the assets held for sale on the Consolidated Balance Sheet were $0.3 billion of inventory and $0.1 billion of property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 22 to the Consolidated Financial Statements.
During 2017, the Company divestitures primarily included: the Codman Neurosurgery business, to Integra LifeSciences Holdings Corporation and the divestiture of COMPEED® to HRA Pharma. In 2017, the pre-tax gains on the divestitures were approximately $1.3 billion.
During 2016, the Company divestitures included: the controlled substance raw material and active pharmaceutical ingredient (API) business; certain anesthetic products in Europe; and certain non-strategic Consumer brands. In 2016, the pre-tax gains on the divestitures were approximately $0.6 billion.
XML 51 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Legal Proceedings
 12 Months Ended
Dec. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Legal Proceedings
Legal Proceedings
Johnson & Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability, intellectual property, commercial, supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business.

The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. As of December 30, 2018, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions. The ability to make such estimates and judgments can be affected by various factors, including whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; or there are numerous parties involved.

In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.

PRODUCT LIABILITY

Johnson & Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.

The most significant of these cases include: the DePuy ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System; the PINNACLE® Acetabular Cup System; pelvic meshes; RISPERDAL®; XARELTO®; body powders containing talc, primarily JOHNSONS® Baby Powder; INVOKANA®; and ETHICON PHYSIOMESH® Flexible Composite Mesh. As of December 30, 2018, in the United States there were approximately 1,800 plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System; 10,500 with respect to the PINNACLE® Acetabular Cup System; 34,800 with respect to pelvic meshes; 13,400 with respect to RISPERDAL®; 25,600 with respect to XARELTO®; 13,000 with respect to body powders containing talc; 1,050 with respect to INVOKANA®; and 2,100 with respect to ETHICON PHYSIOMESH® Flexible Composite Mesh.

In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson & Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than 10,000 claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Québec Superior Court and the Supreme Court of British Columbia. The British Columbia order is currently the subject of an appeal. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR™ Hip-related product liability litigation.

Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson & Johnson (collectively, DePuy) relating to the PINNACLE® Acetabular Cup System used in hip replacement surgery. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States. Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial, the second remains under appeal and the third is pending decision on post-trial motions in the district court. The Company has established an accrual for product liability litigation associated with the PINNACLE® Acetabular Cup System. The Company is negotiating settlements of these cases and the related costs are reflected in the Company’s accruals.

Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson & Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Southern District of West Virginia. The Company has settled or otherwise resolved a majority of the United States cases and the costs associated with these settlements are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands and Belgium, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices. In Australia, a trial of class action issues has been completed and the parties are awaiting a decision. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh products.

Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH® Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson & Johnson alleging personal injury arising out of the use of this hernia mesh device.  Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH® Flexible Composite Mesh.

Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson & Johnson arising out of the use of RISPERDAL®, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism, and related compounds. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.

Claims for personal injury arising out of the use of XARELTO®, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson & Johnson; and JPI's collaboration partner for XARELTO® Bayer AG and certain of its affiliates. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania; and there are coordinated proceedings in Delaware, California and Missouri. Class action lawsuits also have been filed in Canada. The Company has established an accrual for defense costs only in connection with product liability litigation associated with XARELTO®.

Personal injury claims alleging that talc causes cancer have been made against Johnson & Johnson Consumer Inc. and Johnson & Johnson arising out of the use of body powders containing talc, primarily JOHNSONS® Baby Powder. The number of pending product liability lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a verdict in July 2018 of $4.7 billion. The Company believes that it has strong grounds on appeal to overturn these verdicts. The Company has established an accrual for defense costs only in connection with product liability litigation associated with body powders containing talc.

In February 2018, a securities class action lawsuit was filed against Johnson & Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson & Johnson violated the federal securities laws by failing to adequately disclose the alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S® Baby Powder, and that purchasers of Johnson & Johnson’s shares suffered losses as a result.  Plaintiffs are seeking damages.  In October 2018, a shareholder derivative lawsuit was filed against Johnson & Johnson as the nominal defendant and its current directors as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON’S® Baby Powder, and that Johnson & Johnson has suffered damages as a result of those alleged breaches.  Plaintiff is seeking damages and an order for the Company to reform its internal policies and procedures.  In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson & Johnson Savings Plan against Johnson & Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson & Johnson stock as a Johnson & Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON’S® Baby Powder.  Plaintiffs are seeking damages and injunctive relief.  Each of these matters will be adjudicated in conjunction with the multi-district litigation referenced in the prior paragraph. In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice and the Securities and Exchange Commission. The Company is cooperating with these government inquiries and will be producing documents in response.     

Claims for personal injury have been made against a number of Johnson & Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson & Johnson, arising out of the use of INVOKANA®, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts in Pennsylvania, California and New Jersey. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.


INTELLECTUAL PROPERTY
Certain subsidiaries of Johnson & Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company’s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.

Medical Devices
In June 2009, Rembrandt Vision Technologies, L.P. (Rembrandt) filed a patent infringement lawsuit against Johnson & Johnson Vision Care, Inc. (JJVCI) in the United States District Court for the Eastern District of Texas alleging that JJVCI's manufacture and sale of its ACUVUE® ADVANCE and ACUVUE OASYS® Hydrogel Contact Lenses infringed Rembrandt’s United States Patent No. 5,712,327 and seeking monetary relief. The case was transferred to the United States District Court for the Middle District of Florida, where a trial in May 2012 resulted in a verdict of non-infringement that was subsequently upheld on appeal. In July 2014, Rembrandt sought a new trial based on alleged new evidence, which the district court denied. In April 2016, the Court of Appeals overturned that ruling and remanded the case to the district court for a new trial. A new trial was held in August 2017, and the jury returned a verdict of non-infringement in favor of JJVCI. Rembrandt has appealed the verdict to the United States Court of Appeals for the Federal Circuit (CAFC). In February 2019, the CAFC affirmed the judgment in favor of JJVCI.

In March 2013, Medinol Ltd. (Medinol) filed a patent infringement lawsuit against Cordis Corporation (Cordis) and Johnson & Johnson in the United States District Court for the Southern District of New York alleging that Cordis’s sales of the CYPHER™ and CYPHER SELECT™ stents made in the United States since 2005 willfully infringed four of Medinol's patents directed to the geometry of articulated stents. Medinol is seeking damages and attorneys’ fees. Although Johnson & Johnson has since sold Cordis, it has retained liability for this case. After trial in January 2014, the district court dismissed the case, finding Medinol unreasonably delayed bringing its claims (the laches defense). In September 2014, the district court denied a motion by Medinol to vacate the judgment and grant it a new trial. Medinol appealed the decision to the United States Court of Appeals for the Federal Circuit. In March 2017, the United States Supreme Court held that the laches defense is not available in patent cases. In April 2018, the United States Court of Appeals for the Federal Circuit remanded the case back to the district court to reconsider Medinol’s motion for a new trial, and briefing in the district court was completed in June 2018.

In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE® Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants. MedIdea alleges infringement of United States Patent Nos. 6,558,426 (’426); 8,273,132 (’132); 8,721,730 (’730) and 9,492,280 (’280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAMTM Contact feature of the ATTUNE® posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts. A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the ’132, ’730 and ’280 patents, based on the district court’s claim construction and reserving its right to appeal that construction, leaving only the ’426 patent at issue before the district court. In January 2019, the district court stayed the case pending a decision in the Inter Partes Review proceeding on the ’426 patent (see below). In December 2017, DePuy Synthes Products, Inc. filed a Petition for Inter Partes Review with the United States Patent and Trademark Office (USPTO), seeking to invalidate the two claims of the ’426 patent asserted in the district court litigation, and in June 2018, the USPTO instituted review of those claims. A hearing trial is scheduled for March 2019, and a decision in the proceeding is due by June 2019.

In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (the ’735 patent); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (the ’284 patent), are either invalid or not infringed by Ethicon’s ENSEAL® X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the ’735 patent, the ’284 patent and United States Patent Nos. 8,323,310 (the ’310 patent); 9,084,608; 9,241,759 (the ’759 patent) and 9,113,882, and seeking damages and an injunction. Covidien filed a motion for preliminary injunction, which was denied in October 2017. The parties have entered joint stipulations such that only the ’735 patent, the ’310 patent and the ’759 patent remain in dispute. Trial is scheduled to begin in September 2019.

In November 2017, Board of Regents, The University of Texas System and Tissuegen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC alleging the manufacture and sale of VICRYL® Plus Antibacterial Sutures, MONOCRYL® Plus Antibacterial Sutures, PDS® Plus Antibacterial Sutures, STRATAFIX® POS® Antibacterial Sutures and STRATAFIX® MONOCRYL®Plus Antibacterial Sutures infringe plaintiffs’ United States Patent Nos. 6,596,296 and 7,033,603 directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent. UT is seeking damages and an injunction. In December 2018, Ethicon filed petitions with the USPTO, seeking Inter Partes Review (IPR) of both asserted patents. Those petitions have been stayed by the USPTO pending a decision by the U.S. Court of Appeals for the Federal Circuit in an unrelated case.

Pharmaceutical
In April 2016, MorphoSys AG, a German biotech company, filed a patent infringement lawsuit against Janssen Biotech, Inc. (JBI), Genmab U.S. Inc. and Genmab A/S (collectively, Genmab) in the United States District Court for the District of Delaware. MorphoSys alleged that JBI’s manufacture and sale of DARZALEX® (daratumumab) willfully infringed MorphoSys’ United States Patent Nos. 8,263,746, 9,200,061 and 9,785,590. MorphoSys sought money damages. JBI licenses patents and the commercial rights to DARZALEX® from Genmab. In January 2019, the district court granted summary judgment in JBI and Genmab’s favor, invalidating the asserted claims of the patents-in-suit, and the parties filed a joint stipulation of dismissal of the action.

In August 2016, Sandoz Ltd and Hexal AG (collectively, Sandoz) filed a lawsuit in the English High Court against G.D. Searle LLC, a Pfizer company (Searle) and Janssen Sciences Ireland UC (JSI) alleging that Searle’s supplementary protection certificate SPC/GB07/038 (SPC), which is exclusively licensed to JSI, is invalid and should be revoked. Janssen-Cilag Limited sells PREZISTA® (darunavir) in the United Kingdom pursuant to this license. In October 2016, Searle and JSI counterclaimed against Sandoz for threatened infringement of the SPC based on statements of its plans to launch generic darunavir in the United Kingdom. Sandoz admitted that its generic darunavir product would infringe the SPC if it is found valid. Searle and JSI are seeking an order enjoining Sandoz from marketing its generic darunavir before the expiration of the SPC. Following a trial in April 2017, the court entered a decision holding that the SPC is valid and granting a final injunction. Sandoz has appealed the court’s decision and the injunction is stayed pending the appeal. In January 2018, the court referred the issue on appeal to the Court of Justice for the European Union (CJEU) and stayed the proceedings pending the CJEU’s ruling on the issue.

In April 2018, Acerta Pharma B.V., AstraZeneca UK Ltd and AstraZeneca Pharmaceuticals LP filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Pharmacylics LLC and Abbvie Inc. (collectively, Abbvie), alleging that the manufacture and sale of IMBRUVICA® infringes U.S. Patent No. 7,459,554. Janssen Biotech, Inc., which commercializes IMBRUVICA® jointly with Abbvie, intervened in the action in November 2018. A trial is scheduled to begin in January 2021.

REMICADE® Related Cases

In August 2014, Celltrion Healthcare Co. Ltd. and Celltrion Inc. (collectively, Celltrion) filed an application with the United States Food and Drug Administration (FDA) for approval to make and sell its own infliximab biosimilar. In March 2015, Janssen Biotech, Inc. (JBI) filed a lawsuit in the United States District Court for the District of Massachusetts against Celltrion and Hospira Healthcare Corporation (Hospira), which has exclusive marketing rights for Celltrion’s infliximab biosimilar in the United States, seeking, among other things, a declaratory judgment that their biosimilar product infringes or potentially infringes several JBI patents, including United States Patent No. 6,284,471 relating to REMICADE® (infliximab) (the ’471 patent) and United States Patent No. 7,598,083 (the ’083 patent) directed to the cell culture media used to make Celltrion’s biosimilar. In August 2016, the district court granted both Celltrion’s and Hospira’s motions for summary judgment of invalidity of the ’471 patent. JBI appealed those decisions to the United States Court of Appeals for the Federal Circuit. In January 2018, the Federal Circuit dismissed the appeal as moot based on its affirmance of a decision by the USPTO’s Patent Trial and Appeal Board affirming invalidity of the ’471 patent.

In June 2016, JBI filed two additional patent infringement lawsuits asserting the ’083 patent, one against Celltrion and Hospira in the United States District Court for the District of Massachusetts and the other against HyClone Laboratories, Inc., the manufacturer of the cell culture media that Celltrion uses to make its biosimilar product, in the United States District Court for the District of Utah. On July 30, 2018 the district court granted Celltrion’s motion for summary judgment of non-infringement and entered an order dismissing the ’083 lawsuit against Celltrion and Hospira. JBI appealed to the United States Court of Appeals for the Federal Circuit. The litigation against HyClone in Utah is stayed pending the outcome of the Massachusetts actions.

The FDA approved the first infliximab biosimilar for sale in the United States in 2016, and a number of such products have been launched.

Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)
The following summarizes lawsuits pending against generic companies that have filed Abbreviated New Drug Applications (ANDAs) with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson & Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of generic versions of the products at issue to the market prior to the expiration of the relevant patents. The Inter Partes Review (IPR) process with the United States Patent and Trademark Office (USPTO), created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.
ZYTIGA® 
In July 2015, Janssen Biotech, Inc., Janssen Oncology, Inc. and Janssen Research & Development, LLC (collectively, Janssen) and BTG International Ltd. (BTG) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies (and certain of their affiliates and/or suppliers) who filed ANDAs seeking approval to market a generic version of ZYTIGA® 250mg before the expiration of United States Patent No. 8,822,438 (the ’438 patent). The generic companies include Amneal Pharmaceuticals, LLC and Amneal Pharmaceuticals of New York, LLC (collectively, Amneal); Apotex Inc. and Apotex Corp. (collectively, Apotex); Citron Pharma LLC (Citron); Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, Dr. Reddy’s); Mylan Pharmaceuticals Inc. and Mylan Inc. (collectively, Mylan); Par Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. (collectively, Par); Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries, Inc. (collectively, Sun); Teva Pharmaceuticals USA, Inc. (Teva); Wockhardt Bio A.G.; Wockhardt USA LLC and Wockhardt Ltd. (collectively, Wockhardt); West-Ward Pharmaceutical Corp. (West-Ward) and Hikma Pharmaceuticals, LLC (Hikma).

Janssen and BTG also initiated patent infringement lawsuits in the United States District Court for the District of New Jersey against Amerigen Pharmaceuticals Limited (Amerigen) in May 2016, and Glenmark Pharmaceuticals, Inc. (Glenmark) in June 2016, each of whom filed an ANDA seeking approval to market its generic version of ZYTIGA® before the expiration of the ’438 patent. These lawsuits have been consolidated with the lawsuit filed in July 2015.

In August 2015, Janssen and BTG filed an additional jurisdictional protective lawsuit against the Mylan defendants in the United States District Court for the Northern District of West Virginia, which has been stayed.

In August 2017, Janssen and BTG initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva, who filed an ANDA seeking approval to market a generic version of ZYTIGA® 500mg before the expiration of the ’438 patent. This lawsuit has been consolidated with the lawsuit filed in July 2015.

In February 2018, Janssen and BTG filed a patent infringement lawsuit against MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited (collectively, MSN) in United States District Court for the District of New Jersey based on its ANDA seeking approval for a generic version of ZYTIGA® prior to the expiration of the ’438 patent.

In November 2018, Janssen and BTG initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Qilu Pharmaceutical Co., Ltd. and Qilu Pharma, Inc. (collectively, Qilu), who filed an ANDA seeking approval to market a generic version of ZYTIGA® before the expiration of the ’438 patent.

In December 2017, Janssen and BTG entered into a settlement agreement with Glenmark. In January 2018, Janssen dismissed its lawsuit against Sun after it withdrew its ANDA. In April 2018, Janssen and BTG entered into a settlement agreement with Apotex.

In October 2018, the United States District Court for the District of New Jersey issued a ruling invalidating all asserted claims of the ’438 patent. The court held that the patent claims would be infringed if the patent were valid. Janssen appealed the court’s decision.

In November 2018, the United States Court of Appeals for the Federal Circuit denied Janssen’s request for an injunction pending appeal. As a result, several generic versions of ZYTIGA® have entered the market. Janssen has appealed the decision of the United States District Court for the District of New Jersey, and the oral argument on the appeal is scheduled for March 2019.

The lawsuits against MSN and Qilu remain pending in the district courts. In each of these lawsuits, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA® before the expiration of the ’438 patent.

Several generic companies including Amerigen, Argentum Pharmaceuticals LLC (Argentum), Mylan, Wockhardt, Actavis, Amneal, Dr. Reddy’s, Sun, Teva, West-Ward and Hikma filed Petitions for Inter Partes Review (IPR) with the USPTO, seeking to invalidate the ’438 patent. In January 2018, the USPTO issued decisions finding the ’438 patent claims unpatentable, and Janssen requested rehearing. In December 2018, the USPTO denied Janssen’s request for rehearing of the IPR decisions. Janssen filed an appeal, which was consolidated with the above-mentioned appeal of the decision of the United States District Court for the District of New Jersey.

In October 2017, Janssen Inc. and Janssen Oncology, Inc. (collectively, Janssen) initiated two Notices of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) and the Minister of Health in Canada in response to Teva's filing Abbreviated New Drug Submissions (ANDS) and seeking approval to market generic versions of ZYTIGA® 250mg and ZYTIGA® 500mg before the expiration of Canadian Patent No. 2,661,422. In June 2018, the parties entered into a settlement agreement.

In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex’s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA® before the expiration of Canadian Patent No. 2,661,422. The federal court of Canada scheduled the Final Hearing for April 2019. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Apotex’s ANDS before the expiration of Janssen’s patent.

In January 2019, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex and the Minister of Health in Canada in response to Apotex’s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a film-coated generic version of ZYTIGA® before the expiration of Canadian Patent No. 2,661,422. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Apotex’s ANDS before the expiration of Janssen’s patent.


XARELTO® 
Beginning in October 2015, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of XARELTO® before expiration of Bayer’s United States Patent Nos. 7,157,456, 7,585,860 and 7,592,339 relating to XARELTO®. JPI is the exclusive sublicensee of the asserted patents. The following generic companies are named defendants: Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. (collectively, Aurobindo); Breckenridge Pharmaceutical, Inc. (Breckenridge); InvaGen Pharmaceuticals Inc. (InvaGen); Micro Labs USA Inc. and Micro Labs Ltd (collectively, Micro); Mylan Pharmaceuticals Inc. (Mylan); Prinston Pharmaceuticals, Inc.; Sigmapharm Laboratories, LLC (Sigmapharm); Torrent Pharmaceuticals, Limited and Torrent Pharma Inc. (collectively, Torrent). Trial concluded in April 2018. In July 2018 the district court entered judgment against Mylan and Sigmapharm, holding that the asserted compound patent is valid and infringed. In September 2018, the district court entered judgment against the remaining defendants. None of the defendants appealed the judgment.

Beginning in April 2017, JPI and Bayer Intellectual Property GmbH and Bayer AG (collectively, Bayer AG) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of XARELTO® before expiration of Bayer AG’s United States Patent No. 9,539,218 (’218) relating to XARELTO®. JPI is the exclusive sublicensee of the asserted patent. The following generic companies are named defendants: Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc. (Alembic); Aurobindo; Breckenridge; InvaGen; Lupin Limited and Lupin Pharmaceuticals, Inc. (collectively, Lupin); Micro; Mylan; Sigmapharm; Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. (collectively, Taro) and Torrent. Lupin counterclaimed for declaratory judgment of noninfringement and invalidity of United States Patent No. 9,415,053, but Lupin dismissed its counterclaims after it was provided a covenant not to sue on that patent. Aurobindo, Taro, Torrent, Micro, Breckenridge, InvaGen, Sigmapharm, Lupin and Alembic have agreed to have their cases stayed and to be bound by the outcome of any final judgment rendered against any of the other defendants. The ’218 cases have been consolidated for discovery and trial, and are currently set for trial in April 2019.

In December 2018, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. (collectively, Teva) who filed an ANDA seeking approval to market a generic version of XARELTO® before expiration of Bayer AG’s ’218 patent.

In each of these lawsuits, JPI is seeking an order enjoining the defendants from marketing their generic versions of XARELTO® before the expiration of the relevant patents.

In May 2018, Mylan filed a Petition for Inter Partes Review with the USPTO, seeking to invalidate the ’218 patent. In December 2018, the USPTO issued a decision denying institution of Mylan’s Petition for Inter Partes Review.

PREZISTA® 

In May 2018, Janssen Products, L.P. and Janssen Sciences Ireland UC (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Laurus Labs, Ltd. and Pharmaq, Inc. (collectively, DRL) who filed an ANDA seeking approval to market generic versions of PREZISTA® before the expiration of United States Patent Nos. 8,518,987; 7,126,015; and 7,595,408. Trial is scheduled to begin in May 2020.

In December 2018, Janssen initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt Ltd., and Raks Pharma Pvt. Ltd. (collectively, Amneal), who filed an ANDA seeking approval to market generic versions of PREZISTA® before the expiration of United States Patent Nos. 8,518,987; 7,126,015; and 7,595,408.

In each of these lawsuits, Janssen is seeking an order enjoining the defendants from marketing its generic versions of PREZISTA® before the expiration of the relevant patents.


INVOKANA®/INVOKAMET® 

Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey, the United States District Court for the District of Colorado and the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA® and/or INVOKAMET® before expiration of MTPC’s United States Patent Nos. 7,943,582 and/or 8,513,202 relating to INVOKANA® and INVOKAMET®. Janssen is the exclusive licensee of the asserted patents. The following generic companies are named defendants:  Apotex Inc. and Apotex Corp. (Apotex); Aurobindo Pharma USA Inc. (Aurobindo); Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.; InvaGen Pharmaceuticals, Inc. (InvaGen); Prinston Pharmaceuticals Inc.; Dr. Reddy’s Laboratories, Inc. and Dr. Reddy’s Laboratories Ltd; Hetero USA, Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited; MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.; Laurus Labs Ltd.; Indoco Remedies Ltd.; Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); Teva Pharmaceuticals USA, Inc.; and Lupin Ltd. and Lupin Pharmaceuticals, Inc.

Beginning in July 2017, Janssen and MTPC filed patent infringement lawsuits in the United States District Court for the District of New Jersey and the United States District Court for the District of Colorado against Sandoz and InvaGen, who filed ANDAs seeking approval to market generic versions of INVOKANA® and/or INVOKAMET® before expiration of MTPC’s United States Patent No. 7,943,788 (the ’788 patent) relating to INVOKANA® and INVOKAMET® and against Zydus, who filed ANDAs seeking approval to market generic versions of INVOKANA® and INVOKAMET® before expiration of the ’788 patent, MTPC's United States Patent No. 8,222,219 relating to INVOKANA® and INVOKAMET® and MTPC’s United States Patent No. 8,785,403 relating to INVOKAMET®, and against Aurobindo, who filed an ANDA seeking approval to market a generic version of INVOKANA® before expiration of the ’788 patent and the ’219 patent relating to INVOKANA®. Janssen is the exclusive licensee of the asserted patents. In October 2017, the Colorado lawsuits against Sandoz were dismissed. In December 2017, the Delaware lawsuits against Apotex and Teva were dismissed.

In April 2018, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Prinston, who filed an ANDA seeking approval to market a generic version of INVOKANA® before expiration of the ’788 patent relating to INVOKANA®.

In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA® and/or INVOKAMET® before the expiration of the relevant patents.

OPSUMIT® 

In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) and Amneal Pharmaceuticals LLC (Amneal), each of whom filed an ANDA seeking approval to market a generic version of OPSUMIT® before the expiration of United States Patent No. 7,094,781. In the lawsuit, Actelion is seeking an order enjoining Zydus and Amneal from marketing generic versions of OPSUMIT® before the expiration of the patent. In December 2018, the district court entered an order wherein one of the defendants, Amneal, stipulated to infringement. Trial is scheduled to commence in October 2020.

INVEGA SUSTENNA® 

In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA® before the expiration of United States Patent No. 9,439,906. In the lawsuit, Janssen is seeking an order enjoining Teva from marketing a generic version of INVEGA SUSTENNA® before the expiration of the patent.

In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Notices of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) and the Minister of Health in response to Teva's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA® before the expiration of Canadian Patent Nos. 2,309,629 and 2,655,335. Janssen is seeking an order prohibiting the Minister of Health from issuing a Notice of Compliance with respect to Teva’s ANDS before the expiration of these patents. The Final Hearing is scheduled to begin in September 2019.

IMBRUVICA® 

Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA® before expiration of Pharmacyclics’  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA®. JBI is the exclusive licensee of the asserted patents. The following generic companies are named defendants: Cipla Limited and Cipla USA Inc. (Cipla); Fresenius Kabi USA, LLC, Fresenius Kabi USA, Inc., and Fresenius Kabi Oncology Limited (Fresenius Kabi); Sandoz Inc. and Lek Pharmaceuticals d.d. (Sandoz); Shilpa Medicare Limited (Shilpa); Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited (Sun); Teva Pharmaceuticals USA, Inc. (Teva); and Zydus Worldwide DMCC and Cadila Healthcare Limited (Zydus). Trial is scheduled to begin in October 2020.

In October 2018, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Sun asserting newly issued United States Patent No. 10,004,746.

In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA® before the expiration of the relevant patents.

In January 2019, Pharmacyclics and JBI amended their complaints against Fresenius Kabi, Zydus, Teva and Sandoz to further allege infringement of U.S. Patent Nos. 10,106,548, and 10,125,140.

In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA® 70 mg before the expiration of U.S. Patent Nos. 514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140.

GOVERNMENT PROCEEDINGS
Like other companies in the pharmaceutical and medical devices industries, Johnson & Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.

Average Wholesale Price (AWP) Litigation
Johnson & Johnson and several of its pharmaceutical subsidiaries (the J&J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&J AWP Defendants were ultimately dismissed. The J&J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. Two cases remain pending. In a case brought by Illinois, trial has been scheduled for March 2019. In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson & Johnson and ALZA Corporation.

Opioids Litigation
Beginning in 2014 and continuing to the present, Johnson & Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than 1,600 lawsuits brought by certain state and local governments related to the marketing of opioids, including DURAGESIC®, NUCYNTA® and NUCYNTA® ER. To date, complaints against pharmaceutical companies, including Johnson & Johnson and JPI, have been filed in state court by the state Attorneys General in Arkansas, Florida, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma and South Dakota. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama; Arkansas; California; Connecticut; Florida; Georgia; Illinois; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Mississippi; Missouri; Nevada; New Hampshire; New Jersey; New Mexico; New York; North Carolina; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Virginia; Washington; West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. In addition, the Province of British Columbia filed suit in Canada. These actions allege a variety of claims related to opioids marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. These cases are in early stages of litigation. In October 2017, Johnson & Johnson and JPI were both served with a motion to consolidate 66 pending matters into a federal Multi District Litigation in the Southern District of Ohio. In December 2017, the MDL was approved in the Northern District of Ohio and there are over 1,400 cases that have been transferred to the MDL.

Johnson & Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson & Johnson and JPI were contacted by the Texas and Colorado Attorney General’s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. The multi-state coalition served Johnson & Johnson and JPI with subpoenas as part of the investigation. Johnson & Johnson and JPI have also received requests for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs regarding the sales, marketing, and educational strategies related to the promotion of opioids use.

Other
In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson & Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR™ XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a qui tam case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies’ motion to dismiss with prejudice, unsealed the qui tam complaint, and denied the qui tam relators’ request for leave to file a further amended complaint. The qui tam relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court’s dismissal in part, reversed in part, and affirmed the decision to deny the relators’ request to file a third amended complaint. The relators’ remaining claims are now pending before the district court, and fact discovery is currently scheduled to close in September 2019. Additionally, DePuy filed a petition for certiorari with the United States Supreme Court, seeking review of the First Circuit’s decision. The Supreme Court denied the petition in April 2018.
Since October 2013, a group of State Attorneys General have issued Civil Investigative Demands relating to the development, sales and marketing of several of DePuy Orthopaedics, Inc.'s hip products. In July 2014, the Oregon Department of Justice, which was investigating these matters independently of the other states, announced a settlement of its ASR™ XL Hip device investigation with the State of Oregon. In December 2018, the Company, the remaining states and the District of Columbia agreed to settle all of the investigations, and on January 22, 2019, the states and the Company filed consent judgments resolving the matter.
In October 2012, Johnson & Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson & Johnson's subsidiary, Ethicon, Inc. (Ethicon). Johnson & Johnson and Ethicon have since entered into a series of tolling agreements with the 47 states and the District of Columbia participating in the multi-state investigation and have responded to Civil Investigative Demands served by certain of the participating states. The states are seeking monetary and injunctive relief. In May 2016, California and Washington filed civil complaints against Johnson & Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by Kentucky in August 2016 and by Mississippi in October 2017. Johnson & Johnson and Ethicon have entered into a new tolling agreement with the remaining 43 states and the District of Columbia.
In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson & Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex® (methoxsalen) and the Uvar Xts® and Cellex® Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson & Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson & Johnson retains OCD’s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney’s Office requested that Johnson & Johnson produce certain documents, and Johnson & Johnson is cooperating with those requests.
In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson & Johnson and Johnson & Johnson Consumer Companies, Inc. (now known as Johnson & Johnson Consumer Inc.) (JJCI). The complaint alleges that defendants failed to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S® Baby Powder and JOHNSON'S® Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief. Trial is stayed pending interlocutory appeal of a denial of JJCI's motion for summary judgment.

In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney’s Office for the Southern District of New York related to JPI’s contractual relationships with pharmacy benefit managers over the period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products. The demand was issued in connection with an investigation under the False Claims Act.

In January 2017, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Department of Justice relating to allegations concerning the sales and marketing practices of OLYSIO®. In December 2017, Johnson & Johnson and JPI were served with a whistleblower lawsuit filed in the United States District Court for the Central District of California alleging the off-label promotion of OLYSIO® and additional products, including NUCYNTA®, XARELTO®, LEVAQUIN® and REMICADE®.  At this time, the federal and state governments have declined to intervene and the lawsuit, which is related to the Civil Investigative Demand, is being prosecuted by a former company employee.  The United States District Court for the Central District of California dismissed the claim in April 2018. In May 2018, the relator filed a notice of appeal to the United States Court of Appeals for the Ninth Circuit.

In November 2018, a second whistleblower lawsuit was unsealed in the United States District Court for the Central District of California. The lawsuit is substantially similar to the lawsuit under appeal but is brought in the name of the original relator. The federal and state governments have declined to intervene in the second suit at this time.

In February 2017, Johnson & Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking the production of records pertaining to payments to any 501(c)(3) charitable organization that provides financial assistance to Medicare patients. Multiple pharmaceutical companies have publicly reported receipt of subpoenas and ongoing inquiries similar to this one and the one described below. The government has represented that it will not be pursuing action against the company in this matter.

Actelion Pharmaceuticals US, Inc. (Actelion US), received a subpoena in May 2016, with follow-up requests for documents from the United States Attorney's Office for the District of Massachusetts. The subpoena seeks the production of records pertaining to Actelion US’ payments to 501(c)(3) charitable organizations that provide financial assistance to Medicare patients. In December 2018, the Company and the United States Department of Justice agreed to a settlement in this matter.

In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE® or SIMPONI ARIA®.

In April and September 2017, Johnson & Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX®, OLYSIO®, REMICADE®, SIMPONI®, STELARA® and ZYTIGA®. The subpoenas also seek documents relating to Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies.

In June 2017, Johnson & Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson & Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government’s investigation.

In July 2018, Advanced Sterilization Products (ASP) received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning the pricing, quality, marketing and promotion of EvoTech ECR, Tyvek Peel Pouches, or Sterrad Cyclesure 24 biological indicators.

In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson & Johnson do Brasil Indústria e Comércio de Produtos para Saúde Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry. The United States Department of Justice and the United States Securities and Exchange Commission have made additional preliminary inquiries about the inspection in Brazil, and Johnson & Johnson do Brasil Indústria e Comércio de Produtos para Saúde Ltda. is cooperating with those requests.

From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson & Johnson to cooperate with these inquiries by producing the requested information.
GENERAL LITIGATION

In April 2016, a putative class action was filed against Johnson & Johnson, Johnson & Johnson Sales and Logistics Company, LLC and McNeil PPC, Inc. (now known as Johnson & Johnson Consumer, Inc.) in New Jersey Superior Court, Camden County on behalf of persons who reside in the state of New Jersey who purchased various McNeil over-the-counter products from December 2008 through the present. The complaint alleges violations of the New Jersey Consumer Fraud Act. Following the grant of a motion to dismiss and the filing of an amended complaint, in May 2017, the court denied a motion to dismiss the amended complaint. In December 2018, a settlement was reached and the matter has been dismissed.

In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson & Johnson and Johnson & Johnson Consumer Companies, Inc. (now known as Johnson & Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S® Baby Powder and JOHNSON'S® Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson & Johnson's and JJCI’s motion to dismiss one of the cases. In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal. In September 2017, the plaintiff in the second case voluntarily dismissed their complaint. In March 2018, the plaintiff in the second case refiled in Illinois State Court.

In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA®) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015.

In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson & Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In June 2016, the district court denied motions to dismiss filed by JJVCI and other defendants. Discovery is ongoing. In March 2017, the plaintiffs filed a motion for class certification. The district court held a hearing on the motion for class certification in August 2018. In December 2018, the district court granted the plaintiffs motion for class certification.
In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research & Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson & Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO® as safer and more effective than less expensive alternative medications while failing to fully disclose its risks. The complaint seeks damages.
In May 2017, Lonza Sales AG (Lonza) filed a Request for Arbitration with the London Court of International Arbitration against Janssen Research & Development, LLC (Janssen R&D). Lonza alleges that Janssen R&D breached a 2005 agreement between the parties by sublicensing certain Lonza technology used in the manufacture of daratumumab without Lonza’s consent. Lonza seeks monetary damages. The arbitration hearing was held in September 2018. Post hearing briefing is complete, and the parties are awaiting a decision.
In May 2017, a purported class action was filed in the United States District Court for the Western District of Washington against LifeScan Inc., Johnson & Johnson, other diabetes test strip manufacturers and certain Pharmacy Benefit Managers (PBMs). The complaint alleges that consumers paid inflated prices for glucose monitor test strips as a consequence of undisclosed rebates and other incentives paid by manufacturers to PBMs. The complaint includes RICO, ERISA, and state consumer protection claims. The complaint seeks equitable relief and damages. In November 2017, the case was ordered transferred to United States District Court for the District of New Jersey. The LifeScan business was divested in October 2018 and Johnson & Johnson retained liability that may result from these claims prior to the closing of the divestiture.
In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson & Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania. Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE®. The complaint seeks damages and injunctive relief.

Beginning in September 2017, multiple purported class actions were filed against Johnson & Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen’s REMICADE® contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief. In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation.

In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson & Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania. The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE®. The complaint seeks damages and injunctive relief.
 
In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson & Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.  The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health.

Andover Healthcare, Inc. (Andover) filed a Lanham act case against Johnson & Johnson Consumer Inc. in April 2017 in the United States District Court for the District of Massachusetts.  Andover asserts that the claim “not made with natural rubber latex” on COACH® Sports Wrap, BAND-AID® Brand SECURE-FLEX® Wrap and BAND-AID® Brand HURT-FREE® Wrap is false.  Andover seeks actual damages and pre-judgment interest thereon, disgorgement of profits, treble damages, attorney’s fees and injunctive relief.  In December 2018, the parties entered into a settlement agreement.

In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively “Actelion”) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.  The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER®.  TRACLEER® is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on distribution of the product.  In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in federal court in Maryland. 
 
In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research & Development, LLC, and Johnson & Johnson (collectively, Janssen) were served with a qui tam complaint filed on behalf of the United States, 28 states, and the District of Columbia.  The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA® to the government in connection with direct government sales and government-funded drug reimbursement programs.  At this time, the federal and state governments have declined to intervene.

Johnson & Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.
XML 52 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring
 12 Months Ended
Dec. 30, 2018
Restructuring and Related Activities [Abstract]  
Restructuring
Restructuring
In the first quarter of 2016, the Company announced restructuring actions in its Medical Devices segment to better serve the needs of patients and customers in today’s evolving healthcare marketplace. The Company has undertaken actions to strengthen its go-to-market model, accelerate the pace of innovation, further prioritize key platforms and geographies, and streamline operations while maintaining high quality standards.
In 2018, the Company recorded a pre-tax charge of $462 million, of which $46 million was included in cost of products sold and $227 million was included in other (income) expense. Total project costs of $2.5 billion have been recorded since the restructuring has been announced. This restructuring program was completed in the fiscal fourth quarter of 2018.
On April 17, 2018, the Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the global supply chain restructuring strategic collaborations see Note 20 to the Consolidated Financial Statements. In 2018, the Company recorded a pre-tax charge of $238 million, of which $59 million was included in cost of products sold and $117 million was included in other (income) expense. See the following table for additional details on the restructuring programs.
In total, the Company expects the Global Supply Chain actions to generate approximately $0.6 billion to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 billion to $2.3 billion, over the 4 to 5 year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.   

The following table summarizes the severance charges and the associated spending under these initiatives through the fiscal year ended 2018:
(Dollars in Millions)
Severance
Asset Write-offs
Other**
Total
Reserve balance, January 3, 2016
$
484

—

17

501

 
 
 
 
 
2016 activity
(104
)
—

(16
)
(120
)
 
 
 
 
 
Reserve balance, January 1, 2017
380

—

1

381

 
 
 
 
 
2017 activity
(151
)
—

37

(114
)
 
 
 
 
 
Reserve balance, December 31, 2017
229

—

38

267

 
 
 
 
 
Current year activity:
 
 
 
 
   Charges
—

132

568

700

   Cash payments
(35
)
—

(558
)
(593
)
   Settled non cash
—

(132
)
—

(132
)
Reserve balance, December 30, 2018*
$
194

—

48

242

 
 
 
 
 
*Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws.
**Other includes project expense such as salaries for employees supporting the initiative and consulting expenses.

Although the Medical Devices restructuring program was completed in 2018, the Company expects that severance charges will continue beyond that date. The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments has extended due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable. Approximately 2,375 individuals received separation payments since these restructuring announcements.
XML 53 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 30, 2018
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation
The consolidated financial statements include the accounts of Johnson & Johnson and its subsidiaries (the Company). Intercompany accounts and transactions are eliminated.
Description of the Company And Business Segments
Description of the Company and Business Segments
The Company has approximately 135,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the world and its primary focus is on products related to human health and well-being.
The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. The Pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular), diabetes care (divested in the fiscal fourth quarter of 2018) and vision fields, which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

New Accounting Pronouncements
New Accounting Standards
Recently Adopted Accounting Standards
ASU 2014-09: Revenue from Contracts with Customers
On January 1, 2018, the Company adopted the new accounting standard, ASC 606, Revenue from Contracts with Customers and all the related amendments (new revenue standard) to all contracts using the modified retrospective method. The cumulative effect of initially applying the new revenue standard was recognized as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The adoption of the new revenue standard has not had a material impact to either reported Sales to customers or Net earnings. Additionally, the Company will continue to recognize revenue from product sales as goods are shipped or delivered to the customer, as control of goods transfers at the same time.

In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on the Company's Consolidated Statement of Earnings and Balance Sheet was as follows:
Statement of Earnings - For the fiscal year ended December 30, 2018
(Dollars in millions)
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Sales to customers
$
81,581

 
(35
)
 
81,546

 
 
 
 
 
 
Net earnings
15,297

 
(28
)
 
15,269

 
 
 
 
 
 
Balance Sheet - As of December 30, 2018
 
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Assets
152,954

 
23

 
152,977

 
 
 
 
 
 
Liabilities
93,202

 
4

 
93,206

 
 
 
 
 
 
Equity
$
59,752

 
19

 
59,771

 
 
 
 
 
 


The Company made a cumulative effect adjustment to the 2018 opening balance of retained earnings upon adoption of ASU 2014-09, which decreased beginning retained earnings by $47 million.
As part of the adoption of ASC 606 see Note 18 to the Consolidated Financial Statements for further disaggregation of revenue.
ASU 2016-01: Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities
The Company adopted this standard as of the beginning of the fiscal year 2018 on a modified retrospective basis. The amendments in this update supersede the guidance to classify equity securities with readily determinable fair values into different categories (that is, trading or available-for-sale) and require equity securities to be measured at fair value with changes in the fair value recognized through net earnings. The standard amends financial reporting by providing relevant information about an entity’s equity investments and reducing the number of items that are recognized in other comprehensive income.
The Company made a cumulative effect adjustment to the opening balance of retained earnings upon adoption of ASU 2016-01 that increased retained earnings by $232 million net of tax and decreased accumulated other comprehensive income for previously unrealized gains from equity investments. For additional details see Note 6 to the Consolidated Financial Statements.
ASU 2016-16: Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory
The Company adopted this standard as of the beginning of the fiscal year 2018. This update removes the current exception in U.S. GAAP prohibiting entities from recognizing current and deferred income tax expenses or benefits related to transfer of assets, other than inventory, within the consolidated entity. The current exception to defer the recognition of any tax impact on the transfer of inventory within the consolidated entity until it is sold to a third party remains unaffected. As discussed further in Note 8 to the Consolidated Financial Statements, in the fourth fiscal quarter of 2018 the Company elected an accounting policy to treat the tax on global intangible low-taxed income (GILTI) under the deferred tax accounting model. As a result, the Company is required to record an additional deferred tax liability related to the basis difference of these intra-entity asset transfers. The Company recorded net adjustments including an increase to deferred tax assets of approximately $2.0 billion, an increase to deferred tax liabilities of approximately $1.7 billion, related to the GILTI accounting policy election in the fourth fiscal quarter of 2018, a decrease to Other Assets of approximately $0.7 billion and a decrease to retained earnings of approximately $0.4 billion. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

ASU 2017-01: Clarifying the Definition of a Business
The Company adopted this standard as of the beginning of the fiscal year 2018. This update narrows the definition of a business by providing a screen to determine when an integrated set of assets and activities is not a business. The screen specifies that an integrated set of assets and activities is not a business if substantially all of the fair value of the gross assets acquired or disposed of is concentrated in a single or a group of similar identifiable assets. This update was applied prospectively. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

ASU 2017-07: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost
The Company adopted this standard as of the beginning of the fiscal year 2018. This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost (NPBC). In addition, only the service cost component will be eligible for capitalization. The amendments in this update are required to be applied retrospectively for the presentation of the service cost component and the other components of NPBC in the Consolidated Statement of Earnings and prospectively, on and after the adoption date, for the capitalization of the service cost component of NPBC in assets. As required by the transition provisions of this update, the following table shows the impact of the adoption on the respective line items in the Consolidated Statement of Earnings for 2018 and the reclassifications to the 2017 and 2016 fiscal year Consolidated Statement of Earnings to retroactively apply classification of the service cost component and the other components of NPBC:

(Dollars In millions)
 
 
Increase (Decrease) to Net Expense
 
 
2018
2017
 
2016
Cost of products sold
 
$
51

85

 
104

Selling, marketing and administrative expenses
 
55

100

 
122

Research and development expense
 
21

40

 
48

Other (income) expense, net
 
(127
)
(225
)
 
(274
)
Earnings before provision for taxes on income
 
$
—

—

 
—






The following table summarizes the cumulative effect adjustments made to the 2018 opening balance of retained earnings upon adoption of the new accounting standards mentioned above:
(Dollars in Millions)
 
Cumulative Effect Adjustment Increase (Decrease) to Retained Earnings
ASU 2014-09 - Revenue from Contracts with Customers
 
$
(47
)
ASU 2016-01 - Financial Instruments
 
232

ASU 2016-16 - Income Taxes: Intra-Entity Transfers
 
(439
)
Total
 
$
(254
)


ASU 2017-12: Targeted Improvements to Accounting for Hedging Activities
The Company elected to early adopt this standard as of the beginning of the fiscal second quarter of 2018. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. For additional required disclosures see Note 6 to the Consolidated Financial Statements.

Recently Issued Accounting Standards
Not Adopted as of December 30, 2018
ASU 2018-18: Collaborative Arrangements
This update clarifies the interaction between ASC 808, Collaborative Arrangements and ASC 606, Revenue from Contracts with Customers. The update clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue if the counterparty is not a customer for that transaction. This update will be effective for the Company for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2018-18 should be applied retrospectively to the date of initial application of ASC 606 and early adoption is permitted. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2018-16: Derivatives and Hedging (Topic ASC 815)
This update adds the Overnight Index Swap (OIS) rate based on the Secured Overnight Financing Rate (SOFR) as an eligible benchmark interest rate permitted in the application of hedge accounting. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted if an entity has adopted ASU 2017-12. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2018-02: Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
This update allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Job Act enacted in December 2017. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company does not expect this standard to have a material impact on the Company's consolidated financial statements.

ASU 2016-13: Financial Instruments - Credit Losses
This update introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. This update will be effective for the Company for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements and related disclosures.

ASU 2016-02: Leases
This update requires the recognition of lease assets and lease liabilities on the balance sheet for all lease obligations and disclosing key information about leasing arrangements. This update requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current generally accepted accounting principles. This update will be effective for the Company for all annual periods beginning after December 15, 2018, including interim periods within those fiscal years. The Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements. The Company’s operating leases will result in the recognition of additional assets and the corresponding liabilities on its Consolidated Balance Sheets. The adoption of this standard will not have a material impact on the Company's consolidated financial statements.
Cash Equivalents
Cash Equivalents
The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. The Company has a policy of making investments only with commercial institutions that have at least an investment grade credit rating. The Company invests its cash primarily in government securities and obligations, corporate debt securities, money market funds and reverse repurchase agreements (RRAs).
RRAs are collateralized by deposits in the form of Government Securities and Obligations for an amount not less than 102% of their value. The Company does not record an asset or liability as the Company is not permitted to sell or repledge the associated collateral. The Company has a policy that the collateral has at least an A (or equivalent) credit rating. The Company utilizes a third party custodian to manage the exchange of funds and ensure that collateral received is maintained at 102% of the value of the RRAs on a daily basis. RRAs with stated maturities of greater than three months from the date of purchase are classified as marketable securities.
Investments
Investments
Investments classified as held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income. Available-for-sale securities available for current operations are classified as current assets otherwise, they are classified as long term. Management determines the appropriate classification of its investment in debt and equity securities at the time of purchase and re-evaluates such determination at each balance sheet date. The Company reviews its investments in equity securities for impairment and adjusts these investments to fair value through earnings, as required. 
Property, Plant and Equipment and Depreciation
Property, Plant and Equipment and Depreciation
Property, plant and equipment are stated at cost. The Company utilizes the straight-line method of depreciation over the estimated useful lives of the assets:
Building and building equipment
20 - 30 years
Land and leasehold improvements
10 - 20 years
Machinery and equipment
2 - 13 years


The Company capitalizes certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 8 years.
The Company reviews long-lived assets to assess recoverability using undiscounted cash flows. When certain events or changes in operating or economic conditions occur, an impairment assessment may be performed on the recoverability of the carrying value of these assets. If the asset is determined to be impaired, the loss is measured based on the difference between the asset’s fair value and its carrying value. If quoted market prices are not available, the Company will estimate fair value using a discounted value of estimated future cash flows.
Revenue Recognition
Revenue Recognition
The Company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. The Company's global payment terms are typically between 30 to 90 days. Provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.
Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. Rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. The Company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.
Sales returns are estimated and recorded based on historical sales and returns information. Products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.
Sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. The sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. In accordance with the Company’s accounting policies, the Company generally issues credit to customers for returned goods. The Company’s sales returns reserves are accounted for in accordance with the U.S. GAAP guidance for revenue recognition when right of return exists. Sales returns reserves are recorded at full sales value. Sales returns in the Consumer and Pharmaceutical segments are almost exclusively not resalable. Sales returns for certain franchises in the Medical Devices segment are typically resalable but are not material. The Company infrequently exchanges products from inventory for returned products. The sales returns reserve for the total Company has been approximately 1.0% of annual net trade sales during the fiscal reporting years 2018, 2017 and 2016.
Promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. Continuing promotional programs include coupons and volume-based sales incentive programs. The redemption cost of consumer coupons is based on historical redemption experience by product and value. Volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. These arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. The Company also earns profit-share payments through collaborative arrangements for certain products, which are included in sales to customers. For all years presented, profit-share payments were less than 2.0% of the total revenues and are included in sales to customers.
Shipping and Handling
Shipping and Handling
Shipping and handling costs incurred were $1,090 million, $1,042 million and $974 million in 2018, 2017 and 2016, respectively, and are included in selling, marketing and administrative expense. The amount of revenue received for shipping and handling is less than 0.5% of sales to customers for all periods presented.
Inventories
Inventories
Inventories are stated at the lower of cost or net realizable value determined by the first-in, first-out method.
Intangible Assets and Goodwill
Intangible Assets and Goodwill
The authoritative literature on U.S. GAAP requires that goodwill and intangible assets with indefinite lives be assessed annually for impairment. The Company completed the annual impairment test for 2018 in the fiscal fourth quarter. Future impairment tests will be performed annually in the fiscal fourth quarter, or sooner if warranted. Purchased in-process research and development is accounted for as an indefinite lived intangible asset until the underlying project is completed, at which point the intangible asset will be accounted for as a definite lived intangible asset, or abandoned, at which point the intangible asset will be written off or partially impaired.
Intangible assets that have finite useful lives continue to be amortized over their useful lives, and are reviewed for impairment when warranted by economic conditions. See Note 5 for further details on Intangible Assets and Goodwill.
Financial Instruments
Financial Instruments
As required by U.S. GAAP, all derivative instruments are recorded on the balance sheet at fair value. Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. The authoritative literature establishes a three-level hierarchy to prioritize the inputs used in measuring fair value, with Level 1 having the highest priority and Level 3 having the lowest. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.
The Company documents all relationships between hedged items and derivatives. The overall risk management strategy includes reasons for undertaking hedge transactions and entering into derivatives. The objectives of this strategy are: (1) minimize foreign currency exposure’s impact on the Company’s financial performance; (2) protect the Company’s cash flow from adverse movements in foreign exchange rates; (3) ensure the appropriateness of financial instruments; and (4) manage the enterprise risk associated with financial institutions. See Note 6 for additional information on Financial Instruments.
Product Liability
Product Liability
Accruals for product liability claims are recorded, on an undiscounted basis, when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on existing information and actuarially determined estimates where applicable. The accruals are adjusted periodically as additional information becomes available. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.
As a result of cost and availability factors, effective November 1, 2005, the Company ceased purchasing third-party product liability insurance. The Company has self insurance through a wholly-owned captive insurance company. In addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated.
Research and Development
Research and Development
Research and development expenses are expensed as incurred in accordance with ASC 730, Research and Development. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Amounts capitalized for such payments are included in other intangibles, net of accumulated amortization.
The Company enters into collaborative arrangements, typically with other pharmaceutical or biotechnology companies, to develop and commercialize drug candidates or intellectual property. These arrangements typically involve two (or more) parties who are active participants in the collaboration and are exposed to significant risks and rewards dependent on the commercial success of the activities. These collaborations usually involve various activities by one or more parties, including research and development, marketing and selling and distribution. Often, these collaborations require upfront, milestone and royalty or profit share payments, contingent upon the occurrence of certain future events linked to the success of the asset in development. Amounts due from collaborative partners related to development activities are generally reflected as a reduction of research and development expense because the performance of contract development services is not central to the Company’s operations. In general, the income statement presentation for these collaborations is as follows:

Nature/Type of Collaboration
 
Statement of Earnings Presentation
Third-party sale of product & profit share payments received
 
Sales to customers
Royalties/milestones paid to collaborative partner (post-regulatory approval)*
 
Cost of products sold
Royalties received from collaborative partner
 
Other income (expense), net
Upfront payments & milestones paid to collaborative partner (pre-regulatory approval)
 
Research and development expense
Research and development payments to collaborative partner
 
Research and development expense
Research and development payments received from collaborative partner
 
Reduction of Research and development expense
* 
Milestones are capitalized as intangible assets and amortized to cost of products sold over the useful life.
For all years presented, there was no individual project that represented greater than 5% of the total annual consolidated research and development expense.
The Company has a number of products and compounds developed in collaboration with strategic partners including XARELTO®, co-developed with Bayer HealthCare AG and IMBRUVICA®, developed in collaboration and co-marketed with Pharmacyclics LLC, an AbbVie company.
The Company has a number of licensing arrangements for products and compounds including DARZALEX®, licensed from Genmab A/S.
Advertising
Advertising
Costs associated with advertising are expensed in the year incurred and are included in selling, marketing and administrative expenses.
Income Taxes
Income Taxes
Income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between U.S. GAAP accounting and tax reporting, recorded as deferred tax assets or liabilities. The Company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. Future changes in tax laws and rates may affect recorded deferred tax assets and liabilities in the future.
The Company has unrecognized tax benefits for uncertain tax positions. The Company follows U.S. GAAP which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management believes that changes in these estimates would not have a material effect on the Company's results of operations, cash flows or financial position.
In the fourth fiscal quarter of 2018, the Company has elected to account for the GILTI tax under the deferred method. The deferred tax amounts recorded are based on the evaluation of temporary differences that are expected to reverse as GILTI is incurred.
The Company has recorded deferred tax liabilities on all undistributed earnings prior to December 31, 2017 from its international subsidiaries. The Company has not provided deferred taxes on the undistributed earnings subsequent to January 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. The Company intends to continue to reinvest these earnings in those international operations. If the Company decides at a later date to repatriate these earnings to the U.S., the Company would be required to provide for the net tax effects on these amounts. The Company estimates that the total tax effect of this repatriation would be approximately $0.7 billion under current enacted tax laws and regulations and at current currency exchange rates.
Net Earnings Per Share
Net Earnings Per Share
Basic earnings per share is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method.
Use of Estimates
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, rebates, allowances and incentives, product liabilities, income taxes, withholding taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates.
The Company follows the provisions of U.S. GAAP when recording litigation related contingencies. A liability is recorded when a loss is probable and can be reasonably estimated. The best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.
Annual Closing Date
Annual Closing Date
The Company follows the concept of a fiscal year, which ends on the Sunday nearest to the end of the month of December. Normally each fiscal year consists of 52 weeks, but every five or six years the fiscal year consists of 53 weeks, and therefore includes additional shipping days, as was the case in 2015, and will be the case again in 2020.
Reclassification
Reclassification
Certain prior period amounts have been reclassified to conform to current year presentation.
XML 54 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 30, 2018
Accounting Policies [Abstract]  
Schedule of New Accounting Pronouncements
As required by the transition provisions of this update, the following table shows the impact of the adoption on the respective line items in the Consolidated Statement of Earnings for 2018 and the reclassifications to the 2017 and 2016 fiscal year Consolidated Statement of Earnings to retroactively apply classification of the service cost component and the other components of NPBC:

(Dollars In millions)
 
 
Increase (Decrease) to Net Expense
 
 
2018
2017
 
2016
Cost of products sold
 
$
51

85

 
104

Selling, marketing and administrative expenses
 
55

100

 
122

Research and development expense
 
21

40

 
48

Other (income) expense, net
 
(127
)
(225
)
 
(274
)
Earnings before provision for taxes on income
 
$
—

—

 
—






The following table summarizes the cumulative effect adjustments made to the 2018 opening balance of retained earnings upon adoption of the new accounting standards mentioned above:
(Dollars in Millions)
 
Cumulative Effect Adjustment Increase (Decrease) to Retained Earnings
ASU 2014-09 - Revenue from Contracts with Customers
 
$
(47
)
ASU 2016-01 - Financial Instruments
 
232

ASU 2016-16 - Income Taxes: Intra-Entity Transfers
 
(439
)
Total
 
$
(254
)
In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on the Company's Consolidated Statement of Earnings and Balance Sheet was as follows:
Statement of Earnings - For the fiscal year ended December 30, 2018
(Dollars in millions)
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Sales to customers
$
81,581

 
(35
)
 
81,546

 
 
 
 
 
 
Net earnings
15,297

 
(28
)
 
15,269

 
 
 
 
 
 
Balance Sheet - As of December 30, 2018
 
As Reported
 
Effect of change
 
Balance without adoption of ASC 606
Assets
152,954

 
23

 
152,977

 
 
 
 
 
 
Liabilities
93,202

 
4

 
93,206

 
 
 
 
 
 
Equity
$
59,752

 
19

 
59,771

 
 
 
 
 
 
Estimated Useful Lives of Assets
Property, plant and equipment are stated at cost. The Company utilizes the straight-line method of depreciation over the estimated useful lives of the assets:
Building and building equipment
20 - 30 years
Land and leasehold improvements
10 - 20 years
Machinery and equipment
2 - 13 years
XML 55 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash, Cash Equivalents and Current Marketable Securities (Tables)
 12 Months Ended
Dec. 30, 2018
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalent Composition
At the end of 2018 and 2017, cash, cash equivalents and current marketable securities were comprised of:
(Dollars in Millions)
 
2018
 
 
Carrying Amount
 
 
Estimated Fair Value
 
Cash & Cash Equivalents
 
Current Marketable Securities
Cash
 
$
2,619

 
 
2,619

 
2,619

 
—

U.S. Reverse repurchase agreements
 
3,009

 
 
3,009

 
3,009

 
—

Other Reverse repurchase agreements
 
443

 
 
443

 
443

 
—

Money market funds
 
3,397

 
 
3,397

 
3,397

 
—

Time deposits(1)
 
485

 
 
485

 
485

 
—

    Subtotal
 
$
9,953

 
 
9,953

 
9,953

 
—

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gov't Securities
 
$
9,474

 
 
9,474

 
8,144

 
1,330

Corporate debt securities
 
260

 
 
260

 
10

 
250

   Subtotal available for sale(2)
 
$
9,734

 
 
9,734

 
8,154

 
1,580

 
 
 
 
 
 
 
 
 
 
Total cash, cash equivalents and current marketable securities
 


 
 
 
 
$
18,107

 
1,580



In 2018, the carrying amount was the same as the estimated fair value.
In 2017, the carrying amount was the same as the estimated fair value.
(Dollars in Millions)
 
2017
 
 
Carrying Amount
 
 
Estimated Fair Value
 
Cash & Cash Equivalents
 
Current Marketable Securities
Cash
 
$
2,929

 
 
2,929

 
2,929

 
—

Other Sovereign Securities(1)
 
279

 
 
279

 
219

 
60

U.S. Reverse repurchase agreements
 
4,025

 
 
4,025

 
4,025

 
—

Corporate debt securities(1)
 
289

 
 
289

 
244

 
45

Money market funds
 
4,288

 
 
4,288

 
4,288

 
—

Time deposits(1)
 
1,176

 
 
1,176

 
1,175

 
1

    Subtotal
 
$
12,986

 
 
12,986

 
12,880

 
106

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gov't Securities
 
$
4,864

 
 
4,864

 
4,833

 
31

Other Sovereign Securities
 
186

 
 
186

 
80

 
106

Corporate debt securities
 
260

 
 
260

 
31

 
229

   Subtotal available for sale(2)
 
$
5,310

 
 
5,310

 
4,944

 
366

 
 
 
 
 
 
 
 
 
 
Total cash, cash equivalents and current marketable securities
 
 
 
 
 
 
$
17,824

 
472


(1) Held to maturity investments are reported at amortized cost and realized gains or losses are reported in earnings.
(2) Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.
Contractual Maturities of Available for Sale Securities
The contractual maturities of the available for sale debt securities at December 30, 2018 are as follows:
(Dollars in Millions)
 
Cost Basis
 
Fair Value
Due within one year
 
$
9,670

 
9,670

Due after one year through five years
 
64

 
64

Due after five years through ten years
 
—

 
—

Total debt securities
 
$
9,734

 
9,734
XML 56 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories (Tables)
 12 Months Ended
Dec. 30, 2018
Inventory Disclosure [Abstract]  
Summary of Inventories
At the end of 2018 and 2017, inventories were comprised of:
(Dollars in Millions)
 
2018
 
2017
Raw materials and supplies
 
$
1,114

 
1,140

Goods in process
 
2,109

 
2,317

Finished goods
 
5,376

 
5,308

Total inventories
 
$
8,599

(1)
8,765


(1) Net of assets held for sale on the Consolidated Balance Sheet for approximately $0.2 billion related to the divestiture of the Advanced Sterilization Products business and $0.3 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.
XML 57 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property, Plant and Equipment (Tables)
 12 Months Ended
Dec. 30, 2018
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment at Cost and Accumulated Depreciation
At the end of 2018 and 2017, property, plant and equipment at cost and accumulated depreciation were:
(Dollars in Millions)
 
2018
 
2017
Land and land improvements
 
$
807

 
829

Buildings and building equipment
 
11,176

 
11,240

Machinery and equipment
 
25,992

 
25,949

Construction in progress
 
3,876

 
3,448

Total property, plant and equipment, gross
 
$
41,851

 
41,466

Less accumulated depreciation
 
24,816

 
24,461

Total property, plant and equipment, net
 
$
17,035

(1) 
17,005

(1) Net of assets held for sale on the Consolidated Balance Sheet for approximately $0.1 billion related to the divestiture of the Advanced Sterilization Products business and $0.1 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.
XML 58 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets and Goodwill (Tables)
 12 Months Ended
Dec. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets and Goodwill
At the end of 2018 and 2017, the gross and net amounts of intangible assets were:
(Dollars in Millions)
 
2018
 
2017
Intangible assets with definite lives:
 
 

 
 

Patents and trademarks — gross
 
$
35,194

 
36,427

Less accumulated amortization
 
9,784

 
7,223

Patents and trademarks — net
 
$
25,410

 
29,204

Customer relationships and other intangibles — gross
 
$
21,334

 
20,204

Less accumulated amortization
 
8,323

 
7,463

Customer relationships and other intangibles — net
 
$
13,011

 
12,741

Intangible assets with indefinite lives:
 
 

 
 

Trademarks
 
$
6,937

 
7,082

Purchased in-process research and development(1)
 
2,253

 
4,201

Total intangible assets with indefinite lives
 
$
9,190

 
11,283

Total intangible assets — net
 
$
47,611

 
53,228


(1) The decrease was primarily attributable to the write-down of $1.1 billion related to the assets acquired in the acquisitions of Alios Biopharma Inc. (Alios) and XO1 Limited (XO1). Of the $1.1 billion, the Company recorded a partial impairment charge of $0.8 billion related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios. The impairment charge was calculated based on updated cash flow projections discounted for the inherent risk in the asset development and reflects the impact of the phase 2b clinical trial suspension, a decrease in the probability of success factors and the ongoing analysis of asset development activities. In addition, an impairment charge of $0.3 billion was recorded for the discontinuation of the development project for an anti-thrombin antibody associated with the 2015 acquisition of XO1. Additionally, $0.8 billion of IPR&D related to ERLEADA™ was reclassified to definite lived intangible assets upon commercialization.
Goodwill
Goodwill as of December 30, 2018 and December 31, 2017, as allocated by segment of business, was as follows:
(Dollars in Millions)
 
Consumer
 
Pharmaceutical
 
Medical Devices
 
Total
Goodwill at January 1, 2017
 
$
8,263

 
2,840

 
11,702

 
22,805

Goodwill, related to acquisitions (1)
 
102

 
6,161

 
2,200

 
8,463

Goodwill, related to divestitures
 
(74
)
 
(1
)
 
(102
)
 
(177
)
Currency translation/other
 
584

 
109

 
122

 
815

Goodwill at December 31, 2017
 
$
8,875

 
9,109

 
13,922

 
31,906

Goodwill, related to acquisitions
 
168

 
51

 
184

 
403

Goodwill, related to divestitures
 
—

 
—

 
(1,348
)
(2) 
(1,348
)
Currency translation/other
 
(373
)
 
(97
)
 
(38
)
 
(508
)
Goodwill at December 30, 2018
 
$
8,670

 
9,063

 
12,720

 
30,453



(1) Goodwill of $6.2 billion related to the Actelion acquisition acquired in the fiscal second quarter of 2017, within the Pharmaceutical segment and $1.7 billion related to the AMO acquisition acquired in the fiscal first quarter of 2017, within the Medical Devices segment.
(2) Goodwill of $1.0 billion is related to the divestiture of the LifeScan business. Goodwill of $0.3 billion is related to the divestiture of the Advanced Sterilization Products business, which was pending and classified as assets held for sale on the Consolidated Balance Sheet as of December 30, 2018.
XML 59 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 30, 2018
Fair Value Disclosures [Abstract]  
Summary of Derivative Activity
The following table is a summary of the activity related to derivatives and hedges for the fiscal years ended December 30, 2018 and December 31, 2017:
 
December 30, 2018
December 31, 2017
(Dollars in Millions)
Sales
Cost of Products Sold
R&D Expense
Interest (Income) Expense
Other (Income) Expense
Sales
Cost of Products Sold
R&D Expense
Interest (Income) Expense
Other (Income) Expense
The effects of fair value, net investment and cash flow hedging:
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on fair value hedging relationship:
 
 
 
 
 
 
 
 
 
 
Interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
 Hedged items
$
—

—

—

5

—

—

—

—

5

—

 Derivatives designated as hedging instruments
—

—

—

(5
)
—

—

—

—

(5
)
—

 
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on net investment hedging relationship:
 
 
 
 
 
 
 
 
 
 
Cross currency interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing
—

—

—

56

—

—

—

—

—

—

   Amount of gain or (loss) recognized in AOCI
—

—

—

56

—

—

—

—

—

—

 
 
 
 
 
 
 
 
 
 
 
Gain (Loss) on cash flow hedging relationship:
 
 
 
 
 
 
 
 
 
 
Forward foreign exchange contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) reclassified from AOCI into income (1)
47

200

(220
)
—

(24
)
(31
)
(159
)
(165
)
—

(87
)
 
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) recognized in AOCI (1)
(32
)
(17
)
(193
)
—

(4
)
49

96

(199
)
—

(60
)
 
 
 
 
 
 
 
 
 
 
 
Cross currency interest rate swaps contracts:
 
 
 
 
 
 
 
 
 
 
   Amount of gain or (loss) reclassified from AOCI into income
—

—

—

133

—

—

—

—

83

—

   Amount of gain or (loss) recognized in AOCI
$
—

—

—

117

—

—

—

—

110

—


(1) Includes equity collar contracts. The equity collar contracts expired in December of 2017.

 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule of Derivatives Recorded in Consolidated Balance Sheets
For the fiscal years ended December 30, 2018 and December 31, 2017, the following amounts were recorded on the Consolidated Balance Sheet
Line item in the Consolidated Balance Sheet in which the hedged item is included
 
Carrying Amount of the Hedged Liability

 
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability
(Dollars in Millions)
 
December 30, 2018
 
December 31, 2017
 
December 30, 2018
 
December 31, 2017
Current Portion of Long-term Debt
 
$
494

 
597

 
5

 
2

Long-term Debt
 
—

 
496

 
—

 
3
Schedule of Effect of Derivatives not Designated as Hedging Instruments
The following table is the effect of derivatives not designated as hedging instrument for the fiscal years ended December 30, 2018 and December 31, 2017:
 
 
 
 
 
(Dollars in Millions)
 
Location of Gain /(Loss) Recognized in Income on Derivative
 
Gain/(Loss)
Recognized In
Income on Derivative
Derivatives Not Designated as Hedging Instruments
 
 
 
December 30, 2018
 
December 31, 2017
Foreign Exchange Contracts
 
Other (income) expense
 
(68
)
 
(5
)
Schedule of Effect of Net Investment Hedges
The following table is the effect of net investment hedges for the fiscal years ended December 30, 2018 and December 31, 2017:
 
 
Gain/(Loss)
Recognized In
Accumulated OCI
 
Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income
 
Gain/(Loss) Reclassified From
Accumulated OCI
Into Income
(Dollars in Millions)
 
Fiscal Nine Months Ended
 
 
December 30, 2018
 
December 31, 2017
 
 
 
December 30, 2018
 
December 31, 2017
Debt
 
$
218

 
(597
)
 
Other (income) expense

 
—

 
—

Cross Currency interest rate swaps
 
$
150

 
—

 
Other (income) expense
 
—

 
—
Summary of Activity Related to Equity Investments
The following table is a summary of the activity related to equity investments as of December 30, 2018:
(Dollars in Millions)
 
December 31, 2017
 
 
 
 
 
December 30, 2018
 
 
 
 
Carrying Value
 
Changes in Fair Value Reflected in Net Income (1)
 
Sales/ Purchases/Other (2)
 
Carrying Value
 
Non Current Other Assets
Equity Investments with readily determinable value
 
$
751

 
(247
)
 
7

 
511

 
511

 
 
 
 
 
 
 
 
 
 
 
Equity Investments without readily determinable value
 
$
510

 
13

 
158

 
681

 
681

(1) Recorded in Other Income/Expense
(2) Other includes impact of currency
Financial Assets and Liabilities at Fair Value
The Company’s significant financial assets and liabilities measured at fair value as of December 30, 2018 and December 31, 2017 were as follows:
 
 
2018
 
2017
(Dollars in Millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total (1)
Derivatives designated as hedging instruments:
 
 

 
 

 
 

 
 

 
 

Assets:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
$
—

 
501

 
—

 
501

 
418

Interest rate contracts (2)(4)
 
—

 
161

 
—

 
161

 
7

Total
 
—

 
662

 
—

 
662

 
425

Liabilities:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
548

 
—

 
548

 
402

Interest rate contracts (3)(4)
 
—

 
292

 
—

 
292

 
165

Total
 
—

 
840

 
—

 
840

 
567

Derivatives not designated as hedging instruments:
 
 

 
 

 
 

 
 

 
 

Assets:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
32

 
—

 
32

 
38

Liabilities:
 
 

 
 

 
 

 
 

 
 

Forward foreign exchange contracts
 
—

 
32

 
—

 
32

 
38

Available For Sale Other Investments:
 
 
 
 
 
 
 
 
 
 
Equity investments(5)
 
511

 
—

 
—

 
511

 
751

Debt securities(6)
 
$
—

 
9,734

 
—

 
9,734

 
5,310



Gross to Net Derivative Reconciliation
 
2018
 
2017
(Dollars in Millions)
 
 
 
 
Total Gross Assets
 
$
694

 
463

Credit Support Agreement (CSA)
 
(423
)
 
(76
)
Total Net Asset
 
271

 
387

 
 
 
 
 
Total Gross Liabilities
 
872

 
605

Credit Support Agreement (CSA)
 
(605
)
 
(238
)
Total Net Liabilities
 
$
267

 
367

 
 
 
 
 


(1) 
2017 assets and liabilities are all classified as Level 2 with the exception of equity investments of $751 million, which are classified as Level 1.
(2) 
Includes $6 million and $7 million of non-current assets for the fiscal years ending December 30, 2018 and December 31, 2017, respectively.
(3) 
Includes $3 million and $9 million of non-current liabilities for the fiscal years ending December 30, 2018 and December 31, 2017, respectively.
(4) 
Includes cross currency interest rate swaps and interest rate swaps.
(5) 
Classified as non-current other assets. The carrying amount of the equity investments were $511 million and $751 million as of December 30, 2018 and December 31, 2017, respectively.
(6) 
Classified as cash equivalents and current marketable securities.
XML 60 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Borrowings (Tables)
 12 Months Ended
Dec. 30, 2018
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
The components of long-term debt are as follows:
(Dollars in Millions)
 
2018
  
Effective Rate %
  
2017
  
Effective Rate %
 
5.15% Debentures due 2018
 
$
—

  


  
900

  
5.18
 
1.65% Notes due 2018
 
—

 


 
597

 
1.70
 
4.75% Notes due 2019 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)
 
1,139

(2) 
5.83

  
1,192

(3) 
5.83
 
1.875% Notes due 2019
 
494

 
1.93

 
496

 
1.93
 
0.89% Notes due 2019
 
300

 
1.32

 
300

 
1.75
 
1.125% Notes due 2019
 
699

 
1.13

 
699

 
1.13
 
3% Zero Coupon Convertible Subordinated Debentures due 2020
 
51

  
3.00

  
60

  
3.00
 
2.95% Debentures due 2020
 
548

  
3.15

  
547

  
3.15
 
1.950% Notes due 2020
 
499

 
1.99

 
499

 
1.99
 
3.55% Notes due 2021
 
449

 
3.67

 
448

 
3.67
 
2.45% Notes due 2021
 
349

 
2.48

 
349

 
2.48
 
1.65% Notes due 2021
 
998

 
1.65

 
998

 
1.65
 
0.250% Notes due 2022 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)
 
1,137

(2) 
0.26

 
1,191

(3) 
0.26
 
2.25% Notes due 2022
 
996

 
2.31

 
995

 
2.31
 
6.73% Debentures due 2023
 
250

  
6.73

  
250

  
6.73
 
3.375% Notes due 2023
 
805

 
3.17

 
806

 
3.17
 
2.05% Notes due 2023
 
498

 
2.09

 
498

 
2.09
 
0.650% Notes due 2024 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)
 
851

(2) 
0.68

 
891

(3) 
0.68
 
5.50% Notes due 2024 (500MM GBP 1.2636)(2)/(500MM GBP 1.3444)(3)
 
627

(2) 
6.75

  
666

(3) 
6.75
 
2.625% Notes due 2025
 
748

 
2.63

 
747

 
2.63
 
2.45% Notes due 2026
 
1,992

 
2.47

 
1,990

 
2.47
 
2.95% Notes due 2027
 
996

 
2.96

 
995

 
2.96
 
1.150% Notes due 2028 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)
 
847

(2) 
1.21

 
887

(3) 
1.21
 
2.900% Notes due 2028
 
1,493

 
2.91

 
1,492

 
2.91
 
6.95% Notes due 2029
 
297

  
7.14

  
296

  
7.14
 
4.95% Debentures due 2033
 
498

  
4.95

  
498

  
4.95
 
4.375% Notes due 2033
 
856

 
4.24

 
856

 
4.24
 
1.650% Notes due 2035 (1.5B Euro 1.14)(2)/(1.5B Euro 1.1947)(3)
 
1,693

(2) 
1.68

 
1,774

(3) 
1.68
 
3.55% Notes due 2036
 
988

 
3.59

 
987

 
3.59
 
5.95% Notes due 2037
 
991

  
5.99

  
991

  
5.99
 
3.625% Notes due 2037
 
1,486

 
3.64

 
1,486

 
3.64
 
5.85% Debentures due 2038
 
696

  
5.85

  
696

  
5.85
 
3.400% Notes due 2038
 
990

 
3.42

 
990

 
3.42
 
4.50% Debentures due 2040
 
538

  
4.63

  
538

  
4.63
 
4.85% Notes due 2041
 
297

 
4.89

 
296

 
4.89
 
4.50% Notes due 2043
 
495

 
4.52

 
495

 
4.52
 
3.70% Notes due 2046
 
1,972

 
3.74

 
1,971

 
3.74
 
3.75% Notes due 2047
 
991

 
3.76

 
990

 
3.76
 
3.500% Notes due 2048
 
742

 
3.52

 
742

 
3.52
 
Other
 
24

  
—

  
75

  
—
 
Subtotal
 
30,320

(4) 
3.19
%
(1) 
32,174

(4) 
3.19
(1 
) 
Less current portion
 
2,636

  
 

  
1,499

  
 
 
Total long-term debt
 
$
27,684

  
 

  
30,675

  
 
 

(1) 
Weighted average effective rate.
(2) 
Translation rate at December 30, 2018.
(3) 
Translation rate at December 31, 2017.
(4) 
The excess of the fair value over the carrying value of debt was $0.3 billion in 2018 and $2.0 billion in 2017.
Aggregate Maturities of Long Term Obligations
Aggregate maturities of long-term obligations commencing in 2019 are:
(Dollars in Millions)
 
 
 
 
 
 
 
 
2019
 
2020
 
2021
 
2022
 
2023
 
After 2023
$2,636
 
1,098
 
1,796
 
2,134
 
1,553
 
21,103
XML 61 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
 12 Months Ended
Dec. 30, 2018
Income Tax Disclosure [Abstract]  
Provision for Income Taxes
The provision for taxes on income consists of:
(Dollars in Millions)
 
2018
 
2017
 
2016
Currently payable:
 
 
 
 
 
 
U.S. taxes
 
$
1,081

 
11,969

 
1,896

U.S. taxes on international operations
 
203

 
126

 
49

International taxes
 
2,434

 
1,872

 
1,659

Total currently payable
 
3,718

 
13,967

 
3,604

Deferred:
 
 
 
 
 
 
U.S. taxes
 
(148
)
 
(1,956
)
 
294

U.S. taxes on international operations
 
1,358

 
 
 
 
International taxes
 
(2,226
)
 
4,362

 
(635
)
Total deferred
 
(1,016
)
 
2,406

 
(341
)
Provision for taxes on income
 
$
2,702

 
16,373

 
3,263
Comparison of Income Taxes at Statutory Rate and Company's Effective Tax Rate
A comparison of income tax expense at the U.S. statutory rate of 21% in 2018 and 35% in 2017 and 2016, to the Company’s effective tax rate is as follows:
(Dollars in Millions)
 
2018
 
2017
 
2016
U.S. 
 
$
5,575

 
4,865

 
7,457

International
 
12,424

 
12,808

 
12,346

Earnings before taxes on income:
 
$
17,999

 
17,673

 
19,803

Tax rates:
 
 
 
 
 
 
U.S. statutory rate
 
21.0
 %
 
35.0

 
35.0

International operations (1)
 
(3.7
)
 
(12.8
)
 
(17.2
)
Research and orphan drug tax credits
 
(1.0
)
 
(0.4
)
 
(0.4
)
U.S. state and local
 
0.8

 
0.6

 
(0.1
)
U.S. manufacturing deduction
 
—

 
(0.8
)
 
(0.6
)
U.S. tax on international income (2)
 
1.4

 
0.7

 
1.3

Tax benefits on share-based compensation
 
(1.5
)
 
(2.1
)
 
(1.8
)
U.S. tax benefit on asset/business disposals
 
0.5

 
(0.8
)
 
—

All other
 
(0.6
)
 
(0.1
)
 
0.3

TCJA and related impacts (3)
 
(1.9
)
(3) 
73.3

(4) 
—

Effective Rate
 
15.0
 %
 
92.6

 
16.5



(1) For all periods presented the Company has subsidiaries operating in Puerto Rico under various tax incentives. International operations reflects the impacts of operations in jurisdictions with statutory tax rates different than the U.S., particularly Ireland, Switzerland and Puerto Rico, which is a favorable impact on the effective tax rate as compared with the U.S. statutory rate. The 2017 amount also includes tax cost related to the revaluation of deferred tax balances related to the change in the Belgian statutory tax rate increasing the tax provision by approximately 3.4%.
(2) Includes the impact of the GILTI tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.
(3) Represents impact of adjustments to the 2017 TCJA provisional tax charge. This also includes a net tax benefit from the reduction of a deferred tax liability related to foreign withholding taxes originally accrued as part of the provisional charge. This benefit reduced the Company’s effective tax rate by approximately 11%. Further description is included below.
(4) Includes U.S. state and local taxes provisionally recorded as part TCJA provisional charge which was approximately 0.6% of the total effective tax rate.
Temporary Differences and Carryforwards
Temporary differences and carryforwards for 2018 and 2017 were as follows:
 
 
2018 Deferred Tax
 
2017 Deferred Tax
(Dollars in Millions)
 
Asset
 
Liability
 
Asset
 
Liability
Employee related obligations
 
$
2,398

 


 
2,259

 


Stock based compensation
 
639

 


 
507

 


Depreciation & amortization
 
1,784

 


 


 
(9
)
Non-deductible intangibles
 


 
(5,967
)
 


 
(6,506
)
International R&D capitalized for tax
 
1,282

 


 
1,307

 


Reserves & liabilities
 
1,647

 


 
1,718

 


Income reported for tax purposes
 
1,104

 


 
1,316

 


Net operating loss carryforward international
 
786

 


 
762

 


Undistributed foreign earnings
 
693

 
(2,240
)
 
1,101

 
(4,457
)
Global intangible low-taxed income
 
 
 
(2,971
)
 
 
 
 
Miscellaneous international
 
603

 
(93
)
 
755

 
(194
)
Miscellaneous U.S. 
 
469

 


 
177

 


Total deferred income taxes
 
$
11,405

 
(11,271
)
 
9,902

 
(11,166
)
Summary of Activity Related to Unrecognized Tax Benefits
The following table summarizes the activity related to unrecognized tax benefits:
(Dollars in Millions)
 
2018
 
2017
 
2016
Beginning of year
 
$
3,151

 
3,041

 
3,080

Increases related to current year tax positions
 
242

 
332

 
348

Increases related to prior period tax positions
 
145

 
232

 
11

Decreases related to prior period tax positions
 
(137
)
 
(416
)
(1)
(338
)
Settlements
 
(40
)
 
(2
)
 
(37
)
Lapse of statute of limitations
 
(35
)
 
(36
)
 
(23
)
End of year
 
$
3,326

 
3,151

 
3,041


(1) In 2017, $347 million of this decrease is related to the TCJA
XML 62 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Related Obligations (Tables)
 12 Months Ended
Dec. 30, 2018
Compensation Related Costs [Abstract]  
Employee Related Obligations
At the end of 2018 and 2017, employee related obligations recorded on the Consolidated Balance Sheets were:
(Dollars in Millions)
 
2018
 
2017
Pension benefits
 
$
5,327

 
5,343

Postretirement benefits
 
2,283

 
2,331

Postemployment benefits
 
2,330

 
2,250

Deferred compensation
 
410

 
475

Total employee obligations
 
10,350

 
10,399

Less current benefits payable
 
399

 
325

Employee related obligations — non-current
 
$
9,951

 
10,074
XML 63 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans (Tables)
 12 Months Ended
Dec. 30, 2018
Retirement Benefits [Abstract]  
Components of Net Periodic Benefit Cost
Net periodic benefit costs for the Company’s defined benefit retirement plans and other benefit plans for 2018, 2017 and 2016 include the following components:
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Service cost
 
$
1,283

 
1,080

 
949

 
269

 
247

 
224

Interest cost
 
996

 
927

 
927

 
148

 
159

 
158

Expected return on plan assets
 
(2,212
)
 
(2,041
)
 
(1,962
)
 
(7
)
 
(6
)
 
(6
)
Amortization of prior service cost (credit)
 
3

 
2

 
1

 
(31
)
 
(30
)
 
(34
)
Recognized actuarial losses
 
852

 
609

 
496

 
123

 
138

 
135

Curtailments and settlements
 
1

 
17

 
11

 
—

 
—

 
—

Net periodic benefit cost
 
$
923

 
594

 
422

 
502

 
508

 
477
Amounts Expected to be Recognized in Net Periodic Benefit Cost
Amounts expected to be recognized in net periodic benefit cost in the coming year for the Company’s defined benefit retirement plans and other post-retirement plans:
(Dollars in Millions)
 
Amortization of net transition obligation
$
—

Amortization of net actuarial losses
656

Amortization of prior service credit
27
Rates Used to Develop Actuarial Present Value of Projected Benefit Obligation
The following table represents the weighted-average actuarial assumptions:
 
 
Retirement Plans
 
Other Benefit Plans
Worldwide Benefit Plans
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Net Periodic Benefit Cost
 
 
 
 
 
 
 
 
 
 
 
 
Service cost discount rate
 
3.20
%
 
3.59
 
3.98
 
3.85
 
4.63
 
4.77
Interest cost discount rate
 
3.60
%
 
3.98
 
4.24
 
3.62
 
3.94
 
4.10
Rate of increase in compensation levels
 
3.98
%
 
4.01
 
4.02
 
4.29
 
4.31
 
4.32
Expected long-term rate of return on plan assets
 
8.46
%
 
8.43
 
8.55
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Benefit Obligation
 
 
 
 
 
 
 
 
 
 
 
 
Discount rate
 
3.76
%
 
3.30
 
3.78
 
4.40
 
3.78
 
4.42
Rate of increase in compensation levels
 
3.97
%
 
3.99
 
4.02
 
4.29
 
4.30
 
4.29
Assumed Health Care Cost Trend Rates
The following table displays the assumed health care cost trend rates, for all individuals:
Health Care Plans
 
2018
 
2017
Health care cost trend rate assumed for next year
 
6.12
%
 
6.33
%
Rate to which the cost trend rate is assumed to decline (ultimate trend)
 
4.55
%
 
4.55
%
Year the rate reaches the ultimate trend rate
 
2038

 
2038
Effect of One Percentage Point Change in Assumed Health Care Cost Trend Rates
A one-percentage-point change in assumed health care cost trend rates would have the following effect:
 
 
One-Percentage-
 
One-Percentage-
(Dollars in Millions)
 
Point Increase
 
Point Decrease
Health Care Plans
 
 

 
 

Total interest and service cost
 
$
28

 
(22
)
Post-retirement benefit obligation
 
$
340

 
(280
)
Schedule of Net Funded Status
The following table sets forth information related to the benefit obligation and the fair value of plan assets at year-end 2018 and 2017 for the Company’s defined benefit retirement plans and other post-retirement plans:
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
Change in Benefit Obligation
 
 
 
 
 
 
 
 
Projected benefit obligation — beginning of year
 
$
33,221

 
28,116

 
4,582

 
4,605

Service cost
 
1,283

 
1,080

 
269

 
247

Interest cost
 
996

 
927

 
148

 
159

Plan participant contributions
 
66

 
60

 
—

 
—

Amendments
 
26

 
(7
)
 
—

 
(17
)
Actuarial (gains) losses
 
(2,326
)
 
2,996

 
(119
)
 
(166
)
Divestitures & acquisitions
 
(29
)
 
201

 
—

 
88

Curtailments, settlements & restructuring
 
(21
)
 
(35
)
 
—

 
2

Benefits paid from plan
 
(1,018
)
 
(1,050
)
 
(383
)
 
(351
)
Effect of exchange rates
 
(528
)
 
933

 
(17
)
 
15

Projected benefit obligation — end of year
 
$
31,670

 
33,221

 
4,480

 
4,582

Change in Plan Assets
 
 
 
 
 
 
 
 
Plan assets at fair value — beginning of year
 
$
28,404

 
23,633

 
281

 
75

Actual return on plan assets
 
(1,269
)
 
4,274

 
—

 
12

Company contributions
 
1,140

 
664

 
282

 
545

Plan participant contributions
 
66

 
60

 
—

 
—

Settlements
 
(13
)
 
(32
)
 
—

 
—

Divestitures & acquisitions
 
(17
)
 
173

 
—

 
—

Benefits paid from plan assets
 
(1,018
)
 
(1,050
)
 
(383
)
 
(351
)
Effect of exchange rates
 
(475
)
 
682

 
—

 
—

Plan assets at fair value — end of year
 
$
26,818

 
28,404

 
180

 
281

Funded status — end of year
 
$
(4,852
)
 
(4,817
)
 
(4,300
)
 
(4,301
)
Amounts Recognized in the Company’s Balance Sheet consist of the following:
 
 
 
 
 
 
 
 
Non-current assets
 
$
475

 
526

 
—

 
—

Current liabilities
 
(98
)
 
(92
)
 
(281
)
 
(228
)
Non-current liabilities
 
(5,229
)
 
(5,251
)
 
(4,019
)
 
(4,073
)
Total recognized in the consolidated balance sheet — end of year
 
$
(4,852
)
 
(4,817
)
 
(4,300
)
 
(4,301
)
Amounts Recognized in Accumulated Other Comprehensive Income consist of the following:
 
 
 
 
 
 
 
 
Net actuarial loss
 
$
8,323

 
8,140

 
1,263

 
1,500

Prior service cost (credit)
 
2

 
(25
)
 
(106
)
 
(137
)
Unrecognized net transition obligation
 
—

 
—

 
—

 
—

Total before tax effects
 
$
8,325

 
8,115

 
1,157

 
1,363

 
 
 
 
 
 
 
 
 
Accumulated Benefit Obligations — end of year
 
$
28,533

 
29,793

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retirement Plans
 
Other Benefit Plans
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
Amounts Recognized in Net Periodic Benefit Cost and Other Comprehensive Income
 
 
 
 
 
 
 
 
Net periodic benefit cost
 
$
923

 
594

 
502

 
508

Net actuarial (gain) loss
 
1,153

 
740

 
(111
)
 
(169
)
Amortization of net actuarial loss
 
(852
)
 
(609
)
 
(123
)
 
(138
)
Prior service cost (credit)
 
26

 
(7
)
 
—

 
(17
)
Amortization of prior service (cost) credit
 
(3
)
 
(2
)
 
31

 
30

Effect of exchange rates
 
(114
)
 
256

 
(3
)
 
3

Total loss/(income) recognized in other comprehensive income, before tax
 
$
210

 
378

 
(206
)
 
(291
)
Total recognized in net periodic benefit cost and other comprehensive income
 
$
1,133

 
972

 
296

 
217
Information Related to the Benefit Obligation and the Fair Value of Plan Assets
The following table displays the funded status of the Company's U.S. Qualified & Non-Qualified pension plans and international funded and unfunded pension plans at December 31, 2018 and December 31, 2017, respectively:

 
U.S. Plans
International Plans
 
Qualified Plans
Non-Qualified Plans
Funded Plans
Unfunded Plans
(Dollars in Millions)
2018
2017
2018
2017
2018
2017
2018
2017
Plan Assets
$
17,725

18,681

—

—

9,093

9,723

—

—

Projected Benefit Obligation
18,609

19,652

2,176

2,257

10,467

10,863

418

449

Accumulated Benefit Obligation
16,851

17,654

1,793

1,849

9,510

9,893

379

397

Over (Under) Funded Status
 
 
 
 
 
 
 
 
Projected Benefit Obligation
$
(884
)
(971
)
(2,176
)
(2,257
)
(1,374
)
(1,140
)
(418
)
(449
)
Accumulated Benefit Obligation
874

1,027

(1,793
)
(1,849
)
(417
)
(170
)
(379
)
(397
)
Projected Future Benefit Payments from Company's Retirement and Other Benefit Plans
The following table displays the projected future benefit payments from the Company’s retirement and other benefit plans:
(Dollars in Millions)
 
2019
 
2020
 
2021
 
2022
 
2023
 
2024-2028
Projected future benefit payments
 
 
 
 
 
 
 
 
 
 
 
 
Retirement plans
 
$
1,062

 
1,104

 
1,182

 
1,257

 
1,332

 
7,679

Other benefit plans 
 
$
375

 
397

 
411

 
428

 
413

 
2,273
Projected Future Minimum Contributions to the Company's U.S. and International Unfunded Retirement Plans
The following table displays the projected future minimum contributions to the unfunded retirement plans. These amounts do not include any discretionary contributions that the Company may elect to make in the future.
(Dollars in Millions)
 
2019
 
2020
 
2021
 
2022
 
2023
 
2024-2028
Projected future contributions
 
$
92

 
95

 
101

 
108

 
115

 
697
Company' Retirement Plan Asset Allocation and Target Allocations
The Company’s retirement plan asset allocation at the end of 2018 and 2017 and target allocations for 2019 are as follows:
 
 
Percent of
Plan Assets
 
Target
Allocation
 
 
2018
 
2017
 
2019
Worldwide Retirement Plans
 
 
 
 
 
 
Equity securities
 
71
%
 
76
%
 
70
%
Debt securities
 
29

 
24

 
30

Total plan assets
 
100
%
 
100
%
 
100
%
Schedule of Defined Benefit Plans Disclosures
The following table sets forth the Retirement Plans' investments measured at fair value as of December 31, 2018 and December 31, 2017:
 
 
Quoted Prices
in Active
Markets for
Identical Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs(a)
 
Investments Measured at Net Asset Value
 
 
 
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
 
 
 
 
Total Assets
(Dollars in Millions)
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
 
2018
 
2017
Short-term investment funds
 
$
122

 
429

 
529

 
427

 
—

 
—

 
—

 
—

 
651

 
856

Government and agency securities
 
—

 
—

 
3,595

 
3,094

 
—

 
—

 
—

 
—

 
3,595

 
3,094

Debt instruments
 
—

 
—

 
3,105

 
2,013

 
—

 
—

 
—

 
—

 
3,105

 
2,013

Equity securities
 
11,298

 
13,848

 
4

 
—

 
—

 
—

 
—

 
—

 
11,302

 
13,848

Commingled funds
 
—

 
—

 
2,304

 
1,780

 
133

 
57

 
5,201

 
6,158

 
7,638

 
7,995

Insurance contracts
 
—

 
—

 
—

 
—

 
193

 
199

 
—

 
—

 
193

 
199

Other assets
 
—

 
—

 
33

 
121

 
—

 
—

 
301

 
278

 
334

 
399

Investments at fair value
 
$
11,420

 
14,277

 
9,570

 
7,435

 
326

 
256

 
5,502

 
6,436

 
26,818

 
28,404



(a) The activity for the Level 3 assets is not significant for all years presented.
XML 64 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital and Treasury Stock (Tables)
 12 Months Ended
Dec. 30, 2018
Equity [Abstract]  
Changes in Treasury Stock
Changes in treasury stock were:
 
 
Treasury Stock
(Amounts in Millions Except Treasury Stock Shares in Thousands)
 
Shares
 
Amount
Balance at January 3, 2016
 
364,681

 
$
22,684

Employee compensation and stock option plans
 
(30,839
)
 
(3,311
)
Repurchase of common stock
 
79,490

 
8,979

Balance at January 1, 2017
 
413,332

 
28,352

Employee compensation and stock option plans
 
(25,508
)
 
(3,156
)
Repurchase of common stock
 
49,494

 
6,358

Balance at December 31, 2017
 
437,318

 
31,554

Employee compensation and stock option plans
 
(22,082
)
 
(3,060
)
Repurchase of common stock
 
42,283

 
5,868

Balance at December 30, 2018
 
457,519

 
$
34,362
XML 65 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accumulated Other Comprehensive Income (Loss) (Tables)
 12 Months Ended
Dec. 30, 2018
Equity [Abstract]  
Components of Accumulated Other Comprehensive Income
Components of other comprehensive income (loss) consist of the following:
(Dollars in Millions)
 
Foreign
Currency Translation
 
Gain/(Loss) On Securities
 
Employee Benefit Plans
 
Gain/
(Loss) On
Derivatives & Hedges
 
Total
Accumulated
Other
Comprehensive Income (Loss)
January 3, 2016
 
$
(8,435
)
 
604

 
(5,298
)
 
(36
)
 
(13,165
)
Net 2016 changes
 
(612
)
 
(193
)
 
(682
)
 
(249
)
 
(1,736
)
January 1, 2017
 
(9,047
)
 
411

 
(5,980
)
 
(285
)
 
(14,901
)
Net 2017 changes
 
1,696

 
(179
)
 
(170
)
 
355

 
1,702

December 31, 2017
 
(7,351
)
 
232

 
(6,150
)
 
70

 
(13,199
)
Cumulative adjustment to retained earnings
 
 
 
(232
)
(1) 
 
 
 
 
(232
)
Net 2018 changes
 
(1,518
)
 
—

 
(8
)
 
(265
)
 
(1,791
)
December 30, 2018
 
$
(8,869
)
 
—

 
(6,158
)
 
(195
)
 
(15,222
)


(1) See Note 1 to Consolidated Financial Statements for additional details on the adoption of ASU 2016-01
XML 66 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share (Tables)
 12 Months Ended
Dec. 30, 2018
Earnings Per Share [Abstract]  
Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share
The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal years ended December 30, 2018, December 31, 2017 and January 1, 2017:
(In Millions Except Per Share Amounts)
 
2018
 
2017
 
2016
Basic net earnings per share
 
$
5.70

 
0.48

 
6.04

Average shares outstanding — basic
 
2,681.5

 
2,692.0

 
2,737.3

Potential shares exercisable under stock option plans
 
139.0

 
139.7

 
142.4

Less: shares repurchased under treasury stock method
 
(92.5
)
 
(87.3
)
 
(92.1
)
Convertible debt shares
 
0.7

 
0.9

 
1.3

Adjusted average shares outstanding — diluted
 
2,728.7

 
2,745.3

 
2,788.9

Diluted net earnings per share
 
$
5.61

 
0.47

 
5.93
XML 67 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Rental Expense and Lease Commitments (Tables)
 12 Months Ended
Dec. 30, 2018
Leases, Operating [Abstract]  
Schedule of Minimum Rental Payments Under Operating Leases
The approximate minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year at December 30, 2018 are:
(Dollars in Millions)
2019
 
2020
 
2021
 
2022
 
2023
 
After 2023
 
Total
$223
 
188
 
154
 
116
 
76
 
139
 
896
XML 68 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock, Stock Option Plans and Stock Compensation Agreements (Tables)
 12 Months Ended
Dec. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule Valuation Assumptions
The average fair value of options granted was $17.98, $13.38 and $10.01, in 2018, 2017 and 2016, respectively. The fair value was estimated based on the weighted average assumptions of:
 
2018
 
2017
 
2016
Risk-free rate
2.77
%
 
2.25
%
 
1.51
%
Expected volatility
15.77
%
 
15.30
%
 
15.76
%
Expected life (in years)
7.0

 
7.0

 
7.0

Expected dividend yield
2.70
%
 
2.90
%
 
3.10
%
Summary of Stock Option Activity
A summary of option activity under the Plan as of December 30, 2018, December 31, 2017 and January 1, 2017, and changes during the years ending on those dates is presented below:
(Shares in Thousands)
 
Outstanding Shares
 
Weighted
Average Exercise Price
 
Aggregate
Intrinsic
Value
(Dollars in Millions)
Shares at January 3, 2016
 
116,517

 
$
76.41

 
$
3,065

Options granted
 
22,491

 
101.87

 
 
Options exercised
 
(22,547
)
 
65.66

 
 
Options canceled/forfeited
 
(3,006
)
 
92.83

 
 
Shares at January 1, 2017
 
113,455

 
83.16

 
3,636

Options granted
 
19,287

 
115.67

 
 
Options exercised
 
(18,975
)
 
70.87

 
 
Options canceled/forfeited
 
(2,461
)
 
101.40

 
 
Shares at December 31, 2017
 
111,306

 
90.48

 
5,480

Options granted
 
17,115

 
129.51

 
 
Options exercised
 
(16,228
)
 
75.44

 
 
Options canceled/forfeited
 
(2,541
)
 
112.90

 
 
Shares at December 30, 2018
 
109,652

 
$
98.29

 
$
3,214
Summary of Options Outstanding
The following table summarizes stock options outstanding and exercisable at December 30, 2018:
(Shares in Thousands)
 
Outstanding
 
Exercisable
Exercise Price Range
 
Options
 
Average Life(1)
 
Average Exercise Price
 
Options
 
Average Exercise Price
$52.13-$65.62
 
13,466

 
1.8
 
$62.67
 
13,466

 
$62.67
$66.07-$72.54
 
12,710

 
4.0
 
$72.53
 
12,710

 
$72.53
$90.44-$100.48
 
29,162

 
5.6
 
$95.34
 
28,537

 
$95.23
$101.87-$115.67
 
37,877

 
7.6
 
$108.33
 
111

 
$108.04
$115.68-$129.51
 
16,437

 
9.1
 
$129.51
 
38

 
$129.51
 
 
109,652

 
6.2
 
$98.29
 
54,862

 
$82.03


(1) Average contractual life remaining in years.
Summary of Restricted Share Units
A summary of the restricted share units and performance share units activity under the Plans as of December 30, 2018 is presented below:
(Shares in Thousands)
 
Outstanding Restricted Share Units
 
Outstanding Performance Share Units
Shares at December 31, 2017
 
20,161

 
2,625

Granted
 
6,074

 
1,142

Issued
 
(6,684
)
 
(1,151
)
Canceled/forfeited/adjusted
 
(1,091
)
 
(122
)
Shares at December 30, 2018
 
18,460

 
2,494
XML 69 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segments of Business and Geographic Areas (Tables)
 12 Months Ended
Dec. 30, 2018
Segment Reporting [Abstract]  
Schedule of Sales by Segment of Business
 
 
Sales to Customers
 
% Change
(Dollars in Millions)
 
2018
 
2017
 
2016
 
’18 vs. ’17
 
’17 vs. ’16
 
 
 
 
 
 
 
 
 
 
 
CONSUMER
 
 
 
 
 
 
 
 
 
 
Baby Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
$
422

 
449

 
488

 
(6.0
)%
 
(8.0
)
     International
 
1,436

 
1,467

 
1,513

 
(2.1
)
 
(3.0
)
     Worldwide
 
1,858

 
1,916

 
2,001

 
(3.0
)
 
(4.2
)
Beauty
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,403

 
2,335

 
2,135

 
2.9

 
9.4

     International
 
1,979

 
1,865

 
1,762

 
6.1

 
5.8

     Worldwide
 
4,382

 
4,200

 
3,897

 
4.3

 
7.8

Oral Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
637

 
616

 
648

 
3.4

 
(4.9
)
     International
 
918

 
915

 
920

 
0.3

 
(0.5
)
     Worldwide
 
1,555

 
1,531

 
1,568

 
1.6

 
(2.4
)
OTC
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,850

 
1,716

 
1,675

 
7.8

 
2.4

     International
 
2,484

 
2,410

 
2,302

 
3.1

 
4.7

     Worldwide
 
4,334

 
4,126

 
3,977

 
5.0

 
3.7

Women's Health
 
 
 
 
 
 
 
 
 
 
     U.S.
 
13

 
12

 
19

 
8.3

 
(36.8
)
     International
 
1,036

 
1,038

 
1,048

 
(0.2
)
 
(1.0
)
     Worldwide
 
1,049

 
1,050

 
1,067

 
(0.1
)
 
(1.6
)
Wound Care/Other
 
 
 
 
 
 
 
 
 
 
     U.S.
 
436

 
437

 
455

 
(0.2
)
 
(4.0
)
     International
 
239

 
342

 
342

 
(30.1
)
 
0.0

     Worldwide
 
675

 
779

 
797

 
(13.4
)
 
(2.3
)
TOTAL CONSUMER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
5,761

 
5,565

 
5,420

 
3.5

 
2.7

     International
 
8,092

 
8,037

 
7,887

 
0.7

 
1.9

     Worldwide
 
13,853

 
13,602

 
13,307

 
1.8

 
2.2

 
 
 
 
 
 
 
 
 
 
 
PHARMACEUTICAL
 
 
 
 
 
 
 
 
 
 
Immunology
 
 
 
 
 
 
 
 
 
 
     U.S.
 
9,073

 
8,871

 
8,846

 
2.3

 
0.3

     International
 
4,047

 
3,373

 
3,122

 
20.0

 
8.0

     Worldwide
 
13,120

 
12,244

 
11,968

 
7.2

 
2.3

     REMICADE®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
3,664

 
4,525

 
4,842

 
(19.0
)
 
(6.5
)
     U.S. Exports
 
436

 
563

 
782

 
(22.6
)
 
(28.0
)
     International
 
1,226

 
1,227

 
1,342

 
(0.1
)
 
(8.6
)
     Worldwide
 
5,326

 
6,315

 
6,966

 
(15.7
)
 
(9.3
)
 
 
 
 
 
 
 
 
 
 
 
     SIMPONI / SIMPONI ARIA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,051

 
954

 
959

 
10.2

 
(0.5
)
     International
 
1,033

 
879

 
786

 
17.5

 
11.8

     Worldwide
 
2,084

 
1,833

 
1,745

 
13.7

 
5.0

     STELARA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
3,469

 
2,767

 
2,263

 
25.4

 
22.3

     International
 
1,687

 
1,244

 
969

 
35.6

 
28.4

     Worldwide
 
5,156

 
4,011

 
3,232

 
28.5

 
24.1

     TREMFAYA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
453

 
62

 
—

 
*
 
*
     International
 
91

 
1

 
—

 
*
 
*
     Worldwide
 
544

 
63

 
—

 
*
 
*
     OTHER IMMUNOLOGY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—
     International
 
10

 
22

 
25

 
(54.5
)
 
(12.0
)
     Worldwide
 
10

 
22

 
25

 
(54.5
)
 
(12.0
)
 
 
 
 
 
 
 
 
 
 
 
Infectious Diseases
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,378

 
1,358

 
1,461

 
1.5

 
(7.0
)
     International
 
1,926

 
1,796

 
1,747

 
7.2

 
2.8

     Worldwide
 
3,304

 
3,154

 
3,208

 
4.8

 
(1.7
)
     EDURANT® / rilpivirine
 
 
 
 
 
 
 
 
 
 
     U.S.
 
58

 
58

 
52

 
0.0

 
11.5

     International
 
758

 
656

 
521

 
15.5

 
25.9

     Worldwide
 
816

 
714

 
573

 
14.3

 
24.6

     PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,169

 
1,109

 
1,143

 
5.4

 
(3.0
)
     International
 
786

 
712

 
708

 
10.4

 
0.6

     Worldwide
 
1,955

 
1,821

 
1,851

 
7.4

 
(1.6
)
     OTHER INFECTIOUS DISEASES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
151

 
191

 
266

 
(20.9
)
 
(28.2
)
     International
 
382

 
428

 
518

 
(10.7
)
 
(17.4
)
     Worldwide
 
533

 
619

 
784

 
(13.9
)
 
(21.0
)
 
 
 
 
 
 
 
 
 
 
 
Neuroscience
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,574

 
2,630

 
2,628

 
(2.1
)
 
0.1

     International
 
3,503

 
3,356

 
3,457

 
4.4

 
(2.9
)
     Worldwide
 
6,077

 
5,986

 
6,085

 
1.5

 
(1.6
)
     CONCERTA® / Methylphenidate
 
 
 
 
 
 
 
 
 
 
     U.S.
 
229

 
384

 
468

 
(40.4
)
 
(17.9
)
     International
 
434

 
407

 
395

 
6.6

 
3.0

     Worldwide
 
663

 
791

 
863

 
(16.2
)
 
(8.3
)
     INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,791

 
1,590

 
1,343

 
12.6

 
18.4

     International
 
1,137

 
979

 
871

 
16.1

 
12.4

     Worldwide
 
2,928

 
2,569

 
2,214

 
14.0

 
16.0

     RISPERDAL CONSTA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
315

 
360

 
381

 
(12.5
)
 
(5.5
)
     International
 
422

 
445

 
512

 
(5.2
)
 
(13.1
)
     Worldwide
 
737

 
805

 
893

 
(8.4
)
 
(9.9
)
     OTHER NEUROSCIENCE
 
 
 
 
 
 
 
 
 
 
     U.S.
 
239

 
296

 
436

 
(19.3
)
 
(32.1
)
     International
 
1,510

 
1,525

 
1,679

 
(1.0
)
 
(9.2
)
     Worldwide
 
1,749

 
1,821

 
2,115

 
(4.0
)
 
(13.9
)
 
 
 
 
 
 
 
 
 
 
 
Oncology
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,331

 
3,098

 
2,335

 
39.8

 
32.7

     International
 
5,513

 
4,160

 
3,472

 
32.5

 
19.8

     Worldwide
 
9,844

 
7,258

 
5,807

 
35.6

 
25.0

     DARZALEX®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,203

 
884

 
471

 
36.1

 
87.7

     International
 
822

 
358

 
101

 
*
 
*
     Worldwide
 
2,025

 
1,242

 
572

 
63.0

 
*
     IMBRUVICA®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,129

 
841

 
613

 
34.2

 
37.2

     International
 
1,486

 
1,052

 
638

 
41.3

 
64.9

     Worldwide
 
2,615

 
1,893

 
1,251

 
38.1

 
51.3

     VELCADE®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—
     International
 
1,116

 
1,114

 
1,224

 
0.2

 
(9.0
)
     Worldwide
 
1,116

 
1,114

 
1,224

 
0.2

 
(9.0
)
     ZYTIGA® /abiraterone acetate
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,771

 
1,228

 
1,089

 
44.2

 
12.8

     International
 
1,727

 
1,277

 
1,171

 
35.2

 
9.1

     Worldwide
 
3,498

 
2,505

 
2,260

 
39.6

 
10.8

     OTHER ONCOLOGY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
228

 
145

 
162

 
57.2

 
(10.5
)
     International
 
362

 
359

 
338

 
0.8

 
6.2

     Worldwide
 
590

 
504

 
500

 
17.1

 
0.8

 
 
 
 
 
 
 
 
 
 
 
Pulmonary Hypertension
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,651

 
773

 
—

 
*
 
*
     International
 
922

 
554

 
—

 
66.4

 
*
     Worldwide
 
2,573

 
1,327

 
—

 
93.9

 
*
     OPSUMIT®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
700

 
320

 
—

 
*
 
*
     International
 
515

 
253

 
—

 
*
 
*
     Worldwide
 
1,215

 
573

 
—

 
*
 
*
     TRACLEER®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
268

 
161

 
—

 
66.5

 
*
     International
 
278

 
242

 
—

 
14.9

 
*
     Worldwide
 
546

 
403

 
—

 
35.5

 
*
 
 
 
 
 
 
 
 
 
 
 
     UPTRAVI®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
598

 
238

 
—

 
*
 
*
     International
 
65

 
25

 
—

 
*
 
*
     Worldwide
 
663

 
263

 
—

 
*
 
*
     OTHER 
 
 
 
 
 
 
 
 
 
 
     U.S.
 
85

 
54

 
—

 
57.4

 
*
     International
 
64

 
34

 
—

 
88.2

 
*
     Worldwide
 
149

 
88

 
—

 
69.3

 
*
Cardiovascular / Metabolism / Other
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,279

 
4,744

 
4,855

 
(9.8
)
 
(2.3
)
     International
 
1,537

 
1,543

 
1,541

 
(0.4
)
 
0.1

     Worldwide
 
5,816

 
6,287

 
6,396

 
(7.5
)
 
(1.7
)
     XARELTO®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
2,477

 
2,500

 
2,288

 
(0.9
)
 
9.3

     International
 
—

 
—

 
—

 
—

 
—

     Worldwide
 
2,477

 
2,500

 
2,288

 
(0.9
)
 
9.3

     INVOKANA® / INVOKAMET®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
711

 
944

 
1,273

 
(24.7
)
 
(25.8
)
     International
 
170

 
167

 
134

 
1.8

 
24.6

     Worldwide
 
881

 
1,111

 
1,407

 
(20.7
)
 
(21.0
)
     PROCRIT® / EPREX®
 
 
 
 
 
 
 
 
 
 
     U.S.
 
674

 
675

 
767

 
(0.1
)
 
(12.0
)
     International
 
314

 
297

 
338

 
5.7

 
(12.1
)
     Worldwide
 
988

 
972

 
1,105

 
1.6

 
(12.0
)
     OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
417

 
625

 
527

 
(33.3
)
 
18.6

     International
 
1,053

 
1,079

 
1,069

 
(2.4
)
 
0.9

     Worldwide
 
1,470

 
1,704

 
1,596

 
(13.7
)
 
6.8

TOTAL PHARMACEUTICAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
23,286

 
21,474

 
20,125

 
8.4

 
6.7

     International
 
17,448

 
14,782

 
13,339

 
18.0

 
10.8

     Worldwide
 
40,734

 
36,256

 
33,464

 
12.4

 
8.3

 
 
 
 
 
 
 
 
 
 
 
MEDICAL DEVICES
 
 
 
 
 
 
 
 
 
 
Diabetes Care
 
 
 
 
 
 
 
 
 
 
     U.S.
 
371

 
612

 
739

 
(39.4
)
 
(17.2
)
     International
 
638

 
1,003

 
1,050

 
(36.4
)
 
(4.5
)
     Worldwide
 
1,009

 
1,615

 
1,789

 
(37.5
)
 
(9.7
)
Diagnostics
 
 
 
 
 
 
 
 
 
 
     U.S.
 
—

 
—

 
—

 
—

 
—

     International
 
—

 
1

 
66

 
*
 
*
     Worldwide
 
—

 
1

 
66

 
*
 
*
Interventional Solutions
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,283

 
1,148

 
1,031

 
11.8

 
11.3

     International
 
1,363

 
1,148

 
1,024

 
18.7

 
12.1

     Worldwide
 
2,646

 
2,296

 
2,055

 
15.2

 
11.7

Orthopaedics
 
 
 
 
 
 
 
 
 
 
     U.S.
 
5,281

 
5,404

 
5,438

 
(2.3
)
 
(0.6
)
     International
 
3,604

 
3,654

 
3,690

 
(1.4
)
 
(1.0
)
     Worldwide
 
8,885

 
9,058

 
9,128

 
(1.9
)
 
(0.8
)
     HIPS
 
 
 
 
 
 
 
 
 
 
     U.S.
 
841

 
827

 
798

 
1.7

 
3.6

     International
 
577

 
567

 
563

 
1.8

 
0.7

     Worldwide
 
1,418

 
1,394

 
1,361

 
1.7

 
2.4

     KNEES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
911

 
948

 
943

 
(3.9
)
 
0.5

     International
 
591

 
575

 
581

 
2.8

 
(1.0
)
     Worldwide
 
1,502

 
1,523

 
1,524

 
(1.4
)
 
(0.1
)
     TRAUMA
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,599

 
1,576

 
1,545

 
1.5

 
2.0

     International
 
1,100

 
1,040

 
1,024

 
5.8

 
1.6

     Worldwide
 
2,699

 
2,616

 
2,569

 
3.2

 
1.8

     SPINE & OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,930

 
2,053

 
2,152

 
(6.0
)
 
(4.6
)
     International
 
1,336

 
1,472

 
1,522

 
(9.2
)
 
(3.3
)
     Worldwide
 
3,266

 
3,525

 
3,674

 
(7.3
)
 
(4.1
)
Surgery
 
 
 
 
 
 
 
 
 
 
     U.S.
 
4,125

 
4,085

 
4,026

 
1.0

 
1.5

     International
 
5,776

 
5,474

 
5,270

 
5.5

 
3.9

     Worldwide
 
9,901

 
9,559

 
9,296

 
3.6

 
2.8

     ADVANCED
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,657

 
1,620

 
1,524

 
2.3

 
6.3

     International
 
2,345

 
2,136

 
1,993

 
9.8

 
7.2

     Worldwide
 
4,002

 
3,756

 
3,517

 
6.5

 
6.8

     GENERAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,751

 
1,728

 
1,669

 
1.3

 
3.5

     International
 
2,806

 
2,735

 
2,693

 
2.6

 
1.6

     Worldwide
 
4,557

 
4,463

 
4,362

 
2.1

 
2.3

     SPECIALTY
 
 
 
 
 
 
 
 
 
 
     U.S.
 
717

 
737

 
833

 
(2.7
)
 
(11.5
)
     International
 
625

 
603

 
584

 
3.6

 
3.3

     Worldwide
 
1,342

 
1,340

 
1,417

 
0.1

 
(5.4
)
Vision
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,777

 
1,575

 
1,032

 
12.8

 
52.6

     International
 
2,776

 
2,488

 
1,753

 
11.6

 
41.9

     Worldwide
 
4,553

 
4,063

 
2,785

 
12.1

 
45.9

     CONTACT LENSES / OTHER
 
 
 
 
 
 
 
 
 
 
     U.S.
 
1,237

 
1,122

 
1,032

 
10.2

 
8.7

     International
 
2,065

 
1,914

 
1,753

 
7.9

 
9.2

     Worldwide
 
3,302

 
3,036

 
2,785

 
8.8

 
9.0

 
 
 
 
 
 
 
 
 
 
 
     SURGICAL
 
 
 
 
 
 
 
 
 
 
     U.S.
 
540

 
453

 
—

 
19.2

 
*
     International
 
711

 
574

 
—

 
23.9

 
*
     Worldwide
 
1,251

 
1,027

 
—

 
21.8

 
*
 
 
 
 
 
 
 
 
 
 
 
TOTAL MEDICAL DEVICES
 
 
 
 
 
 
 
 
 
 
     U.S.
 
12,837

 
12,824

 
12,266

 
0.1

 
4.5

     International
 
14,157

 
13,768

 
12,853

 
2.8

 
7.1

     Worldwide
 
26,994

 
26,592

 
25,119

 
1.5

 
5.9

 
 
 
 
 
 
 
 
 
 
 
WORLDWIDE
 
 
 
 
 
 
 
 
 
 
     U.S.
 
41,884

 
39,863

 
37,811

 
5.1

 
5.4

     International
 
39,697

 
36,587

 
34,079

 
8.5

 
7.4

     Worldwide
 
$
81,581

 
76,450

 
71,890

 
6.7
 %
 
6.3

*Percentage greater than 100% or not meaningful
Schedule of Segment Reporting Information
 
 
Income Before Tax
 
Identifiable Assets
(Dollars in Millions)
 
2018 (3)
 
2017 (4)
 
2016 (5)
 
2018
 
2017
Consumer
 
$
2,320

 
2,524

 
2,441

 
$
25,877

 
25,030

Pharmaceutical
 
12,568

 
11,083

 
12,827

 
56,636

 
59,450

Medical Devices
 
4,397

 
5,392

 
5,578

 
46,254

 
45,413

Total
 
19,285

 
18,999

 
20,846

 
128,767

 
129,893

Less: Expense not allocated to segments (1)
 
1,286

 
1,326

 
1,043

 
 
 
 
General corporate (2)
 
 
 
 
 
 
 
24,187

 
27,410

Worldwide total
 
$
17,999

 
17,673

 
19,803

 
$
152,954

 
157,303


 
 
Additions to Property,
Plant & Equipment
 
Depreciation and
Amortization
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
Consumer
 
$
438

 
485

 
486

 
$
688

 
674

 
608

Pharmaceutical
 
1,012

 
936

 
927

 
3,802

 
2,416

 
886

Medical Devices
 
1,843

 
1,566

 
1,472

 
2,103

 
2,216

 
1,928

Segments total
 
3,293

 
2,987

 
2,885

 
6,593

 
5,306

 
3,422

General corporate
 
377

 
292

 
341

 
336

 
336

 
332

Worldwide total
 
$
3,670

 
3,279

 
3,226

 
$
6,929

 
5,642

 
3,754
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas
 
 
Sales to Customers
 
Long-Lived Assets (6)
(Dollars in Millions)
 
2018
 
2017
 
2016
 
2018
 
2017
United States
 
$
41,884

 
39,863

 
37,811

 
$
37,117

 
38,556

Europe
 
18,753

 
17,126

 
15,770

 
51,433

 
56,677

Western Hemisphere excluding U.S. 
 
6,113

 
6,041

 
5,734

 
2,752

 
2,990

Asia-Pacific, Africa
 
14,831

 
13,420

 
12,575

 
2,733

 
2,773

Segments total
 
81,581

 
76,450

 
71,890

 
94,035

 
100,996

General corporate
 
 
 
 
 
 
 
1,064

 
1,143

Other non long-lived assets
 
 
 
 
 
 
 
57,855

 
55,164

Worldwide total
 
$
81,581

 
76,450

 
71,890

 
$
152,954

 
157,303

­
See Note 1 for a description of the segments in which the Company operates.
Export sales are not significant. In 2018, the Company had three wholesalers distributing products for all three segments that represented approximately 14.0%, 11.0% and 11.0% of the total consolidated revenues. In 2017, the Company had two wholesalers distributing products for all three segments that represented approximately 14.0% and 10.0% of the total consolidated revenues. In 2016, the Company had two wholesalers distributing products for all three segments that represented approximately 13.5% and 10.7% of the total consolidated revenues.

(1) 
Amounts not allocated to segments include interest (income) expense and general corporate (income) expense.
(2) 
General corporate includes cash, cash equivalents and marketable securities.
(3) 
The Consumer segment includes a gain of $0.3 billion from the divestiture of NIZORAL® and litigation expense of $0.3 billion. The Pharmaceutical segment includes an in-process research and development charge of $1.1 billion related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of $0.2 billion, Actelion acquisition related costs of $0.2 billion, unrealized loss on securities of $0.2 billion and a gain of $0.2 billion from the divestiture of certain non-strategic Pharmaceutical products. The Medical Devices segment includes net litigation expense of $1.7 billion, a restructuring related charge of $0.6 billion, AMO acquisition related costs of $0.1 billion and a gain of $0.5 billion from the divestiture of the LifeScan business in the fiscal fourth quarter.
(4) 
The Pharmaceutical segment includes $0.8 billion for Actelion acquisition related costs, an in-process research and development expense of $0.4 billion and litigation expense of $0.1 billion. The Medical Devices segment includes litigation expense of $1.1 billion, a restructuring related charge of $0.8 billion, an asset impairment of $0.2 billion primarily related to the insulin pump business and $0.1 billion for AMO acquisition related costs. The Medical Devices segment includes a gain of $0.7 billion from the divestiture of Codman Neurosurgery. The Consumer segment includes a gain of $0.5 billion from the divestiture of COMPEED®.
(5) 
Includes net litigation expense of $0.8 billion and a restructuring related charge of $0.7 billion in the Medical Devices segment. The Pharmaceutical segment includes a positive adjustment of $0.5 billion to previous reserve estimates and gains from the divestitures of the controlled substance raw material and active pharmaceutical ingredient (API) business and certain anesthetic products in Europe.
(6) 
Long-lived assets include property, plant and equipment, net for 2018, and 2017 of $17,035 and $17,005, respectively, and intangible assets and goodwill, net for 2018 and 2017 of $78,064 and $85,134, respectively.
XML 70 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Selected Quarterly Financial Data (unaudited) (Tables)
 12 Months Ended
Dec. 30, 2018
Selected Quarterly Financial Information [Abstract]  
Summary of Selected Quarterly Financial Data (unaudited)
Selected unaudited quarterly financial data for the years 2018 and 2017 are summarized below:
 
 
2018
 
2017
(Dollars in Millions Except Per Share Data)
 
First Quarter (1)
 
Second Quarter (2)
 
Third Quarter (3)
 
Fourth Quarter (4)
 
First Quarter (5)
 
Second Quarter (6)
 
Third Quarter (7)
 
Fourth Quarter (8)
Segment sales to customers
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Consumer
 
$
3,398

 
3,504

 
3,415

 
3,536

 
3,228

 
3,478

 
3,356

 
3,540

Pharmaceutical
 
9,844

 
10,354

 
10,346

 
10,190

 
8,245

 
8,635

 
9,695

 
9,681

Medical Devices 
 
6,767

 
6,972

 
6,587

 
6,668

 
6,293

 
6,726

 
6,599

 
6,974

Total sales
 
20,009

 
20,830

 
20,348

 
20,394

 
17,766

 
18,839

 
19,650

 
20,195

Gross profit
 
13,395

 
13,903

 
13,759

 
13,433

 
12,357

 
12,993

 
12,725

 
12,936

Earnings before provision for taxes on income
 
5,481

 
4,973

 
4,423

 
3,122

 
5,575

 
4,748

 
4,790

 
2,560

Net earnings (loss)
 
4,367

 
3,954

 
3,934

 
3,042

 
4,422

 
3,827

 
3,764

 
(10,713
)
Basic net earnings (loss) per share
 
$
1.63

 
1.47

 
1.47

 
1.14

 
1.63

 
1.42

 
1.40

 
(3.99
)
Diluted net earnings (loss) per share
 
$
1.60

 
1.45

 
1.44

 
1.12

 
1.61

 
1.40

 
1.37

 
(3.99
)

(1)
The first quarter of 2018 includes an Actelion acquisition related cost of $92 million after-tax ($96 million before-tax) and a restructuring related charge of $81 million after-tax ($107 million before-tax).
(2) 
The second quarter of 2018 includes a litigation expense of $609 million after-tax ($703 million before-tax) and a restructuring related charge of $152 million after-tax ($176 million before-tax).
(3) 
The third quarter of 2018 includes an in-process research and development expense of $859 million after-tax ($1,126 million before-tax) related to the Alios and XO1 assets and the corresponding XO1 contingent liability reversal of $184 million after and before tax, a restructuring related charge of $162 million after-tax ($190 million before-tax) and a $265 million benefit after-tax from the impact of tax legislation.
(4) 
The fourth quarter of 2018 includes a litigation expense of $1,113 million after-tax ($1,288 million before-tax), a restructuring related charge of $190 million after-tax ($227 million before-tax) and a $137 million benefit after-tax from the impact of tax legislation.
(5) 
The first quarter of 2017 includes a restructuring charge of $121 million after-tax ($161 million before-tax) and an AMO acquisition related cost of $251 million after-tax ($38 million before-tax).
(6) 
The second quarter of 2017 includes a litigation expense of $352 million after-tax ($493 million before-tax), Actelion acquisition related costs of $199 million after-tax ($213 million before-tax) a restructuring charge of $101 million after-tax ($128 million before-tax) and an asset impairment charge of $125 million after-tax ($182 million before-tax).
(7) 
The third quarter of 2017 includes a litigation expense of $97 million after-tax ($118 million before-tax), Actelion acquisition related costs of $255 million after-tax ($367 million before-tax) and a restructuring charge of $136 million after-tax ($187 million before-tax).
(8) 
The fourth quarter of 2017 includes a litigation expense of $506 million after-tax ($645 million before-tax), Actelion acquisition related costs of $313 million after-tax ($217 million before-tax), a restructuring charge of $237 million after-tax ($284 million before-tax), an in-process research and development expense of $266 million after-tax ($408 million before-tax) and an after-tax benefit of $116 million related to the insulin pump business. Additionally, the fourth quarter of 2017 includes a provisional charge of $13.6 billion for recently enacted tax legislation.
XML 71 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations and Divestitures (Tables)
 12 Months Ended
Dec. 30, 2018
Business Combinations [Abstract]  
Schedule of Preliminary Amounts Recognized for Assets Acquired and Liabilities Assumed
(Dollars in Millions)
 
Cash & Cash equivalents
469

Inventory(1)
759

Accounts Receivable
485

Other current assets
93

Property, plant and equipment
104

Goodwill
6,161

Intangible assets
25,010

Deferred Taxes
99

Other non-current assets
19

Total Assets Acquired
33,199

 
 
Current liabilities
956

Deferred Taxes
1,776

Other non-current liabilities
413

Total Liabilities Assumed
3,145

 
 
Net Assets Acquired
30,054

(1) Includes adjustment of $642 million to write-up the acquired inventory to its estimated fair value.
Purchase Price Allocation of Identifiable Intangible Assets
The purchase price allocation to the identifiable intangible assets is as follows:
(Dollars in Millions)
 
 
Intangible assets with definite lives:
 
 
Patents and trademarks*
 
$
24,230

Total amortizable intangibles
 
24,230

 
 
 
In-process research and development
 
780

Total intangible assets
 
$
25,010
Schedule of Pro Forma Results
The following table provides pro forma results of operations for the fiscal year ended December 31, 2017 and January 1, 2017, as if Actelion had been acquired as of January 4, 2016. The pro forma results include the effect of certain purchase accounting adjustments such as the estimated changes in depreciation and amortization expense on the acquired tangible and intangible assets. However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of Actelion. Accordingly, such amounts are not necessarily indicative of the results if the acquisition had occurred on the dates indicated or which may occur in the future.
 
Unaudited Pro forma Consolidated Results
(Dollars in Millions Except Per Share Data)
2017
2016
 
 
 
Net Sales
77,681

74,339

Net Earnings
1,509

13,916

Diluted Net Earnings per Common Share
0.55

4.99
XML 72 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring (Tables)
 12 Months Ended
Dec. 30, 2018
Restructuring and Related Activities [Abstract]  
Summary of Severance Charges and Associated Spending
The following table summarizes the severance charges and the associated spending under these initiatives through the fiscal year ended 2018:
(Dollars in Millions)
Severance
Asset Write-offs
Other**
Total
Reserve balance, January 3, 2016
$
484

—

17

501

 
 
 
 
 
2016 activity
(104
)
—

(16
)
(120
)
 
 
 
 
 
Reserve balance, January 1, 2017
380

—

1

381

 
 
 
 
 
2017 activity
(151
)
—

37

(114
)
 
 
 
 
 
Reserve balance, December 31, 2017
229

—

38

267

 
 
 
 
 
Current year activity:
 
 
 
 
   Charges
—

132

568

700

   Cash payments
(35
)
—

(558
)
(593
)
   Settled non cash
—

(132
)
—

(132
)
Reserve balance, December 30, 2018*
$
194

—

48

242

 
 
 
 
 
*Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws.
**Other includes project expense such as salaries for employees supporting the initiative and consulting expenses.
XML 73 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Narrative (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2017
USD ($)
Dec. 30, 2018
USD ($)
Employee
Segment
Dec. 31, 2017
USD ($)
Jan. 01, 2017
USD ($)
Jan. 01, 2018
USD ($)
Concentration of Credit Risk [Line Items]          
Number of employees | Employee   135,100      
Number of business segments | Segment   3      
Excess tax benefits       $ 353  
GILTI, deferred tax liability $ 1,600   $ 1,600    
Deferred taxes on income 7,105 $ 7,640 7,105    
Other assets 4,971 4,182 4,971    
Retained earnings 101,793 $ 106,216 $ 101,793    
Minimum reverse repurchase agreement collateral (as a percent)   102.00%      
Sales return reserve (as a percent)   1.00% 1.00% 1.00%  
Percentage of profit share payments (less than)   2.00% 2.00% 2.00%  
Shipping and handling costs   $ 1,090 $ 1,042 $ 974  
Shipping and handling costs as a percent of sales   0.50%      
Advertising expense   $ 2,600 2,500 $ 2,400  
Provisional toll tax charge 10,100        
Deferred tax liability foreign taxes 4,457 $ 2,240 4,457    
Deferred tax asset offset $ 1,100   $ 1,100    
Minimum | Software Development          
Concentration of Credit Risk [Line Items]          
Estimated useful lives of the assets   3 years      
Maximum | Software Development          
Concentration of Credit Risk [Line Items]          
Estimated useful lives of the assets   8 years      
R&D Expense          
Concentration of Credit Risk [Line Items]          
Concentration risk (as a percent)   5.00%      
ASU 2016-16 - Income Taxes: Intra-Entity Transfers          
Concentration of Credit Risk [Line Items]          
Deferred taxes, net         $ 2,000
Other assets         (700)
Retained earnings         400
Retained Earnings          
Concentration of Credit Risk [Line Items]          
GILTI, deferred tax liability   $ 1,700     1,700
Retained Earnings | ASU 2014-09 - Revenue from Contracts with Customers          
Concentration of Credit Risk [Line Items]          
Cumulative effect adjustment         (47)
Retained Earnings | ASU 2016-01 - Financial Instruments          
Concentration of Credit Risk [Line Items]          
Cumulative effect adjustment         232
Retained Earnings | ASU 2016-16 - Income Taxes: Intra-Entity Transfers          
Concentration of Credit Risk [Line Items]          
Cumulative effect adjustment         $ (439)
XML 74 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Schedule of Impact of Adoption (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Jan. 03, 2016
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                        
Sales to customers $ 20,394 $ 20,348 $ 20,830 $ 20,009 $ 20,195 $ 19,650 $ 18,839 $ 17,766 $ 81,581 $ 76,450 $ 71,890  
Net earnings 3,042 $ 3,934 $ 3,954 $ 4,367 (10,713) $ 3,764 $ 3,827 $ 4,422 15,297 1,300 16,540  
Assets 152,954       157,303       152,954 157,303    
Liabilities 93,202       97,143       93,202 97,143    
Equity 59,752       $ 60,160       59,752 $ 60,160 $ 70,418 $ 71,150
Balance without adoption of ASC 606                        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                        
Sales to customers                 81,546      
Net earnings                 15,269      
Assets 152,977               152,977      
Liabilities 93,206               93,206      
Equity 59,771               59,771      
ASU 2014-09 - Revenue from Contracts with Customers | Effect of change                        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                        
Sales to customers                 (35)      
Net earnings                 (28)      
Assets 23               23      
Liabilities 4               4      
Equity $ 19               $ 19      
XML 75 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Schedule of Adjustments for Accounting Standards Update 2017-07 (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Selling, marketing and administrative expenses                 $ 22,540 $ 21,520 $ 20,067
Research and development expense                 10,775 10,594 9,143
Other (income) expense, net                 1,405 (42) 210
Earnings before provision for taxes on income $ 3,122 $ 4,423 $ 4,973 $ 5,481 $ 2,560 $ 4,790 $ 4,748 $ 5,575 17,999 17,673 19,803
Accounting Standards Update 2017-07                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of products sold                 51 85 104
Selling, marketing and administrative expenses                 55 100 122
Research and development expense                 21 40 48
Other (income) expense, net                 (127) (225) (274)
Earnings before provision for taxes on income                 $ 0 $ 0 $ 0
XML 76 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Schedule of Cumulative Effect Adjustments (Details)
$ in Millions
Jan. 01, 2018
USD ($)
Adjustments for New Accounting Pronouncement | Retained Earnings  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Cumulative effect adjustment $ (254)
ASU 2014-09 - Revenue from Contracts with Customers | Retained Earnings  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Cumulative effect adjustment (47)
ASU 2016-01 - Financial Instruments | Retained Earnings  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Cumulative effect adjustment 232
ASU 2016-16 - Income Taxes: Intra-Entity Transfers  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Deferred taxes, net 2,000
ASU 2016-16 - Income Taxes: Intra-Entity Transfers | Retained Earnings  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Cumulative effect adjustment $ (439)
XML 77 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details)
 12 Months Ended
Dec. 30, 2018
Minimum | Building and building equipment  
Property, Plant and Equipment [Line Items]  
Estimated useful lives of the assets 20 years
Minimum | Land And Leasehold Improvements  
Property, Plant and Equipment [Line Items]  
Estimated useful lives of the assets 10 years
Minimum | Machinery and Equipment  
Property, Plant and Equipment [Line Items]  
Estimated useful lives of the assets 2 years
Maximum | Building and building equipment  
Property, Plant and Equipment [Line Items]  
Estimated useful lives of the assets 30 years
Maximum | Land And Leasehold Improvements  
Property, Plant and Equipment [Line Items]  
Estimated useful lives of the assets 20 years
Maximum | Machinery and Equipment  
Property, Plant and Equipment [Line Items]  
Estimated useful lives of the assets 13 years
XML 78 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash, Cash Equivalents and Current Marketable Securities - Cash and Cash Equivalent Composition (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Jan. 03, 2016
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Cash & Cash Equivalents $ 18,107 $ 17,824 $ 18,972 $ 13,732
Current Marketable Securities 1,580 472    
Held-to-maturity Securities        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount 9,953 12,986    
Estimated Fair Value 9,953 12,986    
Cash & Cash Equivalents 9,953 12,880    
Current Marketable Securities 0 106    
Held-to-maturity Securities | Cash        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount 2,619 2,929    
Estimated Fair Value 2,619 2,929    
Cash & Cash Equivalents 2,619 2,929    
Current Marketable Securities 0 0    
Held-to-maturity Securities | Other Sovereign Securities(1)        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount   279    
Estimated Fair Value   279    
Cash & Cash Equivalents   219    
Current Marketable Securities   60    
Held-to-maturity Securities | U.S. Reverse repurchase agreements        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount 3,009 4,025    
Estimated Fair Value 3,009 4,025    
Cash & Cash Equivalents 3,009 4,025    
Current Marketable Securities 0 0    
Held-to-maturity Securities | Other Reverse repurchase agreements        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount 443      
Estimated Fair Value 443      
Cash & Cash Equivalents 443      
Current Marketable Securities 0      
Held-to-maturity Securities | Corporate debt securities(1)        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount   289    
Estimated Fair Value   289    
Cash & Cash Equivalents   244    
Current Marketable Securities   45    
Held-to-maturity Securities | Money market funds        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount 3,397 4,288    
Estimated Fair Value 3,397 4,288    
Cash & Cash Equivalents 3,397 4,288    
Current Marketable Securities 0 0    
Held-to-maturity Securities | Time deposits(1)        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Carrying Amount 485 1,176    
Estimated Fair Value 485 1,176    
Cash & Cash Equivalents 485 1,175    
Current Marketable Securities 0 1    
Available-for-sale Securities        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Cash & Cash Equivalents 8,154 4,944    
Current Marketable Securities 1,580 366    
Available-for-sale Securities, Amortized Cost Basis 9,734 5,310    
Available-for-sale Securities 9,734 5,310    
Available-for-sale Securities | Gov't Securities        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Cash & Cash Equivalents 8,144 4,833    
Current Marketable Securities 1,330 31    
Available-for-sale Securities, Amortized Cost Basis 9,474 4,864    
Available-for-sale Securities 9,474 4,864    
Available-for-sale Securities | Other Sovereign Securities(1)        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Cash & Cash Equivalents   80    
Current Marketable Securities   106    
Available-for-sale Securities, Amortized Cost Basis   186    
Available-for-sale Securities   186    
Available-for-sale Securities | Corporate debt securities(1)        
Cash, Cash Equivalents, and Short-term Investments [Abstract]        
Cash & Cash Equivalents 10 31    
Current Marketable Securities 250 229    
Available-for-sale Securities, Amortized Cost Basis 260 260    
Available-for-sale Securities $ 260 $ 260    
XML 79 R58.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash, Cash Equivalents and Current Marketable Securities - Contractual Maturities of Available for Sale Securities (Details)
$ in Millions
Dec. 30, 2018
USD ($)
Cost Basis  
Due within one year $ 9,670
Due after one year through five years 64
Due after five years through ten years 0
Total debt securities 9,734
Fair Value  
Due within one year 9,670
Due after one year through five years 64
Due after five years through ten years 0
Total debt securities $ 9,734
XML 80 R59.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Summary of Inventories    
Raw materials and supplies $ 1,114 $ 1,140
Goods in process 2,109 2,317
Finished goods 5,376 5,308
Total inventories 8,599 $ 8,765
Discontinued Operations, Held-for-sale or Disposed of by Sale | AdvancedSterilizationProducts    
Inventory [Line Items]    
Disposal Group, Including Discontinued Operation, Inventory, Current 200  
Discontinued Operations, Held-for-sale or Disposed of by Sale | Supply Chain    
Inventory [Line Items]    
Disposal Group, Including Discontinued Operation, Inventory, Current $ 300  
XML 81 R60.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property, Plant and Equipment - Property, Plant and Equipment at Cost and Accumulated Depreciation (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Property, Plant and Equipment, Net [Abstract]    
Land and land improvements $ 807 $ 829
Buildings and building equipment 11,176 11,240
Machinery and equipment 25,992 25,949
Construction in progress 3,876 3,448
Total property, plant and equipment, gross 41,851 41,466
Less accumulated depreciation 24,816 24,461
Total property, plant and equipment, net $ 17,035 $ 17,005
XML 82 R61.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property, Plant and Equipment - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Property, Plant and Equipment [Line Items]      
Interest expense capitalized $ 86 $ 94 $ 102
Depreciation expense, including the amortization of capitalized interest 2,600 $ 2,600 $ 2,500
AdvancedSterilizationProducts | Discontinued Operations, Held-for-sale or Disposed of by Sale      
Property, Plant and Equipment [Line Items]      
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment 100    
Supply Chain | Discontinued Operations, Held-for-sale or Disposed of by Sale      
Property, Plant and Equipment [Line Items]      
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment $ 100    
XML 83 R62.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets and Goodwill - Schedule of Intangible Assets and Goodwill (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Intangible assets with indefinite lives:    
Indefinite lived intangible assets $ 9,190 $ 11,283
Total intangible assets - net 47,611 53,228
Trademarks    
Intangible assets with indefinite lives:    
Indefinite lived intangible assets 6,937 7,082
Purchased in-process research and development    
Intangible assets with indefinite lives:    
Indefinite lived intangible assets 2,253 4,201
Patents And Trademarks    
Intangible assets with definite lives:    
Finite lived intangible assets gross 35,194 36,427
Less accumulated amortization 9,784 7,223
Finite lived intangible assets net 25,410 29,204
Customer relationships and other intangible assets    
Intangible assets with definite lives:    
Finite lived intangible assets gross 21,334 20,204
Less accumulated amortization 8,323 7,463
Finite lived intangible assets net 13,011 $ 12,741
Purchased in-process research and development    
Intangible assets with indefinite lives:    
Reclassified to definite lived intangible assets upon commercialization 800  
Alios Biopharma Inc and XO1 Limited | Purchased in-process research and development    
Intangible assets with indefinite lives:    
Indefinite lived intangible assets 1,100  
Alios Biopharma | Purchased in-process research and development    
Intangible assets with indefinite lives:    
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 800  
XO1 | Purchased in-process research and development    
Intangible assets with indefinite lives:    
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $ 300  
XML 84 R63.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets and Goodwill - Goodwill (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Goodwill [Roll Forward]    
Goodwill beginning of period $ 31,906 $ 22,805
Goodwill, related to acquisitions (1) 403 8,463
Goodwill, related to divestitures (1,348) (177)
Currency translation/other (508) 815
Goodwill end of period 30,453 31,906
Consumer    
Goodwill [Roll Forward]    
Goodwill beginning of period 8,875 8,263
Goodwill, related to acquisitions (1) 168 102
Goodwill, related to divestitures 0 (74)
Currency translation/other (373) 584
Goodwill end of period 8,670 8,875
Pharmaceutical    
Goodwill [Roll Forward]    
Goodwill beginning of period 9,109 2,840
Goodwill, related to acquisitions (1) 51 6,161
Goodwill, related to divestitures 0 (1)
Currency translation/other (97) 109
Goodwill end of period 9,063 9,109
Medical Devices    
Goodwill [Roll Forward]    
Goodwill beginning of period 13,922 11,702
Goodwill, related to acquisitions (1) 184 2,200
Goodwill, related to divestitures (1,348) (102)
Currency translation/other (38) 122
Goodwill end of period 12,720 13,922
Actelion    
Goodwill [Roll Forward]    
Goodwill end of period 6,161  
AMO | Medical Devices    
Goodwill [Roll Forward]    
Goodwill beginning of period $ 1,700  
Goodwill end of period   $ 1,700
XML 85 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets and Goodwill - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Finite-Lived Intangible Assets [Line Items]          
Indefinite-Lived Intangible Assets (Excluding Goodwill) $ 9,190 $ 11,283      
Amortization expense of amortizable intangible assets 4,400 3,000 $ 1,200    
Finite lived intangibles, amortization expense next twelve months 4,300        
Finite lived intangibles, amortization expense, year two 4,300        
Finite lived intangibles, amortization expense, year three 4,300        
Finite lived intangibles, amortization expense, year four 4,300        
Finite lived intangibles, amortization expense, year five 4,300        
Goodwill $ 30,453 31,906 22,805    
Patents And Trademarks          
Finite-Lived Intangible Assets [Line Items]          
Intangible assets useful life 11 years        
Customer relationships and other intangible assets          
Finite-Lived Intangible Assets [Line Items]          
Intangible assets useful life 22 years        
Actelion          
Finite-Lived Intangible Assets [Line Items]          
Goodwill $ 6,161        
Consumer          
Finite-Lived Intangible Assets [Line Items]          
Goodwill 8,670 8,875 8,263    
Medical Devices          
Finite-Lived Intangible Assets [Line Items]          
Goodwill 12,720 13,922 11,702    
Medical Devices | AMO          
Finite-Lived Intangible Assets [Line Items]          
Finite-lived Intangible Assets Acquired   2,300      
Goodwill   1,700     $ 1,700
Pharmaceutical          
Finite-Lived Intangible Assets [Line Items]          
Goodwill 9,063 9,109 $ 2,840    
Pharmaceutical | Actelion          
Finite-Lived Intangible Assets [Line Items]          
Goodwill       $ 6,200  
Goodwill | AdvancedSterilizationProducts | Medical Devices          
Finite-Lived Intangible Assets [Line Items]          
Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent 300        
Goodwill | LifeScan | Medical Devices          
Finite-Lived Intangible Assets [Line Items]          
Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent 1,000        
Purchased in-process research and development          
Finite-Lived Intangible Assets [Line Items]          
Indefinite-Lived Intangible Assets (Excluding Goodwill) $ 2,253 $ 4,201      
XML 86 R65.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Jan. 01, 2018
Derivative [Line Items]        
Other Assets, Noncurrent $ 4,182 $ 4,971    
Foreign currency translation (1,518) 1,696 $ (612)  
Deferred net losses (gains) on derivatives included in accumulated other comprehensive income $ 195      
Description of Reclassification of Cash Flow Hedge Gain (Loss) next 12 months      
Maximum length of time for hedging transaction exposure 18 months      
Unrealized holding gain (loss) arising during period $ (1) 159 $ (52)  
Foreign exchange contracts        
Derivative [Line Items]        
Collateral paid 182      
Derivative, notional amount 41,100 34,500    
Cross currency interest rate swaps        
Derivative [Line Items]        
Derivative, notional amount 7,300 2,300    
Interest rate swaps contracts:        
Derivative [Line Items]        
Derivative, notional amount 500 1,100    
Equity securities | Equity Investments with Readily Determinable Value        
Derivative [Line Items]        
Marketable Securities, Noncurrent 511 751    
Other Assets, Noncurrent 511      
Equity, Fair Value Adjustment (247)      
Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period 7      
Unrealized holding gain (loss) arising during period   232    
Equity securities | Equity Investments without Readily Determinable Value        
Derivative [Line Items]        
Equity, Fair Value Adjustment, Impairment Loss 54      
Other Assets, Noncurrent 681      
Equity, Fair Value Adjustment 13      
Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period 158      
Cost Method Investments 681 $ 510    
Equity, Fair Value Adjustment, Change in Observable Prices $ 67      
ASU 2016-01 - Financial Instruments | Retained Earnings        
Derivative [Line Items]        
Cumulative effect adjustment       $ 232
XML 87 R66.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Summary of Derivative Activity (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period $ (73) $ (4) $ (359)
Sales | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments   0  
Sales | Cross currency interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0 0  
Unrealized gain (loss) arising during period 0 0  
Sales | Cross currency interest rate swaps contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period 0 0  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0 0  
Sales | Forward foreign exchange contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period (32) 49  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 47 (31)  
Cost of Products Sold | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 0 0  
Cost of Products Sold | Cross currency interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0 0  
Unrealized gain (loss) arising during period 0 0  
Cost of Products Sold | Cross currency interest rate swaps contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period 0 0  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0 0  
Cost of Products Sold | Forward foreign exchange contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period (17) 96  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 200 (159)  
R&D Expense | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 0 0  
R&D Expense | Cross currency interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0 0  
Unrealized gain (loss) arising during period 0 0  
R&D Expense | Cross currency interest rate swaps contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period 0 0  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0 0  
R&D Expense | Forward foreign exchange contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period (193) (199)  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (220) (165)  
Interest (Income) Expense | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 5 5  
Interest (Income) Expense | Cross currency interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 56 0  
Unrealized gain (loss) arising during period 56 0  
Interest (Income) Expense | Cross currency interest rate swaps contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period 117 110  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 133 83  
Interest (Income) Expense | Forward foreign exchange contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period 0 0  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0 0  
Other (Income) Expense      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0 0  
Other (Income) Expense | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 0 0  
Other (Income) Expense | Cross currency interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0 0  
Unrealized gain (loss) arising during period 0 0  
Other (Income) Expense | Cross currency interest rate swaps contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period 0 0  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0 0  
Other (Income) Expense | Forward foreign exchange contracts: | Cash Flow Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gain (loss) arising during period (4) (60)  
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (24) (87)  
Designated as Hedging Instrument | Sales | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 0 0  
Designated as Hedging Instrument | Cost of Products Sold | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 0 0  
Designated as Hedging Instrument | R&D Expense | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 0 0  
Designated as Hedging Instrument | Interest (Income) Expense | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments (5) (5)  
Designated as Hedging Instrument | Other (Income) Expense | Interest rate swaps contracts: | Fair Value Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments $ 0 $ 0  
XML 88 R67.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Liability $ 267 $ 367
Current Portion of Long-term Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Liability 494 597
Deferred (Gain) Loss on Discontinuation of Fair Value Hedge 5 2
Long-term Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Liability 0 496
Deferred (Gain) Loss on Discontinuation of Fair Value Hedge $ 0 $ 3
XML 89 R68.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Forward foreign exchange contracts: | Not Designated as Hedging Instrument | Other (Income) Expense    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Gain (Loss) on Derivative, Net $ (68) $ (5)
Fair Value Hedging | Interest rate swaps contracts: | Sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments   0
Fair Value Hedging | Interest rate swaps contracts: | Other (Income) Expense    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments $ 0 $ 0
XML 90 R69.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax $ 218 $ (597)
Cross currency interest rate swaps contracts:    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 150 0
Sale of Subsidiary Gain (Loss)    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0 0
Other (Income) Expense    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net $ 0 $ 0
XML 91 R70.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Summary of Activity Related to Equity Investments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Equity Investment [Roll Forward]    
Other Assets, Noncurrent $ 4,182 $ 4,971
Equity securities | Equity Investments with Readily Determinable Value    
Other Investment Not Readily Marketable [Line Items]    
Marketable Securities, Noncurrent 511 751
Equity Investment [Roll Forward]    
Equity, Fair Value Adjustment (247)  
Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period 7  
Other Assets, Noncurrent 511  
Equity securities | Equity Investments without Readily Determinable Value    
Equity Investment [Roll Forward]    
Equity, Fair Value Adjustment 13  
Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period 158  
Other Assets, Noncurrent 681  
Cost Method Investments $ 681 $ 510
XML 92 R71.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset $ 694 $ 463
Derivative Asset, Fair Value, Gross Liability (423) (76)
Financial assets and liabilities at fair value    
Derivative assets 271 387
Derivative liabilities 267 367
Derivative Liability, Fair Value, Gross Liability 872 605
Derivative Liability, Fair Value, Gross Asset (605) (238)
Equity Securities    
Financial assets and liabilities at fair value    
Equity investments 511 751
Level 1    
Financial assets and liabilities at fair value    
Equity method investments, fair market disclosure 511 751
Debt securities 0  
Level 2    
Financial assets and liabilities at fair value    
Equity method investments, fair market disclosure 0  
Debt securities 9,734 5,310
Level 3    
Financial assets and liabilities at fair value    
Equity method investments, fair market disclosure 0  
Debt securities 0  
Interest rate swaps contracts:    
Financial assets and liabilities at fair value    
Non-current assets included in interest rate contracts 6 7
Non-current liabilities included in interest rate contracts 3 9
Designated as Hedging Instrument    
Financial assets and liabilities at fair value    
Derivative assets 662  
Derivative liabilities 840  
Designated as Hedging Instrument | Level 1    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities 0  
Designated as Hedging Instrument | Level 2    
Financial assets and liabilities at fair value    
Derivative assets 662 425
Derivative liabilities 840 567
Designated as Hedging Instrument | Level 3    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities 0  
Designated as Hedging Instrument | Interest rate swaps contracts:    
Financial assets and liabilities at fair value    
Derivative assets 161  
Derivative liabilities 292  
Designated as Hedging Instrument | Interest rate swaps contracts: | Level 1    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities 0  
Designated as Hedging Instrument | Interest rate swaps contracts: | Level 2    
Financial assets and liabilities at fair value    
Derivative assets 161 7
Derivative liabilities 292 165
Designated as Hedging Instrument | Interest rate swaps contracts: | Level 3    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities 0  
Designated as Hedging Instrument | Foreign exchange contracts    
Financial assets and liabilities at fair value    
Derivative assets 501  
Derivative liabilities 548  
Designated as Hedging Instrument | Foreign exchange contracts | Level 1    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities 0  
Designated as Hedging Instrument | Foreign exchange contracts | Level 2    
Financial assets and liabilities at fair value    
Derivative assets 501 418
Derivative liabilities 548 402
Designated as Hedging Instrument | Foreign exchange contracts | Level 3    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities 0  
Not Designated as Hedging Instrument | Foreign exchange contracts    
Financial assets and liabilities at fair value    
Derivative assets 32  
Derivative liabilities 32  
Not Designated as Hedging Instrument | Foreign exchange contracts | Level 1    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities 0  
Not Designated as Hedging Instrument | Foreign exchange contracts | Level 2    
Financial assets and liabilities at fair value    
Derivative assets 32 38
Derivative liabilities 32 $ 38
Not Designated as Hedging Instrument | Foreign exchange contracts | Level 3    
Financial assets and liabilities at fair value    
Derivative assets 0  
Derivative liabilities $ 0  
XML 93 R72.htm IDEA: XBRL DOCUMENT v3.10.0.1
Borrowings - Schedule of Long-term Debt Instruments (Details)
€ in Millions, $ in Millions, £ in Billions
Dec. 30, 2018
USD ($)
Dec. 30, 2018
GBP (£)
Dec. 30, 2018
EUR (€)
Dec. 31, 2017
USD ($)
Dec. 31, 2017
GBP (£)
Dec. 31, 2017
EUR (€)
Debt Instrument [Line Items]            
Effective interest rate 3.19% 3.19% 3.19% 3.19% 3.19% 3.19%
Borrowed under the commercial paper program       $ 2,300    
Less current portion $ 2,600     1,500    
Total long-term debt 27,684     30,675    
Carrying (Reported) Amount, Fair Value Disclosure            
Debt Instrument [Line Items]            
Long-term Debt 30,320     32,174    
Less current portion 2,636     1,499    
Total long-term debt $ 27,684     $ 30,675    
5.15% Debentures due 2018            
Debt Instrument [Line Items]            
Effective interest rate       5.18% 5.18% 5.18%
Borrowed under the commercial paper program       $ 900    
Stated interest rate (as a percent)       5.15% 5.15% 5.15%
1.65% Notes due 2018            
Debt Instrument [Line Items]            
Effective interest rate       1.70% 1.70% 1.70%
Borrowed under the commercial paper program       $ 597    
Stated interest rate (as a percent)       1.65% 1.65% 1.65%
4.75% Notes due 2019 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)            
Debt Instrument [Line Items]            
Effective interest rate 5.83% 5.83% 5.83% 5.83% 5.83% 5.83%
Long-term Debt $ 1,139     $ 1,192    
Stated interest rate (as a percent) 4.75% 4.75% 4.75% 4.75% 4.75% 4.75%
Debt Instrument, Face Amount | €     € 1,000     € 1,000
Foreign Currency Exchange Rate, Translation 1.14 1.14 1.14 1.1947 1.1947 1.1947
1.875% Notes due 2019            
Debt Instrument [Line Items]            
Effective interest rate 1.93% 1.93% 1.93% 1.93% 1.93% 1.93%
Long-term Debt $ 494     $ 496    
Stated interest rate (as a percent) 1.875% 1.875% 1.875% 1.875% 1.875% 1.875%
0.89% Notes due 2019            
Debt Instrument [Line Items]            
Effective interest rate 1.32% 1.32% 1.32% 1.75% 1.75% 1.75%
Long-term Debt $ 300     $ 300    
Stated interest rate (as a percent) 0.89% 0.89% 0.89% 0.89% 0.89% 0.89%
1.125% Notes due 2019            
Debt Instrument [Line Items]            
Effective interest rate 1.13% 1.13% 1.13% 1.13% 1.13% 1.13%
Long-term Debt $ 699     $ 699    
Stated interest rate (as a percent) 1.125% 1.125% 1.125% 1.125% 1.125% 1.125%
3% Zero Coupon Convertible Subordinated Debentures due 2020            
Debt Instrument [Line Items]            
Effective interest rate 3.00% 3.00% 3.00% 3.00% 3.00% 3.00%
Long-term Debt $ 51     $ 60    
Stated interest rate (as a percent) 3.00% 3.00% 3.00% 3.00% 3.00% 3.00%
2.95% Debentures due 2020            
Debt Instrument [Line Items]            
Effective interest rate 3.15% 3.15% 3.15% 3.15% 3.15% 3.15%
Long-term Debt $ 548     $ 547    
Stated interest rate (as a percent) 2.95% 2.95% 2.95% 2.95% 2.95% 2.95%
1.950% Notes due 2020            
Debt Instrument [Line Items]            
Effective interest rate 1.99% 1.99% 1.99% 1.99% 1.99% 1.99%
Long-term Debt $ 499     $ 499    
Stated interest rate (as a percent) 1.95% 1.95% 1.95% 1.95% 1.95% 1.95%
3.55% Notes due 2021            
Debt Instrument [Line Items]            
Effective interest rate 3.67% 3.67% 3.67% 3.67% 3.67% 3.67%
Long-term Debt $ 449     $ 448    
Stated interest rate (as a percent) 3.55% 3.55% 3.55% 3.55% 3.55% 3.55%
2.45% Notes due 2021            
Debt Instrument [Line Items]            
Effective interest rate 2.48% 2.48% 2.48% 2.48% 2.48% 2.48%
Long-term Debt $ 349     $ 349    
Stated interest rate (as a percent) 2.45% 2.45% 2.45% 2.45% 2.45% 2.45%
1.65% Notes due 2021            
Debt Instrument [Line Items]            
Effective interest rate 1.65% 1.65% 1.65% 1.65% 1.65% 1.65%
Long-term Debt $ 998     $ 998    
Stated interest rate (as a percent) 1.65% 1.65% 1.65% 1.65% 1.65% 1.65%
0.250% Notes due 2022 (1B Euro 1.14)(2)/(1B Euro 1.1947)(3)            
Debt Instrument [Line Items]            
Effective interest rate 0.26% 0.26% 0.26% 0.26% 0.26% 0.26%
Long-term Debt $ 1,137     $ 1,191    
Stated interest rate (as a percent) 0.25% 0.25% 0.25% 0.25% 0.25% 0.25%
Debt Instrument, Face Amount | €     € 1,000     € 1,000
Foreign Currency Exchange Rate, Translation 1.14 1.14 1.14 1.1947 1.1947 1.1947
2.25% Notes due 2022            
Debt Instrument [Line Items]            
Effective interest rate 2.31% 2.31% 2.31% 2.31% 2.31% 2.31%
Long-term Debt $ 996     $ 995    
Stated interest rate (as a percent) 2.25% 2.25% 2.25% 2.25% 2.25% 2.25%
6.73% Debentures due 2023            
Debt Instrument [Line Items]            
Effective interest rate 6.73% 6.73% 6.73% 6.73% 6.73% 6.73%
Long-term Debt $ 250     $ 250    
Stated interest rate (as a percent) 6.73% 6.73% 6.73% 6.73% 6.73% 6.73%
3.375% Notes due 2023            
Debt Instrument [Line Items]            
Effective interest rate 3.17% 3.17% 3.17% 3.17% 3.17% 3.17%
Long-term Debt $ 805     $ 806    
Stated interest rate (as a percent) 3.375% 3.375% 3.375% 3.375% 3.375% 3.375%
2.05% Notes due 2023            
Debt Instrument [Line Items]            
Effective interest rate 2.09% 2.09% 2.09% 2.09% 2.09% 2.09%
Long-term Debt $ 498     $ 498    
Stated interest rate (as a percent) 2.05% 2.05% 2.05% 2.05% 2.05% 2.05%
0.650% Notes due 2024 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)            
Debt Instrument [Line Items]            
Effective interest rate 0.68% 0.68% 0.68% 0.68% 0.68% 0.68%
Long-term Debt $ 851     $ 891    
Stated interest rate (as a percent) 0.65% 0.65% 0.65% 0.65% 0.65% 0.65%
Debt Instrument, Face Amount | €     € 750     € 750
Foreign Currency Exchange Rate, Translation 1.14 1.14 1.14 1.1947 1.1947 1.1947
5.50% Notes due 2024 (500MM GBP 1.2636)(2)/(500MM GBP 1.3444)(3)            
Debt Instrument [Line Items]            
Effective interest rate 6.75% 6.75% 6.75% 6.75% 6.75% 6.75%
Long-term Debt $ 627     $ 666    
Stated interest rate (as a percent) 5.50% 5.50% 5.50% 5.50% 5.50% 5.50%
Debt Instrument, Face Amount | £   £ 0.5     £ 0.5  
Foreign Currency Exchange Rate, Translation 1.2636 1.2636 1.2636 1.3444 1.3444 1.3444
2.625% Notes due 2025            
Debt Instrument [Line Items]            
Effective interest rate 2.63% 2.63% 2.63% 2.63% 2.63% 2.63%
Long-term Debt $ 748     $ 747    
Stated interest rate (as a percent) 2.625% 2.625% 2.625% 2.625% 2.625% 2.625%
2.45% Notes due 2026            
Debt Instrument [Line Items]            
Effective interest rate 2.47% 2.47% 2.47% 2.47% 2.47% 2.47%
Long-term Debt $ 1,992     $ 1,990    
Stated interest rate (as a percent) 2.45% 2.45% 2.45% 2.45% 2.45% 2.45%
2.95% Notes due 2027            
Debt Instrument [Line Items]            
Effective interest rate 2.96% 2.96% 2.96% 2.96% 2.96% 2.96%
Long-term Debt $ 996     $ 995    
Stated interest rate (as a percent) 2.95% 2.95% 2.95% 2.95% 2.95% 2.95%
1.150% Notes due 2028 (750MM Euro 1.14)(2)/(750MM Euro 1.1947)(3)            
Debt Instrument [Line Items]            
Effective interest rate 1.21% 1.21% 1.21% 1.21% 1.21% 1.21%
Long-term Debt $ 847     $ 887    
Stated interest rate (as a percent) 1.15% 1.15% 1.15% 1.15% 1.15% 1.15%
Debt Instrument, Face Amount | €     € 750     € 750
Foreign Currency Exchange Rate, Translation 1.14 1.14 1.14 1.1947 1.1947 1.1947
2.900% Notes due 2028            
Debt Instrument [Line Items]            
Effective interest rate 2.91% 2.91% 2.91% 2.91% 2.91% 2.91%
Long-term Debt $ 1,493     $ 1,492    
Stated interest rate (as a percent) 2.90% 2.90% 2.90% 2.90% 2.90% 2.90%
6.95% Notes due 2029            
Debt Instrument [Line Items]            
Effective interest rate 7.14% 7.14% 7.14% 7.14% 7.14% 7.14%
Long-term Debt $ 297     $ 296    
Stated interest rate (as a percent) 6.95% 6.95% 6.95% 6.95% 6.95% 6.95%
4.95% Debentures due 2033            
Debt Instrument [Line Items]            
Effective interest rate 4.95% 4.95% 4.95% 4.95% 4.95% 4.95%
Long-term Debt $ 498     $ 498    
Stated interest rate (as a percent) 4.95% 4.95% 4.95% 4.95% 4.95% 4.95%
4.375% Notes due 2033            
Debt Instrument [Line Items]            
Effective interest rate 4.24% 4.24% 4.24% 4.24% 4.24% 4.24%
Long-term Debt $ 856     $ 856    
Stated interest rate (as a percent) 4.375% 4.375% 4.375% 4.375% 4.375% 4.375%
1.650% Notes due 2035 (1.5B Euro 1.14)(2)/(1.5B Euro 1.1947)(3)            
Debt Instrument [Line Items]            
Effective interest rate 1.68% 1.68% 1.68% 1.68% 1.68% 1.68%
Long-term Debt $ 1,693     $ 1,774    
Stated interest rate (as a percent) 1.65% 1.65% 1.65% 1.65% 1.65% 1.65%
Debt Instrument, Face Amount | €     € 1,500     € 1,500
Foreign Currency Exchange Rate, Translation 1.14 1.14 1.14 1.1947 1.1947 1.1947
3.55% Notes due 2036            
Debt Instrument [Line Items]            
Effective interest rate 3.59% 3.59% 3.59% 3.59% 3.59% 3.59%
Long-term Debt $ 988     $ 987    
Stated interest rate (as a percent) 3.55% 3.55% 3.55% 3.55% 3.55% 3.55%
5.95% Notes due 2037            
Debt Instrument [Line Items]            
Effective interest rate 5.99% 5.99% 5.99% 5.99% 5.99% 5.99%
Long-term Debt $ 991     $ 991    
Stated interest rate (as a percent) 5.95% 5.95% 5.95% 5.95% 5.95% 5.95%
3.625% Notes due 2037            
Debt Instrument [Line Items]            
Effective interest rate 3.64% 3.64% 3.64% 3.64% 3.64% 3.64%
Long-term Debt $ 1,486     $ 1,486    
Stated interest rate (as a percent) 3.625% 3.625% 3.625% 3.625% 3.625% 3.625%
5.85% Debentures due 2038            
Debt Instrument [Line Items]            
Effective interest rate 5.85% 5.85% 5.85% 5.85% 5.85% 5.85%
Long-term Debt $ 696     $ 696    
Stated interest rate (as a percent) 5.85% 5.85% 5.85% 5.85% 5.85% 5.85%
3.400% Notes due 2038            
Debt Instrument [Line Items]            
Effective interest rate 3.42% 3.42% 3.42% 3.42% 3.42% 3.42%
Long-term Debt $ 990     $ 990    
Stated interest rate (as a percent) 3.40% 3.40% 3.40% 3.40% 3.40% 3.40%
4.50% Debentures due 2040            
Debt Instrument [Line Items]            
Effective interest rate 4.63% 4.63% 4.63% 4.63% 4.63% 4.63%
Long-term Debt $ 538     $ 538    
Stated interest rate (as a percent) 4.50% 4.50% 4.50% 4.50% 4.50% 4.50%
4.85% Notes due 2041            
Debt Instrument [Line Items]            
Effective interest rate 4.89% 4.89% 4.89% 4.89% 4.89% 4.89%
Long-term Debt $ 297     $ 296    
Stated interest rate (as a percent) 4.85% 4.85% 4.85% 4.85% 4.85% 4.85%
4.50% Notes due 2043            
Debt Instrument [Line Items]            
Effective interest rate 4.52% 4.52% 4.52% 4.52% 4.52% 4.52%
Long-term Debt $ 495     $ 495    
Stated interest rate (as a percent) 4.50% 4.50% 4.50% 4.50% 4.50% 4.50%
3.70% Notes due 2046            
Debt Instrument [Line Items]            
Effective interest rate 3.74% 3.74% 3.74% 3.74% 3.74% 3.74%
Long-term Debt $ 1,972     $ 1,971    
Stated interest rate (as a percent) 3.70% 3.70% 3.70% 3.70% 3.70% 3.70%
3.75% Notes due 2047            
Debt Instrument [Line Items]            
Effective interest rate 3.76% 3.76% 3.76% 3.76% 3.76% 3.76%
Long-term Debt $ 991     $ 990    
Stated interest rate (as a percent) 3.75% 3.75% 3.75% 3.75% 3.75% 3.75%
3.500% Notes due 2048            
Debt Instrument [Line Items]            
Effective interest rate 3.52% 3.52% 3.52% 3.52% 3.52% 3.52%
Long-term Debt $ 742     $ 742    
Stated interest rate (as a percent) 3.50% 3.50% 3.50% 3.50% 3.50% 3.50%
Other            
Debt Instrument [Line Items]            
Effective interest rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-term Debt $ 24     $ 75    
XML 94 R73.htm IDEA: XBRL DOCUMENT v3.10.0.1
Borrowings - Narrative (Details) - USD ($)
$ in Billions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Debt Disclosure [Abstract]    
Excess of fair value over carrying value of debt $ 0.3 $ 2.0
Line of Credit Facility, Initiation Date Sep. 13, 2018  
Borrowing capacity under credit facility $ 10.0  
Line of Credit Facility, Expiration Date Sep. 12, 2019  
Short-term borrowings and the current portion of long-term debt $ 2.8 3.9
Borrowed under the commercial paper program   2.3
Current portion of long term debt $ 2.6 $ 1.5
XML 95 R74.htm IDEA: XBRL DOCUMENT v3.10.0.1
Borrowings - Aggregate Maturities of Long Term Obligations (Details)
$ in Millions
Dec. 30, 2018
USD ($)
Aggregate maturities of long-term obligations  
2019 $ 2,636
2020 1,098
2021 1,796
2022 2,134
2023 1,553
After 2023 $ 21,103
XML 96 R75.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Provision for Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Income Tax Disclosure [Abstract]          
Increase in effective tax rate (as a percent)   73.30% (77.60%) 9.00%  
Currently payable:          
U.S. taxes     $ 1,081 $ 11,969 $ 1,896
U.S. taxes on international operations     203 126 49
International taxes     2,434 1,872 1,659
Total currently payable     3,718 13,967 3,604
Deferred:          
U.S. taxes     (148) (1,956) 294
U.S. taxes on international operations     1,358    
International taxes     (2,226) 4,362 (635)
Total deferred $ 1,900   (1,016) 2,406 (341)
Provision for taxes on income     $ 2,702 $ 16,373 $ 3,263
XML 97 R76.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Comparison of Income Taxes at Statutory Rate and Company's Effective Tax Rate (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Comparison Of Income Tax Expense At Statutory Rate And Company's Tax Rate Abstract                      
U.S.                 $ 5,575 $ 4,865 $ 7,457
International                 12,424 12,808 12,346
Earnings before provision for taxes on income $ 3,122 $ 4,423 $ 4,973 $ 5,481 $ 2,560 $ 4,790 $ 4,748 $ 5,575 $ 17,999 $ 17,673 $ 19,803
Tax Rates:                      
U.S. statutory rate                 21.00% 35.00% 35.00%
International operations (1)                 (3.70%) (12.80%) (17.20%)
Research and orphan drug tax credits                 (1.00%) (0.40%) (0.40%)
U.S. state and local                 0.80% 0.60% (0.10%)
U.S. manufacturing deduction                 (0.00%) (0.80%) (0.60%)
U.S. tax on international income (2)                 1.40% 0.70% 1.30%
Tax benefits on share-based compensation                 (1.50%) (2.10%) (1.80%)
U.S. tax benefit on asset/business disposals                 0.50% (0.80%) 0.00%
All other                 (0.60%) (0.10%) 0.30%
TCJA and related impacts (3)                 (1.90%) 73.30% 0.00%
Effective tax rate                 15.00% 92.60% 16.50%
Increase in effective tax rate (as a percent)         73.30%       (77.60%) 9.00%  
Foreign Tax Authority                      
Tax Rates:                      
Increase in effective tax rate (as a percent)                 11.00%    
State and Local Jurisdiction                      
Tax Rates:                      
Increase in effective tax rate (as a percent)                 0.60%    
Administration of the Treasury, Belgium                      
Tax Rates:                      
Increase in effective tax rate (as a percent)                 3.40%    
XML 98 R77.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Temporary Differences and Carryforwards (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Components of Deferred Tax Assets and Liabilities [Abstract]    
Deferred Tax Assets, Employee related obligations $ 2,398 $ 2,259
Deferred Tax Assets, Stock based compensation 639 507
Deferred Tax Assets, Property, Plant and Equipment 1,784  
Deferred Tax Assets, International R&D capitalized for tax 1,282 1,307
Deferred Tax Assets, Reserves & liabilities 1,647 1,718
Deferred Tax Assets, Income reported for tax purposes 1,104 1,316
Deferred Tax Assets, Net operating loss carryforward international 786 762
Deferred Tax Assets, Undistributed Foreign Earnings 693 1,101
Deferred Tax Liabilities, Non-deductible intangibles (5,967) (6,506)
Deferred Tax Liabilities, Undistributed Foreign Earnings (2,240) (4,457)
Deferred Tax Liability, Global Intangible Low-Taxed Income (2,971)  
Deferred Tax Assets, Miscellaneous international 603 755
Deferred Tax Assets Other Domestic 469 177
Deferred Tax Assets, Total deferred income taxes 11,405 9,902
Deferred Tax Liabilities, Depreciation (9)
Deferred Tax Liabilities, Miscellaneous international (93) (194)
Deferred Tax Liabilities, Total deferred income taxes $ (11,271) $ (11,166)
XML 99 R78.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Summary of unrecognized tax benefits      
Beginning of year $ 3,151 $ 3,041 $ 3,080
Increases related to current year tax positions 242 332 348
Increases related to prior period tax positions 145 232 11
Decreases related to prior period tax positions (137) (416) (338)
Settlements (40) (2) (37)
Lapse of statute of limitations (35) (36) (23)
End of year $ 3,326 3,151 $ 3,041
Unrecognized tax benefits decrease from TCJA   $ 347  
XML 100 R79.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Jan. 01, 2018
Jan. 03, 2016
Tax Credit Carryforward [Line Items]              
U.S. statutory rate     21.00% 35.00% 35.00%    
TCJA, provisional liability $ 8,200   $ 8,200        
Provisional tax cost   $ 13,000 200        
Provisional toll tax charge   10,100          
Deferred tax liability foreign taxes 2,240 4,457 $ 2,240 $ 4,457      
Deferred tax asset offset   1,100   1,100      
Remeasurement of deferred tax assets and liabilities   600          
GILTI, deferred tax cost 1,400            
GILTI, deferred tax liability   $ 1,600   $ 1,600      
Increase (decrease) in effective tax rate (as a percent)   73.30% (77.60%) 9.00%      
Deferred tax liability, repatriation of foreign earnings 2,800   $ 2,800        
Deferred tax asset, foreign tax credits 900   900        
Net deferred tax benefit 1,900   (1,016) $ 2,406 $ (341)    
Deferred tax assets, net 2,000   $ 2,000        
Effective income tax rate reconciliation, deduction     1.70%        
Effective income tax rate reconciliation, TCJA     1.90% (73.30%) (0.00%)    
Effective income tax rate reconciliation, GILTI     1.60%        
Effective income tax rate reconciliation, stock-based compensation     1.50% 2.00%      
Effective income tax rate reconciliation, divestiture of business     0.80%        
Increase in effective tax rate from prior period (as a percent)     76.10%        
Unrecognized tax benefits 3,326 $ 3,151 $ 3,326 $ 3,151 $ 3,041   $ 3,080
Unrecognized tax benefits, interest on income tax expense     53 60 $ 7    
Unrecognized tax benefits, interest on income taxes accrued 503 436 $ 503 436      
State and Local Jurisdiction              
Tax Credit Carryforward [Line Items]              
Deferred tax liability foreign taxes   $ 100   $ 100      
Increase (decrease) in effective tax rate (as a percent)     0.60%        
Retained Earnings              
Tax Credit Carryforward [Line Items]              
GILTI, deferred tax liability $ 1,700   $ 1,700     $ 1,700  
Administration of the Treasury, Belgium              
Tax Credit Carryforward [Line Items]              
Increase (decrease) in effective tax rate (as a percent)     3.40%        
XML 101 R80.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Related Obligations - Employee Related Obligations (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Employee-related Liabilities [Abstract]    
Pension benefits $ 5,327 $ 5,343
Postretirement benefits 2,283 2,331
Postemployment benefits 2,330 2,250
Deferred compensation 410 475
Total employee obligations 10,350 10,399
Less current benefits payable 399 325
Employee related obligations — non-current $ 9,951 $ 10,074
XML 102 R81.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Related Obligations - Narrative (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Compensation Related Costs [Abstract]    
Prepaid employee related obligations $ 475 $ 526
XML 103 R82.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Retirement Plans      
Components of net periodic benefit cost      
Service cost $ 1,283 $ 1,080 $ 949
Interest cost 996 927 927
Expected return on plan assets (2,212) (2,041) (1,962)
Amortization of prior service cost (credit) 3 2 1
Recognized actuarial losses 852 609 496
Curtailments and settlements 1 17 11
Net periodic benefit cost 923 594 422
Other Benefit Plans      
Components of net periodic benefit cost      
Service cost 269 247 224
Interest cost 148 159 158
Expected return on plan assets (7) (6) (6)
Amortization of prior service cost (credit) (31) (30) (34)
Recognized actuarial losses 123 138 135
Curtailments and settlements 0 0 0
Net periodic benefit cost $ 502 $ 508 $ 477
XML 104 R83.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Amounts Expected to be Recognized in Net Periodic Benefit Cost (Details)
$ in Millions
Dec. 30, 2018
USD ($)
Pension and Other Postretirement Benefit Plans, Amounts that Will be Amortized from Accumulated Other Comprehensive Income (Loss) in Next Fiscal Year [Abstract]  
Amortization of net transition obligation $ 0
Amortization of net actuarial losses 656
Amortization of prior service credit $ 27
XML 105 R84.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Rates Used to Develop Actuarial Present Value of Projected Benefit Obligation (Details)
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Retirement Plans      
Net Periodic Benefit Cost      
Service cost discount rate 3.20% 3.59% 3.98%
Interest cost discount rate 3.60% 3.98% 4.24%
Rate of increase in compensation levels 3.98% 4.01% 4.02%
Expected long-term rate of return on plan assets 8.46% 8.43% 8.55%
Benefit Obligation      
Discount rate 3.76% 3.30% 3.78%
Rate of increase in compensation levels 3.97% 3.99% 4.02%
Other Benefit Plans      
Net Periodic Benefit Cost      
Service cost discount rate 3.85% 4.63% 4.77%
Interest cost discount rate 3.62% 3.94% 4.10%
Rate of increase in compensation levels 4.29% 4.31% 4.32%
Benefit Obligation      
Discount rate 4.40% 3.78% 4.42%
Rate of increase in compensation levels 4.29% 4.30% 4.29%
XML 106 R85.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Assumed Health Care Cost Trend Rates (Details)
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]    
Health care cost trend rate assumed for next year 6.12% 6.33%
Rate to which the cost trend rate is assumed to decline (ultimate trend) 4.55% 4.55%
Year the rate reaches the ultimate trend rate 2038 2038
XML 107 R86.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Effect of One Percentage Point Change in Assumed Health Care Cost Trend Rates (Details)
$ in Millions
 12 Months Ended
Dec. 30, 2018
USD ($)
Effect of one percentage point change in assumed health care cost trend rates  
Effect of one percentage point increase on total interest and service cost $ 28
Effect of one percentage point decrease on total interest and service cost (22)
Effect of one percentage point increase on post-retirement benefit obligation 340
Effect of one percentage point decrease on post-retirement benefit obligation $ (280)
XML 108 R87.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Schedule of Net Funded Status (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Amounts Recognized in the Company’s Balance Sheet consist of the following:      
Non-current assets $ 475 $ 526  
Current liabilities (399) (325)  
Non-current liabilities (9,951) (10,074)  
Retirement Plans      
Change in Benefit Obligation      
Projected benefit obligation - beginning of year 33,221 28,116  
Service cost 1,283 1,080 $ 949
Interest cost 996 927 927
Plan participant contributions 66 60  
Amendments 26 (7)  
Actuarial (gains) losses (2,326) 2,996  
Divestitures & acquisitions (29) 201  
Curtailments, settlements & restructuring (21) (35)  
Benefits paid from plan (1,018) (1,050)  
Effect of exchange rates (528) 933  
Projected benefit obligation - end of year 31,670 33,221 28,116
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Plan assets at fair value — beginning of year 28,404 23,633  
Actual return on plan assets (1,269) 4,274  
Company contributions 1,140 664  
Plan participant contributions 66 60  
Settlements (13) (32)  
Divestitures & acquisitions (17) 173  
Benefits paid from plan assets (1,018) (1,050)  
Effect of exchange rates (475) 682  
Plan assets at fair value - End of year 26,818 28,404 23,633
Funded status - end of year (4,852) (4,817)  
Amounts Recognized in the Company’s Balance Sheet consist of the following:      
Non-current assets 475 526  
Current liabilities (98) (92)  
Non-current liabilities (5,229) (5,251)  
Total recognized in the consolidated balance sheet — end of year (4,852) (4,817)  
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]      
Net actuarial loss 8,323 8,140  
Prior service cost (credit) 2 (25)  
Unrecognized net transition obligation 0 0  
Total before tax effects 8,325 8,115  
Accumulated Benefit Obligation 28,533 29,793  
Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax [Abstract]      
Net periodic benefit cost 923 594 422
Net actuarial (gain) loss 1,153 740  
Amortization of net actuarial loss (852) (609)  
Prior service cost (credit) 26 (7)  
Amortization of prior service (cost) credit (3) (2)  
Effect of exchange rates (114) 256  
Total loss/(income) recognized in other comprehensive income, before tax 210 378  
Total recognized in net periodic benefit cost and other comprehensive income 1,133 972  
Other Benefit Plans      
Change in Benefit Obligation      
Projected benefit obligation - beginning of year 4,582 4,605  
Service cost 269 247 224
Interest cost 148 159 158
Plan participant contributions 0 0  
Amendments 0 (17)  
Actuarial (gains) losses (119) (166)  
Divestitures & acquisitions 0 88  
Curtailments, settlements & restructuring 0 2  
Benefits paid from plan (383) (351)  
Effect of exchange rates (17) 15  
Projected benefit obligation - end of year 4,480 4,582 4,605
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Plan assets at fair value — beginning of year 281 75  
Actual return on plan assets 0 12  
Company contributions 282 545  
Plan participant contributions 0 0  
Settlements 0 0  
Divestitures & acquisitions 0 0  
Benefits paid from plan assets (383) (351)  
Effect of exchange rates 0 0  
Plan assets at fair value - End of year 180 281 75
Funded status - end of year (4,300) (4,301)  
Amounts Recognized in the Company’s Balance Sheet consist of the following:      
Non-current assets 0 0  
Current liabilities (281) (228)  
Non-current liabilities (4,019) (4,073)  
Total recognized in the consolidated balance sheet — end of year (4,300) (4,301)  
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]      
Net actuarial loss 1,263 1,500  
Prior service cost (credit) (106) (137)  
Unrecognized net transition obligation 0 0  
Total before tax effects 1,157 1,363  
Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax [Abstract]      
Net periodic benefit cost 502 508 $ 477
Net actuarial (gain) loss (111) (169)  
Amortization of net actuarial loss (123) (138)  
Prior service cost (credit) 0 (17)  
Amortization of prior service (cost) credit 31 30  
Effect of exchange rates (3) 3  
Total loss/(income) recognized in other comprehensive income, before tax (206) (291)  
Total recognized in net periodic benefit cost and other comprehensive income $ 296 $ 217  
XML 109 R88.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Defined Benefit Plan Disclosure [Line Items]      
Percentage of corridor of greater of market value of assets 10.00%    
Accumulated benefit obligation unfunded plans $ 7,500 $ 3,800  
Projected benefit obligation, unfunded plans 8,800 4,600  
Plan Assets 4,300 700  
Fair value of company's common stock directly held in plan assets $ 876 $ 938  
Percentage of company's common stock to plan asset 3.30% 3.30%  
Retirement Plans      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets $ 26,818 $ 28,404 $ 23,633
Other Benefit Plans      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 180 281 $ 75
U.S. Plans      
Defined Benefit Plan Disclosure [Line Items]      
Contribution to pension plans 679    
International Plans      
Defined Benefit Plan Disclosure [Line Items]      
Contribution to pension plans 461    
Commingled funds | Level 2 | Other Benefit Plans      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 72 81  
Short-term Investments | Level 2 | Other Benefit Plans      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets $ 108 $ 200  
Minimum | Retirement Plans      
Defined Benefit Plan Disclosure [Line Items]      
Retirement plan benefits Employee compensation Period 3 years    
Maximum | Retirement Plans      
Defined Benefit Plan Disclosure [Line Items]      
Retirement plan benefits Employee compensation Period 5 years    
XML 110 R89.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Information Related to the Benefit Obligation and the Fair Value of Plan Assets (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Qualified Plans | U.S. Plans    
Defined Benefit Plan Disclosure [Line Items]    
Plan Assets $ 17,725 $ 18,681
Projected Benefit Obligation 18,609 19,652
Accumulated Benefit Obligation 16,851 17,654
Projected Benefit Obligation (884) (971)
Accumulated Benefit Obligation 874 1,027
Non-Qualified Plans | U.S. Plans    
Defined Benefit Plan Disclosure [Line Items]    
Plan Assets 0 0
Projected Benefit Obligation 2,176 2,257
Accumulated Benefit Obligation 1,793 1,849
Projected Benefit Obligation (2,176) (2,257)
Accumulated Benefit Obligation (1,793) (1,849)
Funded Plans | International Plans    
Defined Benefit Plan Disclosure [Line Items]    
Plan Assets 9,093 9,723
Projected Benefit Obligation 10,467 10,863
Accumulated Benefit Obligation 9,510 9,893
Projected Benefit Obligation (1,374) (1,140)
Accumulated Benefit Obligation (417) (170)
Unfunded Plans | International Plans    
Defined Benefit Plan Disclosure [Line Items]    
Plan Assets 0 0
Projected Benefit Obligation 418 449
Accumulated Benefit Obligation 379 397
Projected Benefit Obligation (418) (449)
Accumulated Benefit Obligation $ (379) $ (397)
XML 111 R90.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Projected Future Benefit Payments from Company's Retirement and Other Benefit Plans (Details)
$ in Millions
Dec. 30, 2018
USD ($)
Retirement plans  
Defined Benefit Plan Disclosure [Line Items]  
2019 $ 1,062
2020 1,104
2021 1,182
2022 1,257
2023 1,332
2024-2028 7,679
Other benefit plans  
Defined Benefit Plan Disclosure [Line Items]  
2019 375
2020 397
2021 411
2022 428
2023 413
2024-2028 $ 2,273
XML 112 R91.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Projected Future Minimum Contributions to the Company's U.S. and International Unfunded Retirement Plans (Details)
$ in Millions
Dec. 30, 2018
USD ($)
Retirement Benefits [Abstract]  
2019 $ 92
2020 95
2021 101
2022 108
2023 115
2024-2028 $ 697
XML 113 R92.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Company' Retirement Plan Asset Allocation and Target Allocations (Details)
Dec. 30, 2018
Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]    
Percent of Plan Assets 100.00% 100.00%
Target Allocation 100.00%  
Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Percent of Plan Assets 71.00% 76.00%
Target Allocation 70.00%  
Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Percent of Plan Assets 29.00% 24.00%
Target Allocation 30.00%  
XML 114 R93.htm IDEA: XBRL DOCUMENT v3.10.0.1
Pensions and Other Benefit Plans - Schedule of Defined Benefit Plans Disclosures (Details) - Retirement plans - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets $ 26,818 $ 28,404 $ 23,633
Fair Value, Measurements, Recurring      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 26,818 28,404  
Investments Measured at Net Asset Value 5,502 6,436  
Fair Value, Measurements, Recurring | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 11,420 14,277  
Fair Value, Measurements, Recurring | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 9,570 7,435  
Fair Value, Measurements, Recurring | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 326 256  
Fair Value, Measurements, Recurring | Short-term investment funds      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 651 856  
Fair Value, Measurements, Recurring | Short-term investment funds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 122 429  
Fair Value, Measurements, Recurring | Short-term investment funds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 529 427  
Fair Value, Measurements, Recurring | Short-term investment funds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Government and agency securities      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 3,595 3,094  
Fair Value, Measurements, Recurring | Government and agency securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Government and agency securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 3,595 3,094  
Fair Value, Measurements, Recurring | Government and agency securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Debt instruments      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 3,105 2,013  
Fair Value, Measurements, Recurring | Debt instruments | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Debt instruments | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 3,105 2,013  
Fair Value, Measurements, Recurring | Debt instruments | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Equity securities      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 11,302 13,848  
Fair Value, Measurements, Recurring | Equity securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 11,298 13,848  
Fair Value, Measurements, Recurring | Equity securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 4 0  
Fair Value, Measurements, Recurring | Equity securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Commingled funds      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 7,638 7,995  
Investments Measured at Net Asset Value 5,201 6,158  
Fair Value, Measurements, Recurring | Commingled funds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Commingled funds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 2,304 1,780  
Fair Value, Measurements, Recurring | Commingled funds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 133 57  
Fair Value, Measurements, Recurring | Insurance contracts      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 193 199  
Investments Measured at Net Asset Value 0 0  
Fair Value, Measurements, Recurring | Insurance contracts | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Insurance contracts | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Insurance contracts | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 193 199  
Fair Value, Measurements, Recurring | Other assets      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 334 399  
Investments Measured at Net Asset Value 301 278  
Fair Value, Measurements, Recurring | Other assets | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 0 0  
Fair Value, Measurements, Recurring | Other assets | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets 33 121  
Fair Value, Measurements, Recurring | Other assets | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan Assets $ 0 $ 0  
XML 115 R94.htm IDEA: XBRL DOCUMENT v3.10.0.1
Savings Plan - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Savings Plan [Abstract]      
Matching contributions $ 242 $ 214 $ 191
XML 116 R95.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital and Treasury Stock - Changes in Treasury Stock (Details) - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Changes in Treasury Stock Shares Outstanding [Roll Forward]      
Treasury Stock, Balance, Shares 437,318 413,332 364,681
Employee compensation and stock option plans, Shares (22,082) (25,508) (30,839)
Treasury Stock, Ending Balance, Shares 457,519 437,318 413,332
Changes in treasury stock      
Treasury Stock, Balance $ 31,554 $ 28,352 $ 22,684
Employee compensation and stock option plans related to treasury stock (3,060) (3,156) (3,311)
Repurchase of common stock, Amounts 5,868 6,358 8,979
Treasury Stock, Ending Balance $ 34,362 $ 31,554 $ 28,352
Treasury Stock      
Changes in Treasury Stock Shares Outstanding [Roll Forward]      
Repurchase of common stock, Shares 42,283 49,494 79,490
Changes in treasury stock      
Repurchase of common stock, Amounts $ 5,868 $ 6,358 $ 8,979
XML 117 R96.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital and Treasury Stock - Narrative (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Dec. 17, 2018
Oct. 13, 2015
Equity, Class of Treasury Stock [Line Items]          
Common stock, shares issued (in shares) 3,119,843 3,119,843 3,119,843    
Cash dividends paid (in dollars per share) $ 3.54 $ 3.32 $ 3.15    
Payments for Repurchase of Common Stock $ 5,868 $ 6,358 $ 8,979    
December 17, 2018 Share Repurchase Program          
Equity, Class of Treasury Stock [Line Items]          
Stock repurchase program, authorized amount       $ 5,000  
Payments for Repurchase of Common Stock $ 900        
October 13, 2015 Share Repurchase Program          
Equity, Class of Treasury Stock [Line Items]          
Stock repurchase program, authorized amount         $ 10,000
XML 118 R97.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning Balance $ 60,160 $ 70,418 $ 71,150
Net change (1,791) 1,702 (1,736)
Cumulative adjustment [1] (486)    
Ending Balance 59,752 60,160 70,418
Foreign Currency Translation      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning Balance (7,351) (9,047) (8,435)
Net change (1,518) 1,696 (612)
Ending Balance (8,869) (7,351) (9,047)
Gain/(Loss) On Securities      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning Balance 232 411 604
Net change 0 (179) (193)
Cumulative adjustment (232)    
Ending Balance 0 232 411
Employee Benefit Plans      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning Balance (6,150) (5,980) (5,298)
Net change (8) (170) (682)
Ending Balance (6,158) (6,150) (5,980)
Gain/ (Loss) On Derivatives & Hedges      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning Balance 70 (285) (36)
Net change (265) 355 (249)
Ending Balance (195) 70 (285)
Accumulated Other Comprehensive Income      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning Balance (13,199) (14,901) (13,165)
Net change (1,791) 1,702 (1,736)
Cumulative adjustment [1] (232)    
Ending Balance $ (15,222) $ (13,199) $ (14,901)
[1] (1) See Note 1 to Consolidated Financial Statements for additional details on the effect of cumulative adjustments to retained earnings.
XML 119 R98.htm IDEA: XBRL DOCUMENT v3.10.0.1
International Currency Translation - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Foreign Currency Translation [Abstract]      
Foreign currency transaction gain (loss), before tax $ (265) $ (216) $ (289)
XML 120 R99.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share - Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share (Details) - $ / shares
shares in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Reconciliation of basic net earnings per share to diluted net earnings per share                      
Basic net earnings per share (in dollars per share) $ 1.14 $ 1.47 $ 1.47 $ 1.63 $ (3.99) $ 1.40 $ 1.42 $ 1.63 $ 5.70 $ 0.48 $ 6.04
Average shares outstanding — basic (in shares)                 2,681.5 2,692.0 2,737.3
Potential shares exercisable under stock option plans (in shares)                 139.0 139.7 142.4
Less: shares repurchased under treasury stock method (in shares)                 (92.5) (87.3) (92.1)
Convertible debt shares (in shares)                 0.7 0.9 1.3
Average shares outstanding - diluted (in shares)                 2,728.7 2,745.3 2,788.9
Diluted net earnings per share (in dollars per share) $ 1.12 $ 1.44 $ 1.45 $ 1.60 $ (3.99) $ 1.37 $ 1.40 $ 1.61 $ 5.61 $ 0.47 $ 5.93
XML 121 R100.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Earnings Per Share [Abstract]      
Interest expense convertible debt $ 1 $ 1 $ 2
XML 122 R101.htm IDEA: XBRL DOCUMENT v3.10.0.1
Rental Expense and Lease Commitments - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Leases, Operating [Abstract]      
Rentals under operating leases $ 332 $ 372 $ 330
XML 123 R102.htm IDEA: XBRL DOCUMENT v3.10.0.1
Rental Expense and Lease Commitments - Schedule of Minimum Rental Payments Under Operating Leases (Details)
$ in Millions
Dec. 30, 2018
USD ($)
Minimum rental payments under operating leases  
2019 $ 223
2020 188
2021 154
2022 116
2023 76
After 2023 139
Total $ 896
XML 124 R103.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock, Stock Option Plans and Stock Compensation Agreements - Narrative (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 30, 2018
USD ($)
StockBasedCompensationPlans
$ / shares
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Jan. 01, 2017
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of stock-based compensation plans | StockBasedCompensationPlans 2    
Compensation cost charged for Long term incentive plan $ 978.0 $ 962.0 $ 878.0
Total income tax benefit recognized 192.0 275.0 256.0
Excess tax benefits     353.0
Total compensation cost not yet recognized for option $ 827.0 $ 798.0 $ 749.0
Weighted average period for total compensation cost not yet recognized 1 year 8 months 23 days 1 year 9 months 4 days 1 year 1 month 2 days
Average fair value of option granted (in dollars per share) | $ / shares $ 17.98 $ 13.38 $ 10.01
Total intrinsic value of options exercised $ 1,028.0 $ 1,060.0 $ 980.0
Stock options outstanding (in shares) | shares 109,652 111,306 113,455
Stock option average life 6 years 2 months 12 days 6 years 3 months 18 days 6 years 2 months 12 days
Stock options exercisable | shares   52,421 50,414
Stock options average price | $ / shares   $ 73.61 $ 65.77
Employee Stock Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock options expiration period 10 years    
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Average fair value of RSU's and PSU's granted | $ / shares $ 119.67 $ 107.69 $ 92.45
Fair Value of RSU or PSU units settled $ 613.7 $ 596.5 $ 587.7
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Average fair value of RSU's and PSU's granted | $ / shares $ 120.64 $ 114.13 $ 105.30
Fair Value of RSU or PSU units settled $ 128.8 $ 132.5 $ 127.7
Minimum | Employee Stock Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 6 months    
Minimum | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 6 months    
Minimum | Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 6 months    
Vesting percentage 0.00%    
Maximum | Employee Stock Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Maximum | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Maximum | Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Vesting percentage 200.00%    
2012 Long-Term Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares authorized for issuance under long-term incentive plan | shares 650,000    
Shares available for future grants under long-term incentive plan | shares 351,000    
XML 125 R104.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock, Stock Option Plans and Stock Compensation Agreements - Schedule Valuation Assumptions (Details)
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Weighted average assumptions of fair value of options      
Risk-free rate 2.77% 2.25% 1.51%
Expected volatility 15.77% 15.30% 15.76%
Expected life (in years) 7 years 7 years 7 years
Expected dividend yield 2.70% 2.90% 3.10%
XML 126 R105.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Jan. 03, 2016
Outstanding Shares        
Options outstanding beginning of period 111,306 113,455 116,517  
Options granted 17,115 19,287 22,491  
Options exercised (16,228) (18,975) (22,547)  
Options canceled/forfeited (2,541) (2,461) (3,006)  
Options outstanding end of period 109,652 111,306 113,455  
Weighted Average Exercise Price        
Options exercise price beginning of period $ 90.48 $ 83.16 $ 76.41  
Options granted, average exercise price (in dollars per share) 129.51 115.67 101.87  
Options exercised, average exercise price (in dollars per share) 75.44 70.87 65.66  
Options canceled/forfeited, average exercise price (in dollars per share) 112.90 101.40 92.83  
Options exercise price end of period $ 98.29 $ 90.48 $ 83.16  
Aggregate intrinsic value $ 3,214 $ 5,480 $ 3,636 $ 3,065
XML 127 R106.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Options Outstanding (Details) - $ / shares
shares in Thousands
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Stock options outstanding and exercisable      
Outstanding number of Options (in shares) 109,652 111,306 113,455
Outstanding, Average Life 6 years 2 months 12 days 6 years 3 months 18 days 6 years 2 months 12 days
Outstanding Average Exercise Price (in dollars per share) $ 98.29    
Exercisable number of Options (in shares) 54,862    
Exercisable, Average Exercise Price (in dollars per share) $ 82.03    
$52.13-$65.62      
Stock options outstanding and exercisable      
Price Range, Minimum (in dollars per share) 52.13    
Price Range, Maximum (in dollars per share) $ 65.62    
Outstanding number of Options (in shares) 13,466    
Outstanding, Average Life 1 year 9 months 18 days    
Outstanding Average Exercise Price (in dollars per share) $ 62.67    
Exercisable number of Options (in shares) 13,466    
Exercisable, Average Exercise Price (in dollars per share) $ 62.67    
$66.07-$72.54      
Stock options outstanding and exercisable      
Price Range, Minimum (in dollars per share) 66.07    
Price Range, Maximum (in dollars per share) $ 72.54    
Outstanding number of Options (in shares) 12,710    
Outstanding, Average Life 4 years    
Outstanding Average Exercise Price (in dollars per share) $ 72.53    
Exercisable number of Options (in shares) 12,710    
Exercisable, Average Exercise Price (in dollars per share) $ 72.53    
$90.44-$100.48      
Stock options outstanding and exercisable      
Price Range, Minimum (in dollars per share) 90.44    
Price Range, Maximum (in dollars per share) $ 100.48    
Outstanding number of Options (in shares) 29,162    
Outstanding, Average Life 5 years 7 months 6 days    
Outstanding Average Exercise Price (in dollars per share) $ 95.34    
Exercisable number of Options (in shares) 28,537    
Exercisable, Average Exercise Price (in dollars per share) $ 95.23    
$101.87-$115.67      
Stock options outstanding and exercisable      
Price Range, Minimum (in dollars per share) 101.87    
Price Range, Maximum (in dollars per share) $ 115.67    
Outstanding number of Options (in shares) 37,877    
Outstanding, Average Life 7 years 7 months 6 days    
Outstanding Average Exercise Price (in dollars per share) $ 108.33    
Exercisable number of Options (in shares) 111    
Exercisable, Average Exercise Price (in dollars per share) $ 108.04    
$115.68-$129.51      
Stock options outstanding and exercisable      
Price Range, Minimum (in dollars per share) 115.68    
Price Range, Maximum (in dollars per share) $ 129.51    
Outstanding number of Options (in shares) 16,437    
Outstanding, Average Life 9 years 1 month 6 days    
Outstanding Average Exercise Price (in dollars per share) $ 129.51    
Exercisable number of Options (in shares) 38    
Exercisable, Average Exercise Price (in dollars per share) $ 129.51    
XML 128 R107.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Restricted Share Units (Details)
shares in Thousands
 12 Months Ended
Dec. 30, 2018
shares
Performance Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Shares, Beginning balance 2,625
Shares, granted 1,142
Shares, issued (1,151)
Shares, canceled/forfeited/adjusted (122)
Shares, Ending balance 2,494
Restricted Stock Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Shares, Beginning balance 20,161
Shares, granted 6,074
Shares, issued (6,684)
Shares, canceled/forfieted (1,091)
Shares, Ending balance 18,460
XML 129 R108.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segments of Business and Geographic Areas - Sales by Segment of Business (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Segment Reporting Information [Line Items]                      
Sales to Customers $ 20,394 $ 20,348 $ 20,830 $ 20,009 $ 20,195 $ 19,650 $ 18,839 $ 17,766 $ 81,581 $ 76,450 $ 71,890
Percentage Change In Sales By Segment Of Business                 6.70% 6.30%  
Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers 3,536 3,415 3,504 3,398 3,540 3,356 3,478 3,228 $ 13,853 $ 13,602 13,307
Percentage Change In Sales By Segment Of Business                 1.80% 2.20%  
Pharmaceutical                      
Segment Reporting Information [Line Items]                      
Sales to Customers $ 10,190 $ 10,346 $ 10,354 $ 9,844 $ 9,681 $ 9,695 $ 8,635 $ 8,245 $ 40,734 $ 36,256 33,464
Percentage Change In Sales By Segment Of Business                 12.40% 8.30%  
Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 13,120 $ 12,244 11,968
Percentage Change In Sales By Segment Of Business                 7.20% 2.30%  
Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,304 $ 3,154 3,208
Percentage Change In Sales By Segment Of Business                 4.80% (1.70%)  
Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 6,077 $ 5,986 6,085
Percentage Change In Sales By Segment Of Business                 1.50% (1.60%)  
Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 9,844 $ 7,258 5,807
Percentage Change In Sales By Segment Of Business                 35.60% 25.00%  
Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,573 $ 1,327 0
Percentage Change In Sales By Segment Of Business                 93.90%    
Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 5,816 $ 6,287 6,396
Percentage Change In Sales By Segment Of Business                 (7.50%) (1.70%)  
Medical Devices                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 26,994 $ 26,592 25,119
Percentage Change In Sales By Segment Of Business                 1.50% 5.90%  
Medical Devices | Diabetes Care                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,009 $ 1,615 1,789
Percentage Change In Sales By Segment Of Business                 (37.50%) (9.70%)  
Medical Devices | Diagnostics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 0 $ 1 66
Medical Devices | Interventional Solutions                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,646 $ 2,296 2,055
Percentage Change In Sales By Segment Of Business                 15.20% 11.70%  
Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 8,885 $ 9,058 9,128
Percentage Change In Sales By Segment Of Business                 (1.90%) (0.80%)  
Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 9,901 $ 9,559 9,296
Percentage Change In Sales By Segment Of Business                 3.60% 2.80%  
Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,553 $ 4,063 2,785
Percentage Change In Sales By Segment Of Business                 12.10% 45.90%  
Baby Care | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,858 $ 1,916 2,001
Percentage Change In Sales By Segment Of Business                 (3.00%) (4.20%)  
Beauty | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,382 $ 4,200 3,897
Percentage Change In Sales By Segment Of Business                 4.30% 7.80%  
Oral Care | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,555 $ 1,531 1,568
Percentage Change In Sales By Segment Of Business                 1.60% (2.40%)  
OTC | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,334 $ 4,126 3,977
Percentage Change In Sales By Segment Of Business                 5.00% 3.70%  
Women's Health | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,049 $ 1,050 1,067
Percentage Change In Sales By Segment Of Business                 (0.10%) (1.60%)  
Wound Care and Other | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 675 $ 779 797
Percentage Change In Sales By Segment Of Business                 (13.40%) (2.30%)  
Remicade | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 5,326 $ 6,315 6,966
Percentage Change In Sales By Segment Of Business                 (15.70%) (9.30%)  
Simponi/Simponi Aria | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,084 $ 1,833 1,745
Percentage Change In Sales By Segment Of Business                 13.70% 5.00%  
Stelara | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 5,156 $ 4,011 3,232
Percentage Change In Sales By Segment Of Business                 28.50% 24.10%  
Tremfaya | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 544 $ 63 0
Other Immunology | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 10 $ 22 25
Percentage Change In Sales By Segment Of Business                 (54.50%) (12.00%)  
EDURANT/rilpivirine | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 816 $ 714 573
Percentage Change In Sales By Segment Of Business                 14.30% 24.60%  
PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,955 $ 1,821 1,851
Percentage Change In Sales By Segment Of Business                 7.40% (1.60%)  
Other Infectious Diseases | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 533 $ 619 784
Percentage Change In Sales By Segment Of Business                 (13.90%) (21.00%)  
CONCERTA/Methylphenidate | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 663 $ 791 863
Percentage Change In Sales By Segment Of Business                 (16.20%) (8.30%)  
INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,928 $ 2,569 2,214
Percentage Change In Sales By Segment Of Business                 14.00% 16.00%  
RISPERDAL CONSTA | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 737 $ 805 893
Percentage Change In Sales By Segment Of Business                 (8.40%) (9.90%)  
OTHER NEUROSCIENCE | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,749 $ 1,821 2,115
Percentage Change In Sales By Segment Of Business                 (4.00%) (13.90%)  
DARZALEX | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,025 $ 1,242 572
Percentage Change In Sales By Segment Of Business                 63.00%    
IMBRUVICA | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,615 $ 1,893 1,251
Percentage Change In Sales By Segment Of Business                 38.10% 51.30%  
VELCADE | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,116 $ 1,114 1,224
Percentage Change In Sales By Segment Of Business                 0.20% (9.00%)  
ZYTIGA | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,498 $ 2,505 2,260
Percentage Change In Sales By Segment Of Business                 39.60% 10.80%  
Other Oncology | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 590 $ 504 500
Percentage Change In Sales By Segment Of Business                 17.10% 0.80%  
OPSUMIT | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,215 $ 573 0
TRACLEER | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 546 403 0
Percentage Change In Sales By Segment Of Business                 35.50%    
UPTRAVI | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 663 263 0
Other | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 149 88 0
Percentage Change In Sales By Segment Of Business                 69.30%    
Other | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,470 $ 1,704 1,596
Percentage Change In Sales By Segment Of Business                 (13.70%) 6.80%  
Xarelto | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,477 $ 2,500 2,288
Percentage Change In Sales By Segment Of Business                 (0.90%) 9.30%  
INVOKANA/INVOKAMET | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 881 $ 1,111 1,407
Percentage Change In Sales By Segment Of Business                 (20.70%) (21.00%)  
PROCRIT/EPREX | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 988 $ 972 1,105
Percentage Change In Sales By Segment Of Business                 1.60% (12.00%)  
HIPS | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,418 $ 1,394 1,361
Percentage Change In Sales By Segment Of Business                 1.70% 2.40%  
KNEES | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,502 $ 1,523 1,524
Percentage Change In Sales By Segment Of Business                 (1.40%) (0.10%)  
TRAUMA | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,699 $ 2,616 2,569
Percentage Change In Sales By Segment Of Business                 3.20% 1.80%  
SPINE & OTHER | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,266 $ 3,525 3,674
Percentage Change In Sales By Segment Of Business                 (7.30%) (4.10%)  
ADVANCED | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,002 $ 3,756 3,517
Percentage Change In Sales By Segment Of Business                 6.50% 6.80%  
GENERAL | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,557 $ 4,463 4,362
Percentage Change In Sales By Segment Of Business                 2.10% 2.30%  
SPECIALTY | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,342 $ 1,340 1,417
Percentage Change In Sales By Segment Of Business                 0.10% (5.40%)  
CONTACT LENSES/OTHER | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,302 $ 3,036 2,785
Percentage Change In Sales By Segment Of Business                 8.80% 9.00%  
SURGICAL | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,251 $ 1,027 0
Percentage Change In Sales By Segment Of Business                 21.80%    
UNITED STATES                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 41,884 $ 39,863 37,811
Percentage Change In Sales By Segment Of Business                 5.10% 5.40%  
UNITED STATES | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 5,761 $ 5,565 5,420
Percentage Change In Sales By Segment Of Business                 3.50% 2.70%  
UNITED STATES | Pharmaceutical                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 23,286 $ 21,474 20,125
Percentage Change In Sales By Segment Of Business                 8.40% 6.70%  
UNITED STATES | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 9,073 $ 8,871 8,846
Percentage Change In Sales By Segment Of Business                 2.30% 0.30%  
UNITED STATES | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,378 $ 1,358 1,461
Percentage Change In Sales By Segment Of Business                 1.50% (7.00%)  
UNITED STATES | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,574 $ 2,630 2,628
Percentage Change In Sales By Segment Of Business                 (2.10%) 0.10%  
UNITED STATES | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,331 $ 3,098 2,335
Percentage Change In Sales By Segment Of Business                 39.80% 32.70%  
UNITED STATES | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,651 $ 773 0
UNITED STATES | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,279 $ 4,744 4,855
Percentage Change In Sales By Segment Of Business                 (9.80%) (2.30%)  
UNITED STATES | Medical Devices                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 12,837 $ 12,824 12,266
Percentage Change In Sales By Segment Of Business                 0.10% 4.50%  
UNITED STATES | Medical Devices | Diabetes Care                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 371 $ 612 739
Percentage Change In Sales By Segment Of Business                 (39.40%) (17.20%)  
UNITED STATES | Medical Devices | Diagnostics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 0 $ 0 0
UNITED STATES | Medical Devices | Interventional Solutions                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,283 $ 1,148 1,031
Percentage Change In Sales By Segment Of Business                 11.80% 11.30%  
UNITED STATES | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 5,281 $ 5,404 5,438
Percentage Change In Sales By Segment Of Business                 (2.30%) (0.60%)  
UNITED STATES | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,125 $ 4,085 4,026
Percentage Change In Sales By Segment Of Business                 1.00% 1.50%  
UNITED STATES | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,777 $ 1,575 1,032
Percentage Change In Sales By Segment Of Business                 12.80% 52.60%  
UNITED STATES | Baby Care | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 422 $ 449 488
Percentage Change In Sales By Segment Of Business                 (6.00%) (8.00%)  
UNITED STATES | Beauty | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,403 $ 2,335 2,135
Percentage Change In Sales By Segment Of Business                 2.90% 9.40%  
UNITED STATES | Oral Care | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 637 $ 616 648
Percentage Change In Sales By Segment Of Business                 3.40% (4.90%)  
UNITED STATES | OTC | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,850 $ 1,716 1,675
Percentage Change In Sales By Segment Of Business                 7.80% 2.40%  
UNITED STATES | Women's Health | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 13 $ 12 19
Percentage Change In Sales By Segment Of Business                 8.30% (36.80%)  
UNITED STATES | Wound Care and Other | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 436 $ 437 455
Percentage Change In Sales By Segment Of Business                 (0.20%) (4.00%)  
UNITED STATES | Remicade | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,664 $ 4,525 4,842
Percentage Change In Sales By Segment Of Business                 (19.00%) (6.50%)  
UNITED STATES | Simponi/Simponi Aria | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,051 $ 954 959
Percentage Change In Sales By Segment Of Business                 10.20% (0.50%)  
UNITED STATES | Stelara | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,469 $ 2,767 2,263
Percentage Change In Sales By Segment Of Business                 25.40% 22.30%  
UNITED STATES | Tremfaya | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 453 $ 62 0
UNITED STATES | Other Immunology | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 0 $ 0 0
Percentage Change In Sales By Segment Of Business                 0.00% 0.00%  
UNITED STATES | EDURANT/rilpivirine | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 58 $ 58 52
Percentage Change In Sales By Segment Of Business                 0.00% 11.50%  
UNITED STATES | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,169 $ 1,109 1,143
Percentage Change In Sales By Segment Of Business                 5.40% (3.00%)  
UNITED STATES | Other Infectious Diseases | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 151 $ 191 266
Percentage Change In Sales By Segment Of Business                 (20.90%) (28.20%)  
UNITED STATES | CONCERTA/Methylphenidate | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 229 $ 384 468
Percentage Change In Sales By Segment Of Business                 (40.40%) (17.90%)  
UNITED STATES | INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,791 $ 1,590 1,343
Percentage Change In Sales By Segment Of Business                 12.60% 18.40%  
UNITED STATES | RISPERDAL CONSTA | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 315 $ 360 381
Percentage Change In Sales By Segment Of Business                 (12.50%) (5.50%)  
UNITED STATES | OTHER NEUROSCIENCE | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 239 $ 296 436
Percentage Change In Sales By Segment Of Business                 (19.30%) (32.10%)  
UNITED STATES | DARZALEX | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,203 $ 884 471
Percentage Change In Sales By Segment Of Business                 36.10% 87.70%  
UNITED STATES | IMBRUVICA | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,129 $ 841 613
Percentage Change In Sales By Segment Of Business                 34.20% 37.20%  
UNITED STATES | VELCADE | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 0 $ 0 0
Percentage Change In Sales By Segment Of Business                 0.00% 0.00%  
UNITED STATES | ZYTIGA | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,771 $ 1,228 1,089
Percentage Change In Sales By Segment Of Business                 44.20% 12.80%  
UNITED STATES | Other Oncology | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 228 $ 145 162
Percentage Change In Sales By Segment Of Business                 57.20% (10.50%)  
UNITED STATES | OPSUMIT | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 700 $ 320 0
UNITED STATES | TRACLEER | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 268 161 0
Percentage Change In Sales By Segment Of Business                 66.50%    
UNITED STATES | UPTRAVI | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 598 238 0
UNITED STATES | Other | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 85 54 0
Percentage Change In Sales By Segment Of Business                 57.40%    
UNITED STATES | Other | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 417 $ 625 527
Percentage Change In Sales By Segment Of Business                 (33.30%) 18.60%  
UNITED STATES | Xarelto | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,477 $ 2,500 2,288
Percentage Change In Sales By Segment Of Business                 (0.90%) 9.30%  
UNITED STATES | INVOKANA/INVOKAMET | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 711 $ 944 1,273
Percentage Change In Sales By Segment Of Business                 (24.70%) (25.80%)  
UNITED STATES | PROCRIT/EPREX | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 674 $ 675 767
Percentage Change In Sales By Segment Of Business                 (0.10%) (12.00%)  
UNITED STATES | HIPS | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 841 $ 827 798
Percentage Change In Sales By Segment Of Business                 1.70% 3.60%  
UNITED STATES | KNEES | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 911 $ 948 943
Percentage Change In Sales By Segment Of Business                 (3.90%) 0.50%  
UNITED STATES | TRAUMA | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,599 $ 1,576 1,545
Percentage Change In Sales By Segment Of Business                 1.50% 2.00%  
UNITED STATES | SPINE & OTHER | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,930 $ 2,053 2,152
Percentage Change In Sales By Segment Of Business                 (6.00%) (4.60%)  
UNITED STATES | ADVANCED | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,657 $ 1,620 1,524
Percentage Change In Sales By Segment Of Business                 2.30% 6.30%  
UNITED STATES | GENERAL | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,751 $ 1,728 1,669
Percentage Change In Sales By Segment Of Business                 1.30% 3.50%  
UNITED STATES | SPECIALTY | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 717 $ 737 833
Percentage Change In Sales By Segment Of Business                 (2.70%) (11.50%)  
UNITED STATES | CONTACT LENSES/OTHER | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,237 $ 1,122 1,032
Percentage Change In Sales By Segment Of Business                 10.20% 8.70%  
UNITED STATES | SURGICAL | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 540 $ 453 0
Percentage Change In Sales By Segment Of Business                 19.20%    
Non-US                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 39,697 $ 36,587 34,079
Percentage Change In Sales By Segment Of Business                 8.50% 7.40%  
Non-US | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 8,092 $ 8,037 7,887
Percentage Change In Sales By Segment Of Business                 0.70% 1.90%  
Non-US | Pharmaceutical                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 17,448 $ 14,782 13,339
Percentage Change In Sales By Segment Of Business                 18.00% 10.80%  
Non-US | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 4,047 $ 3,373 3,122
Percentage Change In Sales By Segment Of Business                 20.00% 8.00%  
Non-US | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,926 $ 1,796 1,747
Percentage Change In Sales By Segment Of Business                 7.20% 2.80%  
Non-US | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,503 $ 3,356 3,457
Percentage Change In Sales By Segment Of Business                 4.40% (2.90%)  
Non-US | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 5,513 $ 4,160 3,472
Percentage Change In Sales By Segment Of Business                 32.50% 19.80%  
Non-US | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 922 $ 554 0
Percentage Change In Sales By Segment Of Business                 66.40%    
Non-US | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,537 $ 1,543 1,541
Percentage Change In Sales By Segment Of Business                 (0.40%) 0.10%  
Non-US | Medical Devices                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 14,157 $ 13,768 12,853
Percentage Change In Sales By Segment Of Business                 2.80% 7.10%  
Non-US | Medical Devices | Diabetes Care                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 638 $ 1,003 1,050
Percentage Change In Sales By Segment Of Business                 (36.40%) (4.50%)  
Non-US | Medical Devices | Diagnostics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 0 $ 1 66
Non-US | Medical Devices | Interventional Solutions                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,363 $ 1,148 1,024
Percentage Change In Sales By Segment Of Business                 18.70% 12.10%  
Non-US | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 3,604 $ 3,654 3,690
Percentage Change In Sales By Segment Of Business                 (1.40%) (1.00%)  
Non-US | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 5,776 $ 5,474 5,270
Percentage Change In Sales By Segment Of Business                 5.50% 3.90%  
Non-US | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,776 $ 2,488 1,753
Percentage Change In Sales By Segment Of Business                 11.60% 41.90%  
Non-US | Baby Care | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,436 $ 1,467 1,513
Percentage Change In Sales By Segment Of Business                 (2.10%) (3.00%)  
Non-US | Beauty | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,979 $ 1,865 1,762
Percentage Change In Sales By Segment Of Business                 6.10% 5.80%  
Non-US | Oral Care | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 918 $ 915 920
Percentage Change In Sales By Segment Of Business                 0.30% (0.50%)  
Non-US | OTC | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,484 $ 2,410 2,302
Percentage Change In Sales By Segment Of Business                 3.10% 4.70%  
Non-US | Women's Health | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,036 $ 1,038 1,048
Percentage Change In Sales By Segment Of Business                 (0.20%) (1.00%)  
Non-US | Wound Care and Other | Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 239 $ 342 342
Percentage Change In Sales By Segment Of Business                 (30.10%) 0.00%  
Non-US | Remicade | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,226 $ 1,227 1,342
Percentage Change In Sales By Segment Of Business                 (0.10%) (8.60%)  
Non-US | Simponi/Simponi Aria | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,033 $ 879 786
Percentage Change In Sales By Segment Of Business                 17.50% 11.80%  
Non-US | Stelara | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,687 $ 1,244 969
Percentage Change In Sales By Segment Of Business                 35.60% 28.40%  
Non-US | Tremfaya | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 91 $ 1 0
Non-US | Other Immunology | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 10 $ 22 25
Percentage Change In Sales By Segment Of Business                 (54.50%) (12.00%)  
Non-US | EDURANT/rilpivirine | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 758 $ 656 521
Percentage Change In Sales By Segment Of Business                 15.50% 25.90%  
Non-US | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 786 $ 712 708
Percentage Change In Sales By Segment Of Business                 10.40% 0.60%  
Non-US | Other Infectious Diseases | Pharmaceutical | Infectious Diseases                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 382 $ 428 518
Percentage Change In Sales By Segment Of Business                 (10.70%) (17.40%)  
Non-US | CONCERTA/Methylphenidate | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 434 $ 407 395
Percentage Change In Sales By Segment Of Business                 6.60% 3.00%  
Non-US | INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,137 $ 979 871
Percentage Change In Sales By Segment Of Business                 16.10% 12.40%  
Non-US | RISPERDAL CONSTA | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 422 $ 445 512
Percentage Change In Sales By Segment Of Business                 (5.20%) (13.10%)  
Non-US | OTHER NEUROSCIENCE | Pharmaceutical | Neuroscience                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,510 $ 1,525 1,679
Percentage Change In Sales By Segment Of Business                 (1.00%) (9.20%)  
Non-US | DARZALEX | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 822 $ 358 101
Non-US | IMBRUVICA | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,486 $ 1,052 638
Percentage Change In Sales By Segment Of Business                 41.30% 64.90%  
Non-US | VELCADE | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,116 $ 1,114 1,224
Percentage Change In Sales By Segment Of Business                 0.20% (9.00%)  
Non-US | ZYTIGA | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,727 $ 1,277 1,171
Percentage Change In Sales By Segment Of Business                 35.20% 9.10%  
Non-US | Other Oncology | Pharmaceutical | Oncology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 362 $ 359 338
Percentage Change In Sales By Segment Of Business                 0.80% 6.20%  
Non-US | OPSUMIT | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 515 $ 253 0
Non-US | TRACLEER | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 278 242 0
Percentage Change In Sales By Segment Of Business                 14.90%    
Non-US | UPTRAVI | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 65 25 0
Non-US | Other | Pharmaceutical | Pulmonary Hypertension                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 64 34 0
Percentage Change In Sales By Segment Of Business                 88.20%    
Non-US | Other | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,053 $ 1,079 1,069
Percentage Change In Sales By Segment Of Business                 (2.40%) 0.90%  
Non-US | Xarelto | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 0 $ 0 0
Percentage Change In Sales By Segment Of Business                 0.00% 0.00%  
Non-US | INVOKANA/INVOKAMET | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 170 $ 167 134
Percentage Change In Sales By Segment Of Business                 1.80% 24.60%  
Non-US | PROCRIT/EPREX | Pharmaceutical | Cardiovascular/Metabolism/Other                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 314 $ 297 338
Percentage Change In Sales By Segment Of Business                 5.70% (12.10%)  
Non-US | HIPS | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 577 $ 567 563
Percentage Change In Sales By Segment Of Business                 1.80% 0.70%  
Non-US | KNEES | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 591 $ 575 581
Percentage Change In Sales By Segment Of Business                 2.80% (1.00%)  
Non-US | TRAUMA | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,100 $ 1,040 1,024
Percentage Change In Sales By Segment Of Business                 5.80% 1.60%  
Non-US | SPINE & OTHER | Medical Devices | Orthopaedics                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 1,336 $ 1,472 1,522
Percentage Change In Sales By Segment Of Business                 (9.20%) (3.30%)  
Non-US | ADVANCED | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,345 $ 2,136 1,993
Percentage Change In Sales By Segment Of Business                 9.80% 7.20%  
Non-US | GENERAL | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,806 $ 2,735 2,693
Percentage Change In Sales By Segment Of Business                 2.60% 1.60%  
Non-US | SPECIALTY | Medical Devices | Surgery                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 625 $ 603 584
Percentage Change In Sales By Segment Of Business                 3.60% 3.30%  
Non-US | CONTACT LENSES/OTHER | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 2,065 $ 1,914 1,753
Percentage Change In Sales By Segment Of Business                 7.90% 9.20%  
Non-US | SURGICAL | Medical Devices | Vision                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 711 $ 574 0
Percentage Change In Sales By Segment Of Business                 23.90%    
UNITED STATES Exports | Remicade | Pharmaceutical | Immunology                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 436 $ 563 $ 782
Percentage Change In Sales By Segment Of Business                 (22.60%) (28.00%)  
XML 130 R109.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segments of Business and Geographic Areas - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Segment Reporting Information [Line Items]                      
Sales to Customers $ 20,394 $ 20,348 $ 20,830 $ 20,009 $ 20,195 $ 19,650 $ 18,839 $ 17,766 $ 81,581 $ 76,450 $ 71,890
Earnings before provision for taxes on income 3,122 4,423 4,973 5,481 2,560 4,790 4,748 5,575 17,999 17,673 19,803
Identifiable Assets 152,954       157,303       152,954 157,303  
Additions to Property, Plant & Equipment                 3,670 3,279 3,226
Depreciation and Amortization                 6,929 5,642 3,754
United States                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 41,884 39,863 37,811
Non-US                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 39,697 36,587 34,079
Consumer                      
Segment Reporting Information [Line Items]                      
Sales to Customers 3,536 3,415 3,504 3,398 3,540 3,356 3,478 3,228 13,853 13,602 13,307
Consumer | United States                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 5,761 5,565 5,420
Consumer | Non-US                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 8,092 8,037 7,887
Pharmaceutical                      
Segment Reporting Information [Line Items]                      
Sales to Customers 10,190 $ 10,346 $ 10,354 $ 9,844 9,681 $ 9,695 $ 8,635 $ 8,245 40,734 36,256 33,464
Pharmaceutical | United States                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 23,286 21,474 20,125
Pharmaceutical | Non-US                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 17,448 14,782 13,339
Medical Devices                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 26,994 26,592 25,119
Medical Devices | United States                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 12,837 12,824 12,266
Medical Devices | Non-US                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 14,157 13,768 12,853
Operating Segments                      
Segment Reporting Information [Line Items]                      
Identifiable Assets 128,767       129,893       128,767 129,893  
Additions to Property, Plant & Equipment                 3,293 2,987 2,885
Depreciation and Amortization                 6,593 5,306 3,422
Corporate, Non-Segment                      
Segment Reporting Information [Line Items]                      
Less: Expense not allocated to segments                 1,286 1,326 1,043
Corporate, Non-Segment | General Corporate                      
Segment Reporting Information [Line Items]                      
Identifiable Assets 24,187       27,410       24,187 27,410  
Additions to Property, Plant & Equipment                 377 292 341
Depreciation and Amortization                 336 336 332
Operating Segments                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 81,581 76,450 71,890
Earnings before provision for taxes on income                 19,285 18,999 20,846
Operating Segments | United States                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 41,884 39,863 37,811
Operating Segments | Consumer                      
Segment Reporting Information [Line Items]                      
Earnings before provision for taxes on income                 2,320 2,524 2,441
Identifiable Assets 25,877       25,030       25,877 25,030  
Additions to Property, Plant & Equipment                 438 485 486
Depreciation and Amortization                 688 674 608
Operating Segments | Pharmaceutical                      
Segment Reporting Information [Line Items]                      
Earnings before provision for taxes on income                 12,568 11,083 12,827
Identifiable Assets 56,636       59,450       56,636 59,450  
Additions to Property, Plant & Equipment                 1,012 936 927
Depreciation and Amortization                 3,802 2,416 886
Operating Segments | Medical Devices                      
Segment Reporting Information [Line Items]                      
Earnings before provision for taxes on income                 4,397 5,392 5,578
Identifiable Assets $ 46,254       $ 45,413       46,254 45,413  
Additions to Property, Plant & Equipment                 1,843 1,566 1,472
Depreciation and Amortization                 2,103 2,216 1,928
Immunology | Pharmaceutical                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 13,120 12,244 11,968
Immunology | Pharmaceutical | United States                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 9,073 8,871 8,846
Immunology | Pharmaceutical | Non-US                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 4,047 3,373 3,122
Immunology | Tremfaya | Pharmaceutical                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 544 63 0
Immunology | Tremfaya | Pharmaceutical | United States                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 453 62 0
Immunology | Tremfaya | Pharmaceutical | Non-US                      
Segment Reporting Information [Line Items]                      
Sales to Customers                 $ 91 $ 1 $ 0
XML 131 R110.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jul. 01, 2018
USD ($)
Apr. 01, 2018
USD ($)
Dec. 31, 2017
USD ($)
Oct. 01, 2017
USD ($)
Jul. 02, 2017
USD ($)
Apr. 02, 2017
USD ($)
Dec. 30, 2018
USD ($)
Segment
Dec. 31, 2017
USD ($)
Segment
Jan. 01, 2017
USD ($)
Segment
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers $ 20,394 $ 20,348 $ 20,830 $ 20,009 $ 20,195 $ 19,650 $ 18,839 $ 17,766 $ 81,581 $ 76,450 $ 71,890
Identifiable Assets 152,954       157,303       152,954 157,303  
Gain (Loss) on Disposition of Assets                 $ 1,200 $ 1,300 $ 600
Number of segments | Segment                 3 3 3
Acquisition related costs         217            
Restructuring charges 227   176           $ 251 $ 309 $ 491
After Tax Restructuring Charge 190 162 152 81 237 136 101 121      
Asset write-downs                 1,258 795 283
In-process research and development   1,126     408       1,126 408 29
Litigation expense 1,288   703   645 118 493        
Gain from divestiture                 1,217 1,307 563
Medical Devices                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 26,994 26,592 25,119
Restructuring charges   190   107 284 187 128 161 462 114 700
Asset write-downs             182     200  
Litigation expense                 1,700 1,100 800
Restructuring Charge, Net of Accrual Adjustment                 600 800  
Gain from divestiture                   700  
Consumer                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers 3,536 3,415 3,504 3,398 3,540 3,356 3,478 3,228 13,853 13,602 13,307
Litigation expense                 300    
Gain from divestiture                   500  
Pharmaceutical                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers 10,190 10,346 $ 10,354 9,844 9,681 9,695 8,635 8,245 40,734 36,256 33,464
Unrealized loss on securities                 200    
In-process research and development                   400  
Litigation expense                   100  
Positive adjustment                     $ 500
Property, Plant and Equipment                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Long-Lived Assets 17,035       17,005       17,035 17,005  
Other Intangible Assets                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Long-Lived Assets 78,064       85,134       78,064 85,134  
Alios Biopharma Inc and XO1 Limited | Pharmaceutical                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
In-process research and development                 1,100    
XO1                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability   $ (184)             (200)    
Actelion                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Acquisition related costs       $ 96   $ 367 $ 213   200 800  
Actelion | Pharmaceutical                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Acquisition related costs                 200 800  
AMO                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Acquisition related costs               $ 38      
AMO | Medical Devices                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Acquisition related costs                 100 100  
Sales Revenue, Net                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Concentration risk (as a percent)                     13.50%
United States                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 41,884 39,863 $ 37,811
United States | Medical Devices                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 12,837 12,824 12,266
United States | Consumer                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 5,761 5,565 5,420
United States | Pharmaceutical                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 23,286 21,474 20,125
Corporate, Non-Segment                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Other Non Long Lived Assets 57,855       55,164       57,855 55,164  
Corporate, Non-Segment | General Corporate                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Long-Lived Assets 1,064       1,143       1,064 1,143  
Identifiable Assets 24,187       27,410       24,187 27,410  
Operating Segments                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 81,581 76,450 71,890
Long-Lived Assets 94,035       100,996       94,035 100,996  
Operating Segments | Medical Devices                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Identifiable Assets 46,254       45,413       46,254 45,413  
Operating Segments | Consumer                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Identifiable Assets 25,877       25,030       25,877 25,030  
Operating Segments | Pharmaceutical                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Identifiable Assets 56,636       59,450       56,636 59,450  
Operating Segments | NIZORAL | Consumer                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Gain (Loss) on Disposition of Assets                 300    
Operating Segments | PANCREASE | Pharmaceutical                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Gain (Loss) on Disposition of Assets                 200    
Operating Segments | LifeScan | Medical Devices                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Gain (Loss) on Disposition of Assets                 500    
Operating Segments | United States                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 41,884 39,863 37,811
Long-Lived Assets 37,117       38,556       37,117 38,556  
Operating Segments | Europe                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 18,753 17,126 15,770
Long-Lived Assets 51,433       56,677       51,433 56,677  
Operating Segments | Western Hemisphere excluding U.S.                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 6,113 6,041 5,734
Long-Lived Assets 2,752       2,990       2,752 2,990  
Operating Segments | Asia-Pacific, Africa                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Sales to Customers                 14,831 13,420 $ 12,575
Long-Lived Assets $ 2,733       $ 2,773       $ 2,733 $ 2,773  
Wholesaler 1 | Sales Revenue, Net                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Concentration risk (as a percent)                 14.00% 14.00%  
Wholesaler 2 | Sales Revenue, Net                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Concentration risk (as a percent)                 11.00% 10.00% 10.70%
Wholesaler 3 | Sales Revenue, Net                      
Revenues from External Customers and Long-Lived Assets [Line Items]                      
Concentration risk (as a percent)                 11.00%    
XML 132 R111.htm IDEA: XBRL DOCUMENT v3.10.0.1
Selected Quarterly Financial Data (unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Summary of Selected Quarterly Financial Data (unaudited)                      
Sales to customers $ 20,394 $ 20,348 $ 20,830 $ 20,009 $ 20,195 $ 19,650 $ 18,839 $ 17,766 $ 81,581 $ 76,450 $ 71,890
Gross profit 13,433 13,759 13,903 13,395 12,936 12,725 12,993 12,357 54,490 51,011 50,101
Earnings before provision for taxes on income 3,122 4,423 4,973 5,481 2,560 4,790 4,748 5,575 17,999 17,673 19,803
Net earnings $ 3,042 $ 3,934 $ 3,954 $ 4,367 $ (10,713) $ 3,764 $ 3,827 $ 4,422 $ 15,297 $ 1,300 $ 16,540
Basic net earnings per share (in dollars per share) $ 1.14 $ 1.47 $ 1.47 $ 1.63 $ (3.99) $ 1.40 $ 1.42 $ 1.63 $ 5.70 $ 0.48 $ 6.04
Diluted net earnings per share (in dollars per share) $ 1.12 $ 1.44 $ 1.45 $ 1.60 $ (3.99) $ 1.37 $ 1.40 $ 1.61 $ 5.61 $ 0.47 $ 5.93
Restructuring charge, after tax $ 190 $ 162 $ 152 $ 81 $ 237 $ 136 $ 101 $ 121      
Restructuring charges 227   176           $ 251 $ 309 $ 491
Litigation income (expense) net after-tax (1,113)   (609)   (506) (97) (352)        
Litigation expense 1,288   703   645 118 493        
Acquisition related costs after tax         313            
Acquisition related costs         217            
In-process research and development, after tax   859     266            
In-process research and development   1,126     408       1,126 408 29
Asset impairment benefit         116            
asset impairment charge after-tax             125        
Asset Impairment Charges                 1,258 795 283
Provisional charge (137) (265)     13,600            
Medical Devices                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Sales to customers                 26,994 26,592 25,119
Restructuring charges   190   107 284 187 128 161 462 114 700
Litigation expense                 1,700 1,100 800
Asset Impairment Charges             182     200  
Consumer                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Sales to customers 3,536 3,415 3,504 3,398 3,540 3,356 3,478 3,228 13,853 13,602 13,307
Litigation expense                 300    
Pharmaceutical                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Sales to customers 10,190 10,346 10,354 9,844 9,681 9,695 8,635 8,245 40,734 36,256 $ 33,464
Litigation expense                   100  
In-process research and development                   400  
Med Devices                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Sales to customers $ 6,668 6,587 $ 6,972 6,767 $ 6,974 6,599 6,726 6,293      
XO1                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability   $ (184)             (200)    
AMO                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Acquisition related costs after tax               251      
Acquisition related costs               $ 38      
AMO | Medical Devices                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Acquisition related costs                 100 100  
Actelion                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Acquisition related costs after tax       92   255 199        
Acquisition related costs       $ 96   $ 367 $ 213   200 800  
Actelion | Pharmaceutical                      
Summary of Selected Quarterly Financial Data (unaudited)                      
Acquisition related costs                 $ 200 $ 800  
XML 133 R112.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations and Divestitures - Narrative (Details)
¥ / shares in Units, $ / shares in Units, ¥ in Billions
 3 Months Ended 4 Months Ended 12 Months Ended
Feb. 13, 2019
USD ($)
Oct. 23, 2018
USD ($)
Oct. 23, 2018
JPY (¥)
Jun. 16, 2017
USD ($)
$ / shares
Jul. 01, 2018
USD ($)
Apr. 01, 2018
USD ($)
Dec. 31, 2017
USD ($)
Oct. 01, 2017
USD ($)
Jul. 02, 2017
USD ($)
Apr. 02, 2017
USD ($)
Oct. 01, 2017
USD ($)
Dec. 30, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jan. 01, 2017
USD ($)
Dec. 30, 2012
USD ($)
Jan. 17, 2019
¥ / shares
Business Acquisition [Line Items]                                
Line of Credit Facility, Maximum Borrowing Capacity                       $ 10,000,000,000        
Goodwill             $ 31,906,000,000         30,453,000,000 $ 31,906,000,000 $ 22,805,000,000    
Acquisition payments                       899,000,000 35,151,000,000 4,509,000,000    
Acquisition related costs             217,000,000                  
Liabilities assumed                       148,000,000 1,786,000,000 77,000,000    
Indefinite lived intangible assets             11,283,000,000         9,190,000,000 11,283,000,000      
Purchase price                       899,000,000 35,151,000,000 4,509,000,000    
Asset write-downs                       1,258,000,000 795,000,000 283,000,000    
Gain on divestitures, pre-tax                       1,200,000,000 1,300,000,000 600,000,000    
Ci:z Holdings Co. Ltd.                                
Business Acquisition [Line Items]                                
Business Combination, Consideration Transferred   $ 2,100,000,000 ¥ 230                          
Foreign Currency Exchange Rate, Translation   109.06 109.06                          
2017 Acquisitions                                
Business Acquisition [Line Items]                                
Purchase price over fair value of assets acquired             34,400,000,000           34,400,000,000      
2016 Acquisitions                                
Business Acquisition [Line Items]                                
Purchase price over fair value of assets acquired                           $ 4,100,000,000    
Vogue International LLC                                
Business Acquisition [Line Items]                                
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                           22 years    
Actelion                                
Business Acquisition [Line Items]                                
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory       $ 642,000,000                        
Goodwill, Subsequent Recognition of Deferred Tax Asset                     $ 200,000,000          
Business Combination, Initial Accounting Incomplete, Adjustment, Current Liabilities                     $ 400,000,000          
Goodwill                       6,161,000,000        
Acquisition payments                         29,600,000,000      
Acquisition price (in dollars per share) | $ / shares       $ 280                        
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life       9 years                        
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual                         1,400,000,000      
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual                         (1,400,000,000)      
Acquisition related costs           $ 96,000,000   $ 367,000,000 $ 213,000,000     $ 200,000,000 800,000,000      
Idorsia                                
Business Acquisition [Line Items]                                
Business Acquisition, Percentage of Voting Interests Acquired       9.90%               9.00%        
Convertible Note, Equity Interest, Percentage       22.10%               20.80%        
AMO                                
Business Acquisition [Line Items]                                
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                   14 years 4 months 24 days            
Acquisition related costs                   $ 38,000,000            
Synthes, Inc                                
Business Acquisition [Line Items]                                
Purchase price                             $ 20,200,000,000  
In Process Research and Development | Actelion                                
Business Acquisition [Line Items]                                
Fair Value Inputs, Discount Rate       9.00%                        
Purchased in-process research and development                                
Business Acquisition [Line Items]                                
Indefinite lived intangible assets             4,201,000,000         $ 2,253,000,000 4,201,000,000      
Medical Devices                                
Business Acquisition [Line Items]                                
Goodwill             13,922,000,000         12,720,000,000 13,922,000,000 $ 11,702,000,000    
Asset write-downs                 $ 182,000,000       200,000,000      
Medical Devices | AMO                                
Business Acquisition [Line Items]                                
Goodwill             1,700,000,000     1,700,000,000     1,700,000,000      
Acquisition payments                   $ 4,300,000,000            
Finite-lived Intangible Assets Acquired                         2,300,000,000      
Acquisition related costs                       100,000,000 100,000,000      
Consumer                                
Business Acquisition [Line Items]                                
Goodwill             8,875,000,000         8,670,000,000 8,875,000,000 8,263,000,000    
Consumer | Vogue International LLC                                
Business Acquisition [Line Items]                                
Acquisition payments                           3,300,000,000    
Finite-lived Intangible Assets Acquired                           2,300,000,000    
Business Acquisition, Goodwill, Expected Tax Deductible Amount                           $ 1,100,000,000    
Maximum | Actelion                                
Business Acquisition [Line Items]                                
Finite-Lived Intangible Asset, Useful Life       10 years                        
Minimum | Actelion                                
Business Acquisition [Line Items]                                
Finite-Lived Intangible Asset, Useful Life       4 years                        
Intellectual Property | Actelion                                
Business Acquisition [Line Items]                                
Finite-lived Intangible Assets Acquired       $ 24,230,000,000                        
Intellectual Property | Valchlor                                
Business Acquisition [Line Items]                                
Finite-lived Intangible Assets Acquired         $ 400,000,000                      
In Process Research and Development | 2018 Acquisitions                                
Business Acquisition [Line Items]                                
Purchase price over fair value of assets acquired                       1,000,000,000        
In Process Research and Development | 2017 Acquisitions                                
Business Acquisition [Line Items]                                
Purchase price over fair value of assets acquired             $ 1,100,000,000           $ 1,100,000,000      
Trademarks | Vogue International LLC                                
Business Acquisition [Line Items]                                
Finite-Lived Intangible Asset, Useful Life                           22 years    
Trademarks | Maximum | Vogue International LLC                                
Business Acquisition [Line Items]                                
Finite-Lived Intangible Asset, Useful Life                           22 years    
Trademarks | Minimum | Vogue International LLC                                
Business Acquisition [Line Items]                                
Finite-Lived Intangible Asset, Useful Life                           10 years    
Line of Credit | Idorsia                                
Business Acquisition [Line Items]                                
Line of Credit Facility, Maximum Borrowing Capacity       250,000,000                        
Convertible Debt | Idorsia                                
Business Acquisition [Line Items]                                
Long-term Debt       $ 500,000,000               $ 500,000,000        
Debt Instrument, Term       10 years                        
Debt Instrument, Redemption, Period One | Convertible Debt | Idorsia                                
Business Acquisition [Line Items]                                
Debt Instrument, Restrictive Covenants, Shareholder Ownership Threshold, Percent       20.00%                        
Convertible Note, Equity Interest, Percentage       16.00%                        
R&D Expense                                
Business Acquisition [Line Items]                                
Concentration risk (as a percent)                       5.00%        
Discontinued Operations, Held-for-sale or Disposed of by Sale | LifeScan                                
Business Acquisition [Line Items]                                
Disposal Group, Including Discontinued Operation, Consideration                       $ 2,100,000,000        
Discontinued Operations, Held-for-sale or Disposed of by Sale | AdvancedSterilizationProducts                                
Business Acquisition [Line Items]                                
Disposal Group, Including Discontinued Operation, Consideration                       2,700,000,000        
Disposal Group, Including Discontinued Operation, Inventory                       200,000,000        
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment                       100,000,000        
Disposal Group, Including Discontinued Operation, Goodwill                       300,000,000        
Disposal Group, Including Discontinued Operation, Receivables Retained                       100,000,000        
Disposal Group, Including Discontinued Operation, Inventory, Current                       200,000,000        
Discontinued Operations, Held-for-sale or Disposed of by Sale | Supply Chain                                
Business Acquisition [Line Items]                                
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment                       100,000,000        
Disposal Group, Including Discontinued Operation, Inventory, Current                       $ 300,000,000        
Subsequent Event | Ci:z Holdings Co. Ltd.                                
Business Acquisition [Line Items]                                
Business Acquisition, Percentage of Voting Interests Acquired                               89.00%
Acquisition price (in dollars per share) | ¥ / shares                               ¥ 5,900
Subsequent Event | Actelion                                
Business Acquisition [Line Items]                                
Acquisition payments $ 3,400,000,000                              
Contingent consideration $ 2,350,000,000                              
XML 134 R113.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations and Divestitures - Schedule of Preliminary Amounts Recognized for Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Business Acquisition [Line Items]      
Goodwill $ 30,453 $ 31,906 $ 22,805
Actelion      
Business Acquisition [Line Items]      
Cash & Cash equivalents 469    
Inventory(1) 759    
Accounts Receivable 485    
Other current assets 93    
Property, plant and equipment 104    
Goodwill 6,161    
Intangible assets 25,010    
Deferred Taxes 99    
Other non-current assets 19    
Total Assets Acquired 33,199    
Current liabilities 956    
Deferred Taxes 1,776    
Other non-current liabilities 413    
Total Liabilities Assumed 3,145    
Net Assets Acquired $ 30,054    
XML 135 R114.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations and Divestitures - Purchase Price Allocation of Identifiable Intangible Assets (Details) - Actelion
$ in Millions
Jun. 16, 2017
USD ($)
Business Acquisition [Line Items]  
Finite-lived and Indefinite-lived Intangible Assets Acquired $ 25,010
In Process Research and Development  
Business Acquisition [Line Items]  
Indefinite-lived Intangible Assets Acquired 780
Intellectual Property  
Business Acquisition [Line Items]  
Finite-lived Intangible Assets Acquired $ 24,230
XML 136 R115.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations and Divestitures - Schedule of Pro Forma Results (Details) - Actelion - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2017
Jan. 01, 2017
Business Acquisition [Line Items]    
Net Sales $ 77,681 $ 74,339
Net Earnings $ 1,509 $ 13,916
Diluted Net Earnings per Common Share $ 0.55 $ 4.99
XML 137 R116.htm IDEA: XBRL DOCUMENT v3.10.0.1
Legal Proceedings (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
USD ($)
claimant
patient
Sep. 30, 2018
USD ($)
Jul. 01, 2018
USD ($)
Apr. 01, 2018
USD ($)
Dec. 31, 2017
USD ($)
claim
Oct. 01, 2017
USD ($)
Jul. 02, 2017
USD ($)
Apr. 02, 2017
USD ($)
Dec. 30, 2018
USD ($)
claimant
patient
Oct. 31, 2017
claim
Dec. 28, 2014
claim
Loss Contingencies [Line Items]                      
Restructuring charge, after tax | $ $ 190 $ 162 $ 152 $ 81 $ 237 $ 136 $ 101 $ 121      
Litigation expense | $ $ 1,288   $ 703   $ 645 $ 118 $ 493        
Xarelto                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 25,600               25,600    
ASR                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 1,800               1,800    
Pinnacle Acetabular Cup System                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 10,500               10,500    
Risperdal                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 13,400               13,400    
Pelvic Meshes                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 34,800               34,800    
Invokana                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 1,050               1,050    
Physiomesh                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 2,100               2,100    
Talc                      
Loss Contingencies [Line Items]                      
Number of plaintiffs 13,000               13,000    
Pending Litigation                      
Loss Contingencies [Line Items]                      
Pending claims | claim         1,400         66 1,600
DePuy ASR U.S. | Settled Litigation                      
Loss Contingencies [Line Items]                      
Number of patients in settlement | patient 10,000               10,000    
Baby Powder | Judicial Ruling | Damages from Product Defects                      
Loss Contingencies [Line Items]                      
Loss Contingency, Damages Sought, Value | $                 $ 4,700    
XML 138 R117.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring - Narrative (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jul. 01, 2018
USD ($)
Apr. 01, 2018
USD ($)
Dec. 31, 2017
USD ($)
Oct. 01, 2017
USD ($)
Jul. 02, 2017
USD ($)
Apr. 02, 2017
USD ($)
Dec. 30, 2018
USD ($)
Employee
Dec. 31, 2017
USD ($)
Jan. 01, 2017
USD ($)
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges $ 227   $ 176           $ 251 $ 309 $ 491
Number of positions eliminated and receiving severance payments | Employee                 2,375    
Medical Devices                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges   $ 190   $ 107 $ 284 $ 187 $ 128 $ 161 $ 462 114 $ 700
Restructuring costs incurred since announced 2,500               2,500    
Medical Devices | Cost of products sold                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                 46    
Medical Devices | Other Income Expense Net                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                 227    
Medical Devices | Severance                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                   $ 151  
Supply Chain                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                 238    
Supply Chain | Cost of products sold                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                 59    
Supply Chain | Other Income Expense Net                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                 117    
Supply Chain | Minimum                      
Restructuring Cost and Reserve [Line Items]                      
Pre-tax restructuring charges 1,900               1,900    
Restructuring and Related Cost, Expected Future Savings 600               $ 600    
Supply Chain | Minimum | Medical Devices                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring and Related Cost, Duration of Restructuring Plan                 4 years    
Supply Chain | Maximum                      
Restructuring Cost and Reserve [Line Items]                      
Pre-tax restructuring charges 2,300               $ 2,300    
Restructuring and Related Cost, Expected Future Savings $ 800               $ 800    
Supply Chain | Maximum | Medical Devices                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring and Related Cost, Duration of Restructuring Plan                 5 years    
Medical Devices                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                 $ 700    
Medical Devices | Severance                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring charges                 $ 0    
XML 139 R118.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring - Summary of Severance Charges and Associated Spending (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2018
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Dec. 31, 2017
Oct. 01, 2017
Jul. 02, 2017
Apr. 02, 2017
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Restructuring Reserve [Roll Forward]                      
Restructuring charges $ (227)   $ (176)           $ (251) $ (309) $ (491)
Medical Devices                      
Restructuring Reserve [Roll Forward]                      
Reserve balance beginning       $ 267       $ 381 267 381 501
Activity during the period                     (120)
Restructuring charges   $ (190)   (107) $ (284) $ (187) $ (128) (161) (462) (114) (700)
Reserve balance ending 242       267       242 267 381
Medical Devices | Severance                      
Restructuring Reserve [Roll Forward]                      
Reserve balance beginning       229       380 229 380 484
Activity during the period                     (104)
Restructuring charges                   (151)  
Reserve balance ending 194       229       194 229 380
Medical Devices | Asset Write-offs                      
Restructuring Reserve [Roll Forward]                      
Reserve balance beginning       0       0 0 0 0
Activity during the period                     0
Restructuring charges                   0  
Reserve balance ending 0       0       0 0 0
Medical Devices | Other                      
Restructuring Reserve [Roll Forward]                      
Reserve balance beginning       $ 38       $ 1 38 1 17
Activity during the period                     (16)
Restructuring charges                   (37)  
Reserve balance ending $ 48       $ 38       48 $ 38 $ 1
Medical Devices                      
Restructuring Reserve [Roll Forward]                      
Restructuring charges                 (700)    
Cash payments                 (593)    
Settled non cash                 (132)    
Medical Devices | Severance                      
Restructuring Reserve [Roll Forward]                      
Restructuring charges                 0    
Cash payments                 (35)    
Settled non cash                 0    
Medical Devices | Asset Write-offs                      
Restructuring Reserve [Roll Forward]                      
Restructuring charges                 (132)    
Cash payments                 0    
Settled non cash                 (132)    
Medical Devices | Other                      
Restructuring Reserve [Roll Forward]                      
Restructuring charges                 (568)    
Cash payments                 (558)    
Settled non cash                 $ 0    
EXCEL 140 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

  •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

    5XR0OJ*ZAXL8> M9)+@ 'U0?04 I"/?'^L.,^?S_>%H7HUW1T?(&Y!$*95E6F*77P8Y>I!? MZZ0==)"V6<.LN,BY)E!OKH[4;-^0\4?VU ]H( M;8"4A=@8)G4>&N!=;SM4ZUH+P\CM_)1M@RFRNV]Q^,TOF,S)F2&6&^,)R0LV M:PD0W"G-&F55*>_SJ)(YXSDV\I9*!J+QZ9%2@!=X""%'EGS2"E/2DCDKX=]/ M$L&WI[BN+)8?<^7GP%5)3#GR;@ ,<4<))(8*99UT3))"9H^2VL /D',M\>%L MMD$ZZH-@6L7,E:-OASAWH#@YRCD$\(TM&@-.0:V(*J1#'*76ZKHU!5?7\]ER7"N[5 MI6,Z**G5 @,B+%->0.D/TE$WLA)O?6QU-:&^QG1,S*G%$""IH/>2,$&*. _K ME-[UVA.)("*NTU8 RIXF$4!P !\ZE,&^0]\R-,Z]]T,=U(0B!HHPH M2C' 5C"((*.%[$BHE O!Z\\(KFE_M8%\?ZPSWR?SA^S#_'U5Q\5LYA?+_TR6 M=Y5H6&; $*>B!3ZB824$3!J+7N9__).1'2D;9LQ%/K:@@AZ+)KP5HA(;W[T= MMP,M!8I';AZM$Q^/WTRR0F[M94K\?67J/6TKTG];3Y;KC@G8+$4NUTQ(5$-_ M]/N6+7],\\R45;4*^:_>"XY0+1FVR(MH?Z@H(+.%K(:1D>4F]TZV^M#W1[/7 M#9(J\>SUBP%HB8!53FC%HU'MJ%?[&"<'$3$IN2 #-/=Z)UH"]@/:3[=)=],_ M-MMT_UUYDR]Q0YK>3I\F\VIDK#AV4-(SICW+E<_BB5 #Q@K,($RZFQI@[E+O M?&U7/?U1>AN4])C-[[;12I48^_.K 0#O&'! "*NQ1,Y',^4@L5(I6;P##*#M MG9!)Z/?'-W6[WDR6T\GL;Y/I_.-B5;$-V=NW@\1(8R6UQ))C92"%184#![%1 M*=MV^=QQN6/=/(L*S^YNQD^^5#TT%D[[3EZ]6<5'5BNS>/QC.M_^T61^9Z=Y M0.9TO5EF17\-FYULU]+63P4&(!1"ZKS3B*8,>^)] 9+B*(6L \Q?[XBE ]%6 MW>(IFV4>1[M=Q-7\[ENV7L^RXM^^QF];;N)<;B5U\K6U7%@$X\^S]8?9E,J_FVSXX4O&)&Y5A$ 3.ZUIX M>9AKWJ=04_[JU.Q&)SWF92V6V?1A'F??,F\$X/Z\W:*8M];:X;E*\X/7&#\8 M)K65W@L*H?9(&&9)@1V%+BDV'OQ%Z/Y4-:"E./$R!R@I.(_'1 )X/#5Z3D:<&"8K1*+.&1D9\I4*,TGTA$(Q-O9 MQX9TT>-N_O/EE7M\FBV>+Y3Z+CE&D$;EZ3V808Z1U=YC"@X8F*2\E:NZ2.^0 MC\VHHN=+R"T^#5ZHEQTTN(A--**4Q<@AJJ(Y[HNK"VRP33FK7]5->H>$;4DW M?8:Z'7R]-??WHR,$C23DT;#!WB"N.>+(%\X)K&%2:X[RE^H_NY'&S\XF5-'8 M#>?+%[1WM9GP&\'D@2Y44H> @8H# D1AA&-LD@(T!UB\O4-^]JVJ(9@#M6^; MC@\1B/!68.TUX< )AHRD!P2@ERE)9.4OX(?CE>]EQT]0R! H^>:*X68YF:]F M6S+4BFBJ,G"TAK@F"L3_4PHX[!&4!WO>L:1@I_(7^&-<:WO1S_C\HYIRE]<' MY1P@(32(5CLMY">&I+BBRM_B#^1&J7?O:#5E]$C&5T4%=P)48^*[U_,[M3Q_ M0#N J18>&RK=X="H7'RO5@G%^O)[!?@8*H:>G3//RXV\:CW-;M=/,RG M_Y/=?9CKR2SOJ?3M>Y:M2U21K#UF8$ Z0CQGVF%AB")0% YCYKU/JU6>H6WZX$%:(2$! MPDON@/4*8<\/^I&DFX+7O7I0VV9RYTH:*K5?251J46YD_*!<'IP&B? .4PNT M9:KP2S-+63>)RW\1O&$]#=8<;M(,#MHPS?(>Q?$ A1 TO,B:Y%A8U(N#ZI? MO?9P4.O!R&A4(X-BZ79RYF7:E]GW?,;F?1AN%X]EV@ T,GZ5[YRF9/F7KW,^\RAW->1K# M_6*9W4S^K!A#6/=G@L*<4J& M/@F^+*>+Y:LR12:R9KINLJT-BE>T-)>$>:EY7D99>6XR)OX[M 26G+^"YYTAT7[NJH: M!+'38P'TNX;]KZR1#AA-[AO,&V0-!23#0L$":8CKZF M79,>G8$HJ;_U^KBXE5;JXT,$I!A7B#AC /.826)I<;4@+$NBZ0#OZOLGTL5E MNQ$]=<74<5)?Y]/GE<+->Y2HJ(6+6K5#I(RMW=,7 M!884!%0!8!FA>5UU=?R3,FO.S_8_+& ()):,6RF-5P(03HL#FK:( MI829#]"%=%63='#:[WNN'K<-CGJC&]XL&_KEP VDS&&@E,S+4TD&Q&%M5)ZE MU%X:X*WVU)0/C%P+X4!@@AG\WJR0DM8A.QH MPT0W3HJ_K-:K8T+-$@7N_CZ[77^^?UU<\U@,]\EG@Q(F?J+A'"$DH:10,GRP MMJVR"80=8,F P="U*84,80\H/7%>YEQGCHJ_!C_8/M71_]F/\X[]<1M[[_B9^TTNI_LJ^+S7\_O;6OC MU<_?D_VYSO+$YO^G_4F;(QF_;D?:O%_$(PU8I #:F' M&A"%+>4PSS40&I:*Z6T'BY=NU)%]KUBWT]%-U(J./_RO,SB4'"$81:F.77615OY5OBQZ +[KC;/G[[^R,KW:;'^9_9JA:Q'RNZVCH08%RPT5/)$FXLPY-01IX("CK$"$8YMROA[@)46W7&Q%!=V3LG!] M?9YG<:V_S37]D'U93.?KHES2=M)E=PVRM^'?# XI20"@T*B\&8WV$-L"8ZQ! M"LT'&(_8+OJ8SR&_R:NV%\U;?FJ, M46J]3!DR.&.)4-Y 0[?W!#;N(8701C.70+O*I7NOFW8=JZ('O])LJ_[XY96V M]'H#!:<,XT9'.X8[:Z'R#)/#;,0^I9U4C6*^5\W,3C30/1^/5&![ 6M5C9(E MQPK$0NJ01U)I@!@1P+J#U4)I4@AZ]>:Y8V-E.TIH_6IYN7C*ENMM"ZO\>MS] M>S-]>GQ5 ;+S&^637U3B'OGBNX%)(K6%/&_9D:\#3KF=$UH1PRTKU0RU8[E? M6%1F5:@R3/"$ L,4Q!QIBS1CU*,"#&3;Z.?[+TV(UF?UMN=@\K>(0L\U=GK@3GXGG MQ>E\D]U]CE#L*C&I/Z?G2J=W\P'!(B&U08Q:#!'Q"E'C]N@;8$FG\5/MT[UY M4BZN0&N=EGR6-F%X^3Z=E:1_5&#!+D&3-062&=9EI@)O4>'PL%2'(Z M#(_50R/=V_(:G2BQIA]7W?W(P;K[%M4TG>T3O>+B<+>Y7:]^RQ[_.-I5O>2; M 5"S;?HR!GZ?+N MN2 -X50R"^-1QP-)O1%\_WD.4)!R4S3 @- NR9&*=2\;IOFY\,)YZ_#"FX%0 MI_*ZM\(P+H'R=AO%LI,7:UK*N7,]W&K=K&L6[@'0JYKE=>S= $'N(28*"(.Y M01+D_5!V,GM-=4HLV]#WMA0&E&=6+9P[Y-:1=?OOV>S.+Y;?)G$N+G>BQ;^^ MU\_YGYS<'I/'#'%_P%C'_1X:S9"V"JD"?8^I'[.=E<:9]VSL1 -=L?3D=J"? M;^*'7-AD2[P=$,161#L3&X&(1( KLC5TU!Q "&"^G]04BGB^&=QK'LE^8=DZ/!/B M68D2!4$\\L3##X/1/"ED0%#2E$(M \RJ:7UQJ@MLI^2X:&6]>BH032E6#$!G M,!74*QC1V,N1;]SC6E)JZ.\8 VIAU_LV]+$H %YG%SJ\'!2 WED.*)5"6QWG M#3X@9Q1)<2P,,(.I/WNG+N*]^!;.>_,N!E9=SO%; V9OYXZ\$YS07 MA@D[*R/GXV1^SJ#)_SHH M;WS&TT)*B7#*N?V:[-TFZ-08REUQR2SF4>3- M;:ZW#[DWX2$J\N+R=.:M@#0B!D?8XFY/L-48*':0TZF4:[,!7H*TRJ;F8.[= M'7Z)4>=?#%1PQ(T6@"EM(:%>>5Y(2S5."3"O[@9OO1UTJZ1J%.FN>'7R'/TT MR_9)UJ^]"G5]))[ZME MQ*ZF&R)HH;"#T@DL/.+ ,( .)BLT((5]U2MWC72EK(YS;R[*GHOTM^MH!!)! MPJ7&'D,G(=>([RI*:\"1X:6L@JZCTU(**;PJ!1\7+;$+E,(2&&LYHX7DPKB1 M!> VR(32D6DUH6Y[HG_-WYCM;U3B!W_,)JO,+!X?I]M.._W-].V'K/;WTO.' M$O/[Q!O;@CC6::61YQA"%16X+U.#J2>F5!1=JS+>?XRGL"RK5AWEXKL!>$*1 MT 8B(6#NP.3(%G)CKD;F$4[6_ELG<,/X]CV1!U,$I;F)327B'',G432ZO2&J M*-1G""18]W@ON/WB;:&N5TJY).';YP/C42)*9*03 =1Q+.Q!/L#4JC9J07!%A( M-7)"2N*]AKI<]'NIB*%+6C@C0Y770]QP*+3>1GO/8VY3X,MCU MK"RMG$7K0'7E77DST78%9??SLIB1=E.F25S%D4)>GR.B*P"C"CHC($2\P,-0 M-9(B/^U0Y&TGTE:A'Q@5S6:Y/.^DKC90(-HS+"@C1C%M$ 74D#T:EA SLKH\ MK7&E'B?K*6%@E/PPO_G/XI_99'GN\J[R6,$:(RP@G@C-C(8.:.KWF#B#24JF MW C6 9&S-IZ&!XWXZ]FS;'S,%J @A,GC6/024DQD\** A=+9,H./L"0F.'Q MLZXF!L=0O]@L&R/H8; %?< D7P[X5)!R2"W!2HHGI;&%60S.'[65<3PZ#G] MT=SZ>1@L>(^E)U(0CXC@##CC#J@0K5-BP :8M3H\>M94Q,#H>?,]6V:3^_79 M]/K*8P7N+-4 *N;R""?'...''<4IG+)V#C ^9V#DK*V'@7$SG9&!2V?R3MA, M,"TTUX *N)??$\52SD #C-09& \KHM_WQ4+/83S-71(H:Z,-#RB"U&!.!1!H MURQ.$,FD*96ZTLG$KW?+7WZ0 !170EA+J'74&<6\M 42R*"1=4!)YL/Y:=X< MT.W/]%U(_V89/[ZW"?W35VPO7;=!MNIV/?TQ74^SE772)*<^1DLZ2FL>^L]N#K M[]ZV(KU0I/+8\P$+K: 07B C))3Q2,3A7C:*/$Z,UD9K,?T]OL?*NE8X\& M;H P0@ JN;D(TF%=X G)V6-"Y=[QH!0F \E1&HG# . M:N;P7@:C6;F _NNA1"?F0TUL.^5'I9+7TGFGL&2$(>^%0AK+0@[+F1E9IF(- M_9TI>5T-N\[*#^TN4RZRX*?G B".>BJDX])@1#'3MECOG/!T9.[N6EI\6TLH M ;_N2E']68X+KY\+!A,0]SPFM.!6,TF%+^P=)Z$>62>^1KB0@%]77'AIB+I9 M3>?9:O4M>]@E 9RW)\Z^%S@WW .L(OV-8"I:QY;M9?4$P91U8X"1F%W8&$WB MW1FW=I]XT4'QTW/!.\08LAQ;A2SV<8Z!8IYX"<;66[XAO;YE2P*B/9U4)75( M4^RBD%@#C0R NOA(S;,$O=^;+4!6INPT XRI[MP9GHQX5PS+FY*]0>7B MOG/RG4!DM-'R&'&LH:$8>>'!04;@QW;N:4KCBW;P[8I#[O%IMGC.LF]9W #R MQND73T@GW@A5DW+FY%)!RBAPLY)1Q%4_@SP!3,;K8U9I#NV=67=S5 MSKX7!(..*R&]AM#A;0E$6HUHO1R3:N';%9?R"?3Y/N]$??ID=O+9 M@!F1@%C)"70L"D4Y+V2*4L%. TZZ.)HUI.%W=<'3<*UY+O^\_K_MO6MS&SN2 M)OQ]?\;^@&[<+Q$;;P2NI[7K(WDMN[NGOR!HJB1S#L72\N(^GE__HD@6)5ED ML5@H%DOEZ9EN7P24D4\F@,Q$7KYE\PU%VTR%ZVQ9:9Y7S @&:2:!=@8K28RQ M$'-3+EEYT:D3^/V)0KOH]L!X_U"C7VJ=Z4$QY+7D$#/+.:+,.&5+RN/_I 2F M]#"][\)F?%/8+R)PKT$IMLQX^WM85^@J/A$0I% X1)B!/N) D--NBP#&A TY MCC]9*.J%\*=B?IEC[MMH_I#5/]8VPP- &D'MD!8,4^^- V[KK[<$1LMU:-=C M=_+4#.$>G%C%?^-U7Y25NONOK->ZO1*1[ZA[OYJ3:-7:[I>%1IC?O\Q7TP*SBW<=/(XF14__I2-L\GW M.&/G/2M3J \H_&W_,X%%.T9RI$&T< !AECI:ZL71W&$#*W1S%K'L 5_:%]I2 M#=CD]]^.BE4V$,J]GPD 4 8-0L8 8*F4U+/2U\P$M"G]%7OH,[V$T+6!>_M" M95?S-;_RU\94$?Y]NFA5?"Q$(#DBWB++F9(XZJI:EX22N+6&9:->0L#:0[_3 M7-_;U>/C:/[CYGYWXFZUU:+3U6*1%PVPLKO;IVQ6-"W]M1*"B65>4Z^0-8C$ M:\=[:( !R$C&.1"U-LV9HM,Z3PC&"FFCJ18*0(T4@Q[@$@NF?,H!TG=?0SLR MDI 0?!KV[RLA6'L&>!NC[SO60@B*(--)QWR!# 43(EK02CU.TFA[F!75Q M^[2)=[]S/9@BW"DBF&24:!MWF=,E+4B1@;6Z:(FOE;D>IR'Z5CK>TS'>D/+W M>7B?+X4"J&AS<4:PQ$S[ C-5FE^26)52TK:'CTB=FP_)B+_/% HHJ.0$:>V@ M!L1K3RW&!JE:+++E/^:399;?WU?:HWM&!F@QU%PPC9V1FFNBF"N7&'?0 MP"K4M,?Z=O#LZJA8!\*^(OOH67%H2I#(,F (5P@H817GTI9>&Z5L4JG-'JHP M[1\6+0'; UWX0UL1R@E H(D4%P) 3"Q63RI>4,48ZK33]E,TG^=WMMX/Z>\B4()T9:H0AA2!GHK>:EJ]58IU)*4-?7 MVU]+U/L7IF;@=B4V93!R)/G5JBM$Y]"48+1GGAKA/ >*.H(]SL*45)$9GT= M?2@'4DLH7_+RN\V6RVEV]X_)\EN^6IK1XALZ\>;;\X5 A"BL7T.Y)M8:1CW9 MT>\0ZZ88QU"D[#R@OR=E/>X>K1R'C OO)8[TX-(;9QAQ*8Z%D\/(-\JZFPW@ MUFL&;Z=QXA?N!]EMX+<2E%K C%>%Q60HA';3(U [0ARH]7[3:>#W5H#TCXU[ MM?!.U.D>U^!K8?T HQRP3BAMN(]Z/2FQH10-.="R'9FI%PC>(@_.?4YLDZE> M)BV=<#[L[Q+S_,F*C7U@9 1>>Z($=93!1"52K!-:SULK:"-&KD=6V;5=CLT M-!B@L# >JJ@D0*B9Y0*5"\5P* 4RB+"M(Z8%6^J MBD?]E*[AXL924Z] WWEN-YO=3V;%>\UL.9]\716P%RLO#K]/V3A_F$W^*ZMZ ML*@U/U#B%!5&<8@1QAY)BDA)/Z=N(+T-D[F?GQ_;LV_%;8SJS7T9M1JO\-^R M_&$^>OHV&:O"17DQE7:[N$_94SZOV>/\T)3@C>.<(^L,@HPI[P%U:]BM$K!F MKY-NJ#RMO7&-V:$("Z$68\"07:(>1PPE"L#\(NT60^["O MU\4*]8_MT.>1ETYA;G/; XD Y\(; ;SUFF,/)&#$8:4EQLT4W;;MU)\7?S6[ MS^>/:W[ON%,_4;GVUX*U4AGAC%#(*@PE0$1OL5$\;I!AW/+MB> M.?9\0(RF=;/&?IX3!)=0VZ*%(B0 >D2-0%L:-15X(,IC)U)P*',L$?..L\9> MKK9N!MG;.<$K#B@'/&K.D%FL*!%F2Z.!WG3:0J;#;++FO-ZOQ"0C>YKT+++Q M7Q[R[W\=YZMH%OW8",_V#S_+S?:OPY?;/0+R_,,@)"?28&>EQQI*@CQ4Y7H5 M-9U6VNA0GTWA7)X(8E='QG4^^W*\B/F+40%#;S%0V%!MJ"44:%7289&W*4$F M/4PG:$\4TK%LF#WRY?KJL[.WG]5G=^O^+"[+ZIH&!\<'3)DK9-4)SK2 BG L MRN5RZU(*&_0P+Z ]UK>):F>!1?/\;C5>WLQOLWF1SGM$/=TW/-@U4!09[#FW M%HIX[I641<%/>9OOXU'1H6;: MP="U+A#]DN=G%4*3TX)S!I%1):$VH1MQ)Q M+TH:'0=)#>IZJ)2FL7F_S"2#VO :TJ.O/TRDNO+N>3TH$.F\\<8(B+DRUGBI M;+DPC]7 7O9;8%#>$I1->9R-5LL?U1Q^,21P'6_+N :+L'3$,V\9*!=%6;VH MEO=S0;3,W^9 -N3NS7PT/;J#7P\*3@DBO>=1L\7 \'A8Z=)X]AJI%-.QARIC MNQQ.@K(ICS^;:O:6/P\P&K1">8B,L @2RVBT7[;+P#@N6FB-44T%H"-(H+LJ4"$9>J4NPJ/G1F)T'9D,>W MD\>G?#;9_J+FDU$EMP\-#R):CY PAV,M@$@0L'2E>6M3"KU(8;.]Y9 ;2H! MRVPZFA]A^\LQ 4",K77"<:^Q9P@KN:71 .!YBN=>#I[7"4@V9/#G>?9X/_I1 MS>'7@X)RT9B/'Z$$>&PDC<:^*!?F+$UI%03!T'FVO=O_3Q<37+I_E# MM>MD[]@ -7<2%(8_YXXK J&EY3)IU#536#YX)UD;D#;DO+-?/JGKS_/)]&GR M?3*?S*KUM4/#@[&RJ">EA>%1H90*,LO+Q=JT7J]P\$ZTEE!M* (?/[E_7=U^ M5L6OYD9?_3/^>O,A_L7M?_S^^)X2( MYJM"CD%D 2Z7#21-*I\V>&]?F] VE(BKZ[^[W]3ME]O/[OI:_=-]_'!U<_WY MT]7UO]3G3^[O5^9S]9U2>W[@#!DNA,/<(,R,MQCM!-PRF^(D9"]8P/2D>@HQH0":(0JG%]Z)]P@+01]^.[#%B!M_-KW M-_?IVGWY='-KKEP\OHZ\_>T='0Q%Q$L-E4?04*VA)COU)]*?Q/W!.Q'; ;4A M_ZWZ]"_UP?VSDNVO!P4#$$=>T$B@8]$ZLD2XAQ] 5?I D-,X)8<5#=Z3F 9F0S[_W7TPRE8? MX:_&!"R-<(IH IC".-HJJDQ),/'K+D7=1X-W':9 V9##__J/SU>_56_CET." ML$)@02F!!'/$.$:"[Q:E8%*%V<&[!A.03/'PW,S&-5\"7H\, 'OO!8]42F& MEX[S4F&,-@1)RLL9O*,O'="F//]X^^7WJ\_5W'XY)EC&'$>:,(B%8@!0(K>! MO 8SEU0_$PW?:Y< 9=-GW$_*?'#N4_4S[JM!00.EE-:*$#Y>$9=,WEWSEJ!$8V4J(8VITN18!^TC8>O ,M M!/=\<-"FS?W<=/1YR=;P<& MK9U443P5)=Z1:/$)>/9D.%_N_IX6\GHYP'QCI%,O!NL,8X-&?M_KIVKYNR+$4%0[XRF!A($HL(0J>"E MXY5(A9*:<0_> ]869VT\-.P@!%E3 %"H% 2$E_$8Y:+0Q8GY1 /WN.5 MB&9#5BO[=W5MG*UN5OUJ4% H&GF$%YUU"79,,8K]=F%42I]476CP3J\D+!LR M^3=W[3ZI#Y4\?C4F*&[B):((X()[:AF"L%3]J#=I+!Z\TRL%RL8GMC-7ZL/G M_SAR8+\:%80Q\2XQ%'E1M,WFQ%&Q$SZ15-4##][YE09F\TCBS\I\_N"N;]WM M\1OZT/#@""804D^=BG<+ D[8W6*C+=82JDVW^I=/OUV9(Z?YZT$A M&O',*XMQ)#;:?)SM2EH:5O0W3&'WX/UA25@>9W([Q=M,/EODTR*./;)GW4_\ M2!W _1-"M"&\\ X;"E648.D\-B5U#"9%D_704.NR$F K@%].G(Z6 CPT)1AG M+(@[#G'G-8EX^9T=PY!**B[90Z==*IN/2DTC5+N2FUUQ[K)E1MENHV[1_'WS M O).X8B3,=0Z2FD\J\NW1:9T4GCB2O%,]/(=:XNO^4OF-$&UJ\L03/ABE\[@%$!MR^O?L;EV3/5M;8I6ML M-<\7XTDV&U?7PWD[,"CHA25*"Z,D5)Q3YLJ755'_'"$X69]HA!'B%#OC1.G-0VY?SN8311._Q-@K"I);^:/N:ST?S'W^)7 MYLMLMHA@5QOTAV<$RRQGB !%$4'<.^9$^8CJ+ 8I92OZJ-BWPO7V\&SJI!O- M[R;Y]]%BO)J.YK]GR]'7?#I9/!Y/QJHQ,T0C1DE,,;'414554XW*O#$'&4EY MONYA,%([(M$^K@U%PTXB6,ML<;0AS=N!01 5C59-)*0>8*(L@SO9%0ZFM)7J M87Q2.XQ/AK$YGQ]F^6(Y&5HDWU^?GR6_XT*CS-1RK;OAD8+ 5%V5W'.3,2.Z?%[MKQ M7J$4*[V/M>];4NQ3<6P:;KB:/V3S:KOMU9A (=6,(66!B+JGQ)++TKOHC>=) M\3Z#];NE0-B0LW^?'+737@X) ")+BQ;*%B%)C#*"ER5.O35)#<;Z6+^^';XF M('B!EY23HTB/S@U8QTL(,Z"*$#YE-2MQ\6D^LSX>?JV*2MXU_$U?7++YN.#/0V:^C68/V=7L=C3- M%KOM=W-?1OT>>H"I_8$ KH)K=_9;E#_/1T[?)6,VS MT>+YW97;)EEI/[Y0Z/I^E,V6XXFT\5K M&K/XJ=E==O<_N]<N.?H"V44P(H/+"<8N((B8:CT-'Z ]& 9 H(X6$M M/?1,5/[,L$5-CJTO]BHLDCX*3.EWU_[ Y77!^ M5IRZ1+\KE>KWT7_F\^>U5SLDW@X.TGN "]^-ELQX)AV@?DN5C'=UDKNYAS+5 MD0CD+>/>E31=CQXC-J^6>]3G<'!.B#:O5= @[Y# 4'--G2EI="BIT&0/92N% MR?EY(&VH0/_C6Z1Z$16P.:QT@+\9%S20ACC$O20*,NF!4W"[/ 4P'%A0<0ML MRMM#,YG9J":S45G0@SN.5%R=59S@:+T)ALKE80^2>NO\.LQNAF8RLW%-9F_' M!:F-AD9*ZK$3'B&EXG>WR[,\R9_7PW#B"0TDP26U+HM!M8I8)4-M>MF'(: MJMW)S3Q:_Z-E=IW/MOZ @_?6T3F!,ZR%C&A!:P7'P A1@F:L-TD=/M^#Y)S* MZC>RTPZP70G/S5,65SN9/91.VJ.B^$3@I:*N' M%UKK@M,.K)V]CI>U85YYWVM6:/IY3E!.* J11E (YP"'T).21B992L).#_7F M"^E";<'?<0#&R]76+=?T=D[@,NH VK%H?^!H@5!%'-O2: 44 U.(6N#U_H"* M9&1/DYY%-O[+0_[]K^-\-5O.?VR$9_N'G^5F^]?AR^T> 7G^85#>0\GCT0FY MH\I!*XKNZYOU>I76P+Z'DI#.MSP1PJX.#+>:YT^'$\3V#0O">PU,W 7,<&J0 M\0+QDA)EW,#<<^T)0PM@-O7.98OBHOQ;]CA9/'W+YMDNAN9+=:^8XQ,#I%@# M2J4B&'@)N6&^U+4<,2[%)]-'/:0U:3@+O WE0RTFHX^C\>1^,E;W\TA4=5^* M_:,#LM07%6XD9-H6<$B,=TO5)B53H8^% UJ5A'8P?3NW+1=3SIE5.#L#I2* $%QF /XEV&2O>=ITZD]+OHH=G0 MG@ )T=]Z_O'1^LD\@S9@F&4%FGK-DIR-Z2I"8:[T*& MFK+Z9U]$"^!V)3A7L[OL?C*;++/UX7P5.3=[F,2SN0Q?WKR?3T>+8^_()WXI ML&AT"2R1HDQ8)@!@Y*,_+E)X(Z3,-1" M\E#X2#^F7 !.(=::E[A8)0=63?5L4G.:=+; B:;91ZOY^-MH42SIXSP?9XMX MG"^R^+%O<8/:N(&G^5/E._;I'PE <"*4$]@R()! 4G)2$@:(27'NO#\12V-] MWA$3.M/N=I>'^W^KR?+'[]GR6QXI^IXMEL7BW_YMEA6X'7OP3/ALX! !1)%7 M"#-'/;1";94C"+WU*1ZH7E<]Z/9-M#L.=?8*/I:>@=-I@#;D]8?)?78['E67Z7H]*&C&.*5":\JE8#)2*/!N83(I MEJ^'#Z%GX'02GEVI"KML_'$$8#%9,ZI:HSTPHWC9)5I"22 SWA$D!=4E?0S@ ME"3&7A>RZ519;0?\2PI7\=MY=EP5/3HW0!\/34X%BF8C9QI!PDI3%=.X*8>E M="1SOH8DI>#;-%1C.LD7>I(_K?O*77GWSQOX8?(X669WU7$;-:8&P*UA MSC+@(QP&1RU%)"DP$"#G5;,<8P$MJ5218CF M VLT?Z;MG0)I4U[_?E/-YO+G 0##-66Z\* 0*%G\G]*10C1A*0=X#V-]SL3A MAFAVI2=^+ *(Y\L?'Z>CV3*JS(4QMGXQT#\^QX4<,4AJS Y&*J\YYM!B:X!R MT7@KK6R"J4DQ3DYN#M%M[_=.S9/V67%Q$2S6?=18J3$[*"HM,HQ21QUP&'+E MY.YP5($95.I:&V?(2@!H,4]TH/ M+:AS2E1[*'>>VEWJHV7*0=WT[GWS @%"&Z<1PDQQI'T\XK=:!60DGOP)$M7' M)DT73O%N@04=IWG73>TN0X-!L;36WV?3(^TI%]W]" "/2.6:$4+8K!<4+D;I'$)S6,ZJ$>DL[K%D!L MR.FB'L[J\5BGWE>#0KSAG"42 J X+_K+>%X>7)R2)*NXAP[<=.XFP=9VHFK[ MH4;7I*:?# X8R9F311<\@YT3J,R#AAPCG%)YM9<-02]C7W3$GHNE"S]W6($5 M0EHU+5!@;-RN4C!+M$4*V[)"<5%P"0W,%W=^@3B6/MP<^XZ/R0OV\S)>Q0N# M2VNI$890ZV1Y?0BG4$KH?@^UZ,YE\OPLZ4I4K^/N6LT+D#?85,CAST,#0,P" M9UGQ1 V5$EP 55+$/4L1LAXJ\YT+62+>#;7_M?,HWD5 W]YLU5RGF MU1.#A$@5Y6JH(LP[J2UFS]2ZI)KX/=E4*&2,*G22Q_?+CH7N-:@ M[\YCO%C.5^-E7.7L(:H(\X=*T=HW/"@- -+8T:+)@Y>1.%H66E)0LZ0'L9,? M(@9I0[< >],$JOM(WN?1GWM6<, S5S&C:%A$M$9.8VRE0+YX6RZ7+ A,:;X# M3WX>&)2DM(M\ITZZJ\>GT61>:(7'SY_]$P)@%B)GA02.%[+%Y0(T\F:V:F?"M09 MI37W$$E?&,-0V_*1QIAXOJ?(Y7^_$IR=(5V)Z-]'T]6&O]-I_N_1+*H!D81" M3YA_C[_=[; JV:S]C0"0AUACQ7C4:2D15,BR_IXA:<7EX'^_!YR/$\_2^+_^ M^H8)<=E_K'^T]R?;[[S!-9[O?QGGCQM6E,\6-_>[RBFSN^>>6VJ>C1;/@=+; MT9^RIWQ>/'I[S^>/Z7[39PY-B4)@>52-**2T*$^)&0<.:*F-\DQ34RMTYDQ4UF&%_K']X3I0O0J T[^V MKF05;6-JF710"NBC1KG#QM*!-9E(%Y&#Q=+/!7EG.<>KKXN:2>VO1P9/#8]4 M"&RBW4$=!MCPDAY)U<"*79^5XS]+5Q+2%Y"EHQ&.#;T!EP]/JYF^31_^%&9]?CSL& P,518227F6.%X MI/+=\8HL'UJG^>;,R5L#L<,23G>K\?)F?AM5X\FX1G&Z-\.#81H !J0%#KDB M"20JTKOST:B4,Z"'R3A=WB MP-VQ(!4&RW:QQZ^3@W,"L<127<33"D^4!=B# MW<%*@1]8G>,T-N^7F610&]XQG^?9X_WH1W6/\M>#@A),OK]W>=.T OCEQ*E.,^R]4P(DTAE-H=(06.<95EKO-HR2*1V >GCV MI++YJ-0T0K4[N=D6C+HN'F0?:E4J/3BG:'7D@+%,V6*_<-WK2*1E')3TQ8L_)6^IA_92ZX+3 M#JR=N=?.4GN4:X<%HM8H#JSGP,<=LJ,5)VG,/I@.D\[H%&-_RNJWR.WW?+._!.-!RVDW]%(!$[Q[?117BYA7R5BWK%M]7*U=>VLMW,"X!P2QQ 0 M!#,3*;-VYV@53 XM7":=U_OMK61D3Y.>13;^RT/^_:_CHJ3-_,=&>+9_^%EN MMG\=OMSN$9#G'X;B?<]K$_-J%KF8+8JFAJ^_4K0X7/[X/5M^R^-/OF?'\_4Z7$7 *FJY M1@)$M;,> L_H[NR1T3(?Y!U_GFW07[8U] ]N*P)4FSPZ M)V .*29$06B)(,(QS7;08L93P.KN;EV@\DC"QY')P4C+!"78$/64N;MT3I/= MMO_1 .-][PQFREH1U4'A#%$EREK[%!7\'=C[+0KWA3ES?B5JFHV7V=W_78WF MD;CI#S^9C691$9S:T7+T939:13,CN[N@!G5H?2].F5IJU0G?";Y(>3,>1(%1 M\1?"A066: MLTA'W@'T/3D@+E]>[A+G!"LZ54GK@2"460 1C/J,-0 @+DPTOB]W3ER^$%V\ MYJ#A%EE-J,#$DZCE;;&1EB4U1'WW)TAMN6FA.MUI?.A*W]ZY;)Z[(AT)S3TP M(RAB&&4@6A*P\()"9@S8TJ>$3'JVZ*.94?#LCGJZ4-%VT-ZK'[G4<73 M0AL"D;3&6B(!LW*[' TU2*H1_C[8W9 ]>3J:#9FK?K^I9.[NYT% ZI3E#F+N M#&6*828VRQ& N*0NL3V,O#D/:QI57<_C5H* <*(HT$EWJ ME6WBWO."&I0X38@UVF"@F"8>NRTM""HR-!NX';Y6%]0X"=$+I6=S*92)YZM@ MA@O XJ^,;!<9+TGZ@]IO.X!1!;.:V+ M!HZ3T<,L7\2%G')V[YL8$,+<2.:LTE(C3UVT=;8$$&/1T*JJM7R.MP#ID/(Q M89$RHIU ABDEN;9:E/=95)Y1RK71QR.E2XNB??@[$[PBG&\;9/);GM\MKK-E MG7?*BFG!:D4Q<$0C1*17Q$-3NF0BKF#@T95IS/]9LMK#^=?)\#546\@D\2+> MU4Q#0'?7/@6.==I JA/[IQ4A:2&W]S3@NQ+(W^;Y8O%QGM]/JDZT%Z,")4!" MI*2-:B,7CL4;P6_I8-:XH54K/(?X-(?SOU.^SY4[C"B,EY#'DB(OK;=*6%3R M 3J7U./I*D?JP6$&YXH'R;+R<.FU<]:>RI+Z,23 M%#&G! E<%2\")69??H98N:HUVJON]4HMJ'N>')4X8A MF?SQZV0VVH5$;J(C/V73HGR7R1?+Q5K,EP=/HM,_%)R&4$'D'8,01O6,85L2 MZ&A4!@>F!Y_K9#H[\EUGIQPGI.+@JO^1P&31HL8P !%#A%B'5?D2X*%W*6_- M_!>1O[.CWO!8BZI<%J=^*Z(KHNDYS=?UP*YF'^?Y."YS5*U5U9P=B) 040L5 M@TACJ(G2I;7I,2,I#D/QBPC0^>#NT(RK6GVU15/U$D;5!FOEG,"Y=!)$ MRT@)YI 5Q"%2+ML FQ2>]4NYY5M$N:M+=[] 5]R1^R<$BZ#C!EIMF4?2:,'+ MYV\)H*))_8)_/>]\*R W3929Y]^C+9O/BE(UVZ"9K9NN^B(Z/C$HJZ2 ED,L MJ,9Q]1QN(V@DM$JE-$V$OY*#OG6HGV7EHE7#+EZ>^1)%PX1#7A*+J8+6:J4L M5W1=W\W$/PI6:U.<"8]=RD9UJ;K3ZYN>\+VH56&K$!2*RJA-02*UE24^5J"4 MN@V]S%XXB^P<+!QV/DZ<_4Q9/3Z.YC]N[F\G#[/)_61<=$08K[L_QK/V8SZ= MC"<7/$S>+J7&R7%X4F!".!EO?$V3VHCT\"!H0Q1^WO7GP+D?V]PMHN55.!>^ M+++[U;2HP+RXN=_48+YT+=*V3P)I8.%]PDQ2;R4D7FGIK?8***6CSM<'A>%@ MGYKZI46K/Q'B$E!4:PWGC"E&(=$>;E%P47,>6 6^-L3AH [0*M*=O445'MPC M%9UV8X(OCDC <$0*184%8T+IA@8->-1KAB4M[;/VYQ>FAL!V*AQ'6VR_&!5( MO-D8DI1A*XGS (BB;-V&#J3C4O!J7,!1 M\H%U(%*CB1)1$2)H2POT4 RLTF9+(S^K"<++\<%H)&&E!**7+1T M"2TJ[N]H(7)@:<>MR$("?EW)PL$K4?_X'!=R1*6H,;MH"($X%TD-0-EH'_*+BUJQ[J.U(VO,#MYK!:2%&CNIN>. ^/+ZCILN*>.A MA]=5JY)05\H:H]U=X%0$K:C\,;LK?WOU^#3/OV]B78Y>>K7F!\D= -I[ZY#5 MS "L?(DK0@ /3$%N51K>A"RUCW?39*S1[*YH6I:-%MFW?'I72V[J30Q &(D- MDQQPHY#V$MM2$R1&))4WZ^$M> Z!.0O0W:G<$;%9-O_Q$HP:"OC!68$2PXQU M7 &GL'*1/&:W=%+L8,H)U,-R*><\@=I#^>*:U(<:U1B/3PY62&.]*]U6/%S5F!^V$L J(J@7DI.B-?N6;F9< MDE/A/>E1#02AKHPU!KL?3YG7HWD1??X]&]J[)892246D4PH@:05 %A5-;HV+ MW,>^5BV86EJMR6?CK"B16'#GYM[$[3!9?IHL_CCT^'A\4C#4 <.8UE11A!1A M2NIR\8Z0E,K//=RV;7 Q/Q.V75T%N_85FWIP)G]\RF?9"6UD]LT+G''/' 9> M"D.B40<1V]$JD$NII=4C.6J3Z8>ZQ;0 ;V?UM%XO]:CG;^_XH FCS+)((27: M0L>M(B5M1;>M88A.RWS^N9A6"\AVEVT;[_]9=E<6 #O^GKUW0I"08NFE$EI$ M78M(8B0LJ4-.=EI^^?QRD\CA-ZFT+4#:63+/W7^NML5*?3Z_SO[]XAJ?Y[/X MVW%6IQ':2=\)WF@@,>%<:&F19AA(M8-6T902.3WR\YWQ1CLGW%V)7N&4NKE7 M=_G3LJHM8]7P0 A6B@DCHFF&&)54>+G;5-H-+$;K3%S/6P>ZL]-K1W^\^F=W MH_G=XLO3750"XG@"Y%&9JC4_,&DL<-0 !J7G'L0]2TO:^> :-Z>Q_^=SZ@P M]T&X&#CY!Y=A9T+5U. >R%*[H2K(< =OD@LGK)QX1 NT;BY M;Z[;-_EA1Z)W1A6_ ]2[/^Q^6TWN1G'% M)YQOKZ>$2)'#5L3_(JX],A;3G2\9(9Q2%;.'RMAYA>#@D9>$^5NI>C]XIT,P MH&ODU<%6'&CZA\YFXV^/H_D?1ZZ,8U.#)1QJ9HCB18 MI%(45(<21Y(V>TS M7@\M(WPYF2H7??2%X]C4X"!'&GBE*:;22\8EV>TBXL3 JCZT)P!')2L)Y^Z> M/O95L-R6N*GQ#G)T=M#0,J$*Y[W7U"D'BXBWTDWAQ?W1IT4']BC/@!GO.*:0MG?C&%=%>QTEC>, 0R9?;"Y-.BV%K$ M^>-H&>&:'7*>UI@5D#0$"55TVB[RM2PRUC]'F("4ZE0]ZO!R!@VA?7#;EXN# M]FRM>8$X[*!$+AIP+,JU8NP9$H[3JG#W3#;:8F0]X6B$;^]2M=G!.T-QS+*2PT#!ND202[P(@(Y #\Z>UP.N?I:R-9:E1/!D.%4 M"$ C;D);#M0N!A90D*+K]J@CU'D?A5L&^>+"U5I=$\@8%Y *)PW&CENLY"[2 M S Z$(WI+)+0H*[):6AW=@'F]\M_%PW/GQW+1\WQ@W,"!(A!C(U1&DBGB-=\ MAQ]'21TXWY-$->'ZSU=A2Q@W-=,.G<8?*DH!U)L8J+?>%<)X<^\>GZ;YCRQ;N-G#Z"&[NYH564&CV0]5 MQ.!,EI-L\8]\/KW[]^3N4%)PDT\%@*6G#" O+4/(8V!?V+@6IO0R[-%)TS;' M\TY1[^H.*TG9]( IMM;6D*C2O@]/"L(X"JC'QEF-N-,2XQV,8)VS8_F_Z%!PZOMO^9(*6FCBK $!'(*."MVWGGE8$I+N[W$@:<=K!=F".= MQ86M'E?3=0F3#<%OHEPGD=RG:43A8S:?Y'?/%*O9$(6OKPSWNA&7V(@)]FG\M6FLM1[.'250X/N3_CK,+E;:X"'9]ABL: M^QVXY#M=0R"22.2M=<0(XHW&!.QVL@QJ?MZSVO MN:/$.(.T='P#3 MDC "I.0$:PZC_KQ[R)-I?;!/?M Z9POC,TM0&^!VEV?PNKQ//'TW:FYV%S?" M9+RWV7']R0'[J/."2"!!%#B/C2*[ YA;E&)YG.Q/?L!J$8<4 M_^WY:/KWT725C1:C:/(4M'_*OA?G_J?L:34??XLVO'J89^LXA /:6_,/!D> M<9)S%D]CJ:4"B.S"9HUA25YF,/CKKE/P+_XLWUKQ8L*-T,@"0R&"E!D%G^-S MC4\K)3?\MXWS(=WP/+L=3;-%/%Q7\UF1R#7_?LC*?#LP%(0K94A4 0U$0@I M=Q>ZQCBEO0,<_E-$*Z VY'H4O_O)\D.^6&P/NL_Y>BD'>']H>*!:2 (9$,9A M ;A4".SB![1E21+P:[P'M 1M9P$YWR9/3U'_^MMH=C?=-+#Y/!_-%NM7M (9 MDR\J'S;K?2!H3 PAT JBO%#0>ZMWMRO@,*D0X*_CL#\+V$TOFNU:XE+*Y:S_ M]6=E*[^O.H-JSP^0$NFHUQ(+BZ-F!IE_KNV!;9+L#-_1?DZL+U:58KOJT4,& M*\ZFJFG!84D,A@0SXA#E2A&[JSOG5-J)-'S']QD@[DJ8U%VT 9>31=P$A]]A M#@\.(M[)C6I>"^Y'9V]\UV"91=X MZGOQ5/]E=C=9+.>3KZNW--9[_JOYL0"@E-PK+1!50GL@Z7/!4,%,DB"_EX#N M5M\$SP/\Q5Z>?YM'V_N4%^?UA."]AQY#R83W&##F"'W.]G4D_&SFW2*N]F[- MQO6Z?WR.0.OXK_U1;=X=G!:8X"@*&5+Q\HS_K/2V,&DWU%I%!I*QT2;;WUIV M;:';<7K])@>@Q.)'?8&J-3\PR8J':6HYBD<8H59)MZ5=(H$T PH3YI V)2+8)_6K[-';S!D%[\R(=^8- M'2V*XIS%+\4S\_?1])F"6O=FG?D!"XZ5D@ JX]<-^*21)>V,DQ0W5X\>;,YY M@9X!YJY$[&KV/=MTLJHO5@?G! -9M".88D8!0F7\D^5;&I61=B"55L\H2FU! M>_&HI?K25/<3P0)DG&=<$4:5D%1RZK<(:"=1RCM.CYYQSBA<9T*ZNWC?[]EL MM>LXH76U#W'5@C'K] M9'Z",5GK T$H#S3E&C 8_Z,Q11B6U$.1] S=HV>9/FRQKF4&BQ]RG XJ^W6"K1="<\N_#.;KXO#U9>A(S,#M9 0Z2V$% ',C*>D MW"R.>YM4$_G7\(>WBW!7$O5ED=WD@X4M$?+R;D[*G?@TW]9DA[T?T]>WX6W:WFF9%R=&2 MIL4FDV8[\G8YFMV-YG>++T]W\> M1!UP6U05F@XG9ML0P9WE\?R(AXA%7$.B M==$>/)K4RIA:N^4\E%;$TMW,S;>BC>35;$\MV74O@F91D<>_&YB$"D$>[TKA MA9 &.T\V>$E+L!]81Y V!*=^B&3K\'?G^WEY@E10>*2#UDG?"8HH@C@EW)AU M@!_@2I582"&3;/K^B6)'[(>T;'A0$ A&%422) M(@DB3;RDS"J95,N@?[)V)J[GK0/=T+@[HN,<%)':FA0HIT8*I1RV MF-"BF1[V.RJ13VGKT,/#L4.I>)-@VA(+NDLOG4Z+(O[9K*@L&]>L[AXGLZ)@ MPJ:'RM%B0O4^$$2\.83R'#)N*%0 6$EW&@O&*14N!G08I@O@6=C1BW 9]^=X MNKHK@J+'_V\UF1<-)B*R1;NI8M,U#:.I_FI !#C+L-4& 0N9(5CM-BVV2;7V M>QA=7SR?+'U2R>,-EBN8[D?OF5(GEN^>/W;/DMOWO.VJPRGCI< M1>":&:8=(\AJ[XUFA,G=5:9=BI^HAV%&E]L._>5IWU[W?FY!^,*W-[2W/$I- M427'".$< =_R,/0*1VW%>1@O#R:59SN\-$_+ M-^K?8=6&X+3ZEG<:_,-^R[.6."H9AMS&8]4@SC0LL7 FK3%&_T2Q([E)>LL[ MC2/OZ2U/0FBX%!01#Q@6B#HA2\J*2EC#DK4S<;W.6]YI0%_^G>:H.!V;&H32 M0"DG'<*(17HQ4GQ+L>?"#2PZ)HWIM>_21MAV=EU6O%@2((^*5*WY 5MJC;-& M1TJYQUXRYTK: ="U*HN^'[EJ3Q1^O@'/ '8?!(T!F"1HN_D!@-02[L]?>R+DU!AO'F\D?G_)9#Q0<*#HMZCE01IM:$5 M$XF&5CSX,I9DFQSH+"'T]5)M_CB:5.7=[!T?J*+: !]IDT1+J072HJ2-&3$P M/T5+?/XY_;,%9+L+ GC=1/OH[;=_0J \7NVL.-:1@_& +_ZSI8X;S9*2LOHG M-XD'Q)O[GRC=TG$UVZ1./GN&JJ)$&W\T0$2D8C!:[I0!#1WSAI4H29CTU-[# M([5#J?HYBK0K%G4ER&]:*+WHSW6=+:_SV7@U+WA2(;>UOQ&X1(HJYZ1PPD83 MGTC@2PPL3:JT-B![)%U,S\61OL5S7#T^C8I-6&ZRH05Q* :8$CR:%(8BZ*-1 M(;:>$ ZD-+5""L]E"ZP+;5\51;9'4_7T--T6!=B<>S^?DR];5%9'<:1].!#$ M#=9(8L%=Q(M :DF)&$1IQ47Z=\*T(3K[*ZAW@_^PXSCB:4JH]MXI() Q46-& MIL2BJ-Q3\MIKL6='G.G,K3R)*XY0CS.=+?^=9;-*DHID^/O(UMJ2W,;G P>X M:!@ #>$,284=5J55@!T3*94W>JA-="[3%^!1=X$0#36S.@_;Z1\/$ FO,+!< M&RBI,5'[4[LS@;.4DAX]?-F^D)[<.9\ZENXRE[CP)O]CLOQF5HME_IC-GVL^ M+!99_/_BD>FX.)_RM6"X\A(PJR@1@D<[6,*2)5BP;GU9W[/YU[RO$MQ E/9+ M\1G9TUVPT?(YA;TR<.C%N("UY\ CJYW#"#-@K=Y& W.JHB;5I1(P<%%+ ;XS M-^KZM;S*3[H>$"2/YJGD$AJ**+#".%]JW=1!F&++#^F&31>:1GAW)2TOHBHJ M1.;%J, 8)_&TA)9BJHB+OP*TI4,Q1%+BM'K8O>N" M8A,C'$_'S67[,9^OF;M =0T4_O6AV M $0LMLX5W85=W$Z.*#2P5*,V1.OGP^62_#A^I>ZM3%]V.;O[LLCN5],/1=OI MF_N-1K@^,8YU(:O_@4!]D38#-1/<'-D4$L! A0#% @ 6(543N_8>;+_.@ B8," !0 ( ! MU8<% &IN:BTR,#$X,3(S,%]C86PN>&UL4$L! A0#% @ 6(543@++H-%) M[ OL$+ !0 ( !!L,% &IN:BTR,#$X,3(S,%]D968N>&UL M4$L! A0#% @ 68543G#6Y,0JS $ \M@8 !0 ( !@:\& M &IN:BTR,#$X,3(S,%]L86(N>&UL4$L! A0#% @ 68543OD&*AR(/ $ MPR@0 !0 ( !W7L( &IN:BTR,#$X,3(S,%]P&UL4$L% 3!@ & 8 A $ )>X"0 $! end

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

    •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end XML 141 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 142 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 144 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 1152 604 1 true 251 0 false 14 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.jnj.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.jnj.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Earnings Sheet http://www.jnj.com/role/ConsolidatedStatementsOfEarnings Consolidated Statements of Earnings Statements 4 false false R5.htm 1003000 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.jnj.com/role/ConsolidatedStatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 5 false false R6.htm 1003501 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical) Sheet http://www.jnj.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical Consolidated Statements of Comprehensive Income (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Consolidated Statements of Equity Sheet http://www.jnj.com/role/ConsolidatedStatementsOfEquity Consolidated Statements of Equity Statements 7 false false R8.htm 1004001 - Statement - Consolidated Statements of Equity (Parenthetical) Sheet http://www.jnj.com/role/ConsolidatedStatementsOfEquityParenthetical Consolidated Statements of Equity (Parenthetical) Statements 8 false false R9.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.jnj.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 9 false false R10.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 2102100 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities Sheet http://www.jnj.com/role/CashCashEquivalentsAndCurrentMarketableSecurities Cash, Cash Equivalents and Current Marketable Securities Notes 11 false false R12.htm 2103100 - Disclosure - Inventories Sheet http://www.jnj.com/role/Inventories Inventories Notes 12 false false R13.htm 2104100 - Disclosure - Property, Plant and Equipment Sheet http://www.jnj.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 13 false false R14.htm 2105100 - Disclosure - Intangible Assets and Goodwill Sheet http://www.jnj.com/role/IntangibleAssetsAndGoodwill Intangible Assets and Goodwill Notes 14 false false R15.htm 2106100 - Disclosure - Fair Value Measurements Sheet http://www.jnj.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 2107100 - Disclosure - Borrowings Sheet http://www.jnj.com/role/Borrowings Borrowings Notes 16 false false R17.htm 2108100 - Disclosure - Income Taxes Sheet http://www.jnj.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 2109100 - Disclosure - Employee Related Obligations Sheet http://www.jnj.com/role/EmployeeRelatedObligations Employee Related Obligations Notes 18 false false R19.htm 2110100 - Disclosure - Pensions and Other Benefit Plans Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlans Pensions and Other Benefit Plans Notes 19 false false R20.htm 2111100 - Disclosure - Savings Plan Sheet http://www.jnj.com/role/SavingsPlan Savings Plan Notes 20 false false R21.htm 2112100 - Disclosure - Capital and Treasury Stock Sheet http://www.jnj.com/role/CapitalAndTreasuryStock Capital and Treasury Stock Notes 21 false false R22.htm 2113100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Notes 22 false false R23.htm 2114100 - Disclosure - International Currency Translation Sheet http://www.jnj.com/role/InternationalCurrencyTranslation International Currency Translation Notes 23 false false R24.htm 2115100 - Disclosure - Earnings Per Share Sheet http://www.jnj.com/role/EarningsPerShare Earnings Per Share Notes 24 false false R25.htm 2116100 - Disclosure - Rental Expense and Lease Commitments Sheet http://www.jnj.com/role/RentalExpenseAndLeaseCommitments Rental Expense and Lease Commitments Notes 25 false false R26.htm 2117100 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements Sheet http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreements Common Stock, Stock Option Plans and Stock Compensation Agreements Notes 26 false false R27.htm 2118100 - Disclosure - Segments of Business and Geographic Areas Sheet http://www.jnj.com/role/SegmentsOfBusinessAndGeographicAreas Segments of Business and Geographic Areas Notes 27 false false R28.htm 2119100 - Disclosure - Selected Quarterly Financial Data (unaudited) Sheet http://www.jnj.com/role/SelectedQuarterlyFinancialDataUnaudited Selected Quarterly Financial Data (unaudited) Notes 28 false false R29.htm 2120100 - Disclosure - Business Combinations and Divestitures Sheet http://www.jnj.com/role/BusinessCombinationsAndDivestitures Business Combinations and Divestitures Notes 29 false false R30.htm 2121100 - Disclosure - Legal Proceedings Sheet http://www.jnj.com/role/LegalProceedings Legal Proceedings Notes 30 false false R31.htm 2122100 - Disclosure - Restructuring Sheet http://www.jnj.com/role/Restructuring Restructuring Notes 31 false false R32.htm 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.jnj.com/role/SummaryOfSignificantAccountingPolicies 32 false false R33.htm 2301302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.jnj.com/role/SummaryOfSignificantAccountingPolicies 33 false false R34.htm 2302301 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities (Tables) Sheet http://www.jnj.com/role/CashCashEquivalentsAndCurrentMarketableSecuritiesTables Cash, Cash Equivalents and Current Marketable Securities (Tables) Tables http://www.jnj.com/role/CashCashEquivalentsAndCurrentMarketableSecurities 34 false false R35.htm 2303301 - Disclosure - Inventories (Tables) Sheet http://www.jnj.com/role/InventoriesTables Inventories (Tables) Tables http://www.jnj.com/role/Inventories 35 false false R36.htm 2304301 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.jnj.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.jnj.com/role/PropertyPlantAndEquipment 36 false false R37.htm 2305301 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://www.jnj.com/role/IntangibleAssetsAndGoodwillTables Intangible Assets and Goodwill (Tables) Tables http://www.jnj.com/role/IntangibleAssetsAndGoodwill 37 false false R38.htm 2306301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.jnj.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.jnj.com/role/FairValueMeasurements 38 false false R39.htm 2307301 - Disclosure - Borrowings (Tables) Sheet http://www.jnj.com/role/BorrowingsTables Borrowings (Tables) Tables http://www.jnj.com/role/Borrowings 39 false false R40.htm 2308301 - Disclosure - Income Taxes (Tables) Sheet http://www.jnj.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.jnj.com/role/IncomeTaxes 40 false false R41.htm 2309301 - Disclosure - Employee Related Obligations (Tables) Sheet http://www.jnj.com/role/EmployeeRelatedObligationsTables Employee Related Obligations (Tables) Tables http://www.jnj.com/role/EmployeeRelatedObligations 41 false false R42.htm 2310301 - Disclosure - Pensions and Other Benefit Plans (Tables) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansTables Pensions and Other Benefit Plans (Tables) Tables http://www.jnj.com/role/PensionsAndOtherBenefitPlans 42 false false R43.htm 2312301 - Disclosure - Capital and Treasury Stock (Tables) Sheet http://www.jnj.com/role/CapitalAndTreasuryStockTables Capital and Treasury Stock (Tables) Tables http://www.jnj.com/role/CapitalAndTreasuryStock 43 false false R44.htm 2313301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeLoss 44 false false R45.htm 2315301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.jnj.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.jnj.com/role/EarningsPerShare 45 false false R46.htm 2316301 - Disclosure - Rental Expense and Lease Commitments (Tables) Sheet http://www.jnj.com/role/RentalExpenseAndLeaseCommitmentsTables Rental Expense and Lease Commitments (Tables) Tables http://www.jnj.com/role/RentalExpenseAndLeaseCommitments 46 false false R47.htm 2317301 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements (Tables) Sheet http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreementsTables Common Stock, Stock Option Plans and Stock Compensation Agreements (Tables) Tables http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreements 47 false false R48.htm 2318301 - Disclosure - Segments of Business and Geographic Areas (Tables) Sheet http://www.jnj.com/role/SegmentsOfBusinessAndGeographicAreasTables Segments of Business and Geographic Areas (Tables) Tables http://www.jnj.com/role/SegmentsOfBusinessAndGeographicAreas 48 false false R49.htm 2319301 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables) Sheet http://www.jnj.com/role/SelectedQuarterlyFinancialDataUnauditedTables Selected Quarterly Financial Data (unaudited) (Tables) Tables http://www.jnj.com/role/SelectedQuarterlyFinancialDataUnaudited 49 false false R50.htm 2320301 - Disclosure - Business Combinations and Divestitures (Tables) Sheet http://www.jnj.com/role/BusinessCombinationsAndDivestituresTables Business Combinations and Divestitures (Tables) Tables http://www.jnj.com/role/BusinessCombinationsAndDivestitures 50 false false R51.htm 2322301 - Disclosure - Restructuring (Tables) Sheet http://www.jnj.com/role/RestructuringTables Restructuring (Tables) Tables http://www.jnj.com/role/Restructuring 51 false false R52.htm 2401403 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 52 false false R53.htm 2401404 - Disclosure - Summary of Significant Accounting Policies - Schedule of Impact of Adoption (Details) Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfImpactOfAdoptionDetails Summary of Significant Accounting Policies - Schedule of Impact of Adoption (Details) Details 53 false false R54.htm 2401405 - Disclosure - Summary of Significant Accounting Policies - Schedule of Adjustments for Accounting Standards Update 2017-07 (Details) Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAdjustmentsForAccountingStandardsUpdate201707Details Summary of Significant Accounting Policies - Schedule of Adjustments for Accounting Standards Update 2017-07 (Details) Details 54 false false R55.htm 2401406 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cumulative Effect Adjustments (Details) Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCumulativeEffectAdjustmentsDetails Summary of Significant Accounting Policies - Schedule of Cumulative Effect Adjustments (Details) Details 55 false false R56.htm 2401407 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) Sheet http://www.jnj.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfAssetsDetails Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) Details 56 false false R57.htm 2402402 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities - Cash and Cash Equivalent Composition (Details) Sheet http://www.jnj.com/role/CashCashEquivalentsAndCurrentMarketableSecuritiesCashAndCashEquivalentCompositionDetails Cash, Cash Equivalents and Current Marketable Securities - Cash and Cash Equivalent Composition (Details) Details 57 false false R58.htm 2402403 - Disclosure - Cash, Cash Equivalents and Current Marketable Securities - Contractual Maturities of Available for Sale Securities (Details) Sheet http://www.jnj.com/role/CashCashEquivalentsAndCurrentMarketableSecuritiesContractualMaturitiesOfAvailableForSaleSecuritiesDetails Cash, Cash Equivalents and Current Marketable Securities - Contractual Maturities of Available for Sale Securities (Details) Details 58 false false R59.htm 2403402 - Disclosure - Inventories (Details) Sheet http://www.jnj.com/role/InventoriesDetails Inventories (Details) Details http://www.jnj.com/role/InventoriesTables 59 false false R60.htm 2404402 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment at Cost and Accumulated Depreciation (Details) Sheet http://www.jnj.com/role/PropertyPlantAndEquipmentPropertyPlantAndEquipmentAtCostAndAccumulatedDepreciationDetails Property, Plant and Equipment - Property, Plant and Equipment at Cost and Accumulated Depreciation (Details) Details 60 false false R61.htm 2404403 - Disclosure - Property, Plant and Equipment - Narrative (Details) Sheet http://www.jnj.com/role/PropertyPlantAndEquipmentNarrativeDetails Property, Plant and Equipment - Narrative (Details) Details 61 false false R62.htm 2405402 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets and Goodwill (Details) Sheet http://www.jnj.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsAndGoodwillDetails Intangible Assets and Goodwill - Schedule of Intangible Assets and Goodwill (Details) Details 62 false false R63.htm 2405403 - Disclosure - Intangible Assets and Goodwill - Goodwill (Details) Sheet http://www.jnj.com/role/IntangibleAssetsAndGoodwillGoodwillDetails Intangible Assets and Goodwill - Goodwill (Details) Details 63 false false R64.htm 2405404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details) Sheet http://www.jnj.com/role/IntangibleAssetsAndGoodwillNarrativeDetails Intangible Assets and Goodwill - Narrative (Details) Details 64 false false R65.htm 2406402 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 65 false false R66.htm 2406403 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details) Sheet http://www.jnj.com/role/FairValueMeasurementsSummaryOfDerivativeActivityDetails Fair Value Measurements - Summary of Derivative Activity (Details) Details 66 false false R67.htm 2406404 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheets (Details) Sheet http://www.jnj.com/role/FairValueMeasurementsScheduleOfDerivativesRecordedInConsolidatedBalanceSheetsDetails Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheets (Details) Details 67 false false R68.htm 2406405 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details) Sheet http://www.jnj.com/role/FairValueMeasurementsScheduleOfEffectOfDerivativesNotDesignatedAsHedgingInstrumentsDetails Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details) Details 68 false false R69.htm 2406406 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details) Sheet http://www.jnj.com/role/FairValueMeasurementsScheduleOfEffectOfNetInvestmentHedgesDetails Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details) Details 69 false false R70.htm 2406407 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details) Sheet http://www.jnj.com/role/FairValueMeasurementsSummaryOfActivityRelatedToEquityInvestmentsDetails Fair Value Measurements - Summary of Activity Related to Equity Investments (Details) Details 70 false false R71.htm 2406408 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details) Sheet http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesAtFairValueDetails Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details) Details 71 false false R72.htm 2407402 - Disclosure - Borrowings - Schedule of Long-term Debt Instruments (Details) Sheet http://www.jnj.com/role/BorrowingsScheduleOfLongTermDebtInstrumentsDetails Borrowings - Schedule of Long-term Debt Instruments (Details) Details 72 false false R73.htm 2407403 - Disclosure - Borrowings - Narrative (Details) Sheet http://www.jnj.com/role/BorrowingsNarrativeDetails Borrowings - Narrative (Details) Details 73 false false R74.htm 2407404 - Disclosure - Borrowings - Aggregate Maturities of Long Term Obligations (Details) Sheet http://www.jnj.com/role/BorrowingsAggregateMaturitiesOfLongTermObligationsDetails Borrowings - Aggregate Maturities of Long Term Obligations (Details) Details 74 false false R75.htm 2408402 - Disclosure - Income Taxes - Provision for Income Taxes (Details) Sheet http://www.jnj.com/role/IncomeTaxesProvisionForIncomeTaxesDetails Income Taxes - Provision for Income Taxes (Details) Details 75 false false R76.htm 2408403 - Disclosure - Income Taxes - Comparison of Income Taxes at Statutory Rate and Company's Effective Tax Rate (Details) Sheet http://www.jnj.com/role/IncomeTaxesComparisonOfIncomeTaxesAtStatutoryRateAndCompanysEffectiveTaxRateDetails Income Taxes - Comparison of Income Taxes at Statutory Rate and Company's Effective Tax Rate (Details) Details 76 false false R77.htm 2408404 - Disclosure - Income Taxes - Temporary Differences and Carryforwards (Details) Sheet http://www.jnj.com/role/IncomeTaxesTemporaryDifferencesAndCarryforwardsDetails Income Taxes - Temporary Differences and Carryforwards (Details) Details 77 false false R78.htm 2408405 - Disclosure - Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details) Sheet http://www.jnj.com/role/IncomeTaxesSummaryOfActivityRelatedToUnrecognizedTaxBenefitsDetails Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details) Details 78 false false R79.htm 2408406 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.jnj.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 79 false false R80.htm 2409402 - Disclosure - Employee Related Obligations - Employee Related Obligations (Details) Sheet http://www.jnj.com/role/EmployeeRelatedObligationsEmployeeRelatedObligationsDetails Employee Related Obligations - Employee Related Obligations (Details) Details 80 false false R81.htm 2409403 - Disclosure - Employee Related Obligations - Narrative (Details) Sheet http://www.jnj.com/role/EmployeeRelatedObligationsNarrativeDetails Employee Related Obligations - Narrative (Details) Details 81 false false R82.htm 2410402 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansComponentsOfNetPeriodicBenefitCostDetails Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details) Details 82 false false R83.htm 2410403 - Disclosure - Pensions and Other Benefit Plans - Amounts Expected to be Recognized in Net Periodic Benefit Cost (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansAmountsExpectedToBeRecognizedInNetPeriodicBenefitCostDetails Pensions and Other Benefit Plans - Amounts Expected to be Recognized in Net Periodic Benefit Cost (Details) Details 83 false false R84.htm 2410404 - Disclosure - Pensions and Other Benefit Plans - Rates Used to Develop Actuarial Present Value of Projected Benefit Obligation (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansRatesUsedToDevelopActuarialPresentValueOfProjectedBenefitObligationDetails Pensions and Other Benefit Plans - Rates Used to Develop Actuarial Present Value of Projected Benefit Obligation (Details) Details 84 false false R85.htm 2410405 - Disclosure - Pensions and Other Benefit Plans - Assumed Health Care Cost Trend Rates (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansAssumedHealthCareCostTrendRatesDetails Pensions and Other Benefit Plans - Assumed Health Care Cost Trend Rates (Details) Details 85 false false R86.htm 2410406 - Disclosure - Pensions and Other Benefit Plans - Effect of One Percentage Point Change in Assumed Health Care Cost Trend Rates (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesDetails Pensions and Other Benefit Plans - Effect of One Percentage Point Change in Assumed Health Care Cost Trend Rates (Details) Details 86 false false R87.htm 2410407 - Disclosure - Pensions and Other Benefit Plans - Schedule of Net Funded Status (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansScheduleOfNetFundedStatusDetails Pensions and Other Benefit Plans - Schedule of Net Funded Status (Details) Details 87 false false R88.htm 2410408 - Disclosure - Pensions and Other Benefit Plans - Narrative (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansNarrativeDetails Pensions and Other Benefit Plans - Narrative (Details) Details 88 false false R89.htm 2410409 - Disclosure - Pensions and Other Benefit Plans - Information Related to the Benefit Obligation and the Fair Value of Plan Assets (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansInformationRelatedToBenefitObligationAndFairValueOfPlanAssetsDetails Pensions and Other Benefit Plans - Information Related to the Benefit Obligation and the Fair Value of Plan Assets (Details) Details 89 false false R90.htm 2410410 - Disclosure - Pensions and Other Benefit Plans - Projected Future Benefit Payments from Company's Retirement and Other Benefit Plans (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansProjectedFutureBenefitPaymentsFromCompanysRetirementAndOtherBenefitPlansDetails Pensions and Other Benefit Plans - Projected Future Benefit Payments from Company's Retirement and Other Benefit Plans (Details) Details 90 false false R91.htm 2410411 - Disclosure - Pensions and Other Benefit Plans - Projected Future Minimum Contributions to the Company's U.S. and International Unfunded Retirement Plans (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansProjectedFutureMinimumContributionsToCompanysUSAndInternationalUnfundedRetirementPlansDetails Pensions and Other Benefit Plans - Projected Future Minimum Contributions to the Company's U.S. and International Unfunded Retirement Plans (Details) Details 91 false false R92.htm 2410412 - Disclosure - Pensions and Other Benefit Plans - Company' Retirement Plan Asset Allocation and Target Allocations (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansCompanyRetirementPlanAssetAllocationAndTargetAllocationsDetails Pensions and Other Benefit Plans - Company' Retirement Plan Asset Allocation and Target Allocations (Details) Details 92 false false R93.htm 2410413 - Disclosure - Pensions and Other Benefit Plans - Schedule of Defined Benefit Plans Disclosures (Details) Sheet http://www.jnj.com/role/PensionsAndOtherBenefitPlansScheduleOfDefinedBenefitPlansDisclosuresDetails Pensions and Other Benefit Plans - Schedule of Defined Benefit Plans Disclosures (Details) Details 93 false false R94.htm 2411401 - Disclosure - Savings Plan - Narrative (Details) Sheet http://www.jnj.com/role/SavingsPlanNarrativeDetails Savings Plan - Narrative (Details) Details 94 false false R95.htm 2412402 - Disclosure - Capital and Treasury Stock - Changes in Treasury Stock (Details) Sheet http://www.jnj.com/role/CapitalAndTreasuryStockChangesInTreasuryStockDetails Capital and Treasury Stock - Changes in Treasury Stock (Details) Details 95 false false R96.htm 2412403 - Disclosure - Capital and Treasury Stock - Narrative (Details) Sheet http://www.jnj.com/role/CapitalAndTreasuryStockNarrativeDetails Capital and Treasury Stock - Narrative (Details) Details 96 false false R97.htm 2413402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) (Details) Details http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeLossTables 97 false false R98.htm 2414401 - Disclosure - International Currency Translation - Narrative (Details) Sheet http://www.jnj.com/role/InternationalCurrencyTranslationNarrativeDetails International Currency Translation - Narrative (Details) Details 98 false false R99.htm 2415402 - Disclosure - Earnings Per Share - Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share (Details) Sheet http://www.jnj.com/role/EarningsPerShareReconciliationOfBasicNetEarningsPerShareToDilutedNetEarningsPerShareDetails Earnings Per Share - Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share (Details) Details 99 false false R100.htm 2415403 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.jnj.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 100 false false R101.htm 2416402 - Disclosure - Rental Expense and Lease Commitments - Narrative (Details) Sheet http://www.jnj.com/role/RentalExpenseAndLeaseCommitmentsNarrativeDetails Rental Expense and Lease Commitments - Narrative (Details) Details 101 false false R102.htm 2416403 - Disclosure - Rental Expense and Lease Commitments - Schedule of Minimum Rental Payments Under Operating Leases (Details) Sheet http://www.jnj.com/role/RentalExpenseAndLeaseCommitmentsScheduleOfMinimumRentalPaymentsUnderOperatingLeasesDetails Rental Expense and Lease Commitments - Schedule of Minimum Rental Payments Under Operating Leases (Details) Details 102 false false R103.htm 2417402 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Narrative (Details) Sheet http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreementsNarrativeDetails Common Stock, Stock Option Plans and Stock Compensation Agreements - Narrative (Details) Details http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreementsTables 103 false false R104.htm 2417403 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Schedule Valuation Assumptions (Details) Sheet http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreementsScheduleValuationAssumptionsDetails Common Stock, Stock Option Plans and Stock Compensation Agreements - Schedule Valuation Assumptions (Details) Details 104 false false R105.htm 2417404 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Stock Option Activity (Details) Sheet http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreementsSummaryOfStockOptionActivityDetails Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Stock Option Activity (Details) Details 105 false false R106.htm 2417405 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Options Outstanding (Details) Sheet http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreementsSummaryOfOptionsOutstandingDetails Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Options Outstanding (Details) Details 106 false false R107.htm 2417406 - Disclosure - Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Restricted Share Units (Details) Sheet http://www.jnj.com/role/CommonStockStockOptionPlansAndStockCompensationAgreementsSummaryOfRestrictedShareUnitsDetails Common Stock, Stock Option Plans and Stock Compensation Agreements - Summary of Restricted Share Units (Details) Details 107 false false R108.htm 2418402 - Disclosure - Segments of Business and Geographic Areas - Sales by Segment of Business (Details) Sheet http://www.jnj.com/role/SegmentsOfBusinessAndGeographicAreasSalesBySegmentOfBusinessDetails Segments of Business and Geographic Areas - Sales by Segment of Business (Details) Details 108 false false R109.htm 2418403 - Disclosure - Segments of Business and Geographic Areas - Schedule of Segment Reporting Information (Details) Sheet http://www.jnj.com/role/SegmentsOfBusinessAndGeographicAreasScheduleOfSegmentReportingInformationDetails Segments of Business and Geographic Areas - Schedule of Segment Reporting Information (Details) Details 109 false false R110.htm 2418404 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) Sheet http://www.jnj.com/role/SegmentsOfBusinessAndGeographicAreasScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasDetails Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) Details 110 false false R111.htm 2419402 - Disclosure - Selected Quarterly Financial Data (unaudited) (Details) Sheet http://www.jnj.com/role/SelectedQuarterlyFinancialDataUnauditedDetails Selected Quarterly Financial Data (unaudited) (Details) Details http://www.jnj.com/role/SelectedQuarterlyFinancialDataUnauditedTables 111 false false R112.htm 2420402 - Disclosure - Business Combinations and Divestitures - Narrative (Details) Sheet http://www.jnj.com/role/BusinessCombinationsAndDivestituresNarrativeDetails Business Combinations and Divestitures - Narrative (Details) Details 112 false false R113.htm 2420403 - Disclosure - Business Combinations and Divestitures - Schedule of Preliminary Amounts Recognized for Assets Acquired and Liabilities Assumed (Details) Sheet http://www.jnj.com/role/BusinessCombinationsAndDivestituresScheduleOfPreliminaryAmountsRecognizedForAssetsAcquiredAndLiabilitiesAssumedDetails Business Combinations and Divestitures - Schedule of Preliminary Amounts Recognized for Assets Acquired and Liabilities Assumed (Details) Details 113 false false R114.htm 2420404 - Disclosure - Business Combinations and Divestitures - Purchase Price Allocation of Identifiable Intangible Assets (Details) Sheet http://www.jnj.com/role/BusinessCombinationsAndDivestituresPurchasePriceAllocationOfIdentifiableIntangibleAssetsDetails Business Combinations and Divestitures - Purchase Price Allocation of Identifiable Intangible Assets (Details) Details 114 false false R115.htm 2420405 - Disclosure - Business Combinations and Divestitures - Schedule of Pro Forma Results (Details) Sheet http://www.jnj.com/role/BusinessCombinationsAndDivestituresScheduleOfProFormaResultsDetails Business Combinations and Divestitures - Schedule of Pro Forma Results (Details) Details 115 false false R116.htm 2421401 - Disclosure - Legal Proceedings (Details) Sheet http://www.jnj.com/role/LegalProceedingsDetails Legal Proceedings (Details) Details http://www.jnj.com/role/LegalProceedings 116 false false R117.htm 2422402 - Disclosure - Restructuring - Narrative (Details) Sheet http://www.jnj.com/role/RestructuringNarrativeDetails Restructuring - Narrative (Details) Details 117 false false R118.htm 2422403 - Disclosure - Restructuring - Summary of Severance Charges and Associated Spending (Details) Sheet http://www.jnj.com/role/RestructuringSummaryOfSeveranceChargesAndAssociatedSpendingDetails Restructuring - Summary of Severance Charges and Associated Spending (Details) Details 118 false false All Reports Book All Reports jnj-20181230.xml jnj-20181230.xsd jnj-20181230_cal.xml jnj-20181230_def.xml jnj-20181230_lab.xml jnj-20181230_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2014-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2017-01-31 true true ZIP 146 0000200406-19-000009-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000200406-19-000009-xbrl.zip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